Beta	B
blocking	O
agents	O
.	O

When	O
extracorporeal	O
CO2	O
removal	O
approximated	O
CO2	O
production	O
(	O
VCO2	O
),	O
alveolar	O
ventilation	O
almost	O
ceased	O
.	O

The	O
variable	O
HMG	B
dosage	O
regimen	O
was	O
found	O
to	O
offer	O
no	O
advantages	O
when	O
compared	O
with	O
our	O
standard	O
daily	O
dosage	O
regimen	O
.	O

By	O
contrast	O
,	O
secretory	B
HI	I
antibodies	I
were	O
not	O
demonstrated	O
at	O
the	O
onset	O
of	O
illness	O
in	O
any	O
of	O
the	O
patients	O
,	O
but	O
their	O
formation	O
started	O
early	O
and	O
the	O
antibodies	O
reached	O
maximal	O
levels	O
about	O
10	O
days	O
after	O
onset	O
of	O
illness	O
.	O

Characteristics	O
of	O
lipase	B
activity	O
.	O

Studies	O
on	O
immunoglobulin	B
E	I
:	O
the	O
impact	O
of	O
a	O
sojourn	O
with	O
Professor	O
Dan	O
H	O
.	O

Peroxydase	B
reaction	O
stains	O
were	O
negative	O
,	O
chloroacetate	B
esterase	I
were	O
strongly	O
positive	O
.	O

In	O
the	O
matched	O
control	O
group	O
the	O
acquisition	O
-	O
rate	O
of	O
both	O
symptomatic	O
and	O
asymptomatic	O
0acteriuria	O
was	O
over	O
12	O
%,	O
a	O
figure	O
similar	O
to	O
the	O
percentage	O
of	O
women	O
present	O
in	O
the	O
practice	O
population	O
during	O
one	O
year	O
with	O
transient	O
,	O
symptomatic	O
,	O
and	O
persistent	O
A	O
.	O
B	O
.	O

Late	O
complications	O
of	O
catheterisation	O
for	O
intravenous	O
nutrition	O
.	O

Sings	O
which	O
are	O
indicative	O
of	O
metaplastic	O
erythropoiesis	O
are	O
absent	O
.	O

False	O
positive	O
amniotic	B
fluid	I
alpha	I
fetoprotein	I
levels	O
resulting	O
from	O
contamination	O
with	O
fetal	O
blood	O
:	O
results	O
of	O
an	O
experiment	O
.	O

Albumin	O
and	O
cyclic	O
AMP	O
levels	O
in	O
peritoneal	O
fluids	O
in	O
the	O
child	O

Erythromycin	O
and	O
clindamycin	O
resistance	O
in	O
Corynebacterium	O
diphtheriae	O
from	O
skin	O
lesions	O
.	O

Imposed	O
angular	O
displacements	O
of	O
monkey	O
'	O
s	O
wrist	O
produce	O
three	O
major	O
peaks	O
of	O
activity	O
(	O
terms	O
M1	O
,	O
M2	O
,	O
and	O
M3	O
peaks	O
)	O
in	O
the	O
averaged	O
gross	O
EMG	O
activity	O
ot	O
the	O
stretched	O
muscles	O
.	O

VII	O
.	O

These	O
observations	O
have	O
led	O
us	O
to	O
conclude	O
that	O
an	O
elevated	O
VIII	O
-	O
ratio	O
is	O
a	O
very	O
sensitive	O
indicator	O
of	O
intravascular	O
coagulation	O
.	O

No	O
post	O
-	O
operative	O
haemorrhages	O
from	O
the	O
prostheses	O
were	O
observed	O
.	O

The	O
incidence	O
of	O
DNCB	O
reactions	O
was	O
78	O
per	O
cent	O
for	O
Stage	O
I	O
and	O
II	O
cancers	O
(	O
37	O
patinets	O
),	O
73	O
per	O
cent	O
for	O
resectable	O
Stage	O
III	O
cancer	O
(	O
22	O
patients	O
),	O
and	O
66	O
per	O
cent	O
in	O
patients	O
with	O
unresectable	O
or	O
inoperable	O
Stage	O
III	O
cancer	O
.	O

Efforts	O
were	O
made	O
to	O
determine	O
the	O
amount	O
of	O
time	O
required	O
for	O
kidney	O
lesions	O
to	O
develop	O
and	O
,	O
if	O
possible	O
,	O
to	O
delineate	O
the	O
potential	O
site	O
of	O
action	O
of	O
PBB	O
.	O

Effect	O
of	O
succimer	O
on	O
the	O
intensity	O
of	O
tricarboxylic	B
acid	I
dehydrogenase	I
reactions	O
in	O
the	O
brain	O
of	O
rats	O
poisoned	O
with	O
mercuric	O
chloride	O

Technetium	O
-	O
99m	O
stannous	O
pyrophosphate	O
myocardial	O
scintigrams	O
were	O
obtained	O
in	O
138	O
clinically	O
stable	O
patients	O
32	O
.	O
7	O
+/-	O
47	O
.	O
3	O
weeks	O
(	O
range	O
6	O
to	O
260	O
)	O
after	O
acute	O
myocardial	O
infarction	O
.	O

The	O
decline	O
in	O
the	O
activity	O
of	O
cytochrome	B
oxidase	I
,	I
peroxidase	I
and	O
in	O
the	O
lipid	O
content	O
of	O
peripheral	O
neutrophils	O
was	O
followed	O
by	O
a	O
decrease	O
in	O
the	O
phagocytic	O
activity	O
.	O

Treatment	O
of	O
2	O
patients	O
with	O
pseudohypoparathyroidism	O
type	O
I	O
with	O
vitamin	B
-	I
D	I
-	I
3	I
and	I
1	I
alpha	I
-	I
Hydroxycholecalciferol	O
consecutively	O
resulted	O
in	O
a	O
nonuniform	O
response	O
with	O
regard	O
to	O
the	O
normalisation	O
of	O
serum	O
-	O
calcium	O
.	O

Modulation	O
of	O
25	B
-	I
hydroxyvitamin	I
D3	I
-	I
24	I
-	I
hydroxylase	I
by	O
aminophylline	O
:	O
a	O
cytochrome	B
P	I
-	I
450	I
monooxygenase	I
system	O
.	O

A	O
rapid	O
fluorimetric	O
procedure	O
for	O
the	O
determination	O
of	O
the	O
fungicide	O
5	O
-	O
fluorocytosine	O
in	O
serum	O
is	O
described	O
.	O

How	O
do	O
graduates	O
of	O
different	O
types	O
of	O
programs	O
perform	O
on	O
state	O
boards	O
?	O

This	O
mechanism	O
is	O
not	O
due	O
to	O
the	O
observed	O
grain	O
boundary	O
precipitates	O
.	O

Because	O
of	O
serious	O
infections	O
(	O
fever	O
larger	O
than	O
or	O
equal	O
to	O
101	O
degrees	O
F	O
.	O
granulocytes	O
less	O
than	O
1	O
,	O
000	O
/	O
mm	O
,	O
3	O
and	O
hospitalization	O
)	O
and	O
1	O
drug	O
death	O
in	O
the	O
first	O
4	O
patients	O
,	O
oral	O
calcium	O
leucovorin	O
,	O
20	O
to	O
30	O
mg	O
/	O
m2	O
orally	O
,	O
was	O
given	O
2	O
days	O
after	O
methotrexate	O
in	O
subsequent	O
treatment	O
cycles	O
.	O

On	O
the	O
basis	O
of	O
serum	B
alpha1AT	I
quantitation	O
,	O
newborn	O
infants	O
may	O
be	O
separated	O
into	O
two	O
groups	O
,	O
characterized	O
respectively	O
by	O
concentrations	O
above	O
or	O
below	O
150	O
mg	O
%.	O

In	O
patients	O
who	O
were	O
not	O
vented	O
,	O
there	O
was	O
overall	O
significant	O
depression	O
of	O
function	O
(	O
67	O
+/-	O
5	O
%	O
of	O
control	O
;	O
range	O
,	O
91	O
--	O
45	O
%,	O
p	O
less	O
than	O
0	O
.	O
01	O
).	O

The	O
response	O
of	O
serum	O
GH	B
to	O
arginine	O
infusion	O
was	O
normal	O
,	O
while	O
that	O
to	O
insulin	B
-	I
induced	O
hypoglycemia	O
was	O
poor	O
.	O

(	O
Emeritus	O
)	O
John	O
Henri	O
Roosegaarde	O
Bisschop	O

Hepatic	O
oxygen	O
supply	O
and	O
selected	O
blood	O
parameters	O
were	O
recorded	O
in	O
fasted	O
male	O
rates	O
given	O
20	O
--	O
30	O
mg	O
/	O
kg	O
Escherichia	O
coli	O
endotoxin	O
intraperitoneally	O
.	O

Basal	O
FSH	B
and	O
LH	B
levels	O
were	O
significantly	O
lower	O
in	O
addicts	O
;	O
after	O
GnRH	B
stimulation	O
the	O
addicts	O
'	O
FSH	B
and	O
LH	B
values	O
increased	O
but	O
not	O
significantly	O
compared	O
to	O
controls	O
.	O

Adriamycin	O
:	O
comparison	O
of	O
a	O
5	O
-	O
week	O
schedule	O
with	O
a	O
3	O
-	O
week	O
schedule	O
in	O
the	O
treatment	O
of	O
breast	O
cancer	O
.	O

Follow	O
-	O
up	O
controls	O
of	O
luteinizing	B
hormone	I
(	I
LH	I
),	O
follicle	B
stimulating	I
hormone	I
(	O
FSH	B
),	O
prolactin	B
(	O
HPRL	B
),	O
oestradiol	O
(	O
E2	O
),	O
progesterone	O
(	O
P	O
)	O
and	O
testosterone	O
(	O
T	O
)	O
in	O
the	O
catabolic	O
and	O
healing	O
phase	O
of	O
burn	O
disease	O
.	O

Renin	B
studies	O
performed	O
in	O
34	O
hypertensive	O
patients	O
and	O
in	O
a	O
control	O
group	O
of	O
11	O
recipients	O
showed	O
that	O
elevation	O
of	O
plasma	B
renin	I
activity	O
and	O
of	O
plasma	O
aldosterone	O
level	O
is	O
frequent	O
but	O
difficult	O
to	O
interpret	O
,	O
particularly	O
when	O
a	O
renal	O
artery	O
stenosis	O
is	O
observed	O
.	O

202	O
-	O
8	O
.	O

It	O
was	O
concluded	O
,	O
that	O
on	O
a	O
given	O
section	O
,	O
75	O
,	O
7	O
per	O
cent	O
of	O
the	O
trabeculae	O
were	O
in	O
contact	O
with	O
vascular	O
cavities	O
.	O

2	O
.	O

Immunologic	O
mechanisms	O
in	O
chronic	O
brucellosis	O
in	O
humans	O
.	O

These	O
techniques	O
have	O
been	O
used	O
by	O
many	O
people	O
for	O
many	O
years	O
and	O
no	O
claim	O
is	O
being	O
made	O
for	O
any	O
innovation	O
in	O
this	O
regard	O
.	O

This	O
multiple	O
-	O
electrode	O
array	O
for	O
round	O
window	O
cochlear	O
implantation	O
is	O
a	O
robust	O
,	O
reliable	O
system	O
for	O
inserting	O
20	O
mm	O
along	O
the	O
scala	O
tympani	O
with	O
a	O
minimum	O
of	O
trauma	O
and	O
can	O
provide	O
for	O
bipolar	O
stimulation	O
.	O

Ophthalmosonographic	O
evaluation	O
of	O
blood	O
flow	O
velocity	O
in	O
arteriocavernous	O
fistula	O

On	O
the	O
basis	O
of	O
a	O
patient	O
'	O
s	O
report	O
of	O
one	O
inaccurate	O
Clinitemp	O
,	O
we	O
undertook	O
to	O
investigate	O
the	O
accuracy	O
of	O
this	O
thermometer	O
.	O

Serial	O
measurements	O
of	O
total	O
serum	B
IgE	I
appears	O
to	O
be	O
a	O
useful	O
index	O
of	O
disease	O
activity	O
in	O
ABPA	O
.	O

In	O
the	O
8	O
patients	O
the	O
difference	O
betweent	O
he	O
mean	O
diastolic	O
values	O
of	O
delta	O
PU	B
and	O
delta	O
PM	O
was	O
-	O
0	O
.	O
54	O
+/-	O
1	O
.	O
0	O
(	O
SD	O
)	O
mmHg	O
.	O

Effect	O
of	O
intraventricular	O
administration	O
of	O
streptolysin	B
O	I
on	O
the	O
electroencephalogram	O
of	O
rabbits	O
.	O

These	O
data	O
confirm	O
the	O
existence	O
of	O
hyperlipemic	O
abdominal	O
crisis	O
as	O
a	O
distinct	O
entity	O
and	O
testify	O
to	O
the	O
importance	O
of	O
recognizing	O
this	O
syndrome	O
in	O
order	O
to	O
avoid	O
the	O
occurrence	O
of	O
acute	O
pancreatitis	O
and	O
the	O
performance	O
of	O
unnecessary	O
and	O
potentially	O
harmful	O
surgery	O
.	O

The	O
sub	O
-	O
acute	O
inhalation	O
toxicity	O
of	O
furfural	O
was	O
studied	O
in	O
Syrian	O
golden	O
hamsters	O
.	O

These	O
differences	O
are	O
smaller	O
than	O
those	O
described	O
in	O
standard	O
textbooks	O
.	O

The	O
present	O
study	O
examined	O
the	O
dependence	O
of	O
difference	O
tone	O
level	O
[	O
L	O
(	O
f2	O
-	O
f1	O
)]	O
on	O
the	O
following	O
parameters	O
of	O
the	O
two	O
-	O
tone	O
input	O
:	O
f1	O
,	O
f2	O
/	O
f1	O
(	O
f2	O
greater	O
than	O
f1	O
),	O
L1	O
,	O
L2	O
,	O
and	O
L1	O
=	O
L2	O
.	O

5	O
)	O
Before	O
and	O
ten	O
days	O
after	O
DOTC	O
infusion	O
,	O
laboratory	O
tests	O
for	O
liver	O
and	O
renal	O
functions	O
and	O
blood	O
were	O
performed	O
.	O

Structural	O
characteristics	O
of	O
the	O
erythrocyte	O
membrane	O
,	O
peroxidation	O
processes	O
and	O
antioxidant	O
function	O
in	O
children	O
with	O
diffuse	O
glomerulonephritis	O

Urinary	O
excretion	O
of	O
oestrone	O
,	O
oestradiol	O
-	O
17	O
beta	O
and	O
oestriol	O
in	O
pregnancies	O
complicated	O
by	O
steroid	B
sulphatase	I
deficiency	O
.	O

Both	O
reduced	O
spontaneous	O
locomotor	O
activity	O
in	O
mice	O
,	O
protected	O
them	O
from	O
death	O
from	O
amphetamine	O
induced	O
toxicity	O
,	O
prolonged	O
hexobarbitone	O
sleeping	O
time	O
and	O
caused	O
a	O
depletion	O
of	O
catecholamines	O
from	O
various	O
organs	O
of	O
the	O
rat	O
.	O

With	O
certain	O
exceptions	O
the	O
method	O
was	O
considered	O
suitable	O
in	O
the	O
routine	O
intravenous	O
cholangiography	O
.	O

Study	O
on	O
re	O
-	O
establishment	O
of	O
ovulation	O
after	O
termination	O
of	O
sex	O
-	O
steroidal	O
treatment	O
--	O
compared	O
with	O
re	O
-	O
appearance	O
of	O
ovulation	O
after	O
abortion	O
and	O
premature	O
delivery	O
.	O

Changes	O
in	O
ionic	O
content	O
of	O
the	O
mucous	O
suggest	O
that	O
cholinergic	O
mechanisms	O
affect	O
pressure	O
in	O
the	O
excretory	O
duct	O
of	O
the	O
gland	O
.	O

Calves	O
fed	O
MCT	O
-	O
milk	O
had	O
significantly	O
lower	O
blood	O
cholesterol	O
than	O
calves	O
fed	O
T	O
-	O
or	O
SBO	O
-	O
milk	O
.	O

Sensory	O
kindling	O
:	O
implications	O
for	O
development	O
of	O
sensory	O
prostheses	O
.	O

None	O
of	O
the	O
cystometrograms	O
showed	O
uninhibited	O
detrusor	O
contractions	O
.	O

The	O
induction	O
of	O
seizures	O
in	O
"	O
Papio	O
papio	O
"	O
following	O
allylglycine	O
alone	O
or	O
in	O
combination	O
with	O
intermittent	O
photic	O
stimulation	O

It	O
was	O
concluded	O
that	O
both	O
of	O
these	O
surgical	O
procedures	O
were	O
as	O
effective	O
as	O
pinealectomy	O
in	O
reversing	O
the	O
pineal	O
-	O
induced	O
alterations	O
in	O
the	O
reproductive	O
physiology	O
of	O
the	O
blind	O
-	O
anosmic	O
female	O
rat	O
.	O

2	O
cases	O
of	O
toxic	O
lymphomononucleosis	O

To	O
study	O
the	O
sensitivity	O
of	O
some	O
central	O
brain	O
structures	O
to	O
the	O
action	O
of	O
an	O
electromagnetic	O
field	O
of	O
decimeter	O
waves	O
(	O
EMF	O
of	O
DW	O
)	O
a	O
dynamic	O
investigation	O
of	O
single	O
unit	O
activity	O
was	O
undertaken	O
.	O

A	O
decrease	O
of	O
the	O
lysozyme	B
activity	O
coincided	O
with	O
the	O
clinical	O
improvement	O
of	O
the	O
bacterial	O
meningitis	O
.	O

These	O
show	O
that	O
the	O
collagen	B
in	O
this	O
tissue	O
is	O
modified	O
compared	O
with	O
that	O
in	O
tendon	O
.	O

Smoking	O
was	O
regarded	O
as	O
the	O
major	O
contribution	O
to	O
pulmonary	O
dysfunction	O
.	O

Diuretics	O
:	O
basic	O
clinical	O
pharmacology	O
and	O
therapeutic	O
use	O
.	O

Kodak	O
XV	O
-	O
2	O
film	O
is	O
wrapped	O
around	O
a	O
cylindrical	O
water	O
-	O
filled	O
phantom	O
and	O
the	O
dose	O
distribution	O
is	O
recorded	O
.	O

Diagnosis	O
and	O
differential	O
diagnosis	O

Potency	O
of	O
enflurane	O
in	O
dogs	O
:	O
comparison	O
with	O
halothane	O
and	O
isoflurane	O
.	O

Prevention	O
of	O
acute	O
paraquat	O
toxicity	O
in	O
rats	O
by	O
superoxide	B
dismutase	I
.	O

Analysis	O
of	O
liver	O
biopsy	O
specimens	O
from	O
patients	O
with	O
hepatitis	O
showed	O
a	O
large	O
variation	O
in	O
the	O
mean	O
iron	O
content	O
of	O
the	O
liver	O
ferritin	B
molecules	I
.	O

Female	O
mice	O
were	O
significantly	O
more	O
resistant	O
to	O
infection	O
than	O
males	O
.	O

The	O
effect	O
of	O
pure	O
natural	O
porcine	B
secretin	I
on	O
endocrine	O
and	O
exocrine	O
pancreatic	O
secretion	O
was	O
studied	O
in	O
the	O
totally	O
isolated	O
perfused	O
porcine	O
pancreas	O
.	O

Urine	O
antibodies	O
could	O
not	O
be	O
demonstrated	O
in	O
any	O
other	O
cases	O
.	O

At	O
this	O
stage	O
,	O
the	O
eventual	O
high	O
mortality	O
of	O
acute	O
ischemia	O
is	O
established	O
whatever	O
the	O
urgency	O
of	O
the	O
operation	O
or	O
the	O
skill	O
with	O
which	O
it	O
is	O
performed	O
.	O

Two	O
out	O
of	O
five	O
patients	O
undergoing	O
selective	O
spinal	O
arteriography	O
developed	O
transient	O
neurological	O
complications	O
during	O
the	O
injection	O
of	O
Urografin	O
310	O
M	O
.	O

Serum	B
relaxin	I
levels	O
in	O
prostaglandin	O
E2	O
induced	O
abortions	O
.	O

Effect	O
of	O
indoramin	O
in	O
small	O
doses	O
on	O
the	O
central	O
vasomotor	O
loci	O
has	O
been	O
studied	O
in	O
chloralose	O
anesthetized	O
cats	O
by	O
localizing	O
it	O
to	O
the	O
central	O
sites	O
.	O

Platelet	O
serotonin	O
(	O
5	O
-	O
HT	O
)	O
and	O
5	B
-	I
HT	I
releasing	I
factor	I
in	O
plasma	O
of	O
migrainous	O
patients	O
.	O

The	O
December	O
armed	O
revolt	O
in	O
Moscow	O
and	O
the	O
paramedical	O
personnel	O

Biological	O
properties	O
of	O
sumithion	O
.	O

We	O
remain	O
convinced	O
that	O
antilymphocyte	B
globulin	I
(	O
ALG	B
)	O
is	O
a	O
potent	O
immunosuppressive	O
agent	O
in	O
humans	O
.	O

On	O
the	O
basis	O
of	O
a	O
global	O
assessment	O
patients	O
showed	O
a	O
highly	O
significant	O
preference	O
for	O
imipramine	O
compared	O
with	O
placebo	O
as	O
adjunctive	O
therapy	O
.	O

Pancreatic	O
and	O
biliary	O
secretion	O
and	O
gastric	O
emptying	O
rates	O
of	O
a	O
liquid	O
test	O
meal	O
(	O
LTM	O
)	O
were	O
determined	O
in	O
normal	O
persons	O
,	O
in	O
patients	O
with	O
subtotal	O
gastrectomy	O
with	O
gastroduodenostomy	O
(	O
STG	O
-	O
BI	O
)	O
or	O
with	O
gastrojejunostomy	O
(	O
STG	O
-	O
BII	O
),	O
and	O
in	O
patients	O
with	O
truncal	O
vagotomy	O
and	O
pyloroplasty	O
(	O
V	O
&	O
P	O
).	O

Also	O
,	O
except	O
in	O
one	O
patient	O
who	O
developed	O
gallstones	O
following	O
institution	O
of	O
colestipol	O
,	O
saturation	O
of	O
gallbladder	O
bile	O
with	O
cholesterol	O
was	O
not	O
markedly	O
increased	O
by	O
this	O
drug	O
alone	O
.	O

The	O
psychological	O
tests	O
consisted	O
of	O
a	O
free	O
-	O
recall	O
task	O
,	O
a	O
test	O
for	O
visuomotor	O
coordination	O
and	O
a	O
recognition	O
task	O
.	O

Selective	O
bronchial	O
intubation	O
in	O
the	O
management	O
of	O
unilateral	O
pulmonary	O
interstitial	O
emphysema	O
.	O

The	O
background	O
processes	O
depending	O
on	O
the	O
etiological	O
factor	O
and	O
the	O
character	O
of	O
lesion	O
of	O
the	O
epithelium	O
are	O
divided	O
into	O
dyshormonal	O
,	O
inflammatory	O
,	O
and	O
posttraumatic	O
.	O

The	O
sense	O
of	O
self	O
.	O

Adaptation	O
of	O
taurocholate	O
transport	O
maximum	O
to	O
increased	O
secretory	O
load	O
in	O
the	O
rat	O
.	O

In	O
diethyl	O
ether	O
solution	O
the	O
main	O
peak	O
is	O
that	O
of	O
2	O
-	O
benzylidenamio	O
-	O
1	O
-	O
phenylpropane	O
,	O
which	O
has	O
a	O
retention	O
time	O
of	O
23	O
,	O
2	O
minutes	O
under	O
the	O
condition	O
delineated	O
.	O

Serum	B
amylase	I
became	O
markedly	O
elevated	O
(	O
2	O
,	O
624	O
CU	O
/	O
100	O
ml	O
),	O
as	O
did	O
the	O
serum	O
FFA	O
(	O
29	O
.	O
19	O
mEq	O
/	O
liter	O
).	O

The	O
morphological	O
effects	O
of	O
two	O
snake	O
venoms	O
,	O
N	O
.	O
naja	O
and	O
A	O
.	O
piscivorus	O
,	O
and	O
of	O
the	O
Direct	B
Lytic	I
Factor	I
and	O
Phospholipase	B
-	I
A	I
,	O
compounds	O
purified	O
from	O
N	O
.	O
naja	O
crude	O
venom	O
,	O
were	O
investigated	O
on	O
lung	O
and	O
cremaster	O
vessels	O
of	O
rats	O
.	O

Near	O
term	O
,	O
under	O
experimental	O
conditions	O
,	O
maternal	O
and	O
fetal	O
blood	O
gases	O
,	O
pH	O
,	O
uterine	O
and	O
umbilical	O
blood	O
flows	O
were	O
measured	O
or	O
calculated	O
.	O

Twenty	O
-	O
nine	O
days	O
after	O
injection	O
of	O
5	O
.	O
8	O
mCi	O
of	O
Tc	O
-	O
99m	O
,	O
which	O
gives	O
28	O
rads	O
to	O
the	O
testis	O
,	O
the	O
number	O
of	O
sperm	O
hads	O
decreased	O
to	O
70	O
%	O
of	O
control	O
.	O

Role	O
of	O
the	O
infectious	O
-	O
disease	O
specialist	O
of	O
a	O
polyclinic	O
in	O
reducing	O
the	O
incidence	O
of	O
communicable	O
diseases	O

Iodine	O
-	O
123	O
was	O
satisfactorily	O
imaged	O
only	O
with	O
the	O
MEC	O
and	O
pinhole	O
collimators	O
,	O
which	O
in	O
turn	O
yielded	O
MTF	O
values	O
comparable	O
to	O
those	O
measured	O
for	O
99mTc	O
.	O

Petrous	O
meningioma	O
en	O
plaque	O
presenting	O
as	O
a	O
right	O
middle	O
ear	O
tumor	O
.	O

The	O
difficulties	O
to	O
analyse	O
prostaglandins	O
(	O
PG	O
)	O
by	O
gas	O
-	O
liquid	O
chromatography	O
are	O
mainly	O
due	O
to	O
the	O
lack	O
of	O
sensitivity	O
of	O
the	O
gas	O
-	O
chromatograph	O
itself	O
(	O
higher	O
than	O
200	O
ng	O
)	O
and	O
to	O
the	O
poor	O
resolution	O
of	O
the	O
packed	O
columns	O
.	O

The	O
effect	O
of	O
food	O
on	O
procainamide	O
absorption	O
.	O

Batch	O
cultures	O
of	O
S	O
.	O
mutans	O
serotype	O
a	O
demonstrated	O
no	O
growth	O
on	O
MSB	O
agar	O
.	O

Crisis	O
of	O
the	O
therapeutic	O
community	O
in	O
Great	O
Britain	O

Haemodilution	O
in	O
cardiopulmonary	O
bypass	O
using	O
a	O
gelatine	O
derivative	O
for	O
priming	O
.	O

Extramedullary	O
plasmacytoma	O
of	O
the	O
parotid	O
gland	O

I	O
.	O

Rainbow	O
trout	O
were	O
obtained	O
from	O
a	O
commercial	O
trout	O
farm	O
,	O
kept	O
in	O
running	O
water	O
and	O
feeding	O
in	O
experimental	O
pellets	O
for	O
4	O
to	O
8	O
weeks	O
.	O

Preflight	O
,	O
inflight	O
,	O
and	O
postflight	O
exercise	O
response	O
tests	O
were	O
conducted	O
on	O
the	O
astronauts	O
of	O
the	O
second	O
Skylab	O
mission	O
(	O
Skylab	O
3	O
)	O
as	O
part	O
of	O
an	O
evaluation	O
of	O
physiological	O
adaptation	O
to	O
long	O
-	O
term	O
weightlessness	O
.	O

State	O
of	O
the	O
body	O
in	O
disorders	O
of	O
diurnal	O
physiological	O
rhythms	O
and	O
long	O
-	O
term	O
hypokinesia	O

Constantly	O
rectilinear	O
pressure	O
curves	O
without	O
uterine	O
activities	O
are	O
interpreted	O
as	O
characteristic	O
tocographic	O
criteria	O
of	O
an	O
advanced	O
ectopic	O
gravidity	O
.	O

Six	O
patients	O
with	O
the	O
diagnosis	O
of	O
acute	O
mania	O
were	O
treated	O
with	O
high	O
doses	O
of	O
the	O
beta	B
-	I
adrenergic	I
blocking	O
agent	O
propranolol	O
.	O

With	O
the	O
help	O
of	O
a	O
nomogram	O
one	O
can	O
read	O
off	O
the	O
refraction	O
,	O
when	O
axis	O
length	O
and	O
corneal	O
curvature	O
are	O
known	O
.	O

Compared	O
to	O
controls	O
,	O
both	O
UB	O
and	O
OCS	O
rats	O
showed	O
a	O
small	O
but	O
significant	O
post	O
-	O
operative	O
reduction	O
in	O
the	O
nocturnality	O
of	O
drinking	O
.	O

Certain	O
characteristics	O
of	O
eye	O
changes	O
in	O
patients	O
with	O
pheochromocytoma	O
including	O
Sipple	O
'	O
s	O
syndrome	O

Potscoital	O
test	O

When	O
a	O
tumour	O
is	O
present	O
nipple	O
discharge	O
is	O
of	O
little	O
importance	O
for	O
the	O
diagnosis	O
and	O
treatment	O
.	O

Who	O
says	O
'	O
National	O
Health	O
Dis	O
-	O
service	O
'.	O

The	O
second	O
and	O
third	O
responded	O
similarly	O
to	O
either	O
a	O
combined	O
cyclophosphamide	O
+	O
antilymphocyte	B
globulin	I
(	O
ALG	B
)	O
treatment	O
or	O
to	O
ALG	B
administration	O
preceded	O
by	O
a	O
small	O
dosage	O
of	O
cyclophosphamide	O
,	O
which	O
had	O
proved	O
ineffective	O
when	O
administered	O
alone	O
.	O

The	O
influence	O
of	O
a	O
mobile	O
pupil	O
on	O
the	O
response	O
in	O
the	O
DC	O
-	O
ERG	O
is	O
demonstrated	O
.	O

Current	O
status	O
of	O
zinc	O
deficiency	O
in	O
the	O
pathogenesis	O
of	O
neurological	O
,	O
dermatological	O
and	O
musculoskeletal	O
disorders	O
.	O

Epididymal	O
growth	O
was	O
retarded	O
in	O
animals	O
maintained	O
solely	O
on	O
chickpea	O
haulm	O
and	O
improved	O
with	O
supplementation	O
.	O

Letter	O
:	O
Perspectives	O
in	O
bone	O
marrow	O
transplantation	O
.	O

Nerve	O
stimulation	O
(	O
1	O
.	O
5	O
-	O
12	O
cycles	O
/	O
s	O
)	O
produced	O
frequency	O
-	O
dependent	O
reductions	O
in	O
CBF	O
,	O
a	O
decrease	O
of	O
50	O
percent	O
occurring	O
with	O
the	O
highest	O
frequency	O
.	O

Risk	O
of	O
infection	O
in	O
the	O
treatment	O
of	O
fractures	O

At	O
the	O
very	O
high	O
dose	O
levels	O
used	O
,	O
sodium	O
saccharin	O
and	O
sodium	O
cyclamate	O
were	O
weak	O
solitary	O
carcinogens	O
producing	O
4	O
/	O
253	O
and	O
3	O
/	O
228	O
bladder	O
tumours	O
respectively	O
,	O
and	O
the	O
first	O
of	O
these	O
tumours	O
did	O
not	O
appear	O
for	O
more	O
than	O
80	O
weeks	O
.	O

The	O
appearance	O
of	O
dyskinetic	O
movement	O
disorders	O
in	O
humans	O
following	O
the	O
chronic	O
use	O
of	O
levodopa	B
or	O
amphetamine	O
may	O
be	O
a	O
manifestation	O
of	O
similarly	O
increased	O
dopamine	B
receptor	I
site	I
sensitivity	O
within	O
the	O
striatum	O
.	O

Like	O
pineal	O
melatonin	O
,	O
serum	O
melatonin	O
was	O
high	O
at	O
mid	O
-	O
dark	O
and	O
low	O
at	O
mid	O
-	O
light	O
.	O

D	O
.	O

Air	O
ion	O
action	O
on	O
bacteria	O
.	O

2	O
-	O
Chemical	O
occlusion	O
of	O
vas	O
is	O
quite	O
effective	O
in	O
producing	O
a	O
block	O
in	O
the	O
vas	O
deferens	O
of	O
dogs	O
.	O

In	O
both	O
cases	O
,	O
at	O
the	O
end	O
of	O
exposure	O
the	O
same	O
level	O
of	O
blood	O
carboxyhemoglobin	B
(	O
COHb	B
)	O
(	O
about	O
50	O
%)	O
was	O
reached	O
.	O

A	O
case	O
observed	O
in	O
Saigon	O

Acquired	O
factor	B
VIII	I
inhibitor	I
in	O
non	O
-	O
hemophilic	O
patients	O

Biohydrogenation	O
of	O
linoleic	O
acid	O
into	O
octadecenoic	O
acid	O
was	O
observed	O
.	O

Nuclear	O
extracts	O
prepared	O
from	O
both	O
neural	O
and	O
non	O
-	O
neural	O
cell	O
lines	O
,	O
mouse	O
brain	O
,	O
and	O
mouse	O
liver	O
contain	O
proteins	O
that	O
recognize	O
and	O
bind	O
to	O
the	O
PROX	O
and	O
PAL	O
sequences	O
indicating	O
that	O
proteins	O
which	O
bind	O
to	O
these	O
target	O
sequences	O
are	O
widespread	O
.	O

Treatment	O
and	O
staining	O
of	O
smears	O
and	O
sections	O
for	O
detection	O
of	O
microorganisms	O

Characterization	O
of	O
the	O
human	B
gene	I
encoding	I
cytokeratin	I
17	O
and	O
its	O
expression	O
pattern	O
.	O

Animals	O
that	O
received	O
DSP	B
-	I
4	I
were	O
significantly	O
retarded	O
in	O
motor	O
recovery	O
compared	O
with	O
the	O
saline	O
group	O
.	O

Gene	O
constructs	O
consisting	O
of	O
human	B
growth	I
hormone	I
(	O
hGH	B
)	I
gene	I
driven	O
by	O
promoter	O
/	O
regulatory	O
sequence	O
of	O
mouse	B
metallothionein	I
(	O
mMT	B
),	O
viral	B
thymidine	I
kinase	I
(	O
vTK	B
),	O
rat	B
cholecystokinin	I
(	O
rCCK	B
),	O
or	O
chicken	B
beta	I
-	I
actin	I
(	O
cBA	B
)	I
gene	I
were	O
injected	O
into	O
the	O
cytoplasm	O
of	O
fertilized	O
medaka	O
eggs	O
via	O
the	O
micropyle	O
.	O

Most	O
of	O
the	O
patients	O
presented	O
with	O
Transient	O
Ischemic	O
Attacks	O
(	O
64	O
%)	O
or	O
Reversible	O
Ischemic	O
Neurologic	O
Deficits	O
(	O
19	O
%).	O

We	O
cloned	O
the	O
third	O
human	B
gene	I
for	O
the	O
LD78	B
,	O
termed	O
LD78	B
gamma	I
and	O
the	O
sequence	O
analysis	O
showed	O
that	O
it	O
is	O
a	O
5	O
'-	O
truncated	O
pseudogene	O
.	O

In	O
the	O
absence	O
of	O
histological	O
criteria	O
,	O
which	O
it	O
is	O
difficult	O
to	O
demand	O
in	O
view	O
of	O
the	O
variability	O
of	O
results	O
and	O
potential	O
dangers	O
of	O
endomyocardial	O
biopsy	O
involving	O
such	O
thin	O
and	O
fragile	O
ventricular	O
walls	O
,	O
the	O
diagnosis	O
of	O
ACRV	O
is	O
based	O
upon	O
the	O
concomitant	O
existence	O
of	O
:	O
(	O
1	O
)	O
electrophysiological	O
criteria	O
:	O
ventricular	O
arrhythmias	O
,	O
in	O
particular	O
sustained	O
monomorphous	O
VT	O
,	O
with	O
the	O
particular	O
feature	O
of	O
a	O
very	O
high	O
degree	O
of	O
sensitivity	O
to	O
adrenergic	O
stimulation	O
(	O
exercise	O
),	O
the	O
existence	O
of	O
late	O
potentials	O
on	O
the	O
high	O
amplification	O
ECG	O
,	O
a	O
highly	O
specific	O
sign	O
,	O
though	O
unfortunately	O
of	O
poor	O
sensitivity	O
in	O
localized	O
froms	O
,	O
those	O
which	O
are	O
most	O
difficult	O
to	O
identify	O
(	O
2	O
);	O
segmentary	O
morphological	O
and	O
kinetic	O
RV	O
abnormalities	O
,	O
most	O
often	O
resulting	O
in	O
localized	O
akinetic	O
or	O
dyskinetic	O
parietal	O
vaulting	O
,	O
with	O
stasis	O
"	O
in	O
situ	O
".	O

Acad	O
.	O

Interestingly	O
,	O
the	O
IR5	B
ORF	I
of	O
EHV	B
-	I
1	I
possesses	O
a	O
sequence	O
of	O
13	O
amino	O
acids	O
(	O
CAYWCCLGHAFAC	O
)	O
that	O
is	O
a	O
perfect	O
match	O
to	O
the	O
consensus	O
zinc	B
finger	I
motif	I
(	I
C	I
-	I
X2	O
-	O
4	O
-	O
C	O
-	O
X2	O
-	O
15	B
-	I
C	I
/	I
H	I
-	I
X2	O
-	O
4	O
-	O
C	O
/	O
H	O
).	O

The	O
DNA	O
sequence	O
of	O
the	O
sulfate	O
activation	O
locus	O
from	O
Escherichia	B
coli	I
K	I
-	I
12	O
has	O
been	O
determined	O
.	O

After	O
the	O
first	O
28	O
patients	O
vincristine	O
was	O
replaced	O
by	O
teniposide	O
(	O
VM	O
-	O
26	O
)	O
due	O
to	O
neurotoxicity	O
.	O

These	O
results	O
indicate	O
that	O
an	O
internal	O
short	O
element	O
located	O
at	O
the	O
very	O
5	O
'	O
terminal	O
of	O
L1	O
sequence	O
and	O
the	O
nuclear	B
factor	I
binding	I
to	O
the	O
element	O
play	O
a	O
crucial	O
role	O
in	O
the	O
transcription	O
of	O
human	B
L1	I
.	O

Transient	O
transfection	O
assays	O
showed	O
that	O
site	O
A	O
is	O
necessary	O
and	O
sufficient	O
for	O
RXR	B
alpha	I
-	I
mediated	O
transactivation	O
of	O
the	O
apoAI	B
gene	I
basal	I
promoter	I
in	O
human	O
hepatoma	O
HepG2	O
cells	O
in	O
the	O
presence	O
of	O
RA	O
and	O
that	O
this	O
transactivation	O
is	O
abolished	O
by	O
increasing	O
amounts	O
of	O
cotransfected	O
ARP	B
-	I
1	I
.	O

Two	O
splice	O
variants	O
of	O
ALF1	B
cDNA	I
have	O
been	O
found	O
,	O
differing	O
by	O
a	O
72	O
-	O
bp	O
insertion	O
,	O
coding	O
for	O
putative	O
proteins	O
of	O
682	O
and	O
706	O
amino	O
acids	O
.	O

Antibodies	O
against	O
this	O
purified	O
protein	O
localize	O
RIM1	B
to	O
mitochondria	O
.	O

Susceptibilities	O
of	O
540	O
anaerobic	O
gram	O
-	O
negative	O
bacilli	O
to	O
amoxicillin	O
,	O
amoxicillin	O
-	O
BRL	O
42715	O
,	O
amoxicillin	O
-	O
clavulanate	O
,	O
temafloxacin	O
,	O
and	O
clindamycin	O
.	O

Nocodazole	O
arrest	O
of	O
DU249	O
cells	O
was	O
exploited	O
for	O
the	O
detection	O
of	O
an	O
M	B
-	I
phase	I
-	I
activated	I
MBP	I
kinase	I
that	O
was	O
resolved	O
from	O
p41	B
MAP	I
kinase	I
by	O
phenyl	O
-	O
Superose	O
chromatography	O
.	O

The	O
319	O
base	O
pair	O
region	O
immediately	O
upstream	O
of	O
the	O
CAP	O
site	O
is	O
characterized	O
by	O
the	O
lack	O
of	O
a	O
proximal	O
TATA	O
box	O
and	O
the	O
presence	O
of	O
sequences	O
similar	O
to	O
GC	O
boxes	O
,	O
CACCC	O
boxes	O
,	O
CCAAT	B
boxes	I
,	I
activator	I
protein	I
2	I
(	O
Ap	B
-	I
2	I
)	I
sites	I
,	O
partial	O
glucocorticoid	O
response	O
elements	O
(	O
GREs	O
),	O
and	O
partial	O
cyclic	O
AMP	O
response	O
elements	O
(	O
CREs	O
).	O

Truncation	O
variants	O
of	O
peptides	O
isolated	O
from	O
MHC	B
class	I
II	I
molecules	I
suggest	O
sequence	O
motifs	O
.	O

Although	O
the	O
E	B
-	I
box	I
consensus	I
is	O
minimally	O
defined	O
as	O
CANNTG	O
,	O
the	O
adjacent	O
nucleotides	O
of	O
functional	O
E	O
-	O
boxes	O
are	O
variable	O
for	O
genes	O
regulated	O
by	O
the	O
bHLH	B
proteins	I
.	O

T	B
-	I
cell	I
receptor	I
beta	I
(	I
TCR	I
beta	I
)	I
gene	I
rearrangements	O
occur	O
in	O
a	O
third	O
of	O
early	O
B	O
-	O
cell	O
acute	O
lymphoblastic	O
leukemias	O
(	O
ALLs	O
).	O

The	O
minimal	O
promoter	O
of	O
the	O
RII	B
beta	I
gene	I
was	O
composed	O
of	O
two	O
adjacent	O
functional	O
elements	O
.	O

Mapping	O
the	O
cAMP	B
receptor	I
protein	I
contact	I
site	I
on	O
the	O
alpha	B
subunit	I
of	O
Escherichia	B
coli	I
RNA	I
polymerase	I
.	O

This	O
soluble	O
form	O
of	O
the	O
HGFr	B
(	O
sHGFr	B
)	O
bound	O
HGF	B
with	O
an	O
affinity	O
similar	O
to	O
that	O
of	O
the	O
authentic	O
,	O
membrane	O
-	O
associated	O
receptor	O
.	O

Comparison	O
of	O
data	O
obtained	O
with	O
the	O
results	O
of	O
chronic	O
treatment	O
with	O
the	O
opioid	O
antagonist	O
permits	O
to	O
conclude	O
that	O
the	O
chronic	O
blockade	O
increases	O
the	O
fatiguability	O
to	O
a	O
great	O
extent	O
than	O
chronic	O
activation	O
of	O
opioid	O
system	O
.	O

Laboratory	O
studies	O
using	O
Ca45	O
labeled	O
teeth	O
and	O
biologically	O
stained	O
teeth	O
confirmed	O
that	O
the	O
dentifrice	O
did	O
not	O
decalcify	O
enamel	O
or	O
bleach	O
teeth	O
.	O

Characterization	O
of	O
the	O
regulon	O
controlled	O
by	O
the	O
leucine	B
-	I
responsive	I
regulatory	I
protein	I
in	O
Escherichia	O
coli	O
.	O

Interestingly	O
,	O
the	O
positions	O
of	O
these	O
introns	O
have	O
been	O
conserved	O
in	O
comparison	O
with	O
the	O
genes	O
of	O
two	O
other	O
transglutaminase	O
-	O
like	O
activities	O
described	O
in	O
the	O
literature	O
,	O
but	O
the	O
TGM1	B
gene	I
is	O
by	O
far	O
the	O
smallest	O
characterized	O
to	O
date	O
because	O
its	O
introns	O
are	O
relatively	O
smaller	O
.	O

In	O
a	O
retrospective	O
analysis	O
of	O
data	O
from	O
35	O
cases	O
with	O
malignant	O
lymphoma	O
from	O
a	O
cohort	O
of	O
2017	O
HIV	O
-	O
infected	O
patients	O
,	O
the	O
stage	O
of	O
HIV	O
-	O
disease	O
,	O
the	O
CD4	B
counts	O
at	O
the	O
time	O
of	O
diagnosis	O
,	O
and	O
the	O
use	O
of	O
antineoplastic	O
agents	O
or	O
radiotherapy	O
were	O
correlated	O
with	O
outcome	O
.	O

Gestational	O
trophoblastic	O
diseases	O
:	O
recent	O
advances	O
in	O
the	O
understanding	O
of	O
cytogenetics	O
,	O
histopathology	O
,	O
and	O
natural	O
history	O
.	O

We	O
propose	O
that	O
plasmids	O
of	O
the	O
pLS1	O
family	O
(	O
pE194	O
,	O
pADB201	O
,	O
and	O
pLB4	O
)	O
share	O
functional	O
and	O
structural	O
characteristics	O
for	O
the	O
regulation	O
of	O
their	O
copy	O
numbers	O
.	O

At	O
some	O
sites	O
,	O
%	O
T	O
is	O
greatly	O
increased	O
by	O
Cl	O
-	O
concentrations	O
up	O
to	O
1	O
M	O
,	O
while	O
at	O
other	O
sites	O
%	O
T	O
is	O
reduced	O
or	O
unaffected	O
by	O
these	O
conditions	O
.	O

Necrosis	O
appears	O
6	O
h	O
after	O
TA	O
infusion	O
,	O
being	O
5	O
.	O
77	O
%	O
in	O
extent	O
after	O
12	O
h	O
,	O
14	O
.	O
9	O
%	O
after	O
24	O
h	O
and	O
animals	O
die	O
with	O
an	O
area	O
of	O
29	O
.	O
5	O
%	O
necrosis	O
.	O

We	O
also	O
report	O
here	O
the	O
complete	O
structural	O
organization	O
of	O
the	O
goat	B
alpha	I
s1	I
-	I
casein	I
transcription	I
unit	I
,	O
deduced	O
from	O
polymerase	O
chain	O
reaction	O
experiments	O
.	O

We	O
have	O
constructed	O
,	O
using	O
synthetic	O
DNA	O
oligonucleotides	O
,	O
a	O
U14	B
snRNA	I
gene	I
which	O
has	O
been	O
positioned	O
behind	O
a	O
T7	B
RNA	I
polymerase	I
promoter	I
site	I
and	O
then	O
inserted	O
into	O
a	O
plasmid	O
.	O

Furthermore	O
it	O
was	O
suggested	O
that	O
FK506	O
plasma	O
levels	O
were	O
concerned	O
with	O
the	O
appearance	O
of	O
side	O
effect	O
.	O

Thus	O
,	O
cibenzoline	O
is	O
an	O
effective	O
antiarrhythmic	O
agent	O
with	O
a	O
favourable	O
pharmacokinetic	O
profile	O
that	O
may	O
be	O
considered	O
with	O
other	O
class	O
I	O
drugs	O
in	O
patients	O
requiring	O
therapy	O
for	O
high	O
risk	O
arrhythmias	O
.	O

In	O
general	O
,	O
two	O
separate	O
high	O
-	O
performance	O
liquid	O
chromatographic	O
runs	O
were	O
performed	O
,	O
one	O
for	O
the	O
gamma	B
-	I
aminobutyric	I
acid	I
determination	O
and	O
one	O
for	O
the	O
determination	O
of	O
the	O
monoamines	O
.	O

We	O
report	O
the	O
successful	O
use	O
of	O
electroconvulsive	O
therapy	O
for	O
treatment	O
of	O
severe	O
depression	O
in	O
a	O
young	O
man	O
with	O
adult	O
GM2	O
gangliosidosis	O
.	O

From	O
all	O
clinically	O
important	O
yeasts	O
species	O
,	O
a	O
total	O
of	O
96	O
%	O
were	O
identified	O
by	O
ATB	O
method	O
according	O
to	O
conventional	O
methods	O
.	O

The	O
neurohypophysial	O
vasopressin	B
and	O
oxytocin	B
content	O
was	O
bioassayed	O
by	O
pressor	O
effect	O
following	O
Dekanski	O
or	O
milk	O
-	O
ejection	O
activity	O
in	O
vitro	O
following	O
van	O
Dongen	O
and	O
Hays	O
,	O
respectively	O
.	O

If	O
no	O
reply	O
was	O
received	O
,	O
telephone	O
contact	O
or	O
home	O
visits	O
were	O
made	O
.	O

The	O
experiments	O
show	O
that	O
it	O
is	O
the	O
micromilieu	O
of	O
the	O
alveoli	O
and	O
the	O
condition	O
of	O
the	O
AM	O
(	O
certain	O
physiological	O
activation	O
states	O
,	O
such	O
as	O
phagocytic	O
activity	O
)	O
that	O
essentially	O
determine	O
the	O
degree	O
of	O
recovery	O
.	O

From	O
these	O
results	O
,	O
CBF	B
-	I
A	I
is	O
a	O
novel	O
CArG	B
box	I
-,	I
ssDNA	I
-	I
and	I
RNA	I
-	I
binding	I
protein	I
,	O
as	O
well	O
as	O
a	O
repressive	O
transcriptional	O
factor	O
.	O

These	O
results	O
demonstrate	O
that	O
endogenous	O
N	O
-	O
methylation	O
of	O
salsolinol	O
into	O
N	O
-	O
methylsalsolinol	O
occurs	O
in	O
the	O
brain	O
in	O
vivo	O
.	O

DR1	B
molecules	I
purified	O
from	O
human	O
lymphoblastoid	O
cell	O
lines	O
could	O
specifically	O
bind	O
to	O
these	O
peptide	O
sequences	O
expressed	O
on	O
the	O
phage	O
surface	O
.	O

To	O
define	O
transcriptional	O
control	O
elements	O
responsible	O
for	O
muscle	O
-	O
specific	O
expression	O
of	O
the	O
human	B
myoglobin	I
gene	I
,	O
we	O
performed	O
mutational	O
analysis	O
of	O
upstream	O
sequences	O
(	O
nucleotide	O
positions	O
-	O
373	O
to	O
+	O
7	O
relative	O
to	O
the	O
transcriptional	O
start	O
site	O
)	O
linked	O
to	O
a	O
firefly	B
luciferase	I
gene	I
.	O

Blood	O
levels	O
of	O
melatonin	O
,	O
serotonin	O
,	O
cortisol	O
,	O
and	O
prolactin	B
in	O
relation	O
to	O
the	O
circadian	O
rhythm	O
of	O
platelet	O
serotonin	O
uptake	O
.	O

We	O
couldn	O
'	O
t	O
detect	O
any	O
effect	O
of	O
n	O
-	O
3	O
FA	O
supplementation	O
on	O
total	O
cholesterol	O
,	O
HDL	B
cholesterol	I
,	O
LDL	B
cholesterol	I
,	O
apo	B
A1	I
,	O
Lp	B
(	O
a	O
),	O
HbA1C	B
,	O
glucose	O
,	O
fibrinogen	B
,	I
factor	I
VIII	I
,	O
antithrombin	B
III	I
,	I
plasminogen	I
activator	I
inhibitor	I
,	O
tissue	B
plasminogen	I
activator	I
and	O
von	B
Willebrand	I
factor	I
concentration	O
,	O
on	O
bleeding	O
time	O
or	O
on	O
systolic	O
or	O
diastolic	O
blood	O
pressure	O
.	O

Using	O
5	O
ng	O
/	O
mL	O
as	O
the	O
cutoff	O
,	O
the	O
sensitivity	O
of	O
CEA	B
was	O
68	O
%.	O

The	O
effects	O
of	O
diltiazem	O
were	O
stereoselective	O
,	O
thus	O
the	O
potentiation	O
induced	O
by	O
d	O
-	O
cis	O
diltiazem	O
was	O
significantly	O
greater	O
in	O
all	O
cases	O
than	O
that	O
induced	O
by	O
l	O
-	O
cis	O
diltiazem	O
,	O
which	O
suggests	O
that	O
calcium	O
channel	O
blockade	O
plays	O
a	O
role	O
in	O
these	O
interactions	O
.	O

Localization	O
of	O
the	O
brachial	O
plexus	O
with	O
the	O
nerve	O
stimulator	O
is	O
equally	O
effective	O
at	O
the	O
interscalene	O
,	O
supraclavicular	O
,	O
and	O
axillary	O
sites	O
.	O

Cicatricial	O
pemphigoid	O
is	O
an	O
autoimmune	O
systemic	O
disease	O
characterized	O
by	O
chronic	O
conjunctival	O
cicatrization	O
.	O

The	O
distinguishing	O
features	O
involved	O
eight	O
amino	O
acid	O
changes	O
,	O
including	O
a	O
single	O
lysine	O
deletion	O
relative	O
to	O
a	O
primate	O
consensus	O
sequence	O
in	O
the	O
first	O
complementary	O
-	O
determing	O
region	O
of	O
V1J1	B
.	O

Clin	O
.	O

Human	O
neutrophil	O
response	O
to	O
short	O
-	O
term	O
exposure	O
to	O
F	O
-	O
75	O
cobalt	O
-	O
based	O
alloy	O
.	O

The	O
second	O
method	O
,	O
the	O
"	O
macro	O
"	O
assay	O
,	O
has	O
a	O
sensitivity	O
range	O
of	O
0	O
.	O
03	O
-	O
5	O
.	O
0	O
micrograms	O
phosphorus	O
with	O
100	O
-	O
500	O
microliters	O
HClO4	O
.	O

In	O
order	O
to	O
investigate	O
the	O
blood	O
compatibility	O
of	O
autogenous	O
vein	O
graft	O
(	O
AVG	O
),	O
changes	O
in	O
prostacyclin	O
(	O
PGI2	O
)	O
production	O
following	O
harvesting	O
and	O
arterial	O
implantation	O
were	O
studied	O
experimentally	O
.	O

Administration	O
of	O
growth	O
hormone	O
leads	O
to	O
faster	O
growth	O
,	O
but	O
also	O
faster	O
bone	O
maturation	O
.	O

Comparisons	O
with	O
the	O
available	O
amino	O
acid	O
residue	O
(	O
aa	O
)	O
sequence	O
information	O
from	O
the	O
complete	O
CPMV	B
RNA	I
1	I
sequence	I
and	O
the	O
partial	O
sequence	O
of	O
red	B
clover	I
mottle	I
virus	I
RNA	I
1	I
suggest	O
that	O
CPSMV	B
RNA	I
1	I
specifies	O
the	O
expected	O
set	O
of	O
five	O
mature	O
proteins	O
:	O
32K	B
proteinase	I
cofactor	I
,	O
58K	B
presumed	I
helicase	I
,	O
VPg	B
5	I
'-	I
linked	I
protein	I
of	O
the	O
genomic	O
RNAs	O
,	O
24K	B
proteinase	I
,	O
and	O
87K	B
presumed	I
polymerase	I
,	O
separated	O
by	O
four	O
cleavage	O
sites	O
.	O

In	O
addition	O
,	O
the	O
utility	O
of	O
beta	B
2	I
transferrin	I
assay	O
in	O
the	O
diagnosis	O
of	O
cerebrospinal	O
fluid	O
otorrhea	O
is	O
presented	O
.	O

To	O
prepare	O
for	O
analyses	O
with	O
the	O
family	O
variables	O
,	O
we	O
next	O
present	O
descriptive	O
data	O
based	O
on	O
separate	O
principal	O
components	O
analysis	O
(	O
PCA	O
)	O
and	O
multidimensional	O
scaling	O
analysis	O
(	O
MDS	O
)	O
of	O
14	O
self	O
-	O
reported	O
health	O
scores	O
for	O
husbands	O
and	O
for	O
wives	O
.	O

For	O
this	O
reason	O
,	O
the	O
particle	O
forming	O
capacity	O
of	O
derivatives	O
of	O
the	O
HIV	B
-	I
1	I
group	I
specific	I
core	I
antigen	I
p55	I
gag	I
was	O
assayed	O
and	O
compared	O
dependent	O
on	O
various	O
expression	O
systems	O
:	O
recombinant	O
bacteria	O
,	O
vaccinia	O
-	O
and	O
baculoviruses	O
were	O
established	O
encoding	O
the	O
entire	O
core	B
protein	I
p55	I
either	O
in	O
its	O
authentic	O
sequence	O
or	O
lacking	O
the	O
myristylation	O
consensus	O
signal	O
.	O

Adapromine	O
was	O
established	O
to	O
evoke	O
a	O
decrease	O
of	O
the	O
amplitude	O
of	O
the	O
dominant	O
peak	O
and	O
dominant	O
theta	O
-	O
activity	O
in	O
power	O
spectra	O
of	O
the	O
EEG	O
in	O
the	O
cortex	O
and	O
hippocamp	O
,	O
with	O
an	O
increase	O
of	O
rapid	O
wave	O
activity	O
in	O
the	O
beta	B
2	I
range	O
in	O
the	O
right	O
cortex	O
and	O
hippocamp	O
.	O

These	O
sequences	O
were	O
then	O
used	O
to	O
clone	O
the	O
full	B
-	I
length	I
genes	I
from	O
a	O
yeast	O
genomic	O
library	O
.	O

Four	O
ruminally	O
and	O
duodenally	O
cannulated	O
Hampshire	O
wethers	O
were	O
used	O
in	O
a	O
4	O
x	O
4	O
Latin	O
square	O
experiment	O
to	O
determine	O
whether	O
linoleoyl	O
methionine	O
and	O
calcium	O
linoleate	O
would	O
increase	O
duodenal	O
flow	O
of	O
unsaturated	O
fatty	O
acids	O
(	O
C18	O
:	O
2	O
+	O
cis	O
C18	O
:	O
1	O
).	O

A	O
case	O
of	O
chronic	O
hepatitis	O
C	O
with	O
primary	O
hypothyroidism	O
manifested	O
during	O
interferon	B
treatment	O

A	O
coiled	B
-	I
coil	I
related	I
protein	I
specific	I
for	O
synapsed	O
regions	O
of	O
meiotic	O
prophase	O
chromosomes	O
.	O

Distribution	O
and	O
changing	O
morphological	O
course	O

The	O
appropriate	O
use	O
and	O
benefits	O
of	O
bile	O
acid	O
sequestrants	O
,	O
nicotinic	O
acid	O
,	O
fibric	O
acids	O
,	O
3	B
-	I
hydroxy	I
-	I
3	I
-	I
methylglutaryl	I
coenzyme	I
A	I
(	I
HMG	I
-	I
CoA	I
)	I
reductase	I
inhibitors	O
,	O
and	O
probucol	O
are	O
individually	O
discussed	O
,	O
whereas	O
nonpharmacologic	O
approaches	O
used	O
in	O
conjunction	O
with	O
the	O
drugs	O
are	O
recommended	O
emphatically	O
.	O

The	O
results	O
of	O
this	O
study	O
demonstrate	O
that	O
strongyloidiasis	O
was	O
the	O
cause	O
of	O
sudden	O
death	O
.	O

Four	O
short	O
nucleotide	O
sequences	O
(	O
boxes	O
I	O
to	O
IV	O
)	O
contribute	O
to	O
the	O
light	O
responsiveness	O
of	O
the	O
parsley	B
chalcone	I
synthase	I
promoter	I
.	O

ME1a1	B
,	O
a	O
16	O
-	O
base	O
-	O
pair	O
nuclear	B
factor	I
binding	I
site	I
residing	O
between	O
the	O
c	B
-	I
MYC	I
P1	O
and	O
P2	O
transcription	O
initiation	O
sites	O
,	O
is	O
required	O
for	O
P2	O
activity	O
.	O

Because	O
of	O
this	O
latter	O
phenomenon	O
,	O
we	O
were	O
able	O
to	O
identify	O
a	O
particular	O
cysteine	O
motif	O
that	O
was	O
repeated	O
multiple	O
times	O
in	O
Dfurin2	B
but	O
present	O
only	O
twice	O
in	O
mammalian	B
furin	I
.	O

Model	O
predictions	O
were	O
in	O
accord	O
with	O
the	O
nine	O
-	O
year	O
survival	O
experience	O
of	O
women	O
in	O
the	O
HIP	O
trial	O
,	O
and	O
,	O
with	O
the	O
exception	O
of	O
women	O
40	O
-	O
44	O
years	O
old	O
,	O
with	O
HIP	O
data	O
on	O
18	O
-	O
year	O
survival	O
.	O

We	O
show	O
that	O
LexA	B
-	O
GAL4	B
and	O
LexA	B
-	O
Bicoid	B
fusion	I
proteins	I
are	O
both	O
dependent	O
on	O
SNF2	B
,	O
SNF5	B
,	O
and	O
SNF6	B
for	O
activation	O
of	O
target	O
genes	O
containing	O
one	O
or	O
multiple	O
lexA	B
operators	I
.	O

A	O
lambda	O
gt10	O
cDNA	O
library	O
was	O
constructed	O
from	O
poly	O
(	O
A	O
)+	O
RNA	O
of	O
young	O
green	O
leaves	O
of	O
spinach	O
.	O

Methods	O
included	O
24	O
-	O
hour	O
dietary	O
recall	O
,	O
menu	O
weights	O
,	O
and	O
recipe	O
analysis	O
.	O

Interferon	B
-	I
alpha	I
-	I
induced	O
gene	O
expression	O
:	O
evidence	O
for	O
a	O
selective	O
effect	O
of	O
ouabain	O
on	O
activation	O
of	O
the	O
ISGF3	B
transcription	I
complex	I
.	O

Thus	O
,	O
this	O
study	O
provides	O
evidence	O
that	O
a	O
novel	O
,	O
ubiquitous	O
factor	O
(	O
HF	B
-	I
1a	I
)	O
and	O
a	O
muscle	O
factor	O
(	O
HF	B
-	I
1b	I
/	I
MEF	I
-	I
2	I
)	O
can	O
form	O
a	O
novel	O
,	O
E	B
-	I
box	I
-	I
independent	O
pathway	O
for	O
muscle	O
-	O
specific	O
expression	O
in	O
ventricular	O
cardiac	O
muscle	O
cells	O
.	O

Expense	O
limits	O
the	O
use	O
of	O
hepatitis	O
B	O
vaccines	O
,	O
but	O
low	O
-	O
dose	O
intradermal	O
immunization	O
has	O
been	O
evaluated	O
as	O
a	O
cost	O
-	O
saving	O
strategy	O
in	O
numerous	O
studies	O
.	O

An	O
unexpected	O
finding	O
was	O
the	O
presence	O
at	O
position	O
-	O
403	O
to	O
-	O
385	O
of	O
a	O
putative	O
dioxin	O
responsive	O
element	O
,	O
a	O
sequence	O
found	O
to	O
be	O
responsible	O
for	O
the	O
induction	O
of	O
transcription	O
of	O
the	O
cytochrome	B
P450IA1	I
gene	I
(	O
CYPIA1	B
)	O
and	O
other	O
genes	O
involved	O
in	O
detoxification	O
/	O
activation	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
.	O

The	O
gene	O
encoding	O
TRP	B
-	I
2	I
maps	O
to	O
mouse	O
chromosome	O
14	O
,	O
in	O
the	O
region	O
of	O
the	O
coat	B
colour	I
mutation	I
slaty	I
.	O

The	O
gene	O
encoding	O
IFN	B
-	I
gamma	I
was	O
previously	O
found	O
to	O
contain	O
an	O
intronic	O
enhancer	O
element	O
that	O
was	O
not	O
tissue	O
-	O
specific	O
in	O
its	O
activity	O
,	O
despite	O
the	O
restricted	O
expression	O
of	O
the	O
intact	O
IFN	B
-	I
gamma	I
-	I
encoding	I
gene	I
.	O

Characterization	O
of	O
these	O
R	O
subunits	O
by	O
their	O
8	O
-	O
azido	O
-	O
cAMP	O
photoaffinity	O
labeling	O
and	O
immunoreactivity	O
,	O
as	O
well	O
as	O
by	O
a	O
phosphorylation	O
-	O
dependent	O
mobility	O
shift	O
on	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
SDS	O
-	O
PAGE	O
),	O
indicated	O
subunit	O
sizes	O
of	O
RII	B
beta	I
(	O
53	O
kDa	O
)	O
greater	O
than	O
RII	B
alpha	I
dephosphoform	O
(	O
51	O
kDa	O
)	O
greater	O
than	O
RI	B
alpha	I
(	I
49	I
kDa	I
).	O

GR63178A	O
is	O
a	O
water	O
-	O
soluble	O
analogue	O
of	O
mitoquidone	O
,	O
a	O
pentacyclic	O
pyrroloquinone	O
.	O

Competition	O
analysis	O
by	O
gel	O
mobility	O
shift	O
electrophoresis	O
indicates	O
that	O
this	O
DNA	O
-	O
protein	O
interaction	O
is	O
novel	O
and	O
not	O
related	O
to	O
many	O
transcription	O
factors	O
previously	O
reported	O
.	O

This	O
DNA	O
motif	O
represents	O
a	O
novel	O
protein	B
-	I
binding	I
sequence	I
.	O

From	O
March	O
5	O
through	O
October	O
26	O
,	O
1991	O
,	O
eight	O
persons	O
were	O
diagnosed	O
with	O
elevated	O
blood	O
lead	O
levels	O
(	O
BLLs	O
)	O
at	O
a	O
local	O
hospital	O
and	O
were	O
reported	O
to	O
the	O
notifiable	O
disease	O
surveillance	O
system	O
maintained	O
by	O
the	O
Alabama	O
Department	O
of	O
Public	O
Health	O
(	O
ADPH	O
).	O

According	O
to	O
the	O
changes	O
of	O
perfusion	O
defects	O
between	O
Ex	O
,	O
RD	O
and	O
ReI	O
images	O
,	O
they	O
were	O
classified	O
into	O
3	O
types	O
:	O
Type	O
I	O
;	O
perfusion	O
defect	O
on	O
the	O
RD	O
image	O
was	O
identical	O
to	O
ReI	O
image	O
(	O
75	O
%)	O
Type	O
I	O
was	O
divided	O
into	O
2	O
subgroups	O
whether	O
perfusion	O
defect	O
at	O
Ex	O
was	O
unchanged	O
(	O
Ia	O
,	O
42	O
%)	O
or	O
improved	O
(	O
Ib	O
,	O
33	O
%)	O
on	O
the	O
RD	O
image	O
.	O

Keck	O
,	O
C	O
.	O
J	O
.	O

Computer	O
-	O
aided	O
"	O
FRAME	O
"	O
analysis	O
revealed	O
four	O
possible	O
open	O
reading	O
frames	O
(	O
ORFs	O
),	O
three	O
in	O
one	O
direction	O
and	O
one	O
in	O
the	O
opposite	O
direction	O
.	O

Here	O
,	O
we	O
present	O
evidence	O
for	O
a	O
model	O
in	O
which	O
mRNA	O
sequences	O
up	O
to	O
around	O
100	O
nucleotides	O
downstream	O
from	O
the	O
start	O
codon	O
of	O
21K	O
fold	O
back	O
and	O
base	O
-	O
pair	O
to	O
the	O
21K	O
translation	O
initiation	O
region	O
,	O
thereby	O
decreasing	O
the	O
translation	O
initiation	O
frequency	O
.	O

Unlike	O
the	O
typical	O
enhancer	O
element	O
,	O
this	O
region	O
functions	O
in	O
an	O
orientation	O
-	O
dependent	O
manner	O
.	O

In	O
the	O
last	O
20	O
years	O
,	O
the	O
therapeutic	O
uses	O
of	O
botulinum	B
toxin	I
,	O
a	O
potent	O
neurotoxin	O
,	O
have	O
been	O
investigated	O
.	O

Neural	O
-	O
specific	O
expression	O
,	O
genomic	O
structure	O
,	O
and	O
chromosomal	O
localization	O
of	O
the	O
gene	O
encoding	O
the	O
zinc	B
-	I
finger	I
transcription	I
factor	I
NGFI	I
-	I
C	I
.	O

Drug	O
-	O
drug	O
interactions	O
are	O
most	O
likely	O
to	O
occur	O
in	O
patients	O
receiving	O
multiple	O
medications	O
and	O
with	O
drugs	O
that	O
have	O
a	O
narrow	O
therapeutic	O
window	O
.	O

The	O
sequence	O
data	O
now	O
permit	O
a	O
detailed	O
interpretation	O
of	O
the	O
X	O
-	O
ray	O
crystallographic	O
structure	O
of	O
the	O
enzyme	O
and	O
the	O
cloning	O
and	O
expression	O
of	O
the	O
clostridial	O
gene	O
will	O
facilitate	O
site	O
-	O
directed	O
mutagenesis	O
.	O

GCR1	B
gene	I
function	O
is	O
required	O
for	O
high	O
-	O
level	O
glycolytic	O
gene	O
expression	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

Coronary	O
flow	O
was	O
reduced	O
by	O
10	O
%	O
in	O
the	O
phosphocreatine	O
and	O
by	O
18	O
%	O
in	O
the	O
control	O
group	O
.	O

Recent	O
investigations	O
have	O
detailed	O
a	O
selective	O
dye	O
release	O
technique	O
in	O
which	O
a	O
pulse	O
of	O
laser	O
light	O
induces	O
the	O
release	O
of	O
a	O
fluorescent	O
dye	O
from	O
temperature	O
-	O
sensitive	O
liposomes	O
circulating	O
in	O
the	O
retinal	O
vasculature	O
.	O

The	O
coating	O
materials	O
were	O
poloxamine	O
904	O
,	O
poloxamine	O
908	O
,	O
poloxamine	O
1508	O
,	O
poloxamer	O
338	O
,	O
and	O
Brij	O
35	O
.	O

The	O
eating	O
and	O
drinking	O
patterns	O
of	O
pygmy	O
goats	O
fed	O
ad	O
lib	O
and	O
kept	O
on	O
a	O
12	O
h	O
light	O
/	O
12	O
h	O
dark	O
cycle	O
were	O
recorded	O
and	O
analyzed	O
.	O

The	O
present	O
study	O
highlights	O
the	O
improvement	O
in	O
sputum	O
amoxycillin	O
(	O
amoxy	O
)	O
levels	O
when	O
a	O
combination	O
tablet	O
,	O
amoxy	O
500	O
mg	O
plus	O
bromhexeine	O
8	O
mg	O
,	O
is	O
administered	O
as	O
compared	O
to	O
plain	O
amoxy	O
500	O
mg	O
.	O

His	O
HC	B
II	I
activity	O
and	O
antigen	O
levels	O
were	O
49	O
%	O
and	O
50	O
%,	O
respectively	O
,	O
and	O
his	O
daughter	O
also	O
showed	O
similar	O
low	O
levels	O
.	O

Because	O
the	O
adrenergic	O
nervous	O
system	O
influences	O
cardiac	O
arrhythmias	O
and	O
myocardial	O
infarction	O
can	O
directly	O
affect	O
sympathetic	O
innervation	O
in	O
the	O
heart	O
,	O
we	O
investigated	O
the	O
role	O
of	O
the	O
sympathetic	O
nervous	O
system	O
on	O
reentry	O
in	O
the	O
canine	O
heart	O
4	O
days	O
after	O
infarction	O
.	O

Intravenous	O
amine	O
pressor	O
tests	O
in	O
healthy	O
volunteers	O
.	O

The	O
mean	O
minimum	O
steady	O
-	O
state	O
concentration	O
after	O
the	O
oral	O
regimen	O
(	O
23	O
micrograms	O
.	O
l	O
-	O
1	O
)	O
was	O
78	O
%	O
of	O
that	O
after	O
the	O
intramuscular	O
regime	O
(	O
29	O
micrograms	O
.	O
l	O
-	O
1	O
).	O

In	O
conclusion	O
,	O
to	O
study	O
and	O
overcome	O
TI	O
region	O
-	O
based	O
expression	O
problems	O
it	O
is	O
worthwhile	O
to	O
start	O
out	O
with	O
a	O
versatile	O
vector	O
containing	O
exhaustive	O
mutations	O
in	O
the	O
periShine	O
-	O
Dalgarno	O
sequences	O
;	O
as	O
a	O
rule	O
the	O
coding	O
MTI	O
subregion	O
can	O
be	O
kept	O
unchanged	O
.	O

Wild	B
-	I
type	I
protein	I
bound	O
azido	O
-	O
ATP	O
well	O
,	O
but	O
mutants	O
with	O
substitutions	O
in	O
the	O
consensus	O
amino	O
acids	O
were	O
unable	O
to	O
bind	O
azido	O
-	O
ATP	O
.	O

In	O
the	O
Rett	O
syndrome	O
we	O
,	O
therefore	O
,	O
suspect	O
there	O
are	O
disturbances	O
in	O
the	O
brain	O
stem	O
functions	O
especially	O
in	O
the	O
ascending	O
reticular	O
activating	O
system	O
which	O
is	O
related	O
to	O
elevation	O
of	O
the	O
conscious	O
level	O
.	O

In	O
a	O
similar	O
experiment	O
,	O
simultaneous	O
nitrofurazone	O
administration	O
and	O
S	O
.	O
enteritidis	O
challenge	O
resulted	O
in	O
no	O
significant	O
differences	O
in	O
S	O
.	O
enteritidis	O
isolation	O
frequency	O
.	O

Cutis	O
aplasia	O
.	O

The	O
DRF	B
-	I
2	I
nuclear	I
protein	I
has	O
characteristics	O
similar	O
to	O
those	O
of	O
the	O
muscle	B
-	I
specific	I
regulatory	I
factor	I
,	O
MEF	B
-	I
2	I
(	O
Buskin	O
and	O
Hauschka	O
1989	O
;	O
Gossett	O
et	O
al	O
.,	O
1989	O
).	O

We	O
found	O
that	O
lung	O
cancer	O
tissues	O
of	O
positive	O
67Ga	O
scan	O
expressed	O
TFR	B
,	O
but	O
those	O
of	O
a	O
negative	O
scan	O
did	O
not	O
.	O

Nucleoprotein	O
(	O
N	O
)	O
expressed	O
by	O
both	O
recombinant	O
vaccinia	O
virus	O
and	O
TGEV	O
had	O
a	O
relative	O
molecular	O
mass	O
(	O
Mr	O
)	O
of	O
47	O
,	O
000	O
and	O
was	O
susceptible	O
to	O
degradation	O
at	O
the	O
C	O
-	O
terminus	O
yielding	O
discrete	O
breakdown	O
products	O
.	O

Patients	O
with	O
an	O
enzymatic	O
activity	O
below	O
X	O
--	O
1	O
manifested	O
a	O
decrease	O
of	O
the	O
content	O
of	O
IgA	B
,	O
IgG	B
,	O
IgM	B
,	O
T	O
and	O
B	O
lymphocytes	O
,	O
and	O
of	O
phagocytic	O
activity	O
of	O
neutrophils	O
as	O
compared	O
to	O
patients	O
exhibiting	O
a	O
high	O
enzymatic	O
activity	O
.	O

The	O
relation	O
between	O
myocardial	O
beta	B
-	I
adrenergic	I
receptor	I
and	O
left	O
ventricular	O
(	O
LV	O
)	O
function	O
was	O
studied	O
in	O
10	O
patients	O
,	O
aged	O
41	O
to	O
61	O
years	O
(	O
average	O
51	O
),	O
with	O
LV	O
volume	O
overload	O
mainly	O
due	O
to	O
chronic	O
mitral	O
regurgitation	O
.	O

Each	O
mRNA	O
contained	O
five	O
or	O
six	O
internal	O
uridine	O
residues	O
,	O
which	O
were	O
transcribed	O
using	O
a	O
mixture	O
of	O
UTP	O
and	O
thio	O
-	O
UTP	O
.	O

In	O
similar	O
transient	O
transfection	O
experiments	O
in	O
HeLa	O
cells	O
,	O
overexpression	O
of	O
the	O
wt	O
human	O
retinoblastoma	B
susceptibility	I
gene	I
product	I
,	O
RB	B
,	O
was	O
found	O
to	O
repress	O
the	O
serum	O
-	O
induced	O
IL	B
-	I
6	I
(-	O
225	O
to	O
+	O
13	O
),	O
c	B
-	I
fos	I
(-	O
711	O
to	O
+	O
42	O
),	O
and	O
beta	B
-	I
actin	I
(-	O
3400	O
to	O
+	O
912	O
)	O
promoters	O
but	O
not	O
the	O
PRV	O
-	O
induced	O
IL	B
-	I
6	I
(-	O
110	O
to	O
+	O
13	O
)	O
or	O
the	O
serum	O
-	O
induced	O
MHC	B
(-	O
528	O
to	O
-	O
38	O
)	O
promoters	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
cloned	O
a	O
region	O
that	O
complements	O
the	O
exoenzyme	B
S	I
-	I
deficient	O
phenotype	O
of	O
strain	O
388	O
exs1	B
::	O
Tn1	B
,	O
a	O
chromosomal	O
Tn1	B
insertional	I
mutation	I
.	O

The	O
single	O
most	O
important	O
element	O
,	O
by	O
linker	O
-	O
scanning	O
analysis	O
,	O
is	O
a	O
10	O
-	O
bp	O
region	O
that	O
contains	O
a	O
CCAAT	O
motif	O
.	O

However	O
,	O
alterations	O
in	O
electrostatic	O
and	O
hydrophobic	O
interactions	O
created	O
by	O
the	O
three	O
amino	O
acid	O
substitutions	O
prevent	O
the	O
conformational	O
change	O
in	O
the	O
enzyme	O
usually	O
produced	O
by	O
calmodulin	B
binding	I
.	O

At	O
1	O
,	O
5	O
,	O
and	O
9	O
months	O
after	O
initial	O
isolation	O
of	O
C	O
.	O
kutscheri	O
from	O
the	O
oral	O
cavity	O
,	O
hamsters	O
were	O
euthanatized	O
,	O
and	O
attempts	O
were	O
made	O
to	O
culture	O
C	O
.	O
kutscheri	O
from	O
13	O
additional	O
sites	O
.	O

The	O
factor	O
which	O
binds	O
to	O
the	O
TR	B
promoter	I
co	O
-	O
sedimented	O
with	O
SV40	O
chromosomes	O
extracted	O
late	O
in	O
infection	O
.	O

The	O
patient	O
with	O
a	O
prolonged	O
fever	O
caused	O
by	O
dissecting	O
aneurysm	O
of	O
the	O
aorta	O
in	O
whom	O
pleuropneumonia	O
masked	O
the	O
real	O
diseases	O
has	O
been	O
presented	O
.	O

The	O
resulting	O
clone	O
pKB11	B
,	O
which	O
has	O
a	O
1369	O
-	O
base	O
pair	O
(	O
bp	O
)	O
cDNA	O
insert	O
,	O
overlapping	O
pCAD142	B
by	O
781	O
bp	O
,	O
was	O
identified	O
by	O
hybridization	O
methods	O
and	O
sequence	O
analysis	O
and	O
found	O
to	O
contain	O
the	O
entire	O
cDNA	O
sequence	O
for	O
the	O
amino	O
end	O
of	O
the	O
CAD	B
polypeptide	I
.	O

Histamine	O
-	O
2	O
blockade	O
in	O
psoriasis	O

Its	O
clearance	O
has	O
been	O
found	O
to	O
be	O
decreased	O
(	O
typically	O
by	O
around	O
25	O
%,	O
but	O
often	O
by	O
far	O
more	O
)	O
by	O
erythromycin	O
,	O
troleandomycin	O
(	O
triacetyloleandomycin	O
),	O
roxithromycin	O
,	O
enoxacin	O
,	O
ciprofloxacin	O
,	O
pefloxacin	O
,	O
norfloxacin	O
,	O
ofloxacin	O
,	O
fluoroquinolone	O
T	O
-	O
3262	O
,	O
pipemidic	O
acid	O
,	O
cimetidine	O
,	O
etintidine	O
,	O
propranolol	O
,	O
verapamil	O
,	O
diltiazem	O
,	O
nifedipine	O
,	O
furosemide	O
(	O
frusemide	O
),	O
at	O
least	O
some	O
anovulent	O
agents	O
,	O
viloxazine	O
,	O
allopurinol	O
,	O
ticlopidine	O
,	O
idrocilamide	O
,	O
thiabendazole	O
,	O
disulfiram	O
,	O
influenza	O
-	O
and	O
BCG	O
-	O
vaccination	O
,	O
interferon	B
,	O
and	O
caffeine	O
(	O
half	O
-	O
life	O
increase	O
).	O

No	O
homology	O
was	O
found	O
between	O
RNA14	B
and	O
RNA15	B
or	O
between	O
RNA14	B
and	O
other	O
proteins	O
contained	O
in	O
data	O
banks	O
.	O

The	O
most	O
striking	O
difference	O
in	O
the	O
birch	B
NAD	I
(	I
P	I
)	I
H	I
-	I
NR	I
sequence	I
in	O
comparison	O
to	O
NADH	B
-	I
NR	I
sequences	I
was	O
found	O
at	O
the	O
putative	O
pyridine	O
nucleotide	O
binding	O
site	O
.	O

Gap	B
b3	I
consists	O
of	O
two	O
polypeptide	O
chains	O
(	O
Mr	O
=	O
110	O
,	O
000	O
and	O
30	O
,	O
000	O
),	O
which	O
seem	O
to	O
be	O
proteolytic	O
cleavage	O
products	O
connected	O
by	O
disulfide	O
bonds	O
from	O
a	O
precursor	O
protein	O
.	O

A	O
new	O
,	O
flexible	O
fiberoptic	O
ventriculoscope	O
for	O
observation	O
of	O
the	O
ventricles	O
and	O
major	O
cisterns	O
is	O
reported	O
.	O

Serum	O
IgG	B
was	O
initially	O
elevated	O
in	O
6	O
patients	O
.	O

Induction	O
of	O
Jurkat	O
leukemic	O
T	O
cells	O
with	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
and	O
ionomycin	O
did	O
not	O
affect	O
the	O
level	O
of	O
FKBP	B
mRNA	I
.	O

e	O
.	O

We	O
speculate	O
that	O
these	O
tumors	O
may	O
represent	O
congenital	O
hamartomatous	O
growths	O
.	O

Relatively	O
large	O
DNA	O
rearrangements	O
spanning	O
the	O
region	O
with	O
tandem	O
direct	O
repeats	O
encoding	O
the	O
carboxy	B
-	I
terminal	I
histone	I
H1	I
-	I
like	I
structure	O
of	O
AlgP	B
were	O
detected	O
in	O
several	O
strains	O
upon	O
conversion	O
from	O
the	O
mucoid	O
to	O
the	O
nonmucoid	O
phenotype	O
.	O

Lymphoproliferative	O
disorders	O
arising	O
under	O
immunosuppression	O
with	O
FK	O
506	O
:	O
initial	O
observations	O
in	O
a	O
large	O
transplant	O
population	O
.	O

The	O
proteins	O
differ	O
in	O
the	O
presence	O
or	O
absence	O
of	O
a	O
21	O
-	O
amino	O
-	O
acid	O
sequence	O
located	O
24	O
amino	O
acids	O
C	O
terminal	O
of	O
the	O
translational	O
initiation	O
codon	O
.	O

The	O
C5	B
alpha	I
-	I
chain	I
was	O
encoded	O
by	O
49	O
kilobases	O
containing	O
26	O
exons	O
;	O
the	O
beta	B
-	I
chain	I
was	O
encoded	O
by	O
29	O
kilobases	O
containing	O
16	O
exons	O
.	O

When	O
desipramine	O
was	O
injected	O
16	O
hrs	O
after	O
fluoxetine	O
injection	O
,	O
brain	O
levels	O
of	O
desipramine	O
were	O
no	O
longer	O
elevated	O
.	O

Finally	O
,	O
some	O
point	O
mutations	O
in	O
the	O
Gag	B
-	I
Pol	I
PR	I
domain	I
inhibited	O
activation	O
of	O
RT	O
in	O
trans	O
by	O
a	O
wild	B
-	I
type	I
PR	I
,	O
suggesting	O
that	O
the	O
correct	O
conformation	O
of	O
the	O
PR	B
domain	I
in	O
Gag	B
-	I
Pol	I
is	O
prerequisite	O
for	O
activation	O
of	O
RT	O
.	O

The	O
alpha	B
inhibin	I
promoter	I
containing	O
a	O
mutated	O
CRE	O
was	O
not	O
regulated	O
by	O
forskolin	O
in	O
granulosa	O
cells	O
and	O
did	O
not	O
bind	O
the	O
CREB	B
protein	I
.	O

Cloning	O
of	O
a	O
human	O
cDNA	O
encoding	O
a	O
CDC2	B
-	I
related	I
kinase	I
by	O
complementation	O
of	O
a	O
budding	O
yeast	O
cdc28	B
mutation	I
.	O

They	O
were	O
checked	O
for	O
anti	B
-	I
HCV	I
(	I
anti	I
-	I
C100	I
-	I
3	I
)	O
with	O
HCV	O
EIA	B
kit	I
(	O
Abbott	O
Lab	O
.,	O
North	O
Chicago	O
,	O
IL	B
).	O

Vaccinia	O
virus	O
(	O
VV	O
)	O
is	O
a	O
potent	O
immunogen	O
,	O
but	O
the	O
nature	O
of	O
VV	O
proteins	O
involved	O
in	O
the	O
activation	O
of	O
the	O
immune	O
response	O
of	O
the	O
host	O
is	O
not	O
yet	O
known	O
.	O

Max	B
:	O
functional	O
domains	O
and	O
interaction	O
with	O
c	B
-	I
Myc	I
.	O

86	O
:	O
3199	O
-	O
3203	O
)	O
or	O
G1	O
to	O
S	O
phase	O
(	O
Reilly	O
,	O
C	O
.	O

Zn	O
(	O
II	O
)	O
coordination	O
domain	O
mutants	O
of	O
T4	B
gene	I
32	I
protein	I
.	O

The	O
tissue	O
specificity	O
of	O
gene	O
expression	O
was	O
identical	O
to	O
that	O
described	O
previously	O
for	O
the	O
CaMV	B
35S	I
domain	I
B	I
enhancer	I
element	I
.	O

The	O
pathophysiology	O
and	O
clinical	O
management	O
of	O
acute	O
brain	O
injury	O
in	O
infancy	O
and	O
childhood	O
are	O
presented	O
using	O
acute	O
traumatic	O
brain	O
injury	O
as	O
a	O
model	O
.	O

In	O
some	O
early	O
B	O
cells	O
and	O
Abelson	O
murine	B
leukemia	I
virus	I
-	I
transformed	O
pre	B
-	I
B	I
-	I
cell	O
lines	O
,	O
LT	B
mRNA	I
is	O
constitutively	O
expressed	O
.	O

The	O
genome	O
of	O
Thogoto	O
virus	O
comprises	O
six	O
segments	O
of	O
single	O
-	O
stranded	O
,	O
negative	O
sense	O
RNA	O
.	O

The	O
upstream	B
delta	I
-	I
alpha	I
breakpoint	I
is	O
flanked	O
by	O
the	O
direct	O
repeats	O
of	O
the	O
acceptor	O
splice	O
site	O
,	O
whereas	O
the	O
down	O
-	O
stream	O
alpha	B
-	I
delta	I
breakpoint	I
is	O
located	O
in	O
the	O
adjacent	O
intron	O
.	O

Complex	O
repetitive	O
discharges	O
were	O
observed	O
in	O
muscles	O
of	O
mdx	O
mice	O
but	O
no	O
complex	O
repetitive	O
discharges	O
or	O
other	O
abnormalities	O
were	O
observed	O
in	O
muscles	O
of	O
normal	O
control	O
mice	O
.	O

J	O
.	O

A	O
mouse	B
brain	I
beta	I
-	I
spectrin	I
of	O
cDNA	O
was	O
identified	O
within	O
a	O
lambda	O
Gt11	O
expression	O
library	O
using	O
an	O
antibody	O
which	O
specifically	O
binds	O
with	O
the	O
235	B
kDa	I
spectrin	I
beta	I
-	I
subunit	I
.	O

The	O
csbA	B
fusion	I
was	O
maximally	O
expressed	O
during	O
early	O
stationary	O
phase	O
in	O
cells	O
grown	O
in	O
Luria	O
broth	O
containing	O
5	O
%	O
glucose	O
and	O
0	O
.	O
2	O
%	O
glutamine	O
.	O

The	O
authors	O
evaluated	O
the	O
potential	O
for	O
thrombotic	O
complications	O
arising	O
from	O
implantation	O
of	O
a	O
ventricular	O
assist	O
device	O
(	O
Sarns	O
/	O
3M	O
-	O
VAD	O
)	O
in	O
four	O
calves	O
.	O

We	O
obtained	O
quantitative	O
evidence	O
on	O
the	O
coding	O
of	O
interaural	O
time	O
differences	O
(	O
ITDs	O
)	O
of	O
click	O
stimuli	O
by	O
40	O
single	O
neurons	O
in	O
the	O
auditory	O
cortex	O
of	O
anesthetized	O
albino	O
rats	O
.	O

CONCLUSION	O
:	O
Monitoring	O
SpO2	O
at	O
the	O
nasal	O
septum	O
site	O
is	O
more	O
reliable	O
than	O
monitoring	O
it	O
at	O
the	O
finger	O
site	O
in	O
hypothermic	O
patients	O
.	O

Diltiazem	O
decreased	O
the	O
total	O
body	O
clearance	O
from	O
34	O
.	O
0	O
+/-	O
8	O
.	O
0	O
to	O
28	O
.	O
6	O
+/-	O
6	O
.	O
1	O
mL	O
/	O
min	O
(	O
P	O
less	O
than	O
.	O
01	O
),	O
and	O
prolonged	O
the	O
elimination	O
half	O
-	O
life	O
from	O
12	O
.	O
6	O
+/-	O
3	O
.	O
0	O
to	O
14	O
.	O
3	O
+/-	O
2	O
.	O
5	O
hours	O
(	O
P	O
less	O
than	O
.	O
01	O
)	O
of	O
antipyrine	O
without	O
any	O
changes	O
in	O
volume	O
of	O
distribution	O
.	O

Hence	O
,	O
the	O
uPA	B
promoter	I
contains	O
multiple	O
weak	O
cis	O
-	O
acting	O
elements	O
distributed	O
over	O
7	O
.	O
0	O
kb	O
5	O
'	O
to	O
the	O
translation	O
start	O
site	O
.	O

Substituting	O
a	O
Ser	O
for	O
Gly69	O
or	O
a	O
Glu	O
for	O
Lys	O
71	O
in	O
the	O
conserved	O
TGEK	B
tetrapeptide	I
in	I
finger	I
II	I
of	O
TFIIIA	B
resulted	O
in	O
the	O
loss	O
of	O
DNA	O
binding	O
.	O

In	O
one	O
,	O
exploratory	O
behavior	O
(	O
assessed	O
by	O
hole	O
pokes	O
)	O
and	O
locomotion	O
were	O
assessed	O
during	O
a	O
10	O
-	O
min	O
test	O
session	O
.	O

12	O
-	O
O	O
-	O
Tetradecanoylphorbol	O
13	O
-	O
acetate	O
was	O
found	O
to	O
inhibit	O
rapidly	O
and	O
potently	O
the	O
expression	O
of	O
mRNAs	O
coding	O
for	O
the	O
myogenic	O
regulators	O
CMD1	B
and	O
myogenin	B
.	O

A	O
method	O
is	O
described	O
for	O
detecting	O
targeted	O
events	O
at	O
the	O
mu	B
heavy	I
chain	I
gene	I
which	O
relies	O
on	O
co	O
-	O
conversion	O
(	O
or	O
co	O
-	O
exchange	O
)	O
of	O
a	O
point	O
mutation	O
with	O
a	O
selectable	O
marker	O
contained	O
on	O
a	O
replacement	O
vector	O
.	O

We	O
exploit	O
the	O
properties	O
of	O
LexA	B
fusion	I
proteins	I
to	O
study	O
the	O
dimerization	O
and	O
DNA	O
-	O
contacting	O
domains	O
of	O
cRel	B
.	O

The	O
alcoholic	O
patient	O
,	O
his	O
work	O
and	O
the	O
subjectivity	O
of	O
the	O
period	O

The	O
possible	O
mechanisms	O
underlying	O
differences	O
in	O
post	O
-	O
tetanic	O
effects	O
from	O
muscle	O
and	O
cutaneous	O
afferents	O
in	O
adults	O
and	O
neonates	O
are	O
discussed	O
.	O

First	O
,	O
the	O
finding	O
of	O
a	O
monomeric	O
Alu	B
family	I
repeat	I
at	O
the	O
junction	O
between	O
nonhomology	O
block	O
I	O
and	O
homology	O
block	O
Y	O
of	O
the	O
alpha	B
2	I
gene	I
-	I
containing	O
unit	O
in	O
rhesus	O
macaque	O
suggests	O
that	O
the	O
dimeric	O
Alu	B
family	I
repeat	I
,	O
Alu	B
3	I
,	O
at	O
the	O
orthologous	O
position	O
in	O
human	O
was	O
generated	O
by	O
insertion	O
of	O
a	O
monomeric	O
Alu	B
family	I
repeat	I
into	O
the	O
3	O
'	O
end	O
of	O
another	O
preexisting	O
Alu	B
family	I
repeat	I
.	O

Felodipine	O
did	O
not	O
alter	O
the	O
baseline	O
FEV1	O
,	O
but	O
showed	O
a	O
small	O
significant	O
inhibitory	O
effect	O
upon	O
histamine	O
and	O
AMP	O
induced	O
bronchoconstriction	O
.	O

Extramedullary	O
relapse	O
in	O
childhood	O
leukemia	O
.	O

CT	O
abnormalities	O
noted	O
in	O
term	O
babies	O
included	O
hemorrhage	O
(	O
subarachnoid	O
5	O
.	O
8	O
%,	O
intracerebral	O
11	O
.	O
6	O
%),	O
hypodensity	O
(	O
mild	O
23	O
.	O
2	O
%,	O
moderate	O
11	O
.	O
6	O
%	O
severe	O
5	O
.	O
8	O
%);	O
hypodensity	O
with	O
hemorrhage	O
5	O
.	O
8	O
%	O
and	O
cerebral	O
atrophy	O
5	O
.	O
8	O
%.	O

TPTA	O
produced	O
brain	O
congestion	O
,	O
and	O
hepatic	O
and	O
pulmonary	O
petechial	O
and	O
generalized	O
hemorrhages	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
identified	O
a	O
strong	O
positive	O
cis	O
-	O
regulatory	O
element	O
at	O
-	O
70	O
bp	O
to	O
-	O
75	O
bp	O
in	O
the	O
LpS1	B
beta	I
promoter	I
with	O
the	O
sequence	O
(	O
G	O
)	O
6	O
and	O
a	O
similar	O
,	O
more	O
distal	O
cis	O
-	O
element	O
at	O
-	O
721	O
bp	O
to	O
-	O
726	O
bp	O
.	O

Resolution	O
of	O
thermographic	O
asymmetry	O
and	O
/	O
or	O
decrease	O
in	O
Delta	O
T	O
was	O
demonstrated	O
in	O
approximately	O
81	O
%	O
of	O
the	O
post	O
-	O
treatment	O
population	O
.	O

It	O
is	O
transparent	O
,	O
cheap	O
to	O
be	O
made	O
,	O
and	O
easy	O
to	O
empty	O
and	O
was	O
tested	O
in	O
118	O
animals	O
for	O
two	O
and	O
four	O
weeks	O
.	O

Potential	O
translational	O
start	O
signals	O
are	O
upstream	O
of	O
ORF1	O
and	O
ORF2	O
.	O

The	O
abundance	O
of	O
transcripts	O
from	O
several	O
unrelated	O
genes	O
is	O
decreased	O
in	O
cdc68	B
-	I
1	I
mutant	I
cells	O
after	O
transfer	O
to	O
the	O
restrictive	O
temperature	O
,	O
while	O
at	O
least	O
one	O
transcript	O
,	O
from	O
the	O
HSP82	B
gene	I
,	O
persists	O
in	O
an	O
aberrant	O
fashion	O
.	O

Previous	O
analysis	O
of	O
the	O
98	O
-	O
bp	O
sequence	O
has	O
delineated	O
several	O
protein	B
-	I
binding	I
domains	I
that	O
are	O
recognized	O
by	O
nuclear	O
factors	O
present	O
in	O
human	O
brain	O
cells	O
.	O

Whereas	O
a	O
PR55	B
beta	I
transcript	I
of	O
about	O
2	O
.	O
3	O
kb	O
was	O
detected	O
at	O
high	O
levels	O
in	O
the	O
neuroblastoma	O
derived	O
cell	O
line	O
LA	O
-	O
N	B
-	I
1	I
,	O
the	O
level	O
of	O
the	O
mRNA	O
was	O
very	O
low	O
in	O
the	O
other	O
human	O
cell	O
lines	O
analyzed	O
.	O

Heterodimers	O
of	O
myogenin	B
and	O
E12	B
(	O
or	O
MyoD	B
and	O
E12	B
)	O
specifically	O
bound	O
a	O
restriction	O
fragment	O
extending	O
from	O
-	O
200	O
to	O
-	O
103	O
relative	O
to	O
the	O
start	O
of	O
cardiac	B
alpha	I
-	I
actin	I
transcription	I
.	O

Nucleotide	O
sequences	O
between	O
the	O
env	B
gene	I
and	O
the	O
LTR	O
of	O
SFV	O
-	O
1	O
were	O
determined	O
.	O

Review	O
:	O
deterioration	O
of	O
glucose	O
tolerance	O
with	O
age	O
:	O
the	O
role	O
of	O
insulin	B
resistance	O
.	O

Thyroid	O
lymphoma	O
and	O
its	O
management	O
.	O

Arterial	O
radioactivity	O
content	O
after	O
the	O
intravenous	O
administration	O
of	O
HMPAO	O
in	O
seven	O
human	O
subjects	O
was	O
analyzed	O
.	O

This	O
indicates	O
that	O
under	O
certain	O
experimental	O
conditions	O
cdc2	B
/	O
p58	B
and	O
cdc2	B
/	O
p62	B
may	O
express	O
some	O
differences	O
in	O
their	O
catalytic	O
activity	O
.	O

Uptake	O
of	O
ofloxacin	O
by	O
Escherichia	O
coli	O

Chlamydia	O
trachomatis	O
and	O
Chlamydia	O
psittaci	O
were	O
not	O
affected	O
by	O
methanol	O
fixation	O
.	O

A	O
deletion	O
series	O
of	O
the	O
5	O
'	O
flanking	O
region	O
was	O
created	O
from	O
position	O
-	O
1329	O
to	O
-	O
74	O
relative	O
to	O
the	O
transcriptional	O
initiation	O
site	O
and	O
similarly	O
examined	O
in	O
transgenic	O
tobacco	O
.	O

Thus	O
,	O
two	O
very	O
different	O
regulatory	O
elements	O
are	O
used	O
to	O
mediate	O
estrogen	O
induction	O
of	O
related	O
genes	O
in	O
chickens	O
and	O
amphibians	O
.	O

Increasing	O
mean	O
arterial	O
pressure	O
by	O
phenylephrine	O
infusion	O
to	O
levels	O
much	O
greater	O
than	O
produced	O
by	O
NMA	O
and	O
NNA	O
caused	O
only	O
small	O
reductions	O
in	O
cardiac	O
output	O
.	O

The	O
IE0	B
gene	I
product	I
also	O
transactivated	O
the	O
IE1	B
promoter	I
but	O
did	O
not	O
affect	O
expression	O
from	O
its	O
own	O
promoter	O
.	O

Bone	O
marrow	O
abnormalities	O
in	O
Hodgkin	O
'	O
s	O
disease	O
are	O
reviewed	O
and	O
the	O
current	O
understanding	O
of	O
the	O
pathological	O
mechanisms	O
leading	O
to	O
aplastic	O
anemia	O
is	O
discussed	O
.	O

DNA	O
hybridization	O
analysis	O
revealed	O
that	O
both	O
pigmented	O
and	O
nonpigmented	O
cells	O
of	O
Y	O
.	O
pestis	O
possess	O
a	O
DNA	O
locus	O
homologous	O
to	O
the	O
Escherichia	B
coli	I
fur	I
gene	I
.	O

Determinants	O
of	O
recurrent	O
ischaemia	O
and	O
revascularisation	O
procedures	O
after	O
thrombolysis	O
with	O
recombinant	B
tissue	I
plasminogen	I
activator	I
in	O
primary	O
coronary	O
occlusion	O
.	O

Relationship	O
between	O
mitochondrial	B
NADH	I
-	I
ubiquinone	I
reductase	I
and	O
a	O
bacterial	B
NAD	I
-	I
reducing	I
hydrogenase	I
.	O

One	O
of	O
its	O
lysine	O
residues	O
is	O
modified	O
by	O
spermidine	O
to	O
form	O
hypusine	O
,	O
a	O
posttranslational	O
modification	O
unique	O
to	O
eIF	B
-	I
5A	I
.	O

In	O
this	O
study	O
,	O
we	O
have	O
cloned	O
the	O
5	O
'-	O
flanking	O
region	O
of	O
the	O
human	B
nidogen	I
gene	I
.	O

Consistent	O
with	O
the	O
in	O
vivo	O
result	O
,	O
the	O
pseudorevertant	O
endonucleases	O
in	O
the	O
crude	O
cell	O
extract	O
display	O
site	O
-	O
specific	O
partial	O
DNA	O
cleavage	O
activity	O
.	O

Additionally	O
,	O
I	B
kappa	I
B	I
beta	I
,	O
but	O
not	O
I	B
kappa	I
B	I
alpha	I
,	O
also	O
prevented	O
the	O
binding	O
of	O
Rel	B
to	O
the	O
kappa	B
B	I
site	I
.	O

In	O
study	O
2	O
,	O
the	O
correlation	O
coefficients	O
between	O
the	O
ISO2	O
measurements	O
obtained	O
at	O
the	O
ulcer	O
margin	O
and	O
at	O
the	O
adjacent	O
normal	O
mucosa	O
,	O
and	O
delta	O
ISO2	O
obtained	O
by	O
the	O
experienced	O
observer	O
and	O
one	O
of	O
the	O
three	O
learners	O
were	O
0	O
.	O
94	O
,	O
0	O
.	O
97	O
,	O
and	O
0	O
.	O
94	O
,	O
respectively	O
.	O

Anti	B
-	I
HBc	I
production	O
of	O
PBMC	O
was	O
enhanced	O
remarkably	O
in	O
this	O
case	O
.	O

Sequence	O
analysis	O
of	O
the	O
sMtCK	B
genomic	O
upstream	O
sequences	O
reveals	O
a	O
typical	O
TATAA	O
box	O
within	O
the	O
80	O
base	O
pairs	O
(	O
bp	O
)	O
that	O
,	O
by	O
transfection	O
experiments	O
,	O
are	O
sufficient	O
to	O
promote	O
expression	O
of	O
chimeric	O
plasmids	O
with	O
the	O
chloramphenicol	B
acetyltransferase	I
reporter	I
.	O

Comparison	O
of	O
the	O
cDNA	O
-	O
predicted	O
avian	B
TnIcardiac	I
amino	O
acid	O
sequences	O
with	O
known	O
TnI	B
sequences	I
indicated	O
1	O
)	O
that	O
the	O
presence	O
of	O
an	O
N	O
-	O
terminal	O
extension	O
sequence	O
carrying	O
a	O
dual	O
protein	B
kinase	I
A	I
phosphorylation	O
target	O
site	O
and	O
an	O
adjacent	O
proline	O
-	O
rich	O
segment	O
is	O
an	O
ancient	O
cardiac	O
-	O
specific	O
feature	O
of	O
TnI	B
which	O
has	O
been	O
conserved	O
since	O
the	O
bird	O
/	O
mammal	O
divergence	O
,	O
2	O
)	O
that	O
features	O
of	O
the	O
near	O
-	O
N	B
-	I
terminal	I
troponin	I
C	I
(	I
TnC	I
)-	I
binding	I
site	I
sequence	I
suggest	O
isoform	O
-	O
specific	O
adaptation	O
of	O
TnI	B
and	I
TnC	I
,	O
and	O
3	O
)	O
that	O
the	O
avian	B
TnIcardiac	I
internal	O
actin	B
/	I
TnC	I
-	I
binding	I
,	I
actomyosin	I
-	I
inhibitory	I
,	O
domain	O
shows	O
significant	O
sequence	O
divergence	O
from	O
mammalian	B
TnIcardiac	I
sequences	I
,	O
including	O
the	O
absence	O
of	O
a	O
protein	B
kinase	I
C	I
target	I
site	I
which	O
is	O
a	O
cardiac	O
-	O
specific	O
feature	O
of	O
TnI	B
in	O
mammals	O
.	O

Of	O
these	O
179	O
samples	O
,	O
Mobiluncus	O
SP	O
was	O
observed	O
in	O
35	O
(	O
19	O
.	O
6	O
%)	O
using	O
Gram	O
staining	O
and	O
in	O
18	O
(	O
10	O
.	O
1	O
%)	O
this	O
microorganism	O
was	O
isolated	O
in	O
agar	O
RLK	O
and	O
anaerobic	O
atmosphere	O
.	O

Twenty	O
-	O
four	O
hours	O
later	O
,	O
the	O
animals	O
were	O
randomized	O
to	O
subretinal	O
treatment	O
with	O
2	O
.	O
5	O
micrograms	O
of	O
tissue	B
plasminogen	I
activator	I
or	O
a	O
similar	O
volume	O
of	O
physiologic	O
saline	O
.	O

Fusion	O
of	O
ubiquitin	B
to	O
pADPRP	B
increased	O
the	O
yield	O
of	O
pADPRP	B
approximately	O
10	O
-	O
fold	O
compared	O
to	O
that	O
of	O
the	O
unfused	O
enzyme	O
.	O

Skeletal	O
muscle	O
metaboreceptor	O
responses	O
are	O
impaired	O
in	O
heart	O
failure	O
.	O

Neither	O
model	O
,	O
as	O
applied	O
,	O
provided	O
a	O
satisfactory	O
account	O
of	O
the	O
effects	O
of	O
the	O
main	O
variables	O
of	O
number	O
of	O
tones	O
and	O
amount	O
of	O
perturbation	O
.(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

The	O
effect	O
of	O
diffusion	O
limitation	O
was	O
quantified	O
in	O
terms	O
of	O
the	O
ratio	O
O2	O
uptake	O
/	O
O2	O
requirement	O
(=	O
fraction	O
of	O
cross	O
-	O
sectional	O
area	O
supplied	O
with	O
O2	O
),	O
assuming	O
local	O
O2	O
requirement	O
per	O
unit	O
volume	O
to	O
be	O
constant	O
and	O
independent	O
of	O
PO2	O
at	O
PO2	O
greater	O
than	O
0	O
.	O

(	O
2	O
)	O
Diffusion	O
limitation	O
in	O
the	O
heterogeneous	O
model	O
sets	O
in	O
at	O
a	O
lower	O
O2	O
requirement	O
value	O
,	O
and	O
increases	O
more	O
gradually	O
with	O
increasing	O
O2	O
requirement	O
,	O
than	O
in	O
the	O
corresponding	O
homogeneous	O
models	O
with	O
the	O
same	O
average	O
cylinder	O
diameter	O
.	O

The	O
antihypertensive	O
effect	O
of	O
Estulic	O
has	O
been	O
examined	O
over	O
a	O
12	O
-	O
month	O
period	O
in	O
101	O
hypertensive	O
patients	O
.	O

The	O
sequence	O
was	O
determined	O
of	O
6493	O
nucleotides	O
encompassing	O
the	O
bet	B
genes	I
of	O
Escherichia	O
coli	O
which	O
encode	O
the	O
osmoregulatory	O
choline	O
-	O
glycine	O
betaine	O
pathway	O
.	O

Confocal	O
fluorescence	O
microscopy	O
in	O
modern	O
cell	O
biology	O
.	O

Urine	O
specimens	O
containing	O
either	O
phencyclidine	O
(	O
PCP	O
)	O
or	O
11	O
-	O
nor	O
-	O
delta	O
9	O
-	O
tetrahydrocannabinol	O
-	O
9	O
-	O
carboxylic	O
acid	O
(	O
9	O
-	O
THC	O
-	O
COOH	O
)	O
were	O
adulterated	O
with	O
sodium	O
chloride	O
,	O
bleach	O
,	O
vinegar	O
,	O
potassium	O
hydroxide	O
,	O
liquid	O
soap	O
,	O
2	O
-	O
propanol	O
,	O
and	O
ammonia	O
.	O

Dose	O
standardisation	O
of	O
botulinum	B
toxin	I
.	O

During	O
exercise	O
K	O
+	O
is	O
released	O
from	O
contracting	O
muscle	O
and	O
plasma	O
K	O
+	O
concentration	O
rises	O
.	O

After	O
base	O
-	O
line	O
CBF	O
was	O
established	O
,	O
hexamethonium	O
bromide	O
(	O
2	O
mg	O
/	O
kg	O
iv	O
),	O
ipratropium	O
bromide	O
(	O
0	O
.	O
5	O
microgram	O
/	O
kg	O
iv	O
),	O
indomethacin	O
(	O
2	O
mg	O
/	O
kg	O
iv	O
),	O
or	O
intravenous	O
0	O
.	O
9	O
%	O
saline	O
was	O
administered	O
.	O

A	O
high	O
-	O
frequency	O
restriction	O
fragment	O
length	O
polymorphism	O
was	O
evident	O
in	O
the	O
DNA	O
from	O
29	O
unrelated	O
individuals	O
using	O
the	O
enzyme	O
BglII	B
.	O

This	O
study	O
suggests	O
that	O
BSPMs	O
are	O
useful	O
in	O
the	O
assessment	O
of	O
AMI	O
in	O
terms	O
of	O
diagnosis	O
,	O
location	O
and	O
extent	O
of	O
myocardial	O
infarct	O
.	O

Early	O
cirrhosis	O
,	O
an	O
early	O
modality	O
of	O
the	O
evolution	O
of	O
acute	O
hepatitis	O
.	O

Combined	O
therapy	O
with	O
MK	O
-	O
801	O
and	O
nimodipine	O
for	O
protection	O
of	O
ischemic	O
brain	O
damage	O
.	O

The	O
addition	O
of	O
an	O
equimolar	O
complex	O
of	O
the	O
fourth	O
and	O
seventh	O
largest	O
subunits	O
,	O
purified	O
from	O
pol	B
II	I
holoenzyme	O
by	O
ion	O
-	O
exchange	O
chromatography	O
in	O
the	O
presence	O
of	O
urea	O
,	O
restored	O
promoter	O
-	O
directed	O
initiation	O
activity	O
to	O
pol	B
II	I
delta	I
4	I
/	I
7	O
.	O

We	O
report	O
here	O
the	O
identification	O
of	O
HSF	B
in	O
the	O
fission	O
yeast	O
Schizosaccharomyces	O
pombe	O
.	O

Induction	O
requires	O
the	O
ACE1	B
gene	I
product	I
,	O
which	O
binds	O
to	O
specific	O
sites	O
in	O
the	O
promoter	O
region	O
of	O
the	O
CUP1	B
gene	I
.	O

The	O
sequence	O
of	O
four	O
clones	O
was	O
sufficient	O
to	O
construct	O
a	O
3018	B
-	I
bp	I
BAL	I
cDNA	I
structure	O
.	O

A	O
.	O

Perilunar	O
luxation	O
--	O
an	O
unusual	O
injury	O
demanding	O
immediate	O
and	O
correct	O
treatment	O

Landsberg	O
(	O
La	B
-	I
O	I
)	O
and	O
cv	O
.	O

The	O
cdr1	B
sequence	I
includes	O
an	O
additional	O
237	O
amino	O
acids	O
of	O
the	O
contiguous	O
fragment	O
and	O
encodes	O
a	O
product	O
of	O
predicted	O
Mr	O
67	O
,	O
000	O
.	O

Armed	O
with	O
a	O
clear	O
understanding	O
of	O
the	O
pathophysiologic	O
pathways	O
that	O
may	O
cause	O
and	O
/	O
or	O
contribute	O
to	O
the	O
development	O
of	O
unconjugated	O
hyperbilirubinemia	O
and	O
the	O
associated	O
jaundice	O
,	O
the	O
practitioner	O
will	O
be	O
successful	O
in	O
helping	O
the	O
family	O
understand	O
their	O
child	O
'	O
s	O
illness	O
.	O

A	O
further	O
subdivision	O
of	O
Category	O
pN1	O
into	O
pN1a	O
(	O
metastasis	O
in	O
single	O
node	O
)	O
and	O
pN1b	O
(	O
two	O
or	O
more	O
nodes	O
)	O
is	O
recommended	O
.	O

These	O
differences	O
involve	O
specific	O
hydrogen	O
-	O
bonding	O
interactions	O
between	O
the	O
protein	O
and	O
DNA	O
,	O
including	O
guanine	O
N7	O
sites	O
in	O
the	O
major	O
groove	O
of	O
DNA	O
,	O
and	O
alterations	O
in	O
DNA	O
phosphodiester	O
conformation	O
induced	O
by	O
protein	O
binding	O
.	O

I	O
propose	O
that	O
their	O
gene	O
products	O
bind	O
to	O
the	O
chromatin	O
to	O
establish	O
or	O
maintain	O
a	O
proper	O
higher	O
order	O
structure	O
as	O
a	O
prerequisite	O
for	O
a	O
regulated	O
gene	O
expression	O
.	O

Once	O
the	O
proliferation	O
of	O
fibroblasts	O
and	O
collagen	B
synthesis	O
had	O
led	O
to	O
an	O
increase	O
of	O
mechanical	O
strength	O
,	O
no	O
negative	O
effect	O
on	O
wound	O
healing	O
could	O
be	O
detected	O
applying	O
the	O
same	O
chemotherapeutic	O
agents	O
.	O

Differences	O
in	O
the	O
clinical	O
presentation	O
and	O
the	O
gross	O
appearance	O
of	O
the	O
two	O
cases	O
are	O
described	O
,	O
and	O
similarities	O
in	O
the	O
microscopic	O
features	O
are	O
discussed	O
.	O

Two	O
patients	O
had	O
immediate	O
adverse	O
effects	O
from	O
NMF	O
;	O
one	O
had	O
a	O
grand	O
mal	O
seizure	O
and	O
the	O
other	O
developed	O
severe	O
abdominal	O
pain	O
.	O

To	O
test	O
promotor	O
function	O
,	O
chimeric	O
genes	O
were	O
constructed	O
linking	O
fragments	O
of	O
chicken	B
IGF	I
-	I
I	I
5	O
'-	O
flanking	O
DNA	O
to	O
a	O
promoterless	O
reporter	O
plasmid	O
.	O

The	O
alpha	B
4	I
gene	I
5	O
'	O
flanking	O
region	O
acted	O
as	O
a	O
promoter	O
in	O
transfection	O
assays	O
.	O

Only	O
the	O
3	O
.	O
0	O
-	O
kb	O
transcript	O
was	O
detected	O
in	O
adult	O
tissues	O
,	O
where	O
its	O
expression	O
was	O
restricted	O
almost	O
exclusively	O
to	O
the	O
central	O
nervous	O
system	O
.	O

We	O
examined	O
the	O
effects	O
of	O
long	O
-	O
term	O
perfusion	O
with	O
pyridoxalated	O
hemoglobin	B
polyoxyethylene	O
conjugate	O
(	O
PHP	O
)	O
solution	O
on	O
cardiac	O
function	O
of	O
isolated	O
rat	O
hearts	O
.	O

A	O
single	O
case	O
of	O
an	O
adenocarcinoma	O
,	O
arising	O
in	O
a	O
retroperitoneal	O
enterogenous	O
cyst	O
and	O
which	O
presented	O
as	O
a	O
left	O
renal	O
cyst	O
,	O
is	O
reported	O
.	O

Using	O
the	O
polymerase	O
chain	O
reaction	O
,	O
we	O
analyzed	O
the	O
U6	B
RNA	I
genes	I
of	O
52	O
organisms	O
.	O

Both	O
tear	O
volume	O
and	O
tear	O
flow	O
were	O
found	O
to	O
be	O
significantly	O
(	O
P	O
less	O
than	O
0	O
.	O
001	O
)	O
decreased	O
up	O
to	O
6	O
h	O
after	O
instillation	O
,	O
reaching	O
a	O
minimum	O
90	O
min	O
after	O
application	O
(	O
tear	O
volume	O
:	O
-	O
63	O
%;	O
tear	O
flow	O
:	O
-	O
71	O
%).	O

Furthermore	O
,	O
the	O
DNA	B
polymerase	I
II	I
complex	I
was	O
difficult	O
to	O
obtain	O
from	O
dpb2	B
-	I
1	I
mutant	I
cells	O
,	O
suggesting	O
that	O
a	O
stable	O
DNA	B
polymerase	I
II	I
complex	I
requires	O
DPB2	B
and	O
is	O
essential	O
for	O
chromosomal	O
replication	O
.	O

There	O
were	O
45	O
to	O
56	O
nt	O
differences	O
between	O
the	O
virulent	O
and	O
avirulent	O
groups	O
while	O
there	O
were	O
6	O
to	O
14	O
nt	O
differences	O
among	O
four	O
avirulent	O
strains	O
.	O

Hemorrhagic	O
shock	O
and	O
bacterial	O
translocation	O
in	O
a	O
swine	O
model	O
.	O

When	O
given	O
the	O
choice	O
between	O
an	O
estrous	O
female	O
and	O
a	O
sexually	O
active	O
male	O
in	O
the	O
AOF	O
,	O
flutamide	O
females	O
,	O
as	O
well	O
as	O
controls	O
,	O
preferred	O
the	O
male	O
partner	O
.	O

Very	O
small	O
deletions	O
within	O
the	O
conserved	O
region	O
completely	O
abolished	O
transforming	O
activity	O
of	O
dbl	B
,	O
while	O
extensive	O
deletion	O
outside	O
of	O
this	O
region	O
had	O
no	O
effect	O
.	O

Endothelial	O
cell	O
seeding	O
.	O

Gemfibrozil	O
in	O
hyperlipidaemic	O
patients	O
with	O
peripheral	O
arterial	O
disease	O
:	O
some	O
undiscovered	O
actions	O
.	O

Its	O
application	O
in	O
Madagascar	O
:	O
advantages	O
and	O
disadvantages	O

Phosphopeptide	O
mapping	O
revealed	O
the	O
same	O
autophosphorylation	O
sites	O
utilized	O
by	O
EGFR	B
-	I
IC	I
as	O
those	O
identified	O
in	O
wild	B
-	I
type	I
EGFR	I
.	O

In	O
this	O
model	O
,	O
eltoprazine	O
has	O
a	O
very	O
specific	O
anti	B
-	I
aggressive	O
(	O
serenic	O
)	O
profile	O
,	O
inhibiting	O
aggression	O
while	O
social	O
interaction	O
and	O
exploration	O
are	O
not	O
decreased	O
but	O
even	O
enhanced	O
;	O
inactivity	O
,	O
a	O
measure	O
for	O
sedation	O
,	O
is	O
not	O
affected	O
.	O

ARPIA	O
has	O
been	O
implemented	O
by	O
using	O
a	O
relational	O
DBMS	O
,	O
very	O
cheap	O
and	O
highly	O
diffused	O
on	O
personal	O
computers	O
.	O

Diuresis	O
was	O
induced	O
by	O
scheduled	O
drinking	O
of	O
tea	O
(	O
150	O
ml	O
/	O
h	O
).	O

Diagnostic	O
value	O
of	O
adenosine	B
deaminase	I
activity	O
in	O
tuberculous	O
effusions	O
.	O

No	O
patient	O
had	O
a	O
history	O
of	O
excess	O
alcohol	O
intake	O
,	O
or	O
prolonged	O
intake	O
of	O
hepatotoxic	O
drugs	O
and	O
steroids	O
,	O
and	O
were	O
not	O
obese	O
or	O
malnourished	O
.	O

An	O
evolutionary	O
comparison	O
of	O
amino	O
acid	O
sequences	O
of	O
34	O
HSP70	B
proteins	I
from	O
17	O
species	O
suggests	O
that	O
BiP	B
genes	I
share	O
a	O
common	O
ancestor	O
,	O
which	O
diverged	O
from	O
other	O
HSP70	B
genes	I
near	O
the	O
time	O
when	O
eukaryotes	O
first	O
appeared	O
.	O

Reverse	B
transcription	I
-	I
PCR	O
was	O
then	O
used	O
to	O
clone	O
from	O
human	O
poly	O
(	O
A	O
)+	O
RNA	O
the	O
cDNA	O
corresponding	O
to	O
the	O
expressed	O
homolog	O
of	O
psi	B
ARF	I
4	I
,	O
referred	O
to	O
as	O
human	B
ARF	I
4	I
.	O

Sequencing	O
the	O
gene	O
for	O
an	O
imipenem	O
-	O
cefoxitin	O
-	O
hydrolyzing	O
enzyme	O
(	O
CfiA	B
)	O
from	O
Bacteroides	O
fragilis	O
TAL2480	O
reveals	O
strong	O
similarity	O
between	O
CfiA	B
and	I
Bacillus	I
cereus	I
beta	I
-	I
lactamase	I
II	I
.	O

The	O
interindividual	O
variability	O
of	O
the	O
parameters	O
is	O
taken	O
into	O
consideration	O
by	O
interactively	O
determining	O
the	O
threshold	O
levels	O
.	O

Our	O
results	O
suggest	O
that	O
a	O
sequence	O
match	O
between	O
enhancers	O
and	O
certain	O
promoter	O
elements	O
is	O
critical	O
.	O

This	O
Mr	O
is	O
similar	O
to	O
those	O
of	O
the	O
purified	B
smg	I
p25A	I
GDI	I
estimated	O
by	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
and	O
sucrose	O
density	O
gradient	O
ultracentrifugation	O
,	O
which	O
are	O
about	O
54	O
,	O
000	O
and	O
65	O
,	O
000	O
,	O
respectively	O
.	O

In	O
this	O
paper	O
,	O
we	O
have	O
analyzed	O
the	O
structure	O
of	O
human	B
gene	I
for	O
Gx	B
alpha	I
,	O
which	O
spans	O
more	O
than	O
60	O
kilobases	O
.	O

In	O
addition	O
,	O
the	O
-	O
119	O
to	O
-	O
81	O
fragment	O
of	O
the	O
CCK	B
promoter	I
contains	O
a	O
transcriptional	O
enhancer	O
that	O
potentiates	O
the	O
transcription	O
from	O
the	O
herpes	B
simplex	I
virus	I
thymidine	I
kinase	I
promoter	I
in	O
a	O
position	O
-	O
and	O
orientation	O
-	O
independent	O
manner	O
.	O

Disruption	O
of	O
ARF2	B
causes	O
no	O
detectable	O
phenotype	O
.	O

Furthermore	O
,	O
expression	O
of	O
the	O
promoter	O
in	O
embryonic	O
Drosophila	B
melanogaster	I
cells	O
that	O
lack	O
MyoD1	B
and	O
Sp1	B
is	O
strictly	O
dependent	O
on	O
all	O
three	O
sites	O
remaining	O
intact	O
and	O
on	O
the	O
presence	O
of	O
exogenously	O
supplied	O
Sp1	B
and	O
MyoD1	B
.	O

Of	O
848	O
patients	O
,	O
819	O
cases	O
with	O
complete	O
description	O
of	O
patient	O
'	O
s	O
background	O
were	O
evaluable	O
:	O
Group	O
A	O
(	O
surgery	O
+	O
MMC	O
+	O
5	O
-	O
FU	O
:	O
chemotherapy	O
)	O
253	O
cases	O
,	O
group	O
B	O
(	O
surgery	O
+	O
MMC	O
+	O
5	O
-	O
FU	O
+	O
OK	O
-	O
432	O
or	O
PSK	O
:	O
immunochemotherapy	O
)	O
282	O
and	O
group	O
C	O
(	O
surgery	O
alone	O
)	O
284	O
.	O

PBSX	B
is	O
induced	O
by	O
agents	O
which	O
elicit	O
the	O
SOS	O
response	O
.	O

Higher	O
fasting	O
serum	O
gastrin	B
concentration	O
(	O
102	O
.	O
0	O
+/-	O
21	O
.	O
1	O
vs	O
63	O
.	O
3	O
+/-	O
8	O
.	O
3	O
ng	O
.	O
l	O
-	O
1	O
),	O
and	O
greater	O
postprandial	O
gastrin	B
release	O
(	O
AUC0	O
-	O
120	O
:	O
16690	O
+/-	O
2648	O
vs	O
10654	O
+/-	O
1283	O
ng	O
.	O
l	O
-	O
1	O
min	O
)	O
were	O
observed	O
after	O
VTP	O
-	O
HM	O
than	O
after	O
VTP	O
-	O
Cas	B
.	O

This	O
study	O
was	O
performed	O
to	O
clarify	O
the	O
location	O
of	O
a	O
transesophageal	O
echocardiographic	O
(	O
TEE	O
)	O
transducer	O
when	O
obtaining	O
the	O
short	O
-	O
axis	O
view	O
of	O
the	O
left	O
ventricle	O
(	O
S	O
-	O
LV	O
).	O

Teicoplanin	O
was	O
given	O
most	O
often	O
because	O
of	O
persistent	O
fever	O
or	O
initial	O
Gram	O
-	O
positive	O
bacteraemia	O
and	O
only	O
one	O
-	O
third	O
of	O
these	O
cases	O
responded	O
.	O

Both	O
antidepressants	O
elevated	O
the	O
pain	O
threshold	O
acutely	O
,	O
while	O
pretreatment	O
with	O
pCPA	O
largely	O
blocked	O
the	O
analgesia	O
.	O

TCR	B
alpha	I
and	I
beta	I
gene	I
expression	O
may	O
be	O
regulated	O
by	O
a	O
common	O
set	O
of	O
T	B
-	I
cell	I
nuclear	I
proteins	I
in	O
that	O
the	O
T	B
beta	I
2	I
element	I
binding	I
a	O
set	O
of	O
cyclic	B
AMP	I
response	I
element	I
-	I
binding	I
proteins	I
that	O
are	O
also	O
bound	O
by	O
the	O
T	B
alpha	I
1	I
element	I
of	O
the	O
human	B
TCR	I
alpha	I
enhancer	I
and	O
the	O
decamer	O
element	O
present	O
in	O
a	O
large	O
number	O
of	O
human	O
and	O
murine	B
TCR	I
beta	I
promoters	I
.	O

In	O
contrast	O
,	O
the	O
CRE	O
of	O
the	O
human	O
c	B
-	I
fos	I
promoter	I
located	O
at	O
-	O
60	O
was	O
weakly	O
induced	O
by	O
cAMP	O
and	O
E1a	B
in	O
both	O
HeLa	O
and	O
PC12	O
cells	O
.	O

The	O
4	O
days	O
dexamethasone	O
suppression	O
test	O
showed	O
more	O
than	O
80	O
%	O
suppression	O
of	O
dehydroepiandrosterone	O
-	O
sulphate	O
and	O
a	O
variable	O
(	O
40	O
-	O
60	O
%)	O
reduction	O
of	O
testosterone	O
and	O
androstenedione	O
levels	O
.	O

This	O
result	O
indicates	O
that	O
separate	O
complexes	O
exist	O
containing	O
ankyrin	B
and	I
fodrin	I
with	O
either	O
uvomorulin	B
or	O
Na	B
+,	I
K	I
+-	I
ATPase	I
.	O

Whether	O
or	O
not	O
there	O
are	O
sequences	O
conferring	O
cAMP	O
responsiveness	O
which	O
are	O
common	O
both	O
to	O
P	B
-	I
450scc	I
and	O
the	O
other	O
steroidogenic	B
P	I
-	I
450	I
genes	I
remains	O
to	O
be	O
established	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
footprinting	O
and	O
gel	O
mobility	O
retardation	O
assays	O
to	O
reveal	O
that	O
bacterially	O
synthesized	O
Zta	B
fusion	I
proteins	I
bound	O
directly	O
to	O
six	O
TGTGCAA	O
-	O
like	O
motifs	O
within	O
DSL	B
.	O

The	O
zta	B
transactivator	I
involved	O
in	O
induction	O
of	O
lytic	O
cycle	O
gene	O
expression	O
in	O
Epstein	B
-	I
Barr	I
virus	I
-	I
infected	O
lymphocytes	O
binds	O
to	O
both	O
AP	B
-	I
1	I
and	O
ZRE	B
sites	I
in	O
target	O
promoter	O
and	O
enhancer	O
regions	O
.	O

Summers	O
,	O
Virology	O
89	O
:	O
517	O
-	O
527	O
,	O
1978	O
).	O

A	O
rabbit	O
antiserum	O
was	O
raised	O
against	O
a	O
synthetic	O
peptide	O
corresponding	O
to	O
a	O
hydrophilic	O
portion	O
of	O
the	O
translated	O
murine	O
cDNA	O
sequence	O
.	O

We	O
have	O
determined	O
the	O
nucleotide	O
(	O
nt	O
)	O
sequence	O
of	O
the	O
7	O
.	O
5	B
-	I
kb	I
COR	I
segment	O
that	O
encompasses	O
a	O
cluster	O
of	O
six	O
genes	O
(	O
CYC1	B
,	O
UTR1	O
,	O
UTR3	B
,	O
OSM1	B
,	O
tRNA	O
(	O
Gly	O
)	O
and	O
RAD7	B
)	O
located	O
on	O
chromosome	O
X	O
of	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

This	O
points	O
to	O
a	O
specific	O
interference	O
with	O
HSV	B
-	I
induced	O
DNA	O
amplification	O
.	O

Constructs	O
were	O
made	O
in	O
which	O
an	O
AATAAA	O
and	O
the	O
GT	B
-	I
rich	O
region	O
were	O
separated	O
by	O
various	O
distances	O
ranging	O
from	O
7	O
to	O
43	O
bp	O
.	O

It	O
is	O
likely	O
that	O
the	O
sequence	O
similarities	O
reflect	O
a	O
common	O
molecular	O
architecture	O
of	O
the	O
two	O
heme	O
binding	O
sites	O
and	O
of	O
a	O
copper	O
binding	O
site	O
in	O
these	O
enzymes	O
.	O

The	O
cDNA	O
sequence	O
has	O
an	O
813	O
-	O
bp	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
whose	O
predicted	O
amino	O
acid	O
sequence	O
is	O
97	O
.	O
6	O
%	O
identical	O
to	O
the	O
272	O
carboxy	O
-	O
terminal	O
amino	O
acids	O
of	O
the	O
human	B
ets	I
-	I
1	I
protein	I
.	O

The	O
TraD	B
protein	I
(	I
83	I
,	I
899	I
Da	I
)	O
contains	O
three	O
hydrophobic	O
regions	O
,	O
of	O
which	O
two	O
are	O
located	O
near	O
the	O
amino	O
-	O
terminal	O
region	O
.	O

Various	O
mutant	O
HN	B
genes	I
were	O
constructed	O
to	O
examine	O
the	O
role	O
of	O
residues	O
flanking	O
the	O
signal	B
-	I
anchor	I
domain	I
,	O
including	O
the	O
cytoplasmic	O
tail	O
,	O
on	O
assembly	O
and	O
intracellular	O
transport	O
of	O
the	O
HN	B
glycoprotein	I
.	O

Disruption	O
of	O
the	O
IRA2	B
gene	I
resulted	O
in	O
(	O
i	O
)	O
increased	O
sensitivity	O
to	O
heat	O
shock	O
and	O
nitrogen	O
starvation	O
,	O
(	O
ii	O
)	O
sporulation	O
defects	O
,	O
and	O
(	O
iii	O
)	O
suppression	O
of	O
the	O
lethality	O
of	O
the	O
cdc25	B
mutant	I
.	O

A	O
gene	O
in	O
Drosophila	B
melanogaster	I
that	O
maps	O
cytologically	O
to	O
2C1	O
-	O
3	O
on	O
the	O
distal	O
portion	O
of	O
the	O
X	O
-	O
chromosome	O
encodes	O
a	O
member	O
of	O
the	O
steroid	B
/	I
thyroid	I
hormone	I
receptor	I
superfamily	I
.	O

A	O
portion	O
of	O
Region	O
II	O
also	O
resembles	O
part	O
of	O
the	O
human	O
c	B
-	I
jun	I
oncoprotein	I
'	I
s	I
leucine	I
zipper	I
,	O
which	O
in	O
turn	O
,	O
has	O
been	O
demonstrated	O
to	O
be	O
the	O
heterodimerization	O
site	O
between	O
the	O
jun	B
and	I
fos	I
oncoproteins	I
.	O

Seventy	O
-	O
two	O
of	O
73	O
negative	O
controls	O
and	O
all	O
positive	O
blocks	O
as	O
seen	O
on	O
soft	O
tissue	O
radiographs	O
(	O
STRs	O
)	O
were	O
correctly	O
coded	O
(	O
specificity	O
98	O
.	O
6	O
%,	O
sensitivity	O
100	O
%).	O

Moreover	O
,	O
radiolabeled	O
EFI	B
,	O
NF	B
-	I
Y	I
,	O
or	O
CBF	O
DNAs	O
give	O
rise	O
to	O
identical	O
gel	O
retardation	O
patterns	O
in	O
extracts	O
from	O
a	O
variety	O
of	O
different	O
cell	O
types	O
.	O

Risk	O
factors	O
influencing	O
lymph	O
nodes	O
metastasis	O
in	O
lung	O
cancer	O
with	O
stage	O
I	O
,	O
II	O
or	O
IIIA	O

The	O
electrically	O
induced	O
motile	O
responses	O
were	O
not	O
suppressed	O
in	O
the	O
presence	O
of	O
dinitrophenol	O
or	O
cytochalasin	O
B	O
.	O

Unlike	O
p59v	B
-	I
rel	I
,	O
which	O
is	O
a	O
nuclear	O
protein	O
in	O
CEF	O
,	O
indirect	O
immunofluorescence	O
showed	O
that	O
p68c	B
-	I
rel	I
in	O
JD214c	O
-	O
rel	B
infected	O
CEF	O
is	O
located	O
exclusively	O
in	O
the	O
cytoplasm	O
of	O
these	O
cells	O
,	O
even	O
though	O
the	O
sequence	O
of	O
p68c	B
-	I
rel	I
showed	O
that	O
it	O
contains	O
a	O
nuclear	O
localizing	O
sequence	O
identical	O
to	O
the	O
one	O
previously	O
identified	O
in	O
p59v	B
-	I
rel	I
.	O

A	O
total	O
of	O
112	O
patients	O
received	O
anistreplase	O
and	O
119	O
received	O
heparin	O
within	O
a	O
mean	O
period	O
of	O
188	O
+/-	O
62	O
min	O
following	O
the	O
onset	O
of	O
symptoms	O
.	O

The	O
Saccharomyces	B
cerevisiae	I
14DM	I
gene	I
,	I
encoding	I
cytochrome	I
P450	I
lanosterol	I
14	I
alpha	I
-	I
demethylase	I
(	I
14DM	I
),	O
was	O
overexpressed	O
in	O
various	O
S	O
.	O
cerevisiae	O
strains	O
under	O
the	O
control	O
of	O
three	O
strong	O
heterologous	O
yeast	O
transcription	O
promoters	O
(	O
pADC1	B
,	O
pGPD	B
,	O
pPHO5	B
)	O
and	O
under	O
the	O
control	O
of	O
its	O
own	O
promoter	O
.	O

The	O
contribution	O
that	O
alternative	O
splicing	O
events	O
in	O
c	B
-	I
myb	I
expression	O
may	O
make	O
on	O
c	B
-	I
myb	I
function	O
remains	O
to	O
be	O
elucidated	O
.	O

Homozygous	O
individuals	O
usually	O
develop	O
purpura	O
fulminans	O
as	O
newborns	O
;	O
heterozygous	O
protein	O
C	O
-	O
deficient	O
individuals	O
are	O
at	O
increased	O
risk	O
for	O
venous	O
thrombosis	O
and	O
pulmonary	O
embolism	O
.	O

Ischemic	O
stroke	O
due	O
to	O
protein	O
C	O
deficiency	O
.	O

These	O
results	O
suggest	O
that	O
5	O
KE	O
X	O
3	O
/	O
W	O
may	O
be	O
the	O
optimal	O
regimen	O
to	O
augment	O
the	O
antitumor	O
immunity	O
of	O
RNL	O
.	O

Guiding	O
patients	O
in	O
the	O
decision	O
should	O
involve	O
a	O
multidisciplinary	O
team	O
composed	O
of	O
a	O
surgical	O
oncologist	O
,	O
geneticist	O
,	O
pathologist	O
,	O
psychotherapist	O
and	O
plastic	O
surgeon	O
.	O

IgG	B
and	O
IgM	B
antibody	I
activity	O
was	O
determined	O
by	O
adding	O
a	O
1	O
:	O
100	O
dilution	O
of	O
serum	O
to	O
plates	O
coated	O
with	O
A60	B
antigen	I
.	O

Among	O
known	O
flea	O
larvae	O
,	O
the	O
genus	O
Anomiopsyllus	O
(	O
Anomiopsyllinae	O
,	O
Anomiopsyllini	O
)	O
is	O
as	O
distinctive	O
in	O
larval	O
form	O
as	O
are	O
the	O
adults	O
.	O

These	O
latter	O
results	O
showed	O
that	O
the	O
ABFI	B
protein	I
,	O
like	O
the	O
RAP1	B
protein	I
,	O
bound	O
sequences	O
required	O
for	O
positive	O
as	O
well	O
as	O
negative	O
regulation	O
of	O
gene	O
expression	O
.	O

The	O
computer	O
-	O
programmed	O
cytocentrifuge	O
is	O
currently	O
most	O
popular	O
.	O

Isolation	O
of	O
a	O
temperature	O
-	O
sensitive	O
mutant	O
with	O
an	O
altered	O
tRNA	B
nucleotidyltransferase	I
and	O
cloning	O
of	O
the	O
gene	O
encoding	O
tRNA	B
nucleotidyltransferase	I
in	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

1	O
,	O
among	O
which	O
nine	O
have	O
been	O
cloned	O
and	O
two	O
(	O
potentially	O
functional	O
)	O
sequenced	O
.	O

The	O
interrelation	O
of	O
the	O
levels	O
of	O
glucocorticoids	O
and	O
insulin	B
in	O
the	O
blood	O
of	O
irradiated	O
animals	O

Foveating	O
saccades	O
,	O
therefore	O
,	O
can	O
be	O
distinguished	O
from	O
other	O
FEMs	O
on	O
the	O
basis	O
of	O
speed	O
.	O

This	O
growth	O
arrest	O
is	O
partly	O
suppressed	O
on	O
minimal	O
medium	O
or	O
under	O
conditions	O
in	O
which	O
the	O
cells	O
are	O
less	O
dependent	O
on	O
mitochondrial	O
metabolism	O
.	O

Further	O
studies	O
of	O
mandibular	O
movement	O
at	O
initial	O
tooth	O
contact	O
.	O

The	O
glial	O
cyst	O
wall	O
was	O
lined	O
in	O
part	O
by	O
flattened	O
or	O
cuboidal	O
epithelium	O
.	O

Modification	O
by	O
this	O
latter	O
compound	O
was	O
so	O
extensive	O
that	O
the	O
amount	O
of	O
membrane	O
-	O
associated	O
N	O
-	O
myristoylated	O
protein	O
was	O
decreased	O
.	O

Rats	O
with	O
one	O
olfactory	O
bulb	O
removed	O
and	O
the	O
contralateral	O
naris	O
closed	O
can	O
detect	O
odors	O
.	O

We	O
have	O
now	O
identified	O
,	O
after	O
21	O
serial	O
undiluted	O
passages	O
of	O
MHV	O
,	O
a	O
small	O
DI	O
RNA	O
,	O
DIssF	B
,	O
which	O
is	O
efficiently	O
packaged	O
into	O
virions	O
.	O

The	O
result	O
suggests	O
that	O
this	O
non	O
-	O
invasive	O
TTD	O
method	O
is	O
easily	O
available	O
and	O
useful	O
in	O
monitoring	O
the	O
intraoperative	O
cardiac	O
output	O
.	O

The	O
SUP44	B
suppressor	I
mutation	I
occurs	O
near	O
a	O
region	O
of	O
the	O
protein	O
that	O
corresponds	O
to	O
the	O
known	O
positions	O
of	O
alterations	O
in	O
E	B
.	I
coli	I
S5	I
ram	I
mutations	O
.	O

The	O
upstream	O
promoter	O
is	O
located	O
within	O
the	O
coding	O
sequence	O
of	O
a	O
divergent	O
gene	O
expressing	O
a	O
protein	O
of	O
Mr	O
39	O
kDa	O
of	O
unknown	O
function	O
.	O

The	O
occurrence	O
,	O
maintenance	O
and	O
possible	O
involvement	O
of	O
these	O
repeated	O
sequences	O
,	O
capable	O
of	O
forming	O
stable	O
secondary	O
structures	O
,	O
are	O
discussed	O
in	O
relation	O
to	O
their	O
location	O
in	O
the	O
region	O
of	O
control	O
signals	O
.	O

IST	B
is	O
not	O
the	O
RNA	O
target	O
(	O
TAR	O
)	O
for	O
Tat	B
trans	I
-	I
activation	O
;	O
however	O
,	O
because	O
it	O
relies	O
entirely	O
on	O
cellular	O
factors	O
for	O
activity	O
,	O
IST	B
may	O
serve	O
to	O
provide	O
abundant	O
RNA	O
targets	O
for	O
Tat	B
trans	I
-	I
activation	O
without	O
a	O
requirement	O
for	O
full	B
-	I
length	I
viral	I
mRNA	I
expression	O
.	O

Genotoxic	O
activity	O
of	O
a	O
tobacco	O
-	O
specific	O
nitrosamine	O
.	O

Common	O
foot	O
pathologies	O
are	O
heel	O
pain	O
,	O
metatarsalgia	O
,	O
hammertoes	O
and	O
clawtoes	O
,	O
bunions	O
,	O
hallux	O
rigidus	O
,	O
corns	O
and	O
calluses	O
,	O
nail	O
pathologies	O
,	O
arthritis	O
,	O
and	O
neuropathies	O
.	O

Liver	O
dysfunction	O
in	O
the	O
presence	O
of	O
different	O
adverse	O
reactions	O
presented	O
with	O
a	O
higher	O
activity	O
in	O
the	O
blood	O
serum	O
of	O
indicator	O
liver	O
enzymes	O
and	O
its	O
impaired	O
protein	O
-	O
forming	O
function	O
.	O

The	O
CT	O
characteristics	O
are	O
discussed	O
and	O
the	O
recent	O
literature	O
is	O
reviewed	O
.	O

Further	O
research	O
is	O
recommended	O
to	O
identify	O
the	O
coping	O
styles	O
associated	O
with	O
the	O
high	O
EE	O
/	O
low	O
EE	O
research	O
classification	O
.	O

Antileukoproteinase	B
(	O
ALP	O
)	O
is	O
a	O
low	O
mol	O
wt	B
mucosal	I
secretory	I
protein	I
which	O
,	O
in	O
human	O
tissues	O
,	O
inhibits	O
the	O
activities	O
of	O
the	O
neutral	O
serine	B
lysosomal	I
proteinases	I
elastase	I
and	O
cathepsin	B
-	I
G	I
.	O

To	O
determine	O
the	O
effects	O
on	O
the	O
pulmonary	O
barrier	O
of	O
several	O
surface	O
active	O
agents	O
,	O
a	O
series	O
of	O
metered	O
dose	O
inhalers	O
(	O
MDIs	O
)	O
was	O
prepared	O
and	O
used	O
to	O
dose	O
aerosolized	O
surfactant	O
to	O
the	O
airways	O
of	O
isolated	O
perfused	O
rat	O
lungs	O
.	O

The	O
therapeutic	O
protocole	O
used	O
at	O
the	O
Gustave	O
Roussy	O
Institute	O
for	O
invasive	O
epithelioma	O
of	O
the	O
uterine	O
cervix	O
rests	O
,	O
for	O
limited	O
forms	O
(	O
T1B	O
-	O
T2	O
proximal	O
),	O
on	O
combined	O
radiology	O
and	O
surgery	O
.	O

Thyrotropin	B
-	I
induced	O
expression	O
of	O
a	O
gene	O
for	O
a	O
ribosomal	B
protein	I
related	I
to	O
the	O
trk	B
oncogene	I
.	O

The	O
persistence	O
of	O
members	O
of	O
the	O
prostigmatid	O
families	O
Tydeidae	O
,	O
Nanorchestidae	O
and	O
Tarsonemidae	O
in	O
the	O
moisture	O
-	O
deficient	O
90	O
%-	O
concentration	O
treatments	O
supports	O
previous	O
evidence	O
of	O
adaptations	O
to	O
low	O
-	O
water	O
-	O
content	O
habitats	O
.	O

The	O
induction	O
of	O
RNKP	B
-	I
1	I
expression	O
in	O
the	O
Con	B
A	I
-	I
cultured	O
spleen	O
cells	O
is	O
accompanied	O
by	O
increases	O
in	O
both	O
NK	O
and	O
lymphokine	O
-	O
activated	O
killer	O
lymphocyte	O
activities	O
.	O

The	O
BAL	O
-	O
to	O
-	O
plasma	O
specific	O
activity	O
of	O
urea	O
was	O
about	O
twice	O
that	O
of	O
Na	O
+,	O
indicating	O
that	O
urea	O
diffused	O
into	O
the	O
ELF	O
more	O
rapidly	O
than	O
Na	O
+	O
during	O
the	O
70	O
s	O
that	O
elapsed	O
between	O
the	O
time	O
the	O
radioactive	O
urea	O
and	O
Na	O
+	O
were	O
injected	O
into	O
the	O
circulation	O
and	O
the	O
time	O
when	O
lavage	O
was	O
complete	O
.	O

TMBr	B
-	I
1	I
is	O
identical	O
to	O
striated	B
muscle	I
alpha	I
-	I
tropomyosin	I
from	O
amino	O
acids	O
1	O
through	O
258	O
but	O
contains	O
a	O
novel	O
COOH	O
-	O
terminal	O
region	O
from	O
amino	O
acids	O
259	O
through	O
281	O
.	O

Intron	O
1	O
is	O
6	O
.	O
5	O
kb	O
long	O
,	O
and	O
the	O
minimal	O
sizes	O
of	O
introns	O
2	O
and	O
3	O
are	O
estimated	O
to	O
be	O
32	O
kb	O
each	O
.	O

After	O
4	O
h	O
,	O
lesions	O
in	O
the	O
secretory	O
part	O
of	O
the	O
stomach	O
were	O
scored	O
and	O
mucosal	O
prostaglandin	O
E2	O
synthesis	O
was	O
determined	O
by	O
the	O
ex	O
vivo	O
prostaglandin	O
generation	O
technique	O
.	O

Comparison	O
of	O
transmembrane	O
and	O
cytoplasmic	O
domains	O
to	O
a	O
third	O
cell	O
-	O
surface	O
proteoglycan	O
,	O
48K5	B
from	O
human	O
lung	O
fibroblasts	O
(	O
Marynen	O
,	O
P	O
.,	O
Zhang	O
,	O
J	O
.,	O
Cassiman	O
,	O
J	O
.,	O
Vanden	O
Berghe	O
,	O
H	O
.,	O
and	O
David	O
,	O
C	O
.	O

The	O
alternative	O
exon	O
introduces	O
the	O
novel	O
carboxyl	O
terminus	O
and	O
a	O
new	O
translation	O
stop	O
signal	O
,	O
while	O
simultaneously	O
converting	O
the	O
coding	O
sequence	O
for	O
40	O
carboxyl	O
-	O
terminal	O
residues	O
in	O
CeCAT	B
alpha	I
into	O
3	O
'-	O
untranslated	O
nucleotides	O
.	O

Lars	O
has	O
AIDS	O
--	O
a	O
more	O
dignified	O
life	O
with	O
care	O
at	O
home	O
.	O

We	O
have	O
synthesized	O
[	O
7	O
,	O
7	O
-	O
2H2	O
]-	O
19	O
-	O
OHA	O
with	O
high	O
deuterium	O
content	O
and	O
,	O
together	O
with	O
[	O
7	O
,	O
7	O
-	O
2H2	O
]	O
A	O
and	O
[	O
9	O
,	O
11	O
-	O
2H2	O
]	O
estrone	O
(	O
E1	O
),	O
have	O
developed	O
a	O
quantitative	O
assay	O
of	O
serum	O
level	O
19	O
-	O
OHA	O
,	O
A	O
,	O
and	O
E1	O
using	O
the	O
gas	O
chromatography	O
/	O
mass	O
spectrometry	O
-	O
mass	O
fragmentography	O
method	O
to	O
monitor	O
individual	O
subjects	O
throughout	O
pregnancy	O
.	O

Fifteen	O
light	O
for	O
dates	O
infants	O
and	O
their	O
placentae	O
were	O
compared	O
to	O
15	O
well	O
-	O
grown	O
infants	O
and	O
their	O
placentae	O
.	O

Treating	O
renal	O
anaemia	O
with	O
recombinant	O
human	B
erythropoietin	I
.	O

In	O
the	O
local	O
geomagnetic	O
field	O
,	O
the	O
animals	O
preferred	O
the	O
SE	O
-	O
sector	O
.	O

Mean	O
(+/-	O
SE	O
)	O
measurements	O
of	O
clearance	O
(	O
24	O
.	O
5	O
+/-	O
2	O
.	O
06	O
v	O
26	O
.	O
5	O
+/-	O
2	O
.	O
05	O
mL	O
/	O
min	O
/	O
m2	O
),	O
half	O
-	O
life	O
(	O
5	O
.	O
7	O
+/-	O
0	O
.	O
5	O
v	O
6	O
.	O
4	O
+/-	O
0	O
.	O
5	O
hours	O
),	O
and	O
volume	O
of	O
distribution	O
(	O
12	O
.	O
4	O
+/-	O
1	O
.	O
1	O
v	O
13	O
.	O
7	O
+/-	O
1	O
.	O
6	O
L	O
/	O
m2	O
)	O
were	O
not	O
significantly	O
different	O
in	O
patients	O
with	O
jaundice	O
when	O
compared	O
with	O
controls	O
.	O

Attitudes	O
were	O
found	O
to	O
be	O
multidimensional	O
,	O
with	O
similar	O
dimensions	O
being	O
identified	O
in	O
both	O
samples	O
.	O

The	O
order	O
of	O
the	O
helicase	B
motif	I
and	O
the	O
nsP3	B
homology	I
region	O
in	O
the	O
RUB	O
genome	O
is	O
reversed	O
with	O
respect	O
to	O
the	O
alphavirus	O
genome	O
indicating	O
that	O
a	O
genetic	O
rearrangement	O
has	O
occurred	O
during	O
the	O
evolution	O
of	O
these	O
viruses	O
.	O

Of	O
the	O
remaining	O
seven	O
,	O
five	O
reacted	O
either	O
with	O
immediate	O
and	O
strong	O
symptoms	O
or	O
had	O
spontaneously	O
reduced	O
gluten	B
intake	O
,	O
or	O
had	O
an	O
acquired	O
IgA	B
deficiency	O
.	O

Co	O
-	O
administration	O
of	O
5FU	O
,	O
angiotensin	B
II	I
and	O
microspheres	O
via	O
the	O
hepatic	O
artery	O
may	O
reduce	O
drug	O
exposure	O
in	O
the	O
systemic	O
compartment	O
and	O
therefore	O
may	O
increase	O
the	O
therapeutic	O
ratio	O
of	O
5FU	O
administration	O
via	O
the	O
hepatic	O
artery	O
.	O

The	O
effects	O
of	O
tap	O
(	O
TW	O
)	O
or	O
carbonated	O
(	O
CW	O
)	O
water	O
on	O
arterial	O
pH	O
,	O
partial	O
pressure	O
of	O
carbon	O
dioxide	O
(	O
PCO2	O
)	O
and	O
plasma	O
lactate	O
were	O
determined	O
in	O
heat	O
-	O
stressed	O
broilers	O
.	O

The	O
results	O
also	O
showed	O
that	O
although	O
oyster	O
shell	O
supplementation	O
generally	O
increased	O
alkaline	B
phosphatase	I
activity	O
,	O
bone	O
mineralization	O
was	O
relatively	O
uninfluenced	O
as	O
judged	O
by	O
the	O
low	O
coefficients	O
of	O
variation	O
(	O
CV	O
)	O
of	O
3	O
.	O
14	O
-	O
3	O
.	O
51	O
%	O
and	O
3	O
.	O
39	O
-	O
4	O
.	O
82	O
%	O
for	O
calcium	O
and	O
phosphorus	O
content	O
in	O
the	O
femur	O
and	O
tibia	O
respectively	O
.	O

Compared	O
to	O
its	O
counterpart	O
in	O
the	O
GPB	B
gene	I
,	O
exon	O
3	O
of	O
the	O
GPE	B
gene	I
contains	O
several	O
point	O
mutations	O
,	O
an	O
insertion	O
of	O
24	O
bp	O
,	O
and	O
a	O
stop	O
codon	O
which	O
shortens	O
the	O
reading	O
frame	O
.	O

Thus	O
,	O
this	O
reading	O
frame	O
was	O
concluded	O
to	O
encode	O
the	O
precursor	O
of	O
mitochondrial	B
fumarase	I
.	O

Information	O
about	O
immunologic	O
drug	O
interactions	O
is	O
needed	O
by	O
pharmacists	O
to	O
make	O
rational	O
drug	O
-	O
use	O
decisions	O
.	O

Therefore	O
,	O
in	O
conjunction	O
with	O
a	O
positive	O
pregnancy	O
test	O
and	O
the	O
patient	O
'	O
s	O
clinical	O
history	O
,	O
a	O
severely	O
depressed	O
or	O
absent	O
serum	O
PAPP	B
-	I
A	I
level	O
may	O
aid	O
in	O
the	O
diagnosis	O
of	O
extrauterine	O
pregnancy	O
.	O

These	O
results	O
support	O
the	O
view	O
that	O
clonidine	O
and	O
6	O
-	O
OHDA	O
,	O
but	O
not	O
alpha	B
-	I
MD	O
,	O
have	O
central	O
pressor	O
actions	O
in	O
the	O
rat	O
that	O
oppose	O
their	O
antihypertensive	O
action	O
.	O

Furthermore	O
,	O
beta	B
2	I
-	I
adrenoceptor	I
sensitivity	O
appears	O
to	O
be	O
unaltered	O
in	O
BHT	O
.	O

Comparison	O
of	O
elastase	B
-	I
1	I
with	O
amylase	B
,	I
lipase	I
,	O
and	O
trypsin	B
-	I
like	I
immunoreactivity	O
in	O
the	O
diagnosis	O
of	O
acute	O
pancreatitis	O
.	O

Svensson	O
et	O
al	O
.	O

Viable	O
flap	O
areas	O
were	O
established	O
following	O
vascular	O
pedicle	O
ligation	O
(	O
both	O
vessels	O
or	O
only	O
artery	O
or	O
vein	O
),	O
on	O
the	O
third	O
day	O
after	O
flap	O
replantation	O
in	O
both	O
island	O
and	O
free	O
flaps	O
.	O

The	O
size	O
discrepancy	O
is	O
not	O
due	O
to	O
glycosylation	O
or	O
phosphorylation	O
of	O
Ag35	B
but	O
may	O
result	O
from	O
a	O
proline	O
-	O
rich	O
sequence	O
which	O
occurs	O
in	O
this	O
polypeptide	O
.	O

The	O
investigation	O
was	O
thereafter	O
continued	O
in	O
an	O
open	O
fashion	O
by	O
administering	O
a	O
single	O
10	O
mg	O
dose	O
of	O
the	O
MAO	B
-	I
B	I
inhibitor	I
deprenyl	O
to	O
the	O
same	O
subjects	O
.	O

Their	O
studies	O
have	O
revealed	O
a	O
considerable	O
increase	O
of	O
CSF	B
AP	I
activity	O
in	O
purulent	O
meningitides	O
whereas	O
in	O
serous	O
meningitides	O
it	O
grows	O
negligibly	O
.	O

A	O
cDNA	O
encoding	O
a	O
new	O
human	B
lymphocyte	I
cell	I
surface	I
molecule	I
has	O
been	O
isolated	O
and	O
shown	O
to	O
identify	O
a	O
fourth	O
member	O
of	O
a	O
recently	O
discovered	O
family	O
of	O
adhesion	O
proteins	O
.	O

Previously	O
,	O
we	O
reported	O
the	O
sequence	O
of	O
the	O
gene	O
encoding	O
human	B
K14	I
(	I
D	I
.	O

Similarly	O
,	O
a	O
human	O
but	O
not	O
a	O
bovine	B
alpha	I
transgene	I
was	O
expressed	O
in	O
placenta	O
in	O
transgenic	O
mice	O
.	O

A	O
rapid	O
staining	O
technique	O
for	O
Leishmania	O
parasites	O
in	O
splenic	O
aspirate	O
smears	O
.	O

NIK	O
-	O
244	O
suppressed	O
coronary	O
ligation	O
-	O
and	O
digitalis	O
-	O
induced	O
arrhythmias	O
,	O
and	O
the	O
minimum	O
effective	O
plasma	O
concentrations	O
for	O
arrhythmias	O
induced	O
by	O
24	O
-	O
h	O
and	O
48	O
-	O
h	O
coronary	O
ligation	O
and	O
digitalis	O
were	O
0	O
.	O
41	O
+/-	O
0	O
.	O
10	O
(	O
by	O
1	O
mg	O
/	O
kg	O
i	O
.	O
v	O
.),	O
0	O
.	O
70	O
+/-	O
0	O
.	O
13	O
(	O
by	O
1	O
mg	O
/	O
kg	O
i	O
.	O
v	O
.),	O
and	O
0	O
.	O
21	O
+/-	O
0	O
.	O
08	O
(	O
by	O
0	O
.	O
5	O
mg	O
/	O
kg	O
i	O
.	O
v	O
.)	O
microgram	O
/	O
ml	O
,	O
respectively	O
(	O
mean	O
+/-	O
SD	O
of	O
the	O
mean	O
,	O
n	O
=	O
6	O
).	O

The	O
diagnostic	O
value	O
of	O
blood	O
serum	O
and	O
urinary	O
amylase	B
,	I
lipase	I
,	O
and	O
trypsin	B
in	O
exacerbations	O
of	O
chronic	O
relapsing	O
pancreatitis	O
is	O
discussed	O
.	O

On	O
the	O
basis	O
of	O
the	O
mechanism	O
of	O
action	O
,	O
two	O
groups	O
of	O
inodilators	O
are	O
distinguished	O
,	O
the	O
phosphodiesterase	O
inhibitors	O
and	O
the	O
dopaminergic	O
agents	O
.	O

Intravenous	O
gamma	B
globulins	I

Immunoglobulin	B
light	I
chain	I
(	O
IgL	B
)	O
diversity	O
is	O
generated	O
in	O
the	O
chicken	O
by	O
recombination	O
between	O
the	O
single	O
functional	O
variable	O
(	O
VL	B
)	O
and	O
joining	O
(	O
JL	B
)	I
gene	I
segments	O
and	O
subsequent	O
somatic	O
diversification	O
of	O
the	O
rearranged	O
VL	B
region	O
.	O

In	O
76	O
%	O
of	O
59	O
lead	O
-	O
toxic	O
children	O
,	O
bone	O
lead	O
values	O
measured	O
by	O
LXRF	O
were	O
equal	O
to	O
or	O
greater	O
than	O
those	O
measured	O
in	O
normal	O
and	O
industrially	O
exposed	O
adults	O
.	O

In	O
resting	O
3T3	O
cells	O
,	O
jun	B
-	I
D	I
is	O
expressed	O
at	O
a	O
higher	O
level	O
compared	O
to	O
c	B
-	I
jun	I
and	I
jun	I
-	I
B	I
,	O
and	O
its	O
transcription	O
is	O
stimulated	O
only	O
slightly	O
by	O
serum	B
growth	I
factors	I
.	O

The	O
thrombolytic	O
effects	O
of	O
native	O
tissue	B
-	I
type	I
plasminogen	I
activator	I
(	O
AK	B
-	I
124	I
)	O
on	O
experimental	O
canine	O
coronary	O
thrombosis	O
.	O

Tonometry	O
of	O
blood	O
samples	O
from	O
patients	O
may	O
also	O
be	O
used	O
in	O
the	O
determination	O
of	O
acid	O
-	O
base	O
quantities	O
and	O
hemoglobin	B
-	I
oxygen	O
affinity	O
e	O
.	O
g	O
.	O
p50	B
.	O

Here	O
,	O
we	O
alter	O
the	O
dimerization	O
specificity	O
of	O
Fos	B
by	O
precisely	O
replacing	O
its	O
leucine	O
zipper	O
with	O
that	O
from	O
GCN4	B
.	O

The	O
ORF1	O
product	O
was	O
required	O
for	O
competence	O
,	O
while	O
ORF2	O
,	O
which	O
was	O
cotranscribed	O
with	O
ORF1	O
and	O
encoded	O
a	O
predicted	O
protein	O
of	O
126	O
amino	O
acids	O
,	O
was	O
not	O
.	O

An	O
immunologically	O
related	O
protein	O
was	O
detected	O
in	O
ribosome	O
and	O
membrane	O
fractions	O
of	O
mitochondria	O
from	O
Saccharomyces	O
cerevisiae	O
.	O

Mapping	O
of	O
RNA	B
-	I
temperature	I
-	I
sensitive	I
mutants	I
of	I
Sindbis	I
virus	I
:	O
complementation	O
group	O
F	O
mutants	O
have	O
lesions	O
in	O
nsP4	B
.	O

The	O
sign	O
of	O
Leser	O
-	O
Trelat	O
:	O
does	O
it	O
exist	O
?	O
The	O
sign	O
of	O
Leser	O
-	O
Trelat	O
is	O
usually	O
regarded	O
as	O
a	O
reliable	O
cutaneous	O
marker	O
of	O
internal	O
malignancy	O
.	O

Southern	O
blot	O
analyses	O
demonstrated	O
a	O
low	O
,	O
if	O
not	O
single	O
,	O
copy	O
number	O
for	O
this	O
gene	O
and	O
conservation	O
of	O
this	O
domain	O
in	O
other	O
vertebrates	O
.	O

The	O
overall	O
prevalence	O
of	O
HBV	O
markers	O
was	O
higher	O
among	O
staff	O
members	O
than	O
in	O
the	O
blood	O
donors	O
of	O
our	O
area	O
.	O

S1	B
nuclease	I
analysis	O
of	O
RNA	O
from	O
chemically	O
induced	O
B95	O
-	O
8	O
cells	O
and	O
from	O
Vero	O
cells	O
cotransfected	O
with	O
NotI	B
repeat	I
promoter	I
-	I
CAT	I
and	O
Z	O
showed	O
that	O
Z	O
transactivation	O
increased	O
the	O
level	O
of	O
correctly	O
initiated	O
,	O
stable	O
RNA	O
transcripts	O
.	O

Effects	O
of	O
nitrogen	O
(	O
PN2	O
:	O
5	O
and	O
14	O
MPa	O
)	O
and	O
helium	O
(	O
PHe	O
:	O
13	O
and	O
14	O
MPa	O
)	O
were	O
also	O
tested	O
.	O

Clone	O
4c	O
(	O
2681	O
bp	O
)	O
had	O
a	O
coding	O
region	O
identical	O
to	O
that	O
of	O
clone	O
22c	O
but	O
it	O
included	O
a	O
putative	O
intron	O
of	O
959	O
bp	O
.	O

The	O
Bacillus	B
subtilis	I
phage	I
phi	I
105	I
repressor	I
,	O
a	O
lambda	B
repressor	I
-	I
like	I
transcriptional	I
regulatory	I
protein	I
,	O
was	O
overproduced	O
in	O
Escherichia	O
coli	O
and	O
purified	O
to	O
near	O
homogeneity	O
in	O
order	O
to	O
examine	O
its	O
in	O
vitro	O
DNA	O
-	O
binding	O
properties	O
.	O

Grossly	O
,	O
the	O
incidence	O
of	O
a	O
type	O
IIc	O
carcinoma	O
was	O
46	O
.	O
5	O
%	O
and	O
that	O
of	O
a	O
IIc	O
+	O
III	O
type	O
was	O
20	O
.	O
5	O
%,	O
respectively	O
.	O

Of	O
202	O
initially	O
seronegative	O
caretakers	O
(	O
observed	O
for	O
an	O
average	O
of	O
305	O
days	O
per	O
woman	O
),	O
19	O
seroconverted	O
,	O
for	O
an	O
annual	O
seroconversion	O
rate	O
of	O
11	O
percent	O
.	O

First	O
,	O
a	O
pet54	B
::	O
LEU2	B
cytoductant	O
bearing	O
the	O
'	O
short	O
'	O
mitochondrial	O
genome	O
that	O
lacks	O
both	O
COX1	B
introns	I
aI5	I
alpha	I
and	I
aI5	I
beta	I
is	O
defective	O
only	O
in	O
COX3	B
gene	I
expression	O
and	O
not	O
in	O
COX1	B
mRNA	I
splicing	O
or	O
mRNA	O
translation	O
.	O

This	O
TC	B
-	I
II	I
enhanson	I
,	O
which	O
is	O
identical	O
to	O
the	O
kappa	B
B	I
motif	I
from	O
the	O
kappa	B
chain	I
enhancer	I
,	O
was	O
active	O
in	O
both	O
lymphoid	O
and	O
non	O
-	O
lymphoid	O
cells	O
,	O
which	O
contrasts	O
with	O
the	O
previously	O
reported	O
lymphoid	O
cell	O
specificity	O
of	O
the	O
kappa	B
B	I
motif	I
.	O

There	O
has	O
been	O
similar	O
improvement	O
in	O
treating	O
ampullary	O
and	O
periampullary	O
cancer	O
,	O
gallbladder	O
cancer	O
,	O
or	O
extrahepatic	O
bile	O
duct	O
cancer	O
.	O

Rare	O
neurogenic	O
tumor	O
with	O
metastasis	O
to	O
mouth	O
,	O
jaw	O
and	O
face	O
regions	O

Drug	O
use	O
in	O
trauma	O
victims	O
.	O

A	O
critical	O
heart	O
rate	O
and	O
/	O
or	O
appropriate	O
sympathetic	O
state	O
was	O
found	O
to	O
provoke	O
all	O
instances	O
of	O
reentrant	O
or	O
automatic	O
atrial	O
tachycardia	O
and	O
atypical	O
junctional	O
tachycardia	O
.	O

The	O
65	O
-	O
bp	O
sequence	O
contains	O
the	O
octameric	O
cAMP	B
-	I
responsive	I
enhancer	I
(	O
CRE	O
)	O
TGACGTCA	O
(	O
nucleotides	O
-	O
48	O
to	O
-	O
41	O
).	O

Somatostatin	B
gene	I
expression	O
in	O
pancreatic	O
islet	O
cells	O
is	O
directed	O
by	O
cell	O
-	O
specific	O
DNA	O
control	O
elements	O
and	O
DNA	B
-	I
binding	I
proteins	I
.	O

The	O
latency	O
time	O
for	O
the	O
lactate	O
concentration	O
to	O
reach	O
the	O
top	O
values	O
was	O
reduced	O
by	O
aerobic	O
training	O
(	O
T2	O
).	O

High	O
ATP	O
/	O
GTP	O
ratios	O
promoted	O
initiation	O
of	O
RNA	O
primer	O
synthesis	O
at	O
3	O
'-	O
dCTTT	O
sites	O
,	O
whereas	O
low	O
ATP	O
/	O
GTP	O
ratios	O
promoted	O
initiation	O
at	O
3	O
'-	O
dCCC	O
sites	O
.	O

Interspecific	O
complementation	O
tests	O
showed	O
that	O
the	O
P7	B
proteins	I
are	O
unable	O
to	O
complement	O
P1	B
parA	I
or	O
parB	B
mutants	I
,	O
and	O
the	O
P1	O
proteins	O
fail	O
to	O
complement	O
the	O
P7	B
mutations	O
.	O

Analysis	O
of	O
the	O
inferred	O
1	B
,	I
859	I
-	I
residue	I
ama	I
-	I
1	I
product	I
showed	O
considerable	O
identity	O
with	O
the	O
largest	O
subunit	O
of	O
RNAP	B
II	I
from	O
other	O
organisms	O
,	O
including	O
the	O
presence	O
of	O
a	O
zinc	B
finger	I
motif	I
near	O
the	O
amino	O
terminus	O
,	O
and	O
a	O
carboxyl	O
-	O
terminal	O
domain	O
of	O
42	O
tandemly	O
reiterated	O
heptamers	O
with	O
the	O
consensus	O
Tyr	O
Ser	O
Pro	O
Thr	O
Ser	O
Pro	O
Ser	O
.	O

During	O
challenge	O
,	O
rebiopsy	O
was	O
done	O
when	O
reticulin	B
antibodies	I
turned	O
positive	O
(	O
mean	O
0	O
.	O
6	O
years	O
,	O
range	O
0	O
.	O
2	O
-	O
2	O
.	O
0	O
)	O
or	O
at	O
the	O
end	O
of	O
the	O
two	O
year	O
study	O
.	O

LON	O
-	O
72	O
(	O
34	O
isolates	O
),	O
LON	O
-	O
73	O
(	O
1	O
),	O
LON	O
-	O
71	O
(	O
2	O
)	O
and	O
LON	O
-	O
10	O
(	O
2	O
)	O
were	O
found	O
at	O
altitudes	O
around	O
2000	O
m	O
,	O
3	O
of	O
them	O
in	O
a	O
single	O
village	O
.	O

Eighty	O
patients	O
presenting	O
to	O
HGGM	O
with	O
non	O
-	O
Hodgkin	O
'	O
s	O
lymphomas	O
between	O
1962	O
and	O
1986	O
,	O
were	O
reviewed	O
.	O

The	O
differential	O
diagnosis	O
of	O
both	O
affections	O
is	O
based	O
on	O
the	O
clinical	O
course	O
,	O
sialography	O
and	O
CT	O
examination	O
which	O
along	O
with	O
modern	O
ATB	O
treatment	O
significantly	O
modify	O
hitherto	O
used	O
surgical	O
therapy	O
.	O

Collaborative	O
study	O
of	O
Japanese	O
Pharmacopoeia	O
Heparin	O
Sodium	O
Reference	O
Standard	O

The	O
maximum	O
stress	O
due	O
to	O
the	O
hygroscopic	O
examination	O
of	O
the	O
composite	O
was	O
0	O
.	O
74	O
kg	O
/	O
mm2	O
at	O
equilibrium	O
of	O
the	O
water	O
absorbed	O
of	O
the	O
composite	O
.	O

In	O
the	O
whole	O
group	O
,	O
basal	O
GH	B
and	I
somatomedin	I
-	I
C	I
levels	O
decreased	O
from	O
a	O
mean	O
(+/-	O
standard	O
error	O
of	O
the	O
mean	O
)	O
of	O
52	O
.	O
3	O
+/-	O
12	O
.	O
7	O
to	O
11	O
.	O
1	O
+/-	O
6	O
.	O
3	O
ng	O
/	O
ml	O
and	O
from	O
7	O
.	O
6	O
+/-	O
0	O
.	O
7	O
to	O
2	O
.	O
5	O
+/-	O
0	O
.	O
5	O
U	O
/	O
ml	O
,	O
respectively	O
.	O

There	O
was	O
no	O
significant	O
correlation	O
between	O
baseline	O
PC40	O
methacholine	O
and	O
the	O
maximal	O
fall	O
in	O
Vp30	O
after	O
either	O
the	O
first	O
(	O
12	O
micrograms	O
)	O
or	O
the	O
second	O
dose	O
(	O
24	O
micrograms	O
)	O
of	O
platelet	B
activating	I
factor	I
.	O

Both	O
BG	O
and	O
IRI	B
concentrations	O
during	O
the	O
OGTT	O
were	O
the	O
lowest	O
in	O
body	O
builders	O
,	O
medium	O
in	O
controls	O
,	O
and	O
the	O
highest	O
in	O
obese	O
men	O
.	O

Many	O
studies	O
have	O
pointed	O
out	O
the	O
possibility	O
of	O
"	O
masked	O
"	O
organic	O
factors	O
in	O
erectile	O
impotence	O
,	O
detectable	O
only	O
by	O
means	O
of	O
laboratory	O
investigations	O
:	O
mild	O
hypogonadism	O
,	O
hyperprolactinemia	O
,	O
occlusions	O
selectively	O
located	O
at	O
the	O
site	O
of	O
the	O
sexual	O
arteries	O
,	O
venous	O
incompetence	O
,	O
subclinical	O
neuropathies	O
.	O

The	O
site	O
-	O
specific	O
DNA	O
inversion	O
system	O
Cin	B
encoded	I
by	O
the	O
bacteriophage	O
P1	O
consists	O
of	O
a	O
recombinase	B
,	O
two	O
inverted	O
crossing	O
-	O
over	O
sites	O
and	O
a	O
recombinational	O
enhancer	O
.	O

More	O
mRNA	O
corresponding	O
to	O
nagB	B
and	O
nagA	B
is	O
detected	O
than	O
that	O
corresponding	O
to	O
the	O
distal	O
genes	O
,	O
nagC	B
and	O
nagD	B
.	O

62	O
:	O
2491	O
-	O
2499	O
,	O
1987	O
).	O

A	O
transcription	O
factor	O
exclusion	O
assay	O
was	O
used	O
to	O
show	O
that	O
the	O
PCF1	B
mutation	I
affects	O
two	O
distinct	O
stages	O
in	O
transcription	O
:	O
one	O
prior	O
to	O
and	O
one	O
after	O
stable	O
complex	O
formation	O
;	O
and	O
that	O
these	O
effects	O
are	O
mediated	O
by	O
a	O
component	O
of	O
the	O
stable	O
complex	O
.	O

Model	O
IV	O
:	O
primary	O
abutments	O
with	O
the	O
lateral	O
incisor	O
and	O
the	O
second	O
molar	O
as	O
secondary	O
abutments	O
.	O

The	O
present	O
data	O
also	O
suggest	O
that	O
when	O
compared	O
to	O
the	O
systemic	O
vascular	O
bed	O
,	O
the	O
pulmonary	O
vascular	O
bed	O
is	O
less	O
responsive	O
to	O
bolus	O
administration	O
of	O
ET	B
-	I
1	I
.	O

On	O
the	O
other	O
hand	O
,	O
knowledge	O
of	O
the	O
epidemiology	O
of	O
Parkinson	O
'	O
s	O
disease	O
is	O
necessary	O
in	O
creating	O
etiological	O
hypotheses	O
,	O
since	O
only	O
hypotheses	O
consistent	O
with	O
the	O
epidemiological	O
profile	O
deserve	O
careful	O
testing	O
.	O

Metformin	O
plasma	O
concentrations	O
remained	O
unchanged	O
except	O
for	O
patients	O
transferred	O
from	O
1	O
.	O
5	O
to	O
2	O
.	O
0	O
g	O
daily	O
to	O
850	O
mg	O
twice	O
daily	O
;	O
in	O
these	O
patients	O
plasma	O
concentrations	O
increased	O
from	O
1	O
.	O
83	O
+/-	O
0	O
.	O
87	O
to	O
2	O
.	O
50	O
+/-	O
0	O
.	O
89	O
micrograms	O
/	O
l	O
(	O
p	O
less	O
than	O
0	O
.	O
01	O
).	O

Diagnosis	O
of	O
primary	O
sclerosing	O
cholangitis	O
in	O
a	O
blood	O
donor	O
with	O
elevated	O
serum	B
alanine	I
aminotransferase	I
.	O

An	O
alternative	O
method	O
of	O
UKM	O
is	O
proposed	O
based	O
on	O
collecting	O
a	O
small	O
fraction	O
of	O
spent	O
dialysate	O
flow	O
for	O
3	O
consecutive	O
dialyses	O
.	O

Validation	O
of	O
the	O
survey	O
of	O
work	O
styles	O
:	O
a	O
profile	O
measure	O
of	O
the	O
type	O
A	O
behaviour	O
pattern	O
.	O

Only	O
one	O
ADR	O
was	O
related	O
definitely	O
to	O
ciprofloxacin	O
therapy	O
.	O

HIV	O
infectiousness	O
and	O
the	O
AIDS	O
epidemic	O
.	O

From	O
day	O
30	O
after	O
turnout	O
,	O
the	O
PFB	O
-	O
group	O
had	O
significantly	O
lower	O
serum	B
pepsinogen	I
levels	O
,	O
which	O
reflects	O
the	O
low	O
degree	O
of	O
abomasal	O
damage	O
in	O
these	O
animals	O
.	O

Chronic	O
dose	O
effects	O
of	O
methyl	O
parathion	O
on	O
nuthatches	O
:	O
cholinesterase	B
and	O
ptilochronology	O
.	O

Molecular	O
cloning	O
and	O
characterisation	O
of	O
the	O
two	O
homologous	O
genes	O
coding	O
for	O
nitrate	B
reductase	I
in	O
tobacco	O
.	O

Epithelial	O
damage	O
was	O
not	O
observed	O
in	O
any	O
controls	O
but	O
was	O
in	O
all	O
tissues	O
exposed	O
to	O
SO2	O
.	O

Transcripts	O
characterized	O
include	O
(	O
i	O
)	O
abundant	O
monocistronic	O
L11e	B
and	O
tricistronic	O
L1e	B
-	O
L10e	B
-	O
L12e	B
transcripts	I
;	O
(	O
ii	O
)	O
less	O
abundant	O
bicistronic	O
NAB	B
-	O
L11e	B
and	O
monocistronic	O
NAB	B
transcripts	I
and	O
(	O
iii	O
)	O
a	O
very	O
rare	O
ORF	O
monocistronic	O
transcript	O
.	O

The	O
transcription	O
initiation	O
site	O
was	O
determined	O
by	O
S1	B
nuclease	I
mapping	O
.	O

This	O
suggested	O
that	O
baboon	B
liver	I
class	I
I	I
ADH	I
is	O
of	O
the	O
same	O
ancestral	O
lineage	O
as	O
the	O
human	B
ADH	I
-	I
beta	I
.	O

Each	O
individual	O
shot	O
25	O
bullets	O
in	O
about	O
5	O
minutes	O
,	O
at	O
an	O
intensity	O
level	O
calculated	O
at	O
163	O
dB	O
.	O

Cord	O
swelling	O
was	O
observed	O
in	O
2	O
patients	O
who	O
developed	O
complete	O
lesions	O
.	O

Definite	O
JPsA	O
(	O
24	O
patients	O
)	O
was	O
defined	O
as	O
arthritis	O
associated	O
,	O
but	O
not	O
necessarily	O
coincident	O
,	O
with	O
a	O
typical	O
psoriatic	O
rash	O
,	O
or	O
arthritis	O
plus	O
at	O
least	O
3	O
of	O
4	O
minor	O
criteria	O
:	O
dactylitis	O
,	O
nail	O
pitting	O
,	O
psoriasis	O
-	O
like	O
rash	O
,	O
or	O
family	O
history	O
of	O
psoriasis	O
.	O

The	O
solitary	O
kidney	O
:	O
a	O
model	O
of	O
chronic	O
hyperfiltration	O
in	O
humans	O
.	O

Another	O
segment	O
of	O
CRL3	B
(-	O
296	O
to	O
-	O
184	O
),	O
also	O
displaying	O
enhancer	O
function	O
,	O
contained	O
tandem	O
repeated	O
sequences	O
(	O
DR	B
-	I
A1	I
and	I
DR	I
-	I
A2	I
).	O

The	O
human	B
immunodeficiency	I
virus	I
type	I
1	I
(	I
HIV	I
-	I
1	I
)	O
preferentially	O
infects	O
CD4	B
+	I
T	I
lymphocytes	O
and	O
may	O
exist	O
as	O
a	O
latent	O
provirus	O
within	O
these	O
cells	O
for	O
extended	O
periods	O
.	O

A	O
cDNA	O
encoding	O
the	O
NF	B
-	I
4FB	I
enhancer	I
binding	I
protein	I
has	O
been	O
cloned	O
by	O
screening	O
a	O
lambda	O
gt11	O
cDNA	O
library	O
with	O
a	O
rabiolabelled	O
oligonucleotide	O
corresponding	O
to	O
the	O
NF	B
-	I
4FB	I
recognition	I
sequence	I
.	O

The	O
two	O
IL6	B
mRNA	I
species	O
are	O
generated	O
by	O
alternative	O
polyadenylation	O
at	O
sites	O
separated	O
by	O
a	O
distance	O
of	O
1	O
.	O
2	O
kilobases	O
.	O

The	O
mature	O
protein	O
also	O
contains	O
a	O
cysteine	O
-	O
rich	O
,	O
highly	O
hydrophilic	O
region	O
homologous	O
to	O
the	O
ovomucoid	B
serine	I
protease	I
inhibitors	O
(	O
residues	O
76	O
-	O
132	O
).	O

Oligosynaptic	O
EPSP	O
components	O
were	O
consistently	O
modulated	O
only	O
in	O
the	O
superficial	O
peroneal	O
responses	O
in	O
flexor	O
motoneurons	O
,	O
which	O
exhibited	O
enhanced	O
amplitude	O
during	O
the	O
flexion	O
phase	O
.	O

On	O
the	O
other	O
hand	O
,	O
lack	O
of	O
conservation	O
of	O
the	O
membrane	O
attachment	O
sequence	O
arginine	O
-	O
glycine	O
-	O
aspartic	O
acid	O
argues	O
against	O
its	O
functional	O
importance	O
in	O
CgA	B
.	O

Third	O
-	O
and	O
later	O
-	O
parity	O
cows	O
were	O
randomly	O
assigned	O
after	O
each	O
parturition	O
to	O
Charolais	O
and	O
Red	O
Poll	O
bulls	O
in	O
multiple	O
-	O
sire	O
pastures	O
.	O

In	O
order	O
to	O
identify	O
and	O
classify	O
the	O
basic	O
CT	O
appearances	O
of	O
interstitial	O
pneumonia	O
,	O
radiologic	O
-	O
pathologic	O
correlative	O
study	O
was	O
performed	O
using	O
inflated	O
and	O
fixed	O
lungs	O
from	O
autopsy	O
and	O
surgery	O
.	O

The	O
disease	O
ran	O
an	O
atypical	O
course	O
;	O
with	O
early	O
jaundice	O
syndrome	O
,	O
severe	O
enterorrhagia	O
and	O
late	O
appearance	O
of	O
roseola	O
.	O

Since	O
1948	O
,	O
the	O
use	O
of	O
saline	O
-	O
washed	O
red	O
cells	O
(	O
WRBCs	O
)	O
has	O
been	O
advocated	O
to	O
minimize	O
hemolysis	O
after	O
transfusion	O
to	O
patients	O
with	O
PNH	O
.	O

A	O
genomic	O
DNA	O
clone	O
encoding	O
oryzacystatin	B
(	O
Oc	B
),	O
a	O
cysteine	B
proteinase	I
inhibitor	I
(	O
cystatin	B
)	O
of	O
rice	O
,	O
was	O
isolated	O
from	O
a	O
lambda	O
EMBL3	O
phage	O
library	O
constructed	O
with	O
Sau3AI	B
partial	O
digests	O
of	O
rice	O
chromosomal	O
DNA	O
,	O
by	O
screening	O
with	O
an	O
oc	B
cDNA	I
as	O
a	O
probe	O
.	O

The	O
accuracies	O
of	O
presence	O
or	O
absence	O
of	O
neuroblastoma	O
were	O
compared	O
between	O
131I	O
-	O
MIBG	O
imaging	O
and	O
several	O
tumor	O
markers	O
.	O

We	O
also	O
found	O
that	O
the	O
same	O
males	O
,	O
breeding	O
in	O
different	O
years	O
on	O
the	O
same	O
territories	O
,	O
had	O
significantly	O
larger	O
harems	O
in	O
the	O
years	O
they	O
had	O
familiar	O
neighbors	O
.	O

Pacing	O
the	O
Roux	O
limb	O
abolished	O
the	O
ectopic	O
pacemakers	O
,	O
restored	O
the	O
slow	O
emptying	O
of	O
liquids	O
to	O
the	O
more	O
rapid	O
rate	O
found	O
in	O
the	O
Billroth	O
dogs	O
(	O
t1	O
/	O
2	O
:	O
paced	O
Roux	O
,	O
72	O
+/-	O
15	O
minutes	O
;	O
Billroth	O
,	O
43	O
+/-	O
9	O
minutes	O
;	O
p	O
greater	O
than	O
0	O
.	O
05	O
)	O
and	O
did	O
not	O
change	O
emptying	O
of	O
solids	O
.	O

The	O
treatments	O
were	O
60	O
mg	O
t	O
.	O
i	O
.	O
d	O
.	O
and	O
120	O
mg	O
t	O
.	O
i	O
.	O
d	O
.	O
during	O
14	O
days	O
'	O
treatment	O
,	O
with	O
the	O
last	O
dose	O
pulsed	O
with	O
1	O
.	O
85	O
MBq	O
[	O
14C	O
]	O
diltiazem	O
.	O

The	O
examination	O
must	O
include	O
T1	O
and	O
T2	O
sequences	O
and	O
scans	O
in	O
three	O
planes	O
.	O

The	O
major	O
inserted	O
DNA	O
has	O
no	O
significant	O
homology	O
to	O
published	O
human	O
nucleic	O
acid	O
sequences	O
.	O

DNA	O
sequence	O
analysis	O
revealed	O
that	O
these	O
clones	O
encode	O
two	O
distinct	O
forms	O
of	O
translocase	B
.	O

The	O
effect	O
of	O
acetazolamide	O
(	O
ACZ	O
)	O
on	O
HCO3	O
-	O
and	O
Cl	O
-	O
activities	O
in	O
inner	O
ear	O
fluid	O
was	O
investigated	O
by	O
ion	O
-	O
selective	O
microelectrode	O
methods	O
.	O

Irmiere	O
,	O
and	O
W	O
.	O

An	O
analysis	O
of	O
the	O
steady	O
state	O
RNA	O
levels	O
in	O
T	O
-	O
lymphoid	O
cell	O
lines	O
showed	O
that	O
at	O
least	O
three	O
different	O
incomplete	O
proviral	O
transcripts	O
and	O
their	O
spliced	O
products	O
made	O
up	O
the	O
majority	O
of	O
expressed	O
RD	B
-	I
114	I
mRNA	I
,	O
and	O
further	O
demonstrated	O
that	O
partially	O
deleted	O
proviral	O
loci	O
have	O
the	O
potential	O
to	O
be	O
transcriptionally	O
vigorous	O
in	O
certain	O
feline	O
cell	O
types	O
.	O

Introduction	O
of	O
v	B
-	I
fms	I
into	O
a	O
CSF	B
-	I
1	I
dependent	I
murine	I
macrophage	I
cell	O
line	O
induced	O
factor	O
independence	O
and	O
tumorigenicity	O
by	O
a	O
nonautocrine	O
mechanism	O
.	O

RNA	O
blot	O
hybridizations	O
identified	O
an	O
1	O
.	O
8	O
-	O
kb	O
mRNA	O
common	O
to	O
cytochrome	B
b6	I
and	I
subunit	I
IV	I
,	O
and	O
an	O
intensely	O
hybridizing	O
0	O
.	O
8	O
-	O
kb	O
mRNA	O
specific	O
to	O
the	O
subunit	O
IV	O
gene	O
probe	O
.	O

All	O
of	O
the	O
indigo	O
-	O
producing	O
bacteria	O
had	O
an	O
indoxyl	B
phosphatase	I
with	O
a	O
pI	O
of	O
6	O
.	O
4	O
.	O

The	O
number	O
of	O
polymerases	O
active	O
in	O
vitro	O
at	O
the	O
E	O
strand	O
promoter	O
was	O
similar	O
to	O
the	O
number	O
of	O
polymerases	O
at	O
the	O
L	O
strand	O
promoter	O
.	O

One	O
of	O
these	O
,	O
the	O
origin	O
core	O
,	O
is	O
required	O
only	O
for	O
DNA	O
replication	O
.	O

Use	O
of	O
serum	B
thyroglobulin	I
determination	O
in	O
the	O
follow	O
-	O
up	O
of	O
differentiated	O
carcinomas	O
of	O
the	O
thyroid	O

Double	O
-	O
blind	O
randomised	O
trial	O
of	O
intravenous	O
tissue	B
-	I
type	I
plasminogen	I
activator	I
versus	O
placebo	O
in	O
acute	O
myocardial	O
infarction	O
.	O

An	O
endometrial	O
luteal	O
phase	O
deficiency	O
was	O
detected	O
in	O
15	O
(	O
30	O
%)	O
of	O
aborting	O
patients	O
.	O

On	O
Days	O
1	O
and	O
14	O
,	O
most	O
young	O
and	O
elderly	O
subjects	O
exhibited	O
monoexponential	O
decline	O
in	O
bevantolol	O
plasma	O
concentrations	O
after	O
absorption	O
phase	O
.	O

Mature	O
and	O
old	O
B6AF1	O
and	O
B6D2F1	O
mice	O
were	O
given	O
acidified	O
tap	O
water	O
or	O
promethazine	O
HCl	O
(	O
a	O
phenothiazine	O
with	O
H1	B
receptor	I
blocking	O
activity	O
),	O
chlorpheniramine	O
(	O
an	O
H1	O
blocker	O
)	O
or	O
trifluoperazine	O
(	O
a	O
phenothiazine	O
with	O
no	O
H1	O
blocking	O
activity	O
)	O
in	O
their	O
drinking	O
water	O
,	O
and	O
the	O
effects	O
of	O
these	O
agents	O
on	O
bone	O
mineral	O
content	O
were	O
assessed	O
by	O
intermittently	O
measuring	O
the	O
24	O
-	O
h	O
whole	O
body	O
retention	O
of	O
Tc	O
99m	O
methylene	O
diphosphonate	O
(	O
Tc	O
99m	O
MDP	O
,	O
an	O
indicator	O
of	O
bone	O
metabolism	O
)	O
and	O
at	O
the	O
end	O
of	O
the	O
studies	O
by	O
determining	O
ash	O
weights	O
of	O
femur	O
,	O
ilium	O
and	O
sacrum	O
.	O

Studies	O
were	O
performed	O
on	O
several	O
superficial	O
veins	O
from	O
the	O
rabbit	O
face	O
to	O
examine	O
the	O
relationship	O
between	O
beta	B
adrenoceptor	I
subtype	I
distribution	O
,	O
intrinsic	O
myogenic	O
tone	O
and	O
sympathetic	O
nerve	O
innervation	O
.	O

Six	O
patients	O
with	O
human	B
T	I
-	I
cell	I
lymphotropic	I
virus	I
type	I
I	I
(	O
HTLV	B
-	I
I	I
)-	I
associated	I
myelopathy	O
(	O
HAM	O
)	O
were	O
studied	O
by	O
electrophysiologic	O
methods	O
.	O

Most	O
patients	O
with	O
high	O
blood	O
pressure	O
(	O
BP	O
)	O
can	O
be	O
managed	O
by	O
using	O
one	O
of	O
4	O
classes	O
of	O
compounds	O
:	O
a	O
diuretic	O
,	O
beta	O
blocker	O
,	O
converting	O
enzyme	O
inhibitor	O
or	O
calcium	O
antagonist	O
.	O

Somatostatin	B
-	I
producing	O
endocrine	O
pancreatic	O
tumor	O
in	O
Recklinghausen	O
'	O
s	O
neurofibromatosis	O
.	O

Finally	O
,	O
the	O
recovery	O
indexes	O
represented	O
by	O
the	O
times	O
required	O
for	O
T1	O
/	O
T0	O
and	O
T4	O
/	O
T1	O
to	O
rise	O
from	O
25	O
%	O
to	O
75	O
%	O
respectively	O
were	O
studied	O
.	O

Transformed	O
bacterial	O
colonies	O
were	O
screened	O
for	O
recombinant	O
plasmids	O
containing	O
cDNA	O
coding	O
for	O
BiP	B
by	O
hybrid	O
-	O
selected	O
mRNA	O
translation	O
.	O

DPA	O
attenuated	O
the	O
increase	O
of	O
the	O
intensity	O
of	O
the	O
ischemic	O
and	O
pressure	O
pain	O
components	O
with	O
increasing	O
ischemia	O
duration	O
,	O
but	O
only	O
the	O
effect	O
on	O
the	O
pressure	O
pain	O
component	O
was	O
significant	O
.	O

A	O
strong	O
correlation	O
exists	O
between	O
the	O
numbers	O
of	O
CFU	O
-	O
GM	B
transfused	O
and	O
the	O
rate	O
of	O
granulocytes	O
and	O
platelets	O
recovery	O
.	O

Efficacy	O
and	O
field	O
evaluation	O
of	O
Bacillus	O
thuringiensis	O
(	O
H	O
-	O
14	O
)	O
and	O
B	O
.	O
sphaericus	O
against	O
floodwater	O
mosquitoes	O
in	O
California	O
.	O

A	O
decamer	O
sequence	O
,	O
5	O
'-	O
CGA	O
-	O
CCCCUCC	O
-	O
3	O
',	O
complementary	O
to	O
a	O
conserved	O
sequence	O
adjacent	O
to	O
the	O
enzymatic	O
cleavage	O
site	O
on	O
the	O
mitochondrial	O
RNA	O
substrate	O
,	O
is	O
present	O
in	O
the	O
RNAase	B
MRP	I
RNA	I
.	O

A	O
patient	O
with	O
an	O
infected	O
wound	O
or	O
one	O
on	O
a	O
primary	O
area	O
(	O
hands	O
,	O
feet	O
,	O
face	O
,	O
or	O
perineum	O
)	O
may	O
have	O
to	O
be	O
hospitalized	O
to	O
ensure	O
proper	O
care	O
.	O

Computer	O
analysis	O
included	O
digital	O
averaging	O
,	O
followed	O
by	O
digital	O
filtering	O
in	O
different	O
frequency	O
bands	O
in	O
order	O
to	O
determine	O
the	O
frequency	O
range	O
corresponding	O
to	O
notches	O
and	O
slurs	O
.	O

Neither	O
verapamil	O
nor	O
nifedipine	O
changed	O
collateral	O
myocardial	O
blood	O
flow	O
from	O
0	O
.	O
10	O
+/-	O
0	O
.	O
02	O
in	O
the	O
subendocardium	O
and	O
0	O
.	O
17	O
+/-	O
0	O
.	O
03	O
ml	O
/	O
min	O
/	O
g	O
in	O
the	O
subepicardium	O
.	O

Hemodynamic	O
assessment	O
was	O
obtained	O
before	O
and	O
following	O
administration	O
of	O
digoxin	O
10	O
micrograms	O
/	O
kg	O
IV	O
or	O
dopamine	O
,	O
5	O
to	O
12	O
micrograms	O
/	O
kg	O
/	O
min	O
IV	O
.	O

During	O
flexion	O
whiplash	O
,	O
the	O
torque	O
at	O
the	O
occipital	O
condyle	O
reverses	O
its	O
direction	O
at	O
about	O
25	O
ms	O
after	O
impact	O
.	O

By	O
adapting	O
a	O
method	O
for	O
DNA	O
-	O
footprinting	O
using	O
impure	O
extracts	O
of	O
ner	B
overproducing	O
cells	O
,	O
we	O
were	O
able	O
to	O
determine	O
that	O
the	O
ner	B
-	I
binding	I
sites	I
are	O
located	O
between	O
nucleotides	O
1026	O
and	O
1058	O
from	O
the	O
Mu	O
left	O
end	O
.	O

Thus	O
,	O
quantitative	O
analysis	O
of	O
thallium	O
-	O
201	O
uptake	O
and	O
washout	O
provided	O
objective	O
evidence	O
for	O
improved	O
myocardial	O
perfusion	O
after	O
coronary	O
angioplasty	O
.	O

This	O
study	O
reports	O
the	O
effects	O
of	O
a	O
preparation	O
with	O
50	O
micrograms	O
ethinyl	O
estradiol	O
and	O
2	O
mg	O
cyproterone	O
acetate	O
on	O
gonadotropins	B
,	O
prolactin	B
,	O
testosterone	O
,	O
sex	B
hormone	I
binding	I
globulin	I
(	I
SHBG	I
),	O
androstenedione	O
,	O
and	O
calculated	O
free	O
testosterone	O
index	O
before	O
and	O
after	O
six	O
months	O
of	O
treatment	O
.	O

Our	O
data	O
,	O
however	O
,	O
did	O
not	O
suggest	O
the	O
existence	O
of	O
a	O
conversion	O
factor	O
for	O
LDF	O
signal	O
to	O
absolute	O
flow	O
values	O
from	O
experiment	O
to	O
experiment	O
.	O

The	O
pathogenesis	O
of	O
Limited	O
Joint	O
Mobility	O
(	O
LJM	O
)	O
in	O
diabetes	O
is	O
unknown	O
,	O
but	O
the	O
abnormality	O
is	O
said	O
to	O
be	O
associated	O
with	O
an	O
increased	O
incidence	O
of	O
microangiopathy	O
.	O

The	O
experimental	O
end	O
points	O
were	O
the	O
time	O
required	O
for	O
treated	O
tumors	O
to	O
reach	O
3	O
times	O
their	O
treatment	O
size	O
,	O
the	O
survival	O
of	O
stem	O
cells	O
in	O
the	O
duodenal	O
crypts	O
,	O
and	O
the	O
breathing	O
rate	O
measured	O
early	O
(	O
19	O
-	O
23	O
weeks	O
)	O
and	O
late	O
(	O
41	O
-	O
46	O
weeks	O
)	O
after	O
treatment	O
.	O

The	O
seco	O
-	O
steroid	B
hormone	I
1	I
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
is	O
known	O
to	O
induce	O
the	O
expression	O
of	O
a	O
calcium	O
binding	O
protein	O
termed	O
calbindin	B
-	I
D28K	I
in	O
a	O
variety	O
of	O
target	O
tissues	O
.	O

In	O
addition	O
,	O
the	O
calbindin	B
-	I
D28K	I
promoter	I
is	O
composed	O
of	O
a	O
variety	O
of	O
simple	O
repeated	O
sequences	O
,	O
some	O
of	O
which	O
are	O
components	O
of	O
putative	O
regulatory	O
signals	O
.	O

To	O
assess	O
the	O
ability	O
of	O
the	O
atria	O
to	O
maintain	O
elevated	O
plasma	O
concentrations	O
of	O
atrial	B
natriuretic	I
peptide	I
(	I
ANP	I
),	O
the	O
temporal	O
changes	O
in	O
plasma	O
ANP	B
concentrations	O
were	O
studied	O
in	O
seven	O
chloralose	O
-	O
anaesthetized	O
dogs	O
during	O
4	O
h	O
of	O
sustained	O
rapid	O
cardiac	O
pacing	O
.	O

The	O
RAD18	B
gene	I
open	O
reading	O
frame	O
encodes	O
a	O
protein	O
of	O
487	O
amino	O
acids	O
,	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
55	O
,	O
512	O
.	O

Phase	O
II	O
study	O
of	O
VP	O
-	O
16	O
(	O
capsule	O
)	O
in	O
solid	O
tumors	O
.	O

Evidence	O
for	O
a	O
role	O
of	O
endogenous	B
corticotropin	I
-	I
releasing	I
factor	I
in	O
cold	O
,	O
ether	O
,	O
immobilization	O
,	O
and	O
traumatic	O
stress	O
.	O

The	O
data	O
obtained	O
up	O
to	O
now	O
only	O
suggest	O
the	O
future	O
potentiality	O
of	O
Bestatin	O
treatment	O
for	O
these	O
types	O
of	O
malignancy	O
.	O

In	O
the	O
absence	O
of	O
enhancer	O
sequences	O
,	O
the	O
adenovirus	B
E1A	I
gene	I
can	O
not	O
stimulate	O
CATase	B
synthesis	O
.	O

Fine	O
analysis	O
at	O
the	O
nucleotide	O
level	O
of	O
the	O
early	O
events	O
in	O
the	O
digestion	O
with	O
nuclease	B
S1	I
shows	O
that	O
the	O
enzyme	O
attacks	O
preferentially	O
the	O
sequence	O
(	O
G	B
-	I
A	I
)	O
12	O
on	O
the	O
message	O
complementary	O
strand	O
.	O

The	O
sequence	O
analysis	O
of	O
both	O
products	O
of	O
individual	O
phi	O
80	O
site	O
-	O
specific	O
recombination	O
events	O
in	O
vivo	O
shows	O
that	O
recombination	O
with	O
a	O
secondary	O
attachment	O
(	O
att	O
)	O
site	O
generates	O
several	O
different	O
novel	O
joints	O
at	O
the	O
mismatched	O
position	O
:	O
one	O
recombination	O
event	O
resulted	O
in	O
a	O
single	O
base	O
-	O
pair	O
deletion	O
and	O
two	O
other	O
recombination	O
events	O
resulted	O
in	O
two	O
different	O
single	O
base	O
-	O
pair	O
substitutions	O
.	O

Temperature	O
-	O
shift	O
experiments	O
using	O
synchronously	O
grown	O
cells	O
of	O
a	O
delta	B
top1	I
top2	I
temperature	O
-	O
sensitive	O
(	O
ts	O
)	O
double	O
mutant	O
and	O
its	O
isogenic	O
top2	B
ts	I
strain	O
show	O
that	O
,	O
whereas	O
mitotic	O
blocks	O
can	O
prevent	O
killing	O
of	O
the	O
top2	B
ts	I
mutant	I
at	O
a	O
nonpermissive	O
temperature	O
,	O
the	O
same	O
treatments	O
are	O
ineffective	O
in	O
preventing	O
cell	O
death	O
of	O
the	O
delta	B
top1	I
top2	I
ts	I
double	I
mutant	I
.	O

Its	O
predicted	O
amino	O
acid	O
sequence	O
shows	O
extensive	O
homology	O
to	O
those	O
of	O
Drosophila	B
hsp70	I
,	O
trout	B
hsp70	I
,	O
Xenopus	B
hsp70	I
,	O
yeast	B
hsp70	I
,	O
and	O
some	O
homology	O
to	O
the	O
heat	B
-	I
inducible	I
dnaK	I
gene	I
product	I
of	O
Escherichia	O
coli	O
.	O

Comparison	O
of	O
sequences	O
of	O
ovine	O
and	O
bovine	O
,	O
rat	O
and	O
guinea	B
-	I
pig	I
alpha	I
s1	I
-	I
casein	I
mRNAs	I
has	O
revealed	O
a	O
greater	O
homology	O
in	O
the	O
3	O
'	O
and	O
especially	O
5	O
'	O
non	O
coding	O
regions	O
.	O

It	O
was	O
also	O
suggested	O
that	O
the	O
biological	O
activities	O
of	O
5	O
-	O
FU	O
,	O
ADM	O
and	O
MMC	O
in	O
FAMLIP	O
were	O
stable	O
in	O
FULIP	O
,	O
ADRLIP	O
and	O
MMCLIP	O
.	O

Further	O
outbreaks	O
of	O
ocular	O
disease	O
in	O
farmed	O
red	O
deer	O
calves	O
caused	O
by	O
HVC	O
-	O
1	O
were	O
investigated	O
.	O

Human	B
alpha	I
-	I
galactosidase	I
A	I
:	O
nucleotide	O
sequence	O
of	O
a	O
cDNA	O
clone	O
encoding	O
the	O
mature	O
enzyme	O
.	O

Among	O
the	O
v	B
-	I
myc	I
codons	O
,	O
the	O
first	O
5	O
are	O
derived	O
from	O
the	O
noncoding	O
5	O
'	O
terminus	O
of	O
the	O
second	O
c	B
-	I
myc	I
exon	O
,	O
and	O
412	O
codons	O
correspond	O
to	O
the	O
c	B
-	I
myc	I
coding	O
region	O
.	O

Next	O
,	O
with	O
carcinoma	O
presenting	O
a	O
leather	O
bottle	O
(	O
linitis	O
plastica	O
type	O
)	O
of	O
the	O
stomach	O
itself	O
,	O
the	O
II	O
c	B
portion	O
of	O
the	O
stomach	O
consisted	O
of	O
fundic	O
glands	O
(	O
undifferentiated	O
carcinoma	O
)	O
shall	O
become	O
the	O
primary	O
focus	O
supporting	O
Nakamura	O
'	O
s	O
theory	O
.	O

The	O
hexanucleotide	O
5	O
'-	O
TGTCCT	O
-	O
3	O
',	O
thought	O
to	O
be	O
important	O
for	O
GRE	O
activity	O
,	O
not	O
only	O
was	O
found	O
in	O
this	O
sequence	O
and	O
in	O
the	O
5	O
'-	O
flanking	O
region	O
,	O
but	O
also	O
was	O
present	O
twice	O
in	O
the	O
3	O
'	O
end	O
of	O
the	O
gene	O
that	O
did	O
not	O
show	O
specific	O
receptor	O
binding	O
.	O

The	O
latent	O
periods	O
from	O
the	O
antral	O
exclusion	O
to	O
the	O
occurrence	O
of	O
anastomotic	O
ulcers	O
after	O
a	O
subtotal	O
gastrectomy	O
with	O
Billroth	O
'	O
s	O
type	O
II	O
reconstruction	O
varied	O
from	O
a	O
few	O
days	O
to	O
19	O
years	O
,	O
with	O
an	O
average	O
of	O
2	O
.	O
8	O
years	O
.	O

Nuclease	O
footprinting	O
revealed	O
that	O
purified	O
glucocorticoid	B
receptor	I
bound	O
at	O
multiple	O
discrete	O
sites	O
within	O
and	O
at	O
the	O
borders	O
of	O
the	O
tandemly	O
repeated	O
sequence	O
motif	O
that	O
defines	O
Sa	B
.	O

The	O
96	O
-	O
bp	O
insert	O
contained	O
a	O
termination	O
signal	O
which	O
caused	O
the	O
premature	O
termination	O
of	O
the	O
protein	O
,	O
leading	O
to	O
the	O
generation	O
of	O
a	O
p53	B
product	I
9	O
amino	O
acids	O
shorter	O
than	O
usual	O
.	O

A	O
single	O
exon	O
encodes	O
the	O
carboxyl	O
-	O
terminal	O
26	O
amino	O
acids	O
of	O
the	O
ssd	B
chain	I
and	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
its	O
mRNA	O
,	O
ending	O
with	O
a	O
poly	O
(	O
A	O
)-	O
addition	O
site	O
.	O

We	O
inserted	O
genes	O
or	O
gene	O
segments	O
,	O
that	O
code	O
for	O
the	O
bacterial	O
chloramphenicol	B
acetyltransferase	I
,	O
the	O
bacterial	B
gene	I
conferring	O
resistance	O
against	O
hygromycin	O
,	O
and	O
the	O
ORF	O
E7	B
of	O
the	O
human	B
papillomavirus	I
type	I
18	O
into	O
these	O
vectors	O
.	O

Oligonucleotide	O
-	O
directed	O
mutagenesis	O
was	O
used	O
to	O
create	O
an	O
NdeI	B
restriction	I
site	I
at	O
the	O
natural	O
ATG	O
of	O
the	O
yeast	O
R	O
.	O

ACTH	B
release	O
is	O
transiently	O
suppressed	O
in	O
some	O
children	O
after	O
exogenous	O
ACTH	B
treatment	O
.	O

Morphine	O
produced	O
a	O
dose	O
-	O
dependent	O
bradycardia	O
followed	O
by	O
tachycardia	O
.	O

The	O
PSS	B
gene	I
was	O
subcloned	O
into	O
a	O
1	O
.	O
1	O
-	O
kb	O
fragment	O
of	O
the	O
yeast	O
DNA	O
on	O
the	O
YEp13	O
vector	O
.	O

The	O
gene	O
is	O
essential	O
for	O
yeast	O
vegetative	O
growth	O
.	O

It	O
is	O
concluded	O
that	O
suppression	O
of	O
elevated	O
prolactin	B
levels	O
in	O
progressive	O
metastatic	O
breast	O
cancer	O
patients	O
is	O
not	O
effective	O
in	O
restoring	O
tumor	O
sensitivity	O
to	O
chemotherapy	O
.	O

Bacteriologic	O
culture	O
of	O
pancreatic	O
tissue	O
was	O
positive	O
in	O
6	O
/	O
8	O
IB	O
and	O
3	O
/	O
17	O
NIB	O
rats	O
(	O
p	O
less	O
than	O
0	O
.	O
01	O
).	O

These	O
similarities	O
suggest	O
that	O
these	O
E2	B
proteins	I
are	O
structurally	O
and	O
evolutionarily	O
related	O
.	O

However	O
,	O
excretion	O
of	O
6	O
-	O
keto	O
-	O
prostaglandin	O
F1	B
alpha	I
was	O
further	O
reduced	O
in	O
the	O
smokers	O
who	O
used	O
oral	O
contraceptives	O
(	O
133	O
+/-	O
20	O
to	O
86	O
+/-	O
9	O
ng	O
/	O
gm	O
of	O
creatinine	O
,	O
p	O
less	O
than	O
0	O
.	O
05	O
).	O

The	O
in	O
vitro	O
activity	O
of	O
mecillinam	O
and	O
amoxicillin	O
/	O
clavulanic	O
acid	O
against	O
Escherichia	O
coli	O
strains	O
producing	O
beta	B
-	I
lactamases	I
of	O
the	O
TEM	B
-	I
1	I
,	O
Oxa	B
-	I
1	I
and	O
chromosomal	O
type	O
were	O
studied	O
using	O
the	O
broth	O
and	O
agar	O
dilution	O
technique	O
.	O

The	O
rci	B
gene	I
was	O
fused	O
with	O
lacZ	B
and	O
its	O
gene	O
product	O
was	O
identified	O
by	O
Western	O
blot	O
analysis	O
.	O

Structure	O
and	O
regulation	O
of	O
a	O
nuclear	O
gene	O
in	O
Saccharomyces	O
cerevisiae	O
that	O
specifies	O
MRP13	B
,	O
a	O
protein	O
of	O
the	O
small	O
subunit	O
of	O
the	O
mitochondrial	O
ribosome	O
.	O

Van	O
der	O
Ende	O
,	O
R	O
.	O

Mechanism	O
of	O
the	O
t	O
(	O
14	O
;	O
18	O
)	O
chromosomal	O
translocation	O
:	O
structural	O
analysis	O
of	O
both	O
derivative	O
14	O
and	O
18	O
reciprocal	O
partners	O
.	O

After	O
age	O
30	O
,	O
mean	O
hemoglobin	B
levels	O
for	O
men	O
gradually	O
declined	O
,	O
while	O
those	O
in	O
women	O
rose	O
,	O
so	O
that	O
the	O
sex	O
difference	O
diminished	O
after	O
60	O
years	O
of	O
age	O
.	O

Ethylene	O
glycol	O
and	O
diethylene	O
glycol	O
were	O
each	O
administered	O
once	O
weekly	O
subcutaneously	O
to	O
groups	O
of	O
100	O
female	O
NMRI	O
mice	O
at	O
3	O
dosages	O
(	O
30	O
;	O
10	O
und	O
3	O
mg	O
single	O
dose	O
per	O
mouse	O
).	O

During	O
BH	O
the	O
ventilator	O
was	O
disconnected	O
and	O
a	O
bias	O
flow	O
of	O
50	O
%	O
O2	O
at	O
4	O
-	O
5	O
l	O
/	O
min	O
was	O
delivered	O
through	O
the	O
side	O
ports	O
of	O
a	O
small	O
catheter	O
whose	O
tip	O
was	O
positioned	O
1	O
cm	O
cephalad	O
of	O
the	O
carina	O
.	O

Comparison	O
of	O
beta	B
2	I
-	I
microglobulin	I
removal	O
using	O
the	O
same	O
polysulphone	O
membrane	O
for	O
haemodialysis	O
and	O
haemofiltration	O
shows	O
that	O
beta	B
2	I
-	I
microglobulin	I
is	O
more	O
effectively	O
removed	O
by	O
convection	O
than	O
by	O
diffusion	O
when	O
both	O
treatment	O
modes	O
are	O
matched	O
for	O
blood	O
flow	O
and	O
urea	O
clearance	O
.	O

40	O
.	O
3	O
+/-	O
10	O
.	O
1	O
mg	O
/	O
l	O
(	O
SD	O
)	O
vs	O
31	O
.	O
2	O
+/-	O
8	O
.	O
0	O
,	O
P	O
less	O
than	O
0	O
.	O
01	O
).	O
beta	B
2m	I
was	O
not	O
significantly	O
higher	O
in	O
patients	O
with	O
bone	O
cysts	O
(	O
37	O
.	O
7	O
+/-	O
11	O
.	O
4	O
mg	O
/	O
l	O
vs	O
37	O
.	O
0	O
+/-	O
10	O
.	O
0	O
),	O
but	O
median	O
duration	O
of	O
dialysis	O
was	O
significantly	O
(	O
P	O
less	O
than	O
0	O
.	O
01	O
)	O
longer	O
in	O
patients	O
with	O
bone	O
cysts	O
(	O
90	O
vs	O
57	O
months	O
).	O
beta	B
2m	I
was	O
lower	O
in	O
patients	O
maintained	O
on	O
dialysis	O
for	O
less	O
than	O
1	O
year	O
and	O
whose	O
residual	O
urine	O
volume	O
was	O
greater	O
than	O
0	O
.	O
1	O
litre	O
per	O
day	O
.	O

In	O
overdoses	O
up	O
to	O
2	O
g	O
fluvoxamine	O
no	O
lasting	O
toxic	O
effects	O
were	O
observed	O
.	O

It	O
is	O
concluded	O
that	O
the	O
plasma	O
prolactin	B
response	O
to	O
12	O
.	O
5	O
micrograms	O
i	O
.	O
v	O
.	O

In	O
addition	O
,	O
a	O
wild	B
-	I
type	I
strain	O
containing	O
a	O
temperature	B
-	I
sensitive	I
threonyl	I
-	I
tRNA	I
synthetase	I
mutation	I
showed	O
increased	O
thr	B
operon	I
expression	O
at	O
the	O
non	O
-	O
permissive	O
temperature	O
,	O
whereas	O
none	O
of	O
the	O
mutants	O
showed	O
any	O
change	O
.	O

The	O
mean	O
weight	O
and	O
height	O
velocities	O
were	O
148	O
%	O
and	O
122	O
%	O
of	O
the	O
standard	O
,	O
respectively	O
.	O

A	O
complementary	O
study	O
,	O
showing	O
a	O
good	O
agreement	O
between	O
surface	O
and	O
oesophageal	O
EMGd	O
seems	O
to	O
confirm	O
that	O
surface	O
EMGd	O
is	O
a	O
useful	O
and	O
promising	O
tool	O
for	O
clinical	O
investigation	O
.	O

The	O
results	O
of	O
these	O
experiments	O
indicate	O
that	O
at	O
least	O
two	O
upstream	O
activator	O
sequences	O
(	O
UAS	O
)	O
mediate	O
maximum	O
induction	O
by	O
galactose	O
.	O

In	O
14	O
patients	O
whose	O
PaCO2	O
was	O
greater	O
than	O
or	O
equal	O
to	O
39	O
torr	O
(	O
range	O
39	O
to	O
58	O
torr	O
)	O
and	O
clinical	O
asthma	O
score	O
was	O
6	O
or	O
greater	O
,	O
PaCO2	O
decreased	O
a	O
mean	O
of	O
11	O
.	O
7	O
torr	O
during	O
a	O
mean	O
of	O
8	O
.	O
1	O
hours	O
.	O

Our	O
findings	O
suggest	O
that	O
the	O
mtr	B
product	I
causes	O
both	O
transcription	O
attenuation	O
and	O
inhibition	O
of	O
translation	O
of	O
trpE	B
mRNA	I
.	O

Although	O
L	O
-	O
threo	O
-	O
dihydroxyphenylserine	O
(	O
DOPS	O
),	O
an	O
artificial	O
norepinephrine	O
(	O
NE	O
)	O
precursor	O
,	O
did	O
not	O
change	O
immobility	O
in	O
intact	O
mice	O
,	O
DOPS	O
significantly	O
reduced	O
immobility	O
in	O
mice	O
pretreated	O
with	O
the	O
selective	O
NE	O
neurotoxin	O
DSP4	O
.	O

The	O
genetic	O
basis	O
for	O
the	O
expression	O
of	O
a	O
latent	O
VH	B
allotype	I
in	O
the	O
rabbit	O
was	O
investigated	O
.	O

Clinical	O
research	O
of	O
non	O
-	O
A	O
,	O
non	O
-	O
B	O
post	O
-	O
transfusion	O
hepatitis	O

The	O
variability	O
is	O
most	O
likely	O
a	O
result	O
of	O
alternative	O
splicing	O
of	O
exons	O
from	O
the	O
primary	O
elastin	B
transcripts	I
.	O

This	O
effect	O
and	O
the	O
fact	O
that	O
all	O
three	O
doses	O
were	O
toxic	O
to	O
the	O
dams	O
dictated	O
that	O
a	O
second	O
experiment	O
be	O
carried	O
out	O
at	O
lower	O
doses	O
.	O

Delayed	O
gallbladder	O
visualization	O
and	O
reduction	O
in	O
ejection	O
fraction	O
were	O
sensitive	O
but	O
nonspecific	O
indicators	O
of	O
biliary	O
disease	O
.	O

Chem	O
.	O

Sequential	O
MR	O
examinations	O
of	O
the	O
nasal	O
cavity	O
and	O
paranasal	O
sinuses	O
were	O
performed	O
within	O
a	O
6	O
-	O
8	O
h	O
period	O
in	O
five	O
normal	O
volunteers	O
.	O

An	O
ELISA	O
procedure	O
was	O
developed	O
for	O
monitoring	O
the	O
specific	O
IgE	B
response	O
in	O
dogs	O
to	O
Dirofilaria	O
immitis	O
infection	O
.	O

The	O
only	O
isolate	O
of	O
Aeromonas	O
hydrophila	O
produced	O
cytotoxic	O
enterotoxin	O
and	O
was	O
invasive	O
.	O

Recovery	O
was	O
characterized	O
by	O
rapid	O
improvement	O
such	O
that	O
all	O
measured	O
parameters	O
normalized	O
by	O
1	O
week	O
,	O
except	O
for	O
cross	O
-	O
sectional	O
cardiac	O
area	O
which	O
remained	O
dilated	O
up	O
to	O
4	O
weeks	O
(	O
14	O
+/-	O
3	O
cm2	O
,	O
p	O
less	O
than	O
0	O
.	O
05	O
versus	O
control	O
).(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Neuromyelitis	O
optica	O
(	O
Devic	O
'	O
s	O
syndrome	O
):	O
not	O
always	O
multiple	O
sclerosis	O
.	O

Increasing	O
the	O
phosphorus	O
content	O
of	O
the	O
diet	O
improved	O
the	O
reabsorption	O
of	O
calcium	O
and	O
magnesium	O
.	O

Baseline	O
measurements	O
of	O
forced	O
expiratory	O
volume	O
in	O
1	O
s	O
(	O
FEV1	O
),	O
specific	O
airway	O
conductance	O
(	O
SGaw	O
)	O
and	O
the	O
provocative	O
dose	O
of	O
carbachol	O
causing	O
a	O
35	O
%	O
reduction	O
in	O
SGaw	O
(	O
PD35	O
),	O
and	O
a	O
20	O
%	O
reduction	O
in	O
FEV1	O
(	O
PD20	O
)	O
were	O
established	O
on	O
entry	O
while	O
each	O
subject	O
was	O
still	O
smoking	O
.	O

R	O
-	O
wave	O
voltage	O
in	O
the	O
right	O
precordial	O
leads	O
in	O
anthracycline	O
cardiomyopathy	O
:	O
a	O
clinical	O
study	O
.	O

These	O
results	O
indicate	O
that	O
CSFHU	B
can	O
increase	O
neutrophil	O
counts	O
by	O
increasing	O
the	O
number	O
and	O
maturity	O
of	O
the	O
marrow	O
neutrophil	O
precursors	O
in	O
some	O
types	O
of	O
childhood	O
chronic	O
neutropenia	O
.	O

The	O
active	O
derivatives	O
of	O
the	O
present	O
series	O
were	O
also	O
tested	O
for	O
their	O
analgesic	O
activity	O
against	O
aconitine	O
-	O
induced	O
writhing	O
in	O
albino	O
mice	O
and	O
ulcerogenic	O
activity	O
in	O
albino	O
rats	O
.	O

The	O
effects	O
of	O
these	O
mutations	O
on	O
RNA	B
polymerase	I
II	I
activity	O
were	O
assayed	O
by	O
measuring	O
the	O
ability	O
of	O
mutant	O
genes	O
to	O
confer	O
alpha	B
-	I
amanitin	I
resistance	O
after	O
transfection	O
of	O
susceptible	O
rodent	O
cells	O
.	O

The	O
indications	O
for	O
its	O
use	O
include	O
every	O
primary	O
and	O
secondary	O
rhinoplasty	O
candidate	O
unless	O
tip	O
grafts	O
are	O
going	O
to	O
be	O
under	O
tension	O
or	O
if	O
the	O
deformity	O
is	O
minor	O
.	O

The	O
SSB	B
-	I
poly	O
(	O
dT	O
)	O
affinity	O
is	O
too	O
high	O
to	O
measure	O
in	O
buffers	O
containing	O
even	O
5	O
M	O
NaCl	O
;	O
however	O
,	O
in	O
1	O
.	O
8	O
-	O
2	O
.	O
5	O
M	O
NaBr	O
,	O
we	O
measure	O
alpha	O
log	O
Kobsd	O
/	O
alpha	O
log	O
[	O
NaBr	O
]	O
=	O
-	O
5	O
.	O
7	O
+/-	O
0	O
.	O
7	O
,	O
with	O
a	O
lower	O
value	O
of	O
omega	O
T	O
/	O
O	O
=	O
130	O
+/-	O
70	O
.	O

The	O
behavior	O
of	O
suf12	B
-	I
null	I
/	I
SUF12	I
+	I
heterozygotes	I
indicates	O
that	O
suf12	B
is	O
co	O
-	O
dominantly	O
expressed	O
and	O
suggests	O
that	O
suf12	B
allele	I
-	I
specific	I
suppression	O
may	O
result	O
from	O
functionally	O
distinct	O
mutant	O
proteins	O
rather	O
than	O
variation	O
in	O
residual	O
wild	B
-	I
type	I
SUF12	I
+	I
activity	O
.	O

Yang	O
and	O
H	O
.	O

Diet	O
and	O
atopic	O
eczema	O
.	O

Clinical	O
chemistry	O
.	O

Plasma	B
renin	I
activity	O
does	O
not	O
predict	O
the	O
antihypertensive	O
efficacy	O
of	O
chlorthalidone	O
.	O

Bullous	O
keratopathy	O
was	O
usually	O
aphakic	O
in	O
origin	O
in	O
1982	O
,	O
but	O
after	O
1983	O
pseudophakic	O
bullous	O
keratopathy	O
(	O
PBK	O
)	O
was	O
the	O
most	O
common	O
cause	O
of	O
bullous	O
keratopathy	O
.	O

The	O
ultrastructural	O
findings	O
,	O
as	O
well	O
as	O
the	O
urinary	O
C	B
-	I
peptide	I
excretion	O
,	O
confirmed	O
that	O
the	O
glycemic	O
effects	O
should	O
not	O
be	O
thought	O
to	O
be	O
due	O
to	O
a	O
direct	O
action	O
of	O
the	O
drugs	O
used	O
on	O
the	O
endocrine	O
pancreas	O
.	O

"	O
In	O
vitro	O
"	O
study	O
of	O
dentin	O
adhesion	O
to	O
adhesives	O
made	O
from	O
urethane	O
molecules	O
with	O
free	O
groups	O
of	O
isocyanate	O

By	O
Felix	O
Lagrange	O
,	O
1918	O
.	O

There	O
is	O
a	O
cysteine	O
clustering	O
region	O
in	O
an	O
N	O
-	O
terminal	O
region	O
of	O
the	O
c	B
-	I
raf	I
(-	I
1	I
)	I
product	I
deduced	O
from	O
the	O
nucleotide	O
sequence	O
,	O
and	O
this	O
cysteine	O
clustering	O
region	O
was	O
found	O
to	O
be	O
highly	O
homologous	O
to	O
that	O
present	O
in	O
an	O
N	B
-	I
terminal	I
region	I
of	I
protein	I
kinase	I
C	I
,	O
although	O
,	O
in	O
the	O
latter	O
cysteine	O
clusters	O
are	O
present	O
in	O
duplicate	O
.	O

The	O
German	O
Society	O
of	O
Pediatric	O
Oncology	O
in	O
1981	O
initiated	O
the	O
Cooperative	O
Ewing	O
'	O
s	O
Sarcoma	O
Study	O
(	O
CESS	O
81	O
)	O
using	O
a	O
four	O
-	O
drug	O
combination	O
of	O
chemotherapy	O
prior	O
to	O
definitive	O
local	O
control	O
with	O
surgery	O
and	O
/	O
or	O
radiation	O
.	O

With	O
histology	O
and	O
Evans	O
blue	O
injections	O
,	O
blood	O
-	O
brain	O
barrier	O
alterations	O
were	O
seen	O
as	O
early	O
as	O
4	O
days	O
after	O
a	O
dose	O
of	O
50	O
Gy	O
.	O

The	O
correlation	O
between	O
PaCO2	O
and	O
PtcO2	O
in	O
RDS	O
was	O
insufficient	O
to	O
make	O
clinical	O
judgement	O
.	O

The	O
epidermal	B
growth	I
factor	I
(	I
EGF	I
)	I
receptor	I
,	O
which	O
exhibits	O
intrinsic	O
protein	B
tyrosine	I
kinase	I
activity	O
,	O
undergoes	O
a	O
rapid	O
,	O
intramolecular	O
self	O
-	O
phosphorylation	O
reaction	O
following	O
EGF	B
activation	O
.	O

A	O
case	O
of	O
AIDS	O
-	O
related	O
complex	O
(	O
ARC	O
/	O
LAS	O
)	O
in	O
a	O
health	O
worker	O

Because	O
the	O
CAP	O
measures	O
variables	O
predictive	O
of	O
abusive	O
behavior	O
,	O
a	O
substantial	O
relationship	O
was	O
expected	O
between	O
the	O
CAP	O
and	O
the	O
MHI	O
Loss	O
of	O
Behavioral	O
/	O
Emotional	O
Control	O
scale	O
.	O

Static	O
magnetic	O
fields	O
affect	O
the	O
diffusion	O
of	O
biological	O
particles	O
in	O
solutions	O
through	O
the	O
Lorentz	O
force	O
and	O
Maxwell	O
stress	O
.	O

Chronic	O
administration	O
of	O
sodium	O
cyanate	O
decreases	O
O2	O
extraction	O
ratio	O
in	O
dogs	O
.	O

Abnormal	O
technetium	O
Tc	O
99m	O
medronate	O
scans	O
in	O
patients	O
with	O
previously	O
undiagnosed	O
polyarthralgias	O
suggested	O
inflammatory	O
arthropathy	O
and	O
influenced	O
management	O
decisions	O
with	O
favorable	O
therapeutic	O
outcomes	O
.	O

The	O
effects	O
produced	O
by	O
oral	O
administration	O
of	O
500	O
mg	O
/	O
kg	O
p	O
-	O
xylene	O
or	O
toluene	O
lasted	O
at	O
least	O
8	O
hr	O
,	O
while	O
the	O
effect	O
of	O
inhaled	O
p	O
-	O
xylene	O
dissipated	O
within	O
75	O
min	O
of	O
removal	O
from	O
the	O
exposure	O
.	O

Papers	O
of	O
the	O
Society	O
for	O
Clinical	O
Vascular	O
Surgery	O
.	O

Pregnant	O
rats	O
were	O
exposed	O
to	O
one	O
of	O
the	O
following	O
:	O
(	O
1	O
)	O
10	O
%	O
O2	O
in	O
N2	O
or	O
100	O
%	O
O2	O
for	O
2	O
days	O
beginning	O
at	O
day	O
7	O
,	O
11	O
,	O
14	O
,	O
or	O
18	O
of	O
pregnancy	O
;	O
(	O
2	O
)	O
10	O
%	O
O2	O
in	O
N2	O
or	O
100	O
%	O
O2	O
for	O
10	O
h	O
/	O
day	O
beginning	O
at	O
day	O
7	O
;	O
or	O
(	O
3	O
)	O
14	O
-	O
11	O
%	O
O2	O
in	O
N2	O
continuously	O
beginning	O
at	O
day	O
14	O
till	O
day	O
21	O
when	O
they	O
were	O
sacrificed	O
.	O

The	O
incidence	O
of	O
cryptosporidiosis	O
in	O
young	O
children	O
was	O
determined	O
by	O
staining	O
of	O
faecal	O
specimens	O
with	O
a	O
modified	O
Kinyoun	O
stain	O
.	O

In	O
Salmo	O
gairdneri	O
,	O
no	O
specialized	O
system	O
of	O
portal	O
vessels	O
appears	O
to	O
exist	O
between	O
the	O
pineal	O
organ	O
and	O
other	O
portions	O
of	O
the	O
brain	O
.	O

Nitrofurazone	O
significantly	O
reduced	O
the	O
rise	O
in	O
LH	B
induced	O
by	O
LHRH	B
.	O

X2	O
test	O
,	O
with	O
Yates	O
correction	O
if	O
need	O
,	O
was	O
used	O
as	O
statistical	O
.	O
method	O
.	O

Hair	O
and	O
blood	O
samples	O
were	O
taken	O
before	O
vitamin	O
C	O
or	O
placebo	O
supplementation	O
was	O
started	O
and	O
at	O
monthly	O
intervals	O
thereafter	O
for	O
three	O
months	O
.	O

Emergency	O
treatment	O
of	O
facial	O
and	O
maxillary	O
/	O
mandibular	O
injuries	O

In	O
14	O
cases	O
,	O
isolates	O
were	O
biotyped	O
yielding	O
eight	O
with	O
biotype	O
II	O
,	O
four	O
with	O
biotype	O
III	O
,	O
and	O
one	O
each	O
with	O
biotypes	O
IV	O
and	O
V	O
.	O

Most	O
of	O
the	O
prepeptide	O
portion	O
of	O
the	O
precursor	O
polypeptide	O
is	O
encoded	O
by	O
the	O
next	O
three	O
exons	O
,	O
and	O
the	O
mature	O
form	O
of	O
IL	B
-	I
1	I
alpha	I
is	O
encoded	O
by	O
the	O
remaining	O
three	O
exons	O
.	O

Hexsyn	O
is	O
the	O
Goodyear	O
Tire	O
and	O
Rubber	O
Company	O
tradename	O
for	O
a	O
polyolefin	O
rubber	O
synthesized	O
from	O
1	O
-	O
hexene	O
with	O
3	O
-	O
5	O
%	O
methylhexadiene	O
as	O
the	O
source	O
of	O
residual	O
double	O
bonds	O
for	O
vulcanization	O
.	O

Chimeric	O
phage	O
-	O
plasmid	O
expression	O
vectors	O
were	O
constructed	O
from	O
pUC18	O
/	O
19	O
plasmids	O
by	O
cloning	O
a	O
single	O
-	O
stranded	O
DNA	O
(	O
ssDNA	O
)	O
origin	O
of	O
replication	O
from	O
bacteriophage	O
f1	O
and	O
inserting	O
a	O
bacteriophage	B
T7	I
promoter	I
within	O
the	O
beta	B
-	I
galactosidase	I
gene	I
.	O

Neither	O
ethanol	O
nor	O
estrogen	O
has	O
been	O
shown	O
to	O
cause	O
UROD	B
-	I
deficiency	O
in	O
animals	O
.	O

Although	O
not	O
common	O
,	O
the	O
disorder	O
is	O
the	O
most	O
frequently	O
diagnosed	O
disturbance	O
of	O
porphyrin	O
metabolism	O
in	O
many	O
countries	O
,	O
and	O
further	O
insight	O
into	O
its	O
unusual	O
pathogenesis	O
may	O
clarify	O
the	O
hepatotoxic	O
effects	O
of	O
the	O
4	O
etiologic	O
agents	O
.	O

Ciprofloxacin	O
:	O
an	O
overview	O
of	O
adverse	O
experiences	O
.	O

Also	O
,	O
component	O
I	O
significantly	O
correlated	O
with	O
fasting	O
insulin	B
and	O
VO2	O
max	O
for	O
both	O
sexes	O
and	O
with	O
basal	O
metabolism	O
and	O
HDL	B
-	I
cholesterol	I
for	O
females	O
and	O
males	O
,	O
respectively	O
.	O

Postglucose	O
serum	O
insulin	B
levels	O
showed	O
no	O
significant	O
correlations	O
with	O
systolic	O
or	O
diastolic	O
blood	O
pressure	O
levels	O
in	O
men	O
,	O
but	O
in	O
female	O
diabetic	O
and	O
non	O
-	O
diabetic	O
subjects	O
significant	O
correlations	O
were	O
found	O
in	O
particular	O
with	O
systolic	O
blood	O
pressure	O
level	O
.	O

We	O
used	O
oligonucleotide	O
-	O
directed	O
mutagenesis	O
to	O
alter	O
a	O
site	O
in	O
MucA	B
homologous	O
to	O
the	O
Ala	O
-	O
Gly	O
cleavage	O
site	O
of	O
LexA	B
.	O

The	O
pharmacology	O
of	O
carnitine	O
.	O

The	O
present	O
investigation	O
sought	O
to	O
identify	O
the	O
principal	O
dimensions	O
of	O
the	O
Framingham	O
Type	O
A	O
scale	O
(	O
FTAS	O
)	O
and	O
then	O
to	O
examine	O
their	O
physiological	O
and	O
psychological	O
correlates	O
.	O

The	O
spleen	O
rate	O
of	O
about	O
600	O
villagers	O
of	O
RK	O
I	O
examined	O
was	O
54	O
.	O
3	O
%	O
and	O
the	O
parasite	O
rate	O
13	O
.	O
2	O
%	O
before	O
the	O
drug	O
intervention	O
.	O

The	O
diagnosis	O
of	O
metachromatic	O
leukodystrophy	O
(	O
MLD	O
)	O
was	O
confirmed	O
by	O
the	O
finding	O
of	O
low	O
arylsulfatase	B
A	I
(	O
ASA	O
)	O
levels	O
in	O
cultured	O
fibroblasts	O
in	O
both	O
sisters	O
.	O

Significantly	O
lower	O
heart	O
rate	O
reactivity	O
and	O
significantly	O
less	O
pronounced	O
left	O
temporal	O
artery	O
pulse	O
amplitude	O
responses	O
were	O
found	O
in	O
non	O
-	O
medicated	O
TH	B
subjects	O
than	O
in	O
controls	O
.	O

Drugs	O
that	O
are	O
transformed	O
via	O
phase	O
II	O
reactions	O
usually	O
do	O
not	O
require	O
dosage	O
adjustment	O
.	O

Development	O
of	O
a	O
provisional	O
information	O
-	O
retrieval	O
descriptor	O
language	O
for	O
"	O
Roentgenology	O
and	O
Medical	O
Radiology	O
"	O
for	O
use	O
in	O
the	O
Medinform	O
system	O

Thus	O
,	O
a	O
negative	O
test	O
is	O
compatible	O
with	O
low	O
disease	O
activity	O
and	O
/	O
or	O
efficacy	O
of	O
calcium	O
antagonist	O
treatment	O
.	O

In	O
subjects	O
(	O
n	O
=	O
5	O
)	O
with	O
quadriplegia	O
and	O
reduced	O
sympathetic	O
tone	O
secondary	O
to	O
cervical	O
cord	O
trauma	O
,	O
TcpO2	O
at	O
42	O
degrees	O
C	O
and	O
vasodilation	O
index	O
were	O
increased	O
(	O
45	O
.	O
0	O
mmHg	O
and	O
0	O
.	O
61	O
);	O
TcpO2	O
at	O
45	O
degrees	O
C	O
did	O
not	O
change	O
.	O

The	O
nucleotide	O
sequences	O
of	O
the	O
human	O
and	O
murine	B
ornithine	I
decarboxylase	I
mRNAs	I
share	O
an	O
85	O
%	O
homology	O
,	O
even	O
in	O
their	O
3	O
'-	O
noncoding	O
regions	O
.	O

Cell	O
.	O

Timing	O
of	O
symptoms	O
and	O
oocyst	O
excretion	O
in	O
human	O
cryptosporidiosis	O
.	O

All	O
these	O
processes	O
were	O
fully	O
developed	O
during	O
the	O
last	O
month	O
of	O
pregnancy	O
,	O
offering	O
the	O
same	O
picture	O
as	O
the	O
controls	O
.	O

This	O
approach	O
enables	O
the	O
sources	O
of	O
error	O
in	O
the	O
calculation	O
of	O
nutrient	O
utilization	O
to	O
be	O
readily	O
identified	O
,	O
and	O
their	O
effect	O
on	O
precision	O
to	O
be	O
assessed	O
in	O
different	O
nutritional	O
and	O
metabolic	O
states	O
.	O

The	O
presence	O
in	O
such	O
patients	O
of	O
antibodies	O
to	O
adrenaline	O
and	O
noradrenaline	O
is	O
indicative	O
of	O
considerable	O
disruption	O
of	O
catecholamine	O
biotransformation	O
.	O

The	O
role	O
of	O
saliva	O
in	O
sour	O
taste	O
perception	O
was	O
investigated	O
in	O
a	O
series	O
of	O
4	O
experiments	O
.	O

W	O
.	O

Hyperthyroidism	O

We	O
conclude	O
that	O
for	O
mono	O
-	O
intronic	O
precursors	O
in	O
which	O
there	O
is	O
only	O
one	O
choice	O
of	O
splice	O
sites	O
,	O
most	O
of	O
the	O
exon	O
sequences	O
are	O
not	O
mechanistically	O
involved	O
in	O
the	O
splicing	O
process	O
.	O

Systemic	O
lupus	O
erythematosus	O
was	O
diagnosed	O
.	O

These	O
results	O
suggest	O
that	O
less	O
antidopaminergic	O
activity	O
of	O
RHAL	O
in	O
this	O
neuroleptic	O
test	O
might	O
be	O
explained	O
by	O
the	O
lesser	O
conversion	O
of	O
RHAL	O
to	O
HAL	O
.	O

The	O
average	O
deviations	O
in	O
the	O
X	O
-	O
ray	O
counts	O
of	O
the	O
constant	O
elements	O
from	O
the	O
series	O
means	O
were	O
used	O
to	O
correct	O
the	O
recorded	O
count	O
of	O
the	O
variable	O
element	O
in	O
each	O
block	O
.	O

To	O
evaluate	O
the	O
relative	O
accuracy	O
of	O
continuous	O
wave	O
(	O
CW	O
)	O
and	O
high	O
pulse	O
repetition	O
frequency	O
(	O
HPRF	O
)	O
Doppler	O
for	O
estimating	O
aortic	O
transvalvular	O
pressure	O
gradients	O
,	O
Doppler	O
examinations	O
with	O
both	O
devices	O
were	O
obtained	O
in	O
87	O
consecutive	O
patients	O
with	O
aortic	O
valve	O
disease	O
.	O

In	O
calves	O
receiving	O
milk	O
-	O
substitute	O
diets	O
containing	O
80	O
-	O
260	O
g	O
DM	O
/	O
kg	O
,	O
milk	O
intakes	O
were	O
reduced	O
by	O
up	O
to	O
30	O
%	O
on	O
the	O
1st	O
day	O
that	O
calves	O
were	O
fed	O
once	O
daily	O
instead	O
of	O
twice	O
daily	O
.	O

The	O
number	O
of	O
fecal	O
pellets	O
ingested	O
peaked	O
at	O
5	O
to	O
6	O
weeks	O
old	O
(	O
13	O
pellets	O
/	O
day	O
)	O
and	O
gradually	O
decreased	O
,	O
thereafter	O
(	O
2	O
.	O
1	O
pellets	O
at	O
78	O
weeks	O
old	O
,	O
1	O
.	O
5	O
pellets	O
at	O
104	O
weeks	O
old	O
).	O

Endurance	O
training	O
resulted	O
in	O
an	O
increase	O
of	O
stiffness	O
associated	O
with	O
a	O
decrease	O
of	O
type	O
II	O
fibers	O
.	O

Two	O
of	O
these	O
six	O
cases	O
showed	O
mucosal	O
spread	O
without	O
stromal	O
invasion	O
(	O
type	O
A	O
);	O
the	O
remaining	O
four	O
cases	O
presented	O
a	O
direct	O
extension	O
(	O
type	O
B	O
)	O
from	O
muscle	O
-	O
invasive	O
carcinomas	O
of	O
the	O
bladder	O
.	O

It	O
is	O
concluded	O
that	O
contact	O
allergy	O
to	O
K	B
-	I
CG	I
is	O
common	O
.	O

Blood	O
serum	B
erythropoietin	I
level	O
and	O
basic	O
hematological	O
indices	O
during	O
the	O
adaptation	O
of	O
healthy	O
newborn	O
infants	O

Contraction	O
of	O
the	O
tracheal	O
muscle	O
and	O
the	O
activity	O
of	O
stretch	O
receptors	O
in	O
the	O
trachea	O

Oxygen	O
delivery	O
and	O
consumption	O
and	O
P50	O
in	O
patients	O
with	O
acute	O
myocardial	O
infarction	O
.	O

The	O
number	O
of	O
crystalline	O
deposits	O
is	O
less	O
in	O
the	O
advanced	O
atrophic	O
areas	O
of	O
the	O
RPE	O
-	O
choriocapillaris	O
complex	O
.	O

Mean	O
weighted	O
skin	O
temperature	O
(	O
Tsk	O
)	O
was	O
lower	O
(	O
P	O
less	O
than	O
0	O
.	O
01	O
)	O
following	O
acclimation	O
than	O
before	O
,	O
and	O
acclimation	O
resulted	O
in	O
a	O
larger	O
(	O
P	O
less	O
than	O
0	O
.	O
02	O
)	O
Tre	O
-	O
to	O
-	O
Tsk	O
gradient	O
.	O

Indium	O
-	O
111	O
leukocyte	O
imaging	O
in	O
patients	O
with	O
rheumatoid	O
arthritis	O
.	O

Factors	O
that	O
showed	O
significant	O
correlation	O
to	O
elevated	O
CIC	O
'	O
s	O
in	O
the	O
highly	O
elevated	O
portion	O
of	O
our	O
CIC	O
population	O
were	O
poor	O
NIH	O
score	O
,	O
increased	O
patient	O
age	O
,	O
low	O
peak	O
expiratory	O
flow	O
rate	O
,	O
and	O
elevated	O
total	O
serum	O
IgG	B
.	O

Estimated	O
nucleic	O
acid	O
N	O
absorption	O
is	O
7	O
-	O
8	O
%	O
of	O
N	O
intake	O
.	O

Nickel	O
is	O
the	O
most	O
common	O
cause	O
of	O
allergic	O
contact	O
dermatitis	O
in	O
Singapore	O
,	O
resulting	O
in	O
positive	O
reactions	O
in	O
patch	O
tests	O
between	O
7	O
and	O
14	O
%.	O

He	O
visited	O
our	O
hospital	O
and	O
left	O
solitary	O
renal	O
cyst	O
was	O
suspected	O
.	O

When	O
the	O
coronary	O
sinus	O
pressure	O
reached	O
15	O
torr	O
,	O
there	O
was	O
a	O
significant	O
decrease	O
in	O
cardiac	O
index	O
(	O
3	O
.	O
60	O
+/-	O
0	O
.	O
5	O
to	O
2	O
.	O
70	O
+/-	O
0	O
.	O
6	O
L	O
/	O
min	O
/	O
m2	O
,	O
p	O
less	O
than	O
0	O
.	O
001	O
),	O
coronary	O
blood	O
flow	O
(	O
13	O
.	O
7	O
+/-	O
3	O
.	O
1	O
to	O
7	O
.	O
0	O
+/-	O
2	O
.	O
1	O
ml	O
/	O
min	O
,	O
p	O
less	O
than	O
0	O
.	O
001	O
),	O
rate	O
of	O
rise	O
of	O
left	O
ventricular	O
pressure	O
(	O
1	O
,	O
567	O
+/-	O
275	O
to	O
1	O
,	O
331	O
+/-	O
314	O
,	O
p	O
less	O
than	O
0	O
.	O
05	O
),	O
and	O
an	O
increase	O
in	O
coronary	O
arteriovenous	O
difference	O
(	O
62	O
.	O
8	O
%	O
+/-	O
9	O
.	O
3	O
%	O
to	O
70	O
.	O
5	O
%	O
+/-	O
5	O
.	O
4	O
%	O
saturation	O
,	O
p	O
less	O
than	O
0	O
.	O
03	O
).	O

In	O
a	O
series	O
of	O
402	O
consecutive	O
autopsies	O
,	O
parietal	O
pleural	O
plaques	O
(	O
PP	O
)	O
were	O
found	O
in	O
68	O
individuals	O
above	O
40	O
years	O
of	O
age	O
.	O

On	O
transition	O
from	O
high	O
to	O
low	O
voltage	O
there	O
was	O
a	O
significant	O
fall	O
in	O
arterial	O
pressure	O
(	O
7	O
%)	O
and	O
an	O
increase	O
in	O
flow	O
(	O
19	O
-	O
38	O
%)	O
to	O
areas	O
of	O
the	O
brain	O
corresponding	O
to	O
the	O
arborization	O
of	O
the	O
reticular	O
formation	O
,	O
i	O
.	O
e	O
.	O
excluding	O
the	O
cerebrum	O
and	O
cerebellum	O
.	O

The	O
combination	O
of	O
F1	O
and	O
F2	O
which	O
was	O
the	O
best	O
predictor	O
of	O
CHD	O
in	O
this	O
population	O
(	O
G1	O
)	O
might	O
be	O
interpreted	O
as	O
reflecting	O
trunk	O
adiposity	O
mainly	O
abdominal	O
.	O

The	O
rats	O
were	O
used	O
for	O
the	O
study	O
of	O
the	O
effects	O
of	O
sepsis	O
on	O
the	O
utilization	O
of	O
exogenous	O
fat	O
emulsion	O
.	O

Prevention	O
by	O
a	O
heparin	O
-	O
antithrombin	B
III	I
combination	O

Although	O
differences	O
were	O
not	O
significant	O
,	O
infants	O
in	O
the	O
experimental	O
group	O
had	O
more	O
changes	O
in	O
the	O
intermittent	O
mandatory	O
ventilation	O
(	O
IMV	O
)	O
settings	O
during	O
transport	O
,	O
and	O
more	O
such	O
infants	O
arrived	O
at	O
the	O
receiving	O
hospital	O
with	O
acceptable	O
pH	O
and	O
PCO2	O
values	O
.	O

A	O
large	O
increase	O
of	O
serum	O
ketones	O
occurred	O
under	O
all	O
conditions	O
,	O
and	O
the	O
exercise	O
respiratory	O
quotient	O
suggested	O
some	O
increase	O
of	O
fat	O
utilization	O
,	O
WW	O
(	O
0	O
.	O
85	O
)	O
through	O
CW	O
(	O
0	O
.	O
84	O
)	O
to	O
CC	O
(	O
0	O
.	O
83	O
).	O

Human	O
and	O
Chinese	O
hamster	B
S14	I
protein	I
sequences	I
deduced	O
from	O
the	O
cDNAs	O
are	O
identical	O
.	O

Selenium	O
(.	O
1	O
ppm	O
)	O
and	O
E	O
(	O
50	O
IU	O
/	O
kg	O
)	O
supplementation	O
of	O
the	O
diet	O
of	O
the	O
sow	O
increased	O
plasma	O
tocopherol	O
and	O
Se	O
concentrations	O
,	O
but	O
did	O
not	O
increase	O
plasma	O
glutathione	B
peroxidase	I
(	I
GSH	I
-	I
Px	I
)	O
activity	O
.	O

The	O
M	O
reading	O
frame	O
differed	O
from	O
the	O
reported	O
sequence	O
by	O
a	O
single	O
nucleotide	O
corresponding	O
to	O
a	O
conservative	O
lysine	O
to	O
arginine	O
amino	O
acid	O
substitution	O
near	O
the	O
carboxy	O
-	O
terminus	O
conserved	O
among	O
the	O
M	O
proteins	O
of	O
paramyxoviruses	O
.	O

An	O
ion	O
chromatographic	O
method	O
was	O
used	O
to	O
determine	O
Br	O
ion	O
in	O
the	O
urine	O
of	O
Greyhounds	O
.	O

II	O
.	O

Intensification	O
of	O
human	O
myocardial	O
contractile	O
activity	O
as	O
affected	O
by	O
blood	O
serum	O

In	O
recent	O
years	O
,	O
successful	O
physiological	O
models	O
have	O
been	O
developed	O
for	O
a	O
variety	O
of	O
volatile	O
and	O
nonvolatile	O
chemicals	O
,	O
and	O
their	O
ability	O
to	O
perform	O
the	O
extrapolations	O
needed	O
in	O
risk	O
assessment	O
has	O
been	O
demonstrated	O
.	O

Linear	O
extrapolation	O
is	O
used	O
below	O
the	O
experimental	O
data	O
range	O
to	O
establish	O
an	O
upper	O
bound	O
on	O
carcinogenic	O
risk	O
at	O
low	O
doses	O
.	O

Eleven	O
healthy	O
,	O
normotensive	O
males	O
undergoing	O
routine	O
restorative	O
dental	O
care	O
were	O
evaluated	O
during	O
treatment	O
for	O
possible	O
hemodynamic	O
alterations	O
in	O
response	O
to	O
potential	O
sympathetic	O
nervous	O
system	O
stimulation	O
.	O

Serum	B
IgM	I
and	I
IgE	I
concentrations	O
,	O
allergen	B
-	I
specific	I
IgE	I
scores	O
,	O
and	O
the	O
tumor	O
E2R	B
status	O
were	O
combined	O
to	O
construct	O
a	O
three	O
-	O
level	O
risk	O
classification	O
that	O
was	O
more	O
prognostic	O
than	O
any	O
of	O
the	O
individual	O
components	O
.	O

Single	O
photon	O
emission	O
computerized	O
tomography	O
(	O
SPECT	O
),	O
by	O
providing	O
three	O
-	O
dimensional	O
representation	O
of	O
myocardial	O
Tl	O
-	O
201	O
,	O
offers	O
promise	O
for	O
improved	O
localization	O
of	O
CAD	O
.	O

MRI	O
disclosed	O
one	O
or	O
more	O
of	O
the	O
following	O
abnormalities	O
in	O
24	O
(	O
63	O
%)	O
of	O
38	O
treated	O
kidneys	O
:	O
(	O
1	O
)	O
loss	O
of	O
corticomedullary	O
differentiation	O
,	O
(	O
2	O
)	O
perirenal	O
fluid	O
,	O
(	O
3	O
)	O
subcapsular	O
hematoma	O
,	O
(	O
4	O
)	O
hemorrhage	O
into	O
a	O
renal	O
cyst	O
,	O
and	O
(	O
5	O
)	O
unexplained	O
abnormalities	O
.	O

The	O
percentage	O
RFR	O
reduction	O
at	O
the	O
end	O
of	O
CPB	O
showed	O
significant	O
correlation	O
with	O
1	O
)	O
CPB	O
duration	O
(	O
r	O
=	O
0	O
.	O
49	O
),	O
2	O
)	O
oxygen	O
flow	O
rate	O
index	O
(	O
OFRI	O
),	O
i	O
.	O
e	O
.	O
flow	O
/	O
min	O
in	O
the	O
bubble	O
oxygenator	O
/	O
m2	O
bsa	O
(	O
r	O
=	O
0	O
.	O
38	O
),	O
and	O
3	O
)	O
blood	O
flow	O
rate	O
index	O
(	O
BFRI	O
),	O
i	O
.	O
e	O
.	O
average	O
volume	O
of	O
blood	O
pumped	O
through	O
the	O
heart	O
-	O
lung	O
machine	O
/	O
min	O
CPB	O
time	O
/	O
m2	O
bsa	O
(	O
r	O
=	O
0	O
.	O
51	O
).	O

A	O
yeast	O
DNA	O
fragment	O
carrying	O
the	O
gene	O
CP	B
A1	I
encoding	O
the	O
small	O
subunit	O
of	O
the	O
arginine	O
pathway	O
carbamoyl	B
-	I
phosphate	I
synthetase	I
has	O
been	O
sequenced	O
.	O

A	O
high	O
efficacy	O
of	O
the	O
combined	O
use	O
of	O
nontoxic	O
doses	O
of	O
two	O
pharmaceuticals	O
:	O
cystamine	O
(	O
50	O
mg	O
/	O
kg	O
)	O
and	O
mexamine	O
(	O
25	O
mg	O
/	O
kg	O
)	O
under	O
the	O
conditions	O
of	O
short	O
-	O
term	O
exogenous	O
hypoxia	O
(	O
7	O
.	O
5	O
%	O
O2	O
)	O
was	O
found	O
in	O
(	O
CBA	O
X	O
C57Bl	O
)	O
F1	O
mice	O
.	O

Nursing	O
education	O
--	O
the	O
computer	O
obligation	O
.	O

Shear	O
bond	O
strength	O
of	O
a	O
composite	O
resin	O
to	O
an	O
etched	O
glass	O
ionomer	O
.	O

We	O
have	O
earlier	O
evolved	O
an	O
experimental	O
model	O
by	O
means	O
of	O
which	O
changes	O
identical	O
to	O
the	O
microembolism	O
syndrome	O
can	O
be	O
induced	O
from	O
a	O
reproducible	O
musculo	O
-	O
skeletal	O
trauma	O
in	O
pigs	O
observed	O
under	O
long	O
-	O
term	O
anesthesia	O
under	O
standardized	O
conditions	O
.	O

Although	O
no	O
statistical	O
significance	O
was	O
achieved	O
,	O
it	O
is	O
remarkable	O
that	O
there	O
was	O
a	O
clear	O
trend	O
for	O
the	O
superiority	O
of	O
Galphimia	O
D6	O
while	O
the	O
Galphimia	O
dilution	O
10	O
(-	O
6	O
)	O
was	O
about	O
equally	O
effective	O
compared	O
with	O
placebo	O
.	O

The	O
volume	O
of	O
blood	O
to	O
the	O
flap	O
ranges	O
from	O
1	O
to	O
2	O
ml	O
/	O
min	O
,	O
collateral	O
circulation	O
to	O
the	O
flap	O
exists	O
,	O
but	O
is	O
negligible	O
,	O
and	O
there	O
is	O
little	O
change	O
in	O
the	O
capillary	O
blood	O
flow	O
as	O
the	O
flap	O
ages	O
.	O

This	O
suggests	O
that	O
alaproclate	O
acutely	O
increases	O
the	O
responsiveness	O
of	O
postsynaptic	B
muscarinic	I
and	I
alpha	I
1	I
adrenoceptors	I
.	O

Greek	O
classicism	O
in	O
living	O
structure	O
?	O
Some	O
deductive	O
pathways	O
in	O
animal	O
morphology	O
.	O

The	O
data	O
indicate	O
that	O
the	O
five	O
different	O
(	O
and	O
partially	O
overlapping	O
)	O
sry	B
messenger	I
RNAs	I
detectable	O
in	O
early	O
embryos	O
are	O
initiated	O
at	O
three	O
separate	O
sites	O
,	O
each	O
directly	O
upstream	O
from	O
one	O
of	O
the	O
three	O
protein	O
-	O
coding	O
regions	O
,	O
designated	O
(	O
in	O
5	O
'	O
to	O
3	O
'	O
order	O
)	O
beta	O
,	O
alpha	O
and	O
delta	O
.	O

Chronic	O
thyroiditis	O
as	O
a	O
risk	O
factor	O
of	O
B	O
-	O
cell	O
lymphoma	O
in	O
the	O
thyroid	O
gland	O
.	O

A	O
comparison	O
among	O
the	O
5	O
'	O
flanking	O
regions	O
encompassing	O
the	O
presumptive	O
HS	B
promoter	I
of	O
the	O
soybean	O
HS	B
-	I
protein	I
genes	I
demonstrated	O
this	O
region	O
to	O
be	O
extremely	O
homologous	O
.	O

Fulminant	O
hepatitis	O
A	O
in	O
chronic	O
HBV	O
carrier	O
.	O

During	O
this	O
time	O
,	O
the	O
patients	O
all	O
had	O
the	O
characteristic	O
plasma	O
thyroid	O
hormone	O
changes	O
associated	O
with	O
amiodarone	O
therapy	O
,	O
i	O
.	O
e	O
.	O
increased	O
T4	O
,	O
free	O
T4	O
,	O
and	O
rT3	O
and	O
decreased	O
T3	O
,	O
while	O
remaining	O
clinically	O
euthyroid	O
.	O

Cortisol	O
excretion	O
,	O
appeared	O
to	O
be	O
markedly	O
affected	O
by	O
the	O
season	O
although	O
other	O
factors	O
such	O
as	O
social	O
and	O
environmental	O
stress	O
cannot	O
be	O
discounted	O
.	O

The	O
results	O
from	O
the	O
first	O
five	O
years	O
of	O
follow	O
up	O
in	O
1972	O
showed	O
a	O
4	O
.	O
7	O
-	O
fold	O
excess	O
mortality	O
for	O
ischaemic	O
and	O
other	O
heart	O
diseases	O
(	O
ICD	O
A83	O
-	O
A84	O
)	O
compared	O
with	O
a	O
comparable	O
reference	O
cohort	O
of	O
paper	O
mill	O
workers	O
.	O

Electrical	O
activity	O
was	O
evaluated	O
by	O
monitoring	O
the	O
general	O
electrocorticogram	O
(	O
ECoG	O
)	O
as	O
well	O
as	O
local	O
DC	O
steady	O
potential	O
(	O
two	O
sites	O
).	O

Piroxicam	O
produced	O
a	O
lower	O
incidence	O
of	O
gastric	O
ulcers	O
than	O
equivalent	O
doses	O
of	O
indomethacin	O
.	O

These	O
findings	O
suggest	O
that	O
both	O
in	O
the	O
early	O
stages	O
(	O
0T	O
,	O
0N	O
)	O
and	O
in	O
more	O
severe	O
stages	O
of	O
VWF	O
(	O
stages	O
1	O
-	O
2	O
)	O
cold	O
induced	O
hyperreactivity	O
in	O
the	O
digital	O
vessels	O
and	O
Raynaud	O
'	O
s	O
syndrome	O
are	O
vascular	O
disorders	O
of	O
functional	O
origin	O
occurring	O
without	O
any	O
prethrombotic	O
alterations	O
.	O

However	O
,	O
kidneys	O
perfused	O
for	O
72	O
hr	O
demonstrated	O
more	O
similar	O
renal	O
functions	O
when	O
tested	O
by	O
either	O
IMPK	O
or	O
IBPK	O
.	O

Ultrastructure	O
of	O
the	O
tumor	O
in	O
1	O
patient	O
in	O
whom	O
transurethral	O
resection	O
was	O
performed	O
2	O
weeks	O
after	O
alum	O
irrigation	O
revealed	O
well	O
preserved	O
nuclear	O
chromatin	O
,	O
thus	O
,	O
suggesting	O
that	O
whatever	O
changes	O
occur	O
after	O
alum	O
irrigation	O
are	O
short	O
-	O
lived	O
.	O

Two	O
siblings	O
with	O
hemolytic	O
anemia	O
caused	O
by	O
triosephosphate	B
isomerase	I
deficiency	O
developed	O
a	O
progressive	O
neurological	O
syndrome	O
featuring	O
dystonic	O
movements	O
,	O
tremor	O
,	O
pyramidal	O
tract	O
signs	O
,	O
and	O
evidence	O
of	O
spinal	O
motor	O
neuron	O
involvement	O
.	O

One	O
extract	O
with	O
the	O
lowest	O
PCA	O
content	O
was	O
non	O
-	O
carcinogenic	O
.	O

Ultrastructure	O
of	O
the	O
heart	O
muscle	O
in	O
experimental	O
myocardial	O
infarct	O
following	O
physical	O
training	O

Viral	O
infections	O
have	O
long	O
been	O
suspected	O
to	O
be	O
causative	O
agents	O
in	O
a	O
number	O
of	O
inner	O
ear	O
dysfunctions	O
.	O

Individual	O
alcohol	O
reaction	O
profiles	O
.	O

Vitiligo	O
in	O
diabetes	O
mellitus	O
.	O

The	O
pharmacokinetics	O
of	O
each	O
tetracycline	O
in	O
serum	O
and	O
dermal	O
,	O
suction	O
blister	O
fluid	O
were	O
determined	O
after	O
oral	O
doses	O
of	O
300	O
mg	O
lymecycline	O
or	O
100	O
mg	O
doxycycline	O
on	O
the	O
3rd	O
day	O
.	O

A	O
high	O
degree	O
of	O
correlation	O
in	O
the	O
sense	O
of	O
the	O
classic	O
conception	O
of	O
brain	O
localization	O
of	O
neuropsychological	O
syndromes	O
was	O
found	O
.	O

Either	O
a	O
UV	O
detector	O
set	O
at	O
268	O
nm	O
or	O
an	O
electrochemical	O
(	O
EC	O
)	O
detector	O
set	O
at	O
a	O
potential	O
of	O
+	O
0	O
.	O
9	O
V	O
(	O
versus	O
Ag	O
/	O
AgCl	O
/	O
3	O
M	O
NaCl	O
)	O
was	O
used	O
to	O
monitor	O
the	O
drug	O
.	O

The	O
mean	O
transfer	O
ratios	O
of	O
the	O
drug	O
into	O
the	O
genital	O
tissues	O
to	O
the	O
concentration	O
in	O
the	O
uterine	O
arterial	O
blood	O
were	O
such	O
that	O
the	O
transfer	O
ratio	O
into	O
the	O
portio	O
vaginalis	O
was	O
the	O
highest	O
,	O
followed	O
by	O
the	O
uterine	O
cervix	O
and	O
the	O
myometrium	O
,	O
and	O
that	O
into	O
the	O
oviduct	O
was	O
the	O
lowest	O
with	O
about	O
1	O
/	O
2	O
that	O
into	O
the	O
portio	O
vaginalis	O
.	O

Lower	O
extremity	O
weight	O
bearing	O
under	O
various	O
standing	O
conditions	O
in	O
independently	O
ambulatory	O
patients	O
with	O
hemiparesis	O
.	O

The	O
results	O
indicate	O
that	O
:	O
1	O
)	O
the	O
initial	O
response	O
to	O
tethering	O
varies	O
according	O
to	O
previous	O
penning	O
and	O
handling	O
experience	O
,	O
2	O
)	O
although	O
the	O
circadian	O
rhythm	O
of	O
cortisol	O
was	O
either	O
altered	O
or	O
disrupted	O
during	O
estrus	O
,	O
such	O
disruptions	O
were	O
not	O
influenced	O
by	O
type	O
of	O
penning	O
and	O
3	O
)	O
tether	O
stalls	O
may	O
chronically	O
increase	O
cortisol	O
concentrations	O
in	O
gilts	O
.	O

Scintigraphic	O
visualisation	O
of	O
Walker	O
carcinoma	O
-	O
256	O
in	O
Sprague	O
-	O
Dawley	O
rats	O
by	O
means	O
of	O
99mTc	O
-	O
labelled	O
monocytes	O
.	O

40	O
,	O
000	O
).	O

Duration	O
of	O
remission	O
in	O
advanced	O
gastric	O
cancer	O
patients	O
responding	O
to	O
sequential	O
dose	O
of	O
MTX	O
and	O
5	O
-	O
FU	O

The	O
fast	O
real	O
-	O
time	O
digital	O
processing	O
of	O
the	O
N2	O
and	O
flow	O
signals	O
incorporated	O
filtering	O
,	O
delay	O
compensation	O
,	O
and	O
corrections	O
for	O
the	O
effects	O
of	O
changes	O
in	O
gas	O
composition	O
and	O
temperature	O
.	O

National	O
Institutes	O
of	O
Health	O
Consensus	O
Development	O
Conference	O
Statement	O
.	O

In	O
controls	O
,	O
most	O
of	O
the	O
output	O
from	O
the	O
conduit	O
occurred	O
during	O
type	O
I	O
activity	O
(	O
73	O
+/-	O
14	O
%).	O

Among	O
the	O
patients	O
grades	O
1	O
-	O
2	O
-	O
3	O
,	O
81	O
%	O
had	O
a	O
good	O
out	O
come	O
without	O
any	O
neurological	O
abnormality	O
,	O
among	O
the	O
patients	O
graded	O
4	O
-	O
5	O
,	O
only	O
27	O
%	O
had	O
a	O
fair	O
out	O
come	O
.	O

Activity	O
of	O
acid	B
hydrolases	I
of	O
peripheral	O
blood	O
leukocytes	O
in	O
focal	O
and	O
segmental	O
pneumonia	O
in	O
children	O

Relations	O
between	O
cellular	O
electrical	O
activity	O
and	O
cardiac	O
mechanical	O
activity	O
in	O
man	O
,	O
the	O
dog	O
and	O
the	O
rabbit	O

Is	O
desensitization	O
'	O
for	O
ragweed	O
hay	O
fever	O
immunologically	O
specific	O
?	O

Experiences	O
with	O
the	O
clinical	O
and	O
experimental	O
use	O
of	O
Urat	O
-	O
I	O
lithotriptor	O
.	O

Hypothalamic	O
control	O
of	O
coronary	O
circulation	O
in	O
the	O
dog	O
.	O

Evidence	O
for	O
two	O
distinctive	O
clinical	O
,	O
epidemiological	O
,	O
and	O
immunological	O
types	O
of	O
infection	O
.	O

Prevention	O
of	O
maternal	O
Rh	O
sensitization	O
:	O
anti	B
-	I
Rh	I
immune	I
globulin	I
.	O

Disorders	O
of	O
platelet	O
function	O
in	O
chronic	O
myeloid	O
leukemias	O

Studies	O
on	O
the	O
organic	O
matrix	O
of	O
human	O
ear	O
ossicles	O

Sensitization	O
to	O
hyperlactatemia	O
induced	O
by	O
phenformin	O
after	O
subtotal	O
ablation	O
of	O
the	O
pancreas	O
.	O

Vitamin	O
D3	O
and	O
calcium	O
absorption	O
in	O
the	O
chick	O
.	O

Disulfiram	O
and	O
the	O
drug	O
-	O
induced	O
effects	O
on	O
motility	O
.	O

Clinical	O
course	O
and	O
nursing	O
care	O
of	O
patients	O
with	O
decubitus	O
ulcer	O
--	O
use	O
of	O
pillows	O
stuffed	O
with	O
buckwheat	O
chaff	O

Treatment	O
and	O
care	O
of	O
adult	O
diabetes	O
mellitus	O
without	O
coma	O

Junctions	O
between	O
cells	O
of	O
the	O
human	O
enamel	O
organ	O
.	O

Electrocardiograms	O
of	O
the	O
month	O
.	O

Intracellular	O
pH	O
,	O
H	O
ion	O
flux	O
and	O
H	O
ion	O
permeability	O
coefficient	O
in	O
bullfrog	O
toe	O
muscle	O
.	O

Blood	O
platelets	O
,	O
coagulation	O
factors	O
and	O
morphologic	O
organ	O
changes	O
following	O
scalding	O
shock	O
in	O
rhesus	O
monkeys	O

State	O
-	O
approved	O
schools	O
of	O
nursing	O
--	O
R	O
.	O
N	O
.,	O
1972	O
.	O

Pneumothorax	O
following	O
lung	O
abscess	O
in	O
the	O
renal	O
transplant	O
patient	O
.	O

The	O
effect	O
of	O
antilymphocyte	O
sera	O
on	O
formation	O
of	O
transplantation	O
and	O
anti	B
-	I
infection	O
immunity	O
in	O
mice	O

60th	O
birthday	O
of	O
colonel	O
prof	O
.	O
e	O
.	O
cerny	O
m	O
.	O
d	O
.	O

Morphology	O
of	O
bacteriophages	O
of	O
Klebsiella	O
bacilli	O
.	O

Resistance	O
pattern	O
of	O
Mycobacterium	O
tuberculosis	O
(	O
H	O
37	O
Rv	O
)	O
to	O
a	O
new	O
antibiotic	O
,	O
lividomycin	O

Sex	O
ratio	O
at	O
birth	O
.	O

Benign	O
intramural	O
tumors	O
of	O
the	O
esophagus	O

General	O
formulae	O
for	O
estimating	O
heritability	O
in	O
a	O
population	O
with	O
related	O
parents	O
.	O

Normal	O
values	O
for	O
the	O
peripheral	O
blood	O
and	O
bone	O
marrow	O
of	O
the	O
grey	O
(	O
Armenian	O
)	O
hamster	O

The	O
relationship	O
of	O
human	O
umbilical	O
arterial	O
and	O
venous	O
plasma	O
levels	O
of	O
corticosteroids	O
to	O
gestational	O
age	O
.	O

Disability	O
insurance	O
under	O
social	O
security	O
.	O

9	O
,	O
11	O
-	O
Seco	O
steroids	O
derived	O
from	O
estradiol	O
3	O
-	O
methyl	O
ether	O
.	O

Combination	O
of	O
3	O
multiple	O
primary	O
malignant	O
and	O
benign	O
tumors	O
of	O
the	O
breasts	O
and	O
uterus	O

Analysis	O
of	O
clearance	O
curve	O
of	O
rose	O
bengal	O
-	O
I	O
-	O
131	O

Antivitamin	O
K	O
agents	O

Hypoglycemic	O
and	O
antidiabetic	O
properties	O

Letter	O
:	O
Aryl	B
hydrocarbon	I
hydroxylase	I
and	O
smoking	O
.	O

Evaluation	O
of	O
1	O
,	O
10	O
-	O
phenanthroline	O
as	O
a	O
reagent	O
for	O
sialic	O
acid	O
determinations	O
.	O

Effect	O
of	O
a	O
high	O
-	O
intensity	O
SHF	O
field	O
on	O
the	O
blood	O
coagulation	O
system	O

Isolation	O
of	O
Proteus	O
vulgaris	O
MC	O
-	O
63	O
from	O
carcinoma	O
63	O
and	O
its	O
antitumor	O
effect	O
on	O
Crocker	O
sarcoma	O
180	O
and	O
Ehrlich	O
carcinoma	O
.	O

Human	O
synovial	O
fluid	O
:	O
detection	O
of	O
a	O
new	O
component	O
.	O

Morphological	O
and	O
functional	O
alterations	O
noted	O
after	O
baboon	O
renal	O
allotransplantation	O
.	O

The	O
effect	O
of	O
osmotic	O
flow	O
on	O
the	O
distribution	O
of	O
horseradish	B
peroxidase	I
within	O
the	O
intercellular	O
spaces	O
of	O
toad	O
bladder	O
epithelium	O
.	O

Working	O
session	O
report	O
:	O
in	O
vivo	O
-	O
in	O
vitro	O
screening	O
.	O

Oscilloscope	O
triggering	O
circuit	O
for	O
recording	O
long	O
transients	O
at	O
fast	O
sweep	O
speeds	O
.	O

Derivatives	O
of	O
boswellic	O
acids	O
.	O

The	O
status	O
of	O
education	O
and	O
training	O
programs	O
in	O
speech	O
pathology	O
and	O
audiology	O
--	O
1971	O
-	O
72	O
.	O

Separation	O
of	O
ninhydrin	O
-	O
positive	O
compounds	O
in	O
urine	O
by	O
the	O
combined	O
methods	O
of	O
medium	O
-	O
tension	O
intophoresis	O
and	O
partition	O
chromatography	O

Slowed	O
lysosomal	O
enzyme	O
release	O
and	O
its	O
normalization	O
by	O
drugs	O
in	O
adjuvant	O
-	O
induced	O
polyarthritis	O
.	O

Bacterial	O
metabolism	O
of	O
4	O
-	O
chlorophenoxyacetate	O
.	O

Dynamics	O
of	O
hospital	O
stay	O
in	O
peptic	O
ulcer	O
patients	O

Surgical	O
treatment	O
of	O
pathologic	O
scars	O
of	O
myocardial	O
infarct	O

1	O
.	O

Abdominal	O
tumors	O
in	O
childhood	O
.	O

Relapse	O
of	O
leukemia	O
after	O
prolonged	O
remission	O
.	O

The	O
non	O
-	O
role	O
of	O
fluoride	O
in	O
the	O
control	O
of	O
plasma	O
calcium	O
in	O
the	O
parathyroidectomized	O
rat	O
.	O

Comparative	O
study	O
on	O
acute	O
oral	O
overload	O
using	O
tolbutamide	O
and	O
tolazamide	O
in	O
normal	O
and	O
diabetic	O
subjects	O
.	O

Factors	O
influencing	O
in	O
vitro	O
skin	O
permeability	O
factor	O
production	O
by	O
Vibrio	O
cholerae	O
.	O

Spinal	O
cord	O
representation	O
of	O
the	O
micturition	O
reflex	O
.	O

Biological	O
action	O
and	O
kinetics	O
of	O
the	O
elimination	O
of	O
tritium	O
oxide	O
in	O
dogs	O

Auto	O
-	O
and	O
isotopy	O
of	O
the	O
conjunctiva	O

The	O
need	O
for	O
including	O
forensic	O
medical	O
expertise	O
in	O
the	O
list	O
of	O
urgent	O
criminal	O
investigative	O
actions	O

The	O
role	O
of	O
ascorbic	O
acid	O
in	O
the	O
prevention	O
of	O
bladder	O
tumor	O
formation	O
.	O

Difficulties	O
bound	O
to	O
measuring	O
of	O
sputum	O
viscosity	O

Behavior	O
of	O
aspartate	B
aminotransferase	I
(	O
EC	B
2	I
.	O
6	O
.	O
1	O
.	O
1	O
)	O
and	O
alanine	B
aminotransferase	I
(	O
EC	B
2	I
.	O
6	O
.	O
1	O
.	O
2	O
)	O
in	O
rat	O
serum	O
during	O
the	O
course	O
of	O
acute	O
radiation	O
syndrome	O
following	O
whole	O
body	O
X	O
-	O
irradiation	O

Diminished	O
forearm	O
arteriolar	O
dilator	O
capacity	O
produced	O
by	O
mineralocorticoid	O
-	O
induced	O
salt	O
retention	O
in	O
man	O
.	O

Studies	O
on	O
the	O
pathogenicity	O
of	O
ECHO	O
9	O
(	O
HILL	O
)	O
virus	O
and	O
its	O
mutants	O
for	O
suckling	O
mice	O

Mae	O
West	O
and	O
the	O
doctor	O
shortage	O
.	O

A	O
new	O
hemagglutination	O
test	O
for	O
the	O
on	O
-	O
slide	O
assay	O
of	O
rheumatoid	O
factor	O

Foreign	O
profiles	O
in	O
air	O
pollution	O
control	O
activities	O
.	O

The	O
effect	O
of	O
low	O
dosage	O
radiation	O
on	O
metabolism	O
and	O
function	O
of	O
the	O
rat	O
kidney	O
damaged	O
by	O
ischemia	O

Morphogenesis	O
of	O
the	O
trochanter	O
produced	O
by	O
femoral	O
regeneration	O
in	O
the	O
phasmid	O
Carausius	O
morosus	O
Br	O

Sensitivities	O
of	O
thromboplastins	B
to	I
factor	I
VII	I
deficiency	O
.	O

The	O
modification	O
of	O
P32	O
uptake	O
into	O
the	O
Jensen	O
sarcoma	O
in	O
vitro	O
by	O
adding	O
of	O
peroxide	O
to	O
the	O
nutritive	O
medium	O

Evaluating	O
dietary	O
department	O
management	O
.	O

Investigation	O
on	O
the	O
exchange	O
of	O
Ca45	O
in	O
intact	O
and	O
burned	O
rats	O
by	O
the	O
kinetic	O
analysis	O
method	O

Identification	O
and	O
estimation	O
of	O
monosaccharides	O
and	O
disaccharides	O
in	O
urine	O
by	O
gas	O
-	O
liquid	O
chromatography	O
.	O

The	O
effects	O
of	O
loading	O
the	O
respiratory	O
pumps	O
on	O
the	O
oxygen	O
consumption	O
of	O
Callionymus	O
lyra	O
.	O

Studies	O
carried	O
out	O
with	O
the	O
Glossina	O
morsitans	O
colony	O
of	O
Lisbon	O
.	O

Transformations	O
in	O
the	O
morphine	O
series	O
.	O

Effect	O
of	O
castration	O
on	O
pituitary	O
and	O
serum	O
LH	B
and	O
FSH	B
in	O
testosterone	O
-	O
sterilized	O
rats	O
.	O

Relationship	O
of	O
mast	O
cells	O
to	O
sarcoidosis	O
granuloma	O
of	O
the	O
skin	O

Specialist	O
in	O
family	O
practice	O
--	O
prototype	O
of	O
a	O
doctor	O
.	O

Oxidative	O
degradation	O
of	O
adrenaline	O
solutions	O
:	O
study	O
of	O
the	O
intermediate	O
stages	O
and	O
their	O
analytic	O
value	O
for	O
the	O
control	O
of	O
this	O
solute	O

The	O
need	O
in	O
the	O
small	O
hospital	O
.	O

Clinical	O
trials	O
with	O
1	O
,	O
3	O
-	O
bis	O
(	O
2	O
-	O
chloroethyl	O
)-	O
1	O
-	O
nitrosourea	O
,	O
NSC	O
-	O
409962	O
.	O

On	O
the	O
diagnosis	O
of	O
bovine	O
leucosis	O
and	O
its	O
control	O
in	O
southern	O
Lower	O
Saxony	O

(	O
3	O
).	O

The	O
effect	O
of	O
feeding	O
patterns	O
on	O
fat	O
deposition	O
in	O
mice	O
.	O

Naphthalene	O
and	O
paradichlorobenzene	O
in	O
clinical	O
toxicology	O

Studies	O
on	O
powdered	O
preparations	O
.	O

Value	O
of	O
the	O
method	O
of	O
passive	O
hemagglutination	O
with	O
polysaccharide	O
C	O
in	O
detecting	O
C	B
-	I
reactive	I
protein	I
as	O
compared	O
to	O
precipitation	O
in	O
capillaries	O
and	O
slide	O
latex	O
test	O
with	O
anti	B
-	I
CRP	I
serum	O

Adrenergic	O
nerve	O
function	O
,	O
noradrenaline	O
level	O
and	O
noradrenaline	O
uptake	O
in	O
cat	O
nictitating	O
membrane	O
after	O
reserpine	O
treatment	O
.	O

Antimicrobial	O
substance	O
isolated	O
from	O
an	O
acorn	O
extract	O
.	O

Studies	O
of	O
lipogenesis	O
by	O
labelled	O
precursors	O
in	O
the	O
pregnant	O
rat	O
.	O

Also	O
discussed	O
is	O
the	O
possibility	O
of	O
a	O
combined	O
genetic	O
and	O
environmental	O
etiology	O
.	O

Courses	O
were	O
repeated	O
monthly	O
upon	O
recovery	O
of	O
myelosuppression	O
.	O

Eight	O
recombinant	O
DNA	O
clones	O
of	O
endogenous	O
murine	O
leukemia	O
virus	O
(	O
MuLV	O
)-	O
related	O
DNA	O
sequences	O
have	O
been	O
isolated	O
from	O
a	O
lambdaphage	O
genomic	O
library	O
of	O
Balb	O
/	O
c	B
mouse	O
DNA	O
.	O

Effect	O
of	O
acute	O
and	O
chronic	O
psychogenic	O
stress	O
on	O
corticoadrenal	O
and	O
pituitary	O
-	O
thyroid	O
hormones	O
in	O
male	O
rats	O
.	O

Upstream	O
activation	O
sites	O
of	O
the	O
CYC1	B
gene	I
of	O
Saccharomyces	O
cerevisiae	O
are	O
active	O
when	O
inverted	O
but	O
not	O
when	O
placed	O
downstream	O
of	O
the	O
"	O
TATA	O
box	O
".	O

An	O
intact	O
5	O
.	O
7	O
-	O
kb	O
provirus	O
of	O
the	O
avian	O
erythroblastosis	O
virus	O
E26	O
has	O
been	O
molecularly	O
cloned	O
for	O
comparisons	O
with	O
avian	O
myeloblastosis	O
virus	O
(	O
AMV	O
)	O
and	O
other	O
avian	O
tumor	O
viruses	O
.	O

The	O
results	O
presented	O
in	O
this	O
report	O
suggest	O
that	O
the	O
SV40	B
G	I
-	I
C	I
-	I
rich	I
sequences	I
can	O
function	O
as	O
independent	O
RNA	B
polymerase	I
II	I
transcriptional	I
-	I
control	O
elements	O
.	O

Theories	O
proffered	O
to	O
account	O
for	O
the	O
modality	O
shift	O
effect	O
are	O
critically	O
evaluated	O
.	O

Endorphins	B
at	O
the	O
approach	O
of	O
death	O
.	O

Trial	O
treatment	O
of	O
schizophrenia	O
with	O
des	B
-	I
Tyr	I
-	I
gamma	I
-	I
endorphin	I

Plasma	O
and	O
erthrocyte	O
lipid	O
profile	O
and	O
lipoprotein	B
lipase	I
activity	O
in	O
postheparin	O
plasma	O
on	O
vasectomized	O
rabbits	O
were	O
studied	O
and	O
also	O
the	O
incidence	O
of	O
atherosclerosis	O
in	O
different	O
arterial	O
beds	O
.	O

(	O
iii	O
)	O
The	O
mRNA	O
is	O
not	O
efficiently	O
polyadenylated	O
at	O
sequences	O
in	O
the	O
3	O
'	O
end	O
of	O
the	O
DHFR	B
cDNA	I
but	O
rather	O
uses	O
polyadenylation	O
signals	O
downstream	O
from	O
the	O
DHFR	B
cDNA	I
.	O

Glutamic	O
acid	O
in	O
a	O
dose	O
of	O
1	O
/	O
100	O
of	O
the	O
LD50	O
was	O
injected	O
in	O
the	O
form	O
of	O
sodium	O
salt	O
into	O
male	O
and	O
female	O
Wistar	O
rats	O
for	O
7	O
days	O
after	O
8	O
-	O
and	O
12	O
-	O
day	O
injections	O
of	O
dexazone	O
.	O

Thalamotomy	O
aiming	O
at	O
the	O
CM	O
-	O
Pf	O
complex	O
and	O
using	O
stereotactic	O
gamma	O
irradiation	O
has	O
been	O
performed	O
in	O
a	O
series	O
of	O
52	O
patients	O
with	O
severe	O
pain	O
due	O
to	O
malignancy	O
.	O

Effect	O
of	O
2	O
-(	O
p	O
-	O
chlorophenyl	O
)	O
cyclopropylamine	O
on	O
5	O
-	O
hydroxyindole	O
concentration	O
and	O
monoamine	B
oxidase	I
activity	O
in	O
rat	O
brain	O
.	O

(	O
2	O
)	O
The	O
inappropriateness	O
of	O
adaptive	O
segmentation	O
for	O
the	O
isolation	O
of	O
spikes	O
and	O
sharp	O
waves	O
,	O
which	O
had	O
been	O
anticipated	O
in	O
view	O
of	O
the	O
short	O
duration	O
of	O
such	O
transients	O
in	O
relation	O
to	O
the	O
length	O
of	O
the	O
window	O
(	O
1	O
.	O
2	O
sec	O
)	O
used	O
for	O
the	O
autocorrelation	O
functions	O
employed	O
in	O
the	O
segmentation	O
algorithm	O
,	O
was	O
confirmed	O
.	O

Bacillus	B
cereus	I
cross	O
-	O
infection	O
in	O
a	O
maternity	O
-	O
unit	O
.	O

In	O
the	O
latter	O
category	O
particular	O
emphasis	O
is	O
being	O
placed	O
on	O
new	O
anthracycline	O
analogues	O
of	O
doxorubicin	O
and	O
analogues	O
of	O
cisplatinum	O
diammine	O
dichloride	O
.	O

Intraoperatively	O
the	O
complement	B
factor	I
C3c	I
decreased	O
by	O
20	O
%,	O
while	O
alpha	B
1	I
-	I
antitrypsin	I
showed	O
postoperatively	O
an	O
increase	O
by	O
30	O
%.	O

Differential	O
drawing	O
size	O
associated	O
with	O
unilateral	O
brain	O
damage	O
.	O

Subdural	O
electrodes	O
may	O
yield	O
larger	O
VEP	O
amplitudes	O
than	O
skull	O
or	O
scalp	O
electrodes	O
.	O

Products	O
of	O
immune	O
cells	O
such	O
as	O
transfer	B
factor	I
and	O
lymphokines	O
form	O
the	O
third	O
and	O
possibly	O
most	O
important	O
group	O
of	O
immune	B
-	I
stimulating	I
agents	O
.	O

This	O
fraction	O
is	O
resistant	O
to	O
digestions	O
by	O
DNase	B
I	I
and	O
RNase	B
T1	O
and	O
disappears	O
completely	O
upon	O
alkali	O
hydrolysis	O
.	O

Experience	O
with	O
the	O
tensor	O
fasciae	O
latae	O
free	O
flap	O
.	O

Synthesis	O
of	O
(+)-	O
lysergic	O
acid	O
diethylamide	O
tartrate	O

The	O
effect	O
of	O
treatment	O
may	O
thus	O
be	O
divided	O
into	O
two	O
main	O
phases	O
--	O
an	O
initial	O
phase	O
with	O
a	O
reduction	O
in	O
LV	O
mass	O
and	O
a	O
reduction	O
in	O
cardiac	O
output	O
and	O
no	O
change	O
in	O
total	O
peripheral	O
resistance	O
--	O
and	O
a	O
second	O
phase	O
with	O
a	O
constant	O
LV	O
mass	O
but	O
an	O
increase	O
in	O
cardiac	O
output	O
to	O
the	O
pretreatment	O
level	O
again	O
and	O
a	O
concomitant	O
decrease	O
in	O
total	O
peripheral	O
resistance	O
.	O

Oxygen	O
profiles	O
calculated	O
for	O
the	O
Krogh	O
model	O
with	O
excentric	O
diffusion	O
were	O
similar	O
to	O
those	O
derived	O
for	O
the	O
two	O
models	O
of	O
concentric	O
diffusion	O
.	O

The	O
antibody	O
titer	O
of	O
202	O
chickens	O
to	O
SA	O
-	O
11	O
rotavirus	O
was	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
blocking	O
assay	O
.	O

The	O
genome	O
of	O
avian	O
erythroblastosis	O
virus	O
contains	O
two	O
independently	O
expressed	O
genetic	O
loci	O
(	O
v	B
-	I
erbA	I
and	O
v	B
-	I
erbB	I
)	O
whose	O
activities	O
are	O
probably	O
responsible	O
for	O
oncogenesis	O
by	O
the	O
virus	O
.	O

Both	O
neural	O
and	O
hormonal	O
pathways	O
and	O
both	O
opiate	O
and	O
nonopiate	O
substances	O
play	O
roles	O
in	O
the	O
complex	O
modulation	O
of	O
pain	O
transmission	O
.	O

Hybridization	O
of	O
plasmid	O
-	O
transformed	O
Escherichia	O
coli	O
RR1	O
colonies	O
with	O
32P	O
-	O
labeled	O
viral	O
genome	O
RNAs	O
demonstrated	O
the	O
presence	O
of	O
DNA	O
clones	O
representative	O
of	O
each	O
of	O
the	O
10	O
reovirus	O
RNAs	O
and	O
10	O
of	O
the	O
11	O
constituent	O
segments	O
of	O
the	O
rotavirus	O
genome	O
.	O

The	O
dnaQ	B
-	I
lacZ	I
and	O
the	O
rnh	B
-	I
lacZ	I
fused	O
genes	O
were	O
constructed	O
and	O
hybrid	O
proteins	O
with	O
beta	B
-	I
galactosidase	I
activity	O
were	O
produced	O
.	O

No	O
significant	O
correlation	O
was	O
found	O
between	O
LVM	O
or	O
wall	O
thickness	O
and	O
body	O
surface	O
area	O
,	O
age	O
,	O
blood	O
pressure	O
,	O
heart	O
rate	O
,	O
cardiac	O
output	O
,	O
total	O
peripheral	O
resistance	O
and	O
left	O
ventricular	O
systolic	O
wall	O
stress	O
,	O
whereas	O
CD25	O
was	O
correlated	O
with	O
urinary	O
catecholamines	O
only	O
in	O
hypertensive	O
patients	O
(	O
r	O
=	O
0	O
.	O
606	O
,	O
p	O
less	O
than	O
0	O
.	O
001	O
).	O

An	O
immunologic	O
test	O
using	O
stomach	O
and	O
tumor	O
antigens	O
for	O
screening	O
of	O
those	O
at	O
high	O
risk	O
for	O
stomach	O
cancer	O
is	O
suggested	O
.	O

Thirty	O
isolates	O
of	O
Haemophilus	O
influenzae	O
type	O
b	O
were	O
obtained	O
during	O
an	O
outbreak	O
of	O
invasive	O
H	O
.	O
influenzae	O
type	O
b	O
disease	O
and	O
were	O
classified	O
by	O
the	O
electrophoretic	O
profile	O
of	O
their	O
lipopolysaccharide	O
(	O
LPS	O
).	O

Frog	O
type	O
I	O
(	O
Ft	O
I	O
)	O
and	O
frog	O
type	O
II	O
(	O
Ft	O
II	O
)	O
slowly	O
adapting	O
(	O
SA	O
)	O
units	O
produced	O
spikes	O
only	O
at	O
the	O
indentation	O
phase	O
,	O
and	O
the	O
threshold	O
response	O
phase	O
(	O
TRP	O
),	O
i	O
.	O
e	O
..	O
the	O
phase	O
of	O
the	O
first	O
spike	O
was	O
for	O
ca	O
.	O

Grimelius	O
stain	O
was	O
positive	O
,	O
Masson	O
Fontana	O
stain	O
negative	O
.	O

Blood	O
glucose	O
and	O
plasma	O
insulin	B
were	O
measured	O
at	O
zero	O
time	O
and	O
then	O
at	O
15	O
,	O
30	O
,	O
60	O
,	O
90	O
and	O
120	O
min	O
after	O
ingestion	O
of	O
25	O
g	O
glucose	O
,	O
fructose	O
or	O
lactose	O
,	O
or	O
30	O
g	O
honey	O
,	O
50	O
g	O
white	O
bread	O
,	O
125	O
g	O
white	O
rice	O
or	O
potatoes	O
,	O
150	O
g	O
apples	O
or	O
260	O
g	O
carrots	O
.	O

In	O
patients	O
in	O
group	O
A	O
("	O
normal	O
"	O
CI	O
),	O
the	O
CI	O
,	O
heart	O
rate	O
and	O
the	O
mean	O
circumferential	O
fiber	O
shortening	O
velocity	O
(	O
mVCF	O
)	O
were	O
normal	O
,	O
but	O
the	O
TPR	O
was	O
increased	O
significantly	O
.	O

In	O
the	O
posthospital	O
phase	O
of	O
AMI	O
,	O
as	O
well	O
as	O
in	O
CCHD	O
,	O
the	O
occurrence	O
of	O
high	O
-	O
grade	O
VPBs	O
usually	O
indicates	O
more	O
advanced	O
degrees	O
of	O
both	O
coronary	O
and	O
left	O
ventricular	O
disease	O
as	O
well	O
as	O
the	O
possibility	O
of	O
cardiac	O
and	O
/	O
or	O
sudden	O
death	O
.	O

The	O
genes	O
at	O
each	O
locus	O
are	O
divergently	O
transcribed	O
and	O
the	O
coding	O
sequences	O
are	O
separated	O
by	O
646	O
base	O
-	O
pairs	O
at	O
one	O
locus	O
and	O
676	O
base	O
-	O
pairs	O
at	O
the	O
other	O
.	O

The	O
clinical	O
efficacy	O
rates	O
evaluated	O
in	O
151	O
cases	O
(	O
KS	O
-	O
R1	O
group	O
in	O
77	O
cases	O
,	O
oral	O
group	O
in	O
74	O
cases	O
)	O
on	O
standard	O
criteria	O
of	O
committee	O
members	O
were	O
88	O
.	O
3	O
%	O
for	O
the	O
KS	O
-	O
R1	O
group	O
and	O
86	O
.	O
5	O
%	O
for	O
the	O
oral	O
group	O
,	O
respectively	O
.	O

Bepridil	O
,	O
a	O
calcium	O
antagonist	O
with	O
a	O
half	O
-	O
life	O
of	O
approximately	O
42	O
hours	O
,	O
was	O
compared	O
with	O
placebo	O
in	O
a	O
double	O
-	O
blind	O
,	O
randomized	O
,	O
crossover	O
trial	O
.	O

EGV	O
had	O
no	O
detectable	O
effect	O
on	O
PP	O
secretion	O
under	O
basal	O
or	O
stimulated	O
conditions	O
.	O

Lung	O
prostacyclin	O
production	O
may	O
be	O
related	O
to	O
flow	O
.	O

Eighteen	O
patients	O
were	O
untreated	O
,	O
and	O
8	O
had	O
been	O
given	O
previous	O
treatment	O
with	O
depot	O
testosterone	O
100	O
mg	O
intramuscularly	O
every	O
2	O
-	O
3	O
weeks	O
for	O
an	O
average	O
duration	O
of	O
4	O
.	O
7	O
years	O
.	O

Freezing	O
of	O
plasma	O
to	O
obtain	O
better	O
yield	O
of	O
factor	B
VIII	I
:	O
C	O
.	O

These	O
children	O
were	O
grouped	O
into	O
four	O
diagnostic	O
categories	O
:	O
1	O
)	O
idiopathic	O
GH	B
deficiency	O
(	O
n	O
=	O
10	O
);	O
2	O
)	O
organic	O
hypopituitarism	O
(	O
n	O
=	O
7	O
);	O
3	O
)	O
intrauterine	O
growth	O
retardation	O
(	O
n	O
=	O
5	O
);	O
and	O
4	O
)	O
constitutional	O
delay	O
of	O
growth	O
and	O
/	O
or	O
familial	O
short	O
stature	O
(	O
n	O
=	O
18	O
),	O
by	O
standard	O
clinical	O
criteria	O
and	O
physiological	O
and	O
pharmacological	O
tests	O
of	O
GH	B
reserve	O
.	O

Each	O
patient	O
had	O
measurable	O
LH	B
and	O
FSH	B
levels	O
,	O
with	O
pulsed	O
nocturnal	O
secretion	O
,	O
and	O
pubertal	O
LH	B
and	O
FSH	B
responses	O
to	O
LRH	B
.	O

Ceftazidime	O
shows	O
promise	O
as	O
single	O
-	O
agent	O
therapy	O
for	O
serious	O
gram	O
-	O
negative	O
bacillary	O
infections	O
.	O

Our	O
results	O
indicate	O
that	O
serum	B
BGP	I
is	O
a	O
valuable	O
measurement	O
of	O
bone	O
metabolism	O
.	O

Finding	O
of	O
Rhodnius	O
prolixus	O
Stal	O
,	O
1859	O
,	O
in	O
babassu	O
palm	O
trees	O

Statokinesimetric	O
recording	O
in	O
Huntington	O
choreas	O

The	O
development	O
and	O
histostructural	O
organization	O
of	O
intrahepatic	O
biliary	O
ducts	O
were	O
studied	O
on	O
a	O
human	O
embryofetal	O
material	O
6	O
to	O
32	O
weeks	O
old	O
.	O

There	O
was	O
a	O
close	O
correlation	O
between	O
plasma	O
clearance	O
of	O
NT	O
by	O
10	O
-	O
hydroxylation	O
and	O
the	O
D	O
metabolic	O
ratio	O
(	O
D	O
/	O
4	O
-	O
OH	O
-	O
D	O
in	O
urine	O
)	O
in	O
the	O
Ghanaians	O
(	O
rs	O
=	O
-	O
0	O
.	O
95	O
;	O
P	O
less	O
than	O
0	O
.	O
01	O
)	O
and	O
Swedes	O
(	O
rs	O
=	O
-	O
0	O
.	O
84	O
;	O
P	O
less	O
than	O
0	O
.	O
01	O
).	O

Endothelium	O
of	O
the	O
central	O
ear	O
artery	O
of	O
an	O
anesthetized	O
rabbit	O
is	O
damaged	O
by	O
placing	O
artery	O
forceps	O
on	O
the	O
ear	O
directly	O
over	O
the	O
vessel	O
.	O

In	O
two	O
experiments	O
,	O
neonatal	O
female	O
BALB	O
/	O
cCrgl	O
or	O
BALB	O
/	O
cfC3HCrgl	O
mice	O
were	O
given	O
subcutaneous	O
injections	O
of	O
5	O
micrograms	O
17	O
beta	B
-	I
estradiol	O
or	O
sesame	O
oil	O
for	O
the	O
first	O
3	O
days	O
of	O
life	O
and	O
were	O
ovariectomized	O
at	O
60	O
days	O
of	O
age	O
,	O
at	O
which	O
time	O
vaginal	O
concretions	O
(	O
Experiments	O
I	O
and	O
II	O
)	O
or	O
silica	O
(	O
Experiment	O
II	O
)	O
were	O
implanted	O
intravaginally	O
.	O

Other	O
than	O
d	O
7	O
,	O
there	O
was	O
no	O
significant	O
effect	O
on	O
the	O
number	O
of	O
implants	O
.	O

According	O
to	O
the	O
biochemical	O
tests	O
,	O
high	O
activity	O
(	O
over	O
200	O
U	O
/	O
l	O
)	O
of	O
alkaline	B
phosphatase	I
was	O
recorded	O
exclusively	O
in	O
patients	O
with	O
the	O
lymphogranulomatosis	O
-	O
induced	O
liver	O
damage	O
.	O

The	O
average	O
birth	O
mass	O
of	O
these	O
newborns	O
was	O
3491	O
.	O
9	O
+/-	O
2	O
SD	O
780	O
.	O
5	O
g	O
and	O
that	O
in	O
the	O
control	O
group	O
3	O
,	O
767	O
.	O
5	O
+/-	O
2	O
SD	O
824	O
.	O
2	O
g	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
).	O

This	O
machine	O
drift	O
,	O
which	O
was	O
not	O
associated	O
with	O
a	O
rise	O
in	O
water	O
phantom	O
temperature	O
and	O
did	O
not	O
consistently	O
correlate	O
with	O
estimated	O
x	O
-	O
ray	O
tube	O
heat	O
,	O
could	O
result	O
in	O
a	O
significant	O
overestimation	O
of	O
regional	O
cerebral	O
blood	O
flow	O
(	O
rCBF	O
)	O
for	O
a	O
xenon	O
/	O
CT	O
rCBF	O
protocol	O
involving	O
5	O
-	O
7	O
sequential	O
scans	O
obtained	O
at	O
1	O
-	O
min	O
interscan	O
intervals	O
.	O

Serodiagnosis	O
of	O
trypanosomiasis	O
in	O
dromedary	O
camels	O
using	O
a	O
card	O
agglutination	O
test	O
set	O
(	O
Testryp	O
CATT	O
).	O

Lymphocytes	O
from	O
all	O
3	O
species	O
yielded	O
maximum	O
responses	O
with	O
a	O
48	O
-	O
hour	O
prelabel	O
and	O
12	O
-	O
to	O
-	O
16	O
hour	O
postlabel	O
incubation	O
period	O
at	O
41	O
C	O
and	O
1	O
:	O
20	O
blood	O
dilution	O
.	O

The	O
salient	O
clinical	O
features	O
,	O
the	O
problems	O
of	O
management	O
and	O
the	O
modern	O
approaches	O
to	O
the	O
reconstruction	O
of	O
facial	O
deformities	O
seen	O
in	O
this	O
disease	O
are	O
described	O
.	O

Besides	O
,	O
it	O
was	O
considered	O
that	O
the	O
NPF	O
was	O
a	O
useful	O
tool	O
for	O
activation	O
of	O
velopharyngeal	O
activity	O
by	O
way	O
of	O
visual	O
feed	O
-	O
back	O
control	O
.	O

As	O
pleural	O
thickening	O
is	O
seen	O
commonly	O
in	O
asbestosis	O
and	O
may	O
influence	O
lung	O
volumes	O
and	O
the	O
ratio	O
of	O
transfer	B
factor	I
to	O
effective	O
alveolar	O
volume	O
,	O
the	O
results	O
of	O
these	O
measurements	O
were	O
compared	O
only	O
in	O
the	O
cases	O
showing	O
absent	O
or	O
minimal	O
pleural	O
thickening	O
.	O

Azygos	O
vein	O
abutting	O
the	O
posterior	O
wall	O
of	O
the	O
right	O
main	O
and	O
upper	O
lobe	O
bronchi	O
:	O
a	O
normal	O
CT	O
variant	O
.	O

Female	O
Wistar	O
rats	O
were	O
fed	O
a	O
liquid	O
diet	O
,	O
Sustacal	O
,	O
which	O
contained	O
ethanol	O
(	O
40	O
%	O
of	O
calories	O
)	O
or	O
isocaloric	O
sucrose	O
.	O

Four	O
patients	O
(	O
group	O
1	O
)	O
had	O
type	O
I	O
basement	O
membrane	O
nephropathy	O
,	O
characterized	O
by	O
marked	O
thickening	O
and	O
lamellation	O
of	O
the	O
basement	O
membrane	O
in	O
a	O
pattern	O
resembling	O
that	O
of	O
Alport	O
'	O
s	O
syndrome	O
.	O

Introductory	O
remarks	O
.	O

Nursing	O
home	O
discharges	O
in	O
clinical	O
practice	O
.	O

Using	O
a	O
MOS	O
-	O
Hypersil	O
reversed	O
-	O
phase	O
column	O
with	O
a	O
phosphate	O
buffer	O
--	O
acetonitrile	O
mobile	O
phase	O
,	O
baseline	O
separation	O
of	O
antipyrine	O
,	O
its	O
metabolites	O
3	O
-	O
hydroxymethylantipyrine	O
,	O
norantipyrine	O
and	O
4	O
-	O
hydroxyantipyrine	O
,	O
and	O
the	O
internal	O
standard	O
,	O
phenacetin	O
,	O
was	O
achieved	O
within	O
6	O
min	O
.	O

The	O
liver	O
in	O
the	O
severely	O
ill	O

These	O
results	O
confirming	O
the	O
high	O
validity	O
of	O
NOM	O
inhibiting	O
test	O
in	O
the	O
diagnosis	O
of	O
tumoural	O
hyperprolactinemic	O
states	O
,	O
reveal	O
contradictory	O
responses	O
to	O
CD	O
/	O
LD	O
,	O
LD	O
and	O
DOM	O
,	O
with	O
sustain	O
the	O
existence	O
of	O
2	O
sub	O
-	O
group	O
of	O
Prolactinomas	O
:	O
with	O
or	O
without	O
a	O
maintained	O
DA	O
central	O
tonus	O
supporting	O
the	O
possibility	O
of	O
different	O
etiopathogenetical	O
factors	O
in	O
inducing	O
a	O
tumoural	O
hyperprolactinemic	O
states	O
.	O

Serum	O
lipids	O
and	O
lipoproteins	O
of	O
29	O
insulin	B
dependent	I
diabetic	O
children	O
have	O
been	O
determined	O
and	O
related	O
to	O
the	O
metabolic	O
status	O
of	O
the	O
patients	O
.	O

Amikacin	O
concentrations	O
in	O
serum	O
and	O
blister	O
fluid	O
in	O
healthy	O
volunteers	O
and	O
in	O
patients	O
with	O
renal	O
impairment	O
.	O

Urinary	B
N	I
-	I
acetylglucosaminidase	I
activity	O
per	O
mg	O
creatinine	O
did	O
not	O
differ	O
significantly	O
between	O
groups	O
.	O

The	O
associations	O
between	O
sex	B
-	I
hormone	I
-	I
binding	I
globulin	I
capacity	O
(	O
SHBG	B
),	O
age	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
),	O
and	O
physical	O
fitness	O
have	O
been	O
studied	O
in	O
34	O
men	O
and	O
36	O
women	O
.	O

After	O
1	O
.	O
5	O
years	O
of	O
such	O
photoperiodic	O
control	O
,	O
all	O
ewes	O
were	O
blinded	O
by	O
bilateral	O
orbital	O
enucleation	O
.	O

Less	O
antibacterial	O
activity	O
was	O
shown	O
toward	O
the	O
Gram	O
-	O
negative	O
bacilli	O
,	O
i	O
.	O
e	O
.,	O
Pseudomonas	O
,	O
Klebsiella	O
-	O
Enterobacter	O
,	O
Shigella	O
,	O
Escherichia	O
coli	O
,	O
Serratia	O
marcescens	O
and	O
Proteus	O
.	O

Ultrastructural	O
studies	O
of	O
retinopathy	O
of	O
premature	O
infants	O

A	O
stable	O
interface	O
depends	O
on	O
overall	O
stress	O
and	O
microstress	O
distribution	O
on	O
the	O
bone	O
,	O
particularly	O
trabecular	O
bone	O
.	O

Within	O
the	O
compartment	O
or	O
dimension	O
of	O
severity	O
of	O
depression	O
a	O
subscale	O
of	O
the	O
Hamilton	O
Depression	O
Scale	O
(	O
or	O
the	O
Melancholia	O
Scale	O
)	O
was	O
shown	O
to	O
have	O
reached	O
an	O
instrumental	O
perfection	O
,	O
e	O
.	O
g	O
.	O
as	O
an	O
outcome	O
measure	O
of	O
antidepressant	O
treatment	O
.	O

The	O
AD	O
components	O
were	O
markedly	O
more	O
dependent	O
on	O
the	O
affective	O
state	O
of	O
the	O
rat	O
then	O
was	O
the	O
V1	O
component	O
.	O

HBB	O
concentration	O
in	O
the	O
fetuses	O
indicated	O
little	O
,	O
if	O
any	O
accumulation	O
.	O

The	O
importance	O
of	O
selective	O
renal	O
vein	O
phlebography	O
in	O
the	O
evaluation	O
of	O
unexplained	O
hematuria	O
and	O
filing	O
defects	O
in	O
the	O
excretory	O
urogram	O
is	O
illustrated	O
.	O

No	O
patient	O
with	O
bradyarrhythmia	O
-	O
related	O
SCD	O
had	O
manifest	O
atrioventricular	O
block	O
or	O
bundle	O
branch	O
block	O
.	O

The	O
measurement	O
of	O
the	O
areas	O
of	O
fibrin	B
,	O
of	O
tissue	O
and	O
fibrinolysis	O
,	O
at	O
the	O
above	O
mentioned	O
times	O
,	O
has	O
been	O
effected	O
at	O
standard	O
magnification	O
(	O
15	O
X	O
)	O
by	O
an	O
image	O
analyser	O
(	O
Videoplan	O
)	O
scale	O
1	O
:	O
8	O
.	O

Twenty	O
-	O
one	O
percent	O
of	O
these	O
patients	O
had	O
neurologic	O
disease	O
that	O
appeared	O
to	O
be	O
responsible	O
for	O
the	O
tinnitus	O
.	O

4	O
Five	O
patients	O
died	O
within	O
one	O
month	O
of	O
captopril	O
and	O
five	O
between	O
four	O
and	O
seven	O
months	O
,	O
three	O
of	O
whom	O
had	O
improved	O
to	O
class	O
IIM	O
and	O
one	O
to	O
IIS	O
before	O
death	O
.	O

Bullous	O
angiolymphoid	O
hyperplasia	O
with	O
eosinophilia	O

Volume	O
of	O
distribution	O
of	O
total	O
DMDZ	O
(	O
range	O
,	O
1	O
.	O
33	O
to	O
6	O
.	O
30	O
l	O
/	O
kg	O
)	O
and	O
of	O
unbound	O
DMDZ	O
after	O
correction	O
for	O
protein	O
binding	O
(	O
range	O
,	O
43	O
to	O
243	O
l	O
/	O
kg	O
)	O
was	O
larger	O
in	O
women	O
than	O
in	O
men	O
of	O
all	O
ages	O
,	O
and	O
in	O
the	O
elderly	O
as	O
opposed	O
to	O
the	O
young	O
.	O

Trypanosoma	O
cruzi	O
.	O

The	O
subjects	O
of	O
the	O
study	O
were	O
10	O
normal	O
subjects	O
and	O
64	O
patients	O
with	O
gastroduodenal	O
disease	O
.	O

1	O
.	O

This	O
study	O
represents	O
the	O
first	O
published	O
long	O
-	O
term	O
follow	O
-	O
up	O
regarding	O
this	O
mode	O
of	O
treatment	O
in	O
patients	O
with	O
alveolar	O
hypoventilation	O
.	O

All	O
62	O
isolates	O
were	O
resistant	O
to	O
lincomycin	O
,	O
colistin	O
,	O
nystatin	O
,	O
amphotericin	O
B	O
,	O
trimethoprim	O
lactate	O
,	O
polymyxin	O
B	O
,	O
and	O
anisomycin	O
.	O

The	O
evaluation	O
of	O
amniotic	O
fluid	O
delta	O
OD450	O
is	O
considered	O
to	O
be	O
the	O
cornerstone	O
of	O
clinical	O
management	O
.	O

Fenfluramine	O
(	O
in	O
doses	O
ranging	O
from	O
0	O
.	O
0625	O
-	O
4	O
.	O
0	O
mg	O
/	O
kg	O
/	O
infusion	O
)	O
did	O
not	O
maintain	O
self	O
-	O
administration	O
behavior	O
at	O
or	O
above	O
the	O
minimum	O
requirement	O
(	O
FR	O
30	O
).	O

The	O
already	O
elevated	O
prolactin	B
levels	O
in	O
nursing	O
women	O
were	O
not	O
influenced	O
by	O
chronic	O
oestradiol	O
administration	O
.	O

Morphine	O
-	O
dependent	O
and	O
control	O
rats	O
in	O
an	O
oral	O
free	O
-	O
choice	O
protocol	O
were	O
treated	O
with	O
gamma	B
-	I
vinyl	O
GABA	O
(	O
GVG	O
),	O
60	O
,	O
120	O
and	O
240	O
mg	O
/	O
kg	O
IP	O
,	O
for	O
3	O
days	O
over	O
three	O
successive	O
periods	O
.	O

Phagocytosis	O
of	O
tubercle	O
bacilli	O
by	O
macrophages	O
.	O

The	O
decrease	O
in	O
HDL	B
-	I
cholesterol	I
with	O
increasing	O
VLDL	B
-	I
triglycerides	I
was	O
relatively	O
much	O
larger	O
than	O
the	O
concomitant	O
decrease	O
in	O
apo	B
A	I
-	I
I	I
.	O

Of	O
270	O
patients	O
with	O
well	O
-	O
defined	O
drug	O
reactions	O
,	O
190	O
(	O
70	O
per	O
cent	O
)	O
gave	O
a	O
positive	O
response	O
to	O
the	O
mast	O
cell	O
test	O
.	O

Diagnostic	O
value	O
of	O
serum	B
myoglobin	I
in	O
cases	O
of	O
neuromuscular	O
disease	O

During	O
the	O
last	O
6	O
months	O
of	O
the	O
study	O
a	O
striking	O
change	O
in	O
epidemiology	O
concerning	O
hepatitis	O
A	O
was	O
seen	O
,	O
apparently	O
caused	O
by	O
a	O
steep	O
increase	O
in	O
the	O
incidence	O
of	O
this	O
type	O
of	O
hepatitis	O
among	O
drug	O
addicts	O
.	O

Of	O
254	O
children	O
with	O
neuroblastoma	O
treated	O
at	O
St	O
.	O

Penicillin	B
-	I
G	I
degradation	O
products	O
inhibit	O
in	O
vitro	O
granulopoiesis	O
.	O

Distal	O
tubular	O
acidification	O
and	O
the	O
threshold	O
for	O
proximal	O
tubular	O
bicarbonate	O
reabsorption	O
were	O
normal	O
,	O
as	O
was	O
urine	O
concentrating	O
capacity	O
.	O

Disturbances	O
of	O
placental	O
maturation	O
,	O
2	O
.	O

On	O
the	O
basis	O
of	O
histopathological	O
findings	O
,	O
the	O
origin	O
of	O
amyloid	O
appeared	O
to	O
be	O
closely	O
related	O
to	O
the	O
fibroblasts	O
.	O

Serum	B
lactate	I
dehydrogenase	I
and	O
haptoglobin	B
levels	O
were	O
normal	O
,	O
and	O
total	O
bilirubin	O
was	O
only	O
slightly	O
elevated	O
.	O

Low	O
-	O
dose	O
D	O
(	O
0	O
.	O
4	O
-	O
0	O
.	O
8	O
mg	O
)	O
and	O
DB	O
(	O
1	O
.	O
0	O
-	O
5	O
.	O
0	O
mg	O
)	O
did	O
not	O
significantly	O
alter	O
any	O
parameter	O
from	O
control	O
.	O

Circulating	O
platelets	O
may	O
be	O
activated	O
by	O
exposed	O
triple	O
-	O
helical	O
collagen	B
in	O
atherosclerotic	O
lesions	O
in	O
Mg	O
-	O
deficient	O
ruminants	O
.	O

Statistics	O
for	O
nurse	O
managers	O
--	O
3	O
.	O

The	O
electrocardiogram	O
.	O

Whereas	O
creatine	B
kinase	I
activity	O
declined	O
exponentially	O
from	O
a	O
single	O
peak	O
,	O
myoglobin	B
appeared	O
in	O
multiple	O
episodes	O
inadequately	O
represented	O
by	O
a	O
single	O
peak	O
value	O
and	O
having	O
no	O
clear	O
clinical	O
correlation	O
.	O

Both	O
examinations	O
are	O
sensitive	O
indicators	O
of	O
CNS	O
abnormalities	O
associated	O
with	O
bacterial	O
meningeal	O
infections	O
and	O
are	O
important	O
determinants	O
of	O
the	O
therapy	O
and	O
ultimate	O
prognosis	O
of	O
such	O
complications	O
.	O

Correlation	O
between	O
intraocular	O
involvement	O
and	O
systemic	O
outcome	O
was	O
poor	O
.	O

A	O
case	O
of	O
anterior	O
cleavage	O
syndrome	O
in	O
a	O
27	O
-	O
year	O
-	O
old	O
female	O
patient	O
is	O
described	O
.	O

Ten	O
days	O
of	O
cefadroxil	O
therapy	O
was	O
used	O
to	O
treat	O
44	O
children	O
with	O
urinary	O
tract	O
infection	O
and	O
CRP	B
values	O
greater	O
than	O
or	O
equal	O
to	O
28	O
microgram	O
/	O
ml	O
(	O
CRP	B
-	I
positive	O
group	O
).	O

After	O
acclimation	O
,	O
resting	O
supine	O
and	O
sitting	O
DPB	O
decreased	O
(	O
P	O
less	O
than	O
0	O
.	O
05	O
)	O
by	O
6	O
and	O
9	O
mmHg	O
,	O
respectively	O
.	O

The	O
relationship	O
between	O
the	O
rare	O
complications	O
mentioned	O
above	O
and	O
the	O
pathophysiology	O
of	O
Bartter	O
'	O
s	O
syndrome	O
is	O
still	O
obscure	O
.	O

Using	O
an	O
opsonophagocytic	O
bacterial	O
assay	O
and	O
a	O
suckling	O
rat	O
model	O
of	O
GBS	O
sepsis	O
,	O
we	O
analyzed	O
a	O
modified	O
human	B
immunoglobulin	I
for	O
opsonic	O
and	O
protective	O
antibody	O
.	O

Glomerular	O
lesions	O
in	O
renal	O
allografts	O
.	O

Investigated	O
the	O
reliability	O
,	O
validity	O
and	O
dimensionality	O
of	O
scores	O
obtained	O
by	O
acute	O
psychiatric	O
inpatients	O
(	O
N	O
=	O
120	O
)	O
on	O
the	O
Michigan	O
Alcoholism	O
Screening	O
Test	O
adapted	O
to	O
assess	O
lifetime	O
and	O
current	O
symptomatology	O
.	O

The	O
differential	O
investigation	O
of	O
lipoproteins	O
,	O
however	O
,	O
showed	O
that	O
the	O
high	B
-	I
density	I
lipoprotein	I
(	O
HDL	B
)	O
fractions	O
are	O
absolutely	O
or	O
relatively	O
decreased	O
with	O
respect	O
to	O
low	O
-	O
density	O
lipoproteins	O
(	O
LDL	B
)	O
in	O
cerebral	O
infarcts	O
and	O
in	O
transient	O
ischaemic	O
attacks	O
.	O

Although	O
noninhibitory	O
fluid	O
had	O
higher	O
mean	O
concentrations	O
of	O
phosphorus	O
and	O
zinc	O
,	O
these	O
differences	O
did	O
not	O
hold	O
after	O
meconium	O
-	O
stained	O
samples	O
were	O
excluded	O
.	O

Selenium	O
status	O
of	O
thoroughbreds	O
in	O
the	O
United	O
Kingdom	O
.	O

In	O
a	O
longitudinal	O
study	O
,	O
14	O
low	O
-	O
risk	O
fetuses	O
were	O
studied	O
at	O
2	O
-	O
week	O
intervals	O
from	O
32	O
weeks	O
of	O
gestation	O
onward	O
.	O

These	O
results	O
suggested	O
the	O
possibility	O
that	O
the	O
fetus	O
played	O
some	O
role	O
in	O
the	O
production	O
of	O
E3	B
-	I
16	I
-	I
G	I
in	O
early	O
pregnancy	O
.	O

The	O
highest	O
doses	O
were	O
found	O
for	O
drivers	O
who	O
transported	O
large	O
numbers	O
of	O
99Mo	O
generators	O
.	O

Conjugated	O
and	O
unconjugated	O
phenylacetic	O
acid	O
and	O
m	O
-	O
and	O
p	O
-	O
hydroxyphenylacetic	O
acid	O
have	O
been	O
determined	O
in	O
the	O
plasma	O
of	O
normal	O
,	O
healthy	O
subjects	O
after	O
fasting	O
,	O
consumption	O
of	O
a	O
meal	O
and	O
ingestion	O
of	O
deuterium	O
labelled	O
amine	O
precursors	O
,	O
by	O
high	O
-	O
resolution	O
gas	O
chromatography	O
--	O
high	O
resolution	O
mass	O
spectrometry	O
with	O
selected	O
ion	O
monitoring	O
of	O
their	O
trifluoroethyl	O
-	O
pentafluoropropionyl	O
derivatives	O
.	O

After	O
MOPP	O
therapy	O
,	O
complete	O
remission	O
of	O
Hodgkin	O
'	O
s	O
disease	O
was	O
accompanied	O
by	O
normalization	O
of	O
the	O
glucocerebrosidase	B
level	O
and	O
disappearance	O
of	O
Gaucher	O
'	O
s	O
cells	O
.	O

Specifically	O
,	O
by	O
the	O
type	O
of	O
adjuvant	O
therapy	O
,	O
the	O
median	O
disease	O
-	O
free	O
interval	O
and	O
survival	O
from	O
stage	O
IVA	O
for	O
23	O
patients	O
receiving	O
Corynebacterium	O
parvum	O
were	O
6	O
.	O
9	O
and	O
19	O
months	O
;	O
for	O
39	O
patients	O
receiving	O
BCG	O
,	O
eight	O
months	O
and	O
26	O
months	O
;	O
for	O
24	O
patients	O
receiving	O
BCG	O
+	O
DTIC	O
,	O
eight	O
and	O
17	O
.	O
4	O
months	O
;	O
and	O
for	O
all	O
51	O
DTIC	O
treated	O
patients	O
6	O
.	O
3	O
and	O
17	O
.	O
8	O
months	O
,	O
respectively	O
.	O

Re	O
:	O
A	O
modified	O
method	O
for	O
the	O
in	O
vivo	O
labeling	O
of	O
red	O
blood	O
cells	O
with	O
Tc	O
-	O
99m	O
.	O

Parasitological	O
and	O
pathological	O
findings	O
in	O
capuchin	O
monkeys	O
infected	O
with	O
Schistosoma	O
japonicum	O
or	O
Schistosoma	O
mansoni	O
.	O

Administration	O
of	O
the	O
dopamine	O
agonist	O
bromocriptine	O
(	O
2	O
.	O
5	O
mg	O
three	O
times	O
a	O
day	O
for	O
4	O
days	O
)	O
suppressed	O
(	O
P	O
less	O
than	O
0	O
.	O
01	O
)	O
mean	O
24	O
-	O
h	O
plasma	O
18	O
-	O
OHB	O
levels	O
from	O
21	O
.	O
9	O
+/-	O
2	O
.	O
0	O
to	O
14	O
.	O
8	O
+/-	O
1	O
.	O
4	O
ng	O
/	O
dl	O
.	O

The	O
favourable	O
effect	O
of	O
thymic	O
shielding	O
was	O
also	O
reflected	O
in	O
a	O
significant	O
increase	O
of	O
LD50	O
/	O
30	O
,	O
and	O
the	O
dose	O
reduction	O
factor	O
was	O
equal	O
to	O
2	O
.	O

Mastocytosis	O
.	O

It	O
was	O
suggested	O
that	O
the	O
absence	O
of	O
pronounced	O
differences	O
between	O
conditions	O
may	O
have	O
been	O
due	O
to	O
the	O
complexity	O
of	O
the	O
task	O
or	O
the	O
type	O
of	O
prompts	O
employed	O
.	O

Organisms	O
were	O
not	O
observed	O
in	O
the	O
5	O
bobcats	O
trapped	O
in	O
2	O
other	O
counties	O
.	O

The	O
average	O
annual	O
cost	O
per	O
head	O
of	O
population	O
was	O
US	O
+	O
0	O
X	O
46	O
.	O

It	O
is	O
postulated	O
that	O
altered	O
blood	O
flow	O
,	O
mediated	O
through	O
the	O
well	O
-	O
known	O
prostaglandin	B
synthetase	I
inhibitory	I
effects	O
of	O
ibuprofen	O
,	O
resulted	O
in	O
tubular	O
necrosis	O
.	O

Either	O
20	O
mg	O
mitomycin	O
/	O
20	O
ml	O
distilled	O
water	O
or	O
40	O
mg	O
/	O
40	O
ml	O
distilled	O
water	O
was	O
locally	O
instilled	O
into	O
the	O
bladder	O
with	O
a	O
catheter	O
after	O
emptying	O
it	O
and	O
was	O
left	O
for	O
about	O
25	O
-	O
l20	O
min	O
.	O

Treatment	O
of	O
meat	O
muscle	O
800	O
V	O
for	O
45	O
s	O
reduced	O
weeping	O
but	O
increased	O
slightly	O
the	O
rate	O
of	O
autoxidation	O
of	O
lipids	O
.	O

Each	O
trial	O
consisted	O
of	O
light	O
and	O
buzzer	O
for	O
five	O
seconds	O
as	O
conditioned	O
stimuli	O
and	O
electric	O
shock	O
for	O
five	O
seconds	O
as	O
an	O
unconditioned	O
stimulus	O
.	O

Adverse	O
reaction	O
of	O
the	O
apparently	O
healthy	O
partner	O
in	O
response	O
to	O
improvement	O
in	O
the	O
overtly	O
dysfunctional	O
partner	O
.	O

To	O
evaluate	O
the	O
gas	O
chromatographic	O
electron	O
capture	O
detection	O
method	O
described	O
earlier	O
,	O
23	O
plasma	O
samples	O
have	O
been	O
analysed	O
by	O
both	O
techniques	O
.	O

Five	O
control	O
subjects	O
with	O
COPD	O
,	O
who	O
performed	O
the	O
same	O
sequence	O
of	O
tests	O
without	O
breathing	O
30	O
%	O
O2	O
,	O
showed	O
no	O
change	O
in	O
flow	O
rates	O
or	O
density	O
dependence	O
.	O

Evoked	O
potential	O
and	O
single	O
unit	O
responses	O
to	O
olfactory	O
nerve	O
volleys	O
in	O
the	O
isolated	O
turtle	O
olfactory	O
bulb	O
.	O

Eight	O
hr	O
of	O
acidosis	O
caused	O
a	O
significant	O
(	O
P	O
less	O
than	O
0	O
.	O
01	O
)	O
decrease	O
in	O
P50	O
in	O
vitro	O
which	O
fell	O
from	O
29	O
.	O
0	O
to	O
24	O
.	O
4	O
torr	O
.	O

These	O
women	O
should	O
not	O
be	O
given	O
the	O
current	O
estrogen	O
PPI	O
,	O
which	O
was	O
designed	O
to	O
warn	O
women	O
of	O
the	O
risks	O
of	O
long	O
-	O
term	O
estrogen	O
use	O
;	O
a	O
PPI	O
should	O
be	O
written	O
specifically	O
for	O
patients	O
receiving	O
short	O
courses	O
.	O

Methisergide	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
,	O
i	O
.	O
p	O
.),	O
a	O
blocker	O
of	O
serotonin	O
receptors	O
,	O
prevented	O
the	O
development	O
of	O
the	O
antinociceptive	O
effect	O
of	O
serotonin	O
.	O

The	O
plasma	O
half	O
-	O
life	O
of	O
slow	O
disposition	O
phase	O
t1	O
/	O
2	O
beta	O
,	O
increases	O
from	O
0	O
.	O
26	O
hour	O
in	O
rabbits	O
with	O
normal	O
renal	O
function	O
to	O
5	O
.	O
41	O
hours	O
in	O
rabbits	O
with	O
severe	O
renal	O
impairment	O
.	O

Corticosteroid	O
therapy	O
is	O
known	O
to	O
be	O
hazardous	O
in	O
patients	O
with	O
occult	O
infection	O
but	O
the	O
mechanism	O
by	O
which	O
the	O
host	O
parasite	O
relationship	O
is	O
altered	O
by	O
steroids	O
is	O
not	O
known	O
.	O
We	O
have	O
used	O
an	O
intestinal	O
protozoal	O
parasite	O
,	O
Giardia	O
muris	O
,	O
to	O
examine	O
the	O
effects	O
of	O
corticosteroids	O
on	O
the	O
number	O
of	O
parasites	O
in	O
the	O
intestine	O
in	O
the	O
course	O
of	O
a	O
primary	O
infection	O
.	O

Of	O
the	O
117	O
patients	O
(	O
out	O
of	O
the	O
136	O
)	O
with	O
serologic	O
evidence	O
of	O
chronic	O
thyroiditis	O
who	O
could	O
be	O
studied	O
,	O
eight	O
(	O
7	O
%)	O
had	O
hyperthyroidism	O
and	O
45	O
(	O
38	O
%)	O
were	O
hypothyroid	O
.	O

The	O
new	O
semi	O
-	O
synthetic	O
oral	O
cephalosporin	O
,	O
CGP	O
9	O
,	O
000	O
,	O
has	O
been	O
evaluated	O
in	O
a	O
large	O
number	O
of	O
hospitalized	O
patients	O
with	O
urinary	O
infections	O
.	O

In	O
Group	O
V	O
,	O
the	O
salvaged	O
tissue	O
was	O
primarily	O
subepicardial	O
with	O
virtually	O
no	O
lateral	O
zone	O
of	O
salvaged	O
tissue	O
(	O
ratio	O
of	O
salvaged	O
subepicardium	O
to	O
salvaged	O
subendocardium	O
14	O
.	O
8	O
+/-	O
1	O
.	O
9	O
to	O
1	O
).	O

Gastrin	B
secretion	O
during	O
food	O
stimulation	O
in	O
digestive	O
system	O
diseases	O

Effect	O
of	O
indomethacin	O
and	O
prostaglandin	O
F2	O
alpha	O
on	O
parturition	O
in	O
swine	O
.	O

Autotransfusion	O
was	O
performed	O
as	O
follows	O
:	O
Heparin	O
-	O
ACD	O
-	O
B	O
-	O
Heparin	O
-	O
DPD	O
-	O
Heparin	O
-	O
ACD	O
-	O
B	O
etc	O
.	O

The	O
architecture	O
of	O
microvasculature	O
in	O
these	O
two	O
regions	O
was	O
also	O
examined	O
by	O
scanning	O
electron	O
microscopy	O
,	O
using	O
the	O
resin	O
casting	O
method	O
.	O

Micro	O
high	O
-	O
performance	O
liquid	O
chromatographic	O
system	O
with	O
micro	O
precolumn	O
and	O
dual	O
electrochemical	O
detector	O
for	O
direct	O
injection	O
analysis	O
of	O
catecholamines	O
in	O
body	O
fluids	O
.	O

A	O
narrow	O
zone	O
of	O
myelin	O
-	O
axonal	O
dissociation	O
was	O
also	O
observed	O
.	O

The	O
IgA	B
deficiency	O
is	O
combined	O
with	O
the	O
IgE	B
one	O
.	O

In	O
PB	O
mice	O
,	O
there	O
was	O
only	O
a	O
small	O
deficit	O
in	O
the	O
number	O
of	O
the	O
hippocampal	O
pyramidal	O
neurons	O
compared	O
to	O
controls	O
(	O
15	O
%,	O
p	O
less	O
than	O
0	O
.	O
01	O
),	O
and	O
no	O
deficit	O
in	O
the	O
granule	O
cells	O
.	O

The	O
quantitative	O
determination	O
of	O
HBSAG	B
--	O
a	O
valuable	O
aid	O
in	O
evaluating	O
the	O
infectiousness	O
of	O
hepatitis	O
B	O
virus	O
carriers	O

Urological	O
complications	O
are	O
frequent	O
during	O
and	O
after	O
the	O
treatment	O
of	O
gynecological	O
malignancy	O
.	O

Twenty	O
patients	O
aged	O
45	O
or	O
older	O
with	O
the	O
diagnosis	O
of	O
endogenous	O
depression	O
were	O
evaluated	O
in	O
terms	O
of	O
safety	O
and	O
efficacy	O
in	O
their	O
response	O
to	O
multiple	O
monitored	O
electroconvulsive	O
therapy	O
(	O
MMECT	O
)	O
versus	O
single	O
electroconvulsive	O
therapy	O
(	O
SECT	O
).	O

Longitudinal	O
force	O
-	O
length	O
relationships	O
of	O
guinea	O
pig	O
ureter	O
were	O
studied	O
in	O
vitro	O
in	O
animals	O
3	O
weeks	O
,	O
3	O
months	O
,	O
and	O
3	O
years	O
of	O
age	O
.	O

The	O
following	O
aspects	O
were	O
assessed	O
:	O
(	O
1	O
)	O
The	O
effect	O
on	O
the	O
cardiovascular	O
system	O
in	O
terms	O
of	O
brachial	O
arterial	O
pressure	O
,	O
pulse	O
rate	O
,	O
and	O
oxygen	O
consumption	O
(	O
VO2	O
)	O
during	O
exercise	O
in	O
5	O
health	O
volunteers	O
;	O
(	O
2	O
)	O
emg	O
activity	O
of	O
the	O
tibialis	O
anterior	O
and	O
gastrocnemius	O
muscles	O
during	O
exercise	O
in	O
the	O
same	O
5	O
volunteers	O
;	O
and	O
(	O
3	O
)	O
postexercise	O
ankle	O
pressure	O
changes	O
in	O
10	O
subjects	O
with	O
angiographically	O
proven	O
occlusive	O
arterial	O
diseases	O
of	O
the	O
lower	O
extremities	O
.	O

The	O
results	O
revealed	O
increased	O
blood	O
lead	O
level	O
associated	O
with	O
decreased	O
blood	O
haemoglobin	B
and	O
increased	O
urinary	O
excretion	O
of	O
delta	O
amino	O
levulinic	O
acid	O
.	O

Following	O
iv	O
injection	O
of	O
0	O
.	O
5	O
g	O
galactose	O
per	O
kg	O
body	O
weight	O
,	O
together	O
with	O
2	O
mu	B
Ci	I
generally	O
14C	O
-	O
labelled	O
galactose	O
,	O
14CO2	O
is	O
collected	O
in	O
regular	O
intervals	O
during	O
one	O
hour	O
.	O

Hippocampal	O
stimulation	O
overlapping	O
conditioned	O
stimulus	O
preexposure	O
produced	O
attenuation	O
of	O
latent	O
inhibition	O
,	O
as	O
did	O
stimulation	O
presented	O
during	O
conditioning	O
after	O
preexposure	O
.	O

Number	O
and	O
size	O
of	O
the	O
myelin	O
structures	O
in	O
the	O
pneumocytes	O
typ	O
II	O
increased	O
simultaneously	O
.	O

In	O
spite	O
of	O
this	O
and	O
other	O
complications	O
of	O
corticosteroids	O
,	O
she	O
made	O
a	O
full	O
recovery	O
from	O
the	O
fungal	O
infection	O
following	O
treatment	O
with	O
amphotericin	O
B	O
and	O
surgical	O
excision	O
of	O
the	O
lung	O
abscess	O
.	O

The	O
C18	O
:	O
1	O
:	O
C10	O
value	O
is	O
a	O
convenient	O
measure	O
of	O
these	O
changes	O
and	O
can	O
be	O
determined	O
more	O
rapidly	O
than	O
determining	O
all	O
the	O
lower	O
fatty	O
acids	O
.	O

A	O
progressive	O
growth	O
of	O
blood	O
erythrocyte	O
membrane	O
injury	O
has	O
been	O
demonstrated	O
after	O
rats	O
were	O
exposed	O
to	O
gamma	B
-	I
irradiaton	O
at	O
a	O
dose	O
of	O
100	O
to	O
500	O
Gy	O
.	O

Thirty	O
cadaver	O
brains	O
were	O
examined	O
under	O
X	O
6	O
to	O
16	O
magnification	O
in	O
order	O
to	O
define	O
the	O
microsurgical	O
anatomy	O
of	O
the	O
pineal	O
region	O
,	O
particularly	O
the	O
relationship	O
of	O
the	O
pineal	O
body	O
,	O
posterior	O
cerebral	O
artery	O
,	O
superior	O
cerebellar	O
artery	O
,	O
vein	O
of	O
Galen	O
,	O
basal	O
vein	O
of	O
Rosenthal	O
,	O
internal	O
cerebral	O
vein	O
,	O
straight	O
sinus	O
,	O
bridging	O
vein	O
,	O
the	O
size	O
of	O
the	O
tentorial	O
notch	O
,	O
and	O
the	O
third	O
and	O
the	O
fourth	O
cranial	O
nerves	O
.	O

We	O
propose	O
that	O
refeeding	O
may	O
be	O
an	O
important	O
mechanism	O
for	O
activation	O
of	O
certain	O
viral	O
infections	O
previously	O
suppressed	O
by	O
famine	O
.	O

All	O
control	O
persons	O
had	O
a	O
normal	O
reaction	O
to	O
DNFB	O
.	O

In	O
the	O
unclipped	O
group	O
arterial	O
pressure	O
decreased	O
50	O
mmHg	O
to	O
normal	O
by	O
24	O
h	O
and	O
was	O
associated	O
with	O
increased	O
diuresis	O
and	O
a	O
small	O
decrease	O
in	O
blood	O
volume	O
(	O
9	O
.	O
8	O
%).	O

As	O
high	O
-	O
speed	O
,	O
volumetric	O
imaging	O
,	O
computed	O
tomographic	O
scan	O
machines	O
such	O
as	O
the	O
Dynamic	O
Spatial	O
Reconstructor	O
become	O
available	O
with	O
higher	O
density	O
resolution	O
,	O
perhaps	O
a	O
single	O
injection	O
of	O
contrast	O
agent	O
into	O
the	O
right	O
atrium	O
or	O
even	O
a	O
peripheral	O
vein	O
may	O
be	O
adequate	O
to	O
obtain	O
all	O
these	O
measurements	O
.	O

No	O
symptoms	O
other	O
than	O
hot	O
flush	O
showed	O
such	O
significant	O
correlation	O
with	O
plasma	O
epinephrine	O
or	O
norepinephrine	O
levels	O
.	O

Pentachlorophenol	O
accelerates	O
the	O
onset	O
of	O
HCB	O
porphyria	O
,	O
in	O
other	O
words	O
it	O
increases	O
the	O
total	O
urinary	O
porphyrin	O
excretion	O
and	O
causes	O
an	O
earlier	O
disturbance	O
of	O
the	O
porphyrin	O
pattern	O
.	O

Family	O
planning	O
continues	O
to	O
play	O
a	O
minor	O
role	O
,	O
and	O
only	O
25	O
.	O
3	O
per	O
cent	O
of	O
all	O
patients	O
reviewed	O
took	O
to	O
oral	O
contraceptives	O
for	O
shorter	O
or	O
longer	O
periods	O
of	O
time	O
.	O
-	O
The	O
percentages	O
of	O
primiparae	O
and	O
secundiparae	O
in	O
all	O
births	O
as	O
well	O
as	O
the	O
high	O
percentage	O
of	O
multigravidity	O
are	O
parameters	O
by	O
which	O
the	O
approach	O
to	O
reproduction	O
differs	O
substantively	O
from	O
behaviour	O
patterns	O
in	O
Europe	O
.	O

However	O
,	O
in	O
contrast	O
with	O
previous	O
in	O
vitro	O
cell	O
-	O
free	O
integration	O
studies	O
,	O
alteration	O
of	O
the	O
highly	O
conserved	O
CA	O
dinucleotide	O
resulted	O
in	O
a	O
mutant	O
which	O
still	O
retained	O
40	O
%	O
of	O
wild	B
-	I
type	I
integration	O
activity	O
.	O

The	O
resulting	O
R	O
protein	O
terminates	O
five	O
codons	O
downstream	O
of	O
the	O
frameshift	O
site	O
at	O
the	O
V	O
protein	O
stop	O
codon	O
.	O

BSE	O
and	O
farmworkers	O
.	O

In	O
addition	O
,	O
two	O
-	O
dimensional	O
nuclear	O
magnetic	O
resonance	O
studies	O
with	O
F17A	O
,	O
K13Q	O
,	O
F15Y	O
and	O
F27Y	O
revealed	O
that	O
the	O
mutants	O
have	O
the	O
same	O
overall	O
structure	O
as	O
the	O
wild	B
-	I
type	I
CspB	I
protein	I
.	O

The	O
number	O
of	O
lactotropes	O
,	O
somatotropes	O
,	O
thyrotropes	O
,	O
and	O
gonadotropes	O
was	O
not	O
altered	O
compared	O
with	O
controls	O
,	O
indicating	O
that	O
in	O
the	O
adult	O
pituitary	O
,	O
POMC	B
products	I
are	O
not	O
required	O
to	O
maintain	O
the	O
distribution	O
of	O
cell	O
types	O
.	O

We	O
have	O
isolated	O
a	O
new	O
,	O
larger	O
rat	B
B	I
-	I
myc	I
genomic	O
clone	O
.	O

In	O
addition	O
to	O
the	O
nine	O
and	O
51	O
terminal	O
amino	O
acid	O
forms	O
already	O
known	O
,	O
we	O
identified	O
a	O
third	O
with	O
43	O
terminal	O
amino	O
acids	O
predicted	O
to	O
encode	O
a	O
novel	O
RET	B
protein	I
isoform	I
.	O

Two	O
experiments	O
investigating	O
the	O
effects	O
of	O
short	O
-	O
term	O
spaceflight	O
on	O
cancellous	O
bone	O
turnover	O
were	O
carried	O
out	O
:	O
Physiological	O
Systems	O
Experiment	O
-	O
1	O
(	O
PSE	B
-	I
1	I
)	O
(	O
a	O
4	O
-	O
d	O
orbital	O
spaceflight	O
)	O
and	O
PSE	B
-	I
2	I
(	O
a	O
10	O
-	O
d	O
flight	O
).	O

Histopathologic	O
observations	O
showed	O
that	O
both	O
somatostatin	B
and	O
triamcinolone	O
acetonide	O
reduced	O
the	O
inflammatory	O
signs	O
in	O
the	O
joint	O
structures	O
,	O
although	O
triamcinolone	O
acetonide	O
appeared	O
to	O
be	O
more	O
effective	O
.	O

These	O
are	O
two	O
regions	O
of	O
known	O
conserved	O
synteny	O
,	O
providing	O
further	O
evidence	O
that	O
the	O
human	B
STEP	I
is	O
a	O
true	O
homolog	O
of	O
the	O
murine	B
STEP	I
gene	I
.	O

Vitamin	O
D3	O
plus	O
nicotine	O
treatment	O
produced	O
parallel	O
increases	O
in	O
cardiac	O
mass	O
and	O
elastic	O
modulus	O
,	O
with	O
a	O
significant	O
correlation	O
between	O
the	O
two	O
.	O

The	O
latter	O
domain	O
appears	O
to	O
be	O
involved	O
in	O
targeting	O
Num1p	B
to	O
the	O
mother	O
cell	O
cortex	O
.	O

Human	B
immunodeficiency	I
virus	I
type	I
1	I
Vpr	I
is	O
a	O
virion	O
-	O
associated	O
,	O
regulatory	O
protein	O
that	O
is	O
required	O
for	O
efficient	O
viral	O
replication	O
in	O
monocytes	O
/	O
macrophages	O
.	O

Here	O
we	O
examine	O
the	O
potential	O
for	O
VP16	B
protein	I
-	I
protein	I
interactions	O
specific	O
to	O
virus	O
-	O
infected	O
cells	O
and	O
show	O
that	O
VP16	B
copurifies	O
in	O
a	O
highly	O
enriched	O
fraction	O
with	O
a	O
single	O
major	O
polypeptide	O
which	O
we	O
identify	O
as	O
the	O
virus	O
-	O
encoded	O
structural	O
protein	O
VP22	B
.	O

Results	O
of	O
the	O
ECAT	O
Angina	O
Pectoris	O
Study	O
Group	O
.	O

At	O
the	O
time	O
of	O
the	O
13	O
latest	O
BPVs	O
,	O
age	O
ranged	O
from	O
three	O
days	O
to	O
13	O
.	O
1	O
years	O
(	O
mean	O
5	O
.	O
7	O
+/-	O
SD	O
4	O
.	O
8	O
years	O
).	O

The	O
effects	O
of	O
a	O
1	O
-	O
or	O
24	O
-	O
hour	O
pretreatment	O
regimen	O
with	O
monophosphoryl	O
lipid	O
A	O
(	O
MLA	O
,	O
35	O
micrograms	O
/	O
kg	O
i	O
.	O
v	O
.)	O
on	O
myocardial	O
stunning	O
produced	O
by	O
repetitive	O
coronary	O
occlusions	O
were	O
studied	O
in	O
barbital	O
-	O
anesthetized	O
dogs	O
.	O

A	O
platelet	B
-	I
derived	I
growth	I
factor	I
receptor	I
(	I
PDGF	I
-	I
R	I
)	I
phosphopeptide	I
containing	I
Tyr	I
-	I
857	O
does	O
not	O
bind	O
appreciably	O
to	O
the	O
Src	B
SH2	I
domain	I
,	O
suggesting	O
it	O
is	O
not	O
the	O
PDGF	B
-	I
R	I
binding	I
site	I
for	O
Src	B
as	O
previously	O
reported	O
.	O

We	O
have	O
also	O
tested	O
Src	B
SH2	I
mutants	I
for	O
their	O
binding	O
properties	O
and	O
have	O
interpreted	O
our	O
results	O
in	O
light	O
of	O
the	O
recent	O
crystal	O
structure	O
solution	O
for	O
the	O
Src	B
SH2	I
domain	I
.	O

There	O
are	O
two	O
immunogenic	O
sites	O
on	O
the	O
type	O
A	O
influenza	O
A	O
/	O
Japan	O
/	O
57	O
(	O
H2N2	O
)	O
hemagglutinin	B
(	O
HA	B
)	O
that	O
can	O
be	O
recognized	O
by	O
class	B
I	I
major	I
histocompatibility	I
complex	I
(	I
MHC	I
),	O
H	B
-	I
2Kd	I
-	I
restricted	O
cytolytic	O
T	O
lymphocytes	O
(	O
CTLs	O
).	O

The	O
highest	O
decrease	O
in	O
mutagenic	O
activity	O
was	O
observed	O
when	O
enzymatic	O
bleaching	O
was	O
used	O
together	O
with	O
chlorine	O
.	O

There	O
was	O
also	O
a	O
highly	O
significant	O
correlation	O
between	O
total	O
selenium	O
intake	O
and	O
liver	O
selenium	O
concentration	O
(	O
r	O
=	O
0	O
.	O
99	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
after	O
1	O
mo	O
of	O
treatment	O
,	O
but	O
this	O
time	O
liver	O
selenium	O
did	O
not	O
change	O
with	O
time	O
,	O
and	O
the	O
correlation	O
remained	O
highly	O
significant	O
throughout	O
the	O
investigation	O
.	O

Antibodies	O
affinity	O
-	O
purified	O
using	O
the	O
bacterially	O
expressed	O
recombinant	B
protein	I
recognized	O
the	O
56K	B
autoantigen	I
in	O
a	O
HeLa	O
cell	O
extract	O
.	O
cDNA	O
sequencing	O
revealed	O
that	O
the	O
56K	B
cDNA	I
shares	O
a	O
high	O
degree	O
of	O
homology	O
in	O
both	O
nucleotide	O
(	O
87	O
%)	O
and	O
amino	O
acid	O
sequence	O
(	O
92	O
.	O
5	O
%)	O
with	O
bovine	B
annexin	I
XI	I
,	O
indicating	O
that	O
the	O
56K	B
cDNA	I
encodes	O
the	O
human	B
homologue	I
of	I
annexin	I
XI	I
,	O
a	O
member	O
of	O
the	O
Ca	B
(	I
2	I
+)-	I
dependent	I
phospholipid	I
binding	I
protein	I
family	I
.	O

The	O
avidin	B
-	I
biotin	I
complex	I
peroxidase	I
(	I
ABC	I
-	I
P	O
)	O
method	O
was	O
used	O
to	O
detect	O
Mycobacterium	O
bovis	O
,	O
and	O
the	O
results	O
were	O
compared	O
with	O
those	O
obtained	O
by	O
the	O
Ziehl	O
-	O
Neelsen	O
(	O
ZN	O
)	O
technique	O
.	O

Its	O
role	O
in	O
these	O
processes	O
suggests	O
that	O
the	O
function	O
of	O
c	B
-	I
Myb	I
may	O
be	O
important	O
early	O
in	O
the	O
establishment	O
of	O
the	O
hematopoietic	O
lineage	O
.	O

We	O
also	O
examined	O
the	O
effect	O
of	O
proteolytic	O
processing	O
in	O
the	O
MVE	O
nonstructural	O
polyprotein	O
segment	O
mediated	O
by	O
the	O
viral	B
proteinase	I
NS3	I
on	O
antigen	O
processing	O
and	O
presentation	O
of	O
the	O
MVE	O
H	O
-	O
2Kk	O
-	O
restricted	O
T	O
cell	O
determinant	O
.	O

A	O
full	B
-	I
length	I
PRL	I
receptor	I
(	O
PRLR	B
)	O
complementary	O
DNA	O
from	O
pigeons	O
was	O
obtained	O
by	O
screening	O
pigeon	O
crop	O
sac	O
libraries	O
and	O
by	O
reverse	O
transcription	O
coupled	O
with	O
polymerase	O
chain	O
reaction	O
.	O

On	O
the	O
other	O
hand	O
,	O
cells	O
containing	O
a	O
PTP1C	B
in	O
which	O
the	O
catalytic	O
site	O
had	O
been	O
inactivated	O
through	O
mutagenesis	O
,	O
stably	O
phosphorylated	O
the	O
phosphatase	O
.	O

Hematopoietic	B
growth	I
factors	I
are	O
being	O
used	O
to	O
accelerate	O
the	O
recovery	O
of	O
myelopoiesis	O
following	O
high	O
-	O
dose	O
chemotherapy	O
in	O
cancer	O
patients	O
.	O

Although	O
both	O
transfected	O
cell	O
lines	O
contain	O
FGF	B
-	I
1	I
cell	I
surface	I
receptors	I
as	O
judged	O
by	O
crosslinking	O
studies	O
,	O
the	O
wild	B
-	I
type	I
transfectants	O
are	O
refractory	O
to	O
exogenous	O
FGF	B
-	I
1	I
,	O
whereas	O
the	O
mutant	O
transfectants	O
respond	O
normally	O
.(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Minor	O
initiation	O
sites	O
were	O
found	O
at	O
positions	O
-	O
128	O
,	O
-	O
111	O
,	O
-	O
91	O
,	O
and	O
-	O
74	O
.	O

To	O
further	O
define	O
the	O
structural	O
requirements	O
for	O
ZAP	B
-	I
70	I
interaction	O
with	O
the	O
TCR	B
,	O
we	O
developed	O
a	O
binding	O
assay	O
using	O
immobilized	O
glutathione	B
S	I
-	I
transferase	I
fusion	I
proteins	I
containing	O
the	O
NH2	O
-	O
and	O
/	O
or	O
COOH	B
-	I
terminal	I
SH2	I
domains	I
of	O
ZAP	B
-	I
70	I
,	O
and	O
soluble	O
synthetic	O
peptides	O
with	O
the	O
sequence	O
of	O
the	O
cytoplasmic	O
region	O
of	O
the	O
TCR	B
zeta	I
chain	I
(	I
TCR	I
zeta	I
cyt	I
)	O
or	O
individual	O
TCR	B
zeta	I
and	I
CD3	I
epsilon	I
TAM	I
motifs	O
.	O

All	O
subsequent	O
patients	O
were	O
treated	O
at	O
the	O
maximal	O
tolerated	O
dose	O
of	O
EDXR	O
(	O
35	O
mg	O
/	O
m2	O
/	O
day	O
).	O

The	O
median	O
post	O
-	O
treatment	O
,	O
pre	O
-	O
operative	O
serum	B
PSA	I
was	O
0	O
.	O
4	O
ng	O
/	O
ml	O
.	O

In	O
vivo	O
association	O
between	O
Shb	B
-	I
SH3	I
domain	I
proteins	I
v	I
-	I
Src	I
and	O
Eps8	B
was	O
detected	O
by	O
coimmunoprecipitation	O
.	O

Our	O
results	O
indicate	O
that	O
interaction	O
between	O
Jak2	B
and	O
PRLR	B
requires	O
a	O
proline	O
-	O
rich	O
sequence	O
in	O
the	O
membrane	O
proximal	O
region	O
of	O
the	O
receptor	O
,	O
which	O
is	O
conserved	O
among	O
the	O
different	O
members	O
of	O
the	O
cytokine	B
receptor	I
superfamily	I
.	O

Experiments	O
with	O
recombinant	B
proteins	I
showed	O
that	O
p50	B
/	I
p65	I
and	O
high	B
-	I
mobility	I
-	I
group	I
I	I
(	I
Y	I
)	I
protein	I
cooperatively	O
facilitated	O
the	O
binding	O
of	O
IRF	B
-	I
1	I
to	O
the	O
VCAM1	B
IRF	I
binding	I
site	I
and	O
that	O
IRF	B
-	I
1	I
physically	O
interacted	O
with	O
p50	B
and	O
with	O
high	B
-	I
mobility	I
-	I
group	I
I	I
(	I
Y	I
)	I
protein	I
.	O

Based	O
on	O
these	O
results	O
the	O
minimal	O
control	O
element	O
(	O
AX	O
470	O
)	O
specifying	O
the	O
anterior	O
boundary	O
of	O
Hox	B
expression	O
was	O
designated	O
as	O
Hoxa	B
-	I
7	I
enhancer	I
.	O

The	O
levels	O
of	O
NSE	B
and	O
MBP	B
in	O
the	O
IJVB	O
were	O
compared	O
to	O
those	O
in	O
the	O
PVB	O
.	O

Sequence	O
analysis	O
of	O
these	O
regions	O
showed	O
a	O
CAAT	O
box	O
upstream	O
of	O
exon	O
1a	O
and	O
high	O
G	B
-	I
C	I
content	O
regions	O
within	O
both	O
P1	O
and	O
P2	O
.	O

A	O
transformation	O
-	O
competent	O
mutant	O
,	O
like	O
the	O
wild	B
-	I
type	I
E5	I
protein	I
,	O
bound	O
the	O
receptor	O
and	O
induced	O
receptor	O
tyrosine	O
phosphorylation	O
and	O
down	O
-	O
regulation	O
.	O

Appropriate	O
restriction	O
sites	O
allow	O
one	O
to	O
insert	O
virtually	O
any	O
desired	O
cDNA	O
fragment	O
directly	O
behind	O
the	O
epitope	O
-	O
specific	O
sequence	O
and	O
before	O
a	O
long	O
poly	O
(	O
A	O
)	O
tail	O
.	O

Echocardiography	O
revealed	O
right	O
ventricular	O
diastolic	O
collapse	O
(	O
RVDC	O
)	O
without	O
physical	O
signs	O
of	O
cardiac	O
tamponade	O
.	O

However	O
,	O
parallax	O
measurements	O
showed	O
that	O
at	O
150K	O
,	O
collapse	O
of	O
Epon	O
sections	O
does	O
not	O
take	O
place	O
.	O

Alanine	B
aminotransferase	I
(	O
ALT	B
)	O
levels	O
had	O
been	O
elevated	O
for	O
six	O
months	O
in	O
all	O
patients	O
and	O
hepatitis	O
B	O
viral	O
infection	O
was	O
replicative	O
.	O

Citrate	B
synthase	I
activity	O
was	O
increased	O
in	O
the	O
medial	O
head	O
(	O
81	O
%,	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
the	O
red	O
long	O
head	O
(	O
88	O
%,	O
P	O
<	O
0	O
.	O
001	O
)	O
of	O
the	O
triceps	O
brachii	O
muscle	O
in	O
R	O
rats	O
but	O
not	O
in	O
the	O
white	O
long	O
head	O
(	O
25	O
%,	O
P	O
=	O
0	O
.	O
06	O
).	O

The	O
expression	O
of	O
the	O
putative	O
operon	O
bglPH	B
of	O
Bacillus	B
subtilis	I
was	O
studied	O
by	O
using	O
bglP	O
'-	O
lacZ	B
transcriptional	I
fusions	I
.	O

The	O
two	O
bases	O
immediately	O
flanking	O
the	O
5	O
'	O
end	O
of	O
the	O
element	O
proved	O
to	O
be	O
very	O
important	O
to	O
its	O
function	O
as	O
a	O
UAS	O
element	O
as	O
did	O
the	O
two	O
bases	O
immediately	O
3	O
'	O
of	O
the	O
bHLH	B
core	I
motif	I
.	O

Comparisons	O
of	O
rrnB	B
P1	I
-	I
lacZ	I
expression	O
at	O
different	O
ppGpp	O
levels	O
is	O
interpreted	O
for	O
the	O
rpoD	B
(	I
P504L	I
)	I
mutant	I
as	O
resulting	O
from	O
a	O
hypersensitivity	O
to	O
ppGpp	O
.	O

These	O
intron	O
chimeras	O
show	O
that	O
peripheral	O
sequences	O
and	O
the	O
elements	O
that	O
define	O
the	O
splice	O
sites	O
are	O
adequate	O
for	O
self	O
-	O
splicing	O
activity	O
but	O
that	O
the	O
central	O
portions	O
containing	O
the	O
catalytic	O
cores	O
of	O
ai4	B
and	O
bi4	B
are	O
deficient	O
;	O
these	O
cores	O
are	O
the	O
likely	O
targets	O
of	O
the	O
splicing	O
proteins	O
.	O

Here	O
we	O
demonstrate	O
genetically	O
that	O
plus	O
-	O
strand	O
DNA	O
synthesis	O
of	O
the	O
yeast	O
Ty1	B
element	I
is	O
initiated	O
at	O
two	O
sites	O
located	O
at	O
the	O
5	O
'	O
boundary	O
of	O
the	O
3	O
'	O
long	O
terminal	O
repeat	O
(	O
PPT1	B
)	O
and	O
near	O
the	O
middle	O
of	O
the	O
pol	B
gene	I
in	O
the	O
integrase	B
coding	O
sequence	O
(	O
PPT2	B
).	O

In	O
cells	O
limited	O
for	O
His	O
,	O
increased	O
expression	O
of	O
arg	B
-	I
2	I
and	O
cpc	B
-	I
1	I
,	O
and	O
decreased	O
expression	O
of	O
cox	B
-	I
5	O
,	O
also	O
had	O
translational	O
and	O
transcriptional	O
components	O
.	O

T	O
-	O
cell	O
hybridomas	O
,	O
thymocytes	O
,	O
and	O
T	O
cells	O
can	O
be	O
induced	O
to	O
undergo	O
apoptotic	O
cell	O
death	O
by	O
activation	O
through	O
the	O
T	B
-	I
cell	I
receptor	I
.	O

Individual	O
mutations	O
in	O
motifs	O
III	O
,	O
IV	O
,	O
and	O
V	O
had	O
distinctive	O
effects	O
on	O
the	O
affinity	O
of	O
enzyme	O
for	O
GTP	O
,	O
the	O
rate	O
of	O
covalent	O
catalysis	O
(	O
EpG	O
formation	O
),	O
or	O
the	O
transfer	O
of	O
GMP	O
from	O
enzyme	O
to	O
RNA	O
.	O

Disruption	O
of	O
the	O
HOG1	B
and	O
PBS2	B
genes	I
leads	O
to	O
a	O
dramatic	O
decrease	O
of	O
the	O
HSP12	B
inducibility	O
in	O
osmostressed	O
cells	O
,	O
whereas	O
overproduction	O
of	O
Hog1	B
produces	O
a	O
fivefold	O
increase	O
in	O
wild	B
-	I
type	I
induced	O
levels	O
upon	O
a	O
shift	O
to	O
a	O
high	O
salt	O
concentration	O
.	O

METHODS	O
:	O
We	O
obtained	O
maximal	O
inspiratory	O
and	O
expiratory	O
flow	O
-	O
volume	O
curves	O
in	O
41	O
unselected	O
patients	O
with	O
essential	O
tremor	O
(	O
14	O
males	O
,	O
27	O
females	O
,	O
age	O
61	O
.	O
7	O
+/-	O
2	O
.	O
14	O
years	O
).	O

Four	O
p53	B
DNA	I
-	I
binding	I
domain	I
peptides	I
bind	O
natural	O
p53	B
-	I
response	I
elements	O
and	O
bend	O
the	O
DNA	O
.	O

Negative	O
-	O
staining	O
,	O
refractile	O
mycobacteria	O
in	O
Romanowsky	O
-	O
stained	O
smears	O
.	O

cDNA	O
encoding	O
a	O
functional	O
feline	B
liver	I
/	I
bone	I
/	I
kidney	I
-	I
type	I
alkaline	I
phosphatase	I
.	O

The	O
debate	O
over	O
electives	O
--	O
1899	O
.	O

Polypeptide	O
growth	O
factors	O
and	O
cytokines	O
mediate	O
their	O
biochemical	O
functions	O
through	O
their	O
responsive	O
receptors	O
.	O

Here	O
we	O
focused	O
on	O
the	O
role	O
of	O
the	O
5	O
'	O
proximal	O
regulatory	O
cassette	O
(-	O
190	O
;	O
+	O
53	O
bp	O
)	O
of	O
the	O
rat	B
enkephalin	I
(	O
rENK	B
)	I
gene	I
in	O
the	O
developmental	O
regulation	O
of	O
the	O
enkephalin	B
phenotype	O
.	O

Infant	O
aged	O
3	O
.	O
5	O
years	O
presents	O
persistence	O
of	O
primordial	O
vitreous	O
body	O
with	O
crystalline	O
dislocation	O
in	O
the	O
camera	O
aquosa	O
and	O
secondary	O
buphthalmos	O
of	O
the	O
left	O
eye	O
and	O
microphthalmos	O
with	O
dislocation	O
of	O
the	O
crystalline	O
in	O
the	O
vitreous	O
body	O
of	O
the	O
right	O
eye	O
.	O

During	O
the	O
dose	O
-	O
finding	O
,	O
two	O
patients	O
were	O
temporarily	O
withdrawn	O
from	O
medication	O
and	O
one	O
patient	O
was	O
excluded	O
because	O
of	O
elevated	O
levels	O
of	O
liver	O
enzymes	O
.	O

MZF	B
-	I
1	I
represses	O
CAT	B
reporter	I
gene	I
expression	O
via	O
GAL4	B
binding	I
sites	I
in	O
the	O
nonhematopoietic	O
cell	O
lines	O
NIH	O
3T3	O
and	O
293	O
.	O

Similarly	O
,	O
we	O
observed	O
synthetic	O
phenotypes	O
between	O
mutations	O
in	O
MIF2	B
and	O
trans	O
-	O
acting	O
mutations	O
in	O
three	O
known	O
yeast	O
centromere	O
protein	O
genes	O
-	O
CEP1	B
/	O
CBF1	B
/	O
CPF1	B
,	O
NDC10	B
/	O
CBF2	B
,	O
and	O
CEP3	B
/	O
CBF3B	B
.	O

Estimated	O
daily	O
intakes	O
(	O
EDIs	O
)	O
per	O
person	O
were	O
0	O
.	O
56	O
microgram	O
for	O
total	O
HCH	O
,	O
0	O
.	O
20	O
microgram	O
for	O
gamma	B
-	I
HCH	O
,	O
0	O
.	O
09	O
microgram	O
for	O
dieldrin	O
,	O
1	O
.	O
42	O
micrograms	O
for	O
total	O
DDT	O
,	O
and	O
0	O
.	O
15	O
microgram	O
for	O
HCB	O
.	O

With	O
each	O
of	O
the	O
three	O
pairs	O
of	O
isolates	O
(	O
case	O
and	O
suspicious	O
case	O
),	O
identical	O
IS6110	O
banding	O
patterns	O
were	O
found	O
suggesting	O
identical	O
MTB	O
strains	O
.	O

A	O
pyrazolo	O
-	O
quinoline	O
compound	O
,	O
6	O
-	O
methoxy	O
-	O
4	O
-[	O
2	O
-[(	O
2	O
-	O
hydroxyethoxyl	O
)-	O
ethyl	O
]	O
amino	O
]-	O
3	O
-	O
methyl	O
-	O
1M	O
-	O
pyrazo	O
lo	O
[	O
3	O
,	O
4	O
-	O
b	O
]	O
quinoline	O
(	O
SCH	O
51344	O
),	O
was	O
identified	O
based	O
on	O
its	O
ability	O
to	O
derepress	O
human	B
smooth	I
muscle	I
alpha	I
-	I
actin	I
promoter	I
activity	O
in	O
ras	B
-	I
transformed	O
cells	O
.	O

Repression	O
of	O
glucocorticoid	B
receptor	I
-	I
mediated	O
transcriptional	O
activation	O
by	O
unliganded	O
thyroid	B
hormone	I
receptor	I
(	O
TR	B
)	O
is	O
TR	B
isoform	I
-	I
specific	I
.	O

The	O
average	O
values	O
were	O
199	O
and	O
424	O
revertants	O
/	O
g	O
for	O
the	O
hamburgers	O
and	O
hot	O
dogs	O
,	O
respectively	O
.	O

The	O
integrity	O
of	O
the	O
cDNA	O
sequence	O
was	O
confirmed	O
by	O
analysis	O
of	O
several	O
overlapping	O
genomic	O
clones	O
that	O
span	O
the	O
GAR1	B
gene	I
.	O

The	O
mechanism	O
of	O
peroxisome	O
proliferation	O
is	O
poorly	O
understood	O
.	O

If	O
NCR	O
-	O
sensitive	O
gene	O
expression	O
occurs	O
exclusively	O
by	O
this	O
pathway	O
,	O
as	O
has	O
been	O
thought	O
to	O
be	O
the	O
case	O
,	O
then	O
the	O
NCR	O
sensitivity	O
of	O
a	O
gene	O
'	O
s	O
expression	O
should	O
be	O
abolished	O
by	O
a	O
ure2	B
delta	I
mutation	I
.	O

Association	O
of	O
human	B
Pur	I
alpha	I
with	O
the	O
retinoblastoma	B
protein	I
,	O
Rb	B
,	O
regulates	O
binding	O
to	O
the	O
single	O
-	O
stranded	O
DNA	O
Pur	B
alpha	I
recognition	I
element	I
.	O

The	O
interferon	B
-	I
inducible	I
protein	I
kinase	I
PKR	I
modulates	O
the	O
transcriptional	O
activation	O
of	O
immunoglobulin	B
kappa	I
gene	I
.	O

Phorbol	O
esters	O
stimulated	O
phosphorylation	O
of	O
CSK	B
35H	I
proteins	I
,	O
thus	O
emphasizing	O
that	O
sequences	O
isolated	O
according	O
to	O
PKC	B
binding	I
activity	O
in	O
vitro	O
are	O
also	O
PKC	B
substrates	O
in	O
vivo	O
.	O

The	O
nucleotide	O
sequence	O
directly	O
upstream	O
of	O
fimA	B
contains	O
two	O
open	O
reading	O
frames	O
,	O
ORF5	O
and	O
ORF1	O
,	O
whose	O
deduced	O
protein	O
products	O
are	O
homologous	O
to	O
members	O
of	O
a	O
superfamily	O
of	O
ATP	B
-	I
binding	I
cassette	I
membrane	I
transport	I
proteins	I
,	O
including	O
both	O
prokaryotic	O
and	O
eukaryotic	O
uptake	O
and	O
export	O
systems	O
.	O

We	O
conclude	O
that	O
pancreatic	O
polypeptide	O
and	O
motilin	B
responses	O
to	O
a	O
meal	O
are	O
different	O
in	O
encopretic	O
children	O
than	O
in	O
children	O
in	O
the	O
control	O
group	O
.	O

The	O
fracture	O
groups	O
were	O
significantly	O
older	O
and	O
had	O
more	O
years	O
since	O
menopause	O
than	O
the	O
control	O
groups	O
.	O

Subjects	O
with	O
a	O
short	O
postexposure	O
time	O
and	O
a	O
dioxin	O
burden	O
>	O
0	O
.	O
6	O
pg	O
/	O
m3	O
had	O
a	O
significantly	O
higher	O
risk	O
of	O
hypoergy	O
than	O
unexposed	O
subjects	O
(	O
hypoergy	O
I	O
:	O
OR	O
=	O
9	O
.	O
51	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
96	O
-	O
42	O
.	O
02	O
;	O
hypoergy	O
II	O
:	O
OR	O
=	O
2	O
.	O
92	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
14	O
-	O
7	O
.	O
5	O
).	O

We	O
now	O
show	O
that	O
the	O
BAT1	B
translation	I
product	I
is	O
the	O
homolog	O
of	O
the	O
rat	B
p47	I
nuclear	I
protein	I
,	O
the	O
WM6	B
Drosophila	I
gene	I
product	I
,	O
and	O
probably	O
also	O
Ce08102	B
of	O
Caenorhabditis	O
elegans	O
,	O
all	O
members	O
of	O
the	O
DEAD	B
protein	I
family	I
of	O
ATP	B
-	I
dependent	I
RNA	I
helicases	I
.	O

There	O
were	O
no	O
significant	O
changes	O
in	O
either	O
the	O
fatty	O
acid	O
composition	O
of	O
biliary	O
lecithin	O
or	O
in	O
the	O
bile	O
acid	O
composition	O
of	O
bile	O
.	O

Increase	O
in	O
urinary	O
calcium	O
and	O
oxalate	O
after	O
fructose	O
infusion	O
.	O

To	O
discern	O
whether	O
these	O
disorders	O
of	O
GnRH	B
deficiency	O
are	O
associated	O
with	O
altered	O
melatonin	O
secretion	O
profiles	O
,	O
we	O
compared	O
untreated	O
young	O
males	O
IGD	O
(	O
n	O
=	O
7	O
)	O
and	O
DP	B
(	O
n	O
=	O
7	O
)	O
to	O
normal	O
pubertal	O
male	O
controls	O
(	O
n	O
=	O
6	O
).	O

Increased	O
blood	O
pressure	O
during	O
CyA	O
treatment	O
was	O
independent	O
of	O
circulating	O
ET	B
-	I
1	I
levels	O
.	O

The	O
analysis	O
of	O
the	O
prevalence	O
values	O
shows	O
clearly	O
that	O
the	O
global	O
MS	O
-	O
frequency	O
is	O
closer	O
related	O
to	O
the	O
geomagnetic	O
than	O
to	O
the	O
geographic	O
latitude	O
.	O

They	O
include	O
genes	O
encoding	O
three	O
subunits	O
of	O
the	O
cytochrome	B
oxidase	I
(	I
cox1	I
to	O
3	O
),	O
apocytochrome	B
b	I
(	O
cob	B
),	O
seven	O
subunits	O
of	O
the	O
NADH	B
dehydrogenase	I
complex	I
(	O
nad1	B
to	O
6	O
,	O
nad4L	B
),	O
two	O
ATPase	B
subunits	I
(	O
atp6	B
and	O
atp9	B
),	O
three	O
ribosomal	O
RNAs	O
(	O
rrn5	B
,	O
srn	B
and	O
lrn	B
),	O
23	O
tRNAs	O
and	O
four	O
ribosomal	B
proteins	I
(	O
rps3	B
,	O
rps11	B
,	O
rps12	B
and	O
rpl16	B
).	O

From	O
day	O
10	O
,	O
a	O
significant	O
increase	O
in	O
platelet	O
count	O
was	O
observed	O
in	O
eight	O
of	O
the	O
ten	O
patients	O
treated	O
with	O
heparin	O
(	O
p	O
<	O
0	O
.	O
05	O
),	O
with	O
return	O
to	O
the	O
initial	O
value	O
after	O
heparin	O
cessation	O
in	O
six	O
of	O
the	O
responders	O
.	O

Resources	O
for	O
helping	O
patients	O
to	O
quit	O
smoking	O
.	O

In	O
human	O
proliferative	O
cells	O
,	O
the	O
NADP	O
-	O
dependent	O
ME	O
activity	O
is	O
poorly	O
expressed	O
and	O
barely	O
inducible	O
by	O
thyroid	O
hormones	O
.	O

Based	O
on	O
previous	O
mapping	O
of	O
the	O
G	B
beta	I
gamma	I
binding	I
region	I
of	I
beta	I
ARK	I
,	O
and	O
conserved	O
residues	O
within	O
the	O
PH	B
domain	I
,	O
we	O
have	O
constructed	O
a	O
series	O
of	O
mutants	O
in	O
the	O
carboxyl	O
terminus	O
of	O
beta	B
ARK	I
in	O
order	O
to	O
determine	O
important	O
residues	O
involved	O
in	O
G	B
beta	I
gamma	I
and	O
PIP2	O
binding	O
.	O

In	O
CV	O
-	O
1	O
cells	O
,	O
cotransfection	O
of	O
the	O
retinoid	O
and	O
estrogen	B
receptors	I
led	O
to	O
mutual	O
inhibition	O
of	O
the	O
other	O
'	O
s	O
activity	O
,	O
while	O
an	O
RA	O
-	O
dependent	O
inhibition	O
of	O
ER	O
activity	O
was	O
observed	O
in	O
breast	O
cancer	O
cells	O
.	O

The	O
double	B
-	I
stranded	I
RNA	I
binding	I
domain	I
(	O
dsRBD	O
)	O
is	O
an	O
approximately	O
65	O
amino	O
acid	O
motif	O
that	O
is	O
found	O
in	O
a	O
variety	O
of	O
proteins	O
that	O
interact	O
with	O
double	O
-	O
stranded	O
(	O
ds	O
)	O
RNA	O
,	O
such	O
as	O
Escherichia	B
coli	I
RNase	I
III	I
and	O
the	O
dsRNA	B
-	I
dependent	I
kinase	I
,	O
PKR	B
.	O

SCA	B
was	O
resistant	O
to	O
inhibitors	O
of	O
serine	O
,	O
aspartyl	O
,	O
and	O
metalloproteases	B
,	O
but	O
it	O
was	O
sensitive	O
to	O
N	O
-	O
ethylmaleimide	O
.	O

Consistent	O
with	O
the	O
protein	O
expression	O
data	O
,	O
V	B
beta	I
8	I
.	I
3	I
gene	I
transcripts	I
were	O
found	O
only	O
in	O
the	O
transgenic	O
lines	O
with	O
the	O
wild	B
-	I
type	I
promoter	I
.	O

These	O
results	O
are	O
very	O
useful	O
for	O
deciding	O
on	O
the	O
doses	O
of	O
hormones	O
and	O
the	O
expected	O
serum	O
estradiol	O
level	O
in	O
HRT	O
for	O
Japanese	O
women	O
.	O

The	O
homeobox	B
gene	I
ATK1	I
of	O
Arabidopsis	O
thaliana	O
is	O
expressed	O
in	O
the	O
shoot	O
apex	O
of	O
the	O
seedling	O
and	O
in	O
flowers	O
and	O
inflorescence	O
stems	O
of	O
mature	O
plants	O
.	O

Retransformation	O
of	O
uvsH77	B
mutants	I
with	O
the	O
rescued	O
cosmids	O
from	O
the	O
MMS	O
-	O
resistant	O
transformants	O
resulted	O
in	O
restoration	O
of	O
both	O
UV	O
and	O
MMS	O
resistance	O
to	O
wild	B
-	I
type	I
levels	O
.	O

A	O
potential	O
binding	O
site	O
for	O
the	O
dShc	B
PTB	I
domain	I
is	O
located	O
at	O
Tyr	O
-	O
1228	O
of	O
DER	B
.	O

After	O
determining	O
isoflurane	O
MAC	O
in	O
triplicate	O
,	O
birds	O
were	O
given	O
a	O
mu	B
-	I
opioid	I
agonist	O
(	O
morphine	O
,	O
n	O
=	O
9	O
)	O
or	O
a	O
kappa	B
-	I
opioid	I
agonist	O
(	O
U50488H	O
,	O
n	O
=	O
9	O
).	O

Max	B
was	O
constantly	O
transcribed	O
at	O
a	O
relatively	O
low	O
level	O
during	O
cell	O
cycle	O
progression	O
.	O

Incubation	O
of	O
the	O
purified	O
fusion	O
proteins	O
with	O
[	O
gamma	B
-	I
32P	O
]	O
ATP	O
in	O
an	O
in	O
vitro	O
assay	O
showed	O
that	O
both	O
proteins	O
were	O
capable	O
of	O
autophosphorylation	O
.	O

Transabdominal	O
repair	O
of	O
type	O
IV	O
thoraco	O
-	O
abdominal	O
aortic	O
aneurysms	O
.	O

Investigation	O
of	O
the	O
control	O
of	O
coronavirus	O
subgenomic	O
mRNA	O
transcription	O
by	O
using	O
T7	O
-	O
generated	O
negative	O
-	O
sense	O
RNA	O
transcripts	O
.	O

The	O
association	O
of	O
p255	B
with	O
splicing	O
complexes	O
is	O
suggested	O
by	O
the	O
finding	O
that	O
mAb	B
CC3	I
can	O
inhibit	O
in	O
vitro	O
splicing	O
and	O
immunoprecipitate	O
pre	B
-	I
messenger	I
RNA	I
and	O
splicing	O
products	O
.	O

Thus	O
,	O
endemic	O
cumlations	O
of	O
hepatitis	O
A	O
diseases	O
are	O
possible	O
.	O

The	O
properties	O
of	O
the	O
phi	O
29	O
SSB	B
-	I
ssDNA	I
complex	I
are	O
described	O
.	O

A	O
single	O
-	O
case	O
experimental	O
ABAB	O
multiple	O
baseline	O
design	O
was	O
employed	O
to	O
test	O
for	O
treatment	O
effectiveness	O
.	O

In	O
one	O
glioblastoma	O
cell	O
line	O
,	O
a	O
Shc	B
-	I
associated	O
p190	B
was	O
identified	O
as	O
the	O
activated	O
PDGFR	B
.	O

Diffuse	O
white	O
matter	O
injury	O
can	O
be	O
attributed	O
to	O
radiation	O
and	O
associated	O
with	O
neurological	O
deficits	O
,	O
but	O
leukoencephalopathy	O
is	O
rarely	O
observed	O
in	O
the	O
absence	O
of	O
chemotherapy	O
.	O

We	O
found	O
a	O
direct	O
correlation	O
between	O
the	O
levels	O
of	O
transcription	O
of	O
the	O
acc	B
genes	I
and	O
the	O
rate	O
of	O
cellular	O
growth	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
two	O
genes	B
encoding	I
gp138	I
,	O
a	O
cell	O
surface	O
glycoprotein	O
involved	O
in	O
the	O
sexual	O
cell	O
fusion	O
of	O
Dictyostelium	O
discoideum	O
.	O

Piroximone	O
is	O
a	O
new	O
phosphodiesterase	B
III	I
inhibitor	I
that	O
combines	O
inotropic	O
and	O
vasodilator	O
properties	O
.	O

To	O
study	O
the	O
origin	O
of	O
different	O
fMLF	B
-	I
R	I
transcripts	I
,	O
the	O
genetic	O
linkage	O
of	O
chemotactic	O
receptor	O
genes	O
,	O
and	O
the	O
regulation	O
of	O
fMLF	B
-	I
R	I
gene	I
expression	O
,	O
we	O
determined	O
the	O
copy	O
number	O
,	O
chromosomal	O
location	O
,	O
structural	O
organization	O
,	O
and	O
5	O
'-	O
flanking	O
sequence	O
of	O
the	O
human	B
fMLF	I
-	I
R	I
gene	I
.	O

The	O
first	O
exon	O
encodes	O
66	O
bp	O
of	O
the	O
5	O
'-	O
untranslated	O
sequence	O
,	O
while	O
exon	O
2	O
encodes	O
the	O
coding	O
and	O
3	O
'-	O
untranslated	O
sequences	O
.	O

Salivary	O
sodium	O
,	O
calcium	O
,	O
and	O
magnesium	O
concentrations	O
were	O
significantly	O
higher	O
in	O
the	O
SLE	O
patients	O
with	O
systemic	O
lupus	O
erythematosus	O
,	O
whereas	O
potassium	O
and	O
total	O
protein	O
concentrations	O
and	O
amylase	B
activity	O
did	O
not	O
differ	O
significantly	O
from	O
the	O
controls	O
.	O

Prostate	B
specific	I
antigen	I
shows	O
the	O
metastatic	O
cases	O
better	O
[	O
correction	O
of	O
worse	O
]	O
than	O
prostatic	B
acid	I
phosphatase	I
.	O

BACKGROUND	O
:	O
Delineation	O
of	O
the	O
morphologic	O
aspects	O
of	O
age	O
-	O
related	O
macular	O
degeneration	O
(	O
ARMD	O
)	O
is	O
helpful	O
in	O
correlation	O
with	O
the	O
clinical	O
features	O
and	O
may	O
contribute	O
to	O
understanding	O
the	O
pathogenesis	O
.	O

DNase	B
I	I
footprinting	O
of	O
the	O
proximal	O
promoter	O
revealed	O
four	O
regions	O
of	O
protection	O
.	O

By	O
contrast	O
,	O
all	O
proteins	O
initiated	O
with	O
a	O
methionine	O
placed	O
one	O
residue	O
upstream	O
of	O
the	O
natural	O
N	O
terminus	O
of	O
PR	B
failed	O
to	O
show	O
specific	O
proteolysis	O
.	O

The	O
leader	O
sequence	O
of	O
the	O
isolated	O
cDNA	O
clone	O
contains	O
several	O
small	O
open	O
reading	O
frames	O
upstream	O
of	O
the	O
initiation	O
codon	O
of	O
the	O
largest	O
open	O
reading	O
frame	O
coding	O
for	O
the	O
homeodomain	B
protein	I
.	O

Cell	O
adhesion	O
and	O
migration	O
assays	O
demonstrate	O
that	O
alpha	B
6	I
beta	I
1	I
is	O
the	O
major	O
laminin	B
receptor	I
in	O
undifferentiated	O
F9	O
cells	O
as	O
well	O
as	O
F9	O
-	O
derived	O
PE	O
cells	O
.	O

Such	O
a	O
mechanism	O
may	O
allow	O
acceleration	O
of	O
degenerative	O
joint	O
conditions	O
,	O
and	O
may	O
account	O
for	O
the	O
increased	O
prevalence	O
of	O
such	O
conditions	O
seen	O
with	O
HMS	O
subjects	O
.	O

In	O
293	O
cells	O
,	O
expression	O
of	O
the	O
NF	B
-	I
kappa	I
B	I
inhibitor	I
,	I
I	I
kappa	I
B	I
-	I
alpha	I
,	O
reduced	O
the	O
stimulatory	O
activity	O
of	O
LMP	B
.	O

We	O
show	O
that	O
these	O
three	O
gain	O
-	O
of	O
-	O
function	O
mutants	O
differ	O
considerably	O
in	O
their	O
ability	O
to	O
bypass	O
the	O
sex	O
determination	O
signal	O
,	O
with	O
SxlM4	B
being	O
the	O
strongest	O
and	O
SxlM1	B
the	O
weakest	O
.	O

Weak	O
allergenicity	O
of	O
recombinant	B
hirudin	I
CGP	I
39393	I
(	O
REVASC	O
)	O
in	O
immunocompetent	O
volunteers	O
.	O

In	O
contrast	O
to	O
the	O
myoD	B
promoter	I
,	O
the	O
myoD	B
enhancer	I
shows	O
striking	O
conservation	O
between	O
humans	O
and	O
mice	O
both	O
in	O
its	O
sequence	O
and	O
its	O
distal	O
position	O
.	O

The	O
Oct	B
and	O
HMG2	B
proteins	I
also	O
interact	O
in	O
vivo	O
.	O

Hematopoietic	B
growth	I
factors	I
have	O
already	O
had	O
an	O
enormous	O
impact	O
on	O
transfusion	O
practice	O
by	O
eliminating	O
or	O
reducing	O
the	O
need	O
for	O
red	O
blood	O
cell	O
transfusions	O
in	O
a	O
variety	O
of	O
anemic	O
states	O
characterized	O
by	O
an	O
absolute	O
or	O
relative	O
decrease	O
in	O
erythropoietin	B
.	O

Conjugated	O
estrogens	O
shorten	O
bleeding	O
time	O
in	O
uraemia	O
:	O
a	O
possible	O
role	O
of	O
serotonin	O
?	O

These	O
six	O
districts	O
have	O
an	O
area	O
of	O
34	O
,	O
000	O
km2	O
and	O
hold	O
a	O
population	O
of	O
30	O
million	O
.	O

According	O
to	O
symptoms	O
,	O
signs	O
,	O
imaging	O
features	O
,	O
operation	O
findings	O
,	O
the	O
original	O
places	O
and	O
the	O
expansive	O
directions	O
of	O
the	O
tumor	O
,	O
they	O
were	O
divided	O
into	O
four	O
clinical	O
types	O
:	O
sellar	O
,	O
clival	O
,	O
occipito	O
-	O
temporal	O
and	O
extent	O
.	O

Female	O
patients	O
with	O
breast	O
cancer	O
diagnosed	O
between	O
1982	O
and	O
1991	O
at	O
Roswell	O
Park	O
Cancer	O
Institute	O
(	O
RPCI	O
)	O
in	O
Buffalo	O
,	O
New	O
York	O
,	O
who	O
provided	O
information	O
on	O
their	O
cigarette	O
smoking	O
history	O
at	O
the	O
time	O
of	O
their	O
diagnosis	O
were	O
included	O
.	O

Data	O
from	O
the	O
V	O
-	O
HeFT	O
II	O
show	O
that	O
at	O
2	O
-	O
year	O
follow	O
-	O
up	O
,	O
a	O
progressive	O
rise	O
of	O
plasma	O
norepinephrine	O
was	O
observed	O
in	O
both	O
treatment	O
arms	O
,	O
suggesting	O
that	O
disease	O
progresses	O
despite	O
treatment	O
with	O
either	O
an	O
angiotensin	B
-	I
converting	I
enzyme	I
inhibitor	I
,	O
enalapril	O
,	O
or	O
vasodilator	O
therapy	O
with	O
hydralazine	O
/	O
isosorbide	O
dinitrate	O
.	O

Radioligand	O
binding	O
was	O
indistinguishable	O
for	O
both	O
transiently	O
expressed	O
constructs	O
.	O

Human	B
papillomavirus	I
type	I
31b	I
late	I
gene	I
expression	O
is	O
regulated	O
through	O
protein	B
kinase	I
C	I
-	I
mediated	O
changes	O
in	O
RNA	O
processing	O
.	O

As	O
it	O
had	O
been	O
previously	O
reported	O
that	O
the	O
18	O
-	O
bp	O
palindrome	O
contains	O
sufficient	O
nucleotide	O
sequence	O
information	O
for	O
E1	B
binding	I
,	O
we	O
speculate	O
that	O
a	O
minimal	O
E1	B
recognition	I
motif	I
is	O
presented	O
in	O
each	O
half	O
site	O
.	O

Rats	O
treated	O
with	O
8	O
-	O
OH	O
-	O
DPAT	O
were	O
not	O
impaired	O
in	O
their	O
ability	O
to	O
learn	O
a	O
visual	O
discrimination	O
in	O
a	O
water	O
maze	O
.	O

Coronary	O
T1	O
and	O
T2	O
weighted	O
images	O
were	O
obtained	O
.	O

Functional	O
analysis	O
of	O
the	O
sGTH	B
alpha	I
subunit	I
promoter	I
by	O
the	O
transient	O
transfection	O
of	O
several	O
sGTH	B
alpha	I
/	O
CAT	B
chimeric	O
plasmids	O
into	O
rainbow	O
trout	O
pituitary	O
cells	O
suggests	O
that	O
its	O
pituitary	B
-	I
specific	I
expression	O
is	O
GSE	B
-	I
dependent	I
.	O

The	O
smallest	O
active	B
FecR	I
derivative	O
contained	O
59	O
amino	O
acid	O
residues	O
as	O
compared	O
to	O
the	O
317	O
residues	O
of	O
wild	B
-	I
type	I
FecR	I
.	O

Growth	O
curves	O
indicated	O
that	O
proliferation	O
of	O
clone	O
CA9	O
in	O
the	O
presence	O
of	O
10	O
%	O
serum	O
was	O
reduced	O
by	O
60	O
%	O
compared	O
with	O
clone	O
ME10	O
.	O

The	O
proteins	O
are	O
more	O
than	O
90	O
%	O
identical	O
to	O
each	O
other	O
within	O
the	O
protein	B
kinase	I
domain	I
but	O
only	O
51	O
-	O
59	O
%	O
identical	O
to	O
other	O
casein	B
kinase	I
I	I
isoforms	I
within	O
this	O
region	O
.	O

Since	O
AP	B
-	I
1	I
is	O
an	O
important	O
mediator	O
of	O
tumor	O
promoter	O
action	O
,	O
these	O
findings	O
may	O
explain	O
the	O
anti	B
-	I
tumor	I
-	I
promoting	I
activity	O
of	O
phenolic	O
antioxidants	O
.	O

The	O
protein	O
expressed	O
from	O
the	O
cloned	O
cDNA	O
is	O
secreted	O
into	O
the	O
culture	O
medium	O
and	O
yields	O
of	O
up	O
to	O
40	O
mg	O
per	O
litre	O
have	O
been	O
obtained	O
.	O

Within	O
their	O
polypeptide	O
chain	O
,	O
they	O
all	O
contain	O
those	O
conserved	O
features	O
that	O
define	O
a	O
plant	O
CDPK	B
;	I
kinase	I
catalytic	I
sequences	I
are	O
linked	O
to	O
a	O
calmodulin	B
-	I
like	I
regulatory	I
domain	I
through	O
a	O
junction	O
region	O
.	O

The	O
timing	O
of	O
fla	B
gene	I
expression	O
in	O
the	O
cell	O
cycle	O
is	O
determined	O
by	O
specialized	O
forms	O
of	O
RNA	B
polymerase	I
and	O
the	O
appearance	O
and	O
/	O
or	O
activation	O
of	O
regulatory	O
proteins	O
.	O

Two	O
major	O
and	O
one	O
minor	O
transcription	O
initiation	O
sites	O
were	O
assigned	O
to	O
positions	O
+	O
1	O
and	O
+	O
24	O
and	O
position	O
+	O
14	O
,	O
respectively	O
,	O
by	O
a	O
combination	O
of	O
ribonuclease	O
protection	O
,	O
primer	O
extension	O
,	O
and	O
5	O
'	O
RACE	O
analyses	O
.	O

The	O
roxithromycin	O
doses	O
that	O
were	O
chosen	O
for	O
these	O
studies	O
were	O
less	O
than	O
achievable	O
blood	O
levels	O
.	O

We	O
demonstrate	O
here	O
that	O
the	O
-	O
DEDDDL	O
sequence	O
stabilizes	O
GDP	O
binding	O
to	O
Ran	B
,	O
and	O
that	O
the	O
domain	O
is	O
required	O
for	O
high	O
affinity	O
interaction	O
with	O
a	O
Ran	B
-	I
binding	I
protein	I
,	O
HTF9A	B
/	O
RanBP1	B
.	O

Transfection	O
of	O
non	O
-	O
deleted	O
expression	O
vector	O
into	O
NIH3T3	O
cells	O
results	O
in	O
acquisition	O
of	O
focus	O
-	O
forming	O
activity	O
while	O
a	O
deleted	O
form	O
of	O
expression	O
vector	O
fails	O
to	O
show	O
this	O
activity	O
even	O
in	O
the	O
presence	O
of	O
basic	B
FGF	I
.	O

CONCLUSION	O
:	O
The	O
MTD	O
for	O
CPT	O
-	O
11	O
administered	O
in	O
a	O
3	O
consecutive	O
-	O
days	O
-	O
every	O
-	O
3	O
weeks	O
schedule	O
in	O
this	O
patient	O
population	O
is	O
115	O
mg	O
/	O
m2	O
/	O
day	O
.	O

A	O
73	O
bp	O
fragment	O
(	O
X1	O
region	O
)	O
of	O
the	O
PRB	B
-	I
1b	I
promoter	I
,	O
located	O
between	O
positions	O
-	O
213	O
and	O
-	O
141	O
,	O
was	O
sufficient	O
to	O
confer	O
ethylene	O
responsiveness	O
to	O
the	O
reporter	O
gene	O
.	O

Moreover	O
,	O
Western	O
blots	O
demonstrated	O
at	O
least	O
six	O
types	O
of	O
Ypt	B
in	O
both	O
Cr	O
and	O
Vc	O
,	O
suggesting	O
that	O
these	O
Ypt	B
are	O
used	O
for	O
household	O
functions	O
responsible	O
for	O
vesicle	O
transport	O
rather	O
than	O
for	O
cellular	O
differentiation	O
.	O

Characterization	O
of	O
fus1	B
of	O
Schizosaccharomyces	O
pombe	O
:	O
a	O
developmentally	O
controlled	O
function	O
needed	O
for	O
conjugation	O
.	O

In	O
the	O
Center	O
for	O
Human	O
Genetics	O
in	O
Leuven	O
,	O
predictive	O
DNA	O
-	O
testing	O
for	O
Huntington	O
'	O
s	O
disease	O
is	O
available	O
as	O
a	O
clinical	O
service	O
since	O
November	O
1987	O
,	O
initially	O
by	O
DNA	O
-	O
linkage	O
and	O
since	O
mid	O
1993	O
by	O
direct	O
mutation	O
analysis	O
.	O

Examination	O
of	O
neurohumoral	O
factors	O
revealed	O
a	O
hyperactive	O
sympathetic	O
nervous	O
system	O
and	O
an	O
increase	O
in	O
plasma	B
renin	I
activity	O
.	O

The	O
amino	O
-	O
terminal	O
DNA	B
-	I
binding	I
domain	I
of	O
Pip	B
exhibits	O
a	O
high	O
degree	O
of	O
homology	O
to	O
the	O
DNA	O
-	O
binding	O
domains	O
of	O
members	O
of	O
the	O
interferon	B
regulatory	I
factor	I
(	I
IRF	I
)	I
family	I
,	O
which	O
includes	O
IRF	B
-	I
1	I
,	O
IRF	B
-	I
2	I
,	O
ICSBP	B
,	O
and	O
ISGF3	B
gamma	I
.	O

We	O
have	O
generated	O
various	O
base	O
substitutions	O
and	O
internal	O
deletions	O
in	O
and	O
around	O
DRE	O
(	O
nucleotide	O
positions	O
-	O
93	O
to	O
-	O
100	O
with	O
respect	O
to	O
the	O
transcription	O
initiation	O
site	O
)	O
of	O
the	O
PCNA	B
gene	I
in	O
vitro	O
and	O
subsequently	O
examined	O
their	O
effects	O
on	O
the	O
binding	O
to	O
DREF	B
(	O
DRE	B
-	I
binding	I
factor	I
)	O
and	O
PCNA	B
gene	I
promote	O
activity	O
in	O
cultured	O
Drosophila	O
Kc	O
cells	O
as	O
well	O
as	O
in	O
living	O
flies	O
.	O

The	O
hsp70	B
gene	I
family	I
of	I
Neurospora	I
crassa	I
:	O
cloning	O
,	O
sequence	O
analysis	O
,	O
expression	O
,	O
and	O
genetic	O
mapping	O
of	O
the	O
major	O
stress	O
-	O
inducible	O
member	O
.	O

Reconstitution	O
of	O
complexes	O
containing	O
p62	B
and	O
the	O
src	B
family	I
kinase	I
p59fyn	I
in	O
HeLa	O
cells	O
demonstrated	O
that	O
complex	O
formation	O
resulted	O
in	O
tyrosine	O
phosphorylation	O
of	O
p62	B
and	O
was	O
mediated	O
by	O
both	O
the	O
SH3	B
and	I
SH2	I
domains	I
of	I
p59fyn	I
.	O

Characterization	O
of	O
the	O
promoter	O
for	O
the	O
human	B
85	I
kDa	I
cytosolic	I
phospholipase	I
A2	I
gene	I
.	O

This	O
structure	O
of	O
cucumisin	B
suggests	O
that	O
it	O
is	O
probably	O
synthesized	O
as	O
an	O
inactive	O
precursor	O
.	O

This	O
study	O
investigated	O
the	O
degree	O
to	O
which	O
racial	O
identity	O
influences	O
Mexican	O
-	O
Americans	O
'	O
performance	O
on	O
the	O
L	O
,	O
K	O
,	O
and	O
MF	O
scales	O
of	O
the	O
MMPI	O
-	O
2	O
.	O

Both	O
can	O
be	O
elevated	O
on	O
a	O
single	O
vascular	O
pedicle	O
based	O
on	O
the	O
superficial	O
temporal	O
artery	O
,	O
the	O
double	O
-	O
layered	O
temporal	O
fascia	O
flap	O
.	O

Inclusion	O
in	O
this	O
family	O
of	O
proteins	O
suggests	O
that	O
FliQ	B
and	O
FliR	B
may	O
participate	O
in	O
an	O
export	O
pathway	O
required	O
for	O
flagellum	O
assembly	O
.	O

For	O
the	O
first	O
time	O
we	O
describe	O
deletion	O
and	O
point	O
mutations	O
within	O
the	O
plasma	B
membrane	I
family	I
of	I
guanylyl	I
cyclase	I
receptors	I
that	O
result	O
in	O
the	O
formation	O
of	O
effective	O
dominant	O
negative	O
proteins	O
.	O

Virol	O
.	O

Conversely	O
,	O
activation	O
of	O
Oct	B
-	I
3	I
/	I
4	I
promoter	I
by	O
RAR	B
:	O
RXR	B
heterodimers	O
was	O
completely	O
abolished	O
by	O
EAR	B
-	I
3	I
/	O
COUP	B
-	I
TFI	I
and	O
by	O
ARP	B
-	I
1	I
/	O
COUP	B
-	I
TFII	I
.	O

These	O
results	O
demonstrate	O
that	O
EKLF	B
provides	O
a	O
crucial	O
transactivation	O
function	O
for	O
globin	B
expression	O
and	O
further	O
reinforce	O
the	O
idea	O
that	O
EKLF	B
is	O
an	O
important	O
regulator	O
of	O
CACCC	O
element	O
-	O
directed	O
transcription	O
in	O
erythroid	O
cells	O
.	O

At	O
different	O
times	O
of	O
the	O
surgical	O
procedures	O
(	O
thorax	O
opening	O
and	O
closure	O
,	O
period	O
of	O
cardiopulmonary	O
bypass	O
)	O
67	O
to	O
100	O
%	O
of	O
the	O
patients	O
in	O
group	O
1	O
had	O
vancomycin	O
concentrations	O
in	O
the	O
studied	O
tissues	O
above	O
the	O
MIC	O
90	O
for	O
Staphylococcus	O
aureus	O
(	O
1	O
microgram	O
/	O
g	O
)	O
and	O
Staphylococcus	O
epidermidis	O
(	O
2	O
micrograms	O
/	O
g	O
).	O

Each	O
type	O
was	O
divided	O
into	O
two	O
subgroups	O
on	O
the	O
basis	O
of	O
whether	O
the	O
body	O
and	O
tail	O
of	O
the	O
pancreas	O
showed	O
intense	O
fatty	O
replacement	O
(	O
type	O
a	O
=	O
negative	O
for	O
intense	O
fatty	O
replacement	O
,	O
type	O
b	O
=	O
positive	O
for	O
intense	O
fatty	O
replacement	O
).	O

Binding	O
of	O
SSP	O
to	O
the	O
stage	B
selector	I
element	I
(	O
SSE	B
)	O
in	O
the	O
proximal	O
gamma	B
-	I
globin	I
promoter	I
is	O
integral	O
to	O
the	O
competitive	O
silencing	O
of	O
a	O
linked	O
beta	B
-	I
promoter	I
in	O
embryonic	O
/	O
fetal	O
stage	O
erythroleukemia	O
(	O
K562	O
)	O
cells	O
.	O

This	O
failure	O
to	O
execute	O
regulated	O
G1	O
/	O
S	O
arrest	O
is	O
correlated	O
with	O
enhanced	O
thermosensitivity	O
of	O
colony	B
-	I
forming	O
ability	O
.	O

Mutations	O
that	O
alter	O
photoreceptor	O
cell	O
structure	O
and	O
development	O
were	O
isolated	O
that	O
fail	O
to	O
complement	O
these	O
deletions	O
.	O

Haplotype	O
mapping	O
and	O
sequence	O
analysis	O
of	O
the	O
mouse	O
Nramp	B
gene	I
predict	O
susceptibility	O
to	O
infection	O
with	O
intracellular	O
parasites	O
.	O

Nucleotide	O
sequence	O
and	O
transcriptional	O
analysis	O
of	O
the	O
DNA	B
polymerase	I
gene	I
of	I
Bombyx	I
mori	I
nuclear	I
polyhedrosis	I
virus	I
.	O

The	O
drug	O
sensitivity	O
was	O
100	O
%	O
for	O
vancomycin	O
(	O
VCM	O
),	O
30	O
%	O
for	O
imipenam	O
(	O
IMP	O
),	O
31	O
%	O
for	O
minomycin	O
(	O
MINO	O
),	O
31	O
%	O
for	O
amikacin	O
(	O
AMK	O
),	O
and	O
7	O
%	O
for	O
fosfomycin	O
(	O
FOM	O
).	O

Intron	O
-	O
exon	O
structure	O
of	O
the	O
porcine	B
I	I
kappa	I
B	I
alpha	I
-	I
encoding	I
gene	I
.	O

Some	O
studies	O
of	O
exercise	O
have	O
associated	O
beta	B
-	I
endorphin	I
release	O
with	O
increased	O
exertion	O
levels	O
,	O
but	O
other	O
evidence	O
suggests	O
that	O
acidosis	O
may	O
stimulate	O
the	O
release	O
of	O
beta	B
-	I
endorphin	I
.	O

A	O
comparison	O
of	O
the	O
Flavobacterium	O
glycosylasparaginase	B
with	O
a	O
mammalian	O
glycosylasparaginase	B
revealed	O
30	O
%	O
structural	O
identity	O
and	O
60	O
%	O
overall	O
similarity	O
between	O
the	O
prokaryotic	O
and	O
eukaryotic	O
forms	O
of	O
the	O
enzyme	O
.	O

Superoxide	B
dismutase	I
(	O
SOD	B
)	O
activity	O
decreased	O
significantly	O
in	O
sperm	O
subjected	O
to	O
direct	O
electric	O
current	O
in	O
comparison	O
to	O
the	O
control	O
or	O
the	O
sample	O
incubated	O
with	O
electrolyzed	O
medium	O
.	O

To	O
understand	O
the	O
function	O
of	O
receptor	B
-	I
linked	I
tyrosine	I
phosphatases	I
in	O
neural	O
development	O
,	O
we	O
sought	O
to	O
identify	O
LAR	B
isoforms	I
preferentially	O
expressed	O
in	O
the	O
nervous	O
system	O
and	O
cellular	O
processes	O
regulating	O
LAR	B
alternative	O
splicing	O
.	O

Chrispeels	O
[	O
1993	O
]	O
EMBO	O
J	O
12	O
:	O
2241	O
-	O
2247	O
).	O

Atrial	O
fibrillation	O
and	O
the	O
autonomic	O
nervous	O
system	O

A	O
reduction	O
of	O
the	O
aspartate	B
aminotransferase	I
activity	O
was	O
observed	O
from	O
800	O
mg	O
/	O
kg	O
b	O
.	O
w	O
./	O
d	O
onwards	O
.	O

Removal	O
of	O
PDMP	O
from	O
the	O
cell	O
medium	O
resulted	O
in	O
reversal	O
of	O
the	O
cell	O
cycle	O
changes	O
,	O
with	O
cells	O
re	O
-	O
entering	O
the	O
S	O
phase	O
.	O

A	O
major	O
task	O
for	O
sports	O
scientists	O
may	O
be	O
to	O
verify	O
empirically	O
the	O
nature	O
of	O
an	O
integrated	O
model	O
of	O
the	O
sport	O
performer	O
.	O

The	O
expression	O
of	O
this	O
clone	O
in	O
a	O
wee1	B
/	O
mik1	B
-	I
deficient	I
mutant	I
causes	O
an	O
elongated	O
cell	O
phenotype	O
under	O
non	O
-	O
permissive	O
growth	O
conditions	O
.	O

We	O
have	O
measured	O
the	O
release	O
of	O
interleukin	B
-	I
1	I
beta	I
(	I
IL	I
-	I
1	I
)	I
and	I
tumour	I
necrosis	I
factor	I
-	I
alpha	I
(	O
TNF	B
)	O
by	O
unstimulated	O
monocytes	O
and	O
monocytes	O
stimulated	O
with	O
lipopolysaccharide	O
(	O
LPS	O
)	O
isolated	O
from	O
the	O
peripheral	O
blood	O
of	O
two	O
patients	O
with	O
acute	O
poststreptococcal	O
glomerulonephritis	O
(	O
AGN	O
)	O
and	O
16	O
healthy	O
controls	O
.	O

UV	O
cross	O
-	O
linking	O
experiments	O
show	O
that	O
TEP	B
has	O
an	O
apparent	O
molecular	O
mass	O
of	O
approximately	O
65	O
kDa	O
.	O

The	O
tissue	O
-	O
specific	O
expression	O
of	O
DP	B
family	I
members	O
suggests	O
that	O
the	O
combination	O
of	O
DP	B
/	I
E2F	I
heterodimers	I
that	O
constitute	O
DRTF1	B
/	I
E2F	I
is	O
influenced	O
by	O
the	O
phenotype	O
of	O
the	O
cell	O
.	O

In	O
this	O
paper	O
,	O
an	O
analysis	O
of	O
the	O
dynamics	O
in	O
the	O
closing	O
phase	O
of	O
the	O
occluder	O
of	O
a	O
mechanical	O
monoleaflet	O
heart	O
valve	O
prosthesis	O
is	O
presented	O
.	O

In	O
nucleus	O
ventralis	O
anterior	O
thalami	O
-	O
nucleus	O
ventralis	O
lateralis	O
thalami	O
neurons	O
with	O
an	O
inhibitory	O
input	O
from	O
nucleus	O
entopeduncularis	O
,	O
a	O
shortening	O
of	O
inhibition	O
from	O
17	O
.	O
5	O
+/-	O
3	O
.	O
6	O
to	O
9	O
.	O
1	O
+/-	O
1	O
.	O
8	O
ms	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
under	O
the	O
haloperidol	O
influence	O
was	O
evident	O
.	O

The	O
high	O
degree	O
of	O
sequence	O
identity	O
(	O
96	O
%)	O
between	O
hydrolase	B
B	I
and	O
C	O
,	O
particularly	O
in	O
the	O
3	O
'	O
untranslated	O
region	O
,	O
suggests	O
that	O
the	O
genes	O
encoding	O
these	O
two	O
carboxylesterases	B
evolved	O
by	O
duplication	O
and	O
divergence	O
of	O
a	O
common	O
ancestral	O
gene	O
.	O

The	O
NR2	O
hybrid	O
is	O
a	O
powerful	O
tool	O
for	O
the	O
mapping	O
of	O
new	O
probes	O
of	O
this	O
region	O
,	O
as	O
well	O
as	O
for	O
obtaining	O
new	O
informative	O
probes	O
specific	O
for	O
the	O
deletion	O
by	O
subtractive	O
cloning	O
of	O
the	O
region	O
.	O

Endocytosis	O
and	O
lysosomal	O
targeting	O
of	O
epidermal	B
growth	I
factor	I
receptors	I
are	O
mediated	O
by	O
distinct	O
sequences	O
independent	O
of	O
the	O
tyrosine	B
kinase	I
domain	I
.	O

Mutations	O
in	O
UPF1	B
lead	O
to	O
the	O
selective	O
stabilization	O
of	O
mRNAs	O
containing	O
early	O
nonsense	O
mutations	O
without	O
affecting	O
the	O
decay	O
rates	O
of	O
most	O
other	O
mRNAs	O
.	O

PMEK1	B
displays	O
96	O
and	O
80	O
%	O
identity	O
respectively	O
with	O
the	O
tobacco	B
NTF3	I
and	I
Arabidopsis	I
ATMPK1	I
kinases	I
,	O
and	O
only	O
50	O
%	O
to	O
the	O
more	O
distantly	O
related	O
plant	O
MAP	B
kinase	O
MsERK1	B
from	O
alfalfa	O
.	O

The	O
presence	O
of	O
type	O
I	O
hypersensitivity	O
in	O
a	O
subgroup	O
of	O
aspergillomas	O
suggests	O
an	O
immunoallergic	O
component	O
to	O
this	O
disease	O
which	O
could	O
contribute	O
to	O
a	O
chronic	O
inflammatory	O
response	O
to	O
Aspergillus	O
in	O
some	O
aspergillomas	O
.	O

Computerized	O
detection	O
of	O
abnormal	O
asymmetry	O
in	O
digital	O
chest	O
radiographs	O
.	O

The	O
resulting	O
integrated	O
physical	O
,	O
genetic	O
,	O
and	O
cytogenetic	O
map	O
constitutes	O
a	O
resource	O
for	O
the	O
characterization	O
of	O
genes	O
that	O
may	O
be	O
involved	O
in	O
the	O
WAGR	O
syndrome	O
.	O

Deletion	O
analyses	O
of	O
the	O
construct	O
revealed	O
that	O
the	O
transcription	O
of	O
BOXF1	B
gene	I
is	O
regulated	O
by	O
BOX	O
DNA	O
,	O
preferentially	O
in	O
undifferentiated	O
EC	O
cells	O
versus	O
differentiated	O
cells	O
.	O

Results	O
from	O
in	O
vitro	O
transcription	O
-	O
translation	O
analysis	O
and	O
maxicell	O
experiments	O
suggested	O
that	O
the	O
447	O
-	O
bp	O
ORF	O
was	O
the	O
one	O
being	O
actively	O
expressed	O
.	O

313	O
,	O
98	O
-	O
102	O
).	O

To	O
examine	O
the	O
possibility	O
that	O
LNNB	O
performance	O
of	O
the	O
schizophrenic	O
groups	O
may	O
have	O
been	O
related	O
to	O
neuroleptic	O
medication	O
,	O
analyses	O
were	O
completed	O
on	O
the	O
relationship	O
between	O
medication	O
levels	O
and	O
LNNB	O
scores	O
.	O

Mitogen	B
-	I
induced	O
lymphocyte	O
proliferation	O
was	O
diminished	O
.	O

In	O
order	O
to	O
define	O
potential	O
candidate	O
genes	O
for	O
inherited	O
disorders	O
characterized	O
by	O
aberrant	O
gene	O
expression	O
,	O
we	O
utilized	O
Kruppel	B
-	I
related	I
sequences	I
to	O
isolate	O
zinc	B
finger	I
-	I
containing	I
cDNAs	I
.	O

This	O
virus	O
is	O
not	O
merely	O
a	O
South	O
African	O
strain	O
of	O
passion	O
fruit	O
woodiness	O
virus	O
(	O
PWV	O
):	O
the	O
deduced	O
CP	O
sequence	O
is	O
only	O
distantly	O
related	O
to	O
CPs	B
of	O
other	O
sequenced	O
strains	O
of	O
PWV	O
,	O
although	O
it	O
is	O
part	O
of	O
a	O
distinct	O
subgroup	O
of	O
potyviruses	O
related	O
to	O
PWV	O
.	O

60	O
patients	O
were	O
entered	O
into	O
a	O
randomised	O
study	O
comparing	O
vindesine	O
(	O
3	O
mg	O
/	O
m2	O
/	O
week	O
)	O
plus	O
interferon	B
-	I
alpha	I
2b	I
(	O
6	O
U	O
/	O
m2	O
3	O
times	O
per	O
week	O
)	O
to	O
vindesine	O
alone	O
or	O
to	O
interferon	B
alone	O
for	O
the	O
treatment	O
of	O
metastatic	O
malignant	O
melanoma	O
.	O

NOT4	B
interacts	O
with	O
NOT1	B
and	O
NOT3	B
in	O
the	O
two	O
-	O
hybrid	O
assay	O
,	O
and	O
overexpression	O
of	O
NOT3	B
or	O
NOT4	B
suppresses	O
not1	B
and	O
not2	B
mutations	O
.	O

ORF	O
2	O
potentially	O
encoded	O
a	O
hydrophobic	O
protein	O
of	O
29	O
,	O
705	O
Da	O
with	O
six	O
potential	O
membrane	O
-	O
spanning	O
regions	O
.	O

As	O
shown	O
previously	O
,	O
EBNA2	B
transactivates	O
the	O
promoters	O
of	O
the	O
viral	B
latent	I
membrane	I
proteins	I
.	O

The	O
p55	B
mRNA	I
is	O
undetectable	O
in	O
non	O
-	O
EBV	O
-	O
infected	O
B	O
-	O
and	O
T	O
-	O
cell	O
lines	O
or	O
in	O
a	O
myelomonocytic	O
cell	O
line	O
(	O
U937	O
).	O

Using	O
an	O
RNase	B
H	I
-	I
mediated	O
mapping	O
technique	O
,	O
we	O
show	O
that	O
the	O
64	O
-	O
kDa	O
subunit	O
of	O
CstF	B
can	O
be	O
photo	O
cross	O
-	O
linked	O
to	O
pre	O
-	O
mRNAs	O
at	O
U	O
-	O
rich	O
regions	O
located	O
downstream	O
of	O
the	O
cleavage	O
site	O
of	O
the	O
simian	O
virus	O
40	O
late	O
and	O
adenovirus	B
L3	I
pre	I
-	I
mRNAs	I
.	O

The	O
parameters	O
of	O
nonspecific	O
humoral	O
immunity	O
--	O
serum	B
immunoglobulins	I
and	O
immune	O
complexes	O
--	O
were	O
evaluated	O
in	O
irradiated	O
group	O
of	O
patients	O
with	O
uterine	O
cervix	O
carcinoma	O
(	O
Stages	O
IIB	O
and	O
IIIB	O
),	O
during	O
one	O
year	O
follow	O
up	O
.	O

Consequently	O
functional	O
mRNAs	O
can	O
be	O
produced	O
by	O
endogenous	B
RNA	I
polymerase	I
I	I
.	O

The	O
individual	O
subunits	O
of	O
Ku	B
have	O
been	O
difficult	O
to	O
isolate	O
from	O
human	O
cells	O
without	O
denaturation	O
and	O
attempts	O
to	O
produce	O
functional	O
recombinant	B
Ku	I
have	O
been	O
largely	O
unsuccessful	O
.	O

Of	O
419	O
persons	O
surveyed	O
,	O
207	O
(	O
49	O
.	O
4	O
%)	O
were	O
antigen	O
-	O
positive	O
with	O
the	O
Og4C3	B
assay	O
.	O

TG	O
-	O
day	O
and	O
TG	O
-	O
night	O
were	O
19	O
.	O
4	O
+/-	O
6	O
.	O
1	O
%,	O
26	O
.	O
6	O
+/-	O
5	O
.	O
3	O
%,	O
(	O
750	O
mm3	O
<	O
T	O
.	O

The	O
fibrinogen	B
,	O
serum	B
proteins	I
,	O
sodium	O
heparin	O
and	O
membrane	O
contributed	O
to	O
Cm	O
by	O
20	O
%,	O
14	O
%,	O
2	O
%	O
and	O
64	O
%,	O
respectively	O
.	O

The	O
site	O
-	O
directed	O
mutation	O
of	O
the	O
kappa	B
B	I
motif	I
in	O
IL	B
-	I
6	I
/	O
CAT	B
plasmid	O
resulted	O
in	O
the	O
complete	O
abrogation	O
of	O
IL	B
-	I
6	I
promoter	I
activity	O
in	O
these	O
cells	O
.	O

Curiously	O
,	O
testololactone	O
was	O
earlier	O
and	O
more	O
widely	O
used	O
than	O
aminoglutethimide	O
in	O
treating	O
advanced	O
breast	O
carcinoma	O
.	O

Use	O
of	O
the	O
vena	O
cava	O
to	O
extend	O
the	O
right	O
renal	O
vein	O
for	O
cadaver	O
transplantation	O
is	O
controversial	O
.	O

Analyses	O
of	O
additional	O
tumors	O
induced	O
in	O
mice	O
from	O
two	O
reciprocal	O
crosses	O
,	O
A	O
/	O
J	O
x	O
C3H	O
/	O
HeJ	O
F1	O
(	O
hereafter	O
called	O
AC3F1	O
)	O
and	O
C3H	O
/	O
HeJ	O
x	O
A	O
/	O
J	O
F1	O
(	O
hereafter	O
called	O
C3AF1	O
),	O
provided	O
evidence	O
for	O
the	O
inactivation	O
of	O
one	O
allele	O
of	O
the	O
putative	O
chromosome	O
4	O
tumor	B
suppressor	I
gene	I
by	O
parental	O
imprinting	O
.	O

Cbf3	B
contains	O
three	O
proteins	O
,	O
Cbf3a	B
,	O
Cbf3b	B
and	O
Cbf3c	B
.	O

A	O
strong	O
trithorax	B
binding	I
site	I
was	O
found	O
at	O
the	O
cytological	O
location	O
of	O
the	O
fork	B
head	I
gene	I
,	O
a	O
region	O
-	O
specific	O
homeotic	B
gene	I
not	O
located	O
within	O
a	O
homeotic	B
complex	I
.	O

Antibodies	O
directed	O
against	O
the	O
SNM1	B
protein	I
immunoprecipitated	O
RNase	B
MRP	I
RNA	I
from	O
whole	O
-	O
cell	O
extracts	O
without	O
precipitating	O
the	O
structurally	O
and	O
functionally	O
related	O
RNase	B
P	I
RNA	I
.	O

C	B
/	I
EBP	I
alpha	I
also	O
activates	O
the	O
promoter	O
of	O
the	O
rat	B
class	I
-	I
I	I
ADH	I
gene	I
in	O
a	O
sequence	O
-	O
specific	O
manner	O
[	O
Potter	O
et	O
al	O
.,	O
Arch	O
.	O

In	O
human	O
brain	O
,	O
contactin	B
was	O
first	O
identified	O
by	O
amino	O
terminal	O
and	O
peptide	O
sequencing	O
of	O
the	O
lentil	B
-	I
lectin	I
-	I
binding	I
glycoprotein	I
Gp135	I
.	O

IFI16	B
consists	O
of	O
ten	O
exons	O
and	O
nine	O
intervening	O
introns	O
spanning	O
at	O
least	O
28	O
kilobases	O
(	O
kb	O
)	O
of	O
DNA	O
.	O

Other	O
adverse	O
events	O
with	O
incidences	O
significantly	O
higher	O
than	O
with	O
placebo	O
were	O
dizziness	O
,	O
constipation	O
,	O
sweating	O
,	O
nervousness	O
,	O
and	O
abnormal	O
ejaculation	O
.	O

The	O
physical	O
and	O
chemical	O
stability	O
of	O
a	O
combination	O
of	O
drugs	O
commonly	O
administered	O
into	O
the	O
epidural	O
or	O
intrathecal	O
space	O
for	O
the	O
treatment	O
of	O
chronic	O
pain	O
was	O
investigated	O
.	O

A	O
candidate	O
gene	O
for	O
Bcg	B
,	O
designated	O
natural	B
resistance	I
-	I
associated	I
macrophage	I
protein	I
(	O
Nramp	B
),	O
has	O
been	O
isolated	O
and	O
shown	O
to	O
encode	O
a	O
novel	O
macrophage	B
-	I
specific	I
membrane	I
protein	I
,	O
which	O
is	O
altered	O
in	O
susceptible	O
animals	O
.	O

One	O
hundred	O
fifty	O
patients	O
were	O
reviewed	O
at	O
1	O
year	O
after	O
arthroplasty	O
.	O

Elementary	O
visual	O
hallucinations	O
in	O
migraine	O
and	O
epilepsy	O
.	O

The	O
defined	O
length	O
of	O
the	O
mRNA	O
,	O
1	O
,	O
838	O
nucleotides	O
,	O
was	O
in	O
agreement	O
with	O
that	O
of	O
a	O
1	O
.	O
9	O
-	O
kb	O
RNA	O
expressed	O
throughout	O
the	O
replication	O
cycle	O
,	O
starting	O
at	O
the	O
early	O
stages	O
of	O
infection	O
.	O

We	O
have	O
recently	O
detected	O
high	O
levels	O
of	O
CKB	B
mRNA	I
in	O
HeLa	O
cells	O
and	O
,	O
in	O
this	O
study	O
,	O
have	O
tested	O
whether	O
this	O
may	O
be	O
due	O
to	O
the	O
extremely	O
low	O
amounts	O
of	O
p53	B
protein	I
present	O
in	O
HeLa	O
cells	O
.	O

In	O
the	O
present	O
article	O
,	O
the	O
causes	O
of	O
death	O
or	O
ill	O
-	O
being	O
as	O
found	O
in	O
10	O
consecutive	O
carcinogenicity	O
studies	O
--	O
5	O
studies	O
with	O
2400	O
OFA	O
(	O
Sprague	O
-	O
Dawley	O
-	O
derived	O
)	O
and	O
Wistar	O
rats	O
and	O
5	O
studies	O
with	O
2400	O
OF1	O
and	O
NMRI	O
mice	O
--	O
were	O
re	O
-	O
examined	O
.	O

Determination	O
of	O
potassium	O
iodide	O
in	O
Polish	O
edible	O
salt	O

Sequencing	O
of	O
the	O
TP53	B
transcripts	I
from	O
exons	O
2	O
to	O
10	O
,	O
however	O
,	O
did	O
not	O
reveal	O
mutations	O
of	O
the	O
remaining	O
allele	O
in	O
any	O
of	O
these	O
tumors	O
.	O

An	O
unusual	O
complication	O
in	O
an	O
unsuitable	O
patient	O
.	O

All	O
other	O
ejaculate	O
parameters	O
(	O
density	O
,	O
motility	O
,	O
swelling	O
test	O
,	O
penetration	O
test	O
)	O
remained	O
unchanged	O
,	O
and	O
there	O
was	O
only	O
one	O
post	O
-	O
therapeutic	O
pregnancy	O
.	O

Acta	O
572	O
,	O
113	O
-	O
120	O
].	O

A	O
stretch	O
of	O
16	O
nucleotides	O
just	O
upstream	O
of	O
the	O
IL	B
-	I
4RE	I
contributed	O
to	O
IL	B
-	I
4	I
inducibility	O
and	O
formed	O
nucleoprotein	O
complexes	O
with	O
constitutive	O
factors	O
.	O

Our	O
previous	O
study	O
suggested	O
that	O
pertussis	B
toxin	I
(	I
IAP	I
)-	I
sensitive	I
GTP	I
-	I
binding	I
protein	I
(	O
s	O
)	O
(	O
G	B
-	I
protein	I
)	O
is	O
involved	O
in	O
the	O
process	O
of	O
differentiation	O
by	O
hormones	O
/	O
IBMX	O
,	O
accompanied	O
by	O
c	B
-	I
fos	I
induction	O
.	O

ATX	B
,	O
like	O
PC	B
-	I
1	I
,	O
was	O
found	O
to	O
hydrolyze	O
the	O
type	B
I	I
phosphodiesterase	I
substrate	I
p	O
-	O
nitrophenyl	O
thymidine	B
-	I
5	O
'-	O
monophosphate	O
.	O

Point	O
mutations	O
that	O
suppressed	O
the	O
in	O
vitro	O
binding	O
of	O
NF	B
-	I
Y	I
to	O
the	O
internal	O
palindromic	O
arm	O
reduced	O
the	O
activity	O
of	O
the	O
resident	O
P4	B
promoter	I
,	O
while	O
those	O
preventing	O
complex	O
formation	O
with	O
USF	B
did	O
not	O
,	O
as	O
determined	O
by	O
transient	O
expression	O
assays	O
using	O
the	O
luciferase	B
reporter	I
gene	I
.	O

The	O
inflation	O
hub	O
of	O
the	O
probe	O
is	O
recreated	O
by	O
modifying	O
a	O
standard	O
USCI	O
Tuohy	O
-	O
Borst	O
Y	O
adaptor	O
and	O
attaching	O
this	O
to	O
the	O
transected	O
probe	O
hypotube	O
.	O

Recently	O
,	O
a	O
protein	O
designated	O
GF14	B
has	O
been	O
isolated	O
that	O
is	O
associated	O
with	O
the	O
GBF	B
protein	I
complex	I
.	O

2	O
patients	O
(	O
11	O
%)	O
had	O
significant	O
morbidity	O
502	O
and	O
529	O
days	O
respectively	O
after	O
transplantation	O
.	O

This	O
technique	O
has	O
a	O
sensitivity	O
and	O
a	O
specificity	O
of	O
almost	O
100	O
%,	O
and	O
is	O
currently	O
the	O
best	O
way	O
to	O
diagnose	O
nodal	O
involvement	O
,	O
apart	O
from	O
laparotomy	O
.	O

A	O
sequence	O
representing	O
about	O
50	O
%	O
of	O
the	O
expected	O
complete	O
sequence	O
was	O
obtained	O
by	O
translation	O
of	O
the	O
two	O
open	O
reading	O
frames	O
present	O
on	O
a	O
1	O
.	O
6	O
kb	O
DNA	O
genomic	O
fragment	O
.	O

Relationship	O
of	O
CDK	B
-	I
activating	I
kinase	I
and	I
RNA	I
polymerase	I
II	I
CTD	I
kinase	O
TFIIH	B
/	O
TFIIK	B
.	O

Differential	O
screening	O
of	O
mitochondrial	O
cDNA	O
libraries	O
from	O
male	O
-	O
fertile	O
and	O
cytoplasmic	O
male	O
-	O
sterile	O
sugar	O
-	O
beet	O
reveals	O
genome	O
rearrangements	O
at	O
atp6	B
and	O
atpA	B
loci	I
.	O

Standard	O
curve	O
correlation	O
coefficients	O
of	O
0	O
.	O
995	O
or	O
greater	O
were	O
obtained	O
during	O
validation	O
experiments	O
and	O
analysis	O
of	O
study	O
samples	O
.	O

A	O
causal	O
analysis	O
of	O
secondary	O
variables	O
showed	O
that	O
the	O
formation	O
of	O
FB	O
memories	O
was	O
primarily	O
associated	O
with	O
the	O
level	O
of	O
importance	O
attached	O
to	O
the	O
event	O
and	O
level	O
of	O
affective	O
response	O
to	O
the	O
news	O
.	O

In	O
control	O
patients	O
,	O
baseline	O
images	O
presented	O
Type	O
I	O
in	O
25	O
,	O
Type	O
II	O
in	O
7	O
,	O
and	O
the	O
Type	O
III	O
&	O
IV	O
in	O
0	O
,	O
and	O
the	O
Type	O
after	O
loading	O
was	O
the	O
same	O
as	O
the	O
Type	O
at	O
baseline	O
.	O

A	O
randomised	O
,	O
controlled	O
trial	O
was	O
undertaken	O
in	O
40	O
patients	O
with	O
active	O
Crohn	O
'	O
s	O
disease	O
to	O
evaluate	O
clinical	O
and	O
nutritional	O
outcomes	O
after	O
an	O
amino	O
acid	O
based	O
diet	O
containing	O
3	O
%	O
fat	O
was	O
given	O
by	O
a	O
feeding	O
tube	O
compared	O
with	O
a	O
peptide	O
based	O
diet	O
containing	O
33	O
%	O
fat	O
.	O

The	O
sequenced	O
genomic	O
region	O
thus	O
accounts	O
for	O
essentially	O
all	O
of	O
the	O
longest	O
known	O
transcript	O
(	O
4	O
.	O
5	O
kb	O
),	O
although	O
the	O
precise	O
ends	O
of	O
this	O
transcript	O
have	O
not	O
been	O
defined	O
.	O

The	O
pexB	B
upstream	O
region	O
contained	O
245	O
nucleotides	O
within	O
which	O
sequences	O
approximating	O
the	O
consensus	O
for	O
cyclic	B
AMP	I
receptor	I
protein	I
and	O
integration	B
host	I
factor	I
binding	I
sites	I
were	O
discernible	O
.	O

Sequence	O
analysis	O
of	O
a	O
6	O
.	O
3	O
-	O
kbp	O
genomic	O
EcoRI	B
-	I
fragment	I
of	O
Alcaligenes	O
eutrophus	O
,	O
which	O
was	O
recently	O
identified	O
by	O
using	O
a	O
dihydrolipoamide	B
dehydrogenase	I
-	I
specific	I
DNA	O
probe	O
(	O
A	O
.	O

In	O
an	O
in	O
vitro	O
study	O
,	O
10	O
/	O
0	O
nylon	O
was	O
found	O
to	O
require	O
a	O
significantly	O
lower	O
laser	O
energy	O
density	O
to	O
produce	O
suture	O
lysis	O
following	O
a	O
single	O
shot	O
than	O
either	O
10	O
/	O
0	O
Dacron	O
or	O
10	O
/	O
0	O
prolene	O
.	O

We	O
report	O
the	O
identification	O
and	O
characterization	O
of	O
myr	B
4	I
(	I
myosin	I
from	O
rat	O
),	O
the	O
first	O
mammalian	B
myosin	I
I	I
that	O
is	O
not	O
closely	O
related	O
to	O
brush	O
border	O
myosin	B
I	I
.	O

The	O
R2	O
region	O
within	O
the	O
class	B
I	I
enhancer	I
acts	O
as	O
a	O
negative	O
element	O
in	O
Ad12	B
-	I
transformed	O
cells	O
and	O
exhibits	O
a	O
stronger	O
binding	O
activity	O
than	O
is	O
observed	O
in	O
nontumorigenic	O
Ad5	O
-	O
transformed	O
cells	O
,	O
which	O
are	O
not	O
reduced	O
in	O
class	O
I	O
expression	O
.	O

Although	O
elevated	O
serum	O
levels	O
of	O
antibodies	O
to	O
the	O
nicotinic	B
acetylcholine	I
receptor	I
(	O
nAChR	B
)	O
have	O
been	O
reported	O
in	O
neuroleptic	O
treated	O
patients	O
with	O
tardive	O
dyskinesia	O
,	O
such	O
antibodies	O
have	O
not	O
been	O
determined	O
in	O
comparable	O
nondyskinetic	O
patients	O
.	O

This	O
DNA	O
containing	O
promoter	O
activity	O
has	O
been	O
sequenced	O
in	O
its	O
entirety	O
and	O
found	O
to	O
contain	O
multiple	O
putative	O
regulatory	O
sites	O
.	O

HupI	B
showed	O
strong	O
identity	O
to	O
rubredoxin	B
and	O
rubredoxin	B
-	I
like	I
proteins	I
from	O
many	O
other	O
bacteria	O
.	O

Immunodepression	O
was	O
combined	O
with	O
the	O
increase	O
of	O
glucocorticoid	O
activity	O
of	O
adrenal	O
cortex	O
,	O
while	O
no	O
significant	O
changes	O
in	O
thyroid	O
hormones	O
were	O
registered	O
.	O

Tryptic	O
cleavage	O
and	O
peptide	O
sequence	O
analysis	O
demonstrated	O
that	O
the	O
98	O
-	O
kD	O
protein	O
is	O
identical	O
to	O
a	O
recently	O
cloned	O
protein	O
,	O
special	B
A	I
-	I
T	I
-	I
rich	I
binding	I
protein	I
1	I
(	O
SATB1	B
),	O
that	O
binds	O
selectively	O
to	O
nuclear	O
matrix	O
/	O
scaffold	O
-	O
associated	O
regions	O
of	O
DNA	O
(	O
MARs	O
/	O
SARs	O
).	O

The	O
relative	O
abundance	O
of	O
each	O
alternatively	O
spliced	O
mRNA	O
was	O
determined	O
by	O
reverse	B
transcription	I
-	I
polymerase	I
chain	I
reaction	O
in	O
various	O
human	O
tissues	O
and	O
cell	O
lines	O
.	O

Each	O
expressed	O
domain	O
,	O
as	O
well	O
as	O
FKBP	B
-	I
33	O
itself	O
,	O
possesses	O
peptidyl	B
-	I
prolyl	I
cis	I
-	I
trans	I
isomerase	I
activity	O
,	O
though	O
with	O
much	O
lower	O
specific	O
activities	O
than	O
FKBP	B
-	I
12	O
.	O

We	O
conclude	O
that	O
c	B
-	I
Abl	I
activates	O
c	B
-	I
myc	I
transcription	I
indirectly	O
with	O
no	O
requirement	O
for	O
DNA	O
binding	O
by	O
c	B
-	I
Abl	I
.	O

The	O
Oct	B
-	I
2	I
glutamine	I
-	I
rich	O
and	O
proline	O
-	O
rich	O
activation	O
domains	O
can	O
synergize	O
with	O
each	O
other	O
or	O
duplicates	O
of	O
themselves	O
to	O
activate	O
transcription	O
.	O

Binding	O
of	O
U2	B
small	I
nuclear	I
ribonucleoprotein	I
(	I
snRNP	I
)	O
to	O
the	O
pre	O
-	O
mRNA	O
is	O
an	O
early	O
and	O
important	O
step	O
in	O
spliceosome	O
assembly	O
.	O

Ariga	O
,	O
Biochem	O
.	O

The	O
maximal	O
effect	O
was	O
seen	O
at	O
100	O
ng	O
/	O
ml	O
EGF	B
,	O
with	O
a	O
time	O
lag	O
of	O
about	O
5	O
h	O
.	O

CDC31	B
is	O
required	O
for	O
SPB	O
duplication	O
and	O
encodes	O
a	O
calmodulin	B
-	I
like	I
protein	I
that	O
is	O
most	O
closely	O
related	O
to	O
caltractin	B
/	O
centrin	B
,	O
a	O
protein	O
associated	O
with	O
the	O
Chlamydomonas	O
basal	O
body	O
.	O

Essential	O
features	O
of	O
this	O
model	O
are	O
bending	O
of	O
the	O
DNA	O
double	O
helix	O
and	O
contact	O
of	O
operator	O
sites	O
with	O
repressor	O
domains	O
bearing	O
sequence	O
homologies	O
with	O
the	O
helix	B
-	I
turn	I
-	I
helix	I
(	O
HTH	O
)	O
motifs	O
of	O
other	O
DNA	B
-	I
binding	I
proteins	I
.	O

The	O
binding	O
of	O
transcription	O
factor	O
AP	B
-	I
1	I
and	O
vitamin	B
D	I
receptor	I
(	O
VDR	B
)	O
to	O
the	O
composite	O
AP	B
-	I
1	I
plus	I
vitamin	I
-	I
D	I
-	I
responsive	I
promoter	I
region	O
(	O
AP	B
-	I
1	I
+	I
VDRE	I
)	O
of	O
the	O
human	B
osteocalcin	I
gene	I
was	O
characterized	O
in	O
osteocalcin	B
-	I
producing	O
(	O
MG	O
-	O
63	O
)	O
and	O
non	O
-	O
producing	O
(	O
U2	B
-	I
Os	O
,	O
SaOs	O
-	O
2	O
)	O
human	O
osteosarcoma	O
cell	O
lines	O
.	O

Acupuncture	O
effect	O
on	O
deep	O
receptors	O
was	O
not	O
limited	O
to	O
one	O
point	O
but	O
within	O
a	O
certain	O
area	O
,	O
namely	O
distant	O
effect	O
existed	O
.	O

(	O
LH	B
P	O
<	O
0	O
.	O
05	O
,	O
LH	B
/	I
FSH	I
P	O
<	O
0	O
.	O
01	O
).	O

The	O
relative	O
R	O
-	O
and	O
L	O
-	O
brain	O
weights	O
were	O
found	O
to	O
be	O
inversely	O
related	O
to	O
the	O
relative	O
R	O
-	O
L	O
brain	O
weight	O
only	O
in	O
the	O
RH	O
female	O
cats	O
with	O
R	O
-	O
L	O
brain	O
weight	O
smaller	O
than	O
zero	O
(	O
testosterone	O
in	O
males	O
,	O
estrogen	O
in	O
females	O
).	O

These	O
results	O
suggest	O
that	O
leader	O
-	O
mRNA	O
fusion	O
in	O
coronavirus	O
transcription	O
does	O
not	O
require	O
direct	O
RNA	B
-	I
RNA	I
interaction	O
between	O
complementary	O
sequences	O
.	O

We	O
describe	O
49	O
cases	O
with	O
papillary	O
tumor	O
<	O
1	O
cm	O
.	O

The	O
polyubiquitin	B
gene	I
was	O
transcribed	O
throughout	O
the	O
Volvox	O
life	O
cycle	O
with	O
peaks	O
in	O
the	O
1	O
.	O
6	O
-	O
kb	O
mRNA	O
levels	O
during	O
pre	O
-	O
cleavage	O
,	O
cleavage	O
,	O
and	O
post	O
-	O
inversion	O
.	O

Here	O
,	O
we	O
present	O
genetic	O
evidence	O
in	O
Saccharomyces	O
cerevisiae	O
for	O
a	O
functional	O
interaction	O
between	O
the	O
DEAH	B
protein	I
Prp16	I
,	O
and	O
the	O
U6	B
and	I
U2	I
spliceosomal	I
snRNAs	I
.	O

An	O
8	O
-	O
bp	O
sequence	O
(	O
ATTTCAAA	O
)	O
within	O
the	O
protected	O
region	O
shares	O
significant	O
homology	O
with	O
promoter	O
sequences	O
required	O
for	O
ethylene	O
responsiveness	O
from	O
the	O
tomato	O
fruit	O
-	O
ripening	O
E4	B
gene	I
.	O

Mutagenesis	O
of	O
each	O
NRF	B
-	I
1	I
motif	I
in	O
the	O
ALAS	B
promoter	I
gave	O
substantially	O
lowered	O
levels	O
of	O
chloramphenicol	B
acetyltransferase	I
expression	O
,	O
whereas	O
mutagenesis	O
of	O
both	O
NRF	B
-	I
1	I
motifs	O
resulted	O
in	O
the	O
almost	O
complete	O
loss	O
of	O
expression	O
.	O

DNase	B
I	I
footprinting	O
analysis	O
indicated	O
that	O
DREF	B
binds	O
to	O
the	O
24	O
-	O
bp	O
DRE	O
region	O
of	O
the	O
DNA	B
polymerase	I
alpha	I
gene	I
in	O
which	O
8	O
-	O
bp	O
palindromic	O
sequences	O
are	O
centered	O
.	O

Effects	O
of	O
moderate	O
hypercapnia	O
on	O
hypothermia	O
induced	O
by	O
cold	O
He	O
-	O
O2	O
in	O
rats	O
.	O

The	O
RFLP	O
patterns	O
of	O
the	O
isolates	O
from	O
six	O
of	O
these	O
patients	O
remained	O
essentially	O
unchanged	O
(	O
two	O
strains	O
showed	O
one	O
additional	O
band	O
)	O
despite	O
the	O
development	O
of	O
drug	O
resistance	O
.	O

We	O
recommend	O
that	O
ovarian	O
stimulation	O
is	O
done	O
only	O
if	O
there	O
is	O
a	O
valid	O
indication	O
after	O
proper	O
assessment	O
of	O
the	O
ovaries	O
,	O
and	O
that	O
women	O
who	O
have	O
had	O
ovarian	O
stimulation	O
are	O
followed	O
for	O
longer	O
than	O
at	O
present	O
.	O

Mutations	O
in	O
a	O
region	O
located	O
15	O
to	O
30	O
bp	O
downstream	O
from	O
the	O
major	O
transcription	O
start	O
site	O
that	O
shows	O
good	O
homology	O
to	O
a	O
sequence	O
in	O
the	O
first	O
exon	O
of	O
c	B
-	I
fos	I
implicated	O
as	O
a	O
negative	O
regulatory	O
element	O
resulted	O
in	O
a	O
significant	O
increase	O
in	O
basal	O
gene	O
expression	O
but	O
did	O
not	O
affect	O
regulation	O
.	O

Salazopyrine	O
desensitization	O

We	O
show	O
that	O
HRI	B
and	O
dsRNA	B
-	I
PK	I
phosphorylate	O
yeast	O
eIF	B
-	I
2	I
alpha	I
in	O
vitro	O
and	O
in	O
vivo	O
and	O
functionally	O
substitute	O
for	O
GCN2	B
protein	I
to	O
stimulate	O
GCN4	B
translation	I
in	O
yeast	O
.	O

These	O
data	O
suggest	O
that	O
:	O
(	O
a	O
)	O
proSRIF	B
cleavage	O
is	O
initiated	O
in	O
the	O
TGN	O
,	O
and	O
(	O
b	O
)	O
this	O
reaction	O
requires	O
an	O
acidic	O
pH	O
which	O
is	O
facilitated	O
by	O
a	O
Golgi	B
-	I
associated	I
vacuolar	I
-	I
type	I
ATPase	I
.	O

Anti	B
-	I
B	I
.	O
burgdorferi	O
,	O
anti	B
-	I
B	I
.	I
turicatae	I
and	O
anti	B
-	I
B	I
.	I
parkeri	I
antibodies	I
,	O
tested	O
by	O
the	O
indirect	O
immunofluorescent	O
assay	O
(	O
IFA	O
),	O
were	O
detected	O
in	O
10	O
.	O
8	O
,	O
16	O
.	O
1	O
and	O
8	O
.	O
2	O
%	O
of	O
the	O
serum	O
samples	O
tested	O
,	O
and	O
confirmed	O
by	O
IFA	O
-	O
ABS	O
in	O
1	O
.	O
3	O
,	O
1	O
.	O
3	O
and	O
1	O
.	O
0	O
%,	O
respectively	O
.	O

Structural	O
organization	O
of	O
the	O
gene	O
encoding	O
the	O
human	B
lipocalin	I
tear	I
prealbumin	I
and	O
synthesis	O
of	O
the	O
recombinant	B
protein	I
in	O
Escherichia	O
coli	O
.	O

The	O
lack	O
of	O
the	O
C2	B
domain	I
of	O
the	O
Ca	B
(	I
2	I
+)-	I
dependent	I
PKCs	I
and	O
the	O
presence	O
of	O
a	O
unique	O
NH2	O
-	O
terminal	O
sequence	O
with	O
a	O
potential	O
signal	O
peptide	O
and	O
a	O
transmembrane	O
domain	O
suggest	O
that	O
PKC	B
mu	I
is	O
a	O
novel	O
member	O
of	O
the	O
subgroup	O
of	O
atypical	O
PKCs	B
.	O

Moreover	O
,	O
we	O
observed	O
that	O
the	O
function	O
of	O
T3R	B
-	O
RXR	B
heterodimers	O
on	O
response	O
elements	O
composed	O
of	O
two	O
half	O
-	O
sites	O
in	O
a	O
directly	O
repeated	O
orientation	O
spaced	O
by	O
4	O
nucleotides	O
is	O
determined	O
in	O
major	O
parts	O
by	O
the	O
5	O
'-	O
flanking	O
sequence	O
of	O
the	O
upstream	O
half	O
-	O
site	O
.	O

However	O
,	O
three	O
Hm1	B
mutants	I
that	O
were	O
moderately	O
deficient	O
in	O
stimulating	O
PI	B
turnover	O
displayed	O
normal	O
sequestration	O
,	O
suggesting	O
distinct	O
mechanisms	O
.	O

The	O
inferred	O
amino	O
acid	O
sequence	O
of	O
the	O
cyanobacterial	B
HemB	I
protein	I
indicates	O
a	O
significant	O
difference	O
in	O
the	O
metal	O
cofactor	O
requirement	O
from	O
the	O
higher	O
-	O
plant	O
enzymes	O
,	O
which	O
was	O
confirmed	O
by	O
overexpression	O
and	O
biochemical	O
analysis	O
.	O

METHODS	O
AND	O
RESULTS	O
:	O
In	O
25	O
open	O
-	O
chest	O
,	O
anesthetized	O
dogs	O
,	O
progressive	O
circumflex	O
artery	O
stenosis	O
led	O
to	O
a	O
concordant	O
decrease	O
of	O
circumflex	O
artery	O
resting	O
and	O
hyperemic	O
flow	O
,	O
coronary	O
flow	O
reserve	O
,	O
and	O
inverse	O
angiographic	O
mean	O
transit	O
time	O
Tmicro	O
-	O
1	O
(	O
P	O
<	O
.	O
01	O
).	O

However	O
,	O
a	O
correlation	O
was	O
observed	O
between	O
SF	B
levels	O
of	O
IL	B
-	I
8	O
with	O
those	O
of	O
lactate	O
,	O
LDH	B
,	I
beta	I
2	I
-	I
microglobulin	I
and	O
glucose	O
.	O

The	O
alpha	O
7A	O
form	O
RNA	O
contains	O
an	O
additional	O
113	O
nucleotides	O
compared	O
to	O
the	O
B	O
form	O
,	O
and	O
a	O
common	O
coding	O
region	O
in	O
the	O
A	O
and	O
B	O
form	O
RNAs	O
is	O
used	O
in	O
alternate	O
reading	O
frames	O
.	O

In	O
order	O
to	O
evaluate	O
the	O
function	O
of	O
the	O
hypothalamic	O
-	O
pituitary	O
-	O
thyroid	O
(	O
HPT	O
)-	O
axis	O
in	O
unipolar	O
depression	O
,	O
the	O
authors	O
measured	O
basal	O
0800h	O
plasma	O
levels	O
of	O
free	O
thyroxine	O
(	O
FT4	O
),	O
free	O
triiodothyronine	O
(	O
FT3	O
),	O
and	O
thyroid	B
stimulating	I
hormone	I
(	I
TSH	I
)	O
by	O
means	O
of	O
the	O
new	O
,	O
ultrasensitive	O
assays	O
(	O
TSH	B
-	I
IRMA	O
)	O
in	O
69	O
healthy	O
controls	O
,	O
62	O
minor	O
,	O
101	O
simple	O
major	O
,	O
and	O
57	O
melancholic	O
depressed	O
subjects	O
.	O

The	O
epidemic	O
occurred	O
in	O
a	O
group	O
of	O
26	O
community	O
members	O
(	O
23	O
men	O
and	O
3	O
women	O
,	O
mean	O
age	O
,	O
28	O
.	O
9	O
--	O
3	O
years	O
)	O
living	O
and	O
working	O
together	O
,	O
who	O
underwent	O
acute	O
and	O
convalescent	O
serologic	O
tests	O
for	O
Mycoplasma	O
pneumoniae	O
,	O
Legionella	O
pneumophila	O
,	O
cytomegalovirus	O
,	O
adenovirus	O
,	O
Coxiella	O
burnetii	O
,	O
and	O
Chlamydia	O
pneumoniae	O
.	O

Members	O
of	O
SVA	B
are	O
also	O
present	O
in	O
the	O
complement	B
C2	I
gene	I
located	O
about	O
20	O
kilobases	O
upstream	O
of	O
RP1	B
in	O
the	O
HLA	B
and	O
in	O
the	O
cytochrome	B
CYP1A1	I
gene	I
.	O

Genetic	O
and	O
phenotypic	O
analysis	O
indicates	O
that	O
NHP6A	B
and	O
NHP6B	B
function	O
downstream	O
of	O
SLT2	B
.	O

Concordantly	O
,	O
it	O
was	O
shown	O
that	O
the	O
dnHLH	B
protein	I
Id1	I
inhibits	O
differentiation	O
of	O
muscle	O
and	O
myeloid	O
cells	O
in	O
vitro	O
.	O

The	O
colony	B
-	I
stimulating	I
factors	I
(	O
CSFs	B
)	O
principally	O
involved	O
in	O
the	O
production	O
of	O
neutrophils	O
and	O
monocytes	O
are	O
granulocyte	B
CSF	I
,	O
granulocyte	B
-	I
macrophage	I
CSF	I
,	I
macrophage	I
CSF	I
,	O
and	O
interleukin	B
3	I
(	O
sometimes	O
called	O
multi	B
-	I
CSF	I
).	O

The	O
degree	O
of	O
lung	O
destruction	O
,	O
reflected	O
by	O
interstitial	O
hemorrhage	O
was	O
assessed	O
by	O
measuring	O
hemoglobin	B
content	O
in	O
the	O
fluid	O
of	O
the	O
lavaged	O
lungs	O
.	O

Panlobular	O
emphysema	O

The	O
usefulness	O
of	O
the	O
lambda	O
PG15	O
and	O
the	O
lambda	O
AD5	O
cloning	O
vectors	O
was	O
demonstrated	O
by	O
constructing	O
large	O
Neurospora	B
crassa	I
cDNA	I
libraries	O
.	O

Altogether	O
,	O
these	O
data	O
suggest	O
that	O
Ypt51p	B
,	O
Ypt52p	B
,	O
and	O
Ypt53p	B
are	O
required	O
for	O
transport	O
in	O
the	O
endocytic	O
pathway	O
and	O
for	O
correct	O
sorting	O
of	O
vacuolar	B
hydrolases	I
suggesting	O
a	O
possible	O
intersection	O
of	O
the	O
endocytic	O
with	O
the	O
vacuolar	O
sorting	O
pathway	O
.	O

Response	O
to	O
treatment	O
was	O
better	O
in	O
patients	O
with	O
less	O
pretreatment	O
(	O
one	O
-	O
two	O
prior	O
treatments	O
)	O
than	O
in	O
heavily	O
pretreated	O
ones	O
(	O
more	O
than	O
three	O
)	O
and	O
this	O
relation	O
was	O
found	O
to	O
be	O
statistically	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
class	B
II	I
Escherichia	I
coli	I
alanine	I
tRNA	I
synthetase	I
aminoacylates	I
RNA	I
miniduplexes	I
,	O
which	O
reconstruct	O
the	O
acceptor	O
end	O
of	O
alanine	O
tRNA	O
with	O
the	O
critical	O
G3	O
:	O
U70	O
base	O
pair	O
.	O

Simple	O
reaction	O
time	O
(	O
RT	O
)	O
to	O
a	O
peripheral	O
visual	O
target	O
(	O
S2	O
)	O
is	O
shortened	O
when	O
a	O
non	O
-	O
informative	O
cue	O
(	O
S1	B
)	O
is	O
flashed	O
at	O
the	O
S2	O
location	O
100	O
-	O
150	O
ms	O
before	O
target	O
onset	O
(	O
early	O
facilitation	O
).	O

Thus	O
,	O
we	O
have	O
separated	O
the	O
signal	O
function	O
from	O
the	O
anchor	O
function	O
of	O
the	O
6	O
.	O
7K	O
SA	O
domain	O
.	O

Alternative	O
splicing	O
of	O
RNA	O
transcripts	O
encoded	O
by	O
the	O
murine	B
p105	I
NF	I
-	I
kappa	I
B	I
gene	I
generates	O
I	B
kappa	I
B	I
gamma	I
isoforms	I
with	O
different	O
inhibitory	O
activities	O
.	O

These	O
rearrangements	O
result	O
in	O
the	O
formation	O
of	O
chimeric	O
genes	O
showing	O
the	O
tyrosine	B
kinase	I
domain	I
of	O
ret	B
fused	O
with	O
the	O
5	O
'	O
end	O
sequences	O
of	O
different	O
genes	O
.	O

Comparison	O
with	O
the	O
crystal	O
structure	O
of	O
Desulfovibrio	O
gigas	O
,	O
Dg	O
,	O
Fd	B
(	O
Kissinger	O
et	O
al	O
.,	O
1991	O
)	O
reveals	O
a	O
very	O
similar	O
folding	O
topology	O
,	O
although	O
several	O
secondary	O
structural	O
elements	O
are	O
extended	O
in	O
Pf	O
relative	O
to	O
Dg	O
Fd	B
.	O

In	O
Mv1Lu	O
lung	O
epithelial	O
cells	O
,	O
ActR	B
-	I
IB	I
and	I
T	I
beta	I
R	I
-	I
I	I
signal	I
a	O
common	O
set	O
of	O
growth	O
-	O
inhibitory	O
and	O
transcriptional	O
responses	O
in	O
association	O
with	O
their	O
corresponding	O
ligands	O
and	O
type	B
II	I
receptors	I
.	O

A	O
genomic	O
clone	O
for	O
the	O
cyc07	B
gene	I
,	O
which	O
is	O
expressed	O
specifically	O
at	O
the	O
S	O
phase	O
during	O
the	O
cell	O
cycle	O
in	O
synchronous	O
cultures	O
of	O
periwinkle	O
(	O
Catharanthus	O
roseus	O
)	O
cells	O
,	O
was	O
isolated	O
.	O

Subunit	O
composition	O
and	O
domain	O
structure	O
of	O
the	O
Spo0A	B
sporulation	I
transcription	I
factor	I
of	I
Bacillus	I
subtilis	I
.	O

Also	O
,	O
HR21ap	B
as	O
well	O
as	O
HR21Xap	B
are	O
specific	O
in	O
their	O
inhibition	O
of	O
Sp1	B
binding	I
.	O

Analysis	O
of	O
the	O
gag	B
and	O
rev	B
proteins	I
in	O
the	O
transfected	O
cells	O
demonstrated	O
that	O
these	O
proteins	O
were	O
not	O
detectable	O
in	O
cells	O
transfected	O
with	O
the	O
tat	B
mutants	I
but	O
could	O
be	O
readily	O
detected	O
when	O
the	O
mutations	O
were	O
complemented	O
in	O
trans	O
with	O
a	O
tat	B
expression	O
vector	O
.	O

The	O
patients	O
in	O
one	O
group	O
had	O
intrauterine	O
catheters	O
inserted	O
and	O
oxytocin	B
was	O
titrated	O
to	O
achieve	O
the	O
75th	O
percentile	O
of	O
uterine	O
activity	O
observed	O
in	O
spontaneous	O
normal	O
labour	O
according	O
to	O
parity	O
.	O

Continued	O
development	O
of	O
the	O
rat	O
conditioning	O
paradigm	O
is	O
especially	O
warranted	O
because	O
of	O
the	O
ability	O
to	O
record	O
sympathetic	O
nerve	O
activity	O
in	O
intact	O
,	O
awake	O
subjects	O
and	O
the	O
large	O
number	O
of	O
readily	O
available	O
genetic	O
strains	O
,	O
which	O
model	O
human	O
pathological	O
states	O
.	O

Thus	O
,	O
we	O
have	O
identified	O
a	O
GRE	O
sufficient	O
to	O
account	O
for	O
full	O
glucocorticoid	O
inducibility	O
and	O
an	O
HNF	B
-	I
1	I
site	I
close	O
to	O
the	O
promoter	O
that	O
are	O
major	O
determinants	O
of	O
transcriptional	O
control	O
of	O
the	O
Xenopus	B
fibrinogen	I
B	I
beta	I
subunit	I
gene	I
in	O
cells	O
from	O
normal	O
liver	O
tissue	O
.	O

The	O
PRB	B
-	I
1b	I
gene	I
encodes	O
for	O
a	O
basic	B
-	I
type	I
component	O
of	O
the	O
pathogenesis	O
-	O
related	O
PR	B
-	I
1	I
protein	I
family	I
.	O

Replacement	O
of	O
the	O
CRE	O
with	O
a	O
second	O
copy	O
of	O
the	O
AP	B
-	I
1	I
site	I
results	O
in	O
a	O
level	O
of	O
transcriptional	O
activity	O
comparable	O
with	O
that	O
of	O
the	O
wild	B
-	I
type	I
sequence	I
,	O
but	O
replacement	O
of	O
the	O
AP	B
-	I
1	I
site	I
with	O
a	O
CRE	O
abolishes	O
activity	O
.	O

We	O
suggest	O
that	O
CT	O
scan	O
be	O
preferable	O
in	O
diagnosis	O
of	O
tumors	O
in	O
that	O
area	O
.	O

SIN	O
-	O
1	O
had	O
no	O
influence	O
on	O
either	O
the	O
ischemic	O
parameters	O
in	O
the	O
surface	O
electrocardiogram	O
(	O
ECG	O
)	O
or	O
the	O
intracoronary	O
ECG	O
.	O

GGS1	B
is	O
the	O
same	O
gene	O
as	O
TPS1	B
which	O
was	O
identified	O
as	O
encoding	O
a	O
subunit	O
of	O
the	O
trehalose	B
-	I
6	I
-	I
phosphate	I
synthase	I
/	I
phosphatase	I
complex	I
and	O
it	O
is	O
allelic	O
to	O
the	O
fdp1	B
,	O
byp1	B
,	O
glc6	B
and	O
cif1	O
mutations	O
.	O

We	O
also	O
compared	O
the	O
sequence	O
with	O
the	O
partly	O
homologous	O
products	O
of	O
the	O
S	O
.	O
cerevisiae	O
genes	O
TPS2	B
and	O
TSL1	B
which	O
code	O
for	O
the	O
larger	O
subunits	O
of	O
the	O
trehalose	B
synthase	I
complex	I
and	O
with	O
a	O
TSL1	B
homologue	I
,	O
TPS3	B
,	O
of	O
unknown	O
function	O
.	O

CONCLUSION	O
:	O
The	O
study	O
demonstrates	O
that	O
transvaginal	O
ultrasonography	O
has	O
an	O
efficiency	O
of	O
88	O
%	O
in	O
differentiating	O
endometriomas	O
from	O
other	O
ovarian	O
masses	O
with	O
a	O
specificity	O
of	O
90	O
%.	O

The	O
product	O
of	O
the	O
vpr	B
open	O
reading	O
frame	O
of	O
human	B
immunodeficiency	I
virus	I
type	I
1	I
(	I
HIV	I
-	I
1	I
)	O
is	O
a	O
15	O
-	O
kDa	O
,	O
arginine	B
-	I
rich	I
protein	I
that	O
is	O
present	O
in	O
virions	O
in	O
molar	O
quantities	O
equivalent	O
to	O
that	O
of	O
Gag	B
.	O

CPAP	O
reduced	O
isotime	O
(	O
defined	O
as	O
the	O
last	O
common	O
minute	O
of	O
exercise	O
)	O
VO2	O
and	O
dyspnea	O
in	O
those	O
patients	O
with	O
more	O
severe	O
lung	O
disease	O
,	O
but	O
these	O
values	O
tended	O
to	O
increase	O
slightly	O
in	O
the	O
patients	O
with	O
only	O
mild	O
lung	O
disease	O
.	O

Effects	O
of	O
diltiazem	O
on	O
netilmicin	O
-	O
induced	O
nephrotoxicity	O
in	O
rabbits	O
.	O

About	O
20	O
%	O
of	O
single	O
-	O
stranded	O
DNA	O
binding	O
was	O
observed	O
in	O
the	O
presence	O
of	O
MgdTDP	O
,	O
but	O
none	O
was	O
detectable	O
in	O
the	O
absence	O
of	O
nucleotides	O
.	O

Northern	O
(	O
RNA	O
)	O
analysis	O
demonstrated	O
expression	O
of	O
human	O
PI	B
3	I
-	I
kinase	I
in	O
all	O
tissues	O
and	O
cell	O
lines	O
tested	O
.	O

In	O
addition	O
to	O
the	O
protein	B
-	I
tyrosine	I
kinase	I
domain	I
,	O
p56lck	B
possesses	O
Src	B
homology	I
2	I
and	I
3	I
(	I
SH2	I
and	O
SH3	B
)	I
domains	I
as	O
well	O
as	O
a	O
unique	O
N	O
-	O
terminal	O
region	O
.	O

Clipping	O
resulted	O
in	O
a	O
serious	O
mislocalization	O
of	O
the	O
position	O
of	O
the	O
peak	O
of	O
the	O
epicortical	O
potential	O
field	O
.	O

The	O
247	O
-	O
kDa	O
complex	O
appears	O
to	O
contain	O
two	O
distinct	O
protein	O
-	O
DNA	O
complexes	O
of	O
approximately	O
232	O
and	O
256	O
kDa	O
and	O
represents	O
two	O
proteins	O
covalently	O
cross	O
-	O
linked	O
to	O
a	O
single	O
DRE	O
oligonucleotide	O
,	O
while	O
the	O
97	O
,	O
105	O
,	O
and	O
115	O
-	O
kDa	O
complexes	O
represent	O
single	O
protein	O
-	O
DRE	O
cross	O
-	O
links	O
.	O

We	O
have	O
explored	O
the	O
mechanism	O
of	O
action	O
of	O
the	O
fibronectin	B
splicing	I
enhancer	I
and	O
found	O
that	O
the	O
SE	O
element	O
is	O
required	O
for	O
efficient	O
assembly	O
of	O
early	O
splicing	O
complexes	O
,	O
allowing	O
a	O
more	O
efficient	O
interaction	O
of	O
the	O
U2	B
snRNP	I
with	O
branch	O
site	O
sequences	O
.	O

We	O
conclude	O
that	O
sequences	O
outside	O
of	O
the	O
hLEF	B
HMG	I
box	I
mediate	O
cell	O
-	O
and	O
context	O
-	O
specific	O
activation	O
of	O
the	O
TCR	B
alpha	I
enhancer	I
and	O
may	O
facilitate	O
interactions	O
between	O
hLEF	B
and	O
other	O
T	B
-	I
cell	I
-	I
specific	I
factors	I
recruited	O
to	O
the	O
enhancer	O
.	O

Using	O
a	O
3	O
'-	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
strategy	O
,	O
we	O
have	O
cloned	O
cDNAs	O
representing	O
the	O
3	O
'-	O
termini	O
of	O
both	O
the	O
native	O
and	O
mutant	O
transcripts	O
from	O
both	O
P388	O
/	O
ADR	O
/	O
3	O
and	O
P388	O
/	O
ADR	O
/	O
7	O
cells	O
.	O

TGF	B
beta	I
1	I
expression	O
is	O
largely	O
governed	O
by	O
three	O
AP	B
-	I
1	I
binding	I
sites	I
located	O
in	O
two	O
different	O
promoters	O
of	O
this	O
gene	O
.	O

Val	O
-->	O
Ala	O
mutations	O
selectively	O
alter	O
helix	O
-	O
helix	O
packing	O
in	O
the	O
transmembrane	O
segment	O
of	O
phage	B
M13	I
coat	I
protein	I
.	O

In	O
vitro	O
translation	O
experiments	O
show	O
that	O
human	B
cDNA	I
derived	I
RNA	I
translates	O
into	O
a	O
protein	O
with	O
a	O
mobility	O
of	O
44	O
-	O
46	O
kD	O
on	O
SDS	O
polyacrylamide	O
gels	O
.	O

A	O
sequence	O
homology	O
analysis	O
between	O
human	B
nm23	I
-	I
H1	I
and	O
the	O
homolog	O
gene	O
of	O
the	O
rat	O
(	O
NDP	B
-	I
K	I
beta	I
)	O
shows	O
that	O
exon	O
-	O
intron	O
boundaries	O
are	O
well	O
conserved	O
between	O
these	O
two	O
species	O
.	O

A	O
favourable	O
response	O
was	O
achieved	O
with	O
a	O
combination	O
of	O
amphotericin	O
B	O
and	O
cotrimoxazole	O
.	O

Peripheral	O
vitreochorioretinal	O
dystrophies	O
in	O
myopia	O
patients	O

Responses	O
to	O
the	O
Plowright	O
Rinderpest	O
vaccine	O
by	O
43	O
calves	O
and	O
70	O
adult	O
cattle	O
in	O
Uganda	O
in	O
1990	O
,	O
through	O
the	O
production	O
of	O
IgG	B
antibodies	I
,	O
were	O
monitored	O
for	O
4	O
weeks	O
using	O
the	O
ELISA	O
assay	O
.	O

Plasma	O
,	O
LDL	B
and	O
liver	O
cholesterol	O
concentrations	O
were	O
higher	O
in	O
the	O
hyperlipidemic	O
control	O
than	O
the	O
nonhyperlipidemic	O
control	O
and	O
lower	O
in	O
the	O
groups	O
fed	O
diets	O
containing	O
pectin	B
or	O
prune	O
fiber	O
than	O
in	O
the	O
hyperlipidemic	O
control	O
group	O
.	O

A	O
single	O
1	O
.	O
8	O
-	O
kb	O
transcript	O
mRNA	O
was	O
detected	O
by	O
Northern	O
(	O
RNA	O
)	O
blot	O
analysis	O
,	O
and	O
its	O
5	O
'	O
end	O
maps	O
to	O
a	O
position	O
51	O
bp	O
upstream	O
from	O
the	O
site	O
of	O
initiation	O
of	O
protein	O
synthesis	O
.	O

Repression	O
is	O
alleviated	O
when	O
the	O
two	O
(	O
for	O
E2	O
)	O
or	O
three	O
(	O
for	O
E2	B
-	I
C	I
)	I
promoter	I
-	I
proximal	O
copies	O
of	O
E2	B
-	I
RS	I
are	O
mutated	O
.	O

The	O
results	O
indicate	O
that	O
rep	B
strongly	O
enhances	O
the	O
function	O
of	O
negative	O
regulatory	O
elements	O
of	O
the	O
LTR	O
.	O

Animal	O
age	O
and	O
sex	O
had	O
no	O
significant	O
effects	O
on	O
CSF	O
composition	O
,	O
but	O
serum	O
IgG	B
concentration	O
increased	O
with	O
age	O
.	O

A	O
randomized	O
,	O
multicenter	O
study	O
comparing	O
the	O
efficacy	O
and	O
tolerability	O
of	O
tropisetron	O
,	O
a	O
new	O
5	B
-	I
HT3	I
receptor	I
antagonist	O
,	O
with	O
a	O
metoclopramide	O
-	O
containing	O
antiemetic	O
cocktail	O
in	O
the	O
prevention	O
of	O
cisplatin	O
-	O
induced	O
emesis	O
.	O

The	O
inserted	O
region	O
,	O
which	O
represents	O
an	O
intron	O
in	O
brain	O
and	O
muscle	O
,	O
is	O
expressed	O
in	O
the	O
tumor	O
cell	O
lines	O
either	O
as	O
a	O
"	O
readthrough	O
"	O
form	O
or	O
with	O
78	O
residues	O
deleted	O
from	O
its	O
5	O
'	O
end	O
.	O

Regression	O
line	O
slopes	O
of	O
IBDQ	O
scores	O
were	O
significantly	O
different	O
in	O
patients	O
who	O
deteriorated	O
from	O
those	O
who	O
remained	O
stable	O
([	O
b	O
]	O
<	O
0	O
.	O
15	O
;	O
P	O
<	O
0	O
.	O
0001	O
).	O

The	O
COOH	O
-	O
terminal	O
46	O
codons	O
of	O
slyD	B
encode	O
a	O
remarkable	O
histidine	O
-	O
rich	O
peptide	O
sequence	O
which	O
is	O
at	O
least	O
partly	O
dispensable	O
for	O
slyD	B
function	O
in	O
E	O
-	O
mediated	O
lysis	O
.	O

We	O
have	O
investigated	O
the	O
influence	O
of	O
NaFe3	O
+	O
EDTA	O
,	O
and	O
of	O
increasing	O
dietary	O
levels	O
of	O
Na2EDTA	O
,	O
on	O
Zn	O
,	O
Cu	O
and	O
Ca	O
metabolism	O
in	O
rats	O
fed	O
on	O
Zn	O
-	O
sufficient	O
and	O
Zn	O
-	O
deficient	O
soya	O
-	O
bean	O
-	O
isolate	O
-	O
based	O
diets	O
.	O

Analysis	O
of	O
the	O
upstream	O
untranslated	O
region	O
of	O
CHL15	B
revealed	O
the	O
presence	O
of	O
the	O
hexamer	O
element	O
,	O
ACGCGT	O
(	O
an	O
MluI	B
restriction	I
site	I
)	O
controlling	O
both	O
the	O
periodic	O
expression	O
and	O
coordinate	O
regulation	O
of	O
the	O
DNA	O
synthesis	O
genes	O
in	O
budding	O
yeast	O
.	O

The	O
C	O
-	O
terminal	O
region	O
of	O
the	O
150	B
-	I
kDa	I
protein	I
contains	O
an	O
NTP	O
-	O
binding	O
helicase	B
motif	I
and	O
the	O
readthrough	O
region	O
,	O
an	O
RNA	B
polymerase	I
motif	I
,	O
indicating	O
that	O
these	O
two	O
overlapping	O
proteins	O
may	O
form	O
an	O
RNA	O
replication	O
complex	O
similar	O
to	O
those	O
of	O
tobamo	O
-	O
and	O
tobraviruses	O
.	O

Using	O
the	O
rap1t	B
alleles	I
to	O
generate	O
wild	B
-	I
type	I
cells	O
differing	O
only	O
in	O
telomere	O
tract	O
lengths	O
,	O
we	O
also	O
show	O
that	O
telomere	O
position	O
effects	O
are	O
highly	O
sensitive	O
to	O
changes	O
in	O
the	O
size	O
(	O
or	O
structure	O
)	O
of	O
the	O
telomeric	O
tract	O
.	O

These	O
lesions	O
were	O
asymptomatic	O
,	O
but	O
both	O
were	O
characterized	O
clinically	O
by	O
central	O
ulceration	O
.	O

The	O
O2	O
deficit	O
was	O
not	O
related	O
to	O
blood	O
lactate	O
during	O
submaximal	O
exercise	O
,	O
muscle	O
enzyme	O
activity	O
(	O
citrate	B
synthase	I
,	I
3	I
-	I
hydroxyacyl	I
-	I
CoA	I
-	I
dehydrogenase	I
,	O
lactate	B
dehydrogenase	I
),	O
number	O
of	O
muscle	O
capillaries	O
,	O
%	O
ST	O
fibres	O
or	O
muscle	O
buffer	O
capacity	O
.	O

The	O
sequence	O
of	O
the	O
putative	O
RBP1	B
protein	I
contains	O
two	O
copies	O
of	O
an	O
RNA	O
recognition	O
motif	O
,	O
two	O
glutamine	O
stretches	O
,	O
an	O
asparagine	O
-	O
rich	O
region	O
,	O
a	O
methionine	O
-	O
rich	O
region	O
,	O
and	O
two	O
long	O
potential	O
alpha	B
-	I
helixes	O
.	O

Indeed	O
,	O
significant	O
level	O
of	O
CAT	B
activity	O
was	O
observed	O
in	O
human	O
lung	O
adenocarcinoma	O
(	O
A549	O
-	O
1	O
)	O
cells	O
which	O
had	O
been	O
incubated	O
with	O
a	O
complex	O
of	O
T7	B
RNA	I
polymerase	I
,	O
pT7	B
-	I
EMC	I
-	I
CAT	I
DNA	O
and	O
DC	O
-	O
chol	O
cationic	O
liposomes	O
.	O

To	O
begin	O
to	O
examine	O
the	O
mechanism	O
controlling	O
expression	O
of	O
this	O
gene	O
during	O
the	O
cell	O
-	O
cycle	O
,	O
a	O
mouse	B
B	I
-	I
myb	I
5	O
'	O
flanking	O
sequence	O
was	O
isolated	O
from	O
a	O
cosmid	O
library	O
and	O
shown	O
to	O
promote	O
efficiently	O
the	O
transcription	O
of	O
a	O
luciferase	B
reporter	I
gene	I
when	O
transfected	O
into	O
NIH3T3	O
fibroblasts	O
.	O

The	O
number	O
of	O
bacteria	O
in	O
the	O
lung	O
,	O
peripheral	O
white	O
blood	O
cell	O
and	O
BAL	O
fluid	O
cell	O
also	O
decreased	O
by	O
the	O
administration	O
of	O
FN	B
.	O

The	O
mean	O
power	O
(	O
in	O
mu	O
W	O
)	O
required	O
to	O
produce	O
the	O
observed	O
flow	O
rate	O
was	O
estimated	O
at	O
each	O
outflow	O
pressure	O
as	O
the	O
product	O
of	O
the	O
flow	O
rate	O
and	O
the	O
pressure	O
across	O
the	O
lymphatic	O
vessel	O
.	O

GAP	B
-	I
N	I
bound	O
constitutively	O
to	O
p190	B
in	O
both	O
serum	O
-	O
deprived	O
and	O
growth	B
factor	I
-	I
stimulated	O
cells	O
.	O

The	O
peptide	O
sequence	O
contains	O
a	O
region	O
of	O
80	O
amino	O
acids	O
that	O
shows	O
similarity	O
to	O
bcl	B
-	I
2	I
and	O
to	O
the	O
recently	O
described	O
bcl	B
-	I
2	I
-	I
related	I
gene	I
,	O
MCL1	B
.	O

The	O
phosphorylation	O
efficiency	O
is	O
improved	O
by	O
increasing	O
the	O
number	O
of	O
N	O
-	O
terminal	O
arginine	O
residues	O
and	O
by	O
moving	O
the	O
arginyl	O
cluster	O
one	O
residue	O
further	O
away	O
from	O
the	O
serine	O
,	O
the	O
nonapeptide	O
(	O
Arg	O
)	O
4	B
-	I
Ala	I
-	I
Ala	I
-	I
Ser	I
-	I
Val	I
-	I
Ala	I
being	O
the	O
best	O
substrate	O
among	O
all	O
the	O
short	O
peptides	O
tested	O
(	O
Km	O
=	O
15	O
microM	O
).	O

The	O
Saccharomyces	B
cerevisiae	I
GAL1	I
and	O
GAL10	B
genes	I
are	O
controlled	O
in	O
response	O
to	O
the	O
availability	O
of	O
galactose	O
and	O
glucose	O
by	O
multiple	O
activating	O
and	O
repressing	O
proteins	O
bound	O
at	O
adjacent	O
or	O
overlapping	O
sites	O
in	O
UASG	O
.	O

Protein	B
tyrosine	I
phosphatases	I
(	O
PTPs	B
),	O
together	O
with	O
protein	B
tyrosine	I
kinases	I
(	O
PTKs	B
),	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
cell	O
activation	O
,	O
growth	O
,	O
and	O
differentiation	O
.	O

HTLV	B
-	I
1	I
gene	I
expression	O
by	O
defective	O
proviruses	O
in	O
an	O
infected	O
T	O
-	O
cell	O
line	O
.	O

Thus	O
,	O
it	O
was	O
confirmed	O
that	O
the	O
sodium	O
lauryl	O
sulfate	O
method	O
of	O
estimating	O
hemoglobin	B
concentration	O
is	O
an	O
appropriate	O
alternative	O
to	O
the	O
cyanmethemoglobin	B
method	O
and	O
avoids	O
the	O
generation	O
of	O
toxic	O
wastes	O
.	O

The	O
simultaneous	O
recording	O
of	O
electrical	O
activity	O
from	O
the	O
surface	O
electrocardiogram	O
,	O
right	O
ventricular	O
apex	O
,	O
His	O
bundle	O
,	O
high	O
right	O
atrium	O
,	O
coronary	O
sinus	O
,	O
with	O
or	O
without	O
a	O
roving	O
mapping	O
catheter	O
,	O
enables	O
us	O
to	O
precisely	O
map	O
the	O
electrical	O
activation	O
sequence	O
in	O
the	O
heart	O
.	O

Cerebro	O
-	O
oculo	O
-	O
facioskeletal	O
syndrome	O
(	O
Pena	O
-	O
Shokeir	O
syndrome	O
II	O
)	O

The	O
Functional	O
Independence	O
Measure	O
:	O
a	O
comparative	O
study	O
of	O
clinician	O
and	O
self	O
ratings	O
.	O

The	O
binding	O
specificity	O
of	O
this	O
protein	O
was	O
compared	O
to	O
that	O
of	O
human	O
E2F	B
using	O
a	O
number	O
of	O
mutant	O
E2F	B
sites	I
as	O
competitors	O
.	O

The	O
7	O
-	O
kb	O
mRNA	O
differs	O
by	O
alternative	O
splicing	O
such	O
that	O
it	O
encodes	O
a	O
protein	O
with	O
a	O
distinct	O
amino	O
terminus	O
.	O

McCann	O
III	O
,	O
F	O
.	O

The	O
E1	B
nuclear	I
transport	I
motif	I
is	O
highly	O
conserved	O
in	O
the	O
animal	O
and	O
human	O
papillomaviruses	O
and	O
is	O
encoded	O
in	O
a	O
similar	O
region	O
in	O
the	O
related	O
E1	B
genes	I
.	O

Together	O
with	O
a	O
considerably	O
shortened	O
and	O
interrupted	O
aromatic	O
aa	O
stretch	O
in	O
this	O
region	O
,	O
these	O
differences	O
are	O
discussed	O
in	O
terms	O
of	O
the	O
peculiar	O
affinity	O
of	O
cyanobacterial	B
cytochrome	I
oxidases	I
for	O
acidic	O
c	B
-	I
type	I
cytochromes	I
.	O

Mutation	O
of	O
the	O
C	B
/	I
EBP	I
binding	I
sites	I
in	O
the	O
Rous	B
sarcoma	I
virus	I
long	I
terminal	I
repeat	I
and	I
gag	I
enhancers	I
.	O

Furthermore	O
,	O
a	O
mutant	B
receptor	I
(	O
Y977F	O
/	O
Y989F	O
[	O
PLC	B
gamma	I
-	I
binding	I
sites	I
])	I
could	O
fully	O
activate	O
Ras	B
,	O
and	O
the	O
direct	O
activation	O
of	O
protein	B
kinase	I
C	I
and	O
calcium	O
mobilization	O
had	O
almost	O
no	O
effect	O
on	O
the	O
GDP	O
/	O
GTP	O
state	O
of	O
Ras	B
in	O
this	O
cell	O
line	O
.	O

This	O
observation	O
suggests	O
that	O
the	O
methyl	O
-	O
directed	O
repair	O
system	O
utilizes	O
the	O
proximal	O
d	O
(	O
GATC	O
)	O
sequence	O
to	O
direct	O
correction	O
.	O

Precipitation	O
using	O
GST	B
fusion	I
proteins	I
containing	O
Fyn	B
SH2	I
,	O
SH3	B
,	O
and	O
SH2	B
/	I
SH3	I
domains	I
revealed	O
that	O
PI	B
3	I
-	I
kinase	I
bound	O
principally	O
to	O
the	O
SH3	B
domain	I
of	O
Fyn	B
.	O

Two	O
putative	O
Rev	B
proteins	I
with	O
apparent	O
molecular	O
masses	O
of	O
18	O
and	O
16	O
kDa	O
were	O
expressed	O
by	O
p2	B
/	I
2	I
and	O
p176	B
,	O
while	O
p20	B
expressed	O
only	O
a	O
16	O
-	O
kDa	O
species	O
.	O

Three	O
group	O
1	O
patients	O
developed	O
CMV	O
disease	O
;	O
1	O
group	O
2	O
patient	O
developed	O
CMV	O
hepatitis	O
.	O

Genetic	O
interactions	O
between	O
BCK2	B
and	O
other	O
pathway	O
components	O
suggested	O
that	O
BCK2	B
functions	O
on	O
a	O
common	O
pathway	O
branch	O
with	O
PPZ1	B
and	O
PPZ2	B
.	O

Steroidogenic	B
factor	I
1	I
,	O
an	O
orphan	B
nuclear	I
receptor	I
,	O
regulates	O
the	O
expression	O
of	O
the	O
rat	B
aromatase	I
gene	I
in	O
gonadal	O
tissues	O
.	O

To	O
study	O
the	O
functional	O
differences	O
between	O
cutaneous	O
HPV5	O
and	O
HPV8	O
E7s	B
and	O
genital	B
HPV16	I
E7	I
,	O
we	O
cloned	O
each	O
of	O
the	O
E7	B
open	O
reading	O
frames	O
and	O
tested	O
their	O
immortalizing	O
and	O
transforming	O
activities	O
,	O
the	O
binding	O
ability	O
of	O
their	O
products	O
with	O
retinoblastoma	B
protein	I
(	O
RB	B
)	O
and	O
their	O
complementation	O
activity	O
of	O
a	O
RB	B
-	I
nonbinding	I
adenovirus	I
E1A	I
mutant	I
.	O

These	O
experiments	O
confirm	O
that	O
the	O
6	O
-	O
S	O
liganded	O
form	O
of	O
the	O
receptor	O
identified	O
in	O
nuclear	O
extracts	O
of	O
cells	O
treated	O
with	O
2	O
,	O
3	O
,	O
7	O
,	O
8	O
-	O
tetrachlorodibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
TCDD	O
)	O
contains	O
the	O
Ah	B
receptor	I
protein	I
and	O
ARNT	B
but	O
not	O
the	O
90	B
-	I
kDa	I
heat	I
shock	I
protein	I
.	O

LDL	B
cholesterol	I
decreased	O
from	O
4	O
.	O
74	O
+/-	O
0	O
.	O
87	O
to	O
3	O
.	O
78	O
+/-	O
0	O
.	O
78	O
mmol	O
/	O
l	O
after	O
8	O
weeks	O
on	O
simvastatin	O
(	O
P	O
<	O
0	O
.	O
001	O
),	O
and	O
apo	B
B	I
fell	O
from	O
142	O
+/-	O
31	O
to	O
112	O
+/-	O
22	O
mg	O
/	O
dl	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

Continued	O
absorption	O
of	O
amino	O
acids	O
by	O
the	O
NBB	O
carrier	O
(	O
for	O
neutral	O
amino	O
acids	O
),	O
the	O
Y	O
+	O
system	O
(	O
for	O
dibasic	O
amino	O
acids	O
),	O
and	O
the	O
PHE	O
carrier	O
were	O
operative	O
even	O
during	O
the	O
actively	O
purging	O
stage	O
of	O
watery	O
diarrhoea	O
due	O
to	O
cholera	O
.	O

A	O
high	O
mean	O
intensity	O
of	O
CLTPA	O
(	O
standardized	O
multivariate	O
regression	O
coefficient	O
beta	B
-	I
0	O
.	O
059	O
,	O
p	O
=	O
0	O
.	O
020	O
)	O
and	O
a	O
high	O
maximal	O
oxygen	O
uptake	O
(	O
beta	B
-	I
0	O
.	O
163	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
were	O
associated	O
with	O
reduced	O
plasma	O
fibrinogen	B
when	O
adjusting	O
for	O
the	O
strongest	O
covariates	O
.	O

Skin	O
and	O
bowel	O
TPO2	O
varied	O
with	O
DO2	O
and	O
each	O
other	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

We	O
have	O
isolated	O
a	O
cosmid	O
containing	O
DNA	O
that	O
corresponds	O
to	O
the	O
site	O
of	O
transposon	O
insertion	O
in	O
257DH4	O
and	O
have	O
localized	O
Tn5	B
on	O
an	O
8	O
.	O
0	O
kb	O
EcoRI	B
fragment	I
.	O

The	O
scr	B
regulon	I
of	O
pUR400	O
and	O
the	O
chromosomally	B
encoded	I
scr	I
regulon	I
of	I
Klebsiella	I
pneumoniae	I
KAY2026	I
are	O
both	O
negatively	O
controlled	O
by	O
a	O
specific	O
repressor	O
(	O
ScrR	B
).	O

Transient	O
transfection	O
experiments	O
revealed	O
that	O
Pax	B
-	I
8	I
isoforms	I
a	O
and	O
b	O
,	O
but	O
not	O
c	B
and	O
d	O
,	O
strongly	O
stimulate	O
transcription	O
from	O
a	O
promoter	O
containing	O
six	O
copies	O
of	O
a	O
paired	B
-	I
domain	I
recognition	I
sequence	I
.	O

These	O
results	O
indicate	O
that	O
Rb	B
protein	I
is	O
interacting	O
with	O
some	O
component	O
(	O
s	O
)	O
of	O
the	O
cell	O
cycle	O
-	O
regulatory	O
machinery	O
during	O
G2	O
phase	O
.	O

METHODS	O
:	O
Fifty	O
-	O
one	O
healthy	O
eyes	O
,	O
169	O
ocular	O
hypertensive	O
eyes	O
with	O
normal	O
visual	O
fields	O
,	O
and	O
132	O
glaucomatous	O
eyes	O
with	O
early	O
visual	O
field	O
defects	O
were	O
evaluated	O
with	O
qualitative	O
and	O
quantitative	O
measures	O
of	O
structural	O
damage	O
to	O
the	O
optic	O
nerve	O
and	O
nerve	O
fiber	O
layer	O
.	O

The	O
ADP	B
-	I
ribosylation	I
factor	I
(	I
ARF	I
)	I
family	I
is	O
one	O
of	O
four	O
subfamilies	O
of	O
the	O
RAS	B
superfamily	I
of	O
low	O
molecular	O
weight	O
GTP	B
-	I
binding	I
proteins	I
(	I
G	I
proteins	I
).	O

The	O
E1	B
gene	I
is	O
located	O
within	O
the	O
first	O
intron	O
of	O
the	O
gene	O
for	O
RCC1	B
,	O
a	O
protein	O
that	O
regulates	O
onset	O
of	O
mitosis	O
.	O

Genomic	O
Southern	O
blot	O
analysis	O
and	O
chromosome	O
mapping	O
showed	O
that	O
GPRK6	B
hybridizes	O
to	O
two	O
closely	O
related	O
genes	O
located	O
on	O
chromosomes	O
5	O
and	O
13	O
and	O
are	O
,	O
therefore	O
,	O
distinct	O
from	O
the	O
GPRK	B
located	O
near	O
the	O
Huntington	O
disease	O
locus	O
on	O
chromosome	O
4	O
.	O

Metabolic	O
labeling	O
studies	O
in	O
S	O
.	O
cerevisiae	O
and	O
co	O
-	O
expression	O
of	O
nmt72p	B
with	O
several	O
protein	O
substrates	O
of	O
Nmt1p	B
in	O
Escherichia	O
coli	O
indicate	O
that	O
the	O
Leu99	O
-->	O
Pro	O
substitution	O
causes	O
a	O
reduction	O
in	O
the	O
acylation	O
of	O
some	O
but	O
not	O
all	O
protein	O
substrates	O
.	O

The	O
sequence	O
of	O
the	O
HIR1	B
gene	I
predicts	O
an	O
88	O
-	O
kDa	O
protein	O
with	O
three	O
repeats	O
of	O
a	O
motif	O
found	O
in	O
the	O
G	B
beta	I
subunit	I
of	O
retinal	O
transducin	B
and	O
in	O
a	O
yeast	O
transcriptional	O
repressor	O
,	O
Tup1	B
.	O

To	O
identify	O
factors	O
that	O
may	O
modify	O
the	O
heterosexual	O
transmission	O
of	O
human	O
T	O
cell	O
leukemia	O
/	O
lymphoma	O
virus	O
type	O
I	O
(	O
HTLV	B
-	I
I	I
),	O
534	O
married	O
couples	O
enrolled	O
in	O
the	O
Miyazaki	O
Cohort	O
Study	O
between	O
November	O
1984	O
and	O
April	O
1989	O
were	O
studied	O
:	O
95	O
husband	O
HTLV	B
-	I
I	I
-	I
seropositive	O
(	O
H	O
+)/	O
wife	O
seropositive	O
(	O
W	O
+),	O
33	O
H	O
+/	O
W	O
-,	O
64	O
H	O
-/	O
W	O
+,	O
and	O
342	O
H	O
-/	O
W	O
-.	O

Biol	O
.	O

SAECG	O
,	O
echocardiography	O
and	O
thallium	O
-	O
201	O
imaging	O
were	O
performed	O
before	O
and	O
1	O
month	O
after	O
attempted	O
angioplasty	O
.	O

As	O
the	O
components	O
of	O
these	O
complexes	O
,	O
at	O
least	O
five	O
TRBPs	B
(	O
p30	B
,	O
p37	B
,	O
p46	B
,	O
p50	B
,	O
and	O
p56	B
)	O
showing	O
specific	O
binding	O
to	O
the	O
TAR	B
RNA	I
were	O
detected	O
in	O
the	O
uv	O
cross	O
-	O
linking	O
assay	O
.	O

The	O
obvious	O
functional	O
necessity	O
for	O
editing	O
in	O
kinetoplastid	O
mitochondria	O
is	O
the	O
formation	O
of	O
translatable	O
mRNAs	O
.	O

Localization	O
of	O
the	O
intronless	O
gene	O
coding	O
for	O
calmodulin	B
-	I
like	I
protein	I
CLP	I
to	O
human	O
chromosome	O
10p13	O
-	O
ter	O
.	O

The	O
half	O
-	O
life	O
of	O
the	O
serum	O
-	O
induced	O
CBP	B
/	I
tk	I
binding	I
activity	O
was	O
estimated	O
to	O
be	O
less	O
than	O
1	O
h	O
.(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

Furthermore	O
,	O
competitor	O
containing	O
the	O
YY1	B
consensus	I
sequence	I
competed	O
for	O
protein	B
B	I
binding	I
,	O
whereas	O
competitor	O
containing	O
a	O
perfect	O
yeast	B
ABF	I
-	I
1	I
consensus	I
sequence	I
did	O
not	O
.(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

These	O
data	O
establish	O
Smd1p	B
as	O
a	O
required	O
component	O
of	O
the	O
cellular	O
splicing	O
apparatus	O
and	O
a	O
factor	O
in	O
snRNA	O
maturation	O
and	O
stability	O
.	O

In	O
Experiment	O
2	O
scopolamine	O
hydrobromide	O
,	O
0	O
.	O
5	O
and	O
1	O
.	O
0	O
mg	O
/	O
kg	O
i	O
.	O
p	O
.,	O
was	O
administered	O
1	O
h	O
before	O
each	O
electrical	O
stimulation	O
until	O
each	O
rat	O
showed	O
the	O
stage	O
-	O
3	O
seizure	O
.	O

PNT	O
,	O
ADD	O
and	O
BSS	O
in	O
the	O
initial	O
stage	O
of	O
kindling	O
,	O
kindling	O
rate	O
for	O
the	O
stage	O
-	O
3	O
and	O
-	O
5	O
seizures	O
,	O
seizure	O
parameters	O
at	O
the	O
first	O
stage	O
-	O
3	O
and	O
-	O
5	O
were	O
recorded	O
and	O
compared	O
to	O
the	O
values	O
of	O
saline	O
-	O
treated	O
,	O
control	O
group	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
pyridinium	O
cross	O
-	O
link	O
excretion	O
and	O
thyroid	O
hormone	O
concentrations	O
.	O

These	O
studies	O
demonstrate	O
that	O
both	O
G	B
alpha	I
i	I
genes	I
are	O
dynamically	O
regulated	O
in	O
LLC	O
-	O
PK1	O
cells	O
by	O
both	O
growth	O
,	O
differentiation	O
,	O
and	O
hormone	O
signals	O
.	O

When	O
ligated	O
to	O
the	O
proIL	B
-	I
1	I
beta	I
cap	I
site	I
-	I
proximal	O
region	O
(	O
located	O
between	O
-	O
131	O
to	O
+	O
12	O
),	O
both	O
the	O
proIL	B
-	I
1	I
beta	I
and	O
the	O
simian	B
virus	I
40	I
enhancer	I
elements	O
functioned	O
more	O
efficiently	O
in	O
monocytes	O
than	O
in	O
HeLa	O
cells	O
,	O
which	O
are	O
not	O
normally	O
competent	O
for	O
IL	B
-	I
1	I
beta	I
expression	O
.	O

We	O
have	O
isolated	O
and	O
characterized	O
the	O
GCD6	B
and	O
GCD7	B
genes	I
and	O
shown	O
that	O
their	O
products	O
are	O
required	O
to	O
repress	O
GCN4	B
translation	I
under	O
nonstarvation	O
conditions	O
.	O

The	O
plateau	O
MO2	O
value	O
was	O
that	O
predicted	O
by	O
allometric	O
relation	O
.	O

Histochemical	O
localization	O
of	O
GUS	B
revealed	O
promoter	O
function	O
in	O
leaf	O
epidermis	O
,	O
mesophyll	O
and	O
vascular	O
bundles	O
,	O
in	O
the	O
cortex	O
and	O
vascular	O
cylinder	O
of	O
the	O
root	O
.	O

Zinc	O
fingers	O
(	O
Zf	O
)	O
are	O
a	O
common	O
structural	O
motif	O
found	O
in	O
many	O
nucleic	O
acid	O
-	O
binding	O
proteins	O
.	O

Endosonography	O
accurately	O
assessed	O
tumor	O
extension	O
in	O
two	O
T2	O
tumors	O
,	O
14	O
T3	O
tumors	O
,	O
and	O
seven	O
T4	O
tumors	O
.	O

In	O
contrast	O
,	O
rats	O
receiving	O
U74500A	O
(	O
2	O
mg	O
/	O
kg	O
i	O
.	O
v	O
.	O
infusion	O
commencing	O
30	O
min	O
prior	O
to	O
revascularisation	O
)	O
exhibited	O
enhanced	O
GMBF	O
throughout	O
reperfusion	O
[	O
PI	B
10	O
min	O
:	O
3	O
.	O
26	O
(	O
2	O
.	O
56	O
-	O
3	O
.	O
63	O
);	O
120	O
min	O
:	O
2	O
.	O
03	O
(	O
1	O
.	O
73	O
-	O
2	O
.	O
25	O
);	O
240	O
min	O
:	O
2	O
.	O
13	O
(	O
1	O
.	O
75	O
-	O
2	O
.	O
44	O
),	O
p	O
<	O
0	O
.	O
01	O
vs	O
.	O
controls	O
and	O
normals	O
]	O
with	O
complete	O
muscle	O
salvage	O
[	O
GMV	O
100	O
%	O
in	O
all	O
reperfused	O
muscles	O
,	O
p	O
<	O
0	O
.	O
01	O
vs	O
.	O
controls	O
,	O
not	O
significant	O
(	O
NS	O
)	O
vs	O
.	O
normals	O
and	O
6	O
h	O
ischaemia	O
].(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Sterile	O
mutants	O
of	O
Saccharomyces	O
cerevisiae	O
were	O
isolated	O
from	O
alpha	B
*	I
cells	O
having	O
the	O
a	O
/	O
alpha	B
aar1	I
-	I
6	I
genotype	O
(	O
exhibiting	O
alpha	O
mating	O
ability	O
and	O
weak	O
a	O
mating	O
ability	O
as	O
a	O
result	O
of	O
a	O
defect	O
in	O
a1	B
-	I
alpha	I
2	I
repression	O
).	O

We	O
studied	O
the	O
functional	O
interaction	O
between	O
human	B
embryonic	I
zeta	I
2	I
globin	I
promoter	I
and	O
the	O
alpha	B
globin	I
regulatory	I
element	I
(	I
HS	I
-	I
40	I
)	O
located	O
40	O
kb	O
upstream	O
of	O
the	O
zeta	B
2	I
globin	I
gene	I
.	O

Initial	O
results	O
indicate	O
that	O
this	O
23S	B
pre	I
-	I
rRNA	I
is	O
the	O
same	O
as	O
the	O
species	O
detected	O
on	O
depletion	O
of	O
the	O
small	B
nucleolar	I
RNA	I
-	I
associated	I
proteins	I
NOP1	I
and	O
GAR1	B
and	O
in	O
an	O
snr10	B
mutant	I
strain	O
.	O

Breitbart	O
,	O
L	O
.	O

OBJECTIVE	O
:	O
Our	O
purpose	O
was	O
to	O
determine	O
the	O
simultaneous	O
concentrations	O
of	O
serum	O
cotinine	O
in	O
both	O
fetal	O
and	O
maternal	O
blood	O
.	O

This	O
prospective	O
study	O
compared	O
the	O
measured	O
energy	O
expenditures	O
of	O
30	O
patients	O
using	O
indirect	O
calorimetry	O
with	O
their	O
predicted	O
basal	O
energy	O
expenditure	O
according	O
to	O
the	O
Harris	O
-	O
Benedict	O
equation	O
,	O
or	O
their	O
calculated	O
energy	O
expenditure	O
derived	O
from	O
basal	O
energy	O
expenditure	O
times	O
,	O
an	O
activity	O
factor	O
,	O
and	O
a	O
stress	O
factor	O
.	O

We	O
discuss	O
the	O
need	O
to	O
use	O
animals	O
older	O
than	O
3	O
months	O
for	O
the	O
study	O
of	O
'	O
adult	O
'	O
regeneration	O
phenomena	O
since	O
3	O
-	O
month	O
-	O
old	O
rats	O
may	O
be	O
somewhat	O
immature	O
.	O

A	O
rat	O
cDNA	O
that	O
encodes	O
eIF	B
-	I
5	O
has	O
been	O
isolated	O
and	O
expressed	O
in	O
Escherichia	O
coli	O
to	O
yield	O
a	O
catalytically	O
active	O
eIF	B
-	I
5	I
protein	I
.	O

Mutational	O
analyses	O
have	O
demonstrated	O
the	O
importance	O
of	O
sequences	O
within	O
the	O
327	O
bp	O
segment	O
that	O
contain	O
a	O
putative	O
cyclic	B
AMP	I
responsive	I
element	I
binding	I
protein	I
(	I
CREB	I
)	I
binding	I
site	I
for	O
TGF	B
-	I
beta	I
1	I
and	O
PMA	O
responsiveness	O
and	O
putative	O
PU	B
-	I
1	I
and	O
Sp1	B
binding	I
sites	I
for	O
basal	O
promoter	O
activity	O
.	O

Examination	O
of	O
the	O
immediate	O
sequence	O
5	O
'	O
to	O
the	O
mRNA	O
start	O
site	O
reveals	O
no	O
TATA	O
box	O
and	O
multiple	O
known	O
enhancer	O
sequences	O
.	O

Pseudosubstrate	O
(	O
19	O
-	O
36	O
),	O
derived	O
from	O
the	O
C	O
-	O
terminus	O
of	O
Ca	B
-	I
dependent	I
PKC	I
isotypes	I
,	O
inhibited	O
beta	B
-	I
PKC	I
but	O
not	O
nPKC	B
activity	O
using	O
either	O
Histone	B
IIIS	I
or	O
peptide	O
(	O
19	O
-	O
31	O
)	O
as	O
substrate	O
.	O

Transient	O
transfection	O
analysis	O
with	O
these	O
mutations	O
revealed	O
that	O
only	O
a	O
10	O
-	O
bp	O
region	O
,	O
containing	O
precisely	O
the	O
Ets	B
and	O
proximal	O
LyF	B
-	I
1	I
binding	I
sites	I
,	O
was	O
needed	O
for	O
D	O
'	O
activity	O
.	O

However	O
,	O
despite	O
its	O
relationship	O
to	O
the	O
TR	B
,	O
Rev	B
-	O
Erb	B
bound	O
poorly	O
to	O
TR	B
binding	I
sites	I
.	O

These	O
protective	O
influences	O
were	O
observed	O
throughout	O
the	O
range	O
of	O
filling	O
pressures	O
measured	O
,	O
from	O
0	O
to	O
30	O
mmHg	O
.	O

The	O
nifJ	B
and	I
nifH	I
promoters	I
of	I
Klebsiella	I
pneumoniae	I
are	O
divergently	O
transcribed	O
sigma	B
54	I
-	I
dependent	I
promoters	I
that	O
are	O
positively	O
activated	O
by	O
the	O
NifA	B
protein	I
.	O

The	O
yeast	B
gene	I
that	O
encodes	O
eIF	B
-	I
5	O
,	O
designated	O
TIF5	B
,	O
has	O
been	O
isolated	O
and	O
expressed	O
in	O
Escherichia	O
coli	O
to	O
yield	O
a	O
catalytically	O
active	O
eIF	B
-	I
5	I
protein	I
.	O

Three	O
patients	O
had	O
well	O
-,	O
6	O
patients	O
had	O
moderately	O
-,	O
and	O
5	O
patients	O
had	O
poorly	O
-	O
differentiated	O
adenocarcinoma	O
of	O
the	O
prostate	O
.	O

Spontaneous	O
burst	O
firing	O
in	O
cat	O
primary	O
auditory	O
cortex	O
:	O
age	O
and	O
depth	O
dependence	O
and	O
its	O
effect	O
on	O
neural	O
interaction	O
measures	O
.	O

As	O
a	O
result	O
of	O
alternative	O
splicing	O
,	O
the	O
BGP	B
gene	I
is	O
transcribed	O
into	O
at	O
least	O
seven	O
distinct	O
mRNA	O
species	O
.	O

However	O
,	O
essential	O
contrast	O
differences	O
existing	O
between	O
the	O
FSE	O
sequences	O
and	O
their	O
routine	O
asymmetric	O
dual	O
SE	O
counterpart	O
can	O
be	O
identified	O
.	O

This	O
sequence	O
similarity	O
raises	O
the	O
possibility	O
that	O
GCN1	B
interacts	O
with	O
ribosomes	O
or	O
tRNA	O
molecules	O
and	O
functions	O
in	O
conjunction	O
with	O
GCN2	B
in	O
monitoring	O
uncharged	O
tRNA	O
levels	O
during	O
the	O
process	O
of	O
translation	O
elongation	O
.	O

Multizone	O
PRK	O
has	O
been	O
suggested	O
to	O
increase	O
the	O
predictability	O
of	O
higher	O
myopic	O
corrections	O
.	O

Second	O
,	O
nitrate	O
induction	O
of	O
aeg	B
-	I
46	I
.	I
5	I
operon	I
expression	O
is	O
substantially	O
enhanced	O
in	O
narL	B
null	I
strains	O
(	O
M	O
.	O
H	O
.	O

One	O
enigmatic	O
aspect	O
of	O
GATA	B
factor	I
expression	O
is	O
that	O
several	O
GATA	B
proteins	I
,	O
which	O
ostensibly	O
share	O
the	O
same	O
DNA	B
-	I
binding	I
site	I
specificity	O
,	O
are	O
coexpressed	O
in	O
erythroid	O
cells	O
.	O

Biol	O
.	O

Characterization	O
and	O
hormonal	O
regulation	O
of	O
the	O
promoter	O
of	O
the	O
rat	B
prostaglandin	I
endoperoxide	I
synthase	I
2	I
gene	I
in	O
granulosa	O
cells	O
.	O

The	O
retention	O
of	O
75SeHCAT	O
was	O
low	O
.	O

Patient	O
characteristics	O
associated	O
with	O
deep	O
wounds	O
as	O
well	O
as	O
patient	O
and	O
wound	O
characteristics	O
predictive	O
of	O
the	O
extent	O
of	O
healing	O
and	O
time	O
required	O
for	O
healing	O
were	O
identified	O
.	O

It	O
is	O
reported	O
that	O
,	O
at	O
present	O
,	O
most	O
of	O
the	O
MRSAs	O
spreading	O
in	O
Japan	O
are	O
acceleratedly	O
acquiring	O
resistance	O
to	O
many	O
drugs	O
,	O
and	O
especially	O
,	O
they	O
are	O
developing	O
high	O
resistance	O
against	O
beta	B
-	I
lactams	O
.	O

Here	O
,	O
we	O
have	O
more	O
closely	O
investigated	O
transactivation	O
of	O
the	O
human	B
HSP70	I
promoter	I
by	O
Myb	B
proteins	I
.	O

Tl	O
-	O
201	O
uptake	O
ratio	O
of	O
the	O
right	O
ventricle	O
,	O
which	O
represents	O
the	O
ratio	O
of	O
total	O
counts	O
of	O
the	O
right	O
ventricle	O
to	O
counts	O
of	O
the	O
administered	O
dose	O
of	O
Tl	O
-	O
201	O
,	O
was	O
higher	O
in	O
COPD	O
,	O
especially	O
in	O
pulmonary	O
emphysema	O
and	O
B	O
type	O
COPD	O
by	O
Burrows	O
classification	O
than	O
in	O
controls	O
.	O

The	O
11	O
;	O
22	O
chromosomal	O
translocation	O
specifically	O
linked	O
to	O
Ewing	O
sarcoma	O
and	O
primitive	O
neuroectodermal	O
tumor	O
results	O
in	O
a	O
chimeric	O
molecule	O
fusing	O
the	O
amino	O
-	O
terminal	O
-	O
encoding	O
portion	O
of	O
the	O
EWS	B
gene	I
to	O
the	O
carboxyl	B
-	I
terminal	I
DNA	I
-	I
binding	I
domain	I
encoded	I
by	O
the	O
FLI1	B
gene	I
.	O

Umweltchem	O
.	O

Egd1p	B
is	O
homologous	O
to	O
human	B
BTF3b	I
,	O
recently	O
identified	O
as	O
the	O
beta	B
subunit	I
of	O
the	O
heterodimeric	B
nascent	I
-	I
polypeptide	I
-	I
associated	I
complex	I
(	O
NAC	B
)	O
involved	O
in	O
ensuring	O
signal	B
-	I
sequence	I
-	I
specific	I
protein	I
sorting	I
and	O
translocation	O
[	O
Wiedmann	O
et	O
al	O
.,	O
Nature	O
370	O
(	O
1994	O
)	O
434	O
-	O
440	O
].	O

A	O
chaotropic	O
detergent	O
,	O
0	O
.	O
1	O
%	O
Nonidet	O
P	O
-	O
40	O
,	O
also	O
abolished	O
the	O
interaction	O
,	O
further	O
supporting	O
the	O
hydrophobic	O
nature	O
of	O
the	O
interaction	O
.	O

Contrary	O
to	O
expectations	O
,	O
we	O
find	O
a	O
relatively	O
high	O
level	O
of	O
variation	O
in	O
the	O
stripe	B
2	I
enhancer	I
region	O
,	O
including	O
point	O
substitutions	O
and	O
insertion	O
/	O
deletions	O
in	O
binding	O
sites	O
,	O
and	O
a	O
comparable	O
level	O
of	O
variation	O
in	O
the	O
other	O
noncoding	O
regions	O
.	O

The	O
domain	O
structure	O
of	O
bovine	B
LTBP	I
-	I
2	I
is	O
very	O
similar	O
to	O
that	O
of	O
the	O
human	B
LTBP	I
-	I
2	I
,	O
containing	O
20	O
examples	O
of	O
6	O
-	O
cysteine	O
epidermal	B
growth	I
factor	I
-	I
like	I
repeats	I
,	O
16	O
of	O
which	O
have	O
the	O
consensus	O
sequence	O
for	O
calcium	O
binding	O
,	O
together	O
with	O
4	O
examples	O
of	O
8	O
-	O
cysteine	O
motifs	O
characteristic	O
of	O
fibrillins	B
and	I
LTBP	I
-	I
1	I
.	O

Differential	O
regulation	O
of	O
the	O
alpha	B
/	I
beta	I
interferon	I
-	I
stimulated	O
Jak	B
/	O
Stat	B
pathway	O
by	O
the	O
SH2	B
domain	I
-	I
containing	I
tyrosine	I
phosphatase	I
SHPTP1	I
.	O

Videonystagmoscopy	O
has	O
been	O
used	O
to	O
subjectively	O
observe	O
the	O
responses	O
of	O
the	O
vestibular	O
system	O
in	O
a	O
population	O
of	O
patients	O
with	O
vestibular	O
deficits	O
.	O

Stems	O
contain	O
distinctly	O
less	O
P	B
protein	I
mRNA	I
and	O
the	O
relative	O
level	O
in	O
roots	O
is	O
very	O
low	O
but	O
still	O
clearly	O
detectable	O
.	O

The	O
B	B
.	I
germanica	I
cyclophilin	I
amino	O
acid	O
sequence	O
shares	O
83	O
%	O
identity	O
with	O
the	O
cytosolic	B
cyclophilin	I
isoform	I
from	O
Drosophila	B
melanogaster	I
(	O
Cyp	B
-	I
1	I
).	O

The	O
site	O
of	O
autophosphorylation	O
is	O
Tyr397	O
which	O
corresponds	O
to	O
the	O
consensus	O
autophosphorylation	O
site	O
of	O
other	O
Src	B
family	I
tyrosine	I
kinases	I
.	O

It	O
is	O
considered	O
that	O
the	O
recurrent	O
annular	O
erythema	O
is	O
a	O
specific	O
skin	O
manifestation	O
of	O
SjS	O
with	O
anti	B
SS	I
-	I
A	I
/	I
SS	I
-	I
B	I
antibodies	I
.	O

An	O
infectious	O
origin	O
should	O
always	O
be	O
excluded	O
since	O
specific	O
etiologic	O
therapy	O
may	O
be	O
implemented	O
.	O

The	O
predicted	O
protein	O
products	O
of	O
ORFs	B
N2417	I
and	O
N2403	B
present	O
similarities	O
with	O
domains	O
from	O
proteins	O
of	O
other	O
organisms	O
:	O
the	O
Candida	O
maltosa	O
cycloheximide	B
-	I
resistance	I
protein	I
,	O
the	O
human	B
interleukin	I
enhancer	I
-	I
binding	I
factor	I
(	O
ILF	B
-	I
2	I
).	O

The	O
subjects	O
from	O
the	O
two	O
regions	O
with	O
a	O
higher	O
pollution	O
level	O
had	O
lower	O
FVC	O
and	O
FEV1	O
values	O
than	O
those	O
from	O
the	O
Viskovo	O
region	O
.	O

DAF	B
is	O
a	O
70	O
kD	O
glycoprotein	O
containing	O
complement	O
regulatory	O
short	O
consensus	O
repeats	O
(	O
SCRs	O
);	O
its	O
gene	O
is	O
located	O
in	O
the	O
regulation	O
of	O
complement	O
activation	O
(	O
RCA	B
)	I
gene	I
cluster	I
on	O
chromosome	O
1	O
and	O
is	O
about	O
40	O
kb	O
in	O
size	O
.	O

There	O
is	O
no	O
TATA	O
box	O
around	O
the	O
transcriptional	O
start	O
points	O
(	O
tsp	O
),	O
as	O
determined	O
by	O
primer	O
extension	O
analysis	O
.	O

Characterization	O
of	O
an	O
EcR	B
/	O
USP	B
heterodimer	I
target	I
site	I
that	O
mediates	O
ecdysone	O
responsiveness	O
of	O
the	O
Drosophila	B
Lsp	I
-	I
2	I
gene	I
.	O

The	O
gene	O
was	O
uniquely	O
mapped	O
with	O
odds	O
>	O
1	O
,	O
000	O
:	O
1	O
on	O
chromosome	O
3p	O
in	O
Centre	O
d	O
'	O
Etude	O
du	O
Polymorphisme	O
Humain	O
pedigrees	O
.	O

The	O
transposon	O
-	O
inactivated	O
gene	O
,	O
designated	O
pilP	B
,	O
is	O
525	O
bp	O
long	O
,	O
potentially	O
encoding	O
a	O
19	O
.	O
1	O
-	O
kDa	O
protein	O
precursor	O
that	O
contains	O
a	O
typical	O
membrane	O
lipoprotein	O
leader	O
sequence	O
.	O

Cheung	O
and	O
S	O
.	O

CXC	O
chemokines	O
bind	O
to	O
unique	O
sets	O
of	O
selectivity	O
determinants	O
that	O
can	O
function	O
independently	O
and	O
are	O
broadly	O
distributed	O
on	O
multiple	O
domains	O
of	O
human	B
interleukin	I
-	I
8	I
receptor	I
B	I
.	O

In	O
this	O
case	O
the	O
degree	O
of	O
promoter	O
methylation	O
,	O
which	O
could	O
extend	O
beyond	O
the	O
T	O
-	O
DNA	O
borders	O
,	O
was	O
not	O
correlated	O
with	O
the	O
reduction	O
in	O
steady	O
-	O
state	O
poly	O
(	O
A	O
)+	O
mRNA	O
levels	O
,	O
the	O
silenced	O
state	O
was	O
transmitted	O
through	O
meiosis	O
and	O
reactivation	O
lasted	O
several	O
generations	O
.	O

Here	O
we	O
report	O
that	O
the	O
proline	O
-	O
rich	O
region	O
of	O
CAP	O
is	O
recognized	O
by	O
the	O
SH3	B
domains	I
of	O
several	O
proteins	O
,	O
including	O
the	O
yeast	B
actin	I
-	I
associated	I
protein	I
Abp1p	I
.	O

Differentiation	O
was	O
not	O
observed	O
after	O
cellular	O
expression	O
of	O
GTPase	B
-	I
deficient	O
forms	O
of	O
alpha	B
i2	I
or	I
alpha	I
0	O
,	O
indicating	O
selectivity	O
for	O
the	O
Gq	B
family	I
of	O
G	B
proteins	I
.	O

By	O
comparing	O
the	O
abundances	O
of	O
many	O
yeast	O
transcripts	O
in	O
isogenic	O
wild	B
-	I
type	I
and	O
paf1	B
mutant	I
strains	O
,	O
we	O
have	O
identified	O
genes	O
whose	O
expression	O
is	O
affected	O
by	O
PAF1	B
.	O

Using	O
a	O
high	O
-	O
copy	O
suppression	O
strategy	O
,	O
we	O
have	O
identified	O
a	O
yeast	B
gene	I
(	O
UBS1	B
)	O
whose	O
elevated	O
expression	O
suppresses	O
the	O
conditional	O
cell	O
cycle	O
defects	O
associated	O
with	O
cdc34	B
mutations	O
.	O

We	O
tested	O
10	O
rats	O
with	O
electrophysiologically	O
guided	O
,	O
ibotenic	O
acid	O
lesions	O
of	O
the	O
PBN	O
(	O
PBNx	O
)	O
to	O
determine	O
whether	O
they	O
could	O
acquire	O
a	O
LiCl	O
-	O
induced	O
CTA	O
to	O
l	O
-	O
alanine	O
(	O
0	O
.	O
3	O
M	O
)	O
or	O
demonstrate	O
a	O
sodium	O
appetite	O
following	O
furosemide	O
treatment	O
and	O
overnight	O
access	O
to	O
sodium	O
deficient	O
chow	O
.	O

Magnetic	O
storm	O
indicators	O
could	O
be	O
used	O
in	O
medicine	O
,	O
in	O
geophysics	O
and	O
for	O
special	O
purposes	O
.	O

Transgenic	O
tobacco	O
plants	O
(	O
ppa	B
-	I
1	I
)	O
constitutively	O
expressing	O
Escherichia	B
coli	I
pyrophosphatase	I
behind	O
the	O
35S	B
CaMV	I
promoter	I
accumulate	O
high	O
levels	O
of	O
soluble	O
sugars	O
in	O
their	O
leaves	O
[	O
27	O
].	O

Hb	B
levels	O
remained	O
adequate	O
(	O
Hb	B
=	O
10	O
.	O
68	O
+/-	O
0	O
.	O
77	O
g	O
/	O
dl	O
)	O
after	O
14	O
.	O
6	O
+/-	O
7	O
.	O
64	O
months	O
.	O

CBT	O
is	O
discussed	O
in	O
comparison	O
with	O
the	O
Wisconsin	O
Card	O
Sorting	O
Test	O
as	O
a	O
potential	O
cognitive	O
activation	O
task	O
for	O
functional	O
neuroimaging	O
of	O
the	O
frontal	O
lobes	O
.	O

Neither	O
class	O
II	O
nor	O
IV	O
infections	O
precluded	O
transplantation	O
.	O

Upstream	O
of	O
-	O
37	O
,	O
the	O
5	O
'	O
untranslated	O
sequences	O
of	O
the	O
isolates	O
differ	O
in	O
both	O
length	O
and	O
sequence	O
.	O

High	O
fibrinogen	B
levels	O
could	O
thus	O
be	O
a	O
risk	O
for	O
perioperative	O
thrombosis	O
.	O

Strontium	O
chloride	O
Sr	O
89	O
is	O
costly	O
,	O
but	O
preliminary	O
analysis	O
indicates	O
that	O
it	O
may	O
reduce	O
management	O
expenditures	O
overall	O
.(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

This	O
5	O
'	O
splice	O
site	O
sequence	O
was	O
required	O
for	O
enhanced	O
polyadenylation	O
and	O
was	O
recognized	O
by	O
both	O
U1	B
small	I
nuclear	I
ribonucleoproteins	I
(	I
snRNPs	I
)	O
and	O
alternative	O
splicing	B
factor	I
/	I
splicing	I
factor	I
2	I
(	O
ASF	B
/	I
SF2	O
).	O

We	O
propose	O
that	O
CTS1	B
and	I
CTS2	I
of	O
Ci	B
are	O
members	O
of	O
two	O
distinct	O
classes	O
of	O
fungal	B
chitinases	I
,	O
an	O
observation	O
not	O
previously	O
reported	O
for	O
a	O
single	O
fungus	O
.	O

Although	O
the	O
consumption	O
of	O
myoglobin	B
-	I
bound	O
O2	O
(	O
MbO2	O
)	O
stores	O
in	O
seal	O
muscles	O
has	O
been	O
demonstrated	O
in	O
seal	O
muscles	O
during	O
laboratory	O
simulations	O
of	O
diving	O
,	O
this	O
may	O
not	O
be	O
a	O
feature	O
of	O
normal	O
field	O
diving	O
in	O
which	O
measurements	O
of	O
heart	O
rate	O
and	O
lactate	O
production	O
show	O
marked	O
differences	O
from	O
the	O
profound	O
diving	O
response	O
induced	O
by	O
forced	O
immersion	O
.	O

The	O
Saccharomyces	O
cerevisiae	O
spindle	O
pole	O
body	O
duplication	O
gene	O
MPS1	B
is	O
part	O
of	O
a	O
mitotic	O
checkpoint	O
.	O

In	O
our	O
opinion	O
,	O
the	O
SM	B
-	I
CMA	O
system	O
is	O
,	O
despite	O
some	O
shortcomings	O
in	O
its	O
user	O
-	O
interface	O
,	O
a	O
useful	O
and	O
versatile	O
instrument	O
for	O
examination	O
of	O
human	O
semen	O
samples	O
,	O
with	O
desirable	O
features	O
.	O

The	O
purpose	O
of	O
the	O
study	O
reported	O
here	O
was	O
to	O
investigate	O
whether	O
differences	O
in	O
T1	O
and	O
T2	O
between	O
tumors	O
are	O
mainly	O
a	O
consequence	O
of	O
differences	O
in	O
the	O
fractional	O
volume	O
of	O
the	O
extracellular	O
compartment	O
.	O

Apparent	O
loss	O
of	O
differentiation	O
markers	O
characterizes	O
advanced	O
malignant	O
neoplasms	O
.	O

The	O
preferential	O
heterodimerization	O
of	O
USF	B
subunits	I
was	O
reproduced	O
ex	O
vivo	O
,	O
while	O
the	O
in	O
vitro	O
association	O
of	O
cotranslated	O
subunits	O
,	O
or	O
recombinant	O
USF	B
proteins	I
,	O
appeared	O
to	O
be	O
random	O
.	O

To	O
elucidate	O
the	O
functional	O
significance	O
of	O
Fyn	B
in	O
the	O
expression	O
of	O
viral	O
promoters	O
,	O
we	O
transfected	O
a	O
Fyn	B
-	I
expression	O
vector	O
together	O
with	O
a	O
reporter	O
plasmid	O
containing	O
the	O
chloramphenicol	B
acetyltransferase	I
gene	I
driven	O
by	O
HIV	B
LTR	I
into	O
a	O
human	O
T	O
cell	O
line	O
,	O
Jurkat	O
.	O

These	O
studies	O
indicate	O
that	O
the	O
acidimetric	O
test	O
was	O
less	O
sensitive	O
than	O
the	O
chromogenic	O
cephalosporin	O
substrates	O
and	O
that	O
nitrocefin	O
and	O
S1	B
could	O
be	O
used	O
to	O
screen	O
for	O
beta	B
-	I
lactamase	I
production	O
in	O
these	O
tested	O
species	O
.	O

This	O
region	O
also	O
contains	O
a	O
gene	O
specifying	O
a	O
Leu	B
-	I
tRNA	I
precursor	I
and	O
a	O
remnant	O
of	O
a	O
tau	O
element	O
.	O

During	O
the	O
following	O
pregnancy	O
ultrasonographic	O
studies	O
of	O
the	O
male	O
fetus	O
in	O
the	O
16th	O
week	O
of	O
gestation	O
revealed	O
severe	O
micrognathia	O
,	O
short	O
and	O
wide	O
thumbs	O
,	O
and	O
big	O
toes	O
,	O
and	O
bowed	O
tibiae	O
.	O

A	O
3	O
-	O
week	O
regimen	O
of	O
erythropoietin	B
may	O
help	O
prevent	O
the	O
donor	O
'	O
s	O
need	O
to	O
receive	O
allogeneic	O
blood	O
transfusion	O
,	O
when	O
the	O
initial	O
Hb	B
levels	O
were	O
below	O
130	O
milligrams	O
.	O

Synthetic	O
enantiomers	O
of	O
drugs	O

Our	O
data	O
suggest	O
that	O
trans	O
-	O
activation	O
from	O
the	O
prothymosin	B
intron	I
enhancer	I
is	O
a	O
faithful	O
reflection	O
of	O
the	O
transforming	O
properties	O
of	O
the	O
Myc	B
protein	I
.	O

In	O
view	O
of	O
the	O
presence	O
of	O
SECIS	O
elements	O
in	O
the	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
of	O
bacterial	B
selenoproteins	I
,	O
we	O
examine	O
the	O
effects	O
in	O
the	O
type	B
1	I
deiodinase	I
of	O
extending	O
the	O
ORF	O
into	O
the	O
SECIS	O
element	O
,	O
and	O
find	O
that	O
this	O
dramatically	O
inhibits	O
SECIS	O
function	O
.	O

This	O
spindle	O
defect	O
of	O
pds1	B
mutants	I
results	O
from	O
a	O
temperature	O
-	O
sensitive	O
step	O
that	O
occurs	O
around	O
the	O
G1	O
/	O
S	O
boundary	O
about	O
the	O
time	O
of	O
spindle	O
assembly	O
.	O

However	O
,	O
for	O
the	O
evaluable	O
cases	O
,	O
the	O
performances	O
of	O
the	O
CD3500	O
and	O
the	O
STKS	O
were	O
broadly	O
similar	O
and	O
generally	O
correlated	O
well	O
with	O
the	O
manual	O
reference	O
procedure	O
.	O

Additional	O
studies	O
with	O
new	O
and	O
reprocessed	O
regenerated	O
cellulose	O
dialyzers	O
comparing	O
450	O
and	O
220	O
mL	O
/	O
min	O
blood	O
flow	O
rates	O
at	O
10	O
minutes	O
showed	O
no	O
change	O
in	O
BTG	O
.	O

The	O
viral	O
LTR	O
was	O
used	O
as	O
the	O
promoter	O
.	O

In	O
conclusion	O
,	O
IgM	B
class	I
CIC	O
is	O
the	O
predominant	O
CIC	O
in	O
acute	O
hepatitis	O
A	O
and	O
correlated	O
with	O
disease	O
activity	O
.	O

Variables	O
evaluated	O
were	O
number	O
of	O
weekly	O
anginal	O
events	O
,	O
data	O
from	O
ergometric	O
exercise	O
testing	O
with	O
simultaneous	O
electrocardiographic	O
registration	O
,	O
semiquantitative	O
evaluation	O
of	O
Tc	O
-	O
99m	O
2	O
-	O
methoxy	O
isobutyl	O
isonitrile	O
(	O
MIBI	O
)	O
scans	O
and	O
rheologic	O
variables	O
.	O

SUMMARY	O
OF	O
REVIEW	O
:	O
We	O
discuss	O
the	O
criteria	O
that	O
make	O
such	O
studies	O
comparable	O
,	O
drawing	O
on	O
the	O
experiences	O
of	O
recent	O
studies	O
performed	O
around	O
the	O
world	O
.	O

Cotransfection	O
with	O
the	O
ie1	B
gene	I
resulted	O
in	O
a	O
dramatic	O
increase	O
in	O
the	O
amount	O
of	O
the	O
two	O
enzymes	O
expressed	O
in	O
the	O
transfected	O
cells	O
.	O

However	O
,	O
only	O
complete	B
DnaJ	I
can	O
cooperate	O
with	O
DnaK	B
and	O
a	O
third	O
protein	O
,	O
GrpE	B
,	O
in	O
refolding	O
denatured	B
firefly	I
luciferase	I
.	O

However	O
,	O
while	O
the	O
sequence	O
similarity	O
between	O
the	O
membrane	O
exons	O
of	O
avian	B
mIgY	I
and	O
mammalian	B
mIgG	I
and	I
IgE	I
is	O
striking	O
,	O
the	O
overall	O
similarity	O
with	O
Xenopus	B
mIgY	I
is	O
very	O
low	O
.	O

Treatment	O
of	O
keratinocytes	O
expressing	O
a	O
normal	O
epidermal	B
growth	I
factor	I
receptor	I
(	I
EGFR	I
)	O
with	O
TGFalpha	B
or	O
epidermal	B
growth	I
factor	I
for	O
5	O
min	O
induced	O
PKCdelta	B
tyrosine	I
phosphorylation	O
.	O

Biol	O
.	O

Polymerization	O
of	O
neurofilament	B
L	I
protein	I
in	O
vitro	O
was	O
inhibited	O
by	O
phosphorylation	O
of	O
neurofilament	B
L	I
protein	I
by	O
PKN	B
.	O

The	O
protein	O
folds	O
correctly	O
with	O
two	O
disulfide	O
bonds	O
and	O
a	O
free	O
thiol	O
group	O
at	O
Cys25	O
.	O

No	O
significant	O
differences	O
existed	O
between	O
the	O
two	O
age	O
groups	O
in	O
baseline	O
characteristics	O
,	O
including	O
treatment	O
protocol	O
,	O
performance	O
status	O
,	O
and	O
serum	B
lactate	I
dehydrogenase	I
(	I
LDH	I
)	O
level	O
.	O

The	O
men	O
self	O
-	O
selected	O
a	O
prescribed	O
diet	O
at	O
home	O
emphasizing	O
saturated	O
fat	O
as	O
the	O
visible	O
fat	O
for	O
1	O
week	O
.	O

These	O
results	O
illuminate	O
a	O
hitherto	O
unanticipated	O
function	O
of	O
U6	B
RNA	I
:	O
the	O
modulation	O
of	O
a	O
phosphorylation	O
-	O
dephosphorylation	O
cycle	O
of	O
C1	B
hnRNP	I
protein	I
that	O
influences	O
the	O
binding	O
affinity	O
of	O
this	O
protein	O
for	O
pre	O
-	O
mRNA	O
.	O

Inclusion	O
of	O
the	O
extended	O
N	O
terminus	O
into	O
the	O
originally	O
reported	O
protein	O
resulted	O
in	O
a	O
striking	O
similarity	O
to	O
the	O
lymphoid	B
factor	I
Lef	I
-	I
1	I
.	O

The	O
17	O
-	O
kDa	O
protein	O
is	O
required	O
for	O
the	O
systemic	O
infection	O
of	O
plants	O
.	O

In	O
sorted	O
bone	O
marrow	O
cells	O
expression	O
of	O
both	O
VpreB	B
genes	I
was	O
detected	O
in	O
pro	B
-	I
B	I
/	I
pre	I
-	I
BI	I
and	O
large	O
pre	O
-	O
BII	O
cells	O
,	O
while	O
the	O
RNA	O
steady	O
state	O
levels	O
were	O
at	O
least	O
100	O
-	O
fold	O
lower	O
in	O
small	O
pre	O
-	O
BII	O
and	O
immature	O
/	O
mature	O
B	O
cells	O
.	O

We	O
have	O
cloned	O
and	O
sequenced	O
a	O
3574	O
-	O
bp	O
Bacillus	B
subtilis	I
(	O
Bs	O
)	O
DNA	O
fragment	O
located	O
between	O
the	O
nrdA	B
and	O
citB	B
genes	I
at	O
about	O
169	O
degrees	O
on	O
the	O
chromosome	O
.	O

In	O
agreement	O
with	O
previous	O
in	O
vitro	O
data	O
,	O
we	O
have	O
shown	O
that	O
UmuD	O
and	O
UmuD	O
'	O
are	O
able	O
to	O
form	O
both	O
homodimers	O
(	O
UmuD	B
-	I
UmuD	I
and	O
UmuD	B
'-	I
UmuD	I
')	I
and	O
a	O
heterodimer	O
(	O
UmuD	B
-	I
UmuD	I
').	O

Using	O
autoantibodies	O
from	O
a	O
Sjogren	O
'	O
s	O
syndrome	O
patient	O
,	O
we	O
have	O
previously	O
identified	O
a	O
230	O
-	O
kDa	O
peripheral	O
membrane	O
protein	O
associated	O
with	O
the	O
cytosolic	O
face	O
of	O
the	O
trans	O
-	O
Golgi	O
(	O
Kooy	O
,	O
J	O
.,	O
Toh	O
,	O
B	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
using	O
crude	O
extracts	O
from	O
FREJ4	O
cells	O
revealed	O
the	O
binding	O
of	O
a	O
member	O
(	O
s	O
)	O
of	O
the	O
Ets	B
family	I
of	O
transcription	O
factors	O
to	O
the	O
P4	B
EBS	I
,	O
as	O
well	O
as	O
the	O
interaction	O
of	O
two	O
members	O
of	O
the	O
Sp1	B
family	I
,	O
Sp1	B
and	O
Sp3	B
,	O
with	O
the	O
adjacent	O
GC	O
box	O
.	O

We	O
show	O
here	O
that	O
these	O
Jun	B
/	O
eb1	B
chimeras	O
are	O
potent	O
transactivators	O
of	O
AP1	B
sites	I
and	O
that	O
they	O
can	O
cooperate	O
with	O
c	B
-	I
Ha	I
-	I
Ras	I
to	O
induce	O
foci	O
.	O

Utilizing	O
transient	O
transfection	O
studies	O
in	O
HepG2	O
cells	O
,	O
we	O
have	O
shown	O
that	O
deletion	O
of	O
the	O
factor	B
VIII	I
promoter	I
sequences	I
distal	O
to	O
nucleotide	O
-	O
44	O
results	O
in	O
a	O
significant	O
but	O
small	O
increase	O
in	O
promoter	O
activity	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
increase	O
in	O
V	O
O2	O
may	O
have	O
been	O
a	O
consequence	O
of	O
the	O
increase	O
in	O
Q	O
O2	O
rather	O
than	O
a	O
response	O
to	O
the	O
procedure	O
itself	O
.	O

As	O
pH	O
and	O
Hb	B
can	O
also	O
affect	O
mixed	O
venous	O
CO2	O
content	O
,	O
the	O
effect	O
on	O
Q	O
was	O
also	O
assessed	O
.	O

No	O
difference	O
in	O
elastin	B
peptide	I
concentration	O
was	O
observed	O
between	O
emphysematous	O
patients	O
and	O
control	O
subjects	O
(	O
mean	O
+/-	O
SD	O
=	O
2	O
.	O
39	O
+/-	O
1	O
.	O
18	O
micrograms	O
/	O
ml	O
in	O
patients	O
versus	O
2	O
.	O
55	O
+/-	O
1	O
.	O
34	O
micrograms	O
/	O
ml	O
in	O
policemen	O
and	O
2	O
.	O
59	O
+/-	O
1	O
.	O
20	O
micrograms	O
/	O
ml	O
in	O
coal	O
miners	O
).	O

The	O
isolated	O
plasmin	B
fragments	I
of	O
VEGF	B
were	O
compared	O
with	O
respect	O
to	O
heparin	O
binding	O
,	O
interaction	O
with	O
soluble	O
VEGF	B
receptors	I
,	O
and	O
ability	O
to	O
promote	O
endothelial	O
cell	O
mitogenesis	O
.	O

In	O
contrast	O
,	O
when	O
the	O
isoform	O
containing	O
the	O
C	B
epsilon4	I
domain	I
joined	O
directly	O
to	O
the	O
M2	O
exon	O
(	O
IgE	B
grande	I
)	O
is	O
expressed	O
in	O
the	O
J558L	O
cell	O
line	O
,	O
it	O
is	O
degraded	O
intracellularly	O
,	O
suggesting	O
a	O
cell	O
line	O
-	O
dependent	O
regulation	O
of	O
secretion	O
.	O

Two	O
XPG	B
regions	O
with	O
putative	O
NLS	O
[	O
amino	O
acid	O
(	O
AA	O
)	O
coordinates	O
:	O
NLS	O
-	O
B	O
(	O
AA	O
1057	O
-	O
1074	O
)	O
and	O
NLS	O
-	O
C	O
(	O
AA	O
1171	O
-	O
1185	O
)]	O
were	O
each	O
shown	O
to	O
independently	O
localize	O
the	O
beta	B
-	I
gal	I
extensively	O
(>	O
80	O
%)	O
to	O
the	O
nucleus	O
of	O
HeLa	O
cells	O
.	O

The	O
lacS	B
gene	I
was	O
cloned	O
in	O
an	O
E	O
.	O
coli	O
-	O
Streptococcus	O
shuttle	O
vector	O
and	O
was	O
expressed	O
both	O
in	O
a	O
lacS	B
deletion	O
derivative	O
of	O
S	O
.	O
thermophilus	O
and	O
in	O
a	O
pNZ63	O
-	O
cured	O
strain	O
,	O
L	O
.	O
lactis	O
NZ6091	O
.	O

The	O
frequency	O
of	O
integrations	O
that	O
led	O
to	O
transcription	O
of	O
the	O
lacZ	B
gene	I
was	O
estimated	O
to	O
be	O
0	O
.	O
5	O
%	O
of	O
all	O
integrations	O
,	O
of	O
which	O
14	O
%	O
were	O
downregulated	O
on	O
differentiation	O
of	O
32D	O
cells	O
towards	O
neutrophils	O
.	O

A	O
study	O
was	O
performed	O
to	O
compare	O
the	O
ONLINE	O
and	O
EMIT	O
II	O
immunoassays	O
with	O
gas	O
chromatographic	O
/	O
mass	O
spectrometric	O
(	O
GC	O
/	O
MS	O
)	O
analysis	O
of	O
methaqualone	O
metabolites	O
on	O
urine	O
using	O
samples	O
obtained	O
from	O
a	O
clinical	O
study	O
.	O

Isolation	O
by	O
PCR	O
of	O
a	O
cDNA	O
clone	O
from	O
pea	O
petals	O
with	O
similarity	O
to	O
petunia	O
and	O
wheat	B
zinc	I
finger	I
proteins	I
.	O

DNA	O
-	O
STAT	B
complexes	I
were	O
detected	O
in	O
all	O
Bcr	B
/	I
Abl	I
-	I
transformed	O
cell	O
lines	O
and	O
they	O
were	O
supershifted	O
by	O
antibodies	O
against	O
STAT1	B
and	O
STAT5	B
.	O

The	O
humanized	B
LL2	I
(	O
hLL2	B
),	O
lacking	O
light	O
chain	O
variable	O
region	O
glycosylation	O
,	O
exhibited	O
immunoreactivities	O
that	O
were	O
comparable	O
to	O
that	O
of	O
chimeric	B
LL2	I
(	O
cLL2	B
),	O
which	O
was	O
shown	O
previously	O
to	O
have	O
antigen	O
-	O
binding	O
properties	O
similar	O
to	O
its	O
murine	O
counterpart	O
,	O
suggesting	O
that	O
the	O
VK	O
-	O
appended	O
oligosaccharides	O
found	O
in	O
mLL2	B
are	O
not	O
necessary	O
for	O
antigen	O
binding	O
.	O

Two	O
overlapping	O
clones	O
contained	O
the	O
complete	O
Adh	B
-	I
2	I
gene	I
composed	O
of	O
nine	O
exons	O
in	O
a	O
12	O
-	O
kb	O
region	O
,	O
with	O
the	O
placement	O
of	O
introns	O
matching	O
that	O
observed	O
in	O
other	O
mammalian	B
ADH	I
genes	I
.	O

Northern	O
blot	O
hybridization	O
demonstrated	O
that	O
HEP	B
-	I
COP	I
was	O
expressed	O
in	O
a	O
wide	O
range	O
of	O
human	O
adult	O
and	O
fetal	O
tissues	O
.	O

A	O
human	O
cytoplasmic	O
signaling	O
protein	O
has	O
been	O
cloned	O
that	O
possesses	O
the	O
same	O
structural	O
arrangement	O
of	O
SH3	B
-	I
SH2	I
-	I
SH3	I
domains	I
as	O
Grb2	B
.	O

ORF	B
E8	I
colinear	O
with	O
ORF	O
E6	B
,	O
which	O
could	O
generate	O
a	O
50	O
-	O
amino	O
-	O
acid	O
protein	O
with	O
a	O
hydrophobic	O
segment	O
,	O
did	O
not	O
transform	O
cells	O
when	O
cloned	O
into	O
the	O
pZipNeo	O
vector	O
.	O

A	O
secondary	O
spread	O
of	O
an	O
imported	O
methicillin	O
-	O
resistant	O
Staphylococcus	O
aureus	O
strain	O
(	O
MRSA	O
)	O
to	O
two	O
other	O
patients	O
occurred	O
within	O
a	O
Danish	O
surgical	O
ward	O
in	O
spite	O
of	O
isolation	O
of	O
a	O
multitraumatized	O
index	O
-	O
patient	O
immediately	O
after	O
arrival	O
from	O
a	O
hospital	O
in	O
the	O
Mediterranean	O
area	O
.	O

More	O
specific	O
adverse	O
events	O
,	O
also	O
frequently	O
considered	O
as	O
dose	O
-	O
limiting	O
toxicities	O
,	O
include	O
hypotension	O
with	O
IL	B
-	I
1	I
,	O
severe	O
headache	O
or	O
skin	O
rash	O
with	O
IL	B
-	I
3	I
,	O
and	O
nasal	O
congestion	O
and	O
gastroduodenal	O
lesions	O
with	O
IL	B
-	I
4	I
.	O

Therefore	O
,	O
magnetic	O
resonance	O
imaging	O
was	O
used	O
to	O
determine	O
liver	O
volume	O
in	O
pediatric	O
and	O
adolescent	O
patients	O
,	O
in	O
whom	O
systemic	O
clearance	O
of	O
three	O
model	O
substrates	O
[	O
lorazepam	O
(	O
0	O
.	O
03	O
mg	O
/	O
kg	O
),	O
antipyrine	O
(	O
10	O
mg	O
/	O
kg	O
),	O
and	O
indocyanine	O
green	O
(	O
ICG	O
;	O
0	O
.	O
5	O
mg	O
/	O
kg	O
)]	O
was	O
also	O
determined	O
.	O

To	O
determine	O
the	O
signal	O
recognition	O
particle	O
(	O
SRP	B
)-	I
SRP	I
receptor	I
(	O
Srb	B
)	O
system	O
in	O
Bacillus	B
subtilis	I
(	O
Bs	O
),	O
we	O
cloned	O
the	O
Bs	B
srb	I
gene	I
,	O
which	O
encodes	O
a	O
homologue	O
of	O
the	O
mammalian	B
SRP	I
receptor	I
alpha	I
-	I
subunit	I
[	O
Oguro	O
et	O
al	O
.,	O
DNA	O
Res	O
.	O

A	O
novel	O
gene	O
designated	O
cmr	B
,	O
which	O
mapped	O
to	O
18	O
.	O
8	O
min	O
of	O
the	O
Escherichia	B
coli	I
K	I
-	I
12	O
genome	O
,	O
was	O
shown	O
to	O
mediate	O
resistance	O
to	O
chloramphenicol	B
when	O
it	O
was	O
expressed	O
from	O
a	O
multicopy	O
vector	O
.	O

The	O
gene	O
was	O
expressed	O
as	O
an	O
approximately	O
1	O
.	O
5	O
-	O
kb	O
mRNA	O
in	O
most	O
nonlymphoid	O
human	O
cells	O
/	O
tissues	O
including	O
prostate	O
,	O
lung	O
,	O
liver	O
,	O
and	O
colon	O
.	O

Oncogenic	B
Raf	I
-	I
1	I
activates	O
p70	B
S6	I
kinase	I
via	O
a	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
-	I
independent	O
pathway	O
.	O

A	O
cis	O
-	O
acting	O
DNA	O
element	O
located	O
between	O
TATA	O
box	O
and	O
transcription	O
initiation	O
site	O
is	O
critical	O
in	O
response	O
to	O
regulatory	O
sequences	O
in	O
human	O
angiotensinogen	B
gene	I
.	O

The	O
promoter	O
of	O
the	O
rat	B
PGS	I
-	I
2	I
gene	I
contains	O
a	O
CAAT	B
enhancer	I
-	I
binding	I
protein	I
consensus	I
site	I
(	O
CAAT	O
box	O
)	O
which	O
can	O
confer	O
hormone	O
inducibility	O
to	O
a	O
PGS	B
-	I
2	I
.	O
CAT	B
reporter	I
gene	I
,	O
as	O
well	O
as	O
a	O
putative	O
E	B
-	I
box	I
region	O
.	O

Clinical	O
evaluation	O
of	O
the	O
Allergan	O
Humphrey	O
500	O
autorefractor	O
and	O
the	O
Nidek	O
AR	B
-	I
1000	O
autorefractor	O
.	O

None	O
of	O
the	O
five	O
proprotein	O
processing	O
proteases	O
tested	O
were	O
capable	O
of	O
cleaving	O
human	B
pro	I
-	I
LPH	I
,	O
strongly	O
suggesting	O
that	O
they	O
are	O
not	O
involved	O
in	O
the	O
maturation	O
of	O
this	O
enzyme	O
.	O

These	O
changes	O
may	O
be	O
the	O
result	O
of	O
,	O
on	O
the	O
one	O
hand	O
,	O
an	O
increased	O
sensitivity	O
of	O
the	O
neuromuscular	O
transmission	O
and	O
/	O
or	O
decreased	O
muscle	O
contractility	O
and	O
,	O
on	O
the	O
other	O
hand	O
,	O
the	O
result	O
of	O
a	O
reduced	O
plasma	O
clearance	O
during	O
hypothermia	O
.	O

SETTING	O
--	O
Delhi	O
,	O
urban	O
India	O
,	O
1985	O
-	O
6	O
.	O

By	O
using	O
interleukin	B
-	I
3	I
-	I
dependent	I
cells	O
that	O
ectopically	O
express	O
the	O
three	O
ErbB	B
proteins	I
or	O
their	O
combinations	O
,	O
we	O
found	O
that	O
ErbB	B
-	I
3	I
is	O
devoid	O
of	O
any	O
biological	O
activity	O
but	O
both	O
ErbB	B
-	I
1	I
and	O
ErbB	B
-	I
2	I
can	O
reconstitute	O
its	O
extremely	O
potent	O
mitogenic	O
activity	O
.	O

ZIOS	O
was	O
significantly	O
more	O
sensitive	O
than	O
all	O
subsequent	O
methods	O
,	O
and	O
Ptc	O
,	O
O2	O
was	O
significantly	O
more	O
sensitive	O
than	O
FEV1	O
.	O

The	O
Dox	B
-	I
A2	I
ORF	I
driven	O
by	O
the	O
TDH3	B
promoter	I
complemented	O
the	O
phenotype	O
of	O
a	O
strain	O
deleted	O
for	O
sun2	B
.	O

FTF	B
is	O
also	O
abundantly	O
expressed	O
in	O
the	O
pancreas	O
and	O
may	O
exert	O
differentiation	O
functions	O
in	O
endodermal	O
sublineages	O
,	O
similar	O
to	O
SF	B
-	I
1	I
in	O
steroidogenic	O
tissues	O
.	O

Cluster	O
formation	O
of	O
E	B
-	I
cadherin	I
on	O
the	O
cell	O
surface	O
is	O
believed	O
to	O
be	O
of	O
major	O
importance	O
for	O
cell	O
-	O
cell	O
adhesion	O
.	O

DNA	B
polymerase	I
E	I
,	I
DNA	I
ligase	I
III	I
and	O
a	O
DNA	O
structure	O
-	O
specific	O
endonuclease	O
co	O
-	O
purify	O
with	O
the	O
five	O
polypeptide	O
complex	O
.	O

RESULTS	O
:	O
The	O
bilinear	O
model	O
provided	O
a	O
significantly	O
better	O
fit	O
to	O
the	O
acuity	O
outcome	O
data	O
.	O

The	O
mean	O
values	O
of	O
protease	O
activity	O
were	O
significantly	O
higher	O
in	O
the	O
test	O
groups	O
than	O
in	O
the	O
control	O
group	O
at	O
baseline	O
.	O

However	O
,	O
one	O
3	O
'	O
splice	O
site	O
,	O
located	O
at	O
nucleotide	O
(	O
nt	O
)	O
3225	O
,	O
is	O
used	O
for	O
the	O
processing	O
of	O
most	O
BPV	B
-	I
1	I
pre	I
-	I
mRNAs	I
in	O
BPV	B
-	I
1	I
-	I
transformed	O
C127	O
cells	O
and	O
at	O
early	O
to	O
intermediate	O
times	O
in	O
productively	O
infected	O
warts	O
.	O

A	O
phylogenetic	O
tree	O
of	O
members	O
of	O
the	O
T2	B
/	I
S	I
-	I
RNase	I
superfamily	I
in	O
plants	O
was	O
obtained	O
.	O

It	O
was	O
shown	O
that	O
administration	O
of	O
immunomodulator	O
neurotropin	B
(	O
NSP	B
)	O
results	O
in	O
more	O
steady	O
consolidation	O
and	O
retention	O
of	O
feeding	O
and	O
avoidance	O
behavior	O
,	O
and	O
some	O
neurophysiological	O
mechanisms	O
of	O
that	O
phenomena	O
were	O
revealed	O
.	O

Sestamibi	O
scintigraphy	O
,	O
performed	O
in	O
70	O
patients	O
,	O
was	O
less	O
sensitive	O
than	O
ultrasonography	O
(	O
80	O
%).	O

METHODS	O
:	O
Rats	O
received	O
continuous	O
intragastric	O
infusion	O
of	O
elemental	O
diet	O
or	O
with	O
supplementation	O
of	O
oatbase	O
,	O
Lactobacillus	O
reuteri	O
R2LC	O
,	O
and	O
Lactobacillus	O
plantarum	O
DSM	O
9843	O
,	O
with	O
and	O
without	O
fermentation	O
,	O
from	O
the	O
beginning	O
of	O
the	O
study	O
.	O

Limited	O
role	O
for	O
PCR	O
-	O
based	O
diagnosis	O
of	O
Whipple	O
'	O
s	O
disease	O
from	O
peripheral	O
blood	O
mononuclear	O
cells	O
.	O

The	O
Pro	O
-	O
258	O
-->	O
Leu	O
(	O
P258L	O
)	O
mutation	O
caused	O
constitutive	O
receptor	O
signaling	O
that	O
was	O
equivalent	O
to	O
about	O
45	O
%	O
of	O
the	O
maximum	O
level	O
observed	O
in	O
wild	B
-	I
type	I
cells	O
stimulated	O
with	O
alpha	B
-	I
factor	I
.	O

By	O
using	O
a	O
DNA	O
sequence	O
selected	O
for	O
its	O
ability	O
to	O
bind	O
recombinant	O
BCL	B
-	I
6	I
in	O
vitro	O
,	O
we	O
show	O
here	O
that	O
BCL	B
-	I
6	I
is	O
present	O
in	O
DNA	O
-	O
binding	O
complexes	O
in	O
nuclear	O
extracts	O
from	O
various	O
B	O
-	O
cell	O
lines	O
.	O

Because	O
chromosome	O
X	O
is	O
frequently	O
involved	O
in	O
structural	O
alterations	O
in	O
neoplastic	O
Syrian	O
hamster	O
cells	O
transformed	O
by	O
chemical	O
carcinogens	O
and	O
oncogenic	O
viruses	O
,	O
the	O
localization	O
of	O
the	O
cph	B
locus	I
on	O
this	O
chromosome	O
supports	O
the	O
notion	O
that	O
the	O
cph	B
oncogene	I
plays	O
a	O
role	O
in	O
the	O
malignant	O
conversion	O
of	O
chemically	O
transformed	O
hamster	O
fibroblasts	O
.	O

The	O
mechanism	O
involves	O
Gbetagamma	B
subunit	I
-	I
mediated	O
increases	O
in	O
tyrosine	O
phosphorylation	O
of	O
the	O
Shc	B
adapter	I
protein	I
,	O
Shc	B
*	I
Grb2	I
complex	I
formation	O
,	O
and	O
recruitment	O
of	O
Ras	B
guanine	I
nucleotide	I
exchange	I
factor	I
activity	O
.	O

A	O
cDNA	O
encoding	O
the	O
amino	O
-	O
terminal	O
17	O
%	O
of	O
apoB	B
(	O
apoB17	B
)	O
was	O
fused	O
to	O
a	O
cDNA	O
coding	O
for	O
the	O
last	O
37	O
amino	O
acids	O
of	O
decay	B
-	I
accelerating	I
factor	I
(	O
DAF	B
),	O
which	O
contains	O
the	O
signal	O
for	O
glycosylphosphatidylinositol	O
anchor	O
attachment	O
.	O

The	O
small	B
GTPase	I
Rho	I
is	O
implicated	O
in	O
physiological	O
functions	O
associated	O
with	O
actin	B
-	I
myosin	I
filaments	I
such	O
as	O
cytokinesis	O
,	O
cell	O
motility	O
,	O
and	O
smooth	O
muscle	O
contraction	O
.	O

Furthermore	O
,	O
upstream	O
insertion	O
of	O
the	O
GSTP1	B
silencer	I
element	I
failed	O
to	O
inhibit	O
activity	O
of	O
a	O
heterologous	O
promoter	O
in	O
MCF7	O
cells	O
.	O

Therefore	O
,	O
we	O
have	O
identified	O
a	O
cis	O
-	O
acting	O
element	O
,	O
the	O
E1	B
E	I
-	I
box	I
,	O
located	O
in	O
the	O
GAP	B
-	I
43	I
promoter	I
region	O
that	O
modulates	O
either	O
positively	O
or	O
negatively	O
the	O
expression	O
of	O
the	O
GAP	B
-	I
43	I
gene	I
depending	O
on	O
which	O
E	B
-	I
box	I
-	I
binding	I
proteins	I
occupy	O
this	O
site	O
.	O

It	O
is	O
exclusively	O
observed	O
in	O
smooth	O
muscle	O
cells	O
by	O
Northern	O
blotting	O
and	O
immunohistochemical	O
analysis	O
and	O
therefore	O
designated	O
"	B
smoothelin	I
."	I
A	I
human	O
smooth	O
muscle	O
cDNA	O
library	O
was	O
screened	O
with	O
the	O
monoclonal	B
antibody	I
R4A	I
,	O
and	O
a	O
full	O
-	O
size	O
cDNA	O
of	O
the	O
protein	O
was	O
selected	O
.	O

Epstein	B
-	I
Barr	I
virus	I
nuclear	I
protein	I
2	I
(	I
EBNA2	I
)	O
binds	O
to	O
a	O
component	O
of	O
the	O
human	O
SNF	O
-	O
SWI	B
complex	I
,	O
hSNF5	B
/	O
Ini1	B
.	O

The	O
data	O
further	O
indicate	O
that	O
the	O
IL	B
-	I
7R	I
alpha	I
chains	I
are	O
directly	O
involved	O
in	O
the	O
activation	O
of	O
JAKs	B
and	O
STATs	B
and	O
have	O
a	O
major	O
role	O
in	O
proliferative	O
signaling	O
in	O
precursor	O
B	O
cells	O
.	O

We	O
have	O
been	O
studying	O
the	O
interaction	O
of	O
the	O
oncogenic	O
human	O
polyomavirus	B
BK	O
(	O
BKV	O
)	O
with	O
the	O
tumor	B
-	I
suppressor	I
protein	I
p53	I
to	O
understand	O
the	O
biology	O
of	O
this	O
virus	O
as	O
well	O
as	O
to	O
understand	O
the	O
basic	O
mechanisms	O
of	O
p53	B
transactivation	O
.	O

Site	B
S	I
-	I
II	I
also	O
spans	O
a	O
23	O
bp	O
sequence	O
containing	O
two	O
tandem	O
consensus	O
binding	O
sites	O
with	O
three	O
base	O
pair	O
mismatches	O
in	O
each	O
and	O
a	O
one	O
base	O
pair	O
deletion	O
.	O

Microcomputer	O
management	O
of	O
chronic	O
hepatitis	O
B	O
virus	O
asymptomatic	O
patients	O

Our	O
results	O
demonstrate	O
that	O
distinct	O
cytoplasmic	O
domains	O
of	O
these	O
cytokine	O
receptors	O
elicit	O
convergent	O
signaling	O
pathways	O
and	O
provide	O
evidence	O
that	O
beta	O
c	B
and	O
IL	B
-	I
2R	I
beta	I
function	O
as	O
a	O
complete	O
signal	O
transducer	O
.	O

U24	B
has	O
two	O
separate	O
12	O
nt	O
long	O
complementarities	O
to	O
a	O
highly	O
conserved	O
tract	O
of	O
28S	B
rRNA	I
.	O

This	O
transition	O
is	O
regulated	O
positively	O
by	O
G1	O
-	O
specific	O
cyclin	B
-	I
dependent	I
kinases	I
(	O
cdks	B
)	O
and	O
negatively	O
by	O
the	O
product	O
of	O
the	O
retinoblastoma	B
tumour	I
suppressor	I
gene	I
,	O
pRb	B
.	O

To	O
derive	O
quantitative	O
concentration	O
changes	O
from	O
measurements	O
of	O
light	O
attenuation	O
,	O
the	O
optical	O
path	O
length	O
must	O
be	O
known	O
.	O

The	O
most	O
frequent	O
causes	O
of	O
the	O
meningitis	O
was	O
the	O
external	O
ventricular	O
drainage	O
(	O
14	O
.	O
8	O
%),	O
post	O
-	O
neurosurgical	O
(	O
0	O
.	O
8	O
%)	O
and	O
head	O
injury	O
(	O
0	O
.	O
0007	O
%).	O

With	O
the	O
increasing	O
use	O
of	O
ACE	B
inhibitors	O
,	O
the	O
incidence	O
of	O
rare	O
adverse	O
effects	O
such	O
as	O
potentially	O
lethal	O
pancreatitis	O
is	O
likely	O
to	O
increase	O
.	O

Thus	O
,	O
the	O
characterization	O
of	O
the	O
promoter	O
region	O
should	O
help	O
to	O
define	O
regulatory	O
elements	O
that	O
control	O
neuron	B
-	I
specific	I
and	O
developmental	O
expression	O
of	O
the	O
MAP1B	B
gene	I
.	O

Alterations	O
of	O
the	O
5q23	O
-	O
q31	O
interval	O
are	O
frequently	O
observed	O
in	O
myelodysplasia	O
and	O
myeloid	O
leukemia	O
.	O

The	O
extent	O
of	O
the	O
fbpA	O
operator	O
sequence	O
(	O
42	O
bp	O
),	O
as	O
defined	O
by	O
our	O
footprinting	O
analysis	O
,	O
would	O
suggest	O
the	O
binding	O
of	O
two	O
Fur	B
repressor	I
dimers	I
.	O

Our	O
results	O
support	O
a	O
model	O
where	O
both	O
E2F	B
-	I
and	O
CDE	O
-	O
mediated	O
repression	O
,	O
acting	O
at	O
different	O
stages	O
in	O
the	O
cell	O
cycle	O
,	O
are	O
dependent	O
on	O
promoter	O
-	O
specific	O
CHR	O
elements	O
.	O

The	O
cDNA	O
clone	O
was	O
used	O
as	O
a	O
homologous	O
probe	O
to	O
isolate	O
a	O
truncated	O
genomic	O
clone	O
encoding	O
H2A1	B
.	O

Large	O
strain	O
differences	O
were	O
found	O
for	O
all	O
variables	O
recorded	O
,	O
i	O
.	O
e	O
.,	O
the	O
proportion	O
of	O
attacking	O
males	O
,	O
the	O
time	O
spent	O
in	O
the	O
brightly	O
lit	O
box	O
,	O
and	O
the	O
number	O
of	O
transitions	O
between	O
the	O
lit	O
and	O
the	O
dark	O
boxes	O
.	O

The	O
effect	O
of	O
ligustrazine	O
hydrochloride	O
(	O
LTH	O
)	O
on	O
depressing	O
pulmonary	O
artery	O
hypertension	O
has	O
been	O
proved	O
in	O
recent	O
studies	O
.	O

Phenylephrine	O
is	O
a	O
pure	O
alpha	B
-	I
1	I
adrenoreceptor	I
agonist	O
known	O
to	O
produce	O
marked	O
systemic	O
vasoconstriction	O
and	O
associated	O
hypertension	O
with	O
occasional	O
profound	O
reflex	O
bradycardia	O
.	O

Because	O
the	O
hcf109	B
locus	I
was	O
mapped	O
at	O
a	O
distance	O
<	O
0	O
.	O
1	O
centimorgans	O
from	O
the	O
phytochrome	B
C	I
gene	I
,	O
its	O
molecular	O
characterization	O
by	O
positional	O
cloning	O
is	O
possible	O
.	O

We	O
have	O
recently	O
shown	O
that	O
the	O
tissue	O
-	O
specific	O
expression	O
of	O
the	O
RAR	B
beta	I
2	I
gene	I
in	O
mouse	O
embryos	O
is	O
regulated	O
at	O
the	O
translational	O
level	O
by	O
short	O
upstream	O
open	O
reading	O
frames	O
(	O
uORFs	O
)	O
In	O
the	O
5	O
'-	O
untranslated	O
region	O
(	O
Zimmer	O
,	O
A	O
.,	O
A	O
.	O
M	O
.	O

All	O
patients	O
had	O
abnormal	O
von	B
Willebrand	I
factor	I
(	O
vWF	B
)	O
fragmentation	O
as	O
reflected	O
by	O
decreased	O
high	O
molecular	O
weight	O
and	O
increased	O
low	O
molecular	O
weight	O
vWF	B
multimers	I
in	O
the	O
circulation	O
.	O

Stably	O
transfected	O
human	O
kidney	O
293	O
cells	O
expressing	O
the	O
wild	O
type	O
rat	B
LH	I
/	I
CG	I
receptor	I
(	O
rLHR	B
)	O
or	O
receptors	O
with	O
C	O
-	O
terminal	O
tails	O
truncated	O
at	O
residues	O
653	O
,	O
631	O
,	O
or	O
628	O
(	O
designated	O
rLHR	B
-	I
t653	I
,	O
rLHR	B
-	I
t631	I
,	O
and	O
rLHR	B
-	I
t628	I
)	O
were	O
used	O
to	O
probe	O
the	O
importance	O
of	O
this	O
region	O
on	O
the	O
regulation	O
of	O
hormonal	O
responsiveness	O
.	O

The	O
patients	O
are	O
two	O
healthy	O
adult	O
males	O
.	O

We	O
present	O
this	O
case	O
because	O
of	O
the	O
rarity	O
of	O
left	O
ventricular	O
involvement	O
associated	O
with	O
ARVD	O
.	O

The	O
5	O
'	O
flanking	O
region	O
of	O
the	O
mouse	B
Met	I
-	I
ase	I
-	I
1	I
gene	I
also	O
shares	O
considerable	O
regions	O
of	O
identity	O
with	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
rat	B
Met	I
-	I
ase	I
-	I
1	I
gene	I
.	O

We	O
conclude	O
that	O
CPET	O
is	O
a	O
useful	O
investigation	O
in	O
the	O
management	O
of	O
patients	O
with	O
cardiopulmonary	O
disease	O
and	O
complements	O
the	O
various	O
other	O
investigations	O
offered	O
by	O
a	O
pulmonary	O
function	O
laboratory	O
.	O

Using	O
fluorescence	O
in	O
situ	O
hybridization	O
,	O
we	O
mapped	O
the	O
chromosome	O
-	O
17	O
breakpoint	O
in	O
a	O
patient	O
with	O
acampomelic	O
CMPD	O
and	O
sex	O
reversal	O
,	O
who	O
carries	O
a	O
de	O
novo	O
constitutional	O
t	O
(	O
12	O
;	O
17	O
)	O
translocation	O
,	O
between	O
two	O
known	O
cosmid	O
markers	O
in	O
the	O
17q24	O
-	O
q25	O
region	O
.	O

A	O
transgenic	O
complementation	O
assay	O
was	O
used	O
to	O
test	O
whether	O
NIa	B
supplied	O
in	O
trans	O
could	O
rescue	O
amplification	O
-	O
defective	O
viral	O
genomes	O
encoding	O
altered	O
NIa	B
proteins	I
.	O

The	O
characterization	O
of	O
the	O
promoter	O
region	O
indicated	O
that	O
three	O
distinct	O
regulatory	O
elements	O
corresponding	O
to	O
an	O
AP	B
-	I
1	I
binding	I
site	I
(	O
or	O
TRE	O
),	O
a	O
PRDII	B
/	I
kappaB	I
domain	I
,	O
and	O
a	O
CAAT	O
box	O
are	O
involved	O
in	O
the	O
activation	O
by	O
pp60	B
(	O
v	B
-)	I
src	I
.	O

A	O
novel	O
phosphotyrosine	O
-	O
binding	O
domain	O
in	O
the	O
N	O
-	O
terminal	O
transforming	O
region	O
of	O
Cbl	B
interacts	O
directly	O
and	O
selectively	O
with	O
ZAP	B
-	I
70	I
in	O
T	O
cells	O
.	O

The	O
presence	O
of	O
unidentified	O
macroscopic	O
or	O
microscopic	O
clusters	O
of	O
neoplastic	O
cells	O
,	O
lying	O
around	O
,	O
more	O
or	O
less	O
close	O
to	O
,	O
the	O
line	O
of	O
insertion	O
of	O
lesion	O
,	O
could	O
render	O
any	O
attempt	O
to	O
gain	O
a	O
"	O
radical	O
"	O
excision	O
useless	O
.	O

Although	O
the	O
RAD23	B
equivalents	O
are	O
well	O
conserved	O
during	O
evolution	O
,	O
the	O
mammalian	B
genes	I
did	O
not	O
express	O
the	O
UV	O
-	O
inducible	O
phenotype	O
of	O
their	O
yeast	O
counterpart	O
.	O

Sequence	O
analysis	O
of	O
reverse	O
transcribed	O
,	O
amplified	O
cDNA	O
generated	O
from	O
total	O
RNA	O
isolated	O
from	O
transfected	O
cells	O
demonstrated	O
the	O
presence	O
of	O
abnormally	O
spliced	O
products	O
containing	O
13	O
and	O
78	O
additional	O
bases	O
as	O
well	O
as	O
the	O
accumulation	O
of	O
unspliced	O
mRNA	O
.	O

Melatonin	O
and	O
seasonality	O
:	O
filling	O
the	O
gap	O
.	O

The	O
effects	O
of	O
procedural	O
variations	O
on	O
lateralized	O
Stroop	O
effects	O
.	O

In	O
a	O
third	O
experiment	O
,	O
a	O
Chessmaster	O
gradually	O
increases	O
the	O
number	O
of	O
boards	O
he	O
can	O
reproduce	O
with	O
higher	O
than	O
70	O
%	O
average	O
accuracy	O
to	O
nine	O
,	O
replacing	O
as	O
many	O
as	O
160	O
pieces	O
correctly	O
.	O

PCNA	B
mRNA	I
has	O
a	O
3	O
'	O
UTR	O
antisense	O
to	O
yellow	O
crescent	O
RNA	O
and	O
is	O
localized	O
in	O
ascidian	O
eggs	O
and	O
embryos	O
.	O

Adding	O
phytase	B
and	O
nP	O
improved	O
the	O
orderliness	O
of	O
development	O
,	O
mineralization	O
and	O
arrangement	O
of	O
cartilage	O
and	O
bone	O
cells	O
,	O
and	O
alleviated	O
the	O
effects	O
of	O
P	O
deficiency	O
on	O
the	O
histological	O
and	O
gross	O
structure	O
of	O
the	O
tibias	O
.	O

Data	O
supported	O
the	O
brevity	O
of	O
the	O
WISC	O
-	O
III	O
short	O
form	O
and	O
the	O
criterion	O
-	O
related	O
validity	O
of	O
both	O
the	O
K	O
-	O
FAST	O
and	O
and	O
Kaufman	O
Short	O
Neuropsychological	O
Assessment	O
Procedure	O
(	O
K	B
-	I
SNAP	I
).	O

The	O
elevation	O
of	O
cyclic	O
AMP	O
(	O
cAMP	O
)	O
levels	O
in	O
the	O
cell	O
downregulates	O
the	O
activity	O
of	O
the	O
Raf	B
-	I
1	I
kinase	I
.	O

Two	O
closely	O
related	O
variants	O
of	O
Stat5	B
,	O
Stat5a	B
and	I
Stat5b	I
,	O
are	O
encoded	O
by	O
distinct	O
genes	O
.	O

Human	O
ESP1	B
/	O
CRP2	B
protein	I
has	O
two	O
LIM	B
domains	I
,	O
and	O
each	O
shares	O
35	O
.	O
1	O
%	O
and	O
77	O
or	O
79	O
%	O
identical	O
residues	O
with	O
human	B
cysteine	I
-	I
rich	I
protein	I
(	I
CRP	I
)	O
and	O
rat	B
CRIP	I
,	O
respectively	O
.	O

The	O
fragments	O
are	O
separated	O
and	O
directly	O
sized	O
by	O
agarose	O
gel	O
electrophoresis	O
.	O

This	O
element	O
,	O
termed	O
CREsp	O
-	O
a	O
(	O
TGACCTCA	O
),	O
differs	O
by	O
one	O
nucleotide	O
from	O
a	O
palindromic	O
CRE	O
(	O
CREpal	O
,	O
TGACGTCA	O
),	O
which	O
is	O
known	O
to	O
bind	O
CREB	B
as	O
a	O
homodimer	O
.	O

Feline	O
leukemia	O
viruses	O
(	O
FeLVs	O
),	O
which	O
are	O
replication	O
-	O
competent	O
oncoretroviruses	O
of	O
the	O
domestic	O
cat	O
species	O
,	O
are	O
contagiously	O
transmitted	O
in	O
natural	O
environments	O
.	O

Both	O
verapamil	O
and	O
propranolol	O
can	O
exhibit	O
additive	O
effects	O
with	O
adenosine	O
in	O
prolonging	O
AV	O
nodal	O
conduction	O
time	O
;	O
however	O
,	O
only	O
verapamil	O
can	O
reduce	O
the	O
dose	O
of	O
adenosine	O
required	O
to	O
produce	O
AV	O
nodal	O
block	O
.	O

Although	O
isl	B
-	I
1	I
binds	O
to	O
both	O
the	O
insulin	B
and	I
amylin	I
gene	I
promoter	I
elements	O
in	O
vitro	O
,	O
these	O
sequences	O
display	O
marked	O
differences	O
in	O
their	O
relative	O
transcriptional	O
properties	O
when	O
ligated	O
adjacent	O
to	O
a	O
heterologous	O
promoter	O
and	O
transfected	O
into	O
InR1	O
-	O
G9	O
islet	O
cells	O
.	O

The	O
CD4	B
count	O
at	O
which	O
remission	O
occurs	O
may	O
reflect	O
severe	O
immunodeficiency	O
such	O
that	O
risk	O
for	O
AIDS	O
-	O
related	O
infection	O
is	O
high	O
.	O

RVR	B
'	O
loss	O
of	O
function	O
'	O
studies	O
by	O
constitutive	O
over	O
-	O
expression	O
of	O
a	O
dominant	O
negative	O
RVR	B
delta	I
E	I
resulted	O
in	O
increased	O
levels	O
of	O
p21Cip1	B
/	O
Waf1	B
and	O
myogenin	B
mRNAs	I
after	O
serum	O
withdrawal	O
.	O

To	O
explore	O
the	O
functional	O
significance	O
of	O
these	O
subdomains	O
in	O
PRL	B
binding	I
and	O
signal	O
transduction	O
,	O
deletion	O
mutants	O
of	O
S1	B
or	O
/	O
and	O
S2	O
subdomains	O
were	O
constructed	O
.	O

Constitutive	O
phosphorylation	O
of	O
the	O
CD30v	B
protein	I
was	O
demonstrated	O
by	O
in	O
vitro	O
labeling	O
with	O
[	O
32P	O
].	O

MVR	O
typing	O
of	O
rare	O
-	O
length	O
alleles	O
indicates	O
that	O
they	O
are	O
comprised	O
of	O
disorganized	O
sequences	O
,	O
although	O
they	O
usually	O
bear	O
a	O
resemblance	O
to	O
one	O
of	O
the	O
common	O
alleles	O
at	O
the	O
5	O
'-	O
most	O
end	O
.	O

How	O
many	O
embryos	O
to	O
transfer	O
in	O
patients	O
undergoing	O
IVF	O
?	O

Demispan	O
is	O
a	O
reliable	O
and	O
reproducible	O
measure	O
of	O
stature	O
in	O
the	O
elderly	O
.	O

Two	O
techniques	O
based	O
on	O
assay	O
coefficients	O
of	O
variation	O
were	O
employed	O
to	O
characterize	O
a	O
normal	O
circadian	O
pattern	O
of	O
cortisol	O
.	O

We	O
have	O
performed	O
toeprinting	O
analyses	O
on	O
repA	B
mRNA	I
of	O
plasmid	O
R1	O
,	O
both	O
free	O
and	O
in	O
duplex	O
with	O
the	O
antisense	O
RNA	O
,	O
CopA	B
.	O

Tonsillectomy	O
is	O
an	O
effective	O
means	O
of	O
prophylaxis	O
for	O
upper	O
respiratory	O
infection	O
in	O
habitual	O
angina	O
patients	O
.	O

In	O
lean	O
mice	O
,	O
the	O
fat	O
/	O
water	O
intensity	O
ratio	O
was	O
about	O
1	O
:	O
4	O
,	O
about	O
half	O
that	O
in	O
normal	O
mice	O
.	O

If	O
we	O
apply	O
the	O
finding	O
of	O
non	O
-	O
visualization	O
of	O
the	O
GB	O
at	O
4	O
h	O
post	O
injection	O
as	O
the	O
criterion	O
for	O
the	O
diagnosis	O
of	O
AC	O
,	O
the	O
diagnostic	O
accuracy	O
was	O
only	O
40	O
.	O
7	O
%	O
(	O
11	O
/	O
27	O
).	O

These	O
bacteria	O
produce	O
and	O
export	O
proteins	O
capable	O
of	O
specific	O
interactions	O
with	O
key	O
mammalian	O
cell	O
regulatory	O
molecules	O
in	O
order	O
to	O
derail	O
the	O
normal	O
functions	O
of	O
the	O
cells	O
.	O

Thus	O
,	O
although	O
p28	B
may	O
play	O
only	O
a	O
limited	O
role	O
during	O
the	O
early	O
embryonic	O
cleavages	O
,	O
it	O
may	O
function	O
later	O
in	O
development	O
to	O
establish	O
a	O
somatic	O
type	O
of	O
cell	O
cycle	O
.	O

Moreover	O
,	O
it	O
also	O
discusses	O
the	O
effects	O
of	O
antihypertensive	O
drugs	O
currently	O
regarded	O
as	O
first	O
-	O
choice	O
agents	O
,	O
i	O
.	O
e	O
.	O
calcium	O
antagonists	O
and	O
the	O
angiotensin	B
converting	I
enzyme	I
inhibitors	O
,	O
on	O
intrarenal	O
hemodynamics	O
.	O

B	B
cell	I
antigen	I
receptor	I
(	O
BCR	B
)-	I
induced	O
apoptosis	O
in	O
the	O
WEHI	O
-	O
231	O
B	O
lymphoma	O
cell	O
line	O
can	O
be	O
prevented	O
by	O
engaging	O
CD40	B
.	O

Five	O
of	O
these	O
eight	O
patients	O
in	O
group	O
II	O
also	O
received	O
8	O
-	O
in	O
-	O
1	O
chemotherapy	O
.	O

Administration	O
of	O
RIFA	O
at	O
200	O
mg	O
/	O
kg	O
/	O
day	O
in	O
combination	O
with	O
ATO	O
at	O
100	O
mg	O
/	O
kg	O
/	O
day	O
resulted	O
in	O
a	O
marked	O
prolongation	O
of	O
survival	O
compared	O
with	O
that	O
for	O
mice	O
that	O
received	O
ATO	O
or	O
RIFA	O
alone	O
.	O

Using	O
anchored	O
PCR	O
,	O
a	O
VL	B
element	I
rearranged	I
to	O
CL2	B
was	O
isolated	O
.	O

Sodium	O
polystyrene	O
sulfonate	O
treatment	O
for	O
lithium	O
toxicity	O
:	O
effects	O
on	O
serum	O
potassium	O
concentrations	O
.	O

The	O
TYAC	O
/	O
P1	O
resource	O
,	O
derivative	O
STSs	O
,	O
and	O
polymorphisms	O
constitute	O
an	O
enabling	O
resource	O
to	O
further	O
studies	O
of	O
telomere	O
structure	O
and	O
function	O
and	O
a	O
means	O
for	O
physical	O
and	O
genetic	O
map	O
integration	O
and	O
closure	O
.	O

We	O
conclude	O
that	O
common	O
upstream	O
signals	O
cause	O
activation	O
of	O
Ras	B
and	O
TC21	B
,	O
but	O
activated	O
TC21	B
controls	O
cell	O
growth	O
via	O
distinct	O
Raf	B
-	I
independent	O
downstream	O
signaling	O
pathways	O
.	O

Selection	O
was	O
based	O
on	O
expression	O
of	O
an	O
integrated	O
DNA	O
fragment	O
containing	O
the	O
con	B
-	I
10	I
promoter	I
-	I
regulatory	I
region	O
followed	O
by	O
the	O
initial	O
segment	O
of	O
the	O
con	B
-	I
10	O
open	O
reading	O
frame	O
fused	O
in	O
frame	O
with	O
the	O
bacterial	B
hygromycin	I
B	I
phosphotransferase	I
structural	I
gene	I
(	O
con10	B
'-'	I
hph	I
).	O

IRF	B
-	I
1	I
acts	O
as	O
a	O
transcriptional	O
activator	O
,	O
while	O
IRF	B
-	I
2	I
acts	O
as	O
a	O
repressor	O
.	O

A	O
subset	O
of	O
these	O
DMP1	B
recognition	I
sequences	I
containing	O
a	O
GGA	O
trinucleotide	O
core	O
can	O
also	O
function	O
as	O
Ets	B
-	I
responsive	I
elements	O
.	O

In	O
both	O
settings	O
,	O
it	O
can	O
be	O
phosphorylated	O
by	O
cyclin	B
D	I
-	I
dependent	I
kinases	I
,	O
suggesting	O
that	O
its	O
transcriptional	O
activity	O
may	O
normally	O
be	O
regulated	O
through	O
such	O
mechanisms	O
.	O

Enterococcus	O
faecium	O
strains	O
with	O
vanA	O
-	O
mediated	O
glycopeptide	O
resistance	O
were	O
isolated	O
by	O
enrichment	O
culture	O
from	O
the	O
intestines	O
and	O
feces	O
of	O
several	O
animal	O
species	O
,	O
mainly	O
horses	O
and	O
dogs	O
(	O
8	O
%	O
positive	O
),	O
chickens	O
(	O
7	O
%	O
positive	O
),	O
and	O
pigs	O
(	O
6	O
%	O
positive	O
).	O

The	O
amino	O
-	O
terminal	O
region	O
of	O
E1A	B
binds	O
several	O
high	O
molecular	O
weight	O
proteins	O
and	O
inhibits	O
the	O
transcriptional	O
coactivator	O
function	O
of	O
p300	B
and	O
the	O
homologous	O
cAMP	O
response	O
element	O
(	O
CRE	B
)-	I
binding	I
protein	I
.	O

Molecular	O
cloning	O
of	O
Elk	B
-	I
3	I
,	O
a	O
new	O
member	O
of	O
the	O
Ets	B
family	I
expressed	O
during	O
mouse	O
embryogenesis	O
and	O
analysis	O
of	O
its	O
transcriptional	O
repression	O
activity	O
.	O

Frozen	O
/	O
thawed	O
extensor	O
digitorum	O
longus	O
muscle	O
tendon	O
units	O
had	O
significantly	O
lower	O
values	O
for	O
load	O
to	O
failure	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
energy	O
absorbed	O
to	O
failure	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
and	O
strain	O
at	O
failure	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
and	O
they	O
tended	O
to	O
fail	O
at	O
a	O
different	O
anatomic	O
location	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
(	O
broadly	O
at	O
the	O
fascia	O
-	O
muscle	O
interface	O
as	O
compared	O
with	O
horizontally	O
at	O
the	O
musculotendinous	O
junction	O
)	O
than	O
fresh	O
units	O
.	O

Northern	O
analysis	O
of	O
the	O
3	B
.	I
1	I
-	I
kb	I
PWP2H	I
cDNA	I
revealed	O
that	O
a	O
3	O
.	O
3	O
-	O
kb	O
major	O
transcript	O
is	O
ubiquitously	O
expressed	O
in	O
human	O
adult	O
tissues	O
.	O

Forty	O
-	O
eight	O
10	O
-	O
12	O
-	O
week	O
-	O
old	O
male	O
Sprague	O
-	O
Dawley	O
rats	O
were	O
randomized	O
to	O
receive	O
,	O
daily	O
for	O
28	O
days	O
:	O
(	O
1	O
)	O
CsA	O
vehicle	O
p	O
.	O
o	O
.	O
plus	O
FB	O
vehicle	O
sc	O
;	O
(	O
2	O
)	O
CsA	O
(	O
15	O
mg	O
/	O
kg	O
)	O
p	O
.	O
o	O
.	O
plus	O
FB	O
vehicle	O
sc	O
,	O
(	O
3	O
)	O
CsA	O
vehicle	O
p	O
.	O
o	O
.	O
plus	O
FB	O
(	O
1	O
.	O
5	O
mg	O
/	O
kg	O
)	O
sc	O
;	O
and	O
(	O
4	O
)	O
CsA	O
(	O
15	O
mg	O
/	O
kg	O
)	O
p	O
.	O
o	O
.	O
plus	O
FB	O
(	O
1	O
.	O
5	O
mg	O
/	O
kg	O
)	O
sc	O
.	O

In	O
spite	O
of	O
much	O
effort	O
,	O
no	O
one	O
has	O
succeeded	O
in	O
isolating	O
and	O
characterizing	O
the	O
enzyme	O
(	O
s	O
)	O
responsible	O
for	O
synthesis	O
of	O
cellulose	O
,	O
the	O
major	O
cell	O
wall	O
polymer	O
of	O
plants	O
.	O

Intraperitoneal	O
administration	O
of	O
L	B
-	I
5	I
-	I
hydroxytryptophan	O
(	O
L	B
-	I
5	I
-	I
HTP	O
)	O
at	O
doses	O
of	O
25	O
to	O
100	O
mg	O
/	O
kg	O
dramatically	O
increase	O
defecation	O
in	O
mice	O
.	O

In	O
the	O
VA	O
-	O
SMV	O
mode	O
,	O
the	O
connection	O
was	O
made	O
with	O
valved	O
conduits	O
from	O
the	O
LV	O
apex	O
(	O
inflow	O
)	O
to	O
the	O
ascending	O
aorta	O
(	O
outflow	O
)	O
(	O
n	O
=	O
11	O
)	O
or	O
to	O
the	O
DAo	O
(	O
n	O
=	O
12	O
).	O

The	O
human	B
gene	I
fragment	I
ligated	O
to	O
the	O
minimal	O
rat	B
liver	I
glucokinase	I
promoter	I
was	O
shown	O
to	O
work	O
as	O
an	O
enhancer	O
in	O
the	O
hepatocyte	B
transfection	O
system	O
.	O

Rifabutin	O
has	O
substantial	O
efficacy	O
when	O
combined	O
with	O
other	O
agents	O
.	O

Ninety	O
-	O
four	O
percent	O
of	O
the	O
EPs	O
were	O
tubal	O
,	O
and	O
90	O
%	O
of	O
the	O
tubes	O
exhibited	O
some	O
pathologic	O
changes	O
,	O
including	O
chronic	O
salpingitis	O
(	O
49	O
.	O
5	O
%)	O
and	O
follicular	O
salpingitis	O
(	O
10	O
%),	O
among	O
others	O
.	O

Moloney	O
murine	O
leukemia	O
virus	O
(	O
MMLV	O
)-	O
derived	O
pUCMoTiN	O
-	O
based	O
retroviral	O
vectors	O
were	O
engineered	O
to	O
allow	O
constitutive	O
and	O
Tat	B
(	I
trans	I
-	I
activator	I
of	O
transcription	O
)-	O
inducible	O
expression	O
of	O
five	O
hammerhead	O
ribozymes	O
targeted	O
against	O
highly	O
conserved	O
sequences	O
within	O
the	O
group	O
antigen	O
(	O
Gag	B
),	O
protease	O
(	O
Pro	O
),	O
reverse	B
transcriptase	I
(	O
RT	O
),	O
tat	B
,	O
and	O
envelope	O
(	O
Env	B
)	O
coding	O
regions	O
of	O
human	B
immunodeficiency	I
virus	I
type	I
-	I
1	I
(	I
HIV	I
-	I
1	I
)	I
RNA	I
.	O

The	O
same	O
ligands	O
also	O
exhibit	O
a	O
similar	O
inhibitory	O
effect	O
on	O
PDGF	B
-	I
BB	I
-	I
dependent	I
[	O
3H	O
]	O
thymidine	B
incorporation	O
in	O
PAE	O
cells	O
expressing	O
the	O
PDGF	B
beta	I
-	I
receptors	I
.	O

An	O
essential	O
role	O
of	O
c	B
-	I
Jun	I
and	O
c	B
-	I
Fos	I
in	O
basal	O
and	O
PMA	O
-	O
stimulated	O
transcription	O
of	O
the	O
PAI	B
-	I
1	I
gene	I
is	O
demonstrated	O
by	O
our	O
finding	O
that	O
antisense	O
c	B
-	I
jun	I
and	O
c	B
-	I
fos	I
oligodeoxynucleotides	O
both	O
strongly	O
reduced	O
basal	O
and	O
PMA	O
-	O
stimulated	O
PAI	B
-	I
1	I
synthesis	O
.	O

Leukemia	B
-	I
inhibitory	I
factor	I
(	O
LIF	B
)	O
is	O
a	O
neuropoietin	B
able	O
to	O
regulate	O
the	O
differentiation	O
and	O
the	O
survival	O
of	O
many	O
cell	O
types	O
,	O
which	O
include	O
some	O
neuronal	O
populations	O
.	O

To	O
analyze	O
the	O
mechanism	O
of	O
fos	B
/	I
jun	I
activation	O
by	O
TCDD	O
we	O
have	O
used	O
electrophoretic	O
mobility	O
shift	O
and	O
transient	O
expression	O
assays	O
of	O
reporter	O
gene	O
constructs	O
containing	O
response	O
elements	O
for	O
12	O
-	O
O	O
-	O
tetradecanoyl	O
-	O
phorbol	O
-	O
13	O
-	O
acetate	O
(	O
TRE	O
),	O
serum	O
(	O
SRE	O
),	O
cAMP	O
(	O
CRE	O
),	O
and	O
aromatic	O
hydrocarbons	O
(	O
AhRE	O
)	O
from	O
the	O
fos	B
and	I
jun	I
genes	I
fused	O
to	O
the	O
firefly	B
luciferase	I
gene	I
under	O
the	O
control	O
of	O
the	O
SV40	B
minimal	I
promoter	I
.	O

The	O
optimal	O
sequence	O
for	O
interaction	O
with	O
mu	B
2	I
and	O
with	O
AP	B
-	I
2	I
has	O
tyrosine	O
as	O
an	O
anchor	O
and	O
prefers	O
arginine	O
at	O
position	O
Y	O
+	O
2	O
and	O
leucine	O
at	O
position	O
Y	O
+	O
3	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
the	O
successful	O
resection	O
of	O
a	O
MFH	O
originating	O
in	O
the	O
renal	O
capsular	O
tissue	O
and	O
extending	O
into	O
the	O
inferior	O
vena	O
cava	O
.	O

A	O
given	O
standard	O
input	O
function	O
and	O
a	O
given	O
value	O
of	O
distribution	O
volume	O
(	O
Vd	O
)	O
used	O
for	O
the	O
rCBF	O
measurement	O
of	O
this	O
method	O
were	O
calculated	O
from	O
the	O
dynamic	O
study	O
by	O
six	O
normal	O
volunteers	O
.	O

They	O
lack	O
a	O
predicted	O
single	O
stranded	O
(	O
ss	O
)	O
DNA	O
binding	O
motif	O
that	O
is	O
unique	O
the	O
large	O
terminase	B
proteins	I
in	O
T4	O
gp17	B
,	O
and	O
that	O
has	O
been	O
implicated	O
in	O
recognizing	O
ssDNA	O
regions	O
in	O
replicating	O
and	O
recombining	O
T4DNA	O
destined	O
to	O
be	O
packaged	O
.	O

It	O
can	O
be	O
concluded	O
that	O
in	O
normotensive	O
subjects	O
,	O
uric	O
acid	O
and	O
xanthine	B
oxidase	I
have	O
significant	O
association	O
with	O
blood	O
pressure	O
and	O
thus	O
are	O
one	O
of	O
the	O
many	O
factors	O
which	O
are	O
involved	O
in	O
the	O
cause	O
or	O
effect	O
of	O
hypertension	O
.	O

Jerseys	O
had	O
higher	O
hepatic	O
Cu	O
concentrations	O
than	O
did	O
Holsteins	O
on	O
d	O
60	O
(	O
346	O
vs	O
.	O

RUSH	B
-	I
1	I
beta	I
is	O
a	O
95	O
-	O
kDa	O
truncated	O
version	O
of	O
RUSH	B
-	I
1	I
alpha	I
that	O
results	O
from	O
alternative	O
splicing	O
of	O
a	O
57	O
-	O
bp	O
exon	O
as	O
confirmed	O
by	O
genomic	O
cloning	O
.	O

Exons	O
III	O
to	O
VIII	O
,	O
which	O
cover	O
the	O
coding	O
region	O
and	O
the	O
3	O
'	O
untranslated	O
region	O
,	O
are	O
almost	O
identical	O
in	O
all	O
types	O
of	O
PST	B
or	O
AST	B
cDNAs	I
.	O

Recombinant	B
erythropoietin	I
(	I
r	I
-	I
HuEPO	I
)	O
in	O
the	O
treatment	O
of	O
anemia	O
in	O
multiple	O
myeloma	O

Epidemiological	O
data	O
are	O
quite	O
controversial	O
but	O
sudden	O
death	O
occurring	O
during	O
sporting	O
activity	O
is	O
probably	O
not	O
a	O
rare	O
occurrence	O
.	O

The	O
nm23	B
-	I
H1	I
/	I
nm23	I
-	I
H2	I
gene	I
transcriptional	O
activity	O
ratio	O
varied	O
depending	O
on	O
the	O
cell	O
line	O
.	O

The	O
Escherichia	B
coli	I
tet	I
-	I
repressor	I
(	O
TetR	B
)	I
operator	I
system	O
was	O
used	O
to	O
develop	O
a	O
variation	O
of	O
the	O
yeast	O
two	O
-	O
hybrid	O
assay	O
in	O
which	O
disruptions	O
of	O
protein	B
-	I
protein	I
interactions	O
can	O
be	O
identified	O
by	O
a	O
positive	O
selection	O
.	O

Administration	O
of	O
a	O
second	O
dose	O
of	O
vaccine	O
during	O
the	O
outbreak	O
was	O
not	O
protective	O
.	O

The	O
ERH	B
expression	O
profile	O
is	O
similar	O
,	O
to	O
that	O
of	O
An3	B
,	O
which	O
localizes	O
to	O
the	O
animal	O
hemisphere	O
of	O
oocytes	O
and	O
is	O
abundantly	O
expressed	O
in	O
the	O
embryo	O
.	O

Waves	O
N1	O
,	O
P3	O
and	O
CNV	O
were	O
recorded	O
during	O
a	O
CNV	O
paradigm	O
in	O
a	O
simple	O
reaction	O
time	O
task	O
with	O
a	O
constant	O
interstimulus	O
interval	O
(	O
ISI	O
)	O
of	O
1	O
sec	O
.	O

Several	O
particular	O
features	O
of	O
this	O
polypeptide	O
fragment	O
from	O
the	O
hamster	O
lysyl	B
-	I
tRNA	I
synthetase	I
suggest	O
that	O
it	O
is	O
implicated	O
in	O
the	O
assembly	O
of	O
that	O
enzyme	O
within	O
the	O
multisynthetase	O
complex	O
.	O

Comparison	O
of	O
the	O
proportion	O
of	O
nonsynonymous	O
(	O
pN	O
)	O
and	O
synonymous	O
(	O
pS	O
)	O
substitutions	O
occurring	O
per	O
site	O
within	O
tamarin	B
variable	I
region	I
genes	I
demonstrated	O
a	O
reduction	O
in	O
pN	O
in	O
the	O
framework	O
regions	O
compared	O
with	O
pN	O
in	O
the	O
presumed	O
MHC	B
contact	O
regions	O
(	O
CDR1	B
and	O
CDR2	B
).	O

The	O
effects	O
of	O
oral	O
vanadyl	O
sulfate	O
(	O
VOSO4	O
)	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
/	O
day	O
)	O
on	O
anthropometry	O
,	O
body	O
composition	O
,	O
and	O
performance	O
were	O
investigated	O
in	O
a	O
12	O
-	O
week	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
involving	O
weight	O
-	O
training	O
volunteers	O
.	O

Disruption	O
of	O
re	O
-	O
replication	O
control	O
by	O
overexpression	O
of	O
human	B
ORC1	I
in	O
fission	O
yeast	O
.	O

The	O
0	O
.	O
22	O
-	O
kb	O
NheI	B
/	O
BglII	B
promoter	I
exhibited	O
PMA	O
inducibility	O
in	O
myeloid	O
cells	O
and	O
contained	O
a	O
PMA	O
-	O
responsive	O
element	O
recognized	O
by	O
Sp1	B
and	O
EGR	B
-	I
1	I
transcription	I
factors	I
.	O

Northern	O
(	O
RNA	O
)	O
blot	O
analyses	O
indicated	O
that	O
the	O
cdh	B
genes	I
encoding	O
the	O
five	O
subunits	O
and	O
an	O
open	O
reading	O
frame	O
(	O
ORF1	O
)	O
with	O
unknown	O
function	O
are	O
cotranscribed	O
during	O
growth	O
on	O
acetate	O
.	O

Abnormal	O
urinary	O
coproporphyrin	O
levels	O
in	O
patients	O
infected	O
by	O
hepatitis	O
C	O
virus	O
with	O
or	O
without	O
human	B
immunodeficiency	I
virus	I
.	O

Thrombosis	O
of	O
the	O
renal	O
vein	O
may	O
be	O
dramatic	O
and	O
include	O
renal	O
failure	O
.	O

The	O
microdensitometric	O
scores	O
and	O
their	O
side	O
-	O
to	O
-	O
side	O
differences	O
in	O
patients	O
correlated	O
negatively	O
with	O
the	O
serum	O
25	O
-	O
OHD	O
concentration	O
and	O
positively	O
with	O
the	O
degree	O
of	O
paralysis	O
.	O

In	O
contrast	O
,	O
extracts	O
of	O
the	O
mutant	O
virions	O
catalyze	O
the	O
wild	B
-	I
type	I
level	O
of	O
transcription	O
from	O
an	O
exogenous	O
template	O
containing	O
an	O
early	O
promoter	O
.	O

In	O
Group	O
IV	O
dogs	O
that	O
received	O
alpha	B
-	I
MSH	I
only	O
during	O
reperfusion	O
,	O
BAEPs	O
were	O
increased	O
approximately	O
10	O
to	O
14	O
%	O
more	O
than	O
in	O
Group	O
II	O
during	O
the	O
late	O
reperfusion	O
period	O
.	O

The	O
Fas	B
receptor	I
mediates	O
a	O
signalling	O
cascade	O
resulting	O
in	O
programmed	O
cell	O
death	O
(	O
apoptosis	O
)	O
within	O
hours	O
of	O
receptor	O
cross	O
-	O
linking	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
hGCN5	B
is	O
also	O
an	O
HAT	O
and	O
has	O
the	O
same	O
substrate	O
specificity	O
as	O
yGCN5	B
.	O

To	O
examine	O
whether	O
thiamine	O
(	O
vitamin	O
B1	O
)	O
deficiency	O
is	O
associated	O
with	O
recurrent	O
aphthous	O
stomatitis	O
,	O
we	O
studied	O
vitamin	O
B1	O
levels	O
in	O
70	O
patients	O
with	O
recurrent	O
aphthous	O
stomatitis	O
and	O
in	O
50	O
members	O
of	O
a	O
control	O
group	O
.	O

Liver	O
injuries	O

By	O
screening	O
a	O
cDNA	O
library	O
with	O
a	O
probe	O
derived	O
from	O
sequences	O
downstream	O
of	O
the	O
p53p2	B
start	I
site	I
,	O
we	O
have	O
cloned	O
and	O
characterized	O
a	O
cDNA	O
that	O
represents	O
a	O
mRNA	O
that	O
appears	O
to	O
have	O
been	O
initiated	O
from	O
the	O
p53p2	B
promoter	I
.	O

Such	O
multisensory	O
interactions	O
can	O
be	O
significant	O
for	O
behavior	O
.	O

The	O
cDNA	O
of	O
cpm7	B
encodes	O
a	O
closely	O
related	O
protein	O
of	O
36	O
.	O
8	O
kDa	O
.	O

Mortality	O
on	O
the	O
last	O
ranch	O
was	O
particularly	O
severe	O
among	O
certain	O
segregated	O
groups	O
of	O
turkeys	O
that	O
included	O
toms	O
,	O
heavier	O
birds	O
,	O
and	O
birds	O
undergoing	O
a	O
stressful	O
event	O
such	O
as	O
artificial	O
insemination	O
.	O

INTERVENTION	O
(	O
S	O
):	O
Twenty	O
-	O
six	O
hemostasis	O
parameters	O
evaluated	O
repeatedly	O
in	O
patients	O
undergoing	O
IVF	O
-	O
ET	O
.	O

In	O
contrast	O
with	O
previous	O
two	O
-	O
pool	O
models	O
,	O
provisions	O
were	O
made	O
for	O
folate	O
turnover	O
by	O
urinary	O
folate	O
excretion	O
(	O
as	O
measured	O
here	O
)	O
and	O
by	O
fecal	O
excretion	O
and	O
catabolic	O
processes	O
.	O

Several	O
artifacts	O
occurred	O
that	O
interfered	O
with	O
visualization	O
of	O
the	O
diaphragm	O
.	O

Because	O
of	O
the	O
potential	O
implications	O
of	O
these	O
findings	O
in	O
human	O
physiology	O
,	O
we	O
cloned	O
the	O
hPACAP	B
-	I
R	I
gene	I
.	O

Ectopic	O
expression	O
of	O
Apo	B
-	I
3	I
in	O
HEK293	O
or	O
HeLa	O
cells	O
induced	O
marked	O
apoptosis	O
.	O

Similarity	O
is	O
most	O
striking	O
in	O
the	O
zinc	B
knuckle	I
region	O
,	O
a	O
region	O
characteristic	O
of	O
gag	B
genes	I
of	O
most	O
replication	O
-	O
competent	O
retroelements	O
.	O

Identification	O
of	O
a	O
cis	O
-	O
acting	O
element	O
in	O
the	O
class	B
I	I
major	I
histocompatibility	I
complex	I
gene	I
promoter	I
responsive	I
to	O
activation	O
by	O
retroviral	O
sequences	O
.	O

(	O
ii	O
)	O
ICP27	B
binds	O
preferentially	O
to	O
less	O
modified	O
forms	O
of	O
ICP4	B
,	O
a	O
protein	O
that	O
is	O
extensively	O
modified	O
posttranslationally	O
.	O

Specific	O
IgG	B
,	O
specific	O
IgE	B
and	O
total	O
IgE	B
immunoglobulins	I
against	O
Toxocara	B
canis	I
excretory	I
/	I
secretory	I
antigens	I
(	O
TES	B
)	O
were	O
detected	O
by	O
using	O
ELISA	O
technique	O
.	O

SUMMARY	O
BACKGROUND	O
DATA	O
:	O
Melanoma	O
care	O
has	O
not	O
changed	O
significantly	O
in	O
the	O
last	O
20	O
years	O
,	O
and	O
the	O
controversy	O
of	O
elective	O
lymph	O
node	O
dissections	O
in	O
this	O
disease	O
continues	O
to	O
be	O
discussed	O
.	O

The	O
resurgence	O
of	O
drug	O
-	O
resistant	O
malaria	O
makes	O
urgent	O
the	O
evaluation	O
of	O
new	O
antimalarial	O
agents	O
.	O

The	O
relatively	O
high	O
level	O
transcription	O
from	O
this	O
gene	O
shows	O
that	O
the	O
polymorphic	O
chromosome	O
ends	O
of	O
P	O
.	O
falciparum	O
,	O
which	O
have	O
been	O
proposed	O
to	O
be	O
transcriptionally	O
silent	O
,	O
can	O
be	O
active	O
expression	O
sites	O
for	O
var	O
genes	O
.	O

A	O
total	O
of	O
1459	O
men	O
aged	O
48	O
to	O
84	O
years	O
,	O
who	O
were	O
diagnosed	O
for	O
the	O
first	O
time	O
by	O
physicians	O
as	O
having	O
BPH	O
in	O
1994	O
and	O
who	O
had	O
not	O
received	O
treatment	O
,	O
participated	O
in	O
the	O
study	O
.	O

Full	B
-	I
length	I
AT	I
-	I
PHH1	I
,	O
and	O
both	O
AT	B
-	I
PHH1	I
and	O
AT	B
-	I
PHH1	I
delta	I
C	I
-	I
513	I
(	O
truncated	O
to	O
be	O
approximately	O
the	O
size	O
of	O
microbial	B
photolyase	I
genes	I
)	I
cDNAs	I
,	O
were	O
overexpressed	O
,	O
respectively	O
,	O
in	O
yeast	O
and	O
Escherichia	B
coli	I
mutants	I
hypersensitive	I
to	O
ultraviolet	O
light	O
.	O

The	O
human	B
p100	I
protein	I
was	O
recently	O
identified	O
as	O
a	O
coactivator	O
of	O
the	O
Epstein	B
-	I
Barr	I
virus	I
nuclear	I
antigen	I
2	I
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
reproducibility	O
of	O
a	O
number	O
of	O
simplified	O
clearance	O
methods	O
using	O
chromium	O
-	O
51	O
ethylenediamine	O
tetraacetic	O
acid	O
(	O
51Cr	O
-	O
EDTA	O
)	O
and	O
to	O
compare	O
these	O
with	O
the	O
multiple	O
blood	O
sample	O
technique	O
.	O

Sp1	B
binds	O
the	O
CTC	O
repeat	O
with	O
an	O
affinity	O
,	O
KD	O
=	O
0	O
.	O
37	O
nM	O
,	O
at	O
least	O
as	O
high	O
as	O
the	O
consensus	O
GC	O
box	O
.	O

Mutant	O
enzyme	O
forms	O
were	O
prepared	O
to	O
eliminate	O
the	O
initial	O
autoprocessing	O
site	O
and	O
thus	O
form	O
an	O
active	O
single	B
-	I
chain	I
protein	I
for	O
structure	O
-	O
function	O
studies	O
.	O

This	O
R	B
-	I
domain	I
may	O
modulate	O
the	O
interaction	O
with	O
SRF	B
,	O
providing	O
a	O
mechanism	O
that	O
would	O
be	O
unique	O
to	O
FLI1	B
and	O
EWS	B
-	O
FLI1	B
,	O
thus	O
implicating	O
a	O
novel	O
function	O
for	O
these	O
ETS	B
transcription	I
factors	I
in	O
the	O
regulation	O
of	O
the	O
Egr1	B
gene	I
.	O

The	O
total	O
number	O
of	O
specimens	O
was	O
131	O
with	O
78	O
nonsmokers	O
and	O
53	O
smokers	O
.	O

One	O
possible	O
solution	O
is	O
a	O
thin	O
radial	O
forearm	O
free	O
flap	O
.	O

Both	O
HEF1	B
and	O
Cas	B
were	O
found	O
to	O
complex	O
with	O
the	O
related	O
adhesion	O
focal	B
tyrosine	I
kinase	I
(	O
RAFTK	B
),	O
and	O
when	O
tyrosine	O
phosphorylated	O
,	O
with	O
the	O
adapter	O
molecule	O
CrkL	B
.	O

Moreover	O
,	O
the	O
effect	O
exerted	O
by	O
TIS1	B
appeared	O
to	O
be	O
selective	O
for	O
the	O
MCK	B
promoter	I
.	O

Experimental	O
data	O
showed	O
that	O
these	O
abnormal	O
proteins	O
are	O
constitutively	O
localized	O
in	O
the	O
nucleus	O
,	O
have	O
lost	O
the	O
transcriptional	O
repressor	O
functions	O
typical	O
of	O
normal	O
NF	B
-	I
kappa	I
B2p52	I
and	O
may	O
be	O
capable	O
of	O
transactivation	O
activity	O
.	O

cDNA	O
cloning	O
,	O
expression	O
analysis	O
,	O
and	O
chromosomal	O
localization	O
of	O
a	O
gene	O
with	O
high	O
homology	O
to	O
wheat	B
eIF	I
-(	I
iso	I
)	I
4F	I
and	O
mammalian	B
eIF	I
-	I
4G	I
.	O

Surprisingly	O
,	O
however	O
,	O
TCR	B
-	I
mediated	O
tyrosine	O
phosphorylation	O
of	O
phospholipase	B
C	I
gamma	I
1	I
remains	O
intact	O
in	O
the	O
Jurkat	O
cells	O
expressing	O
the	O
A2	O
/	O
HCP	B
chimera	I
.	O

The	O
14	B
.	I
1	I
(	I
IGLL1	I
)	I
gene	I
is	O
expressed	O
in	O
a	O
lineage	O
-	O
and	O
stage	O
-	O
restricted	O
manner	O
.	O

Object	O
relations	O
,	O
affect	O
management	O
,	O
and	O
psychic	O
structure	O
formation	O
.	O

In	O
rlf2	B
mutants	I
,	O
telomeric	O
chromatin	O
is	O
perturbed	O
:	O
Telomeric	O
silencing	O
is	O
reduced	O
and	O
Rap1p	B
localization	O
is	O
altered	O
.	O

Interaction	O
of	O
Ets	B
-	I
1	I
and	O
the	O
POU	B
-	I
homeodomain	I
protein	I
GHF	I
-	I
1	I
/	I
Pit	I
-	I
1	I
reconstitutes	O
pituitary	B
-	I
specific	I
gene	I
expression	O
.	O

Studies	O
using	O
HLA	B
-	I
DR	I
-	I
B7	I
-	I
1	I
-	O
LFA	B
-	I
3	I
triple	O
transfectants	O
showed	O
that	O
the	O
LFA	B
-	I
3	I
-	I
induced	O
NF	B
-	I
AT	I
DNA	I
binding	I
activity	O
was	O
negatively	O
regulated	O
by	O
B7	B
-	I
1	I
costimulation	O
.	O

Constitutive	O
activation	O
of	O
Rac1	B
and	O
RhoA	B
causes	O
tumorigenic	O
transformation	O
of	O
NIH	O
3T3	O
cells	O
,	O
and	O
their	O
functions	O
may	O
be	O
required	O
for	O
full	O
Ras	B
transformation	O
.	O

Overexpression	O
of	O
the	O
bZip	O
interaction	O
domain	O
of	O
CBP	B
specifically	O
abolishes	O
the	O
positive	O
cross	O
talk	O
between	O
TR	B
and	O
p45	B
/	I
NF	I
-	I
E2	I
.	O

Identification	O
of	O
a	O
promoter	O
-	O
specific	O
transactivation	O
domain	O
in	O
the	O
herpes	B
simplex	I
virus	I
regulatory	I
protein	I
ICP4	I
.	O

The	O
workup	O
included	O
skin	O
tests	O
(	O
up	O
to	O
1	O
microgram	O
/	O
ml	O
,	O
Pharmacia	O
),	O
measurement	O
of	O
specific	O
serum	B
IgE	I
with	O
RAST	O
-	O
CAP	O
(	O
Pharmacia	O
),	O
and	O
CAST	O
with	O
three	O
concentrations	O
of	O
bee	O
(	O
Apis	O
mellifera	O
)	O
and	O
wasp	O
(	O
Vespula	O
spec	O
.)	O
venom	O
(	O
Aquagen	O
ALK	B
).	O

The	O
FBF	O
questionnaire	O
did	O
not	O
highlight	O
a	O
characteristic	O
basic	O
symptoms	O
profile	O
of	O
schizoaffective	O
disorder	O
,	O
when	O
compared	O
with	O
bipolar	O
affective	O
disorder	O
and	O
schizophrenia	O
.	O

Here	O
we	O
show	O
that	O
the	O
type	O
of	O
tyrosine	B
kinase	I
receptor	I
stimulated	O
also	O
participates	O
in	O
the	O
nature	O
of	O
the	O
cAMP	O
effect	O
.	O

The	O
best	O
endometrial	O
ablation	O
was	O
seen	O
when	O
SnET2	O
was	O
given	O
by	O
intrauterine	O
administration	O
with	O
light	O
treatment	O
at	O
150	O
J	O
/	O
cm	O
24	O
hours	O
later	O
.	O

Cytohesin	B
-	I
1	I
,	O
a	O
protein	O
abundant	O
in	O
cells	O
of	O
the	O
immune	O
system	O
,	O
has	O
been	O
proposed	O
to	O
be	O
a	O
human	B
homolog	I
of	O
the	O
Saccharomyces	B
cerevisiae	I
Sec7	I
gene	I
product	I
,	O
which	O
is	O
crucial	O
in	O
protein	O
transport	O
.	O

Snail	O
mortality	O
did	O
not	O
differ	O
among	O
the	O
various	O
treatment	O
conditions	O
.	O

99mTc	O
-	O
HMPAO	O
was	O
distributed	O
in	O
the	O
territories	O
of	O
the	O
ACA	O
and	O
MCA	O
in	O
the	O
two	O
patients	O
who	O
were	O
treated	O
with	O
intraarterial	O
infusion	O
of	O
papaverine	O
from	O
the	O
C4	O
segment	O
,	O
but	O
was	O
distributed	O
only	O
to	O
the	O
territory	O
of	O
the	O
ACA	O
in	O
four	O
patients	O
who	O
were	O
treated	O
with	O
intraarterial	O
infusion	O
of	O
papaverine	O
from	O
the	O
C1	O
segment	O
at	O
1	O
ml	O
/	O
min	O
.	O

A	O
miracle	O
cure	O
and	O
its	O
solution	O

Ume6p	B
,	O
which	O
also	O
controls	O
the	O
expression	O
of	O
early	O
meiotic	O
genes	O
,	O
represses	O
CAR1	B
expression	O
through	O
a	O
sequence	O
called	O
URS	O
,	O
as	O
a	O
function	O
of	O
nitrogen	O
availability	O
.	O

A	O
previous	O
report	O
described	O
that	O
a	O
548	O
-	O
bp	O
BglII	B
-	I
SmaI	I
fragment	I
has	O
an	O
SSO	O
activity	O
(	O
ori2	O
;	O
Kataoka	O
et	O
al	O
.,	O
Mol	O
.	O

GH	B
deficiency	O
may	O
be	O
absolute	O
,	O
but	O
often	O
is	O
not	O
and	O
the	O
diagnosis	O
may	O
be	O
complicated	O
by	O
a	O
constellation	O
of	O
physical	O
and	O
hormonal	O
findings	O
that	O
are	O
along	O
a	O
spectrum	O
from	O
low	O
normal	O
GH	B
sufficiency	O
to	O
absent	O
GH	B
secretion	O
.	O

Recognition	O
mechanisms	O
of	O
the	O
minus	O
-	O
strand	O
origin	O
of	O
phage	O
f1	O
by	O
Escherichia	B
coli	I
RNA	I
polymerase	I
.	O

MOP5	B
contained	O
the	O
characteristic	O
PAS	B
domain	I
and	O
a	O
variable	O
C	O
terminus	O
;	O
it	O
is	O
possible	O
that	O
the	O
cDNA	O
contains	O
a	O
bHLH	B
domain	I
,	O
but	O
the	O
entire	O
open	O
reading	O
frame	O
has	O
yet	O
to	O
be	O
completed	O
.	O

Purified	B
Pra	I
was	O
also	O
shown	O
to	O
physically	O
interact	O
with	O
pyruvate	B
kinase	I
(	O
Pk	B
);	O
Pk	B
and	O
Pra	B
can	O
form	O
a	O
complex	O
,	O
but	O
when	O
the	O
12	B
-	I
kDa	I
Ndk	I
,	O
Pk	B
,	O
and	O
Pra	B
are	O
all	O
present	O
,	O
Pk	B
has	O
a	O
higher	O
affinity	O
than	O
Pra	B
for	O
forming	O
a	O
complex	O
with	O
the	O
12	B
-	I
kDa	I
Ndk	I
.	O

Apart	O
from	O
iron	O
regulation	O
,	O
sodA	B
expression	O
was	O
affected	O
by	O
changes	O
in	O
DNA	O
topology	O
induced	O
by	O
coumermycin	O
A	O
but	O
not	O
by	O
the	O
global	O
virulence	O
regulatory	O
Bvg	B
system	O
.	O

The	O
binding	O
site	O
for	O
OxyR	B
overlapped	O
P1oxyR	B
,	O
reminiscent	O
of	O
the	O
autoregulatory	O
loops	O
controlling	O
expression	O
of	O
oxyR	B
in	O
enteric	O
bacteria	O
and	O
characteristic	O
of	O
the	O
LysR	B
superfamily	I
in	O
general	O
.	O

Thirty	O
-	O
five	O
patients	O
were	O
included	O
.	O

Grade	O
3	O
-	O
4	O
mucositis	O
was	O
present	O
in	O
13	O
%	O
of	O
the	O
cycles	O
.	O

None	O
of	O
these	O
organic	O
manifestations	O
was	O
discovered	O
by	O
scintigraphic	O
means	O
.	O

The	O
prominent	O
lesions	O
were	O
confined	O
to	O
the	O
cerebral	O
surface	O
layer	O
and	O
leptomeningeal	O
tissue	O
including	O
the	O
arachnoid	O
vessels	O
,	O
which	O
were	O
all	O
bathed	O
in	O
the	O
cerebrospinal	O
fluid	O
,	O
suggesting	O
that	O
some	O
necrotizing	O
toxins	O
had	O
been	O
secreted	O
into	O
the	O
fluid	O
by	O
the	O
B	O
.	O
cereus	O
.	O

Purified	B
P7	I
could	O
be	O
assembled	O
onto	O
particles	O
lacking	O
P7	B
and	O
particles	O
lacking	O
both	O
P2	O
(	O
RNA	B
polymerase	I
)	O
and	O
P7	B
.	O

Sequences	O
downstream	O
of	O
the	O
two	O
human	B
CA	I
genes	I
,	O
possibly	O
containing	O
homologous	O
enhancer	O
elements	O
,	O
have	O
not	O
yet	O
been	O
reported	O
.	O

Recombinant	B
plasmids	O
containing	O
the	O
entire	O
322	O
nt	O
5	O
'	O
UTR	O
of	O
exon	O
1	O
and	O
a	O
1630	O
nt	O
segment	O
of	O
5	O
'	O
flanking	O
sequence	O
stimulated	O
luciferase	B
activity	O
nearly	O
70	O
times	O
higher	O
than	O
a	O
promoterless	O
control	O
plasmid	O
.	O

It	O
is	O
also	O
homologous	O
to	O
other	O
sugar	O
carriers	O
from	O
human	O
,	O
mouse	O
and	O
Escherichia	O
coli	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
examined	O
the	O
regulation	O
of	O
B	B
-	I
Myb	I
activity	O
by	O
cyclin	B
-	O
Cdks	B
.	O

Candidate	O
tumor	B
suppressor	I
genes	I
,	O
Mts1	B
(	O
p16INK4a	B
)	O
and	O
Mts2	B
(	O
p15INK4b	B
),	O
have	O
been	O
mapped	O
to	O
this	O
region	O
,	O
but	O
by	O
Southern	O
blot	O
analysis	O
,	O
no	O
homozygous	O
deletions	O
were	O
detected	O
in	O
either	O
gene	O
.	O

Active	O
complexes	O
eluted	O
at	O
a	O
higher	O
molecular	O
weight	O
than	O
inactive	O
complexes	O
,	O
were	O
relatively	O
deficient	O
in	O
both	O
p21	B
and	O
p27	B
,	O
and	O
contained	O
Cdk2	B
with	O
increased	O
threonine	O
160	O
phosphorylation	O
,	O
consistent	O
with	O
a	O
mechanism	O
of	O
activation	O
of	O
cyclin	B
E	I
-	I
Cdk2	I
involving	O
both	O
reduced	O
CDK	B
inhibitor	I
association	O
and	O
CDK	B
-	I
activating	I
kinase	I
-	I
mediated	O
phosphorylation	O
of	O
Cdk2	B
.	O

The	O
effect	O
of	O
Vpu	B
on	O
class	O
I	O
biogenesis	O
was	O
analyzed	O
in	O
more	O
detail	O
using	O
a	O
Vpu	B
-	I
expressing	O
recombinant	O
vaccinia	O
virus	O
(	O
VV	O
).	O

Having	O
an	O
LRR	B
domain	I
and	O
an	O
SH3	B
-	I
binding	I
domain	I
,	O
Acan125	B
and	O
the	O
C	O
.	O
elegans	O
homologue	O
define	O
a	O
novel	O
family	O
of	O
bifunctional	O
binding	O
proteins	O
.	O

Unlike	O
the	O
MAR	O
-	O
binding	O
domain	O
,	O
the	O
homeodomain	B
when	O
isolated	O
binds	O
poorly	O
and	O
with	O
low	O
specificity	O
to	O
DNA	O
.	O

The	O
importance	O
of	O
posttranslational	O
regulation	O
of	O
p15INK4B	B
by	O
TGF	B
-	I
beta	I
is	O
underlined	O
by	O
the	O
observation	O
that	O
in	O
TGF	B
-	I
beta	I
-	I
resistant	O
184A1L5R	O
,	O
although	O
the	O
p15	B
transcript	I
increased	O
,	O
p15INK4B	B
protein	I
was	O
not	O
stabilized	O
and	O
did	O
not	O
accumulate	O
,	O
and	O
cyclin	B
D1	I
-	O
cdk	B
association	O
and	O
kinase	O
activation	O
were	O
not	O
inhibited	O
.	O

The	O
likelihood	O
that	O
a	O
common	O
region	O
of	O
deletions	O
would	O
contain	O
a	O
tumor	O
suppressor	O
is	O
strongly	O
enhanced	O
by	O
coincidence	O
of	O
that	O
region	O
with	O
a	O
chromosome	O
fragment	O
suppressing	O
tumorigenicity	O
upon	O
introduction	O
in	O
tumor	O
cells	O
.	O

In	O
particular	O
,	O
Western	O
,	O
supershift	O
,	O
and	O
promoter	O
deletion	O
analyses	O
suggested	O
a	O
role	O
for	O
CCAAT	B
/	I
enhancer	I
-	I
binding	I
protein	I
-	I
beta	I
(	I
C	I
/	I
EBP	I
-	I
beta	I
)	I
binding	I
site	I
between	O
-	O
2010	O
and	O
-	O
1954	O
in	O
regulating	O
transcription	O
of	O
collagenase	B
-	I
1	I
in	O
monocytic	O
cells	O
.	O

Cdc2	B
co	O
-	O
precipitates	O
with	O
Pch1	B
in	O
S	O
.	O
pombe	O
cell	O
lysates	O
,	O
although	O
Cdc2	B
may	O
not	O
be	O
the	O
major	O
catalytic	O
partner	O
of	O
a	O
Pch1	B
kinase	I
in	O
vivo	O
.	O

L	O
-	O
canavanine	O
,	O
a	O
selective	O
inhibitor	O
of	O
the	O
inducible	O
nitric	B
oxide	I
synthase	I
,	O
increases	O
the	O
mean	O
systemic	O
filling	O
pressure	O
,	O
thereby	O
improving	O
venous	O
return	O
,	O
under	O
these	O
conditions	O
.	O

RESULTS	O
:	O
Of	O
the	O
29	O
patients	O
who	O
received	O
concurrent	O
chemotherapy	O
and	O
G	B
-	I
CSF	I
,	O
ten	O
(	O
34	O
%;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
17	O
.	O
9	O
to	O
54	O
.	O
3	O
%)	O
were	O
believed	O
to	O
have	O
clinically	O
significant	O
bleomycin	O
toxicity	O
.	O

Shc	B
stimulates	O
Ras	B
/	I
mitogen	I
-	I
activated	I
protein	I
kinase	I
(	I
MAPK	I
)	O
through	O
forming	O
a	O
complex	O
with	O
Grb2	B
at	O
the	O
phosphorylated	O
tyrosine	O
(	O
Y	O
)	O
residue	O
317	O
.	O

Domain	O
switch	O
experiments	O
reveal	O
that	O
C	B
/	I
EBP	I
beta	I
proteins	I
containing	O
either	O
the	O
leucine	O
zipper	O
or	O
the	O
activation	O
domain	O
of	O
C	B
/	I
EBP	I
alpha	I
are	O
unable	O
to	O
stimulate	O
the	O
2D5	B
promoter	I
yet	O
are	O
fully	O
capable	O
of	O
transactivating	O
an	O
artificial	O
promoter	O
bearing	O
a	O
high	O
-	O
affinity	O
C	B
/	I
EBP	I
site	I
.	O

These	O
activities	O
are	O
all	O
required	O
for	O
stimulation	O
of	O
cell	O
growth	O
by	O
middle	O
-	O
T	O
and	O
activate	O
members	O
of	O
the	O
MAP	B
kinase	I
family	I
.	O

A	O
role	O
for	O
the	O
small	B
GTPase	I
Rac	I
in	O
polyomavirus	B
middle	I
-	I
T	I
antigen	I
-	I
mediated	O
activation	O
of	O
the	O
serum	O
response	O
element	O
and	O
in	O
cell	O
transformation	O
.	O

Our	O
results	O
indicate	O
that	O
RA	O
-	O
mediated	O
repression	O
of	O
the	O
hMGP	B
gene	I
is	O
due	O
to	O
binding	O
of	O
liganded	O
RAR	B
/	O
RXR	B
to	O
a	O
novel	O
negative	O
RA	O
response	O
element	O
.	O

The	O
electromyographically	O
recorded	O
responses	O
consisted	O
of	O
an	O
early	O
R1	O
response	O
in	O
the	O
orbicularis	O
oculi	O
muscle	O
ipsilateral	O
to	O
the	O
side	O
of	O
stimulation	O
,	O
a	O
bilateral	O
late	O
response	O
(	O
ipsilateral	O
R2	O
and	O
contralateral	O
Rc	O
)	O
and	O
a	O
third	O
,	O
R3	O
response	O
,	O
in	O
the	O
ipsilateral	O
orbicularis	O
oculi	O
muscle	O
.	O

Here	O
we	O
report	O
the	O
cloning	O
of	O
the	O
protein	O
that	O
binds	O
to	O
enhancer	O
site	O
III	O
.	O

Sequences	O
needed	O
for	O
iron	O
-	O
regulated	O
expression	O
of	O
sid1	B
were	O
localized	O
to	O
a	O
306	O
bp	O
region	O
mapping	O
2	O
.	O
3	O
and	O
2	O
.	O
6	O
kb	O
upstream	O
of	O
the	O
ATG	O
.	O

A	O
genetic	O
screen	O
applied	O
to	O
mutants	O
in	O
the	O
branch	O
site	O
region	O
shows	O
that	O
all	O
positions	O
in	O
the	O
conserved	O
TACTAAC	O
sequence	O
are	O
important	O
for	O
intron	O
recognition	O
.	O

Comparison	O
of	O
the	O
p50	B
sequence	I
to	O
other	O
cloned	O
proteins	O
revealed	O
89	O
%	O
homology	O
with	O
a	O
glycosaminoglycan	O
-	O
binding	O
protein	O
and	O
54	O
%	O
homology	O
with	O
Drosophila	B
cell	I
cycle	I
control	I
protein	I
(	I
cdc	I
)	O
37	O
.	O

Glycemic	O
response	O
to	O
malted	O
,	O
popped	O
and	O
roller	O
dried	O
wheat	B
-	I
legume	O
based	O
foods	O
in	O
normal	O
subjects	O
.	O

The	O
results	O
indicate	O
that	O
DNA	O
methylation	O
,	O
chromatin	O
structure	O
,	O
and	O
transactivation	O
at	O
an	O
Sp1	B
site	I
contribute	O
to	O
the	O
highly	O
restricted	O
expression	O
of	O
this	O
myelomonocytic	O
lineage	O
specific	O
gene	O
.	O

This	O
protein	O
can	O
bind	O
to	O
a	O
region	O
of	O
the	O
promoter	O
of	O
an	O
Arabidopsis	B
light	I
-	I
harvesting	I
chlorophyll	I
a	I
/	I
b	I
protein	I
gene	I
,	O
Lhcb1	B
*	I
3	I
,	O
which	O
is	O
necessary	O
for	O
its	O
regulation	O
by	O
phytochrome	B
.	O

Congruent	O
with	O
empirical	O
predictions	O
,	O
the	O
most	O
homesick	O
children	O
perceived	O
low	O
control	O
over	O
homesickness	O
and	O
separation	O
,	O
and	O
coped	O
by	O
relinquishing	O
control	O
.	O

Each	O
sample	O
was	O
analysed	O
as	O
soon	O
as	O
possible	O
,	O
and	O
repeated	O
15	O
,	O
30	O
,	O
60	O
and	O
120	O
min	O
after	O
sampling	O
.	O

Anesthesia	O
was	O
maintained	O
with	O
isoflurane	O
(	O
ISO	O
)/	O
N2O	O
/	O
O2	O
inhalation	O
.	O

The	O
altered	O
amino	O
acid	O
residues	O
of	O
the	O
seven	O
mutant	B
9ORF1	I
polypeptides	I
clustered	O
within	O
three	O
separate	O
regions	O
referred	O
to	O
as	O
region	O
I	O
(	O
residues	O
34	O
to	O
41	O
),	O
region	O
II	O
(	O
residues	O
89	O
to	O
91	O
),	O
and	O
C	B
-	I
terminal	I
region	I
III	I
(	O
residues	O
122	O
to	O
125	O
).	O

Rep	B
-	I
Rep	I
protein	I
interaction	O
was	O
confirmed	O
in	O
vitro	O
through	O
coimmunoprecipitation	O
experiments	O
with	O
a	O
bacterially	O
expressed	O
maltose	B
-	I
binding	I
protein	I
-	O
Rep78	B
fusion	I
protein	I
in	O
combination	O
with	O
[	O
35S	O
]	O
methionine	O
-	O
labeled	O
Rep78	B
synthesized	O
in	O
a	O
coupled	O
in	O
vitro	O
transcription	O
-	O
translation	O
system	O
.	O

Fourteen	O
patients	O
with	O
New	O
York	O
Heart	O
Association	O
class	O
II	O
congestive	O
heart	O
failure	O
were	O
enrolled	O
in	O
a	O
double	O
-	O
blind	O
,	O
cross	O
-	O
over	O
study	O
.	O

Transfection	O
experiments	O
using	O
preformed	O
triplexes	O
with	O
a	O
reporter	O
plasmid	O
containing	O
the	O
collagen	B
promoter	I
sequence	I
showed	O
significant	O
inhibition	O
of	O
transcription	O
when	O
compared	O
with	O
a	O
control	O
phosphorothioate	O
ODN	O
.	O

These	O
results	O
suggest	O
that	O
dietary	O
safflower	O
phospholipids	O
may	O
be	O
a	O
valuable	O
ingredient	O
to	O
layers	O
for	O
reducing	O
liver	O
triglycerides	O
and	O
serum	O
cholesterol	O
without	O
any	O
adverse	O
effects	O
.	O

Saturable	O
spermidine	O
transport	O
in	O
stk2	B
::	O
lacZ	B
mutants	I
had	O
an	O
approximately	O
fivefold	O
-	O
lower	O
affinity	O
and	O
twofold	O
-	O
lower	O
Vmax	O
than	O
in	O
the	O
parental	O
strain	O
.	O

Inhibition	O
of	O
the	O
Raf	B
-	I
1	I
kinase	I
by	O
cyclic	O
AMP	O
agonists	O
causes	O
apoptosis	O
of	O
v	B
-	I
abl	I
-	I
transformed	O
cells	O
.	O

We	O
show	O
here	O
that	O
the	O
protein	O
kinase	O
MEKK1	B
can	O
induce	O
reporter	O
gene	O
expression	O
from	O
the	O
atrial	B
natriuretic	I
factor	I
(	O
ANF	B
)	I
promoter	I
,	O
a	O
genetic	O
marker	O
that	O
is	O
activated	O
during	O
in	O
vivo	O
hypertrophy	O
.	O

This	O
association	O
appears	O
to	O
be	O
mediated	O
by	O
Src	B
-	I
SH2	I
domain	I
,	O
because	O
PECAM	B
-	I
1	I
can	O
be	O
precipitated	O
by	O
a	O
GST	B
-	I
Src	I
-	I
SH2	I
affinity	O
matrix	O
.	O

An	O
alternatively	O
spliced	O
MAdCAM	B
-	I
1	I
variant	I
was	O
identified	O
that	O
lacks	O
exon	O
4	O
encoding	O
the	O
mucin	B
domain	I
,	O
and	O
may	O
mediate	O
leukocyte	O
adhesion	O
to	O
LPAM	B
-	I
1	I
without	O
adhesion	O
to	O
the	O
alternate	O
receptor	O
,	O
L	B
-	I
selectin	I
.	O

In	O
summary	O
,	O
the	O
data	O
establish	O
that	O
the	O
previously	O
reported	O
human	B
MAdCAM	I
-	I
1	I
cDNA	I
does	O
indeed	O
encode	O
the	O
human	B
homologue	I
of	O
mouse	B
MAdCAM	I
-	I
1	I
,	O
despite	O
gross	O
dissimilarities	O
in	O
the	O
MAdCAM	B
-	I
1	I
C	I
-	I
terminal	I
structures	O
.	O

We	O
have	O
used	O
a	O
site	O
-	O
directed	O
mutagenesis	O
approach	O
to	O
examine	O
how	O
the	O
Xaa	O
and	O
hydroxy	O
(	O
Ser	O
/	O
Thr	O
)	O
amino	O
acid	O
residues	O
in	O
sequons	O
influence	O
core	O
-	O
glycosylation	O
efficiency	O
.	O

METHODS	O
:	O
The	O
responses	O
of	O
a	O
31	O
-	O
year	O
-	O
old	O
woman	O
with	O
complex	O
regional	O
pain	O
syndrome	O
type	O
I	O
(	O
reflex	O
sympathetic	O
dystrophy	O
)	O
to	O
a	O
thermal	O
grill	O
were	O
evaluated	O
before	O
and	O
after	O
stellate	O
ganglion	O
block	O
.	O

More	O
recently	O
,	O
however	O
,	O
a	O
number	O
of	O
developments	O
such	O
as	O
the	O
successful	O
use	O
of	O
the	O
inhaled	O
steroid	O
budesonide	O
and	O
oral	O
dexamethasone	O
have	O
reinforced	O
the	O
argument	O
for	O
using	O
steroids	O
.	O

Mutation	O
of	O
nucleotides	O
adjacent	O
to	O
the	O
AP	B
-	I
1	I
cis	I
-	I
response	I
elements	O
had	O
no	O
effect	O
on	O
trans	O
-	O
activation	O
.	O

The	O
mammalian	B
phosphoinositide	I
3	I
-	I
kinases	I
(	O
PI3Ks	B
)	O
p110alpha	B
,	O
beta	O
,	O
and	O
delta	O
form	O
heterodimers	O
with	O
Src	B
homology	I
2	I
(	I
SH2	I
)	I
domain	I
-	I
containing	O
adaptors	O
such	O
as	O
p85alpha	B
or	O
p55	B
(	O
PIK	B
).	O

In	O
the	O
studies	O
reported	O
here	O
,	O
the	O
5	O
'-	O
flanking	O
region	O
of	O
the	O
human	B
gp130	I
gene	I
was	O
isolated	O
and	O
the	O
transcription	O
initiation	O
sites	O
were	O
mapped	O
.	O

Here	O
,	O
a	O
case	O
of	O
Sjogren	O
'	O
s	O
syndrome	O
is	O
presented	O
that	O
was	O
initially	O
diagnosed	O
because	O
of	O
dental	O
complaints	O
,	O
and	O
long	O
-	O
term	O
treatment	O
of	O
Sjogren	O
'	O
s	O
patients	O
is	O
discussed	O
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
cDNA	O
encoding	O
a	O
bacteriophage	B
-	I
type	I
RNA	I
polymerase	I
from	O
the	O
higher	O
plant	O
Chenopodium	O
album	O
.	O

Characterization	O
of	O
CR1	O
repeat	O
random	O
PCR	O
markers	O
for	O
mapping	O
the	O
chicken	O
genome	O
.	O

A	O
reversed	O
-	O
phase	O
high	O
-	O
performance	O
liquid	O
chromatographic	O
(	O
HPLC	O
)	O
method	O
for	O
the	O
determination	O
of	O
cocaine	O
metabolites	O
produced	O
in	O
vitro	O
by	O
serum	B
and	I
liver	I
esterases	I
is	O
described	O
.	O

A	O
similar	O
chimera	O
was	O
assembled	O
from	O
the	O
two	O
halves	O
of	O
the	O
molecule	O
expressed	O
separately	O
in	O
different	O
bacteria	O
and	O
refolded	O
together	O
.	O

EGF	B
acts	O
primarily	O
by	O
means	O
of	O
transactivation	O
domain	O
AF	B
-	I
1	I
,	O
whereas	O
cAMP	O
acts	O
via	O
transactivation	O
domain	O
AF	B
-	I
2	I
of	O
the	O
ER	O
.	O

A	O
neonatal	O
alloimmune	O
thrombocytopenia	O
with	O
an	O
HPA	B
-	I
3a	I
(	O
Baka	O
)	O
incompatibility	O
was	O
confirmed	O
.	O

Most	O
eukaryotic	O
mRNAs	O
are	O
translated	O
by	O
a	O
"	O
scanning	O
ribosome	O
"	O
mechanism	O
.	O

SSeCKS	B
(	O
pronounced	O
essex	O
)	O
encodes	O
a	O
major	B
protein	I
kinase	I
C	I
substrate	I
,	O
the	O
expression	O
of	O
which	O
is	O
down	O
-	O
regulated	O
in	O
src	B
-	I
and	I
ras	I
-	I
transformed	O
rodent	O
fibroblasts	O
but	O
not	O
in	O
raf	B
-	I
transformed	O
rodent	O
fibroblasts	O
(	O
X	O
.	O

We	O
have	O
found	O
that	O
mcs4	B
-	I
cells	O
are	O
defective	O
at	O
activation	O
of	O
Spc1	B
in	O
response	O
to	O
various	O
forms	O
of	O
stress	O
.	O

The	O
extended	O
rat	O
SP	B
-	I
A	I
isoforms	I
were	O
enriched	O
in	O
the	O
more	O
fully	O
glycosylated	O
and	O
multimeric	O
SP	B
-	I
A	I
species	O
separated	O
on	O
SDS	O
-	O
PAGE	O
gels	O
.	O

Alternative	O
splicing	O
of	O
CDC25B	B
may	O
therefore	O
contribute	O
to	O
the	O
control	O
of	O
cell	O
proliferation	O
.	O

The	O
findings	O
suggest	O
that	O
ERP	O
effects	O
of	O
distinct	O
memory	O
processes	O
are	O
differentially	O
influenced	O
by	O
the	O
encoding	O
instructions	O
.	O

The	O
second	O
primary	O
mutant	O
contained	O
a	O
proline	O
-	O
to	O
-	O
leucine	O
change	O
at	O
position	O
243	O
(	O
P243L	O
).	O

Thus	O
,	O
the	O
PCE	B
binds	O
a	O
Pbx	B
dimer	I
partner	I
that	O
behaves	O
unlike	O
Class	B
I	I
Hox	I
proteins	I
.	O

Using	O
mouse	O
-	O
human	O
somatic	O
hybrids	O
and	O
FISH	O
analysis	O
,	O
the	O
PE	B
-	I
2	I
gene	I
is	O
localized	O
to	O
human	O
chromosome	O
19q13	O
.	O
2	O
,	O
a	O
region	O
involved	O
in	O
translocations	O
and	O
deletions	O
in	O
leukemias	O
and	O
several	O
solid	O
tumors	O
,	O
suggesting	O
that	O
this	O
novel	O
ETS	B
factor	I
may	O
play	O
a	O
role	O
in	O
carcinogenesis	O
.	O

Denaturation	O
of	O
the	O
simian	O
virus	O
40	O
origin	O
of	O
replication	O
mediated	O
by	O
human	B
replication	I
protein	I
A	I
.	O

Liquid	O
chromatographic	O
separation	O
was	O
achieved	O
on	O
a	O
Zorbax	O
RX	O
C8	O
analytical	O
column	O
using	O
gradient	O
elution	O
.	O

The	O
data	O
suggest	O
that	O
like	O
in	O
yeast	O
,	O
in	O
plants	O
a	O
certain	O
subfamily	O
of	O
UBC	B
is	O
specifically	O
involved	O
in	O
the	O
proteolytic	O
degradation	O
of	O
abnormal	O
proteins	O
as	O
result	O
of	O
stress	O
.	O

A	O
striking	O
feature	O
of	O
the	O
recombinant	O
H19	B
allele	I
is	O
the	O
occurrence	O
of	O
a	O
parental	O
imprint	O
set	O
on	O
the	O
neo	O
replacement	O
cassette	O
.	O

Lung	O
and	O
multi	O
-	O
system	O
damage	O
were	O
early	O
indicators	O
of	O
poor	O
outcome	O
in	O
severe	O
non	O
-	O
fatal	O
disease	O
.	O

Sternocleidomastoid	O
,	O
neck	O
or	O
facial	O
muscles	O
wasting	O
were	O
also	O
found	O
in	O
three	O
cases	O
.	O

However	O
,	O
we	O
could	O
not	O
find	O
the	O
homologous	O
regions	O
with	O
guanine	B
nucleotide	I
exchange	I
factors	I
or	I
GTPase	I
-	I
activating	I
proteins	I
in	O
the	O
c	B
-	I
cbl	I
gene	I
.	O

Stromelysin	B
-	I
1	I
,	O
matrix	B
metalloproteinase	I
-	I
3	I
(	O
MMP	B
-	I
3	I
),	O
is	O
an	O
important	O
endopeptidase	O
selectively	O
expressed	O
by	O
somatic	O
cells	O
in	O
organ	O
tissues	O
.	O

Pseudomonas	O
aeruginosa	O
strains	O
infecting	O
patients	O
with	O
cystic	O
fibrosis	O
(	O
CF	O
)	O
acquire	O
a	O
mucoid	O
phenotype	O
due	O
to	O
overproduction	O
of	O
alginate	O
.	O

Human	B
thymine	I
-	I
DNA	I
glycosylase	I
maps	O
at	O
chromosome	O
12q22	O
-	O
q24	O
.	O
1	O
:	O
a	O
region	O
of	O
high	O
loss	O
of	O
heterozygosity	O
in	O
gastric	O
cancer	O
.	O

Though	O
the	O
BACTEC	O
9000	O
MB	O
system	O
is	O
recommended	O
for	O
respiratory	O
specimens	O
,	O
we	O
demonstrated	O
that	O
it	O
can	O
be	O
successfully	O
used	O
also	O
for	O
recovery	O
of	O
mycobacteria	O
from	O
clinical	O
specimens	O
from	O
various	O
extrapulmonary	O
sites	O
.	O

The	O
two	O
mouse	O
lines	O
carrying	O
the	O
unfragmented	O
Hnf3g	B
-	I
lacZ	I
YAC	O
showed	O
tissue	O
-	O
specific	O
,	O
copy	O
number	O
-	O
dependent	O
and	O
position	O
-	O
independent	O
expression	O
,	O
proving	O
that	O
170	O
kb	O
of	O
the	O
Hnf3g	B
locus	I
contain	O
all	O
elements	O
important	O
in	O
the	O
regulation	O
of	O
Hnf3g	B
.	O

In	O
situ	O
hybridization	O
analysis	O
in	O
adult	O
rat	O
tissue	O
reveals	O
good	O
correlation	O
with	O
this	O
pattern	O
and	O
indicates	O
that	O
drm	B
mRNA	I
is	O
most	O
highly	O
expressed	O
in	O
nondividing	O
and	O
terminally	O
differentiated	O
cells	O
,	O
such	O
as	O
neurons	O
,	O
type	O
1	O
lung	O
cells	O
,	O
and	O
goblet	O
cells	O
.	O

Neither	O
of	O
these	O
proteins	O
,	O
individually	O
or	O
as	O
a	O
pair	O
,	O
can	O
bind	O
the	O
alpha	B
-	I
globin	I
3	I
'	I
UTR	I
unless	O
they	O
are	O
complexed	O
with	O
the	O
remaining	O
non	O
-	O
poly	O
(	O
C	B
)	I
binding	I
proteins	I
of	O
the	O
alpha	B
-	I
complex	I
.	O

Sustained	O
activation	O
of	O
p21	B
expression	O
is	O
proposed	O
to	O
be	O
a	O
distinguishing	O
feature	O
of	O
the	O
activity	O
of	O
NGF	B
that	O
contributes	O
to	O
PC12	O
growth	O
arrest	O
during	O
differentiation	O

The	O
remaining	O
80	O
patients	O
underwent	O
recordings	O
of	O
ECG	O
,	O
beat	O
-	O
to	O
-	O
beat	O
arterial	O
oxygen	O
saturation	O
(	O
SaO2	O
),	O
and	O
respiration	O
during	O
both	O
spontaneous	O
and	O
controlled	O
breathing	O
.	O

In	O
all	O
experimental	O
eyes	O
,	O
there	O
was	O
a	O
marked	O
reduction	O
,	O
but	O
never	O
a	O
complete	O
absence	O
of	O
adrenergic	O
nerves	O
in	O
the	O
iris	O
.	O

It	O
is	O
present	O
in	O
the	O
nucleus	O
of	O
the	O
cells	O
in	O
which	O
it	O
is	O
expressed	O
and	O
can	O
phosphorylate	O
and	O
activate	O
the	O
cyclic	B
AMP	I
response	I
element	I
binding	I
proteins	I
CREB	I
and	O
CREM	B
tau	I
in	O
a	O
manner	O
analogous	O
to	O
protein	B
kinase	I
A	I
.	O

The	O
Ogg1	B
protein	I
efficiently	O
cleaves	O
a	O
DNA	O
duplex	O
where	O
a	O
preformed	O
AP	B
site	I
is	O
placed	O
opposite	O
a	O
cytosine	O
(	O
AP	B
/	I
C	I
).	O

A	O
consensus	O
sequence	O
indicates	O
a	O
highly	O
conserved	O
lysine	O
residue	O
,	O
K120	O
of	O
endonuclease	B
III	I
or	O
K241	O
of	O
Ogg1	B
,	O
respectively	O
.	O

In	O
addition	O
,	O
the	O
DNA	O
-	O
binding	O
experiments	O
show	O
that	O
either	O
one	O
of	O
the	O
two	O
MADS	B
domains	I
of	O
a	O
dimer	O
can	O
be	O
sufficient	O
to	O
confer	O
a	O
particular	O
DNA	O
-	O
binding	O
specificity	O
to	O
the	O
complex	O
and	O
that	O
sequences	O
outside	O
the	O
amino	O
-	O
terminal	O
basic	O
region	O
of	O
the	O
MADS	B
domain	I
can	O
,	O
in	O
some	O
cases	O
,	O
contribute	O
to	O
the	O
DNA	O
-	O
binding	O
specificity	O
of	O
the	O
proteins	O
.	O

Mutagenesis	O
of	O
the	O
pecT	B
regulatory	I
region	O
revealed	O
the	O
presence	O
of	O
two	O
sites	O
in	O
which	O
insertions	O
reproduced	O
the	O
pec	B
-	I
1	I
phenotype	O
.	O

Twenty	O
-	O
one	O
ELISA	O
-	O
positive	O
sera	O
were	O
tested	O
and	O
confirmed	O
positive	O
by	O
plaque	O
reduction	O
neutralization	O
testing	O
.	O

We	O
had	O
previously	O
analyzed	O
repair	O
rates	O
of	O
cyclobutane	O
pyrimidine	O
dimers	O
at	O
nucleotide	O
resolution	O
along	O
the	O
human	B
JUN	I
gene	I
in	O
normal	O
fibroblasts	O
and	O
found	O
very	O
efficient	O
repair	O
of	O
sequences	O
near	O
the	O
transcription	O
initiation	O
site	O
but	O
slow	O
repair	O
along	O
the	O
promoter	O
.	O

They	O
also	O
interact	O
with	O
GTPase	B
activating	I
proteins	I
encoded	I
by	O
IRA1	B
and	O
IRA2	B
.	O

RESULTS	O
:	O
For	O
E1	O
,	O
itraconazole	O
plasma	O
drug	O
concentration	O
extrapolated	O
to	O
time	O
zero	O
(	O
IV	O
dose	O
)	O
was	O
5	O
.	O
2	O
+/-	O
1	O
.	O
4	O
micrograms	O
/	O
ml	O
,	O
and	O
mean	O
residence	O
time	O
(	O
MRT	O
)	O
was	O
37	O
+/-	O
16	O
hours	O
.	O

The	O
used	O
expression	O
system	O
could	O
allow	O
to	O
produce	O
mutated	O
forms	O
of	O
SsEF	B
-	I
2	I
obtained	O
by	O
mutagenesis	O
of	O
the	O
corresponding	O
gene	O
.	O

Supershift	O
assays	O
,	O
using	O
Jun	B
and	I
Fos	I
family	I
member	I
-	I
specific	I
antibodies	I
,	O
showed	O
that	O
protein	O
complexes	O
formed	O
by	O
AtT	O
-	O
20	O
cell	O
nuclear	O
extracts	O
bound	O
to	O
the	O
c	B
-	I
jun	I
AP	I
-	I
1	I
site	I
were	O
comprised	O
of	O
Jun	B
family	I
members	O
,	O
JunD	B
,	O
JunB	B
,	O
and	O
cJun	B
.	O

As	O
demonstrated	O
by	O
gel	O
mobility	O
shift	O
analysis	O
and	O
supershift	O
experiments	O
,	O
FIRE1	B
,	O
located	O
between	O
-	O
516	O
and	O
-	O
498	O
,	O
is	O
responsible	O
for	O
binding	O
NF	B
-	I
Y	I
.	O

Gag	B
protein	I
sequence	I
motifs	O
of	O
the	O
NC	B
domain	I
of	O
primate	O
foamy	O
viruses	O
assumed	O
to	O
be	O
involved	O
in	O
genome	O
encapsidation	O
are	O
not	O
conserved	O
in	O
FeFV	O
.	O

All	O
the	O
women	O
received	O
13	O
.	O
5	O
mg	O
plain	O
bupivacaine	O
via	O
subarachnoid	O
injection	O
at	O
the	O
L2	O
-	O
3	O
interspace	O
.	O

Here	O
,	O
we	O
describe	O
directional	O
chromosome	O
walking	O
studies	O
starting	O
from	O
D8S260	B
as	O
well	O
as	O
D8S285	B
.	O

Together	O
,	O
these	O
data	O
support	O
a	O
model	O
in	O
which	O
Tax	B
anchors	O
CBP	B
to	O
the	O
HTLV	B
-	I
1	I
promoter	I
,	O
with	O
strong	O
transcriptional	O
activation	O
resulting	O
from	O
the	O
CBP	B
-	I
associated	I
activities	O
of	O
nucleosome	O
remodeling	O
and	O
recruitment	O
of	O
the	O
general	O
transcription	O
machinery	O
.	O

Mapping	O
features	O
of	O
HIV	B
-	I
1	I
integrase	I
near	O
selected	O
sites	O
on	O
viral	O
and	O
target	O
DNA	O
molecules	O
in	O
an	O
active	O
enzyme	O
-	O
DNA	O
complex	O
by	O
photo	O
-	O
cross	O
-	O
linking	O
.	O

Analysis	O
of	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
gene	O
also	O
revealed	O
the	O
presence	O
of	O
multiple	O
TATA	O
and	O
CAAT	O
sequences	O
.	O

Heterogeneous	B
nuclear	I
ribonucleoprotein	I
A1	I
binds	O
to	O
the	O
transcription	O
-	O
regulatory	O
region	O
of	O
mouse	O
hepatitis	O
virus	O
RNA	O
.	O

The	O
m7GpppN	O
cap	O
structure	O
of	O
eukaryotic	O
mRNA	O
is	O
formed	O
cotranscriptionally	O
by	O
the	O
sequential	O
action	O
of	O
three	O
enzymes	O
:	O
RNA	B
triphosphatase	I
,	I
RNA	I
guanylyltransferase	I
,	O
and	O
RNA	O
(	O
guanine	B
-	I
7	I
)-	I
methyltransferase	I
.	O

Two	O
experiments	O
(	O
N	O
=	O
20	O
each	O
)	O
were	O
carried	O
out	O
to	O
explore	O
the	O
nature	O
of	O
ERP	O
negativities	O
in	O
a	O
visuospatial	O
memory	O
task	O
and	O
in	O
an	O
auditory	O
spatial	O
memory	O
task	O
,	O
respectively	O
.	O

Substrate	O
specificity	O
of	O
the	O
RNase	B
activity	O
of	O
yeast	B
RNA	I
polymerase	I
III	I
.	O

4	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
identify	O
neuronal	O
cell	O
cultures	O
that	O
express	O
RC3	B
/	O
neurogranin	B
,	O
to	O
check	O
whether	O
they	O
are	O
sensitive	O
to	O
T3	O
,	O
and	O
to	O
examine	O
the	O
mechanism	O
of	O
regulation	O
.	O

Plasma	O
leptin	B
concentrations	O
were	O
higher	O
in	O
women	O
than	O
men	O
,	O
even	O
after	O
the	O
adjustment	O
for	O
differences	O
in	O
fat	O
mass	O
(	O
28	O
+/-	O
3	O
ng	O
/	O
ml	O
for	O
women	O
vs	O
.	O

Polarised	O
expression	O
of	O
human	B
intestinal	I
N	I
-	I
benzoyl	I
-	I
L	I
-	I
tyrosyl	I
-	I
p	I
-	I
aminobenzoic	I
acid	I
hydrolase	I
(	I
human	I
meprin	I
)	I
alpha	I
and	I
beta	I
subunits	I
in	O
Madin	O
-	O
Darby	O
canine	O
kidney	O
cells	O
.	O

Among	O
38	O
patients	O
with	O
inducible	O
reentrant	O
VTs	O
who	O
underwent	O
electrophysiologic	O
study	O
(	O
EPS	O
),	O
10	O
VTs	O
of	O
six	O
patients	O
were	O
selected	O
.	O

The	O
por	B
gene	I
has	O
been	O
expressed	O
,	O
for	O
the	O
first	O
time	O
,	O
in	O
anaerobically	O
grown	O
Escherichia	O
coli	O
behind	O
the	O
isopropyl	O
-	O
beta	B
-	I
D	I
-	I
thiogalactopyranoside	O
-	O
inducible	O
tac	B
promoter	I
,	O
resulting	O
in	O
the	O
production	O
of	O
POR	B
in	O
its	O
active	O
form	O
.	O

The	O
ORF3	O
mutant	O
produced	O
reduced	O
levels	O
of	O
tabtoxin	B
,	O
indicating	O
that	O
ORF3	O
may	O
have	O
a	O
role	O
in	O
T	B
beta	I
L	I
biosynthesis	O
.	O

However	O
,	O
the	O
published	O
reports	O
consist	O
of	O
a	O
small	O
number	O
of	O
patients	O
and	O
limited	O
data	O
.	O

As	O
a	O
result	O
,	O
the	O
subendocardial	O
/	O
subepicardial	O
blood	O
flow	O
ratio	O
(	O
ENDO	O
/	O
EPI	O
)	O
increased	O
from	O
0	O
.	O
44	O
+/-	O
0	O
.	O
09	O
during	O
control	O
stenosis	O
to	O
0	O
.	O
85	O
+/-	O
0	O
.	O
13	O
after	O
ITF	O
1129	O
(	O
10	O
micrograms	O
/	O
kg	O
/	O
min	O
i	O
.	O
v	O
.)	O
and	O
to	O
0	O
.	O
81	O
+/-	O
0	O
.	O
12	O
after	O
NTG	O
.	O

For	O
sputum	O
interleukin	B
-	I
8	O
there	O
was	O
an	O
estimated	O
true	O
treatment	O
median	O
difference	O
of	O
142	O
pg	O
/	O
ml	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
8	O
to	O
2866	O
pg	O
/	O
ml	O
)	O
in	O
favour	O
of	O
placebo	O
;	O
while	O
for	O
maximal	O
expiratory	O
flow	O
at	O
25	O
%	O
(	O
MEF25	O
%)	O
remaining	O
forced	O
vital	O
capacity	O
predicted	O
for	O
sex	O
and	O
height	O
there	O
was	O
a	O
15	O
percentage	O
points	O
(	O
pp	O
)	O
(	O
95	O
%	O
CI	O
4	O
to	O
26	O
pp	O
)	O
mean	O
treatment	O
difference	O
in	O
favour	O
of	O
placebo	O
.	O

Gaucher	O
'	O
s	O
disease	O
is	O
a	O
rare	O
metabolic	O
disorder	O
characterized	O
by	O
the	O
lack	O
of	O
beta	B
-	I
glucocerebrosidase	I
enzyme	I
.	O

In	O
the	O
absence	O
of	O
MHC	B
class	I
II	I
,	O
purified	O
soluble	B
D10	I
TCR	I
bound	O
to	O
Staphylococcus	B
aureus	I
enterotoxin	I
C2	I
with	O
an	O
association	O
rate	O
of	O
1	O
.	O
69	O
+/-	O
0	O
.	O
12	O
x	O
10	O
(	O
4	O
)	O
M	O
(-	O
1	O
)	O
sec	O
(-	O
1	O
)	O
and	O
a	O
dissociation	O
rate	O
of	O
1	O
.	O
9	O
+/-	O
0	O
.	O
47	O
x	O
10	O
(-	O
2	O
)	O
sec	O
(-	O
1	O
),	O
giving	O
a	O
dissociation	O
constant	O
of	O
1	O
.	O
1	O
microM	O
.	O

Evidence	O
for	O
such	O
peak	O
shifts	O
has	O
been	O
found	O
in	O
the	O
responses	O
of	O
auditory	O
nerve	O
fibers	O
,	O
cochlear	O
microphonics	O
,	O
and	O
the	O
responses	O
of	O
outer	O
hair	O
cells	O
and	O
supporting	O
cells	O
in	O
the	O
cochlea	O
,	O
as	O
well	O
as	O
in	O
basilar	O
membrane	O
vibration	O
measurements	O
,	O
and	O
indirectly	O
,	O
in	O
psychophysical	O
data	O
.	O

Underlying	O
the	O
clustering	O
of	O
these	O
risk	O
variables	O
were	O
three	O
factors	O
.	O

Detection	O
of	O
airborne	O
Mycobacterium	O
tuberculosis	O
by	O
air	O
filtration	O
and	O
polymerase	O
chain	O
reaction	O
.	O

Previously	O
,	O
we	O
reported	O
that	O
scanthrough	O
translation	O
,	O
where	O
the	O
initiating	O
AUG	O
of	O
a	O
primary	O
open	O
reading	O
frame	O
is	O
bypassed	O
,	O
is	O
most	O
likely	O
to	O
account	O
for	O
the	O
presentation	O
of	O
cryptic	O
epitopes	O
from	O
alternative	O
reading	O
frames	O
within	O
the	O
influenza	O
A	O
PR	B
/	I
8	I
/	I
34	I
nucleoprotein	I
gene	I
.	O

Furthermore	O
,	O
our	O
novel	O
observation	O
that	O
expression	O
of	O
a	O
highly	O
activated	O
FGFR3	B
kinase	I
domain	I
is	O
able	O
to	O
morphologically	O
transform	O
fibroblasts	O
suggests	O
that	O
dysregulation	O
of	O
FGFR3	B
has	O
the	O
potential	O
to	O
play	O
a	O
role	O
in	O
human	O
neoplasia	O
.	O

This	O
newly	O
described	O
organism	O
was	O
difficult	O
to	O
identify	O
due	O
to	O
discrepancies	O
between	O
the	O
Vitek	O
and	O
API	O
20E	O
identification	O
systems	O
.	O

Ig	B
heavy	I
chain	I
class	I
switching	O
is	O
directed	O
by	O
cytokines	O
inducing	O
transcription	O
from	O
unrearranged	O
CH	B
genes	I
.	O

In	O
this	O
study	O
we	O
have	O
introduced	O
mutations	O
into	O
the	O
corresponding	O
elements	O
of	O
two	O
cox3	B
promoters	I
and	O
show	O
that	O
while	O
the	O
core	O
element	O
is	O
essential	O
for	O
cox3	B
promoter	I
activity	O
,	O
upstream	O
element	O
mutations	O
have	O
little	O
or	O
no	O
effect	O
.	O

Widening	O
of	O
the	O
abdominal	O
aortic	O
wall	O
on	O
an	O
ultrasound	O
examination	O
was	O
the	O
key	O
to	O
the	O
incidental	O
diagnosis	O
of	O
a	O
clinically	O
unsuspected	O
type	O
B	O
dissection	O
.	O

Ovaries	O
of	O
10	O
animals	O
per	O
group	O
from	O
16	O
studies	O
in	O
CD	O
-	O
1	O
mice	O
and	O
1	O
study	O
each	O
in	O
C3H	O
and	O
C57BL	O
/	O
6	O
mice	O
were	O
sectioned	O
serially	O
at	O
6	O
microm	O
.	O

U4	B
/	I
U6	I
snRNP	I
is	O
one	O
of	O
four	O
essential	O
small	B
nuclear	I
ribonucleoprotein	I
(	I
snRNP	I
)	I
particles	I
(	I
U1	I
,	O
U2	B
,	O
U5	B
and	O
U4	B
/	I
U6	I
)	O
present	O
in	O
the	O
spliceosome	O
.	O

The	O
growth	O
-	O
promoting	O
properties	O
of	O
the	O
retroviral	O
v	B
-	I
erbA	I
oncogene	I
,	O
a	O
highly	O
mutated	O
version	O
of	O
the	O
chicken	B
thyroid	I
hormone	I
receptor	I
(	O
TR	B
)	I
alpha	I
,	O
have	O
so	O
far	O
exclusively	O
been	O
linked	O
to	O
dominant	O
repression	O
of	O
the	O
antimitogenic	O
roles	O
of	O
TR	B
and	O
retinoic	B
acid	I
receptors	I
.	O

Serum	O
concentrations	O
of	O
E2	O
and	O
TBOH	O
were	O
measured	O
on	O
d	O
0	O
,	O
1	O
,	O
3	O
,	O
5	O
,	O
7	O
,	O
13	O
,	O
21	O
,	O
28	O
,	O
42	O
,	O
56	O
,	O
84	O
,	O
112	O
,	O
and	O
140	O
in	O
finishing	O
heifers	O
administered	O
the	O
following	O
treatments	O
:	O
1	O
)	O
control	O
;	O
2	O
)	O
MGA	O
,	O
.	O
5	O
mg	O
per	O
heifer	O
daily	O
;	O
3	O
)	O
Revalor	O
-	O
H	O
(	O
140	O
mg	O
TBA	O
+	O
14	O
mg	O
E2	O
);	O
4	O
)	O
Revalor	O
-	O
H	O
+	O
MGA	O
;	O
5	O
)	O
Finaplix	O
-	O
H	O
(	O
200	O
mg	O
TBA	O
);	O
and	O
6	O
)	O
Finaplix	O
-	O
H	O
+	O
MGA	O
.	O

Interferon	B
Regulatory	I
Factor	I
(	I
IRF	I
)-	I
1	I
has	O
been	O
characterized	O
as	O
an	O
important	O
growth	O
regulatory	O
and	O
immunomodulatory	O
transcription	O
factor	O
.	O

One	O
skull	O
does	O
not	O
a	O
species	O
make	O
.	O

Null	O
mutations	O
in	O
daf	B
-	I
3	I
suppress	O
mutations	O
in	O
genes	O
encoding	O
this	O
TGF	B
-	I
beta	I
signal	I
,	O
its	O
receptors	O
,	O
and	O
associated	O
Smad	B
signal	I
transduction	I
proteins	I
.	O
daf	B
-	I
3	I
encodes	O
a	O
Smad	B
protein	I
that	O
is	O
most	O
closely	O
related	O
to	O
mammalian	B
DPC4	I
,	O
and	O
is	O
expressed	O
throughout	O
development	O
in	O
many	O
of	O
the	O
tissues	O
that	O
are	O
remodeled	O
during	O
dauer	O
development	O
.	O

Nucleotide	O
sequence	O
analysis	O
of	O
R	O
has	O
revealed	O
similarities	O
to	O
the	O
R1	O
plasmid	O
found	O
in	O
some	O
South	O
American	O
maize	O
races	O
with	O
RU	O
cytoplasm	O
,	O
to	O
the	O
M1	O
plasmid	O
found	O
in	O
one	O
source	O
of	O
Zea	O
luxurians	O
teosinte	O
,	O
to	O
the	O
atp9	B
mitochondrial	I
gene	I
and	O
its	O
3	O
'	O
flanking	O
sequence	O
,	O
and	O
also	O
to	O
a	O
region	O
3	O
'	O
to	O
the	O
orf221	B
gene	I
.	O

Effect	O
of	O
alcohol	O
on	O
minimal	O
effective	O
nCPAP	O
pressure	O

Processivity	O
of	O
DNA	O
synthesis	O
by	O
the	O
mutant	O
holoenzyme	O
containing	O
pcna	B
-	I
79	O
was	O
unaffected	O
on	O
poly	O
(	O
dA	O
)	O
x	O
oligo	O
(	O
dT	O
)	O
but	O
was	O
dramatically	O
reduced	O
on	O
a	O
natural	O
template	O
with	O
secondary	O
structure	O
.	O

Ki	B
-	I
ras4BVal	I
-	I
12	O
transfectant	O
cells	O
expressed	O
2	O
-	O
fold	O
elevated	O
protein	O
levels	O
of	O
the	O
lysosomal	B
cysteine	I
protease	I
cathepsin	I
B	I
but	O
did	O
not	O
up	O
-	O
regulate	O
cathepsin	B
B	I
mRNA	I
expression	O
.	O

Induction	O
of	O
AtP5CS1	B
mRNA	I
accumulation	O
in	O
salt	O
-	O
treated	O
seedlings	O
involves	O
an	O
immediate	O
early	O
transcriptional	O
response	O
regulated	O
by	O
ABA	O
signalling	O
that	O
is	O
not	O
inhibited	O
by	O
cycloheximide	O
,	O
but	O
abolished	O
by	O
the	O
deficiency	O
of	O
ABA	O
biosynthesis	O
in	O
the	O
aba1	B
Arabidopsis	I
mutant	I
.	O

A	O
positive	O
correlation	O
between	O
serum	B
myoglobin	I
and	I
CA	I
III	I
concentrations	O
(	O
rs	O
=	O
0	O
.	O
933	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
was	O
observed	O
in	O
hemodialyzed	O
patients	O
with	O
chronic	O
renal	O
failure	O
.	O

Rip1p	B
is	O
inessential	O
,	O
associated	O
with	O
nuclear	O
pore	O
complexes	O
,	O
and	O
structurally	O
related	O
to	O
the	O
FG	B
-	I
nucleoporin	I
family	I
of	O
pore	O
proteins	O
.	O

Deletions	O
in	O
each	O
of	O
these	O
regions	O
abolish	O
membrane	O
localization	O
of	O
Tiam1	B
and	O
membrane	O
ruffling	O
,	O
suggesting	O
that	O
they	O
function	O
cooperatively	O
.	O

Their	O
biosynthesis	O
proceeds	O
via	O
linear	O
precursors	O
that	O
become	O
branched	O
by	O
beta1	B
,	I
6	I
-	I
GlcNAc	I
transferases	I
(	O
IGnT6	O
,	O
GlcNAc	O
to	O
Gal	O
).	O

Parodoxical	O
rise	O
in	O
urinary	O
albumin	B
levels	O
after	O
treatment	O
of	O
essential	O
hypertension	O
.	O

20	O
%	O
of	O
total	O
HSL	B
transcripts	I
in	O
human	O
subcutaneous	O
adipocytes	O
.	O

These	O
residues	O
,	O
Ile244	O
at	O
the	O
extracellular	O
end	O
of	O
transmembrane	O
helix	O
3	O
,	O
and	O
Tyr318	O
at	O
the	O
COOH	O
-	O
terminal	O
portion	O
of	O
extracellular	O
loop	O
2	O
,	O
are	O
replaced	O
by	O
Leu	O
and	O
Ile	O
in	O
the	O
PTH	B
-	I
1	I
receptor	I
,	O
respectively	O
.	O

The	O
Fis	B
protein	I
regulates	O
site	O
-	O
specific	O
DNA	O
inversion	O
catalyzed	O
by	O
a	O
family	O
of	O
DNA	O
invertases	B
when	O
bound	O
to	O
a	O
cis	O
-	O
acting	O
recombinational	O
enhancer	O
.	O

The	O
cell	O
cycle	O
-	O
regulated	O
transcription	O
factor	O
E2F	B
is	O
also	O
known	O
to	O
bend	O
DNA	O
upon	O
binding	O
.	O

The	O
mHIF	B
-	I
1	I
alpha	I
structural	I
gene	I
is	O
composed	O
of	O
15	O
exons	O
.	O

However	O
,	O
when	O
a	O
second	O
,	O
upstream	B
IRE	I
-	I
like	I
sequence	I
was	O
evaluated	O
by	O
EMSA	O
,	O
a	O
DNA	O
binding	O
pattern	O
distinct	O
from	O
that	O
seen	O
following	O
exposure	O
to	O
IFN	B
-	I
gamma	I
alone	O
was	O
observed	O
after	O
prolonged	O
stimulation	O
with	O
both	O
IFN	B
-	I
alpha	I
and	O
IFN	B
-	I
gamma	I
.	O

Mutational	O
analysis	O
shows	O
that	O
both	O
an	O
AP	B
-	I
1	I
like	I
sequence	I
(-	O
294	O
/-	O
285	O
,	O
TGAATCATCA	O
)	O
and	O
an	O
A	O
/	O
T	O
-	O
rich	O
myocyte	B
enhancer	I
factor	I
(	I
MEF	I
)-	I
2	I
like	I
sequence	I
(-	O
310	O
/-	O
298	O
,	O
TTAAAAATAAAAA	O
)	O
in	O
the	O
33	O
-	O
bp	O
region	O
are	O
necessary	O
for	O
the	O
OP	B
-	I
1	I
effect	O
.	O

Unlike	O
most	O
other	O
members	O
of	O
the	O
Bcl	B
-	I
2	I
family	I
,	O
BAD	B
(	O
Bcl	B
-	I
xL	I
/	I
Bcl	I
-	I
2	I
associated	I
death	I
promoter	I
),	O
a	O
death	O
enhancer	O
,	O
has	O
no	O
C	B
-	I
terminal	I
transmembrane	I
domain	I
for	O
targeting	O
to	O
the	O
outer	O
mitochondrial	O
membrane	O
and	O
nuclear	O
envelope	O
.	O

Chimeras	O
containing	O
IE1	B
peptides	I
dramatically	O
activated	O
transcription	O
of	O
the	O
basal	O
promoter	O
only	O
when	O
lac	B
operator	I
sequences	I
were	O
present	O
.	O

Epitopes	O
of	O
adhesion	O
-	O
perturbing	O
monoclonal	O
antibodies	O
map	O
within	O
a	O
predicted	O
alpha	B
-	I
helical	O
domain	O
of	O
the	O
integrin	B
beta	I
1	I
subunit	I
.	O

Comparison	O
of	O
genomic	O
sequence	O
shows	O
that	O
the	O
ph	B
locus	I
has	O
been	O
duplicated	O
,	O
and	O
that	O
it	O
contains	O
proximal	O
and	O
distal	O
transcription	O
units	O
.	O

In	O
this	O
paper	O
,	O
characterization	O
is	O
given	O
of	O
clinical	O
and	O
biochemical	O
features	O
of	O
VH	B
B	I
course	O
against	O
the	O
background	O
of	O
narcomania	O
.	O

The	O
ZnF20	B
cDNA	I
hybridized	O
to	O
multiple	O
transcripts	O
in	O
a	O
thyroid	O
cancer	O
cell	O
line	O
(	O
8	O
.	O
0	O
,	O
4	O
.	O
5	O
and	O
2	O
kb	O
)	O
that	O
increased	O
after	O
cycloheximide	O
treatment	O
and	O
decayed	O
<	O
2	O
h	O
after	O
addition	O
of	O
actinomycin	O
D	O
.	O

Two	O
sterol	B
regulatory	I
element	I
-	I
like	I
sequences	I
mediate	O
up	O
-	O
regulation	O
of	O
caveolin	B
gene	I
transcription	I
in	O
response	O
to	O
low	O
density	O
lipoprotein	O
free	O
cholesterol	O
.	O

Furthermore	O
,	O
DNA	O
-	O
bound	O
LAZ3	B
/	O
BCL6	B
recruits	O
SMRT	B
in	O
vivo	O
,	O
and	O
both	O
overexpressed	O
proteins	O
completely	O
colocalize	O
in	O
nuclear	O
dots	O
.	O

Ischaemia	O
was	O
induced	O
by	O
a	O
low	O
flow	O
rate	O
of	O
0	O
.	O
8	O
mL	O
min	O
-	O
1	O
for	O
30	O
min	O
,	O
and	O
was	O
followed	O
by	O
a	O
40	O
-	O
minute	O
reperfusion	O
.	O

First	O
,	O
two	O
MCTs	O
using	O
a	O
long	O
electrode	O
,	O
3	O
cm	O
in	O
size	O
,	O
were	O
performed	O
in	O
the	O
central	O
area	O
of	O
the	O
tumor	O
,	O
and	O
eight	O
MCTs	O
by	O
a	O
short	O
electrode	O
,	O
2	O
cm	O
in	O
size	O
,	O
were	O
done	O
in	O
the	O
peripheral	O
and	O
surrounding	O
area	O
of	O
the	O
tumor	O
.	O

All	O
pigs	O
had	O
significant	O
regional	O
LV	O
dysfunction	O
and	O
reduced	O
LV	O
ejection	O
fraction	O
(	O
41	O
+/-	O
11	O
%).	O

The	O
amplitudes	O
of	O
DPOAE	O
also	O
recovered	O
to	O
a	O
greater	O
extent	O
and	O
outer	O
hair	O
cell	O
losses	O
were	O
less	O
severe	O
in	O
the	O
R	O
-	O
PIA	O
-	O
treated	O
ears	O
.	O

Inhibition	O
appears	O
to	O
result	O
from	O
titration	O
of	O
general	O
transcription	O
factors	O
because	O
MDM2	B
overexpression	O
inhibits	O
c	B
-	I
fos	I
as	O
well	O
as	O
other	O
promoters	O
in	O
vivo	O
and	O
basal	O
transcription	O
in	O
vitro	O
.	O

The	O
mobility	O
shift	O
of	O
both	O
of	O
these	O
proteins	O
is	O
abolished	O
by	O
treatment	O
with	O
inhibitors	O
of	O
PKC	B
or	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
/	I
extracellular	I
signal	I
-	I
related	I
kinase	I
kinase	I
.	O

AIDS	O
-	O
related	O
disseminated	O
histoplasmosis	O
in	O
San	O
Francisco	O
,	O
California	O
.	O

These	O
observations	O
provide	O
strong	O
support	O
for	O
the	O
idea	O
that	O
expression	O
of	O
mutant	O
tRNA	O
can	O
confer	O
a	O
mutator	O
phenotype	O
,	O
including	O
the	O
UVM	O
-	O
constitutive	O
phenotype	O
observed	O
in	O
mutA	B
and	O
mutC	B
cells	O
.	O

Thus	O
,	O
the	O
absence	O
of	O
residual	O
infarct	O
-	O
zone	O
viability	O
discriminates	O
patients	O
who	O
develop	O
progressive	O
left	O
ventricular	O
dilation	O
after	O
reperfused	O
AMI	O
from	O
those	O
who	O
maintain	O
normal	O
left	O
ventricular	O
geometry	O
.	O

Using	O
GST	B
-	I
PKR	I
fusion	I
chromatography	O
,	O
direct	O
physical	O
interaction	O
between	O
the	O
mouse	O
and	O
human	O
PKR	B
homologs	I
was	O
established	O
.	O

Similarities	O
between	O
the	O
hIGFBP	B
-	I
1	I
and	O
phosphoenolpyruvate	B
kinase	I
(	O
PEPCK	B
)	I
promoters	I
,	O
including	O
regions	O
conferring	O
insulin	B
,	O
glucocorticoid	O
,	O
and	O
cyclic	B
adenosine	I
-	I
monophosphate	O
responses	O
,	O
are	O
consistent	O
with	O
our	O
previous	O
hypothesis	O
that	O
IGFBP	B
-	I
1	I
is	O
involved	O
in	O
regulation	O
of	O
glucose	O
metabolism	O
.	O

As	O
a	O
sequence	O
-	O
specific	O
DNA	B
binding	I
transcription	I
factor	I
,	O
p53	B
specifically	O
binds	O
to	O
a	O
20	O
-	O
bp	O
consensus	O
motif	O
5	O
'-	O
PuPuPuC	O
(	O
A	O
/	O
T	O
)	O
(	O
T	O
/	O
A	O
)	O
GPyPyPyPuPuPuC	O
(	O
A	O
/	O
T	B
)(	I
T	I
/	I
A	I
)	O
GPyPyPy	O
-	O
3	O
'.	O

Moreover	O
,	O
moderate	O
overexpression	O
of	O
Chk1	B
suppresses	O
the	O
phenotypes	O
of	O
cut5	B
and	O
crb2	B
mutants	I
.	O

Structure	O
and	O
localization	O
of	O
the	O
human	B
gene	I
encoding	I
SR	I
-	I
BI	I
/	O
CLA	B
-	I
1	I
.	O

We	O
introduced	O
the	O
gel	O
technique	O
as	O
a	O
routine	O
assay	O
for	O
antibody	O
detection	O
and	O
identification	O
in	O
1993	O
.	O

Multiple	O
regression	O
analyses	O
revealed	O
that	O
WAIS	O
-	O
R	B
factor	I
scores	O
Verbal	O
Comprehension	O
and	O
Freedom	O
from	O
Distractibility	O
accounted	O
for	O
up	O
to	O
42	O
%	O
of	O
the	O
variance	O
in	O
WMS	O
-	O
R	O
and	O
CVLT	O
indices	O
.	O

The	O
Saccharomyces	B
cerevisiae	I
RAD30	I
gene	I
,	O
a	O
homologue	O
of	O
Escherichia	B
coli	I
dinB	I
and	O
umuC	B
,	O
is	O
DNA	O
damage	O
inducible	O
and	O
functions	O
in	O
a	O
novel	O
error	O
-	O
free	O
postreplication	O
repair	O
mechanism	O
.	O

However	O
,	O
in	O
a	O
new	O
experiment	O
in	O
which	O
the	O
deletion	O
task	O
was	O
presented	O
as	O
a	O
puppet	O
game	O
,	O
and	O
with	O
pretraining	O
and	O
selection	O
on	O
vowel	O
deletion	O
,	O
a	O
significantly	O
higher	O
level	O
of	O
success	O
was	O
achieved	O
by	O
the	O
children	O
working	O
with	O
the	O
CVCC	O
material	O
.	O

These	O
results	O
indicate	O
that	O
in	O
addition	O
to	O
Grb2	B
-	I
mediated	O
activation	O
of	O
Ras	B
,	O
PLC	B
-	I
gamma1	I
-	I
mediated	O
DAG	O
production	O
is	O
required	O
for	O
EGF	B
-	I
and	O
PDGF	B
-	I
induced	O
S	O
-	O
phase	O
entry	O
and	O
gene	O
expression	O
,	O
possibly	O
through	O
activation	O
of	O
PKC	B
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
STAT	B
activation	O
in	O
a	O
panel	O
of	O
rodent	O
fibroblast	O
cell	O
lines	O
stably	O
transformed	O
by	O
diverse	O
viral	O
oncoproteins	O
.	O

In	O
serum	O
-	O
stimulated	O
cells	O
,	O
the	O
binding	O
of	O
NF	B
-	I
Y	I
/	I
CBF	O
to	O
TKC1	B
increased	O
gradually	O
,	O
reaching	O
a	O
plateau	O
at	O
the	O
S	O
phase	O
.	O

Cell	O
factor	O
-	O
mediated	O
regulatory	O
interactions	O
are	O
involved	O
in	O
regulating	O
the	O
restricted	O
expression	O
of	O
the	O
HCMV	O
major	O
immediate	B
-	I
early	I
(	I
IE	I
)	I
gene	I
(	O
J	O
.	O

The	O
critical	O
mutations	O
were	O
likely	O
to	O
have	O
been	O
multiple	O
and	O
dispersed	O
,	O
including	O
elongation	O
of	O
the	O
TM	O
and	O
Nef	B
coding	I
sequences	I
;	O
changes	O
in	O
RNA	O
splice	O
donor	O
and	O
acceptor	O
sites	O
,	O
TATA	O
box	O
sites	O
,	O
and	O
Sp1	B
sites	I
;	O
multiple	O
changes	O
in	O
the	O
V2	B
region	O
of	O
SU	O
,	O
including	O
a	O
consensus	O
neutralization	O
epitope	O
;	O
and	O
five	O
new	O
N	O
-	O
linked	O
glycosylation	O
sites	O
in	O
SU	O
.	O

C	O
.	O

The	O
cglIM	B
gene	I
is	O
organized	O
in	O
an	O
unusual	O
operon	O
which	O
contains	O
,	O
in	O
addition	O
,	O
two	O
genes	O
encoding	O
stress	O
-	O
sensitive	O
restriction	O
enzymes	O
.	O

The	O
purpose	O
of	O
this	O
investigation	O
was	O
to	O
describe	O
a	O
new	O
formulation	O
of	O
silver	O
sulfadiazine	O
in	O
a	O
water	O
soluble	O
gel	O
,	O
poloxamer	O
188	O
.	O

A	O
cytosolic	O
variant	O
of	O
the	O
protein	O
underwent	O
efficient	O
transphosphorylation	O
,	O
yet	O
failed	O
to	O
activate	O
appreciably	O
either	O
p70	B
(	O
S6k	B
)	O
or	O
MAP	B
kinase	I
following	O
treatment	O
with	O
FK1012	O
.	O

The	O
promoter	O
for	O
HMG	B
-	I
CoA	I
synthase	I
contains	O
two	O
binding	O
sites	O
for	O
the	O
sterol	B
regulatory	I
element	I
-	I
binding	I
proteins	I
(	O
SREBPs	B
).	O

The	O
organization	O
of	O
SPP1	B
genes	I
involved	O
in	O
the	O
replication	O
,	O
DNA	O
packaging	O
and	O
phage	O
assembly	O
proteins	O
resembles	O
the	O
organization	O
of	O
genes	O
of	O
equivalent	O
regions	O
of	O
different	O
E	O
.	O
coli	O
double	O
-	O
stranded	O
DNA	O
phages	O
.	O

This	O
review	O
seeks	O
to	O
summarize	O
the	O
disease	O
,	O
to	O
propose	O
pathways	O
of	O
carcinogenesis	O
and	O
to	O
suggest	O
ways	O
in	O
which	O
the	O
"	O
traditional	O
"	O
risk	O
factors	O
may	O
be	O
interpreted	O
on	O
the	O
basis	O
of	O
evolving	O
knowledge	O
.	O

The	O
patient	O
underwent	O
two	O
intracytoplasmic	O
sperm	O
injection	O
cycles	O
with	O
thawed	O
epididymal	O
spermatozoa	O
,	O
in	O
which	O
,	O
due	O
to	O
a	O
pharmacist	O
'	O
s	O
mistake	O
,	O
ovarian	O
stimulation	O
was	O
carried	O
out	O
by	O
a	O
combination	O
of	O
long	O
-	O
acting	O
gonadotrophin	B
-	I
releasing	I
hormone	I
agonist	O
(	O
leuprolide	O
depot	O
)	O
and	O
gonadotrophins	B
.	O

Altogether	O
46	O
phase	O
III	O
activities	O
were	O
recorded	O
.	O

We	O
have	O
used	O
mutation	O
-	O
directed	O
chemical	O
cross	O
-	O
linking	O
with	O
bis	O
(	O
sulfosuccinimidyl	O
)	O
suberate	O
(	O
BS3	O
)	O
to	O
investigate	O
the	O
architecture	O
of	O
the	O
gp41	B
oligomer	I
.	O

PowerBLAST	O
analysis	O
identified	O
six	O
clusters	O
of	O
expressed	O
sequence	O
tags	O
(	O
ESTs	O
),	O
two	O
known	O
genes	O
(	O
BIR	B
,	O
SUR1	B
)	O
mapped	O
previously	O
to	O
this	O
region	O
,	O
and	O
a	O
previously	O
characterized	O
but	O
unmapped	O
gene	B
NEFA	I
(	I
DNA	I
binding	I
/	I
EF	I
hand	I
/	I
acidic	I
amino	I
-	I
acid	I
-	I
rich	O
).	O

A	O
fusion	O
protein	O
composed	O
of	O
beta	B
-	I
galactosidase	I
and	O
full	B
-	I
length	I
Ahr	I
translocates	O
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
in	O
a	O
ligand	O
-	O
dependent	O
manner	O
.	O

Reconstitution	O
of	O
Raf	B
-	I
1	I
activity	O
was	O
observed	O
only	O
with	O
kinase	O
active	O
Jak1	B
in	O
both	O
cell	O
lines	O
.	O

Consistent	O
with	O
this	O
interpretation	O
,	O
a	O
mutant	O
form	O
of	O
XRN1	B
,	O
which	O
encodes	O
a	O
5	O
'-	O
3	O
'	O
exonuclease	O
,	O
was	O
identified	O
as	O
an	O
extragenic	O
suppressor	O
that	O
increases	O
the	O
half	O
-	O
life	O
of	O
rhis4	B
mRNA	I
,	O
leading	O
to	O
a	O
10	O
-	O
fold	O
increase	O
in	O
steady	O
-	O
state	O
mRNA	O
levels	O
compared	O
to	O
the	O
wild	B
-	I
type	I
HIS4	I
mRNA	I
level	O
.	O

Our	O
findings	O
suggest	O
that	O
striatal	O
FDG	O
and	O
particularly	O
RACLO	O
are	O
sensitive	O
and	O
effective	O
measures	O
of	O
striatal	O
function	O
and	O
may	O
help	O
characterizing	O
patients	O
with	O
multiple	O
system	O
atrophy	O
.	O

This	O
region	O
,	O
however	O
,	O
contains	O
a	O
CCAATC	O
box	O
in	O
the	O
reverse	O
complement	O
and	O
several	O
GC	O
boxes	O
that	O
are	O
recognition	O
sites	O
for	O
SP1	B
.	O

Our	O
purpose	O
was	O
to	O
determine	O
if	O
intact	O
perianal	O
(	O
S4	B
-	I
5	O
)	O
pin	O
sensation	O
(	O
PPS	O
)	O
and	O
bulbocavernosus	O
(	O
S2	B
-	I
4	I
)	O
reflex	O
(	O
BCR	B
)	O
shortly	O
after	O
spinal	O
cord	O
injury	O
(	O
SCI	O
)	O
are	O
predictive	O
of	O
bladder	O
function	O
recovery	O
.	O

Levels	O
of	O
the	O
MEK	B
inhibitor	I
PD98059	O
that	O
block	O
EGF	B
-	I
induced	O
mitogenesis	O
and	O
MAP	B
kinase	I
phosphorylation	O
also	O
abrogate	O
EGF	B
-	I
induced	O
focal	O
adhesion	O
disassembly	O
and	O
cell	O
motility	O
.	O

51	O
.	O
9	O
%	O
(	O
P	O
=	O
0	O
.	O
0006	O
)	O
in	O
the	O
MMF	O
versus	O
the	O
AZA	O
groups	O
,	O
respectively	O
.	O

Nine	O
cats	O
received	O
PMEA	O
at	O
a	O
dosage	O
of	O
10	O
mg	O
/	O
kg	O
body	O
weight	O
,	O
nine	O
cats	O
received	O
FPMPA	O
at	O
a	O
dosage	O
of	O
25	O
mg	O
/	O
kg	O
body	O
weight	O
.	O

We	O
present	O
the	O
preliminary	O
results	O
obtained	O
on	O
36	O
patients	O
which	O
were	O
followed	O
for	O
a	O
mean	O
period	O
of	O
12	O
months	O
.	O

PATIENTS	O
AND	O
METHOD	O
:	O
Since	O
1986	O
,	O
62	O
patients	O
were	O
irradiated	O
stereotactically	O
.	O

Expression	O
and	O
characterization	O
of	O
recombinant	B
single	I
-	I
chain	I
Fv	I
and	I
Fv	I
fragments	I
derived	I
from	O
a	O
set	O
of	O
catalytic	O
antibodies	O
.	O

Using	O
himA	B
mutants	I
,	O
we	O
confirmed	O
that	O
IHF	B
plays	O
a	O
role	O
in	O
the	O
molybdate	O
-	O
dependent	O
regulation	O
of	O
dmsA	B
-	I
lacZ	I
expression	O
in	O
vivo	O
.	O

Cytoskeletal	O
polarization	O
of	O
T	O
cells	O
is	O
regulated	O
by	O
an	O
immunoreceptor	O
tyrosine	O
-	O
based	O
activation	O
motif	O
-	O
dependent	O
mechanism	O
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

It	O
may	O
also	O
be	O
suggested	O
that	O
particular	O
care	O
should	O
be	O
taken	O
when	O
such	O
a	O
trans	O
-	O
dominant	B
Rev	I
mutant	I
is	O
considered	O
to	O
be	O
used	O
as	O
a	O
genetic	O
therapy	O
against	O
HIV	B
-	I
I	I
infection	O
,	O
in	O
individuals	O
infected	O
with	O
both	O
HIV	B
-	I
I	I
and	O
HTLV	B
-	I
1	I
.	O

Simple	O
models	O
of	O
bimolecular	O
interaction	O
did	O
not	O
fully	O
account	O
for	O
the	O
kinetic	O
profiles	O
obtained	O
with	O
the	O
parental	O
antibodies	O
and	O
the	O
hybrids	O
,	O
and	O
this	O
complexity	O
suggested	O
the	O
existence	O
of	O
a	O
conformational	O
heterogeneity	O
in	O
these	O
molecules	O
.	O

In	O
order	O
to	O
decipher	O
the	O
pathway	O
that	O
leads	O
to	O
Hox	B
gene	I
induction	O
,	O
we	O
have	O
investigated	O
whether	O
a	O
Hox	B
gene	I
regulator	I
,	O
the	O
leucine	O
zipper	O
transcription	O
factor	O
MafB	B
/	O
Kr	B
,	O
is	O
itself	O
transcriptionally	O
regulated	O
by	O
the	O
environmental	O
signals	O
.	O

Furthermore	O
,	O
direct	O
association	O
with	O
D3	O
phosphatidylinositides	O
seems	O
to	O
be	O
essential	O
for	O
activation	O
of	O
PKB	B
/	O
Akt	B
.	O

The	O
FMN	O
moiety	O
but	O
not	O
the	O
[	O
3Fe	O
-	O
4S	O
]	O
cluster	O
of	O
the	O
subunit	O
appears	O
to	O
participate	O
in	O
this	O
reaction	O
.	O

The	O
ESEM	O
differs	O
from	O
conventional	O
SEM	O
in	O
that	O
no	O
sample	O
preparation	O
is	O
needed	O
,	O
eliminating	O
artifactual	O
changes	O
.	O

E2F	B
activity	O
is	O
regulated	O
in	O
part	O
by	O
the	O
retinoblastoma	B
family	I
of	O
tumor	B
suppressor	I
proteins	I
.	O

For	O
the	O
5HT5A	B
receptor	I
the	O
addition	O
of	O
yohimbine	O
resulted	O
in	O
a	O
similar	O
but	O
smaller	O
effect	O
.	O

Structural	O
and	O
evolutionary	O
studies	O
on	O
sterol	B
14	I
-	I
demethylase	I
P450	I
(	O
CYP51	B
),	O
the	O
most	O
conserved	O
P450	B
monooxygenase	I
:	O
I	O
.	O

CONCLUSIONS	O
:	O
XCoe2	B
may	O
play	O
a	O
pivotal	O
role	O
in	O
the	O
transcriptional	O
cascade	O
that	O
specifies	O
primary	O
neurons	O
in	O
Xenopus	O
embryos	O
:	O
by	O
maintaining	O
Delta	B
-	I
Notch	I
signalling	O
,	O
XCoe2	B
stabilises	O
the	O
higher	O
neural	O
potential	O
of	O
selected	O
progenitor	O
cells	O
that	O
express	O
X	B
-	I
ngnr	I
-	I
1	I
,	O
ensuring	O
the	O
transition	O
between	O
neural	O
competence	O
and	O
irreversible	O
commitment	O
to	O
a	O
neural	O
fate	O
;	O
and	O
it	O
promotes	O
neuronal	O
differentiation	O
by	O
activating	O
XNeuroD	B
expression	O
,	O
directly	O
or	O
indirectly	O
.	O

In	O
patients	O
with	O
myalgia	O
,	O
Raynaud	O
'	O
s	O
syndrome	O
,	O
skin	O
vasculitis	O
and	O
vascular	O
diseases	O
WFAg	B
concentrations	O
were	O
higher	O
than	O
in	O
patients	O
without	O
them	O
.	O

Although	O
the	O
expression	O
of	O
the	O
4E	B
-	I
BP1	I
gene	I
alone	O
has	O
not	O
yet	O
been	O
accomplished	O
,	O
the	O
gene	O
was	O
expressed	O
in	O
Escherichia	O
coli	O
[	O
BL21	O
(	O
DE3	O
)]	O
as	O
a	O
fusion	O
gene	O
with	O
the	O
glutathione	B
-	I
S	I
-	I
transferase	I
(	O
GST	B
)	I
gene	I
using	O
a	O
prokaryotic	B
gene	I
fusion	I
vector	O
(	O
pGEX	O
-	O
4T	O
-	O
2	O
),	O
which	O
contains	O
a	O
gene	O
sequence	O
coding	O
the	O
cleavage	O
site	O
for	O
a	O
specific	O
protease	O
,	O
alpha	B
-	I
thrombin	I
.	O

Peripheral	O
visual	O
stimuli	O
and	O
monoaural	O
auditory	O
stimuli	O
were	O
used	O
as	O
targets	O
.	O

A	O
review	O
of	O
studies	O
published	O
between	O
1983	O
and	O
1995	O
shows	O
that	O
there	O
are	O
some	O
common	O
factors	O
as	O
regards	O
the	O
psychological	O
distress	O
and	O
social	O
and	O
functional	O
limitations	O
this	O
group	O
of	O
patients	O
has	O
to	O
deal	O
with	O
.	O

We	O
further	O
show	O
that	O
proteolytic	O
targeting	O
by	O
calpain	B
II	I
and	O
the	O
proteasome	O
involves	O
different	O
structural	O
elements	O
of	O
YY1	B
.	O

Primers	O
for	O
subsequent	O
rounds	O
of	O
RACE	O
were	O
designed	O
from	O
the	O
5	O
'-	O
ends	O
of	O
amplified	O
RACE	O
products	O
.	O

RESULTS	O
:	O
Using	O
information	O
in	O
the	O
dbEST	O
database	O
of	O
expressed	O
sequence	O
tags	O
,	O
we	O
isolated	O
an	O
Arabidopsis	O
thaliana	O
gene	O
(	O
GCR1	B
)	O
that	O
encodes	O
a	O
protein	O
with	O
seven	O
predicted	O
membrane	O
-	O
spanning	O
domains	O
and	O
other	O
features	O
characteristic	O
of	O
7TM	B
receptors	I
.	O

Position	O
-	O
independent	O
expression	O
of	O
a	O
human	O
nerve	B
growth	I
factor	I
-	I
luciferase	I
reporter	I
gene	I
cloned	O
on	O
a	O
yeast	O
artificial	O
chromosome	O
vector	O
.	O

Ganciclovir	O
and	O
foscarnet	O
efficacy	O
in	O
AIDS	O
-	O
related	O
CMV	O
polyradiculopathy	O
.	O

From	O
250	O
g	O
of	O
cells	O
,	O
we	O
isolated	O
1	O
mg	O
of	O
PDH	B
complex	I
with	O
a	O
specific	O
activity	O
of	O
12	O
.	O
6	O
U	O
/	O
mg	O
of	O
protein	O
.	O

The	O
PDH	B
complex	I
-	I
encoding	I
genes	I
were	O
identified	O
by	O
hybridization	O
experiments	O
and	O
sequence	O
analysis	O
in	O
two	O
separate	O
gene	O
regions	O
in	O
the	O
genome	O
of	O
Z	O
.	O
mobilis	O
.	O

Drosophila	B
orthodenticle	I
(	O
otd	B
)	O
and	O
murine	B
Otx	I
genes	I
exemplify	O
this	O
,	O
both	O
in	O
terms	O
of	O
expression	O
patterns	O
and	O
mutant	O
phenotypes	O
.	O

Both	O
variants	O
display	O
the	O
seven	O
-	O
transmembrane	O
topology	O
that	O
is	O
typical	O
for	O
G	B
protein	I
-	I
coupled	I
receptors	I
.	O

A	O
constitutive	O
allele	O
of	O
GPA2	B
could	O
stimulate	O
growth	O
of	O
a	O
strain	O
lacking	O
both	O
RAS	B
genes	I
.	O

PCR	O
analysis	O
indicates	O
that	O
this	O
new	O
beta	B
-	I
adducin	I
isoform	I
is	O
expressed	O
in	O
fetal	O
brain	O
and	O
liver	O
,	O
bone	O
marrow	O
,	O
and	O
NT	O
-	O
2	O
(	O
neuroepithelial	O
)	O
cells	O
,	O
but	O
is	O
not	O
detected	O
in	O
several	O
other	O
tissues	O
.	O

The	O
gene	O
lac	B
-	I
1	I
,	O
encoding	O
the	O
enzyme	O
laccase	B
,	O
is	O
the	O
best	O
characterized	O
of	O
a	O
number	O
of	O
genes	O
in	O
the	O
chestnut	O
blight	O
fungus	O
,	O
Cryphonectria	O
parasitica	O
,	O
that	O
are	O
repressed	O
by	O
hypoviruses	O
,	O
a	O
group	O
of	O
virulence	O
-	O
attenuating	O
mycoviruses	O
.	O
lac	B
-	I
1	I
has	O
also	O
been	O
shown	O
to	O
be	O
transcriptionally	O
activated	O
by	O
low	O
concentrations	O
of	O
the	O
translational	O
inhibitor	O
cycloheximide	O
(	O
CHX	O
)	O
and	O
by	O
the	O
immunosuppressant	O
cyclosporin	O
A	O
.	O

The	O
RAS	B
-	O
cyclic	B
AMP	I
-	I
dependent	I
protein	I
kinase	I
cAPK	I
pathway	O
prevents	O
the	O
UAS	O
activity	O
of	O
IREu	B
in	O
the	O
presence	O
of	O
glucose	O
as	O
the	O
sole	O
carbon	O
source	O
,	O
while	O
the	O
transcriptional	O
activators	O
Msn2p	B
and	O
Msn4p	B
promote	O
the	O
UAS	O
activity	O
of	O
this	O
repeat	O
in	O
the	O
presence	O
of	O
acetate	O
.	O

In	O
some	O
cases	O
,	O
the	O
aberrant	O
methylation	O
of	O
CpGs	O
within	O
5	O
'	O
regulatory	O
regions	O
has	O
led	O
to	O
suppression	O
of	O
gene	O
activity	O
.	O

Potential	O
indicators	O
were	O
assessed	O
for	O
the	O
two	O
classifications	O
of	O
protein	O
-	O
energy	O
malnutrition	O
in	O
the	O
guidelines	O
for	O
integrated	O
management	O
of	O
childhood	O
illness	O
:	O
severe	O
malnutrition	O
,	O
which	O
requires	O
immediate	O
referral	O
to	O
hospital	O
,	O
and	O
very	O
low	O
weight	O
,	O
which	O
calls	O
for	O
feeding	O
assessment	O
,	O
nutritional	O
counselling	O
and	O
follow	O
-	O
up	O
.	O

SNAC	O
or	O
PBS	O
was	O
infused	O
for	O
6	O
.	O
5	O
h	O
,	O
beginning	O
30	O
min	O
before	O
ischemia	O
and	O
continuing	O
throughout	O
the	O
duration	O
of	O
reperfusion	O
.	O

Recent	O
studies	O
have	O
revealed	O
unconventional	O
myosin	B
V	I
to	O
be	O
an	O
important	O
actin	B
-	I
based	O
molecular	O
motor	O
involved	O
in	O
vesicular	O
movement	O
.	O

The	O
dominant	O
negative	O
mutant	O
of	O
SHP	B
-	I
2	I
was	O
found	O
to	O
inhibit	O
the	O
induction	O
of	O
tyrosine	O
phosphorylation	O
and	O
DNA	O
-	O
binding	O
activity	O
of	O
m	B
-	I
Stat5a	I
,	O
m	B
-	I
Stat5b	I
,	O
and	O
the	O
carboxyl	B
-	I
terminal	I
deletion	I
variant	I
m	I
-	I
Stat5adelta749	I
,	O
as	O
well	O
as	O
the	O
transactivation	O
potential	O
of	O
m	B
-	I
Stat5a	I
and	O
m	B
-	I
Stat5b	I
.	O

Furthermore	O
,	O
interactions	O
were	O
identified	O
between	O
endogenous	B
E	I
-	I
cadherin	I
and	O
the	O
chimera	O
containing	O
the	O
E	B
-	I
cadherin	I
extracellular	I
domain	I
and	O
the	O
desmoglein	B
1	I
intracellular	O
domain	O
providing	O
in	O
vivo	O
evidence	O
for	O
previously	O
predicted	O
lateral	O
interactions	O
of	O
E	B
-	I
cadherin	I
extracellular	I
domains	I
.	O

The	O
ether	O
phospholipid	O
1	O
-	O
O	O
-	O
octadecyl	O
-	O
2	O
-	O
O	O
-	O
methyl	O
-	O
rac	O
-	O
glycero	O
-	O
3	O
-	O
phosphocholine	O
(	O
ET	B
-	I
18	I
-	I
OCH3	O
;	O
edelfosine	O
)	O
is	O
a	O
potent	O
inducer	O
of	O
apoptosis	O
in	O
human	O
tumor	O
cells	O
.	O

Serum	O
levels	O
of	O
testosterone	O
also	O
showed	O
no	O
significant	O
changes	O
by	O
exposure	O
to	O
p	O
,	O
p	O
'-	O
DDE	O
under	O
the	O
conditions	O
of	O
this	O
study	O
.	O

When	O
data	O
were	O
expressed	O
in	O
a	O
cumulative	O
manner	O
,	O
the	O
response	O
to	O
intravenous	O
adenosine	O
3	O
mg	O
,	O
6	O
mg	O
,	O
9	O
mg	O
and	O
12	O
mg	O
in	O
the	O
24	O
episodes	O
of	O
PSVT	O
were	O
5	O
episodes	O
(	O
21	O
%),	O
16	O
episodes	O
(	O
67	O
%),	O
20	O
episodes	O
(	O
83	O
%)	O
and	O
20	O
episodes	O
(	O
83	O
%)	O
respectively	O
.	O

RNAs	O
are	O
not	O
only	O
essential	O
components	O
of	O
both	O
ribosomal	B
subunits	I
but	O
also	O
transiently	O
interacting	O
factors	O
during	O
particle	O
formation	O
.	O

To	O
identify	O
nuclear	O
regulatory	O
factors	O
,	O
we	O
have	O
located	O
and	O
functionally	O
characterized	O
the	O
CCR5	B
gene	I
promoter	I
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
of	O
metaphase	O
spreads	O
of	O
chromosome	O
8	O
,	O
containing	O
hybrid	O
cell	O
line	O
706	O
-	O
B6	O
clone	O
17	O
(	O
CL	O
-	O
17	O
)	O
with	O
cosmid	O
c101F1	O
,	O
placed	O
the	O
9804	B
gene	I
close	O
to	O
the	O
telomere	O
at	O
8q24	O
.	O
3	O
.	O

The	O
N	O
-	O
syndecan	O
-	O
dependent	O
neurite	O
outgrowth	O
is	O
inhibited	O
by	O
the	O
tyrosine	B
kinase	I
inhibitors	O
herbimycin	O
A	O
and	O
PP1	B
.	O

Among	O
the	O
H	B
/	I
ACA	I
snoRNAs	I
associated	I
with	O
Gar1p	B
,	O
one	O
can	O
distinguish	O
a	O
large	O
group	O
of	O
snoRNAs	O
that	O
are	O
not	O
essential	O
in	O
yeast	O
and	O
serve	O
as	O
guides	O
for	O
pseudouridine	O
synthesis	O
onto	O
the	O
pre	B
-	I
rRNA	I
molecule	I
.	O

We	O
previously	O
demonstrated	O
that	O
acute	O
expression	O
of	O
the	O
bovine	B
papillomavirus	I
type	I
1	I
(	O
BPV1	O
)	O
E2	B
protein	I
in	O
HeLa	O
and	O
HT	O
-	O
3	O
cervical	O
carcinoma	O
cell	O
lines	O
greatly	O
reduced	O
cellular	O
proliferation	O
by	O
imposing	O
a	O
specific	O
G1	O
/	O
S	O
phase	O
growth	O
arrest	O
.	O

A	O
cDNA	O
,	O
cak1At	B
,	O
was	O
isolated	O
that	O
suppressed	O
the	O
CAK	B
mutation	I
in	O
budding	O
yeast	O
,	O
and	O
it	O
also	O
complemented	O
a	O
fission	O
yeast	O
CAK	B
mutant	I
.	O
cak1At	B
encodes	O
a	O
protein	O
related	O
to	O
animal	B
CAKs	I
.	O

A	O
cluster	O
of	O
basic	O
amino	O
acids	O
,	O
KKKR	O
,	O
generated	O
by	O
joining	O
of	O
the	O
sequences	O
encoded	O
by	O
the	O
constitutive	O
exon	O
13	O
and	O
the	O
alternative	O
exon	O
16	O
,	O
is	O
necessary	O
for	O
the	O
nuclear	O
targeting	O
of	O
4	O
.	O
1H	O
,	O
as	O
demonstrated	O
by	O
site	O
-	O
directed	O
mutagenesis	O
analysis	O
.	O

In	O
this	O
study	O
,	O
the	O
effect	O
of	O
acute	O
administration	O
of	O
various	O
doses	O
of	O
malathion	O
via	O
oral	O
and	O
dermal	O
routes	O
to	O
mice	O
and	O
rats	O
on	O
serum	O
levels	O
of	O
histamine	O
was	O
evaluated	O
.	O

The	O
complete	O
exon	O
-	O
intron	O
organization	O
of	O
the	O
murine	B
gene	I
encoding	I
M	I
-	I
protein	I
,	O
a	O
structural	O
protein	O
of	O
sarcomeric	O
myofibrils	O
,	O
was	O
determined	O
.	O

Two	O
of	O
these	O
resulted	O
in	O
increased	O
levels	O
of	O
the	O
alpha	B
subunit	I
,	O
and	O
one	O
caused	O
a	O
substitution	O
of	O
glycine	O
for	O
the	O
aspartic	O
acid	O
residue	O
at	O
position	O
171	O
,	O
in	O
the	O
N	O
-	O
terminal	O
domain	O
.	O

The	O
localization	O
of	O
ZAP	B
-	I
70	I
to	O
the	O
cell	O
cortex	O
is	O
,	O
therefore	O
,	O
regulated	O
by	O
the	O
activity	O
of	O
SRC	B
-	I
family	I
kinases	I
,	O
independently	O
of	O
their	O
ability	O
to	O
phosphorylate	O
immunoreceptor	O
tyrosine	O
-	O
based	O
activation	O
motifs	O
of	O
the	O
TCR	B
.	O

The	O
effect	O
of	O
nitric	B
oxide	I
synthase	I
inhibitor	I
on	O
reperfusion	O
injury	O
of	O
the	O
brain	O
under	O
hypothermic	O
circulatory	O
arrest	O
.	O

We	O
studied	O
the	O
human	O
vestibulo	O
-	O
ocular	O
reflex	O
(	O
VOR	O
)	O
in	O
response	O
to	O
head	O
'	O
impulses	O
':	O
brief	O
,	O
unpredictable	O
,	O
passive	O
,	O
high	O
-	O
acceleration	O
(	O
up	O
to	O
4000	O
degrees	O
/	O
s2	O
),	O
low	O
-	O
amplitude	O
(	O
20	O
-	O
30	O
degrees	O
)	O
head	O
rotations	O
.	O

These	O
modifications	O
may	O
improve	O
the	O
interlaboratory	O
reproducibility	O
of	O
CD34	B
determinations	O
due	O
to	O
the	O
reduction	O
in	O
sample	O
handling	O
and	O
calculation	O
of	O
results	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
is	O
78	O
.	O
0	O
%	O
identical	O
to	O
the	O
cytoplasmic	B
dynein	I
heavy	I
chain	I
of	I
Neurospora	I
crassa	I
,	O
70	O
.	O
2	O
%	O
identical	O
to	O
that	O
of	O
Aspergillus	O
nidulans	O
and	O
24	O
.	O
8	O
%	O
identical	O
to	O
that	O
of	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
DNA	O
binding	O
activities	O
of	O
the	O
three	O
repressor	O
preparations	O
were	O
studied	O
using	O
fragments	O
containing	O
CIRs	O
(	O
CIR3	O
-	O
CIR6	O
)	O
from	O
the	O
essential	O
early	O
region	O
as	O
templates	O
for	O
DNase	B
I	I
footprinting	O
.	O

We	O
have	O
shown	O
previously	O
that	O
GH3	O
cells	O
transfected	O
with	O
the	O
rat	O
GnRH	B
receptor	I
cDNA	I
(	O
GGH3	O
-	O
1	O
'	O
cells	O
)	O
support	O
the	O
expression	O
of	O
a	O
cotransfected	O
fusion	O
gene	O
composed	O
of	O
797	O
base	O
pairs	O
of	O
rat	B
LHbeta	I
gene	I
5	O
'-	O
flanking	O
sequence	O
and	O
the	O
first	O
5	O
base	O
pairs	O
of	O
the	O
5	O
'-	O
untranslated	O
region	O
fused	O
to	O
a	O
luciferase	B
reporter	I
(-	I
797	I
/+	I
5LHbetaLUC	I
)	O
and	O
respond	O
to	O
a	O
GnRH	B
agonist	O
with	O
a	O
10	O
-	O
fold	O
stimulation	O
of	O
activity	O
.	O

Results	O
showed	O
that	O
the	O
mean	O
bond	O
strength	O
of	O
H	O
.	O
T	O
.	O
V	O
.	O
specimens	O
ranged	O
from	O
9	O
.	O
6	O
to	O
13	O
.	O
12	O
kg	O
/	O
cm2	O
,	O
while	O
the	O
mean	O
bond	O
strength	O
of	O
R	O
.	O
T	O
.	O
V	O
.	O
specimens	O
ranged	O
from	O
0	O
.	O
36	O
to	O
1	O
.	O
75	O
kg	O
/	O
cm2	O
.	O

DESIGN	O
AND	O
METHODS	O
:	O
Case	O
study	O
.	O

Control	O
subjects	O
'	O
evoked	O
potentials	O
(	O
EPs	O
)	O
were	O
characterized	O
by	O
an	O
initial	O
positivity	O
in	O
the	O
90	O
-	O
140	O
ms	O
range	O
(	O
P1	O
)	O
at	O
the	O
temporo	O
-	O
occipital	O
site	O
.	O

Class	B
I	I
alpha1	I
,	I
2	I
-	I
mannosidases	I
play	O
an	O
essential	O
role	O
in	O
the	O
elaboration	O
of	O
complex	O
and	O
hybrid	O
N	O
-	O
glycans	O
in	O
mammalian	O
cells	O
.	O

We	O
show	O
that	O
the	O
surfaces	O
of	O
tracheal	O
cartilage	O
matrix	O
are	O
collagen	B
-	I
rich	O
and	O
surround	O
a	O
proteoglycan	O
-	O
rich	O
core	O
.	O

Roles	O
of	O
the	O
Candida	O
albicans	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
homolog	I
,	O
Cek1p	B
,	O
in	O
hyphal	O
development	O
and	O
systemic	O
candidiasis	O
.	O

In	O
contrast	O
to	O
other	O
known	O
retroviruses	O
,	O
the	O
FV	B
pol	I
genes	I
are	O
expressed	O
via	O
spliced	O
transcripts	O
.	O

Fregnac	O
,	O
M	O
.	O

Demographic	O
and	O
clinical	O
data	O
were	O
compared	O
with	O
a	O
control	O
group	O
of	O
339	O
healthy	O
age	O
-	O
matched	O
women	O
and	O
with	O
a	O
sample	O
of	O
224	O
women	O
with	O
wrist	O
fracture	O
.	O

Combined	O
expression	O
of	O
c	B
-	I
Jun	I
and	O
p65	B
induced	O
vigorous	O
transcription	O
of	O
IL	B
-	I
2	I
promoter	I
-	I
and	O
CD28RE	B
-	I
driven	I
reporter	I
constructs	I
in	O
both	O
LFA	B
-	I
3	I
-	I
and	O
B7	B
-	I
1	I
-	I
costimulated	O
Jurkat	O
cells	O
.	O

Interferon	B
beta	I
therapy	O
was	O
discontinued	O
for	O
4	O
weeks	O
.	O

CONCLUSION	O
:	O
In	O
women	O
who	O
want	O
or	O
require	O
conservative	O
management	O
of	O
grade	O
4	O
prolapse	O
and	O
are	O
unable	O
to	O
retain	O
a	O
single	O
pessary	O
,	O
the	O
placement	O
of	O
two	O
pessaries	O
often	O
will	O
be	O
successful	O
.	O

Rev	B
-	O
erbAalpha	B
/	I
beta	I
),	O
Mxi	B
-	I
1	I
and	O
Mad	B
bHLH	I
-	I
zip	O
proteins	O
and	O
the	O
oncoproteins	O
PLZF	B
and	O
LAZ3	B
/	O
BCL6	B
is	O
mediated	O
by	O
the	O
corepressors	O
N	B
-	I
CoR	I
and	O
SMRT	B
.	O

The	O
ParaSight	O
-	O
F	O
test	O
alone	O
was	O
used	O
to	O
monitor	O
serum	B
antigen	I
levels	O
after	O
treatment	O
in	O
24	O
patients	O
.	O

Essentially	O
,	O
2	O
'-	O
O	O
-	O
methyl	O
oligoribonucleotides	O
(	O
2	O
'	O
OMeRNA	O
)	O
were	O
delivered	O
to	O
the	O
nuclei	O
of	O
primary	O
mdx	O
myoblasts	O
in	O
culture	O
.	O

Moreover	O
,	O
the	O
observation	O
of	O
enhanced	O
luteal	O
HSP	O
-	O
27	O
phosphorylation	O
in	O
vivo	O
,	O
in	O
late	O
pregnancy	O
,	O
when	O
PKC	B
-	I
delta	I
is	O
abundant	O
and	O
active	O
,	O
suggests	O
that	O
select	O
PKC	B
family	I
members	O
contribute	O
to	O
sHSP	B
phosphorylation	O
events	O
in	O
vivo	O
.	O

The	O
importance	O
of	O
these	O
sites	O
for	O
transcriptional	O
activation	O
was	O
studied	O
by	O
site	O
-	O
directed	O
mutagenesis	O
followed	O
by	O
promoter	O
function	O
analysis	O
of	O
the	O
mutants	O
with	O
a	O
chloramphenicol	B
acetyltransferase	I
reporter	I
system	O
.	O

Anti	B
-	I
PTB	I
antibodies	I
did	O
not	O
inhibit	O
the	O
binding	O
of	O
PTB	O
to	O
RNA	O
because	O
they	O
were	O
able	O
to	O
supershift	O
RNA	B
-	I
PTB	I
complexes	I
.	O

In	O
the	O
ePTFE	O
specimens	O
,	O
tissue	O
coverage	O
had	O
increased	O
.	O

Thus	O
,	O
included	O
in	O
the	O
KG1a	O
EST	O
dataset	O
are	O
candidates	O
for	O
new	O
human	B
genes	I
that	O
may	O
play	O
roles	O
in	O
hematopoietic	O
differentiative	O
progression	O
and	O
lineage	O
commitment	O
.	O

We	O
found	O
the	O
following	O
:	O
Specific	O
mutations	O
affected	O
the	O
precise	O
carbohydrate	O
structure	O
and	O
folding	O
of	O
the	O
HA	B
trimer	I
.	O

Yeast	B
U1	I
snRNP	I
therefore	O
contains	O
16	O
different	O
proteins	O
,	O
including	O
seven	O
snRNP	O
core	O
proteins	O
,	O
three	O
homologues	O
of	O
the	O
metazoan	B
U1	I
snRNP	I
-	I
specific	I
proteins	I
,	O
and	O
six	O
yeast	B
-	I
specific	I
U1	I
snRNP	I
proteins	I
.	O

The	O
virus	O
-	O
associated	O
VAI	B
RNA	I
of	O
adenovirus	O
is	O
a	O
small	O
highly	O
structured	O
RNA	O
that	O
is	O
required	O
for	O
the	O
efficient	O
translation	O
of	O
cellular	O
and	O
viral	O
mRNAs	O
at	O
late	O
times	O
after	O
infection	O
.	O

After	O
profound	O
normovolemic	O
hemodilution	O
(	O
Hct	O
9	O
%)	O
superiority	O
of	O
LV	O
MC	O
and	O
LV	O
diastolic	O
properties	O
was	O
found	O
,	O
when	O
myocardial	O
oxygenation	O
was	O
supported	O
by	O
i	O
.	O
v	O
.	O
perflubron	O
emulsion	O
,	O
a	O
temporary	O
O2	O
carrier	O
.	O

These	O
genes	O
may	O
represent	O
interesting	O
targets	O
for	O
new	O
therapeutic	O
strategies	O
.	O

In	O
this	O
report	O
we	O
studied	O
the	O
role	O
of	O
protein	B
-	I
tyrosine	I
phosphatase	I
SHP	I
-	I
2	I
in	O
ErbB	B
-	I
mediated	O
activation	O
of	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	I
MAPK	I
)	O
by	O
overexpressing	O
SHP	B
-	I
2	I
mutants	I
in	O
COS	O
-	O
7	O
cells	O
.	O

Osteoadherin	B
is	O
a	O
recently	O
described	O
bone	O
proteoglycan	O
containing	O
keratan	O
sulfate	O
.	O

Intron	O
8	O
harbored	O
a	O
strong	O
erythroid	B
-	I
specific	I
enhancer	I
activity	O
which	O
was	O
orientation	O
-	O
dependent	O
.	O

A	O
major	O
pool	O
of	O
Dsg	B
-	O
plakoglobin	B
complexes	I
sedimented	O
at	O
8S	O
and	O
exhibited	O
a	O
1	O
:	O
1	O
stoichiometry	O
.	O

It	O
can	O
also	O
be	O
used	O
to	O
examine	O
various	O
laryngeal	O
parameters	O
obtained	O
from	O
videotaped	O
endoscopic	O
and	O
stroboscopic	O
examinations	O
.	O

We	O
have	O
used	O
the	O
hydrophobic	O
repeats	O
of	O
the	O
HSF1	B
trimerization	I
domain	I
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
protein	O
interaction	O
assay	O
to	O
identify	O
heat	B
shock	I
factor	I
binding	I
protein	I
1	I
(	O
HSBP1	B
),	O
a	O
novel	O
,	O
conserved	O
,	O
76	O
-	O
amino	O
-	O
acid	O
protein	O
that	O
contains	O
two	O
extended	O
arrays	O
of	O
hydrophobic	O
repeats	O
that	O
interact	O
with	O
the	O
HSF1	B
heptad	I
repeats	I
.	O

Genomic	O
and	O
cDNA	O
clones	O
homologous	O
to	O
the	O
yeast	O
GCN2	B
eIF	I
-	I
2alpha	I
kinase	I
(	O
yGCN2	O
)	O
were	O
isolated	O
from	O
Drosophila	B
melanogaster	I
.	O

VirD2	B
is	O
one	O
of	O
the	O
key	O
Agrobacterium	O
tumefaciens	O
proteins	O
involved	O
in	O
T	O
-	O
DNA	O
processing	O
and	O
transfer	O
.	O

Cystatin	B
A	I
,	O
a	O
cysteine	B
proteinase	I
inhibitor	I
,	O
is	O
one	O
of	O
the	O
precursor	O
proteins	O
of	O
cornified	B
cell	I
envelope	I
of	O
keratinocytes	O
and	O
is	O
expressed	O
during	O
the	O
late	O
stage	O
of	O
keratinocyte	O
differentiation	O
.	O

Initially	O
,	O
we	O
observed	O
that	O
unmutated	O
p53	B
is	O
strongly	O
expressed	O
in	O
premalignant	O
mammary	O
glands	O
and	O
in	O
mammary	O
tumors	O
derived	O
from	O
the	O
MMTV	B
-	I
c	I
-	I
myc	I
strain	O
.	O

Comparison	O
of	O
cDNA	O
and	O
genomic	O
sequences	O
shows	O
that	O
the	O
ZNF189	B
gene	I
spans	O
approximately	O
11	O
kb	O
and	O
is	O
organized	O
into	O
at	O
least	O
four	O
exons	O
,	O
the	O
large	O
3	O
'-	O
end	O
exon	O
coding	O
for	O
the	O
complete	O
zinc	B
finger	I
domain	I
and	O
the	O
3	O
'	O
untranslated	O
region	O
.	O

In	O
the	O
DNA	O
recognition	O
helix	O
of	O
finger	O
II	O
,	O
the	O
conserved	O
Arg	O
at	O
position	O
62	O
(	O
N	O
-	O
terminal	O
side	O
of	O
the	O
first	O
zinc	O
-	O
coordinating	O
histidine	O
)	O
was	O
changed	O
to	O
a	O
Leu	O
or	O
Gln	O
.	O

Dosage	O
in	O
both	O
cases	O
was	O
0	O
.	O
2	O
g	O
/	O
m2	O
.	O

Five	O
additional	O
copies	O
of	O
Lian	B
elements	O
were	O
isolated	O
,	O
mapped	O
by	O
restriction	O
digestion	O
,	O
and	O
partially	O
sequenced	O
.	O

The	O
Dax	B
-	I
1	I
gene	I
encodes	O
a	O
protein	O
that	O
is	O
structurally	O
related	O
to	O
members	O
of	O
the	O
orphan	B
nuclear	I
receptor	I
superfamily	I
.	O

As	O
the	O
high	O
-	O
affinity	O
Mg2	O
+	O
binding	O
sites	O
are	O
filled	O
,	O
the	O
primer	O
terminus	O
migrates	O
from	O
the	O
exonuclease	O
site	O
to	O
a	O
highly	O
based	O
stacked	O
polymerase	O
active	O
site	O
.	O

The	O
report	O
highlights	O
the	O
possible	O
contribution	O
of	O
stress	O
factors	O
in	O
the	O
context	O
of	O
therapy	O
resistant	O
periodontal	O
disease	O
,	O
and	O
the	O
results	O
seem	O
to	O
be	O
understandable	O
within	O
the	O
context	O
of	O
a	O
stress	O
system	O
disorder	O
perspective	O
.	O

We	O
isolated	O
the	O
human	B
FGF	I
-	I
BP	I
promoter	I
and	O
determined	O
by	O
deletion	O
analysis	O
that	O
TPA	O
regulatory	O
elements	O
were	O
all	O
contained	O
in	O
the	O
first	O
118	O
base	O
pairs	O
upstream	O
of	O
the	O
transcription	O
start	O
site	O
.	O

We	O
propose	O
that	O
noi	B
/	O
pax2	B
.	O
1	O
participates	O
in	O
sequential	O
signaling	O
processes	O
as	O
a	O
key	O
integrator	O
of	O
midbrain	O
-	O
hindbrain	O
boundary	O
development	O
.	O

To	O
gain	O
insight	O
into	O
the	O
expression	O
of	O
the	O
AtCP1	B
gene	I
,	O
northern	O
blot	O
analysis	O
was	O
carried	O
out	O
.	O

The	O
biochemical	O
and	O
molecular	O
spectrum	O
of	O
ornithine	B
transcarbamylase	I
deficiency	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
crucial	O
role	O
of	O
the	O
mutations	O
activating	O
v	B
-	I
erbA	I
as	O
an	O
oncogene	O
is	O
to	O
'	O
freeze	O
'	O
c	B
-	I
ErbA	I
/	O
TRalpha	B
in	O
its	O
non	O
-	O
liganded	O
,	O
repressive	O
conformation	O
and	O
to	O
facilitate	O
its	O
overexpression	O
.	O

This	O
repressor	O
is	O
however	O
unlikely	O
to	O
mediate	O
spi	B
2	I
.	I
3	I
3	I
'	I
UTR	I
silencer	I
action	O
since	O
it	O
was	O
not	O
detected	O
in	O
rat	O
hepatocytes	O
.	O

We	O
propose	O
a	O
model	O
in	O
which	O
Sro7	B
function	O
is	O
involved	O
in	O
the	O
targeting	O
of	O
the	O
myosin	B
proteins	I
to	O
their	O
intrinsic	O
pathways	O
.	O

Specifically	O
,	O
I	O
use	O
molecular	O
markers	O
that	O
identify	O
particular	O
neuroectodermal	O
domains	O
,	O
all	O
neuroblasts	O
or	O
individual	O
neuroblasts	O
,	O
to	O
show	O
that	O
in	O
DER	B
mutant	I
embryos	O
(	O
1	O
)	O
intermediate	O
column	O
neuroblasts	O
do	O
not	O
form	O
,	O
(	O
2	O
)	O
medial	O
column	O
neuroblasts	O
often	O
acquire	O
identities	O
inappropriate	O
for	O
their	O
position	O
,	O
while	O
(	O
3	O
)	O
lateral	O
neuroblasts	O
develop	O
normally	O
.	O

Cochlear	O
microphonic	O
potentials	O
in	O
patients	O
with	O
vestibular	O
schwannomas	O
.	O

On	O
the	O
comparison	O
of	O
correlated	O
proportions	O
for	O
clustered	O
data	O
.	O

A	O
safe	O
and	O
simple	O
system	O
for	O
the	O
detection	O
of	O
sudden	O
infant	O
death	O
syndrome	O
(	O
SIDS	O
)	O
is	O
proposed	O
.	O

Homozygous	O
mutant	O
mice	O
,	O
designated	O
Cux	B
/	O
CDPDeltaCR1	B
,	O
display	O
a	O
phenotype	O
characterized	O
by	O
curly	O
vibrissae	O
and	O
wavy	O
hair	O
.	O

METHODS	O
:	O
We	O
retrospectively	O
reviewed	O
242	O
adult	O
cadaveric	O
renal	O
transplant	O
recipients	O
treated	O
between	O
11	O
/	O
91	O
and	O
5	O
/	O
97	O
.	O

Our	O
laboratory	O
has	O
recently	O
identified	O
two	O
phosducin	B
-	I
like	I
orphan	I
proteins	I
(	O
PhLOP1	B
and	O
PhLOP2	B
)	O
that	O
lack	O
the	O
ability	O
to	O
interact	O
with	O
Gbetagamma	B
.	O

In	O
contrast	O
,	O
transcription	O
initiating	O
from	O
opuE	B
P	I
-	I
1	I
(	I
sigma	I
A	I
)	O
rose	O
in	O
proportion	O
to	O
the	O
external	O
osmolarity	O
and	O
was	O
maintained	O
at	O
high	O
levels	O
.	O

IA	O
-	O
CT	O
with	O
cisplatin	O
50	O
mg	O
and	O
doxorubicin	O
30	O
mg	O
was	O
administered	O
by	O
one	O
shot	O
method	O
in	O
bilateral	O
internal	O
iliac	O
arteries	O
.	O

Arnt3	B
mRNA	I
was	O
expressed	O
in	O
brain	O
,	O
skeletal	O
muscle	O
,	O
13	O
.	O
5	O
-	O
day	O
embryos	O
,	O
and	O
P19	O
cells	O
treated	O
with	O
retinoic	O
acid	O
.	O

MK	O
-	O
801	O
administration	O
resulted	O
in	O
a	O
biphasic	O
response	O
in	O
seizure	O
latency	O
.	O

The	O
effect	O
of	O
Rho	B
on	O
AP	B
-	I
1	I
is	O
independent	O
of	O
the	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
pathway	O
,	O
as	O
a	O
dominant	O
-	O
negative	O
MEK	B
and	O
a	O
MEK	B
inhibitor	I
(	O
PD98059	O
)	O
did	O
not	O
affect	O
Rho	B
-	I
induced	O
AP	B
-	I
1	I
activity	O
.	O

Persistent	O
activation	O
of	O
mitogen	B
-	I
activated	I
protein	I
kinases	I
p42	I
and	O
p44	B
and	I
ets	I
-	I
2	I
phosphorylation	O
in	O
response	O
to	O
colony	B
-	I
stimulating	I
factor	I
1	I
/	I
c	I
-	I
fms	I
signaling	O
.	O

The	O
binding	O
of	O
NF	B
-	I
ATp	I
,	O
although	O
not	O
NF	B
-	I
AT4	I
,	O
to	O
this	O
enhancer	O
also	O
occurs	O
along	O
with	O
HTLV	B
-	I
I	I
-	I
mediated	O
infection	O
of	O
human	O
peripheral	O
blood	O
T	O
-	O
cells	O
.	O

The	O
activity	O
of	O
the	O
minimal	O
promoter	O
was	O
found	O
to	O
be	O
controlled	O
by	O
a	O
combination	O
of	O
the	O
activities	O
of	O
the	O
transcription	O
factors	O
Sp1	B
,	O
Sp3	B
,	O
and	O
NF	B
-	I
Y	I
.	O

Isolation	O
of	O
a	O
novel	O
TP53	B
target	I
gene	I
from	O
a	O
colon	O
cancer	O
cell	O
line	O
carrying	O
a	O
highly	O
regulated	O
wild	B
-	I
type	I
TP53	I
expression	O
system	O
.	O

When	O
the	O
blood	O
pressure	O
increase	O
in	O
response	O
to	O
smoking	O
was	O
blunted	O
by	O
nitroprusside	O
infusion	O
,	O
there	O
was	O
a	O
striking	O
increase	O
in	O
muscle	O
SNA	O
.	O

After	O
that	O
report	O
,	O
carboxypeptidase	B
D	I
(	O
CPD	B
)	O
was	O
subsequently	O
purified	O
from	O
bovine	O
pituitary	O
and	O
characterized	O
as	O
a	O
novel	O
carboxypeptidase	B
E	I
(	O
CPE	B
)-	I
like	I
enzyme	I
,	O
with	O
many	O
characteristics	O
in	O
common	O
with	O
duck	O
gp180	B
(	O
Song	O
,	O
L	O
.,	O
Fricker	O
,	O
L	O
.	O
D	O
.,	O
1995	O
.	O

These	O
sequence	O
analyses	O
suggest	O
that	O
xIRS	B
-	I
u	I
is	O
a	O
novel	O
member	O
of	O
the	O
IRS	B
family	I
rather	O
than	O
a	O
Xenopus	B
homolog	I
of	O
an	O
existing	O
member	O
.	O

The	O
present	O
study	O
sought	O
to	O
develop	O
an	O
equation	O
to	O
estimate	O
VO2peak	O
in	O
peripheral	O
arterial	O
occlusive	O
disease	O
(	O
PAOD	O
)	O
patients	O
with	O
intermittent	O
claudication	O
and	O
to	O
determine	O
independent	O
predictors	O
of	O
VO2peak	O
in	O
this	O
population	O
.	O

This	O
hypothesis	O
was	O
tested	O
by	O
introducing	O
mutations	O
at	O
each	O
of	O
the	O
three	O
histidine	O
pairs	O
,	O
the	O
H382	O
-	O
X2	O
-	O
H385	O
pair	O
,	O
the	O
H411	B
-	I
X2	O
-	O
H414	O
pair	O
and	O
the	O
H430	O
-	O
X5	O
-	O
H436	O
pair	O
,	O
which	O
constitute	O
the	O
histidine	O
-	O
rich	O
region	O
near	O
the	O
C	O
terminus	O
of	O
gp17	B
.	O

Furthermore	O
,	O
we	O
demonstrated	O
that	O
Galpha11	B
Q209L	I
stimulated	I
Src	I
family	I
kinase	I
activity	O
and	O
induced	O
tyrosine	O
phosphorylation	O
of	O
several	O
proteins	O
in	O
HEK	O
-	O
293	O
cells	O
.	O

Furthermore	O
,	O
early	O
-	O
and	O
late	O
-	O
firing	O
origins	O
differ	O
not	O
in	O
the	O
timing	O
of	O
their	O
recruitment	O
of	O
an	O
Mcm	B
protein	I
,	O
but	O
in	O
the	O
timing	O
of	O
RPA	B
'	O
s	O
recruitment	O
.	O

JCAHO	O
revised	O
interpretation	O

Molecular	O
cloning	O
and	O
functional	O
characterization	O
of	O
murine	B
sphingosine	I
kinase	I
.	O

The	O
rat	B
branched	I
-	I
chain	I
-	I
2	I
-	I
oxo	I
-	I
acid	I
dehydrogenase	I
(	I
BCOD	I
)	I
kinase	I
mRNA	I
is	O
transcribed	O
from	O
a	O
TATA	O
-	O
less	O
promoter	O
that	O
has	O
GC	O
-	O
rich	O
sequences	O
and	O
two	O
putative	O
Sp1	B
binding	I
sites	I
near	O
the	O
transcription	O
start	O
site	O
.	O

This	O
sequence	O
,	O
Thr	O
-	O
Gly	O
-	O
X	B
-	I
X	I
-	I
Gly	I
-	I
Asp	I
-	I
Gly	I
-	I
Lys	I
-	I
Ile	O
-	O
Phe	O
,	O
forms	O
part	O
of	O
the	O
B	O
-	O
loop	O
and	O
is	O
conserved	O
in	O
a	O
wide	O
variety	O
of	O
organisms	O
that	O
include	O
bacteria	O
,	O
algae	O
and	O
archeabacteria	O
.	O

Second	O
,	O
the	O
wild	B
-	I
type	I
m8	I
3	I
'	I
UTR	I
strongly	O
reduces	O
accumulation	O
of	O
heterologous	O
transcripts	O
in	O
vivo	O
,	O
an	O
activity	O
that	O
requires	O
its	O
K	O
box	O
sequences	O
.	O

MEKs	B
and	O
ERKs	B
inhibited	O
IL	B
-	I
6	I
activation	O
of	O
Stat3	B
harboring	O
a	O
mutation	O
at	O
serine	O
-	O
727	O
,	O
the	O
major	O
site	O
for	O
serine	O
phosphorylation	O
,	O
similar	O
to	O
inhibition	O
of	O
wild	B
-	I
type	I
Stat3	I
,	O
and	O
inhibited	O
Janus	B
kinases	I
Jak1	I
and	O
Jak2	B
upstream	O
of	O
Stat3	B
in	O
the	O
Jak	B
-	I
STAT	I
-	I
signaling	O
pathway	O
.	O

Furthermore	O
,	O
phosphatidylinositol	B
(	O
3	O
,	O
4	O
,	O
5	O
)	O
trisphosphate	O
specifically	O
stimulates	O
the	O
activity	O
of	O
ILK	B
in	O
vitro	O
,	O
and	O
in	O
addition	O
,	O
membrane	O
targetted	O
constitutively	O
active	O
Pi	O
(	O
3	O
)	O
K	O
activates	O
ILK	B
in	O
vivo	O
.	O

OBJECTIVE	O
:	O
The	O
purpose	O
of	O
this	O
article	O
is	O
to	O
review	O
balance	O
instruments	O
developed	O
within	O
the	O
past	O
10	O
years	O
that	O
can	O
be	O
used	O
in	O
the	O
clinic	O
or	O
home	O
environment	O
.	O

Whereas	O
,	O
in	O
the	O
single	O
-	O
chambered	O
body	O
box	O
,	O
PenH	O
units	O
(	O
Enhanced	O
Pause	O
)	O
reflect	O
"	O
effort	O
of	O
breathing	O
."	O
This	O
is	O
measured	O
as	O
the	O
pause	O
between	O
inspiration	O
and	O
expiration	O
.	O

Surprisingly	O
,	O
double	O
mutants	O
of	O
the	O
shy2	B
-	I
1D	I
mutant	I
with	O
the	O
phytochrome	B
-	I
deficient	O
mutants	O
hy2	B
,	O
hy3	B
(	O
phyB	B
-	I
1	I
)	O
and	O
fre1	B
-	I
1	I
(	O
phyA	B
-	I
201	O
)	O
showed	O
reduced	O
photomorphogenic	O
response	O
in	O
darkness	O
with	O
a	O
longer	O
hypocotyl	O
,	O
a	O
longer	O
inflorescence	O
stem	O
,	O
and	O
a	O
lower	O
level	O
expression	O
of	O
the	O
CAB	B
gene	I
than	O
the	O
shy2	B
-	I
1D	I
single	O
mutant	O
.	O

It	O
may	O
be	O
time	O
to	O
reevaluate	O
the	O
dichotomy	O
between	O
AD	O
and	O
VaD	O
.	O

Clone	O
39	O
was	O
a	O
homolog	O
of	O
CONSTANS	B
,	O
which	O
is	O
a	O
gene	O
involved	O
in	O
controlling	O
the	O
flowering	O
time	O
in	O
Arabidopsis	O
.	O

The	O
effects	O
of	O
high	O
intensity	O
light	O
emissions	O
,	O
produced	O
by	O
a	O
novel	O
pulsed	O
power	O
energization	O
technique	O
(	O
PPET	O
),	O
on	O
the	O
survival	O
of	O
bacterial	O
populations	O
of	O
verocytotoxigenic	O
Escherichia	O
coli	O
(	O
serotype	O
0157	O
:	O
H7	O
)	O
and	O
Listeria	O
monocytogenes	O
(	O
serotype	O
4b	O
)	O
were	O
investigated	O
.	O

These	O
results	O
suggest	O
that	O
Thr115	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
MyoD	B
function	O
under	O
conditions	O
of	O
high	O
mitogenesis	O
.	O

The	O
hBRAG	B
gene	I
was	O
localized	O
to	O
the	O
long	O
arm	O
of	O
chromosome	O
10	O
(	O
10q26	O
).	O

The	O
interaction	O
of	O
U1	B
-	I
70K	I
with	O
the	O
SRZ	B
proteins	I
is	O
confirmed	O
further	O
in	O
vitro	O
using	O
a	O
blot	O
overlay	O
assay	O
.	O

Small	B
GTPases	I
of	O
the	O
Ypt	B
/	O
Rab	B
family	I
are	O
involved	O
in	O
the	O
regulation	O
of	O
vesicular	O
transport	O
.	O

The	O
murine	B
facilitative	I
glucose	I
transporter	I
isoform	I
3	I
(	O
Glut	B
3	I
)	O
is	O
developmentally	O
regulated	O
and	O
is	O
predominantly	O
expressed	O
in	O
neurons	O
and	O
trophoblasts	O
.	O

Cotransfection	O
of	O
the	O
helicase	B
-	I
primase	I
proteins	I
,	O
one	O
of	O
which	O
was	O
fused	O
to	O
a	O
heterologous	O
activation	O
domain	O
,	O
led	O
to	O
Zta	B
-	I
dependent	I
superactivation	O
of	O
CAT	B
expression	O
.	O

Previous	O
genetic	O
studies	O
led	O
to	O
the	O
conclusion	O
that	O
nitrate	O
and	O
nitrite	O
induction	O
of	O
nasF	B
operon	I
expression	O
is	O
determined	O
by	O
a	O
transcriptional	O
antitermination	O
mechanism	O
.	O

The	O
results	O
indicate	O
that	O
anthraquinone	O
sennoside	O
B	O
and	O
rhein	O
are	O
weakly	O
genotoxic	O
.	O

Furthermore	O
,	O
LB1	B
gene	I
mapped	O
to	O
chromosome	O
13q14	O
,	O
a	O
region	O
that	O
has	O
been	O
involved	O
as	O
a	O
chromosomal	O
breakpoint	O
in	O
DLBL	O
.	O

Forskolin	O
significantly	O
enhanced	O
heregulin	B
-	I
stimulated	O
expression	O
of	O
cyclin	B
D	I
and	O
phosphorylation	O
of	O
the	O
retinoblastoma	B
gene	I
product	I
.	O

CM	O
reduced	O
the	O
nuclear	O
binding	O
activity	O
of	O
transcription	O
factor	O
AP	B
-	I
1	I
.	O

Multivariate	O
Cox	O
survival	O
analysis	O
identified	O
baseline	O
EF	O
<	O
or	O
=	O
30	O
%,	O
presence	O
of	O
significant	O
mitral	O
regurgitation	O
(>	O
2	O
+)	O
before	O
ablation	O
,	O
and	O
failure	O
to	O
exhibit	O
improved	O
cardiac	O
performance	O
by	O
1	O
month	O
after	O
ablation	O
as	O
the	O
only	O
independent	O
predictors	O
of	O
death	O
.	O

Cost	O
-	O
effectiveness	O
analysis	O
provides	O
a	O
rational	O
means	O
of	O
allocating	O
limited	O
health	O
care	O
resources	O
by	O
allowing	O
the	O
comparison	O
of	O
the	O
costs	O
of	O
lipid	O
-	O
lowering	O
therapy	O
,	O
in	O
particular	O
,	O
therapy	O
with	O
beta	B
-	I
hydroxy	I
-	I
beta	I
-	I
methylglutaryl	I
-	I
CoA	I
(	I
coenzyme	I
A	I
)	I
reductase	I
inhibitors	O
(	O
statins	O
),	O
with	O
the	O
costs	O
of	O
atherosclerosis	O
that	O
could	O
be	O
prevented	O
by	O
lowering	O
cholesterol	O
.	O

The	O
predicted	O
domain	O
structures	O
of	O
FkbB	B
and	O
FkbC	B
are	O
analogous	O
to	O
that	O
of	O
FkbA	B
and	O
comprise	O
30	O
fatty	B
-	I
acid	I
-	I
synthase	I
(	O
FAS	B
)-	I
like	I
domains	I
arranged	O
in	O
6	O
modules	O
.	O

The	O
cwg2	B
-	I
1	I
mutation	I
was	O
identified	O
as	O
a	O
guanine	O
to	O
adenine	O
substitution	O
at	O
nucleotide	O
604	O
of	O
the	O
coding	O
region	O
,	O
originating	O
the	O
change	O
A202T	O
in	O
the	O
cwg2p	B
.	O

We	O
previously	O
delineated	O
a	O
region	O
in	O
the	O
fatty	B
-	I
acid	I
synthase	I
promoter	I
,	O
which	O
was	O
responsible	O
for	O
obesity	O
-	O
related	O
overexpression	O
of	O
the	O
fatty	B
-	I
acid	I
synthase	I
(	O
FAS	B
)	I
gene	I
,	O
by	O
negatively	O
regulating	O
the	O
activity	O
of	O
the	O
downstream	O
promoter	O
in	O
lean	O
but	O
not	O
obese	O
rat	O
fat	O
cells	O
.	O

Finally	O
,	O
using	O
in	O
vitro	O
binding	O
studies	O
,	O
we	O
showed	O
that	O
SREBP2	B
was	O
able	O
to	O
displace	O
ADD1	B
/	O
SREBP1	B
binding	I
from	O
the	O
sterol	B
regulatory	I
element	I
(	O
SRE	O
)	O
site	O
.	O

Htra2	B
-	I
beta3	I
is	O
developmentally	O
regulated	O
and	O
expressed	O
predominantly	O
in	O
brain	O
,	O
liver	O
testis	O
,	O
and	O
weakly	O
in	O
kidney	O
.	O

The	O
interaction	O
of	O
AF	B
-	I
1	I
with	O
proteins	O
that	O
regulate	O
distinct	O
steps	O
of	O
transcription	O
may	O
provide	O
a	O
mechanism	O
for	O
synergistic	O
activation	O
of	O
gene	O
expression	O
by	O
AF	B
-	I
1	I
.	O

The	O
role	O
of	O
protein	B
kinase	I
C	I
signaling	O
in	O
activated	O
DRA	B
transcription	I
.	O

On	O
Day	O
8	O
,	O
the	O
CIDR	O
-	O
B	O
was	O
removed	O
and	O
500	O
micrograms	O
cloprostenol	O
injected	O
,	O
IM	O
.	O

Based	O
on	O
sequence	O
homology	O
,	O
the	O
genes	O
were	O
identified	O
as	O
TEF	B
,	I
encoding	I
translation	I
elongation	I
factor	I
-	I
1	I
alpha	I
and	O
RPS7	B
,	O
encoding	O
ribosomal	O
protein	O
S7	B
.	O

We	O
propose	O
that	O
two	O
pathways	O
regulate	O
Stat5	B
serine	I
phosphorylation	O
,	O
one	O
that	O
is	O
prolactin	B
-	I
activated	I
and	O
PD98059	O
-	O
resistant	O
and	O
one	O
that	O
is	O
constitutively	O
active	O
and	O
PD98059	O
-	O
sensitive	O
and	O
preferentially	O
targets	O
Stat5a	B
.	O

We	O
have	O
previously	O
mapped	O
the	O
defect	O
in	O
RIIIS	O
/	O
J	O
to	O
distal	O
mouse	O
Chr	O
11	O
,	O
distinct	O
from	O
the	O
Vwf	B
locus	I
on	O
Chr	O
6	O
.	O

These	O
data	O
may	O
also	O
aid	O
in	O
the	O
localization	O
of	O
other	O
disease	O
loci	O
mapped	O
to	O
this	O
region	O
,	O
including	O
the	O
gene	O
for	O
tricho	O
-	O
dento	O
-	O
osseous	O
syndrome	O
and	O
a	O
murine	B
locus	I
for	O
susceptibility	O
to	O
ozone	O
-	O
induced	O
acute	O
lung	O
injury	O
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

Identification	O
of	O
a	O
new	O
gene	O
in	O
the	O
streptococcal	O
plasmid	O
pLS1	O
:	O
the	O
rnaI	B
gene	I
.	O

RESULTS	O
:	O
An	O
herpetic	O
seroconversion	O
is	O
observed	O
with	O
presence	O
of	O
type	O
I	O
herpes	B
simplex	I
virus	I
(	I
HSV	I
I	I
)	O
nucleic	O
acids	O
in	O
the	O
recipient	O
'	O
s	O
aqueous	O
humor	O
.	O

These	O
results	O
indicate	O
that	O
HIV	B
-	I
1	I
Gag	I
sequences	I
can	O
influence	O
the	O
viral	O
PR	B
-	I
mediated	O
processing	O
of	O
the	O
MuLV	O
TM	O
Env	B
protein	I
p15	O
(	O
E	O
).	O

(	O
1992	O
)	O
Biochemistry	O
31	O
,	O
3351	O
-	O
3358	O
].	O

By	O
directly	O
interacting	O
with	O
both	O
Arfs	B
and	I
tyrosine	I
kinases	I
involved	O
in	O
regulating	O
cell	O
growth	O
and	O
cytoskeletal	O
organization	O
,	O
ASAP1	B
could	O
coordinate	O
membrane	O
remodeling	O
events	O
with	O
these	O
processes	O
.	O

In	O
vitro	O
protein	O
retention	O
experiments	O
in	O
which	O
Hsp90	B
heterocomplexes	I
were	O
precipitated	O
resulted	O
in	O
coprecipitation	O
of	O
Cns1	B
.	O

Endogenous	O
RMP	O
was	O
immunologically	O
detected	O
interacting	O
with	O
assembled	O
RPB5	B
in	O
RNA	B
polymerase	I
in	O
mammalian	O
cells	O
.	O

Thus	O
,	O
hypoxia	O
-	O
inducible	O
nuclear	O
import	O
and	O
transactivation	O
by	O
recruitment	O
of	O
CBP	B
can	O
be	O
functionally	O
separated	O
from	O
one	O
another	O
and	O
play	O
critical	O
roles	O
in	O
signal	O
transduction	O
by	O
HIF	B
-	I
1alpha	I
.	O

Quinone	O
-	O
binding	O
domain	O
and	O
amino	O
acid	O
residues	O
involved	O
in	O
quinone	B
binding	I
.	O

These	O
studies	O
support	O
the	O
view	O
that	O
HMG	B
I	I
(	I
Y	I
)	O
is	O
an	O
important	O
cofactor	O
for	O
HLA	B
-	I
DRA	I
gene	I
activation	O
by	O
Oct	B
-	I
2A	I
and	O
provide	O
insights	O
into	O
its	O
mechanism	O
of	O
action	O
.	O

CONCLUSION	O
:	O
We	O
were	O
unable	O
to	O
identify	O
features	O
of	O
disease	O
likely	O
to	O
be	O
associated	O
with	O
a	O
clinically	O
useful	O
response	O
to	O
inhaled	O
NO	O
therapy	O
using	O
the	O
parameters	O
studied	O
.	O

No	O
mutations	O
were	O
found	O
in	O
follicular	O
adenomas	O
.	O

Positive	O
genetic	O
selections	O
for	O
inhibition	O
of	O
cyclin	B
/	O
CDK	B
function	O
were	O
characterized	O
using	O
the	O
E	O
.	O
coli	O
neo	O
and	O
yeast	B
LEU2	I
genes	I
.	O

We	O
evaluated	O
regional	O
right	O
ventricular	O
wall	O
motion	O
during	O
systole	O
in	O
patients	O
with	O
surgically	O
repaired	O
tetralogy	O
of	O
Fallot	O
(	O
TOF	O
)	O
using	O
color	O
kinesis	O
imaging	O
.	O

RT	O
-	O
PCR	O
analysis	O
showed	O
that	O
PLP	B
-	I
H	I
as	O
well	O
as	O
PLP	B
-	I
C	I
and	O
PLP	B
-	I
D	I
are	O
expressed	O
in	O
all	O
rat	O
strains	O
examined	O
,	O
confirming	O
that	O
PLP	B
diversity	O
is	O
not	O
due	O
to	O
strain	O
differences	O
.	O

Interestingly	O
,	O
we	O
find	O
that	O
the	O
interaction	O
between	O
Tat	B
and	O
hCycT1	B
requires	O
zinc	O
as	O
well	O
as	O
essential	O
cysteine	O
residues	O
in	O
both	O
proteins	O
.	O

The	O
exodomain	O
alone	O
has	O
the	O
high	O
affinity	O
hormone	O
binding	O
site	O
but	O
is	O
not	O
capable	O
of	O
generating	O
hormonal	O
signal	O
.	O

The	O
retrovesical	O
hydatid	O
cyst	O
is	O
a	O
very	O
rare	O
site	O
.	O

Initial	O
experience	O
with	O
the	O
new	O
technology	O
indicates	O
that	O
SieScape	O
is	O
an	O
alternative	O
to	O
other	O
methods	O
such	O
as	O
CT	O
and	O
MRI	O
.	O

This	O
model	O
is	O
supported	O
by	O
experiments	O
showing	O
that	O
Cdr2	B
associates	O
with	O
the	O
N	B
-	I
terminal	I
regulatory	I
domain	I
of	O
Wee1	B
in	O
cell	O
lysates	O
and	O
phosphorylates	O
Wee1	B
in	O
vitro	O
.	O

A	O
-	O
tracts	O
functioned	O
best	O
when	O
positioned	O
close	O
to	O
the	O
-	O
35	O
hexamer	O
rather	O
than	O
one	O
helical	O
turn	O
farther	O
upstream	O
,	O
similar	O
to	O
the	O
positioning	O
optimal	O
for	O
UP	O
element	O
function	O
.	O

Collagen	B
was	O
extracted	O
from	O
the	O
skin	O
,	O
and	O
the	O
lack	O
of	O
type	B
III	I
collagen	I
was	O
determined	O
by	O
means	O
of	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
SDS	O
-	O
PAGE	O
).	O

In	O
turn	O
,	O
assembly	O
of	O
this	O
complex	O
mediates	O
the	O
enzymatic	O
activation	O
of	O
the	O
p21	B
-	I
activated	I
protein	I
kinase	I
1	I
and	O
facilitates	O
actin	B
polymerization	O
.	O

Nhp2p	B
is	O
a	O
highly	O
basic	B
protein	I
that	O
belongs	O
to	O
a	O
family	O
of	O
putative	O
RNA	B
-	I
binding	I
proteins	I
.	O

Also	O
,	O
the	O
amplitude	O
of	O
the	O
oscillatory	O
potentials	O
(	O
O1	O
+	O
O2	O
+	O
O3	O
+	O
O4	O
)	O
was	O
significantly	O
reduced	O
in	O
the	O
early	O
postoperative	O
period	O
.	O

Elevated	O
expression	O
of	O
a	O
previously	O
uncharacterized	O
gene	O
,	O
SPP381	B
,	O
efficiently	O
suppresses	O
the	O
growth	O
and	O
splicing	O
defects	O
of	O
a	O
temperature	O
-	O
sensitive	O
(	O
Ts	O
)	O
mutant	B
prp38	I
-	I
1	I
.	O

Another	O
ORF	O
,	O
dda	B
.	O
2	O
located	O
between	O
modA	B
and	O
dda	B
,	O
shares	O
sequence	O
similarity	O
with	O
sigma70	B
,	O
and	O
we	O
call	O
it	O
srd	B
.	O

BIAcore	O
analysis	O
gave	O
a	O
Kaff	O
of	O
4	O
.	O
4	O
x	O
10	O
(	O
10	O
)	O
M	B
-	I
1	I
for	O
the	O
binding	O
of	O
N	B
-	I
A3	I
to	O
T84	O
.	O
1	O
and	O
2	O
.	O
2	O
x	O
10	O
(	O
10	O
)	O
M	B
-	I
1	I
for	O
the	O
binding	O
of	O
N	B
-	I
A3	I
to	O
T84	O
.	O
66	O
.	O

Positive	O
correlations	O
were	O
seen	O
between	O
the	O
measurements	O
for	O
protein	O
intake	O
(	O
r	O
=.	O
58	O
,	O
P	O
=.	O
0026	O
)	O
energy	O
intake	O
(	O
r	O
=.	O
78	O
,	O
P	O
<.	O
00001	O
),	O
with	O
mean	O
differences	O
of	O
.	O
066	O
g	O
/	O
kg	O
/	O
d	O
(	O
SD	O
.	O
38	O
)	O
2	O
.	O
04	O
kcal	O
/	O
kg	O
/	O
day	O
(	O
SD	O
6	O
.	O
67	O
),	O
respectively	O
.	O

The	O
Mig1	B
repressor	I
is	O
a	O
zinc	B
finger	I
protein	I
that	O
mediates	O
glucose	O
repression	O
in	O
yeast	O
.	O

We	O
showed	O
that	O
Stat3	B
and	O
Stat3beta	B
were	O
affinity	O
purified	O
using	O
phosphopeptides	O
containing	O
Y704	O
and	O
Y744	O
but	O
not	O
by	O
nonphosphorylated	O
peptide	O
analogues	O
or	O
by	O
phosphopeptides	O
containing	O
Y729	O
and	O
Y764	O
.	O

This	O
c	B
-	I
Jun	I
activity	O
is	O
inhibited	O
by	O
c	B
-	I
Fos	I
,	O
another	O
protooncoprotein	O
that	O
can	O
dimerize	O
with	O
c	B
-	I
Jun	I
to	O
form	O
the	O
transcription	O
factor	O
AP	B
-	I
1	I
.	O

Dorsal	O
root	O
ganglia	O
neuron	B
-	I
specific	I
promoter	I
activity	O
of	O
the	O
rabbit	B
beta	I
-	I
galactoside	I
alpha1	I
,	I
2	I
-	I
fucosyltransferase	I
gene	I
.	O

This	O
suggests	O
roles	O
for	O
both	O
the	O
CE1	O
and	O
CE2	O
elements	O
in	O
regulating	O
Hoxb1	B
gene	I
expression	O
during	O
development	O
.	O

Further	O
,	O
we	O
show	O
that	O
this	O
EIA	B
-	I
inducible	O
CBF	B
/	I
cdc2	I
is	O
related	O
to	O
the	O
CBF	O
which	O
was	O
shown	O
to	O
activate	O
the	O
heat	B
shock	I
protein	I
70	I
promoter	I
.	O

The	O
percutaneous	O
absorption	O
of	O
clindamycin	O
was	O
studied	O
in	O
healthy	O
male	O
volunteers	O
,	O
comparing	O
two	O
investigative	O
clindamycin	O
(%	O
w	O
/	O
v	O
)/	O
tretinoin	O
(	O
0	O
.	O
025	O
%	O
w	O
/	O
v	O
)	O
gels	O
,	O
containing	O
clindamycin	O
phosphate	O
ester	O
and	O
clindamycin	O
HCl	O
,	O
respectively	O
,	O
relative	O
to	O
a	O
clindamycin	O
phosphate	O
lotion	O
(	O
1	O
%	O
clindamycin	O
;	O
Dalacin	O
T	O
).	O

Phosphorylation	O
analyses	O
indicated	O
that	O
inhibition	O
of	O
ERK	B
-	I
1	I
/	I
2	I
decreased	O
okadaic	O
acid	O
-	O
elevated	O
phosphorylation	O
of	O
JunD	B
and	O
FosB	B
.	O

MPO	B
was	O
labeled	O
with	O
1	O
mCi	O
125I	O
by	O
a	O
technique	O
of	O
self	O
-	O
labeling	O
in	O
the	O
presence	O
of	O
10	O
(-	O
4	O
)	O
M	O
hydrogen	O
peroxide	O
.	O

It	O
is	O
related	O
to	O
a	O
variety	O
of	O
mammalian	O
Golgi	B
-	I
associated	I
proteins	I
and	O
to	O
the	O
yeast	O
Uso1p	B
,	O
an	O
essential	O
protein	O
involved	O
in	O
docking	O
of	O
endoplasmic	O
reticulum	O
-	O
derived	O
vesicles	O
to	O
the	O
cis	O
-	O
Golgi	O
.	O

These	O
data	O
further	O
define	O
a	O
role	O
for	O
TRADD	B
and	O
TRAF2	B
in	O
JNK	B
activation	O
and	O
confirm	O
that	O
LMP1	B
utilizes	O
signalling	O
mechanisms	O
used	O
by	O
the	O
TNF	B
receptor	I
/	O
CD40	B
family	I
to	O
elicit	O
its	O
pleiotropic	O
activities	O
.	O

However	O
,	O
serial	O
passages	O
of	O
fetal	O
lamb	O
kidney	O
(	O
FLK	O
)	O
cells	O
,	O
which	O
are	O
sensitive	O
to	O
infection	O
with	O
BLV	O
,	O
after	O
transient	O
transfection	O
revealed	O
that	O
mutation	O
of	O
a	O
second	O
tyrosine	O
residue	O
in	O
the	O
N	O
-	O
terminal	O
motif	O
completely	O
prevented	O
the	O
propagation	O
of	O
the	O
virus	O
.	O

To	O
this	O
end	O
,	O
we	O
analyzed	O
the	O
phosphorylation	O
status	O
of	O
a	O
universal	O
tyrosine	B
kinase	I
substrate	I
,	O
the	O
transforming	O
Shc	B
adapter	I
protein	I
,	O
in	O
fibroblasts	O
expressing	O
the	O
viral	B
oncogene	I
.	O

In	O
this	O
study	O
,	O
evidence	O
is	O
presented	O
that	O
temporally	O
and	O
spatially	O
specific	O
mef2	B
expression	O
is	O
controlled	O
by	O
a	O
complex	O
array	O
of	O
cis	O
-	O
acting	O
regulatory	O
modules	O
that	O
are	O
responsive	O
to	O
different	O
genetic	O
signals	O
.	O

OBJECTIVE	O
:	O
To	O
evaluate	O
the	O
accuracy	O
of	O
working	O
casts	O
for	O
crown	O
and	O
bridge	O
restorations	O
made	O
from	O
twin	O
mix	O
putty	O
/	O
wash	O
silicone	O
elastomeric	O
impression	O
materials	O
using	O
different	O
types	O
of	O
stock	O
tray	O
.	O

The	O
transcriptional	O
activity	O
of	O
PPARgamma	B
is	O
positively	O
modulated	O
by	O
ligand	O
binding	O
and	O
negatively	O
regulated	O
by	O
phosphorylation	O
mediated	O
by	O
the	O
MEK	B
/	I
ERK	I
signaling	O
pathway	O
.	O

Bioplastique	O
granuloma	O
presents	O
with	O
irregularly	O
shaped	O
cystic	O
spaces	O
of	O
varying	O
size	O
containing	O
jagged	O
,	O
translucent	O
,	O
nonbirefringent	O
foreign	O
bodies	O
whereas	O
Artecoll	O
granuloma	O
shows	O
numerous	O
round	O
vacuoles	O
nearly	O
identical	O
in	O
size	O
and	O
shape	O
enclosing	O
round	O
and	O
sharply	O
circumscribed	O
,	O
translucent	O
,	O
nonbirefringent	O
foreign	O
bodies	O
.	O

Structure	O
-	O
function	O
analysis	O
of	O
the	O
Z	B
-	I
DNA	I
-	I
binding	I
domain	I
Zalpha	O
of	O
dsRNA	B
adenosine	I
deaminase	I
type	I
I	I
reveals	O
similarity	O
to	O
the	O
(	O
alpha	B
+	I
beta	I
)	I
family	I
of	I
helix	I
-	I
turn	I
-	I
helix	I
proteins	I
.	O

Carbohydrates	O
and	O
glycoconjugates	O
biophysical	O
methods	O
.	O

Molecular	O
cloning	O
of	O
mouse	B
glycolate	I
oxidase	I
.	O

We	O
isolated	O
a	O
ribosomal	B
protein	I
L18	I
by	O
interaction	O
with	O
PKR	B
.	O

Processing	O
of	O
the	O
polycistronic	O
precursor	O
requires	O
nucleases	O
also	O
involved	O
in	O
rRNA	O
processing	O
,	O
i	O
.	O
e	O
.,	O
Rnt1p	B
and	O
Rat1p	B
.	O

As	O
expected	O
for	O
a	O
positive	O
SpHE	B
transcriptional	O
regulator	O
,	O
the	O
timing	O
of	O
SpEts4	B
gene	I
expression	O
precedes	O
the	O
transient	O
expression	O
of	O
SpHE	B
in	O
the	O
very	O
early	O
sea	O
urchin	O
blastula	O
.	O

Overexpression	O
of	O
PTTG	B
in	O
transfected	O
NIH	O
3T3	O
cells	O
also	O
stimulated	O
expression	O
and	O
secretion	O
of	O
basic	B
fibroblast	I
growth	I
factor	I
,	O
a	O
human	B
pituitary	I
tumor	I
growth	I
-	I
regulating	I
factor	I
.	O

Additionally	O
,	O
a	O
variety	O
of	O
regulatory	O
schemes	O
contribute	O
temporal	O
and	O
/	O
or	O
spatial	O
restriction	O
to	O
TGF	B
-	I
beta	I
responses	O
.	O

A	O
comparison	O
of	O
the	O
clinical	O
profile	O
of	O
cavernous	O
malformations	O
with	O
and	O
without	O
associated	O
venous	O
malformations	O
.	O

Nuclear	B
factor	I
kappa	I
B	I
(	O
NF	B
-	I
kappaB	I
)	O
is	O
an	O
important	O
transcription	O
factor	O
for	O
the	O
genes	O
of	O
many	O
pro	O
-	O
inflammatory	O
proteins	O
and	O
is	O
strongly	O
activated	O
by	O
the	O
cytokines	O
interleukin	B
-	I
1	I
and	I
tumor	I
necrosis	I
factor	I
(	O
TNF	B
)	I
alpha	I
under	O
various	O
pathological	O
conditions	O
.	O

The	O
promoter	O
of	O
the	O
rat	O
pgp2	B
/	I
mdr1b	I
gene	I
has	O
a	O
GC	O
-	O
rich	O
region	O
(	O
pgp2GC	B
)	O
that	O
is	O
highly	O
conserved	O
in	O
mdr	B
genes	I
and	O
contains	O
an	O
consensus	O
Sp1	B
site	I
.	O

Human	B
MGP	I
is	O
a	O
10	O
-	O
kD	O
skeletal	O
extracellular	B
matrix	I
(	I
ECM	I
)	I
protein	I
that	O
consists	O
of	O
an	O
84	O
-	O
aa	O
mature	O
protein	O
and	O
a	O
19	O
-	O
aa	O
transmembrane	O
signal	O
peptide	O
.	O

The	O
pattern	O
of	O
RNase	B
E	I
digestion	O
of	O
finP305	B
RNA	I
differed	O
from	O
FinP	B
,	O
and	O
GST	B
-	O
FinO	B
did	O
not	O
protect	O
finP305	B
RNA	I
from	O
cleavage	O
in	O
vitro	O
.	O

Transcription	O
readthrough	O
into	O
the	O
inverted	O
repeats	O
has	O
little	O
effect	O
on	O
this	O
event	O
.	O

The	O
high	O
conservation	O
of	O
the	O
3	O
'	O
terminus	O
suggests	O
that	O
this	O
region	O
directs	O
the	O
assembly	O
of	O
proteins	O
required	O
for	O
the	O
initiation	O
of	O
RNA	O
replication	O
.	O

Chem	O
.	O

No	O
significant	O
differences	O
between	O
the	O
substituted	O
and	O
wild	B
type	I
peptides	I
were	O
observed	O
,	O
suggesting	O
that	O
this	O
substitution	O
in	O
the	O
intact	O
protein	O
may	O
cause	O
disruption	O
of	O
global	O
rather	O
than	O
local	O
structures	O
.	O

Taken	O
together	O
,	O
our	O
results	O
demonstrate	O
that	O
CAP1	B
is	O
involved	O
in	O
multidrug	O
resistance	O
and	O
oxidative	O
stress	O
response	O
in	O
C	O
.	O
albicans	O
.	O

Trinipatch	O
is	O
a	O
small	O
,	O
transparent	O
,	O
matricial	O
,	O
monolayer	O
patch	O
with	O
an	O
absorption	O
promoter	O
,	O
marketed	O
in	O
two	O
dose	O
-	O
strengths	O
(	O
5	O
mg	O
/	O
24	O
h	O
and	O
10	O
mg	O
/	O
24	O
h	O
)	O
by	O
Laboratoires	O
Synthelabo	O
.	O

Overexpression	O
of	O
POG1	B
inhibits	O
alpha	B
-	I
factor	I
-	I
induced	O
G1	O
arrest	O
and	O
transcriptional	O
repression	O
of	O
the	O
CLN1	B
and	O
CLN2	B
genes	I
.	O

Neither	O
the	O
p42	B
/	I
44	O
nor	O
the	O
JNK	B
pathway	O
was	O
involved	O
in	O
the	O
action	O
of	O
IL	B
-	I
1beta	I
.	O

Expression	O
of	O
the	O
second	O
gene	O
(	O
XT3	B
)	O
was	O
found	O
to	O
be	O
conserved	O
in	O
human	O
kidney	O
,	O
and	O
partial	O
sequence	O
was	O
obtained	O
from	O
a	O
human	O
cDNA	O
library	O
.	O

II	O
.	O

Model	O
of	O
spatiotemporal	O
dynamics	O
of	O
stick	O
-	O
slip	O
motion	O
.	O

Anisotropic	O
heat	O
transport	O
in	O
the	O
octylcyanobiphenyl	O
(	O
8CB	O
)	O
liquid	O
crystal	O
.	O

Here	O
we	O
describe	O
the	O
identification	O
and	O
characterization	O
of	O
several	O
Sp100	B
splice	I
variant	I
proteins	I
and	O
support	O
their	O
existence	O
by	O
elucidation	O
of	O
the	O
3	O
'-	O
end	O
of	O
the	O
Sp100	B
gene	I
.	O

Its	O
early	O
lesions	O
were	O
characterized	O
by	O
angiomatosis	O
,	O
vasculopathy	O
,	O
and	O
proliferation	O
of	O
synoviocytes	O
and	O
fibroblasts	O
.	O

TPO	B
by	O
itself	O
did	O
not	O
activate	O
ERK1	B
,	O
ERK2	B
and	I
protein	I
kinase	I
C	I
(	I
PKC	I
),	O
whereas	O
TPO	B
directly	O
enhanced	O
the	O
PKC	B
-	I
dependent	I
activation	O
of	O
ERKs	B
induced	O
by	O
other	O
agonists	O
including	O
thrombin	B
and	O
phorbol	O
esters	O
,	O
without	O
affecting	O
the	O
PKC	B
activation	O
by	O
those	O
agonists	O
.	O

19F	O
NMR	O
studies	O
in	O
ABF4	O
-	O
type	O
layered	O
antiferromagnets	O
.	O

Quantum	O
-	O
statistical	O
theory	O
of	O
high	O
-	O
field	O
transport	O
phenomena	O
.	O

Chirality	O
-	O
glass	O
and	O
spin	O
-	O
glass	O
correlations	O
in	O
the	O
two	O
-	O
dimensional	O
random	O
-	O
bond	O
XY	O
model	O
.	O

Far	O
-	O
infrared	O
hopping	O
conductivity	O
in	O
the	O
CuO	O
chains	O
of	O
a	O
single	O
-	O
domain	O
YBa2Cu3O7	O
-	O
delta	O
crystal	O
.	O

Precision	O
measurement	O
of	O
the	O
pion	O
mass	O
difference	O
m	O
pi	O
--	O
m	O
pi	O
0	O
.	O

Genetic	O
experiments	O
using	O
mutants	O
defective	O
in	O
apontic	B
and	O
bruno	B
reveal	O
a	O
functional	O
interaction	O
between	O
these	O
genes	O
.	O

In	O
the	O
current	O
model	O
,	O
Wingless	B
/	O
Wnt	B
signal	I
stabilizes	O
Armadillo	B
/	I
beta	I
-	I
catenin	I
,	O
which	O
then	O
accumulates	O
in	O
nuclei	O
and	O
binds	O
TCF	B
/	O
LEF	B
family	I
proteins	I
,	O
forming	O
bipartite	O
transcription	O
factors	O
which	O
activate	O
transcription	O
of	O
Wingless	B
/	O
Wnt	B
responsive	I
genes	I
.	O

In	O
support	O
of	O
clinical	O
antianginal	O
studies	O
,	O
the	O
vasodilator	O
nicorandil	O
(	O
NIC	O
)	O
was	O
combined	O
with	O
the	O
beta	B
-	I
adrenergic	I
receptor	I
antagonists	O
propranolol	O
(	O
PRO	O
)	O
and	O
atenolol	O
(	O
ATN	O
)	O
and	O
with	O
the	O
calcium	O
channel	O
blocker	O
diltiazem	O
(	O
DTZ	O
)	O
to	O
determine	O
their	O
cardiovascular	O
and	O
pharmacokinetic	O
interactions	O
.	O

Factors	O
influencing	O
direct	O
-	O
immersion	O
(	O
DI	O
)-	O
SPME	O
process	O
were	O
also	O
checked	O
and	O
chosen	O
experimentally	O
.	O

Elimination	O
of	O
ETH1	B
in	O
apn1	B
strains	O
also	O
increased	O
spontaneous	O
mutation	O
rates	O
9	O
-	O
or	O
31	O
-	O
fold	O
compared	O
to	O
the	O
wild	O
type	O
as	O
determined	O
by	O
reversion	O
to	O
adenine	O
or	O
lysine	O
prototrophy	O
,	O
respectively	O
.	O

Mammalian	B
Ras	I
GTPase	I
-	I
activating	I
protein	I
(	I
GAP	I
),	O
p120	B
Ras	I
-	I
GAP	I
,	O
has	O
been	O
implicated	O
as	O
both	O
a	O
downregulator	O
and	O
effector	O
of	O
Ras	B
proteins	I
,	O
but	O
its	O
precise	O
role	O
in	O
Ras	B
-	I
mediated	O
signal	O
transduction	O
pathways	O
is	O
unclear	O
.	O

Systematic	O
functional	O
analysis	O
of	O
V1a	B
/	I
V2	I
hybrid	I
receptors	I
showed	O
that	O
the	O
second	O
intracellular	O
loop	O
of	O
the	O
V1a	B
receptor	I
is	O
required	O
and	O
sufficient	O
for	O
efficient	O
coupling	O
to	O
Gq	B
/	I
11	O
,	O
whereas	O
the	O
third	O
intracellular	O
loop	O
of	O
the	O
V2	B
receptor	I
is	O
required	O
and	O
sufficient	O
for	O
coupling	O
to	O
Gs	B
.	O

Northern	O
blot	O
and	O
in	O
situ	O
hybridization	O
analyses	O
revealed	O
GPR34	B
mRNA	I
transcripts	I
in	O
several	O
human	O
and	O
rat	O
brain	O
regions	O
.	O

The	O
microphthalmia	B
-	I
TFE	I
(	O
MiT	B
)	I
subfamily	I
of	O
basic	B
helix	I
-	I
loop	I
-	I
helix	I
leucine	I
zipper	I
(	I
bHLH	I
-	I
ZIP	I
)	I
transcription	I
factors	I
,	O
including	O
TFE3	B
,	O
TFEB	B
,	O
TFEC	B
,	O
and	O
Mitf	B
,	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
tissue	B
-	I
specific	I
gene	I
expression	O
in	O
several	O
cell	O
lineages	O
.	O

Early	O
-	O
onset	O
scleral	O
necrosis	O
after	O
iodine	O
I	O
125	O
plaque	O
radiotherapy	O
for	O
ciliochoroidal	O
melanoma	O
.	O

Current	O
world	O
literature	O
.	O

These	O
results	O
show	O
that	O
Ski	B
is	O
a	O
component	O
of	O
the	O
HDAC	B
complex	I
and	O
that	O
Ski	B
is	O
required	O
for	O
the	O
transcriptional	O
repression	O
mediated	O
by	O
this	O
complex	O
.	O

Analysis	O
of	O
the	O
consensus	O
binding	O
sequence	O
and	O
the	O
DNA	B
-	I
binding	I
domain	I
of	O
ZF5	B
.	O

Therefore	O
,	O
high	O
set	O
-	O
up	O
accuracy	O
and	O
reproducibility	O
are	O
mandatory	O
.	O

Acoustic	O
transmission	O
spectra	O
in	O
the	O
Penrose	O
lattice	O
.	O

On	O
the	O
other	O
hand	O
,	O
subjects	O
with	O
air	O
trapping	O
(	O
residual	O
volume	O
(	O
RV	O
)/	O
total	O
lung	O
capacity	O
(	O
TLC	O
)	O
>	O
37	O
%)	O
disclosed	O
not	O
only	O
a	O
higher	O
n	O
(	O
mit	O
)	O
(	O
0	O
.	O
63	O
+/-	O
0	O
.	O
17	O
versus	O
0	O
.	O
43	O
+/-	O
0	O
.	O
07	O
mt	O
x	O
microm	O
(-	O
2	O
),	O
p	O
<	O
0	O
.	O
05	O
)	O
but	O
shorter	O
sarcomeres	O
(	O
L	O
(	O
sar	O
))	O
than	O
subjects	O
without	O
this	O
functional	O
abnormality	O
(	O
2	O
.	O
08	O
+/-	O
0	O
.	O
16	O
to	O
2	O
.	O
27	O
+/-	O
0	O
.	O
15	O
microm	O
,	O
p	O
<	O
0	O
.	O
05	O
).	O

In	O
order	O
to	O
better	O
characterize	O
the	O
distribution	O
of	O
ML	O
and	O
MAP	B
estimates	O
under	O
these	O
conditions	O
,	O
we	O
derive	O
a	O
point	O
approximation	O
to	O
density	O
values	O
of	O
the	O
conditional	O
distribution	O
of	O
such	O
estimates	O
.	O

RT	O
-	O
PCR	O
was	O
performed	O
using	O
previously	O
reported	O
degenerate	O
oligonucleotide	O
primers	O
to	O
the	O
ligand	O
binding	O
domain	O
(	O
LBD	O
)	O
of	O
known	O
beta	B
integrin	I
subunits	I
and	O
Bge	B
cDNA	I
.	O

The	O
lowest	O
culture	O
failure	O
rate	O
of	O
0	O
.	O
2	O
per	O
cent	O
was	O
found	O
after	O
EAF	O
compared	O
with	O
0	O
.	O
9	O
per	O
cent	O
among	O
CVS	O
.	O

On	O
the	O
other	O
side	O
,	O
when	O
the	O
aortic	O
ring	O
was	O
perfused	O
with	O
L	O
-	O
NNA	O
(	O
NO	O
-	O
synthesis	O
inhibitor	O
)	O
or	O
methylene	O
blue	O
(	O
soluble	O
cGMPase	B
inhibitor	I
),	O
the	O
changes	O
could	O
be	O
attenuated	O
.	O

Nevertheless	O
,	O
inactivation	O
of	O
the	O
cyclin	B
E	I
-	I
Cdk2	I
complex	I
in	O
response	O
to	O
mitogen	B
starvation	O
occurs	O
normally	O
in	O
MEFs	O
that	O
have	O
a	O
homozygous	O
deletion	O
of	O
the	O
p27	B
gene	I
.	O

These	O
data	O
provide	O
the	O
molecular	O
tools	O
for	O
the	O
final	O
identification	O
of	O
the	O
MKS	B
and	O
the	O
MUL	B
genes	I
.	O

Comparison	O
of	O
frequencies	O
of	O
atrial	O
fibrillation	O
after	O
coronary	O
artery	O
bypass	O
grafting	O
with	O
and	O
without	O
the	O
use	O
of	O
cardiopulmonary	O
bypass	O
.	O

The	O
results	O
showed	O
that	O
IFN	B
-	I
gamma	I
stimulated	O
the	O
rapid	O
accumulation	O
of	O
interferon	B
regulated	I
factor	I
(	I
IRF	I
)-	I
1	I
mRNA	I
,	O
followed	O
by	O
a	O
delayed	O
and	O
dose	O
-	O
dependent	O
inhibition	O
of	O
alpha1	B
(	I
I	I
)	I
procollagen	I
mRNA	I
expression	O
in	O
skin	O
fibroblasts	O
from	O
several	O
different	O
donors	O
.	O

However	O
,	O
with	O
the	O
alpha1	O
antagonist	O
prazosin	O
(	O
5	O
x	O
10	O
(-	O
8	O
)-	O
5	O
x	O
10	O
(-	O
7	O
)	O
M	O
),	O
no	O
relaxation	O
occurred	O
.	O

The	O
algorithm	O
also	O
limited	O
TG	O
to	O
20	O
and	O
64	O
%,	O
apoB	B
to	O
6	O
and	O
20	O
%,	O
and	O
Lp	B
(	O
a	O
)	O
to	O
15	O
and	O
56	O
%,	O
of	O
low	O
-	O
and	O
high	O
-	O
risk	O
groups	O
,	O
respectively	O
.	O

Schwab	O
and	O
England	O
ADL	O
scores	O
in	O
the	O
"	O
off	O
"	O
state	O
were	O
improved	O
by	O
18	O
%	O
and	O
in	O
the	O
"	O
on	O
"	O
state	O
the	O
scores	O
declined	O
by	O
2	O
%.	O

Recent	O
work	O
in	O
this	O
laboratory	O
has	O
shown	O
that	O
the	O
gene	O
coding	O
for	O
acetate	B
kinase	I
(	O
ackA	B
)	O
in	O
Sinorhizobium	O
meliloti	O
is	O
up	O
-	O
regulated	O
in	O
response	O
to	O
phosphate	O
limitation	O
.	O

Dopaminergic	O
modulation	O
of	O
transcallosal	O
activity	O
of	O
cat	O
motor	O
cortical	O
neurons	O
.	O

In	O
contrast	O
,	O
no	O
change	O
was	O
detected	O
in	O
the	O
phenotype	O
of	O
'	O
unstressed	O
'	O
clones	O
,	O
with	O
respect	O
to	O
any	O
of	O
the	O
following	O
parameters	O
:	O
proliferation	O
rate	O
in	O
monolayer	O
,	O
serum	O
-	O
dependence	O
for	O
proliferation	O
or	O
survival	O
,	O
tumorigenicity	O
,	O
cellular	O
morphology	O
,	O
or	O
tissue	O
-	O
specific	O
differentiation	O
markers	O
.	O

In	O
all	O
trials	O
,	O
antigen	O
challenge	O
followed	O
1	O
h	O
after	O
the	O
last	O
treatment	O
.	O

Here	O
we	O
describe	O
the	O
optimization	O
and	O
characterization	O
of	O
a	O
140	O
-	O
residue	O
fragment	O
,	O
containing	O
the	O
Runt	B
domain	I
of	O
AML1	B
,	O
which	O
is	O
suitable	O
for	O
structural	O
studies	O
.	O

Ultrasonography	O
provides	O
excellent	O
intraoperative	O
evaluation	O
of	O
spinal	O
cord	O
injury	O
.	O

This	O
is	O
in	O
contrast	O
to	O
PPARgamma2	B
,	O
which	O
was	O
previously	O
shown	O
to	O
be	O
phosphorylated	O
at	O
a	O
single	O
site	O
in	O
a	O
motif	O
that	O
is	O
not	O
homologous	O
to	O
the	O
sites	O
now	O
described	O
in	O
PPARalpha	B
.	O

These	O
results	O
suggest	O
KCC3	B
is	O
a	O
new	O
member	O
of	O
the	O
KCC	B
family	I
that	O
is	O
under	O
distinct	O
regulation	O
from	O
KCC1	B
.	O

A	O
list	O
of	O
12	O
names	O
for	O
the	O
disease	O
and	O
37	O
diagnostic	O
criteria	O
were	O
proposed	O
to	O
a	O
Consensus	O
Panel	O
of	O
12	O
Italian	O
experts	O
who	O
ranked	O
them	O
in	O
order	O
so	O
as	O
to	O
identify	O
a	O
core	O
set	O
of	O
criteria	O
.	O

However	O
,	O
F	B
-	I
SRC	I
-	I
1	I
mutant	I
lacking	O
CBP	B
-	I
interacting	I
domain	I
still	O
preserved	O
enhancing	O
activity	O
.	O

The	O
catalytic	O
site	O
has	O
an	O
S1	B
pocket	O
lined	O
with	O
conserved	O
hydrophobic	O
residues	O
to	O
accommodate	O
the	O
pyroglutamyl	O
residue	O
.	O

Three	O
different	O
site	O
-	O
directed	O
mutations	O
of	O
the	O
cyclic	B
AMP	I
response	I
element	I
each	O
reduced	O
the	O
nerve	B
growth	I
factor	I
effect	O
by	O
>	O
90	O
%.	O

In	O
ischemic	O
and	O
hypoxic	O
hypoxia	O
,	O
a	O
strong	O
correlation	O
was	O
found	O
between	O
cyt	O
a	O
,	O
a3	O
oxidation	O
level	O
and	O
VO2	O
in	O
both	O
ischemic	O
and	O
hypoxic	O
hypoxia	O
(	O
r2	O
=.	O
90	O
and	O
.	O
87	O
,	O
respectively	O
).	O

Plasma	O
glucose	O
,	O
immunoreactive	O
insulin	B
(	O
IRI	B
),	O
C	B
-	I
peptide	I
,	O
glucagon	B
,	O
and	O
GLP	B
-	I
1	I
levels	O
at	O
each	O
time	O
point	O
during	O
OGTT	O
were	O
measured	O
.	O

Technetium	O
-	O
99m	O
methylene	O
diphosphonate	O
scintimammography	O
for	O
evaluation	O
of	O
palpable	O
breast	O
masses	O
.	O

Bacteria	O
can	O
also	O
cause	O
a	O
labyrinthitis	O
acting	O
directly	O
on	O
the	O
inner	O
ear	O
:	O
among	O
these	O
,	O
Treponemas	O
Pallidum	O
,	O
a	O
spirochaete	O
which	O
causes	O
syphilis	O
and	O
Borrelia	O
Burgdorferi	O
,	O
a	O
spirochaete	O
that	O
causes	O
Lyme	O
Disease	O
,	O
must	O
be	O
mentioned	O
.	O

MEF	B
and	O
AML1B	B
synergistically	O
transactivated	O
an	O
interleukin	B
3	I
promoter	I
reporter	I
gene	I
construct	I
,	O
yet	O
the	O
activating	O
activity	O
of	O
MEF	B
was	O
abolished	O
when	O
MEF	B
was	O
coexpressed	O
with	O
AML1	B
/	I
ETO	O
.	O

Mechanistically	O
,	O
the	O
presence	O
of	O
the	O
GRR	O
appears	O
to	O
stop	O
further	O
degradation	O
of	O
p50	B
and	O
to	O
stabilize	O
the	O
molecule	O
.	O

The	O
Fyn	B
NH2	I
terminus	O
was	O
necessary	O
but	O
not	O
sufficient	O
for	O
interaction	O
with	O
zeta	B
and	O
both	O
Fyn	B
kinase	I
and	I
SH2	I
domains	I
were	O
required	O
,	O
directing	O
phosphorylation	O
of	O
zeta	B
ITAM	I
tyrosines	O
and	O
binding	O
to	O
zeta	B
ITAM	I
phosphotyrosines	O
.	O

We	O
show	O
here	O
that	O
,	O
despite	O
their	O
structural	O
and	O
functional	O
similarities	O
,	O
the	O
pop1	B
and	O
pop2	B
genes	I
fail	O
to	O
complement	O
each	O
other	O
'	O
s	O
deletion	O
phenotypes	O
,	O
indicating	O
that	O
they	O
perform	O
non	O
-	O
redundant	O
,	O
but	O
potentially	O
interdependent	O
,	O
functions	O
in	O
proteolysis	O
.	O

Antithrombin	B
III	I
prevents	O
60	O
min	O
warm	O
intestinal	O
ischemia	O
reperfusion	O
injury	O
in	O
rats	O
.	O

In	O
retrospect	O
,	O
the	O
diagnoses	O
were	O
reconsidered	O
applying	O
strict	O
criteria	O
.	O

Stress	B
-	I
inducible	I
protein	I
kinases	I
capable	O
of	O
activating	O
c	B
-	I
jun	I
expression	O
include	O
stress	B
-	I
activated	I
protein	I
kinase	I
/	I
c	I
-	I
Jun	I
N	I
-	I
terminal	I
protein	I
kinase	I
(	O
SAPK	B
/	O
JNK	B
)	O
and	O
p38	B
members	O
of	O
the	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	I
MAPK	I
)	I
superfamily	I
of	O
signaling	O
molecules	O
.	O

Uroflowmetry	O
can	O
detect	O
dysuria	O
,	O
which	O
may	O
be	O
poorly	O
perceived	O
or	O
even	O
unknown	O
to	O
the	O
subjects	O
themselves	O
.	O

Marked	O
racial	O
variation	O
in	O
birthweight	O
percentiles	O
by	O
gestational	O
age	O
was	O
evident	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
determine	O
and	O
rank	O
the	O
frequency	O
of	O
self	O
reported	O
visual	O
disability	O
in	O
daily	O
tasks	O
performed	O
by	O
glaucoma	O
patients	O
;	O
to	O
examine	O
the	O
interrelation	O
between	O
disabilities	O
using	O
factor	O
analysis	O
;	O
to	O
study	O
the	O
relation	O
between	O
perceived	O
visual	O
difficulty	O
and	O
a	O
measure	O
of	O
the	O
severity	O
of	O
visual	O
field	O
loss	O
;	O
to	O
develop	O
a	O
glaucoma	O
specific	O
subgroup	O
of	O
questions	O
;	O
and	O
examine	O
the	O
validity	O
and	O
reliability	O
of	O
this	O
subgroup	O
of	O
questions	O
.	O

RESULTS	O
AND	O
CONCLUSIONS	O
:	O
Brandt	O
'	O
s	O
double	O
cuff	O
-	O
tubes	O
(	O
G2	O
)	O
succeed	O
in	O
avoiding	O
uncontrolled	O
increase	O
of	O
cuff	O
-	O
pressure	O
during	O
anaesthesia	O
with	O
N2O	O
.	O

Constrictive	O
pericarditis	O
and	O
pleuropulmonary	O
disease	O
linked	O
to	O
ergot	O
dopamine	O
agonist	O
therapy	O
(	O
cabergoline	O
)	O
for	O
Parkinson	O
'	O
s	O
disease	O
.	O

An	O
undilated	O
type	O
of	O
APBD	O
is	O
frequently	O
associated	O
with	O
AMT	O
and	O
we	O
believe	O
,	O
therefore	O
,	O
that	O
clinicians	O
should	O
be	O
aware	O
of	O
a	O
possible	O
coexistence	O
of	O
APBD	O
and	O
AMT	O
.	O

In	O
epithelial	O
cells	O
,	O
the	O
PH	B
domain	I
of	O
Akt	B
/	O
PKB	B
localised	O
to	O
sites	O
of	O
cell	O
-	O
cell	O
and	O
cell	O
-	O
matrix	O
contact	O
,	O
distinct	O
from	O
focal	O
contacts	O
,	O
even	O
in	O
the	O
absence	O
of	O
serum	O
.	O

The	O
5	O
'	O
untranslated	O
and	O
coding	O
regions	O
are	O
contained	O
within	O
12	O
exons	O
,	O
with	O
the	O
translation	O
start	O
site	O
located	O
within	O
the	O
first	O
exon	O
.	O

We	O
analyzed	O
the	O
modular	O
organization	O
of	O
DNA	B
polymerase	I
beta	I
and	O
found	O
that	O
residues	O
making	O
contact	O
with	O
DNA	O
phosphates	O
were	O
localized	O
to	O
five	O
modules	O
.	O

Regulatory	O
motifs	O
for	O
gene	O
expression	O
such	O
as	O
nuclear	B
-	I
factor	I
-	I
kappaB	I
-	I
binding	I
-	I
site	I
-	I
like	I
sequence	I
(	I
kappaB	I
site	I
)	I
and	I
nuclear	I
-	I
factor	I
-	I
interleukin	I
-	I
6	I
-	I
binding	I
-	I
site	I
-	I
like	I
sequence	I
(	O
NF	B
-	I
IL	I
-	I
6	I
site	I
)	O
were	O
found	O
in	O
the	O
5	O
'-	O
upstream	O
regulatory	O
region	O
.	O

The	O
gene	O
structure	O
of	O
Elk1	B
spans	O
15	O
.	O
2	O
kb	O
and	O
consists	O
of	O
seven	O
exons	O
and	O
six	O
introns	O
.	O

Prostate	B
-	I
specific	I
antigen	I
(	I
PSA	I
)	I
promoter	I
-	I
driven	O
androgen	O
-	O
inducible	O
expression	O
of	O
sodium	B
iodide	I
symporter	I
in	O
prostate	O
cancer	O
cell	O
lines	O
.	O

Ras2p	B
activates	O
invasive	O
growth	O
using	O
either	O
of	O
two	O
downstream	O
signaling	O
pathways	O
,	O
the	O
filamentation	O
MAPK	B
(	O
Cdc42p	B
/	I
Ste20p	I
/	I
MAPK	I
)	O
cascade	O
or	O
the	O
cAMP	B
-	I
dependent	I
protein	I
kinase	I
(	O
Cyr1p	B
/	I
cAMP	O
/	O
PKA	B
)	O
pathway	O
.	O

Consistent	O
with	O
this	O
prediction	O
,	O
transfections	O
into	O
the	O
hematopoietic	O
cell	O
line	O
Jurkat	O
showed	O
a	O
9	O
.	O
0	O
-	O
and	O
2	O
.	O
5	O
-	O
fold	O
activation	O
of	O
the	O
mim	B
-	I
1	I
promoter	I
by	O
the	O
p32	O
and	O
p30	B
isoforms	I
,	O
respectively	O
.	O

Medicare	O
SNF	O
benefits	O
revised	O
--	O
again	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
investigated	O
the	O
functional	O
role	O
of	O
the	O
other	O
MAP	B
kinases	I
in	O
PDGF	B
-	I
mediated	O
cellular	O
responses	O
.	O

Interferon	B
-	I
alpha	I
may	O
exacerbate	O
cryoblobulinemia	O
-	O
related	O
ischemic	O
manifestations	O
:	O
an	O
adverse	O
effect	O
potentially	O
related	O
to	O
its	O
anti	B
-	I
angiogenic	O
activity	O
.	O

The	O
enhanced	O
binding	O
of	O
c	B
-	I
Abl	I
to	O
DNA	O
containing	O
5	O
-	O
methylcytosine	O
residues	O
may	O
result	O
from	O
an	O
increased	O
propensity	O
of	O
the	O
double	O
helix	O
to	O
denature	O
locally	O
coupled	O
with	O
a	O
protein	O
-	O
induced	O
reduction	O
in	O
the	O
base	O
stacking	O
interaction	O
.	O

Homozygous	O
mutation	O
in	O
two	O
children	O
led	O
to	O
amputation	O
of	O
legs	O
due	O
to	O
purpura	O
fulminans	O
.	O

All	O
of	O
the	O
elements	O
exhibited	O
a	O
uniform	O
structure	O
.	O

In	O
contrast	O
,	O
the	O
deduced	O
amino	O
acid	O
sequence	O
of	O
a	O
second	O
family	O
(	O
ART5	B
)	O
of	O
transferases	O
,	O
cloned	O
from	O
murine	O
lymphoma	O
cells	O
and	O
expressed	O
in	O
high	O
abundance	O
in	O
testis	O
,	O
displays	O
a	O
hydrophobic	O
amino	O
terminus	O
,	O
consistent	O
with	O
a	O
signal	O
sequence	O
,	O
but	O
lacks	O
a	O
hydrophobic	O
signal	O
sequence	O
at	O
its	O
carboxyl	O
terminus	O
,	O
suggesting	O
that	O
the	O
protein	O
is	O
destined	O
for	O
export	O
.	O

The	O
hTERT	B
gene	I
encompasses	O
more	O
than	O
37kb	O
and	O
consists	O
of	O
16	O
exons	O
.	O

This	O
repression	O
was	O
reversed	O
agonists	O
of	O
either	O
receptor	O
demonstrating	O
a	O
functional	O
interaction	O
between	O
NCoR	B
and	O
PPARalpha	B
.	O
RXRalpha	B
heterodimeric	O
complexes	O
in	O
mammalian	O
cells	O
.	O

Serine	O
phosphorylation	O
of	O
STAT3	B
was	O
only	O
apparent	O
after	O
somatostatin	B
treatment	O
and	O
was	O
abolished	O
by	O
pertussis	B
toxin	I
or	O
PD	O
98059	O
,	O
together	O
with	O
the	O
associated	O
increases	O
in	O
proliferation	O
.	O

The	O
influence	O
of	O
Epstein	B
-	I
Barr	I
virus	I
seropositivity	O
on	O
the	O
efficacy	O
of	O
intravenous	O
immune	B
globulin	I
in	O
children	O
with	O
immune	O
thrombocytopenic	O
purpura	O
.	O

Latexin	B
,	O
a	O
carboxypeptidase	B
A	I
inhibitor	I
,	O
is	O
expressed	O
in	O
a	O
cell	O
type	O
-	O
specific	O
manner	O
in	O
both	O
central	O
and	O
peripheral	O
nervous	O
systems	O
in	O
the	O
rat	O
.	O

Regression	O
analyses	O
identified	O
7	O
risk	O
and	O
7	O
protective	O
factors	O
with	O
minimal	O
overlap	O
.	O

In	O
addition	O
,	O
these	O
cells	O
contained	O
one	O
,	O
two	O
,	O
or	O
multiple	O
nuclei	O
indicative	O
of	O
a	O
G2	O
/	O
M	O
delay	O
in	O
nuclear	O
division	O
and	O
also	O
a	O
defect	O
in	O
cytokinesis	O
and	O
/	O
or	O
cell	O
separation	O
.	O

Nevertheless	O
,	O
they	O
are	O
functionally	O
distinct	O
in	O
that	O
FcalphaRI	B
binds	O
human	B
IgA	I
(	O
hIgA	B
)	O
but	O
not	O
bovine	B
IgG2	I
(	O
bIgG2	B
),	O
whereas	O
bFcgamma2R	B
binds	O
bIgG2	B
but	O
not	O
hIgA	B
.	O

The	O
yeast	B
LPD1	I
gene	I
encoding	O
lipoamide	B
dehydrogenase	I
is	O
subject	O
to	O
the	O
general	O
control	O
of	O
amino	O
acid	O
biosynthesis	O
mediated	O
by	O
the	O
GCN4	B
transcription	I
factor	I
.	O

However	O
,	O
the	O
serum	O
TNF	B
-	I
a	O
concentration	O
decreased	O
significantly	O
in	O
patients	O
receiving	O
pentoxifylline	O
(	O
basal	O
623	O
+/-	O
366	O
pg	O
/	O
ml	O
;	O
6th	O
month	O
562	O
+/-	O
358	O
pg	O
/	O
ml	O
,	O
p	O
<	O
0	O
.	O
01	O
),	O
but	O
not	O
in	O
the	O
control	O
group	O
.	O

To	O
address	O
these	O
questions	O
,	O
a	O
recombinant	O
FRAP	B
/	O
mTOR	B
protein	I
and	O
a	O
FRAP	B
/	O
mTOR	B
immunoprecipitate	O
were	O
utilized	O
in	O
in	O
vitro	O
kinase	O
assays	O
to	O
phosphorylate	O
4E	B
-	I
BP1	I
.	O

Hrs	B
has	O
a	O
FYVE	O
double	O
zinc	B
finger	I
domain	I
,	O
which	O
specifically	O
binds	O
phosphatidylinositol	B
(	I
3	I
)-	I
phosphate	I
and	O
is	O
conserved	O
in	O
several	O
proteins	O
involved	O
in	O
vesicular	O
traffic	O
.	O

The	O
coexpression	O
of	O
full	O
-	O
length	O
expression	O
constructs	O
for	O
both	O
DBP	O
and	O
hepatic	B
leukemia	I
factor	I
resulted	O
in	O
a	O
dramatic	O
increase	O
in	O
activation	O
mediated	O
by	O
the	O
GAL4	B
-	O
DBP	B
fusion	I
proteins	I
,	O
suggesting	O
the	O
involvement	O
of	O
a	O
regulated	O
coactivator	O
in	O
this	O
process	O
.	O

Campomelic	O
dysplasia	O
translocation	O
breakpoints	O
are	O
scattered	O
over	O
1	O
Mb	O
proximal	O
to	O
SOX9	B
:	O
evidence	O
for	O
an	O
extended	O
control	O
region	O
.	O

cDNA	O
and	O
structural	O
organization	O
of	O
the	O
gene	B
Pole1	I
for	O
the	O
mouse	B
DNA	I
polymerase	I
epsilon	I
catalytic	I
subunit	I
.	O

The	O
FCMS	O
conditions	O
were	O
as	O
follows	O
:	O
2	O
kW	O
maximum	O
electrical	O
power	O
consumption	O
,	O
800	O
V	O
maximum	O
capacitor	O
voltage	O
,	O
720	O
microseconds	O
pulsewidth	O
(	O
180	O
microseconds	O
rise	O
time	O
),	O
and	O
5	O
-	O
30	O
Hz	O
frequency	O
.	O

The	O
major	O
transcription	O
factors	O
controlling	O
arginine	O
metabolism	O
in	O
Escherichia	B
coli	I
and	I
Bacillus	I
subtilis	I
,	O
ArgR	B
and	O
AhrC	B
,	O
respectively	O
,	O
are	O
homologous	O
multimeric	O
proteins	O
that	O
form	O
l	O
-	O
arginine	B
-	I
dependent	I
DNA	I
-	I
binding	I
complexes	I
capable	O
of	O
repressing	O
transcription	O
of	O
the	O
biosynthetic	O
genes	O
(	O
both	O
),	O
activating	O
transcription	O
of	O
catabolic	O
genes	O
(	O
AhrC	B
only	O
)	O
or	O
facilitating	O
plasmid	O
dimer	O
resolution	O
(	O
both	O
).	O

Three	O
new	O
aromatase	B
inhibitors	O
have	O
recently	O
completed	O
phase	O
III	O
evaluation	O
as	O
treatment	O
of	O
metastatic	O
breast	O
cancer	O
in	O
post	O
-	O
menopausal	O
women	O
whose	O
disease	O
has	O
progressed	O
despite	O
tamoxifen	O
therapy	O
:	O
anastrozole	O
(	O
ARIMIDEX	O
,	O
Zeneca	O
),	O
letrozole	O
(	O
FEMARA	O
,	O
Novartis	O
)	O
and	O
vorozole	O
(	O
RIVIZOR	O
,	O
Janssen	O
).	O

Of	O
those	O
injuries	O
,	O
143	O
cases	O
were	O
snowboard	O
related	O
and	O
158	O
cases	O
were	O
ski	O
related	O
.	O

Both	O
filters	O
equally	O
contributed	O
to	O
elevation	O
of	O
iliac	O
venous	O
pressure	O
(	O
median	O
,	O
9	O
.	O
3	O
and	O
7	O
.	O
2	O
mm	O
Hg	O
[	O
n	O
=	O
9	O
]	O
with	O
the	O
spring	O
filter	O
and	O
RF02	O
filter	O
,	O
respectively	O
).	O

OBJECTIVE	O
:	O
To	O
perform	O
a	O
cost	O
-	O
effectiveness	O
analysis	O
(	O
CEA	B
)	O
between	O
a	O
standard	O
antiemetic	O
regimen	O
-	O
chlorpromazine	O
+	O
dexamethasone	O
(	O
CPM	O
-	O
DEX	O
)-	O
and	O
a	O
5	B
-	I
HT3	I
receptor	I
antagonist	O
-	O
tropisetron	O
(	O
TROP	O
)--	O
in	O
the	O
control	O
of	O
acute	O
emesis	O
induced	O
by	O
highly	O
emetogenic	O
chemotherapy	O
in	O
children	O
,	O
considering	O
two	O
analytic	O
perspectives	O
:	O
hospital	O
and	O
patients	O
.	O

Forty	O
-	O
eight	O
sequences	O
,	O
30	O
not	O
previously	O
identified	O
as	O
IR	B
-	I
responsive	I
,	O
were	O
significantly	O
regulated	O
by	O
IR	O
.	O

The	O
penicillin	B
binding	I
proteins	I
(	O
PBPs	B
)	O
synthesize	O
and	O
remodel	O
peptidoglycan	O
,	O
the	O
structural	O
component	O
of	O
the	O
bacterial	O
cell	O
wall	O
.	O

Gab2	B
,	O
a	O
new	O
pleckstrin	B
homology	I
domain	I
-	I
containing	I
adapter	I
protein	I
,	O
acts	O
to	O
uncouple	O
signaling	O
from	O
ERK	B
kinase	I
to	O
Elk	B
-	I
1	I
.	O

DDP1	B
also	O
localizes	O
to	O
heterochromatin	O
in	O
interphase	O
nuclei	O
of	O
larval	O
neuroblasts	O
.	O

Sequence	O
of	O
10q24	B
locus	I
surrounding	O
the	O
HOX11	B
oncogene	I
reveals	O
a	O
new	O
gene	O
HUG1	B
expressed	O
in	O
a	O
T	O
-	O
ALL	O
cell	O
line	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
of	O
the	O
R2	B
protein	I
was	O
used	O
to	O
provide	O
evidence	O
that	O
this	O
motif	O
is	O
also	O
part	O
of	O
the	O
active	O
site	O
of	O
the	O
endonuclease	O
encoded	O
by	O
this	O
element	O
.	O

A	O
multi	O
-	O
centre	O
evaluation	O
of	O
the	O
card	O
indirect	O
agglutination	O
test	O
for	O
trypanosomiasis	O
(	O
TrypTect	O
CIATT	O
).	O

The	O
results	O
of	O
these	O
analyses	O
indicate	O
that	O
the	O
proteinase	O
cleaves	O
at	O
amino	O
acid	O
residues	O
E960	O
-	O
A961	O
,	O
E1071	O
-	O
S1072	O
,	O
E1345	O
-	O
T1346	O
,	O
and	O
E1419	O
-	O
G1420	O
;	O
however	O
,	O
the	O
cleavage	O
efficiency	O
is	O
varied	O
.	O

SM	O
is	O
also	O
shown	O
to	O
be	O
associated	O
in	O
vivo	O
with	O
other	O
components	O
of	O
the	O
CRM	B
1	I
export	O
pathway	O
,	O
including	O
the	O
small	B
GTPase	I
Ran	I
and	O
the	O
nucleoporin	O
CAN	B
/	O
Nup214	B
.	O

Comparison	O
with	O
the	O
bHLH	O
/	O
PAS	B
family	I
genes	I
revealed	O
that	O
the	O
intron	O
/	O
exon	O
splice	O
pattern	O
of	O
mBMAL1	B
most	O
closely	O
matches	O
that	O
of	O
the	O
mAhr	B
,	O
which	O
suggests	O
that	O
BMAL1	B
and	I
Ahr	I
belong	O
to	O
the	O
same	O
subclass	O
and	O
may	O
be	O
derived	O
from	O
a	O
common	O
primordial	O
gene	O
.	O

Classical	O
ligand	O
-	O
activated	O
nuclear	O
receptors	O
(	O
e	O
.	O
g	O
.	O
thyroid	B
hormone	I
receptor	I
,	O
retinoic	B
acid	I
receptor	I
),	O
orphan	B
nuclear	I
receptors	I
(	O
e	O
.	O
g	O
.	O

67	O
393	O
bp	O
of	O
contiguous	O
DNA	O
located	O
between	O
markers	O
cdc18	B
and	O
cdc14	B
on	O
the	O
right	O
arm	O
of	O
fission	O
yeast	O
chromosome	O
II	O
has	O
been	O
sequenced	O
as	O
part	O
of	O
the	O
European	O
Union	O
Schizosaccharomyces	O
pombe	O
genome	O
sequencing	O
project	O
.	O

Activation	O
of	O
ERK1	B
/	I
2	I
is	O
correlated	O
with	O
induction	O
of	O
the	O
immediate	B
-	I
early	I
response	I
genes	I
.	O

We	O
have	O
isolated	O
three	O
mutant	O
alleles	O
of	O
CDC4	B
(	O
cdc4	B
-	I
10	O
,	O
cdc4	B
-	I
11	O
,	O
and	O
cdc4	B
-	I
16	O
)	O
which	O
suppress	O
the	O
nuclear	O
division	O
defect	O
of	O
cdc20	B
-	I
1	I
cells	O
.	O

In	O
summary	O
,	O
Ca	B
(	I
2	I
+)-	I
dependent	I
activation	O
of	O
NO	O
production	O
mediates	O
apoptosis	O
after	O
TG	O
exposure	O
in	O
JT	O
/	O
Neo	O
cells	O
.	O

Expression	O
of	O
various	O
FAK	B
mutants	I
in	O
the	O
FAK	B
-	I
cells	O
showed	O
that	O
FAK	B
kinase	I
activity	O
,	O
the	O
Tyr	B
-	I
397	I
/	I
SH2	I
domain	I
binding	I
site	I
,	O
and	O
the	O
first	O
proline	O
-	O
rich	O
SH3	B
binding	I
region	O
in	O
the	O
FAK	B
C	I
-	I
terminal	I
domain	I
were	O
individually	O
needed	O
to	O
promote	O
full	O
FAK	B
-	I
mediated	O
FAK	B
-	I
cell	O
migration	O
to	O
FN	B
whereas	O
direct	O
paxillin	B
binding	I
to	O
FAK	B
was	O
not	O
required	O
.	O

DESIGN	O
:	O
Comparison	O
of	O
number	O
of	O
women	O
with	O
PKU	O
aged	O
15	O
-	O
44	O
years	O
on	O
the	O
NSW	O
PKU	O
database	O
(	O
observed	O
number	O
)	O
with	O
expected	O
number	O
derived	O
from	O
population	O
data	O
.	O

PURPOSE	O
:	O
The	O
purposes	O
of	O
the	O
present	O
study	O
were	O
to	O
assess	O
the	O
effects	O
of	O
a	O
12	O
-	O
wk	O
laboratory	O
based	O
aerobic	O
exercise	O
program	O
on	O
cardiopulmonary	O
function	O
,	O
CD4	B
cell	O
count	O
,	O
and	O
physician	O
-	O
assessed	O
health	O
status	O
among	O
symptomatic	O
pre	O
-	O
AIDS	O
HIV	O
-	O
infected	O
individuals	O
(	O
N	O
=	O
28	O
)	O
and	O
to	O
assess	O
the	O
degree	O
to	O
which	O
ill	O
health	O
was	O
associated	O
with	O
exercise	O
relapse	O
.	O

The	O
enzyme	O
displays	O
optimal	O
activity	O
at	O
about	O
0	O
.	O
5	O
mM	O
pantoate	O
(	O
k	O
(	O
cat	O
)	O
0	O
.	O
63	O
s	O
(-	O
1	O
))	O
and	O
at	O
pH	O
7	O
.	O
8	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
the	O
RP	O
,	O
like	O
the	O
20S	B
proteasome	I
,	O
is	O
functionally	O
and	O
structurally	O
conserved	O
among	O
eukaryotes	O
and	O
indicate	O
that	O
the	O
plant	B
RPT	I
subunits	I
,	O
like	O
their	O
yeast	O
counterparts	O
,	O
have	O
non	O
-	O
redundant	O
functions	O
.	O

Epidemiologic	O
evidence	O
indicates	O
that	O
estrogen	O
replacement	O
therapy	O
after	O
menopause	O
increases	O
breast	O
cancer	O
risk	O
.	O

A	O
diagnosis	O
of	O
IgA	B
lambda	I
multiple	O
myeloma	O
with	O
peritoneal	O
involvement	O
was	O
made	O
.	O

In	O
about	O
770	O
bp	O
upstream	O
region	O
of	O
Spam1	B
that	O
has	O
been	O
cloned	O
and	O
sequenced	O
,	O
multiple	O
transcription	B
factor	I
binding	I
sites	I
including	O
a	O
CRE	O
(	O
cAMP	B
-	I
responsive	I
element	I
)	O
were	O
found	O
.	O

Furthermore	O
,	O
addition	O
of	O
B	B
-	I
Myb	I
-	O
glutathionine	B
S	I
-	I
transferase	I
fusion	I
protein	I
inhibited	O
complex	O
formation	O
.	O

Repair	O
of	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
in	O
chromosomal	O
DNA	O
by	O
nonhomologous	O
end	O
-	O
joining	O
(	O
NHEJ	O
)	O
is	O
not	O
well	O
characterized	O
in	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

Thus	O
,	O
elongin	B
C	I
is	O
found	O
to	O
oligomerize	O
in	O
solution	O
and	O
to	O
undergo	O
significant	O
structural	O
rearrangements	O
upon	O
binding	O
of	O
two	O
different	O
partner	O
proteins	O
.	O

METHODS	O
:	O
109	O
suspected	O
cases	O
with	O
SS	O
underwent	O
the	O
biopsies	O
.	O

Identity	O
elements	O
in	O
tRNA	O
for	O
mono	O
-	O
and	O
dimethylation	O
reactions	O
by	O
the	O
recombinant	B
pfTrm1p	I
were	O
identified	O
using	O
in	O
vitro	O
T7	O
transcripts	O
of	O
33	O
variants	O
of	O
tRNA	O
(	O
Asp	O
)	O
and	O
tRNA	O
(	O
Phe	O
)	O
from	O
yeast	O
.	O

Fewer	O
recombination	O
events	O
are	O
detected	O
in	O
four	O
different	O
B	O
and	O
T	O
cell	O
lines	O
that	O
do	O
not	O
undergo	O
switch	O
recombination	O
of	O
their	O
endogenous	O
genes	O
.	O

PKNbeta	B
had	O
high	O
sequence	O
homology	O
with	O
PKNalpha	B
,	O
originally	O
isolated	O
PKN	B
,	O
especially	O
in	O
the	O
repeats	O
of	O
charged	O
amino	O
acid	O
-	O
rich	O
region	O
with	O
leucine	B
-	I
zipper	I
like	I
sequences	I
(	O
CZ	O
region	O
/	O
HR1	O
),	O
in	O
the	O
carboxyl	O
-	O
terminal	O
catalytic	O
domain	O
,	O
and	O
in	O
approximately	O
130	O
amino	O
acid	O
stretch	O
(	O
D	O
region	O
/	O
HR2	O
),	O
located	O
between	O
CZ	O
region	O
/	O
HR1	O
and	O
the	O
catalytic	O
domain	O
.	O

Some	O
of	O
them	O
produce	O
gigantic	O
sperm	O
several	O
times	O
the	O
total	O
male	O
body	O
length	O
.	O

M	B
-	I
Ras	I
interacted	O
poorly	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
assay	O
with	O
multiple	O
Ras	B
effectors	I
,	O
including	O
c	B
-	I
Raf	I
-	I
1	I
,	I
A	I
-	I
Raf	I
,	I
B	I
-	I
Raf	I
,	O
phosphoinositol	B
-	I
3	I
kinase	I
delta	I
,	O
RalGDS	B
,	O
and	O
Rin1	B
.	O

In	O
the	O
course	O
of	O
investigating	O
the	O
mechanisms	O
by	O
which	O
OF5	B
and	O
OF3	B
regulated	O
CYP11A1	B
transcription	I
,	O
we	O
found	O
that	O
OF5	B
and	O
OF3	B
bound	O
Sp1	B
and	O
Sp3	B
in	O
JEG	O
-	O
3	O
cells	O
.	O

In	O
contrast	O
,	O
the	O
differentiation	O
of	O
neoplastically	O
transformed	O
cells	O
does	O
not	O
repress	O
mitogenic	O
responsiveness	O
or	O
junB	B
or	O
c	B
-	I
fos	I
inducibility	O
.	O

The	O
Cr	B
.	I
psbA	I
-	I
4	I
ORF	I
contains	O
an	O
H	B
-	I
N	I
-	I
H	I
motif	I
,	O
and	O
possibly	O
a	O
GIY	O
-	O
YIG	O
motif	O
.	O

Nuclear	B
hormone	I
receptors	I
(	O
NRs	O
)	O
are	O
ligand	O
-	O
inducible	O
transcription	O
factors	O
that	O
mediate	O
critical	O
functions	O
in	O
many	O
species	O
.	O

A	O
limited	O
sampling	O
strategy	O
was	O
used	O
based	O
on	O
a	O
bayesian	O
parameter	O
estimation	O
algorithm	O
that	O
is	O
part	O
of	O
the	O
ADAPT	O
II	O
software	O
package	O
.	O

CONCLUSIONS	O
:	O
In	O
healthy	O
individuals	O
,	O
whole	O
body	O
insulin	B
sensitivity	O
is	O
related	O
,	O
or	O
"	O
coupled	O
,	O
"	O
to	O
the	O
anaerobic	O
threshold	O
.	O

We	O
report	O
the	O
construction	O
of	O
an	O
approximately	O
1	O
.	O
7	O
-	O
Mb	O
sequence	O
-	O
ready	O
YAC	O
/	O
BAC	O
clone	O
contig	O
of	O
8p22	O
-	O
p23	O
.	O

Velocity	O
sedimentation	O
,	O
cross	O
-	O
linking	O
,	O
and	O
immunoprecipitation	O
analyses	O
of	O
detergent	O
-	O
solubilized	O
rat	O
brain	O
revealed	O
that	O
the	O
32	O
and	O
34	O
kDa	O
polypeptides	O
reside	O
within	O
heterotetramers	O
.	O

N	O
-	O
terminal	O
sequence	O
analysis	O
and	O
NMR	O
measurements	O
revealed	O
that	O
this	O
fragment	O
originates	O
from	O
the	O
C	O
-	O
terminal	O
80	O
residues	O
of	O
MBF1	B
and	O
form	O
a	O
well	O
structured	O
C	B
-	I
terminal	I
domain	I
of	O
MBF1	B
,	O
MBF1CTD	B
.	O

The	O
arrangement	O
of	O
these	O
cutoff	O
-	O
levels	O
leads	O
to	O
a	O
sensitivity	O
of	O
85	O
%	O
at	O
a	O
specificity	O
of	O
55	O
%	O
for	O
Protein	B
S100	I
when	O
measured	O
by	O
RIA	O
,	O
and	O
to	O
a	O
sensitivity	O
of	O
77	O
%	O
at	O
a	O
specificity	O
of	O
61	O
%	O
when	O
measured	O
by	O
LIA	O
.	O

In	O
early	O
Xenopus	O
embryos	O
,	O
the	O
transforming	B
growth	I
factor	I
-	I
beta	I
member	I
activin	I
induces	O
the	O
gene	B
Mix	I
.	O
2	O
by	O
stimulating	O
the	O
formation	O
of	O
a	O
multiprotein	O
complex	O
,	O
activin	B
-	I
responsive	I
factor	I
(	I
ARF	I
).	O

Cross	O
-	O
linking	O
the	O
B	B
cell	I
Ag	I
receptor	I
(	O
BCR	B
)	O
to	O
surface	O
Fc	B
receptors	I
for	O
IgG	B
(	I
Fc	I
gamma	I
R	I
)	O
inhibits	O
G1	O
-	O
to	O
-	O
S	O
progression	O
;	O
the	O
mechanism	O
by	O
which	O
this	O
occurs	O
is	O
not	O
completely	O
known	O
.	O

Cross	O
-	O
linking	O
the	O
B	B
cell	I
Ag	I
receptor	I
(	O
BCR	B
)	O
to	O
surface	O
Fc	B
receptors	I
for	O
IgG	B
(	I
Fc	I
gamma	I
R	I
)	O
inhibits	O
G1	O
-	O
to	O
-	O
S	O
progression	O
;	O
the	O
mechanism	O
by	O
which	O
this	O
occurs	O
is	O
not	O
completely	O
known	O
.	O

TRAF2	B
is	O
a	O
potent	O
activator	O
of	O
a	O
95	B
-	I
kDa	I
serine	I
/	I
threonine	I
kinase	I
termed	O
germinal	B
center	I
kinase	I
related	I
(	O
GCKR	B
,	O
also	O
referred	O
to	O
as	O
KHS1	B
),	O
which	O
signals	O
activation	O
of	O
the	O
SAPK	B
pathway	O
.	O

Cotransfection	O
of	O
the	O
coactivator	O
CREB	B
-	I
binding	I
protein	I
relieved	O
the	O
transcriptional	O
repression	O
of	O
PPARalphawt	B
by	O
PPARalphatr	B
,	O
suggesting	O
that	O
the	O
dominant	O
negative	O
effect	O
of	O
PPARalphatr	B
might	O
occur	O
through	O
competition	O
for	O
essential	O
coactivators	O
.	O

RESULTS	O
:	O
CK	B
-	I
MB	I
elevation	O
was	O
detected	O
in	O
313	O
patients	O
(	O
18	O
.	O
7	O
%),	O
with	O
1	O
-	O
3x	O
in	O
12	O
.	O
8	O
%,	O
3	O
-	O
5x	O
in	O
3	O
.	O
5	O
%	O
and	O
>	O
5x	O
normal	O
in	O
2	O
.	O
4	O
%	O
of	O
patients	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
Sp1	B
and	O
Sp3	B
as	O
major	O
factors	O
binding	O
to	O
the	O
Sp1	B
sites	I
of	O
the	O
p21	B
/	O
WAF1	B
/	O
Cip1	B
promoter	I
in	O
MG63	O
cells	O
through	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
showed	O
that	O
TSA	O
treatment	O
did	O
not	O
change	O
their	O
binding	O
activities	O
.	O

A	O
tyrosine	O
-	O
based	O
sorting	O
signal	O
in	O
the	O
beta2	B
integrin	I
cytoplasmic	I
domain	I
mediates	O
its	O
recycling	O
to	O
the	O
plasma	O
membrane	O
and	O
is	O
required	O
for	O
ligand	O
-	O
supported	O
migration	O
.	O

Using	O
transgenic	O
Xenopus	O
embryos	O
,	O
we	O
demonstrate	O
that	O
the	O
integrity	O
of	O
these	O
two	O
sequences	O
is	O
necessary	O
for	O
correct	O
spatial	O
expression	O
of	O
a	O
Xbra2	B
promoter	I
-	I
driven	I
reporter	I
gene	I
.	O

NuA4	B
has	O
an	O
apparent	O
molecular	O
mass	O
of	O
1	O
.	O
3	O
MDa	O
.	O

Two	O
patients	O
with	O
recurrent	O
tumors	O
had	O
high	O
S	O
-	O
phase	O
fractions	O
both	O
on	O
the	O
first	O
resected	O
specimens	O
and	O
at	O
the	O
time	O
of	O
the	O
second	O
operation	O
.	O

Insulin	B
-	I
like	I
growth	I
factor	I
-	I
I	I
induces	O
bcl	B
-	I
2	I
promoter	I
through	O
the	O
transcription	B
factor	I
cAMP	I
-	I
response	I
element	I
-	I
binding	I
protein	I
.	O

Synthesis	O
of	O
antisense	O
RNA	O
and	O
S	O
phase	O
-	O
dependent	O
binding	O
of	O
E2F	B
complexes	I
in	O
intron	O
1	O
.	O

A	O
human	B
nuclear	I
-	I
localized	O
chaperone	O
that	O
regulates	O
dimerization	O
,	O
DNA	O
binding	O
,	O
and	O
transcriptional	O
activity	O
of	O
bZIP	B
proteins	I
.	O

Sputum	B
IL	I
-	I
8	O
and	O
MPO	B
were	O
significantly	O
increased	O
after	O
BPT	O
in	O
both	O
TDI	O
-	O
and	O
grain	O
dust	O
-	O
asthma	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Treatment	O
of	O
unstable	O
angina	O
:	O
role	O
of	O
antithrombotic	O
therapy	O
.	O

In	O
fact	O
,	O
SPT	O
activity	O
in	O
the	O
fly	O
expressing	O
epitope	O
-	O
tagged	O
Lace	B
was	O
absorbed	O
by	O
epitope	O
-	O
specific	O
antibody	O
.	O

Protein	B
kinase	I
A	I
-	I
Ialpha	I
subunit	I
-	I
directed	O
antisense	O
inhibition	O
of	O
ovarian	O
cancer	O
cell	O
growth	O
:	O
crosstalk	O
with	O
tyrosine	B
kinase	I
signaling	O
pathway	O
.	O

The	O
phosphotransferase	O
system	O
(	O
PTS	O
)	O
of	O
Streptomyces	O
coelicolor	O
identification	O
and	O
biochemical	O
analysis	O
of	O
a	O
histidine	B
phosphocarrier	I
protein	I
HPr	I
encoded	I
by	O
the	O
gene	O
ptsH	B
.	O

Structural	O
changes	O
in	O
the	O
C	O
-	O
terminus	O
of	O
Ca2	O
+-	O
bound	O
rat	B
S100B	I
(	I
beta	I
beta	I
)	O
upon	O
binding	O
to	O
a	O
peptide	O
derived	O
from	O
the	O
C	B
-	I
terminal	I
regulatory	I
domain	I
of	O
p53	B
.	O

CONCLUSIONS	O
:	O
These	O
results	O
show	O
that	O
once	O
daily	O
oral	O
valganciclovir	O
can	O
produce	O
exposures	O
of	O
ganciclovir	O
(	O
AUC24	O
)	O
exceeding	O
those	O
attained	O
using	O
intravenous	O
ganciclovir	O
10	O
mg	O
/	O
kg	O
.	O

A	O
genetic	O
screen	O
in	O
yeast	O
has	O
allowed	O
us	O
to	O
identify	O
a	O
novel	O
transcriptional	O
factor	O
binding	O
to	O
the	O
GlRE	O
,	O
i	O
.	O
e	O
.	O
the	O
chicken	B
ovalbumin	I
upstream	I
promoter	I
-	I
transcription	I
factor	I
II	I
(	O
COUP	B
-	I
TFII	I
).	O

These	O
observations	O
establish	O
that	O
RsmC	B
negatively	O
regulates	O
rsmB	B
transcription	I
but	O
positively	O
affects	O
RsmA	B
production	O
.	O

SCOB	O
testing	O
of	O
food	O
-	O
restricted	O
animals	O
,	O
using	O
a	O
multiple	O
fixed	O
ratio	O
(	O
FR	O
)/	O
fixed	O
interval	O
(	O
FI	O
)	O
schedule	O
(	O
FR20	O
:	O
FI120	O
),	O
was	O
conducted	O
prior	O
to	O
each	O
exposure	O
to	O
maintain	O
the	O
operant	O
behavior	O
;	O
the	O
data	O
from	O
Weeks	O
-	O
1	O
,	O
4	O
,	O
8	O
,	O
and	O
13	O
were	O
evaluated	O
for	O
evidence	O
of	O
neurotoxicity	O
.	O

IL	B
-	I
12	O
production	O
was	O
correlated	O
with	O
C3a	O
concentration	O
measured	O
at	O
the	O
outlet	O
of	O
hemodialyzer	O
after	O
15	O
min	O
of	O
dialysis	O
(	O
r	O
=	O
0	O
.	O
69	O
,	O
P	O
<	O
0	O
.	O
01	O
).	O

Assembly	O
of	O
a	O
complex	O
between	O
FAK	B
and	I
Src	I
kinases	I
may	O
serve	O
to	O
regulate	O
the	O
subcellular	O
localization	O
and	O
the	O
enzymatic	O
activity	O
of	O
members	O
of	O
the	O
Src	B
family	I
of	I
kinases	I
.	O

In	O
the	O
work	O
reported	O
here	O
,	O
we	O
used	O
peptide	O
mapping	O
,	O
mass	O
spectrometry	O
,	O
and	O
site	O
-	O
directed	O
mutagenesis	O
to	O
identify	O
two	O
sets	O
of	O
pAP	B
phosphorylation	O
sites	O
.	O

Western	O
blot	O
analysis	O
showed	O
a	O
rapid	O
corresponding	O
increase	O
in	O
p21WAF1	B
/	I
CIP1	I
protein	I
,	O
whereas	O
protein	O
levels	O
of	O
another	O
member	O
of	O
the	O
cyclin	B
-	I
dependent	I
kinase	I
inhibitor	I
family	I
,	O
p27kip1	B
,	O
were	O
unchanged	O
.	O

Although	O
upstream	O
regulators	O
of	O
Tec	B
family	I
kinases	I
are	O
relatively	O
well	O
characterized	O
,	O
little	O
is	O
known	O
of	O
the	O
downstream	O
effectors	O
of	O
these	O
enzymes	O
.	O

Efficient	O
phosphorylation	O
of	O
BRDG1	B
by	O
Tec	B
required	O
the	O
PH	B
and	I
SH2	I
domains	I
as	O
well	O
as	O
the	O
kinase	O
domain	O
of	O
the	O
latter	O
.	O

CONCLUSION	O
:	O
These	O
findings	O
imply	O
that	O
eotaxin	O
either	O
is	O
mechanistically	O
involved	O
in	O
acute	O
asthma	O
or	O
serves	O
as	O
a	O
biomarker	O
for	O
activity	O
of	O
the	O
CCR3	B
receptor	I
ligand	O
system	O
,	O
which	O
is	O
functionally	O
linked	O
to	O
asthma	O
.	O

The	O
expression	O
analysis	O
of	O
the	O
KlHIS4	B
gene	I
under	O
phosphate	O
starvation	O
or	O
high	O
adenine	O
supply	O
shows	O
that	O
factors	O
,	O
such	O
as	O
Bas1	B
or	O
Bas2	B
,	O
involved	O
in	O
the	O
basal	O
control	O
may	O
also	O
operate	O
in	O
a	O
different	O
way	O
in	O
K	O
.	O
lactis	O
.	O

ESS	O
type	O
1	O
,	O
with	O
FT3	O
low	O
and	O
FT4	O
and	O
TSH	B
normal	O
,	O
is	O
the	O
most	O
frequent	O
form	O
.	O

Paleoceanographic	O
data	O
from	O
the	O
Laurentian	O
Fan	O
,	O
used	O
as	O
a	O
proxy	O
for	O
sea	O
surface	O
temperature	O
,	O
reveal	O
that	O
surface	O
slope	O
waters	O
north	O
of	O
the	O
Gulf	O
Stream	O
experienced	O
warming	O
during	O
the	O
Little	O
Ice	O
Age	O
of	O
the	O
16th	O
to	O
19th	O
centuries	O
and	O
support	O
the	O
notion	O
of	O
an	O
NAO	O
-	O
driven	O
coupled	O
system	O
.	O

This	O
effect	O
required	O
(	O
i	O
)	O
IR	O
activation	O
since	O
it	O
was	O
abrogated	O
by	O
IR	O
mutation	O
at	O
tyrosines	O
1162	O
and	O
1163	O
and	O
(	O
ii	O
)	O
NF	B
-	I
kappaB	I
activation	O
since	O
it	O
was	O
abolished	O
by	O
overexpression	O
of	O
dominant	B
-	I
negative	I
IkappaB	I
-	I
alpha	I
(	I
A32	I
/	I
36	O
)	O
and	O
mimicked	O
by	O
overexpression	O
of	O
the	O
NF	B
-	I
kappaB	I
c	I
-	I
Rel	I
subunit	I
.	O

The	O
factor	O
designated	O
B	O
formed	O
a	O
complex	O
centered	O
on	O
the	O
sequence	O
TGTGGT	O
,	O
a	O
core	O
motif	O
recognized	O
by	O
members	O
of	O
the	O
AML	B
/	I
CBFalpha	I
transcription	I
factor	I
family	I
.	O

Furthermore	O
,	O
overexpression	O
of	O
AML3	B
/	O
CBFalpha1	B
could	O
rescue	O
the	O
AML1	B
-	I
ETO	O
repression	O
.	O

Cloning	O
and	O
expression	O
of	O
a	O
specific	O
human	B
alpha	I
1	I
,	I
2	I
-	I
mannosidase	I
that	O
trims	O
Man9GlcNAc2	O
to	O
Man8GlcNAc2	O
isomer	O
B	O
during	O
N	O
-	O
glycan	O
biosynthesis	O
.	O

Regulation	O
of	O
avian	B
fibroblast	I
growth	I
factor	I
receptor	I
1	I
(	I
FGFR	I
-	I
1	I
)	I
gene	I
expression	O
during	O
skeletal	O
muscle	O
differentiation	O
.	O

OBJECTIVE	O
:	O
Although	O
the	O
preponderance	O
of	O
findings	O
offer	O
support	O
for	O
transient	O
(	O
where	O
is	O
it	O
?)	O
as	O
opposed	O
to	O
sustained	O
(	O
what	O
is	O
it	O
?)	O
deficit	O
,	O
a	O
need	O
remains	O
for	O
specific	O
depiction	O
of	O
the	O
deficit	O
.	O

16	O
percent	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
and	O
sustained	O
normalization	O
of	O
serum	B
alanine	I
aminotransferase	I
levels	O
(	O
41	O
percent	O
vs	O
.	O

In	O
assays	O
with	O
purified	O
enzymes	O
,	O
wild	B
-	I
type	I
but	O
not	O
PTPS	B
-	O
S19A	B
was	O
a	O
specific	O
substrate	O
for	O
the	O
cGMP	B
-	I
dependent	I
protein	I
kinase	I
(	I
cGK	I
)	I
type	I
I	I
and	I
II	I
.	O

The	O
N	O
-	O
terminal	O
domain	O
of	O
approximately	O
70	O
kDa	O
exhibits	O
11	O
imperfect	O
amino	O
acid	O
repeats	O
that	O
show	O
some	O
homology	O
to	O
promastigote	O
surface	O
glycoproteins	O
of	O
the	O
psa2	B
/	O
gp46	B
complex	I
.	O

In	O
PC12	O
cells	O
,	O
nerve	B
growth	I
factor	I
induces	O
neuronal	O
differentiation	O
and	O
repressed	O
expression	O
of	O
nrg	B
-	I
1	I
.	O

Oseltamivir	O
(	O
GS4104	O
),	O
which	O
can	O
be	O
administered	O
orally	O
,	O
is	O
the	O
prodrug	O
of	O
GS4071	O
,	O
a	O
potent	O
and	O
selective	O
inhibitor	O
of	O
influenzavirus	B
neuraminidases	I
.	O

After	O
14	O
d	O
of	O
overfeeding	O
,	O
hepatic	O
PL	O
profiles	O
were	O
identical	O
in	O
the	O
two	O
breeds	O
and	O
similar	O
to	O
that	O
in	O
control	O
livers	O
;	O
choline	O
-	O
containing	O
PL	O
accounted	O
for	O
95	O
%	O
of	O
total	O
PL	O
.	O

Intensive	O
synthesis	O
of	O
PNA	B
in	O
the	O
cells	O
of	O
microvascular	O
wall	O
evidenced	O
of	O
their	O
high	O
functional	O
activity	O
,	O
and	O
the	O
synthesis	O
of	O
DNA	O
in	O
them	O
showed	O
their	O
ability	O
for	O
proliferation	O
,	O
i	O
.	O
g	O
.--	O
for	O
growth	O
.	O

Tracheal	O
transsection	O
combined	O
with	O
hilar	O
ligation	O
(	O
TL	O
&	O
PL	O
)	O
effected	O
a	O
reduction	O
of	O
19	O
.	O
9	O
%	O
(	O
n	O
.	O
s	O
.).	O

The	O
yeast	B
C	I
-	I
type	I
cyclin	I
Ume3p	I
/	O
Srb11p	B
and	O
its	O
cyclin	B
-	I
dependent	I
kinase	I
(	O
Cdk	B
)	O
Ume5p	B
are	O
required	O
for	O
the	O
full	O
repression	O
of	O
genes	O
involved	O
in	O
the	O
stress	O
response	O
or	O
meiosis	O
.	O

The	O
RNA	O
transcripts	O
structurally	O
equivalent	O
to	O
I	B
(	I
2	I
)	I
sgRNAs	I
of	O
TMV	B
U1	I
and	O
crTMV	O
,	O
but	O
containing	O
a	O
hairpin	O
structure	O
(	O
H	O
)	O
immediately	O
upstream	O
of	O
IRES	B
(	I
MP	I
,	O
75	O
)	O
(	O
HIRES	B
(	I
MP	I
),	I
(	I
75	I
)(	I
CR	I
)-	I
MP	I
-	I
CP	I
-	I
3	I
'	I
UTR	I
;	I
HIRES	I
(	I
MP	I
,	I
75	I
)(	I
U1	I
)-	I
MP	I
-	I
CP	I
-	I
3	I
'	I
UTR	I
),	O
were	O
able	O
to	O
express	O
the	O
MP	B
gene	I
in	O
vitro	O
.	O

For	O
example	O
,	O
introduction	O
of	O
immunogenic	O
and	O
purification	O
tag	O
sequences	O
into	O
the	O
C	O
-	O
terminal	O
coding	O
region	O
significantly	O
decreased	O
bop	B
gene	I
mRNA	I
and	I
protein	I
accumulation	O
.	O

With	O
regard	O
to	O
nonhematologic	O
toxicities	O
,	O
diarrhea	O
,	O
infection	O
and	O
elevated	O
serum	B
alkaline	I
phosphatase	I
of	O
grade	O
3	O
or	O
over	O
were	O
observed	O
in	O
2	O
%	O
of	O
cycles	O
,	O
but	O
were	O
tolerable	O
and	O
reversible	O
.	O

LHbeta	B
is	O
expressed	O
in	O
pituitary	O
gonadotrope	O
cells	O
and	O
CGbeta	B
is	O
expressed	O
in	O
placental	O
trophoblast	O
cells	O
.	O

Human	B
LTBP	I
-	I
1	I
is	O
known	O
to	O
exist	O
in	O
different	O
forms	O
.	O

It	O
consists	O
of	O
2185	O
amino	O
acid	O
residues	O
encoded	O
by	O
a	O
9	O
-	O
kilobase	O
pair	O
mRNA	O
;	O
several	O
splice	O
variants	O
have	O
been	O
detected	O
in	O
human	O
and	O
rat	O
cDNA	O
libraries	O
.	O

Cyclic	B
AMP	I
-	I
dependent	I
protein	I
kinase	I
binding	I
to	I
A	I
-	I
kinase	I
anchoring	O
proteins	O
in	O
living	O
cells	O
by	O
fluorescence	O
resonance	O
energy	O
transfer	O
of	O
green	B
fluorescent	I
protein	I
fusion	I
proteins	I
.	O

Factor	B
XI	I
deficiency	O
is	O
a	O
rare	O
hereditary	O
bleeding	O
disorder	O
affecting	O
the	O
intrinsic	O
pathway	O
.	O

The	O
Ishasha	O
samples	O
show	O
a	O
range	O
encompassing	O
three	O
trophic	O
levels	O
.	O

S	O
.,	O
Kim	O
,	O
S	O
.	O

The	O
cop	B
region	O
also	O
harbors	O
a	O
region	O
of	O
plasmid	O
incompatibility	O
,	O
inc	B
,	O
encompassing	O
a	O
stem	O
-	O
loop	O
structure	O
,	O
the	O
repA	B
promoter	I
,	O
Prep	B
,	O
as	O
well	O
as	O
two	O
distinct	O
RepA	B
binding	I
sites	I
,	O
BD	O
-	O
1	O
and	O
BD	O
-	O
2	O
.	O

These	O
kinases	O
belong	O
to	O
a	O
new	O
subfamily	O
related	O
to	O
the	O
Trk	B
subfamily	I
.	O

ULKs	B
and	O
UNC	B
-	I
51	O
share	O
a	O
typical	O
domain	O
structure	O
of	O
an	O
amino	B
-	I
terminal	I
kinase	I
domain	I
,	O
a	O
central	O
proline	O
/	O
serine	O
rich	O
(	O
PS	O
)	O
domain	O
,	O
and	O
a	O
carboxy	O
-	O
terminal	O
(	O
C	O
)	O
domain	O
.	O

These	O
results	O
suggest	O
that	O
ULK2	B
is	O
involved	O
in	O
a	O
previously	O
uncharacterized	O
signaling	O
pathway	O
in	O
mammalian	O
cells	O
.	O

Connector	B
enhancer	I
of	I
KSR	I
(	O
CNK	B
)	O
is	O
a	O
multidomain	O
protein	O
required	O
for	O
RAS	B
signaling	O
.	O

We	O
present	O
a	O
case	O
of	O
carcinoma	O
of	O
the	O
breast	O
presenting	O
concurrently	O
with	O
SSc	O
that	O
subsequently	O
progressed	O
to	O
dialysis	O
-	O
dependent	O
renal	O
failure	O
in	O
just	O
1	O
month	O
.	O

In	O
contrast	O
,	O
AP	B
-	I
2	I
binding	I
activity	O
was	O
significantly	O
greater	O
in	O
T47D	O
cells	O
,	O
and	O
Western	O
blots	O
confirmed	O
increased	O
AP	B
-	I
2	I
protein	I
levels	O
in	O
these	O
cells	O
.	O

In	O
addition	O
,	O
all	O
three	O
Opa	B
proteins	I
of	O
C751	O
bind	O
equally	O
well	O
to	O
HeLa	O
cells	O
transfected	O
with	O
cDNA	O
encoding	O
the	O
carcinoembryonic	B
antigen	I
[	I
CEA	I
(	O
CD66e	B
)]	O
subgroup	O
of	O
the	O
CD66	B
family	I
,	O
but	O
show	O
distinct	O
tropism	O
for	O
CGM1	B
-	I
(	O
CD66d	B
)	O
and	O
NCA	O
(	O
CD66c	B
)-	I
expressing	O
cells	O
.	O

The	O
effect	O
of	O
smoking	O
was	O
not	O
examined	O
in	O
this	O
study	O
,	O
as	O
such	O
data	O
were	O
not	O
available	O
.	O

In	O
addition	O
,	O
the	O
acetyltransferase	O
activity	O
of	O
p300	B
was	O
observed	O
to	O
be	O
distinct	O
from	O
the	O
broadly	O
essential	O
activation	O
function	O
of	O
the	O
CH3	B
domain	I
/	I
E1A	I
-	I
binding	I
region	O
.	O

The	O
role	O
of	O
transport	O
by	O
sea	O
ice	O
from	O
the	O
Kara	O
Sea	O
into	O
the	O
Arctic	O
Ocean	O
was	O
assessed	O
by	O
a	O
small	O
subgroup	O
at	O
GEOMAR	O
.	O

Results	O
confirmed	O
that	O
stress	O
produced	O
CA3	O
dendritic	O
atrophy	O
and	O
tianeptine	O
prevented	O
it	O
.	O

Klebsiella	O
oxytoca	O
can	O
assimilate	O
nitrate	O
and	O
nitrite	O
by	O
using	O
enzymes	O
encoded	O
by	O
the	O
nasFEDCBA	B
operon	I
.	O

By	O
negatively	O
regulating	O
GRK	B
-	I
mediated	I
receptor	I
phosphorylation	O
,	O
beta	B
-	I
arrestin	I
-	I
mediated	O
processes	O
such	O
as	O
Src	B
recruitment	O
and	O
clathrin	B
-	I
mediated	O
internalization	O
,	O
which	O
are	O
required	O
for	O
GPCR	B
-	I
mediated	O
ERK	B
activation	O
,	O
are	O
inhibited	O
,	O
thus	O
dampening	O
further	O
ERK	B
activation	O
.	O

The	O
results	O
of	O
these	O
studies	O
demonstrate	O
that	O
the	O
rat	O
HDL	B
receptor	I
SR	I
-	I
BI	I
promoter	I
contains	O
two	O
sterol	O
response	O
elements	O
(	O
pSRE	O
and	O
dSRE	O
)	O
through	O
which	O
SREBP	B
-	I
1a	I
can	O
bind	O
and	O
activate	O
transcription	O
of	O
this	O
gene	O
.	O

Of	O
these	O
patients	O
,	O
46	O
,	O
164	O
were	O
placed	O
on	O
a	O
waiting	O
list	O
for	O
transplantation	O
,	O
23	O
,	O
275	O
of	O
whom	O
received	O
a	O
first	O
cadaveric	O
transplant	O
between	O
1991	O
and	O
1997	O
.	O

Syndromes	O
of	O
abnormal	O
fat	O
redistribution	O
and	O
metabolic	O
complications	O
in	O
HIV	O
-	O
infected	O
patients	O
.	O

Cytoprotection	O
with	O
amifostine	O
in	O
radiotherapy	O
or	O
radio	O
-	O
chemotherapy	O
of	O
head	O
and	O
neck	O
tumors	O

Residual	O
urinary	O
abnormalities	O
were	O
significantly	O
more	O
frequent	O
in	O
patients	O
with	O
type	O
III	O
than	O
type	O
I	O
MPGN	O
.	O

To	O
define	O
the	O
minimal	O
VDRE	O
binding	O
domain	O
for	O
human	O
VDR	B
(	O
hVDR	B
),	O
a	O
series	O
of	O
C	B
-	I
terminally	I
truncated	O
hVDR	B
mutants	I
(	O
Delta134	O
,	O
Delta113	O
,	O
Delta102	O
,	O
Delta90	O
,	O
Delta84	O
,	O
Delta80	O
,	O
and	O
Delta60	O
)	O
was	O
generated	O
and	O
expressed	O
in	O
bacteria	O
.	O

In	O
addition	O
,	O
narZ	B
expression	O
was	O
induced	O
approximately	O
20	O
-	O
fold	O
intracellularly	O
in	O
Madin	O
-	O
Darby	O
canine	O
kidney	O
epithelial	O
cells	O
and	O
16	O
-	O
fold	O
in	O
intracellular	O
salts	O
medium	O
,	O
which	O
is	O
believed	O
to	O
mimic	O
the	O
intracellular	O
milieu	O
.	O

Measurements	O
in	O
the	O
LWS	O
p	O
.	O
a	O
.	O
,	O
LWS	O
lat	O
.	O
and	O
at	O
Ward	O
'	O
s	O
triangle	O
were	O
made	O
in	O
a	O
total	O
of	O
100	O
patients	O
.	O

The	O
RET	B
/	O
PTC3	B
rearrangement	O
is	O
formed	O
by	O
fusion	O
of	O
the	O
ELE1	B
and	O
RET	B
genes	I
,	O
and	O
is	O
highly	O
prevalent	O
in	O
radiation	O
-	O
induced	O
post	O
-	O
Chernobyl	O
papillary	O
thyroid	O
carcinomas	O
.	O

Apoptosis	O
of	O
small	O
cells	O
is	O
still	O
observed	O
after	O
co	O
-	O
transfection	O
of	O
JBD	B
and	O
LMP1	B
but	O
in	O
addition	O
a	O
few	O
apoptotic	O
HD	B
-	I
MyZ	O
cells	O
with	O
large	O
fused	O
nuclear	O
masses	O
are	O
identified	O
suggesting	O
that	O
specific	O
inhibition	O
of	O
JNK	B
leads	O
also	O
to	O
apoptosis	O
of	O
LMP1	B
induced	O
RS	O
cells	O
.	O

To	O
understand	O
the	O
basis	O
for	O
the	O
increased	O
cell	O
surface	O
stability	O
compared	O
with	O
wild	B
-	I
type	I
peptide	I
and	O
to	O
understand	O
the	O
differences	O
in	O
T	O
cell	O
recognition	O
between	O
I1Y	B
and	O
I1F	B
,	O
we	O
determined	O
the	O
x	O
-	O
ray	O
crystal	O
structures	O
of	O
the	O
two	O
class	B
I	I
MHC	I
-	I
peptide	I
complexes	I
.	O

In	O
addition	O
,	O
SLK	B
displays	O
high	O
homology	O
to	O
microtubule	B
and	I
nuclear	I
associated	I
protein	I
(	I
M	I
-	I
NAP	I
)	O
and	O
AT1	B
-	I
46	O
,	O
both	O
of	O
unknown	O
function	O
.	O

The	O
signalling	O
molecules	O
Wnt1	B
and	O
Sonic	B
hedgehog	I
,	O
implicated	O
in	O
the	O
activation	O
of	O
Myf5	B
in	O
myogenic	O
progenitor	O
cells	O
in	O
the	O
somite	O
,	O
are	O
also	O
produced	O
in	O
the	O
viscinity	O
of	O
the	O
Myf5	B
expression	O
domain	O
in	O
the	O
mesencephalon	O
.	O

Snail	B
family	I
proteins	I
are	O
zinc	O
finger	O
transcriptional	O
regulators	O
first	O
identified	O
in	O
Drosophila	O
which	O
play	O
critical	O
roles	O
in	O
cell	O
fate	O
determination	O
.	O

These	O
data	O
indicate	O
that	O
the	O
interaction	O
of	O
eIF4A	B
with	O
the	O
middle	O
region	O
of	O
eIF4GI	B
is	O
necessary	O
for	O
translation	O
,	O
whereas	O
the	O
interaction	O
of	O
eIF4A	B
with	O
the	O
C	O
-	O
terminal	O
region	O
plays	O
a	O
modulatory	O
role	O
.	O

Northern	O
blot	O
and	O
reverse	O
transcription	O
-	O
PCR	O
analyses	O
of	O
human	B
mRNA	I
samples	O
demonstrate	O
that	O
RNR	B
is	O
expressed	O
exclusively	O
in	O
the	O
retina	O
,	O
with	O
transcripts	O
of	O
approximately	O
7	O
.	O
5	O
kb	O
,	O
approximately	O
3	O
.	O
0	O
kb	O
,	O
and	O
approximately	O
2	O
.	O
3	O
kb	O
by	O
Northern	O
blot	O
analysis	O
.	O

The	O
VirR	B
response	I
regulator	I
from	O
Clostridium	O
perfringens	O
binds	O
independently	O
to	O
two	O
imperfect	O
direct	O
repeats	O
located	O
upstream	O
of	O
the	O
pfoA	B
promoter	I
.	O

Maximum	O
induction	O
of	O
AP	B
-	I
1	I
was	O
reached	O
at	O
a	O
concentration	O
of	O
250	O
nmol	O
/	O
L	O
of	O
CalC	O
.	O

Rams	O
were	O
weighed	O
and	O
testis	O
size	O
was	O
estimated	O
by	O
orchimetry	O
at	O
each	O
time	O
period	O
.	O

In	O
all	O
tissues	O
examined	O
only	O
transcripts	O
positive	O
for	O
insert	O
3	O
,	O
an	O
18	O
bp	O
insertion	O
in	O
repeat	O
21	O
,	O
were	O
amplified	O
,	O
even	O
under	O
conditions	O
in	O
which	O
a	O
30	O
%	O
level	O
of	O
insert	O
3	O
negative	O
transcript	O
could	O
be	O
easily	O
detected	O
in	O
artificially	O
prepared	O
control	O
samples	O
.	O

We	O
demonstrate	O
that	O
both	O
R	O
and	O
Z	O
activate	O
the	O
cellular	O
stress	O
mitogen	B
-	I
activated	I
protein	I
(	I
MAP	I
)	I
kinases	I
,	O
p38	B
and	O
JNK	B
,	O
resulting	O
in	O
phosphorylation	O
(	O
and	O
activation	O
)	O
of	O
the	O
cellular	B
transcription	I
factor	I
ATF2	I
.	O

Two	O
US	O
commercial	O
cultivars	O
(	O
Tehama	O
and	O
Vina	O
),	O
three	O
European	O
commercial	O
cultivars	O
(	O
Esterhazy	O
,	O
139	O
,	O
G120	O
)	O
and	O
five	O
New	O
Zealand	O
selections	O
(	O
Rex	B
,	O
Dublin	O
'	O
s	O
Glory	O
,	O
Meyric	O
,	O
McKinster	O
,	O
Stanley	O
)	O
were	O
evaluated	O
.	O

Previously	O
,	O
we	O
showed	O
that	O
the	O
APRE	O
is	O
a	O
cytokine	O
[	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
(	O
TNFalpha	B
)]-	O
inducible	O
enhancer	O
by	O
binding	O
the	O
heterodimeric	B
nuclear	I
factor	I
-	I
kappaB	I
(	O
NF	B
-	I
kappaB	I
)	I
complex	I
Rel	I
A	I
x	O
NF	B
-	I
kappaB1	I
.	O

The	O
single	O
strandedness	O
is	O
manifested	O
as	O
a	O
terminal	O
extension	O
of	O
the	O
G	B
-	I
rich	O
strand	O
(	O
G	O
tails	O
)	O
that	O
can	O
occur	O
independently	O
of	O
telomerase	B
,	O
suggesting	O
that	O
cdc17	B
/	O
pol1	B
mutants	I
exhibit	O
defects	O
in	O
telomeric	O
lagging	O
-	O
strand	O
synthesis	O
.	O

In	O
addition	O
,	O
CaMig1	B
formed	O
specific	O
complexes	O
with	O
the	O
URS1	O
region	O
of	O
the	O
S	B
.	I
cerevisiae	I
FBP1	I
gene	I
.	O

Arhythmacanthus	O
Yamaguti	O
,	O
1935	O
is	O
maintained	O
as	O
a	O
synonym	O
of	O
Heterosentis	O
because	O
the	O
distinction	O
between	O
two	O
and	O
three	O
hook	O
types	O
is	O
made	O
equivocal	O
when	O
the	O
transition	O
between	O
the	O
apical	O
and	O
subapical	O
hooks	O
is	O
gradual	O
.	O

AF154055	B
.	O

Alignment	O
of	O
the	O
cervical	O
spine	O
,	O
vertebral	O
abnormalities	O
,	O
and	O
disc	O
changes	O
also	O
were	O
evaluated	O
.	O

After	O
i	O
.	O
v	O
.	O
administration	O
of	O
500	O
mg	O
acetazolamide	O
and	O
disinfection	O
of	O
the	O
conjunctiva	O
,	O
50	O
micrograms	O
rt	B
-	I
PA	I
in	O
0	O
.	O
1	O
ml	O
(	O
BSS	O
)	O
and	O
0	O
.	O
5	O
ml	O
SF6	O
were	O
injected	O
intravitreally	O
.	O

These	O
results	O
suggest	O
that	O
VP1	B
was	O
efficiently	O
transported	O
to	O
the	O
nucleus	O
and	O
localized	O
in	O
the	O
discrete	O
subnuclear	O
regions	O
,	O
possibly	O
with	O
VP2	B
and	O
VP3	B
.	O

Differential	O
expression	O
and	O
regulation	O
by	O
20	O
-	O
hydroxyecdysone	O
of	O
mosquito	O
ultraspiracle	O
isoforms	O
.	O

The	O
three	O
isoforms	O
purified	O
with	O
anti	B
-	I
FLAG	I
antibody	I
affinity	O
column	O
transferred	O
sulfate	O
to	O
heparan	O
sulfate	O
and	O
heparin	O
but	O
not	O
to	O
other	O
glycosaminoglycans	O
.	O

The	O
RNA	O
aptamer	O
contains	O
three	O
stems	O
separated	O
by	O
a	O
pair	O
of	O
two	O
-	O
base	O
bulges	O
,	O
and	O
adopts	O
an	O
unanticipated	O
fold	O
in	O
which	O
both	O
junctional	O
sites	O
are	O
anchored	O
through	O
base	O
triple	O
formation	O
.	O

The	O
study	O
suggests	O
the	O
presence	O
of	O
an	O
anatomical	O
sphincter	O
at	O
the	O
RSJ	O
which	O
seems	O
to	O
regulate	O
the	O
passage	O
of	O
stools	O
from	O
the	O
sigmoid	O
colon	O
to	O
the	O
rectum	O
.	O

Two	O
episodes	O
of	O
peritonitis	O
occurred	O
while	O
the	O
patient	O
received	O
CAPD	O
(	O
1	O
episode	O
/	O
3	O
.	O
5	O
patient	O
-	O
months	O
).	O

Characterization	O
of	O
a	O
human	O
alternatively	O
spliced	O
truncated	O
reduced	O
folate	O
carrier	O
increasing	O
folate	O
accumulation	O
in	O
parental	O
leukemia	O
cells	O
.	O

Consistently	O
,	O
activation	O
of	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
downstream	O
of	O
Rho	B
family	I
GTP	I
-	I
binding	I
proteins	I
was	O
also	O
enhanced	O
when	O
Dbl	B
was	O
tyrosine	O
-	O
phosphorylated	O
.	O

The	O
applicability	O
of	O
laparoscopic	O
donor	O
nephrectomy	O
(	O
LDN	O
)	O
has	O
not	O
been	O
assessed	O
in	O
the	O
obese	O
donor	O
.	O

Like	O
their	O
yeast	O
counterpart	O
,	O
the	O
mouse	B
GCN2	I
isoforms	I
contain	O
HisRS	B
-	I
related	I
sequences	I
juxtaposed	O
to	O
the	O
kinase	O
catalytic	O
domain	O
.	O

MBI	O
and	O
MMBI	O
showed	O
similar	O
Cmax	O
values	O
,	O
but	O
the	O
former	O
disappeared	O
slower	O
in	O
the	O
serum	O
than	O
the	O
latter	O
and	O
resulted	O
in	O
its	O
larger	O
AUC	O
values	O
.	O

METHODS	O
:	O
The	O
former	O
group	O
included	O
patients	O
who	O
had	O
been	O
treated	O
with	O
at	O
least	O
four	O
PGE1	O
alpha	B
-	I
ciclodestrina	O
,	O
short	O
-	O
term	O
treatment	O
cycles	O
per	O
year	O
while	O
the	O
latter	O
was	O
a	O
historical	O
reference	O
group	O
managed	O
without	O
prostaglandins	O
.	O

The	O
rrd1	B
,	I
2delta	I
mutant	I
was	O
partially	O
rescued	O
by	O
inactivation	O
of	O
HOG1	B
or	O
PBS2	B
,	O
suggesting	O
an	O
interaction	O
between	O
the	O
RRD	B
genes	I
and	O
the	O
Hog1p	B
signal	I
transduction	O
pathway	O
.	O

Members	O
of	O
the	O
JAK	B
/	O
Tyk	B
family	I
of	I
tyrosine	I
kinases	I
mediate	O
phosphorylation	O
of	O
STAT3	B
at	O
Tyr705	O
during	O
CNTF	B
signaling	O
;	O
however	O
,	O
the	O
kinase	O
responsible	O
for	O
phosphorylation	O
at	O
STAT3	B
Tyr727	O
appears	O
to	O
depend	O
on	O
both	O
the	O
extracellular	O
stimulus	O
and	O
the	O
cellular	O
context	O
.	O

Zebrafish	O
cyclops	B
(	O
cyc	B
)	O
encodes	O
a	O
Transforming	B
Growth	I
Factor	I
beta	I
(	O
TGFbeta	B
)	O
signaling	O
factor	O
closely	O
related	O
to	O
mouse	O
Nodal	B
.	O

An	O
increase	O
in	O
the	O
level	O
of	O
serum	O
enzymes	O
,	O
such	O
as	O
aspartate	B
transaminase	I
,	O
alkaline	B
phosphatase	I
,	O
creatine	B
phosphokinase	I
,	O
lactate	B
dehydrogenase	I
after	O
D	O
.	O
russelli	O
venom	O
injection	O
in	O
albino	O
rats	O
is	O
indicative	O
of	O
cell	O
or	O
tissue	O
damage	O
.	O

Thus	O
,	O
the	O
induction	O
of	O
E2F	B
binding	I
to	O
the	O
E2F	B
-	I
1	I
promoter	I
by	O
the	O
E4	B
-	I
6	I
/	I
7	I
protein	I
observed	O
in	O
vitro	O
correlates	O
with	O
transactivation	O
of	O
E2F	B
-	I
1	I
promoter	I
activity	O
in	O
vivo	O
.	O

CONCLUSION	O
:	O
Presence	O
of	O
APOE	B
epsilon4	I
/*	I
seems	O
to	O
increase	O
the	O
risk	O
for	O
dementia	O
and	O
AD	O
independently	O
of	O
its	O
effect	O
on	O
dyslipidemia	O
and	O
atherogenesis	O
.	O

Dermatology	O
is	O
no	O
exception	O
.	O

Protein	O
sequence	O
analysis	O
reveals	O
that	O
MAN1	B
shares	O
a	O
conserved	O
globular	O
domain	O
of	O
approximately	O
40	O
amino	O
acids	O
,	O
which	O
we	O
term	O
the	O
LEM	B
module	I
,	O
with	O
inner	O
nuclear	O
membrane	O
proteins	O
lamina	B
-	I
associated	I
polypeptide	I
2	I
and	O
emerin	B
.	O

Molecular	O
cloning	O
of	O
a	O
novel	O
human	B
I	I
-	I
mfa	I
domain	I
-	I
containing	I
protein	I
that	O
differently	O
regulates	O
human	B
T	I
-	I
cell	I
leukemia	I
virus	I
type	I
I	I
and	O
HIV	B
-	I
1	I
expression	O
.	O

The	O
encoded	O
amino	O
acid	O
sequences	O
in	O
the	O
full	O
-	O
length	O
bovine	O
and	O
porcine	O
cDNAs	O
were	O
identical	O
,	O
consisting	O
of	O
209	O
amino	O
acid	O
residues	O
,	O
and	O
were	O
nearly	O
the	O
same	O
as	O
the	O
published	O
sequence	O
determined	O
by	O
Edman	O
degradation	O
.	O

Acad	O
.	O

We	O
have	O
previously	O
demonstrated	O
that	O
expression	O
of	O
the	O
gene	O
for	O
the	O
reproductive	O
neuropeptide	O
,	O
GnRH	B
,	O
is	O
repressed	O
by	O
the	O
glutamate	O
/	O
NO	O
/	O
cyclic	O
GMP	O
(	O
cGMP	O
)	O
signal	O
transduction	O
pathway	O
through	O
cGMP	B
-	I
dependent	I
protein	I
kinase	I
in	O
the	O
hypothalamic	O
GnRH	B
-	I
secreting	O
neuronal	O
cell	O
line	O
GT1	O
-	O
7	O
.	O

MSSPs	B
are	O
believed	O
to	O
regulate	O
DNA	O
replication	O
,	O
transcription	O
,	O
apopotosis	O
and	O
cell	O
cycle	O
progression	O
by	O
interacting	O
with	O
the	O
C	B
-	I
MYC	I
protein	I
.	O

In	O
vitro	O
expression	O
of	O
four	O
different	O
naturally	O
occurring	O
nonsense	O
and	O
missense	O
mutations	O
revealed	O
a	O
dramatically	O
altered	O
subcellular	O
location	O
of	O
the	O
protein	O
in	O
cultured	O
cells	O
.	O

Despite	O
resolution	O
of	O
the	O
solid	O
portion	O
of	O
the	O
tumor	O
,	O
serial	O
MRI	O
showed	O
enlargement	O
of	O
a	O
bilobar	O
tumor	O
cyst	O
3	O
years	O
after	O
the	O
original	O
diagnosis	O
.	O

Second	O
,	O
when	O
the	O
NBF1	B
+	I
R	I
protein	I
,	O
the	O
NBF2	B
protein	I
,	O
and	O
a	O
mixture	O
of	O
the	O
two	O
proteins	O
were	O
folded	O
separately	O
and	O
analyzed	O
by	O
molecular	O
sieve	O
chomatography	O
,	O
the	O
mixture	O
was	O
found	O
to	O
elute	O
prior	O
to	O
either	O
NBF1	B
+	I
R	I
or	O
NBF2	B
.	O

Copyright	O
2000	O
Academic	O
Press	O
.	O

Sulfhydryl	O
titration	O
with	O
iodoacetamide	O
,	O
monitored	O
by	O
quantitating	O
the	O
residual	O
thiols	O
after	O
reaction	O
with	O
a	O
maleimide	O
derivative	O
of	O
biotin	O
,	O
revealed	O
a	O
striking	O
difference	O
in	O
the	O
apparent	O
pK	O
(	O
a	O
)	O
values	O
of	O
the	O
cysteines	O
at	O
the	O
two	O
splice	O
junctions	O
.	O

Forty	O
4	O
-	O
month	O
old	O
SD	O
female	O
rats	O
were	O
randomly	O
divided	O
into	O
four	O
groups	O
,	O
namely	O
sham	O
operation	O
,	O
bilateral	O
ovariectomy	O
,	O
ovariectomy	O
plus	O
supplementary	O
ethinyl	O
estradiol	O
(	O
0	O
.	O
2	O
microgram	O
/	O
100	O
g	O
B	O
.	O

Protamine	B
and	O
heparin	O
doses	O
,	O
their	O
sum	O
(	O
Sigma	O
-	O
dose	O
)	O
and	O
differential	O
(	O
Delta	O
-	O
dose	O
)	O
doses	O
,	O
and	O
activated	O
clotting	O
times	O
were	O
tabulated	O
.	O

Deglutition	O
is	O
considered	O
to	O
be	O
immature	O
in	O
infants	O
and	O
to	O
mature	O
postnatally	O
.	O

Finally	O
,	O
the	O
mechanism	O
of	O
ASK1	B
activation	O
involves	O
,	O
in	O
part	O
,	O
homo	O
-	O
oligomerization	O
.	O

The	O
variations	O
were	O
caused	O
by	O
opposite	O
shifts	O
in	O
TSH	B
frequency	O
distribution	O
in	O
mothers	O
and	O
neonates	O
.	O

Static	O
and	O
dynamic	O
compliance	O
was	O
measured	O
after	O
induction	O
of	O
anesthesia	O
,	O
before	O
and	O
immediately	O
after	O
filtration	O
in	O
the	O
operating	O
theater	O
,	O
1	O
hour	O
after	O
return	O
to	O
the	O
pediatric	O
intensive	O
care	O
unit	O
,	O
and	O
24	O
hours	O
after	O
the	O
operation	O
.	O

Antipyretic	O
therapy	O
:	O
physiologic	O
rationale	O
,	O
diagnostic	O
implications	O
,	O
and	O
clinical	O
consequences	O
.	O

Selective	O
visual	O
attention	O
involves	O
dynamic	O
interplay	O
between	O
attentional	O
control	O
systems	O
and	O
sensory	O
brain	O
structures	O
.	O

Together	O
,	O
these	O
data	O
identify	O
ERK2	B
as	O
a	O
specific	O
and	O
direct	O
target	O
of	O
HePTP	B
and	O
are	O
consistent	O
with	O
a	O
model	O
in	O
which	O
HePTP	B
negatively	O
regulates	O
ERK2	B
activity	O
as	O
part	O
of	O
a	O
feedback	O
mechanism	O
.	O

Strontium	O
nitrate	O
mixed	O
with	O
glycolic	O
acid	O
,	O
in	O
comparison	O
with	O
glycolic	O
acid	O
alone	O
,	O
markedly	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
shortened	O
the	O
duration	O
of	O
the	O
irritation	O
sensation	O
from	O
24	O
.	O
4	O
+/-	O
4	O
.	O
1	O
(	O
mean	O
+/-	O
SEM	O
)	O
min	O
to	O
8	O
.	O
9	O
+/-	O
3	O
.	O
7	O
(	O
mean	O
+/-	O
SEM	O
)	O
min	O
,	O
and	O
significantly	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
reduced	O
the	O
mean	O
magnitude	O
of	O
the	O
irritation	O
sensation	O
at	O
all	O
time	O
points	O
(	O
overall	O
).	O

The	O
pCMBS	O
-	O
reactive	O
sulfhydryl	O
groups	O
were	O
located	O
exclusively	O
in	O
the	O
exofacial	O
half	O
of	O
the	O
plasma	O
membrane	O
and	O
,	O
when	O
presented	O
in	O
a	O
helical	O
model	O
,	O
lie	O
along	O
one	O
side	O
of	O
the	O
helices	O
.	O

Human	B
AP	I
-	I
2rep	I
repressed	O
both	O
reporter	O
expression	O
from	O
a	O
transiently	O
transfected	O
AP	B
-	I
2alpha	I
promoter	I
and	O
the	O
endogenous	O
AP	B
-	I
2alpha	I
gene	I
and	O
inversely	O
was	O
negatively	O
regulated	O
by	O
AP	B
-	I
2alpha	I
.	O

However	O
,	O
when	O
,	O
where	O
and	O
how	O
the	O
DSPP	B
is	O
cleaved	O
into	O
DSP	O
and	O
DPP	B
is	O
not	O
clear	O
.	O

It	O
has	O
a	O
grave	O
prognosis	O
with	O
>	O
70	O
%	O
mortality	O
in	O
3	O
months	O
,	O
despite	O
mechanical	O
ventilation	O
.	O

Thus	O
,	O
patients	O
with	O
metastatic	O
melanoma	O
are	O
not	O
tolerant	O
to	O
gp100	B
Ag	I
based	O
on	O
the	O
detection	O
of	O
CD8	B
+	I
T	I
cells	O
specific	O
for	O
multiple	O
HLA	B
-	I
A	I
*	I
0201	I
-	I
restricted	O
,	O
gp100	B
-	I
derived	I
epitopes	I
.	O

Valuing	O
families	O
:	O
social	O
work	O
practice	O
with	O
families	O
from	O
a	O
strengths	O
perspective	O
.	O

PURPOSE	O
:	O
A	O
two	O
-	O
generation	O
consanguineous	O
Pakistani	O
family	O
with	O
autosomal	O
recessive	O
Leber	O
congenital	O
amaurosis	O
(	O
LCA	O
,	O
MIM	O
204	O
,	O
000	O
)	O
and	O
keratoconus	O
was	O
identified	O
.	O

An	O
amino	O
-	O
acid	O
sequence	O
comparison	O
revealed	O
that	O
Bacillus	B
YM55	I
-	I
1	I
aspartase	I
shared	O
71	O
%	O
homology	O
with	O
Bacillus	B
subtilis	I
aspartase	I
and	O
49	O
%	O
with	O
Escherichia	O
coli	O
and	O
Pseudomonas	B
fluorescens	I
aspartases	I
.	O

Inactivation	O
of	O
Ulp2	B
also	O
suppresses	O
several	O
ulp1	B
(	I
ts	I
)	O
defects	O
,	O
and	O
the	O
double	O
mutant	O
accumulates	O
far	O
fewer	O
Smt3	B
-	I
protein	I
conjugates	O
than	O
either	O
single	O
mutant	O
.	O

D	O
-	O
cyclin	B
-	O
cdk	B
activity	O
is	O
required	O
for	O
Rb	B
phosphorylation	O
in	O
v	B
-	I
Jun	I
-	I
transformed	O
cells	O
,	O
since	O
ectopic	O
expression	O
of	O
the	O
cdk4	B
-	I
and	O
cdk6	B
-	I
specific	I
inhibitor	O
p16	B
(	O
INK4A	B
)	O
inhibits	O
both	O
DNA	O
synthesis	O
and	O
cell	O
proliferation	O
.	O

CONCLUSION	O
:	O
A	O
valve	O
-	O
like	O
mechanism	O
formed	O
by	O
the	O
capsulorhexis	O
rim	O
partially	O
adhered	O
to	O
the	O
IOL	O
optic	O
can	O
occur	O
postoperatively	O
.	O

BACKGROUND	O
:	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
response	O
rates	O
and	O
toxicity	O
of	O
two	O
regimens	O
containing	O
granulocyte	B
-	I
macrophage	I
-	I
colony	I
stimulating	I
factor	I
(	O
GM	B
-	I
CSF	I
)	O
in	O
combination	O
with	O
interleukin	B
-	I
2	I
(	I
IL	I
-	I
2	I
)	O
in	O
the	O
treatment	O
of	O
patients	O
with	O
metastatic	O
renal	O
cell	O
carcinoma	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
revealed	O
that	O
Sp1	B
binds	O
to	O
two	O
different	O
regions	O
in	O
the	O
proximal	O
promoter	O
,	O
a	O
typical	O
Sp1	B
site	I
located	O
at	O
(-	O
38	O
;	O
-	O
33	O
)	O
and	O
a	O
G	B
/	I
C	I
-	I
rich	O
region	O
between	O
(-	O
67	O
;	O
-	O
62	O
).	O

Here	O
we	O
review	O
progress	O
to	O
date	O
in	O
this	O
area	O
.	O

This	O
paper	O
reviews	O
the	O
middleware	O
-	O
based	O
approach	O
adopted	O
by	O
CEN	O
ENV	O
12967	O
-	O
1	O
and	O
the	O
specialisation	O
necessary	O
for	O
the	O
healthcare	O
record	O
based	O
on	O
CEN	O
ENV	O
12265	O
'	O
Electronic	O
Healthcare	O
Record	O
Architecture	O
'.	O

Molecule	O
(	O
s	O
)	O
secreted	O
by	O
neuronal	O
cultures	O
contribute	O
to	O
this	O
induction	O
of	O
GLT	B
-	I
1	I
,	O
but	O
little	O
is	O
known	O
about	O
the	O
signaling	O
pathways	O
mediating	O
this	O
regulation	O
.	O

Early	O
treatment	O
mechanics	O
of	O
the	O
Class	O
II	O
division	O
2	O
malocclusion	O
.	O

In	O
transient	O
assays	O
,	O
using	O
rice	O
suspension	O
-	O
cultured	O
cells	O
transformed	O
by	O
particle	O
bombardment	O
,	O
we	O
showed	O
previously	O
that	O
Oshox1	B
can	O
transcriptionally	O
repress	O
the	O
activity	O
of	O
reporter	O
gene	O
constructs	O
with	O
upstream	O
HD	B
-	I
Zip	I
binding	I
sites	I
.	O

It	O
was	O
established	O
that	O
intrathecal	O
or	O
intraperitoneal	O
PTFL	O
,	O
elevated	O
the	O
nociceptive	O
threshold	O
for	O
mechanical	O
stimuli	O
in	O
the	O
formalin	O
test	O
in	O
rats	O
.	O

Invertases	B
are	O
responsible	O
for	O
the	O
breakdown	O
of	O
sucrose	O
to	O
fructose	O
and	O
glucose	O
.	O

We	O
now	O
describe	O
a	O
second	O
RIM	B
protein	I
,	O
called	O
RIM2	B
,	O
that	O
is	O
highly	O
homologous	O
to	O
RIM1	B
and	O
also	O
expressed	O
primarily	O
in	O
brain	O
.	O

Inhibitor	B
-	I
1	I
(	I
I	I
-	I
1	I
)	I
and	I
inhibitor	I
-	I
2	I
(	I
I	I
-	I
2	I
)	O
selectively	O
inhibit	O
type	B
1	I
protein	I
serine	I
/	I
threonine	I
phosphatases	I
(	O
PP1	B
).	O

These	O
studies	O
identify	O
several	O
of	O
the	O
signal	O
-	O
transduction	O
events	O
involved	O
in	O
the	O
apoptosis	O
of	O
malignant	O
B	O
cells	O
that	O
transpire	O
following	O
ligation	O
of	O
CD20	B
by	O
anti	B
-	I
CD20	I
antibodies	I
in	O
the	O
presence	O
of	O
Fc	B
-	I
receptor	I
-	I
expressing	O
cells	O
or	O
secondary	O
goat	O
anti	B
-(	I
mouse	I
Ig	I
)	I
antibodies	I
and	O
which	O
may	O
contribute	O
to	O
the	O
tumor	O
regressions	O
observed	O
in	O
mouse	O
models	O
and	O
clinical	O
trials	O
.	O

Recently	O
,	O
identical	O
RBE	O
sequences	O
have	O
been	O
identified	O
at	O
other	O
locations	O
in	O
the	O
human	O
genome	O
.	O

In	O
vivo	O
dimethyl	O
sulfate	O
footprinting	O
of	O
the	O
cyclin	B
E	I
promoter	I
revealed	O
several	O
regions	O
of	O
protection	O
and	O
hypersensitivity	O
that	O
were	O
unique	O
to	O
infected	O
cells	O
.	O

METHODS	O
:	O
The	O
most	O
distal	O
muscle	O
fibres	O
from	O
the	O
deep	O
and	O
superficial	O
finger	O
flexors	O
were	O
measured	O
relative	O
to	O
the	O
pisiform	O
bone	O
in	O
18	O
cadaveric	O
specimens	O
.	O

METHODS	O
:	O
We	O
determined	O
an	O
odds	O
ratio	O
(	O
OR	O
),	O
as	O
a	O
measure	O
of	O
the	O
relative	O
risk	O
of	O
being	O
exposed	O
to	O
a	O
potential	O
interaction	O
,	O
comparing	O
the	O
use	O
of	O
the	O
H2	B
-	I
receptor	I
antagonist	O
,	O
cimetidine	O
,	O
with	O
that	O
of	O
the	O
noninteracting	O
agents	O
ranitidine	O
,	O
famotidine	O
and	O
nizatidine	O
in	O
users	O
and	O
nonusers	O
of	O
warfarin	O
,	O
phenytoin	O
and	O
theophylline	O
.	O

The	O
prevalence	O
of	O
malnutrition	O
was	O
30	O
%	O
in	O
the	O
47	O
patients	O
without	O
CVD	O
and	O
was	O
significantly	O
higher	O
(	O
70	O
%,	O
P	O
<	O
0	O
.	O
001	O
)	O
in	O
the	O
70	O
patients	O
with	O
CVD	O
,	O
who	O
also	O
had	O
lower	O
tHcy	O
,	O
SAlb	O
,	O
plasma	O
IGF	B
-	I
1	I
,	O
serum	O
creatinine	O
(	O
SCr	O
),	O
and	O
blood	O
hemoglobin	B
.	O

Our	O
data	O
suggest	O
that	O
,	O
at	O
least	O
at	O
high	O
temperature	O
,	O
a	O
critical	O
minimal	O
level	O
of	O
Ypt	B
protein	I
prenylation	O
is	O
required	O
for	O
maintaining	O
vesicle	O
polarization	O
.	O

A	O
distinct	O
staining	O
pattern	O
for	O
the	O
N	B
-	I
utrophin	I
was	O
not	O
detectable	O
,	O
although	O
it	O
was	O
expected	O
to	O
localise	O
at	O
the	O
actin	B
stress	O
fibers	O
.	O

These	O
data	O
show	O
that	O
the	O
alpha	B
-	I
helix	I
domain	I
of	O
p57	B
(	O
Kip2	B
),	O
which	O
is	O
conserved	O
in	O
the	O
Cip	B
/	O
Kip	B
proteins	I
,	O
is	O
implicated	O
in	O
protein	B
-	I
protein	I
interaction	O
and	O
confers	O
a	O
specific	O
regulatory	O
mechanism	O
,	O
outside	O
of	O
their	O
Cdk	B
-	I
inhibitory	I
activity	O
,	O
by	O
which	O
the	O
p57	B
(	O
Kip2	B
)	I
family	I
members	O
positively	O
act	O
on	O
myogenic	O
differentiation	O
.	O

The	O
mode	O
of	O
resistance	O
to	O
quinupristin	O
/	O
dalfopristin	O
was	O
not	O
evident	O
(	O
sat	O
A	O
-	O
negative	O
by	O
PCR	O
);	O
and	O
these	O
cases	O
illustrate	O
the	O
existence	O
of	O
streptogramin	O
-	O
resistant	O
isolates	O
before	O
the	O
introduction	O
of	O
this	O
antimicrobial	O
class	O
into	O
human	O
clinical	O
practice	O
.	O

Recombination	O
,	O
replication	O
,	O
repair	O
:	O
from	O
complexity	O
to	O
harmony	O
.	O

Results	O
from	O
transient	O
assays	O
using	O
these	O
mutants	O
showed	O
that	O
the	O
DE1	O
received	O
signals	O
from	O
phytochromes	B
A	I
and	O
B	O
,	O
demonstrating	O
that	O
this	O
element	O
is	O
indeed	O
a	O
light	O
-	O
responsive	O
element	O
.	O

We	O
conclude	O
that	O
,	O
both	O
in	O
atrial	O
myocytes	O
and	O
in	O
Xenopus	O
oocytes	O
,	O
beta	B
-	I
adrenergic	I
stimulation	O
potentiates	O
the	O
ACh	O
-	O
evoked	O
GIRK	B
channels	I
via	O
a	O
pathway	O
that	O
involves	O
PKA	B
-	I
catalyzed	O
phosphorylation	O
downstream	O
from	O
beta	B
(	I
2	I
)	I
AR	I
.	O

Overexpressing	O
the	O
coactivator	O
,	O
SRC1a	B
or	O
GRIP1	B
,	O
further	O
enhances	O
ERRalpha1	B
-	I
induced	O
transcriptional	O
activity	O
.	O

The	O
median	O
levels	O
of	O
particles	O
with	O
50	O
%	O
cut	B
-	I
off	O
aerodynamic	O
diameters	O
of	O
10	O
(	O
PM10	O
)	O
and	O
2	O
.	O
5	O
microm	O
(	O
PM2	O
.	O
5	O
)	O
were	O
170	O
(	O
range	O
103	O
-	O
613	O
)	O
and	O
95	O
(	O
range	O
61	O
-	O
218	O
)	O
micro	O
x	O
m	O
-	O
3	O
,	O
respectively	O
.	O

Specific	O
and	O
heritable	O
genetic	O
interference	O
by	O
double	O
-	O
stranded	O
RNA	O
in	O
Arabidopsis	O
thaliana	O
.	O

Purple	O
photosynthetic	O
bacteria	O
are	O
capable	O
of	O
generating	O
cellular	O
energy	O
from	O
several	O
sources	O
,	O
including	O
photosynthesis	O
,	O
respiration	O
,	O
and	O
H	O
(	O
2	O
)	O
oxidation	O
.	O

T1	O
-	O
weighted	O
MRI	O
on	O
the	O
49th	O
postoperative	O
day	O
demonstrated	O
bilateral	O
and	O
symmetrical	O
hyperintense	O
lesions	O
in	O
the	O
globus	O
pallidus	O
.	O

CONCLUSION	O
:	O
The	O
probability	O
of	O
cardiopulmonary	O
complications	O
increases	O
significantly	O
when	O
patients	O
develop	O
class	O
1	O
HELLP	O
syndrome	O
.	O

Identification	O
of	O
an	O
AfsA	B
homologue	I
(	O
BarX	B
)	O
from	O
Streptomyces	O
virginiae	O
as	O
a	O
pleiotropic	O
regulator	O
controlling	O
autoregulator	O
biosynthesis	O
,	O
virginiamycin	O
biosynthesis	O
and	O
virginiamycin	O
M1	O
resistance	O
.	O

The	O
structural	O
study	O
of	O
peptides	O
belonging	O
to	O
the	O
terminal	O
domains	O
of	O
histone	B
H1	I
can	O
be	O
considered	O
as	O
a	O
step	O
toward	O
the	O
understanding	O
of	O
the	O
function	O
of	O
H1	O
in	O
chromatin	O
.	O

Cerebral	O
vasculitis	O
secondary	O
to	O
Crohn	O
'	O
s	O
disease	O
seems	O
to	O
be	O
a	O
very	O
rare	O
phenomenon	O
.	O

SELECTION	O
CRITERIA	O
:	O
Randomised	O
trials	O
comparing	O
children	O
undergoing	O
systematic	O
therapy	O
focusing	O
on	O
the	O
family	O
in	O
conjunction	O
with	O
asthma	O
medication	O
,	O
with	O
children	O
taking	O
asthma	O
medication	O
only	O
.	O

Sequential	O
cleavage	O
by	O
metallopeptidases	B
and	O
proteasomes	O
is	O
involved	O
in	O
processing	O
HIV	B
-	I
1	I
ENV	I
epitope	I
for	O
endogenous	O
MHC	B
class	I
I	I
antigen	I
presentation	O
.	O

Cloning	O
and	O
characterization	O
of	O
human	B
Lnk	I
,	O
an	O
adaptor	O
protein	O
with	O
pleckstrin	B
homology	I
and	I
Src	I
homology	I
2	I
domains	I
that	O
can	O
inhibit	O
T	O
cell	O
activation	O
.	O

The	O
Siglecs	B
are	O
a	O
subfamily	O
of	O
I	B
-	I
type	I
lectins	I
(	I
immunoglobulin	I
superfamily	I
proteins	I
that	O
bind	O
sugars	O
)	O
that	O
specifically	O
recognize	O
sialic	O
acids	O
.	O

This	O
activity	O
is	O
stimulated	O
by	O
complex	O
formation	O
with	O
the	O
other	O
eIF2B	B
subunits	I
.	O

In	O
the	O
SPP2	O
screening	O
test	O
,	O
a	O
few	O
plates	O
were	O
not	O
seen	O
in	O
both	O
groups	O
.	O

Consistent	O
with	O
this	O
,	O
we	O
show	O
that	O
peptides	O
representing	O
docking	O
sites	O
within	O
the	O
target	O
substrates	O
Elk	B
-	I
1	I
and	O
p90	B
(	O
rsk	B
)	O
inhibit	O
ERK	B
-	I
dependent	I
activation	O
of	O
MKP	B
-	I
3	I
.	O

C	O
.	O
elegans	O
KLP	B
-	I
11	O
/	O
OSM	B
-	I
3	I
/	O
KAP	B
-	I
1	I
:	O
orthologs	O
of	O
the	O
sea	B
urchin	I
kinesin	I
-	I
II	I
,	O
and	O
mouse	O
KIF3A	B
/	O
KIFB	B
/	O
KAP3	B
kinesin	I
complexes	I
.	O

These	O
natural	O
antisense	O
S	O
transcripts	O
co	O
-	O
exist	O
with	O
several	O
less	O
abundant	O
sense	O
S	O
transcripts	O
.	O

The	O
patients	O
who	O
presented	O
with	O
mucocutaneous	O
disease	O
also	O
had	O
low	O
CD4	B
+	I
T	I
lymphocyte	I
counts	O
,	O
and	O
most	O
of	O
them	O
had	O
AIDS	O
defining	O
illnesses	O
.	O

Endostatin	O
treatment	O
for	O
10	O
minutes	O
or	O
24	O
hours	O
induced	O
tyrosine	O
phosphorylation	O
of	O
Shb	B
and	O
formation	O
of	O
multiprotein	O
complexes	O
.	O

To	O
isolate	O
this	O
gene	O
,	O
a	O
P	B
-	I
1	I
artificial	O
chromosome	O
(	O
PAC	O
)	O
library	O
was	O
screened	O
with	O
a	O
full	B
length	I
UGT2B7	I
probe	O
and	O
a	O
clone	O
of	O
approximately	O
100	O
kb	O
in	O
length	O
was	O
isolated	O
.	O

Age	O
>/=	O
50	O
years	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
14	O
.	O
1	O
),	O
BMI	O
>/=	O
28	O
kg	O
/	O
m	O
(	O
2	O
)	O
(	O
OR	O
,	O
5	O
.	O
7	O
),	O
triglycerides	O
>/=	O
1	O
.	O
7	O
mmol	O
/	O
L	O
(	O
OR	O
,	O
5	O
),	O
and	O
alanine	B
aminotransferase	I
(	O
ALT	B
)	O
>/=	O
2N	O
(	O
OR	O
,	O
4	O
.	O
6	O
)	O
were	O
independently	O
associated	O
with	O
septal	O
fibrosis	O
.	O

Tumor	B
stages	O
were	O
IIB	O
(	O
T3	O
N0	O
)	O
in	O
52	O
%,	O
IIIA	O
in	O
15	O
%,	O
and	O
IIIB	O
in	O
27	O
%	O
of	O
patients	O
.	O

OBJECTIVE	O
:	O
To	O
determine	O
the	O
efficacy	O
and	O
safety	O
of	O
amphotericin	O
B	O
oral	O
suspension	O
(	O
ABOS	O
)	O
for	O
the	O
treatment	O
of	O
fluconazole	O
refractory	O
oral	O
candidiasis	O
in	O
persons	O
with	O
HIV	O
infection	O
.	O

The	O
experimentally	O
mapped	O
regions	O
of	O
RPB5	B
involved	O
in	O
these	O
interactions	O
correspond	O
to	O
distinct	O
and	O
surface	O
-	O
exposed	O
alpha	B
-	I
helical	O
structures	O
.	O

The	O
model	O
indicates	O
that	O
a	O
0	O
.	O
076	O
%	O
reduction	O
in	O
cigarette	O
consumption	O
is	O
associated	O
with	O
the	O
availability	O
of	O
nicotine	O
patches	O
after	O
1992	O
.	O

Phosphorylation	O
of	O
tyrosine	O
residues	O
in	O
the	O
kinase	O
domain	O
and	O
juxtamembrane	O
region	O
regulates	O
the	O
biological	O
and	O
catalytic	O
activities	O
of	O
Eph	B
receptors	I
.	O

Moreover	O
,	O
expression	O
of	O
antisense	O
Ha	B
-	I
Ras	I
or	O
dominant	O
negative	O
Raf	B
-	I
1	I
abrogated	O
the	O
mitogenic	O
effect	O
of	O
TGF	B
-	I
beta1	I
in	O
TSU	O
-	O
Pr1	O
,	O
and	O
the	O
TGF	B
-	I
beta1	I
inhibition	O
of	O
DU145	O
was	O
switched	O
to	O
stimulation	O
by	O
V12Ha	B
-	I
Ras	I
transfection	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
prostate	O
carcinomas	O
with	O
the	O
Ras	B
/	I
MAPK	I
pathway	O
activation	O
might	O
have	O
a	O
selective	O
growth	O
advantage	O
by	O
autocrine	O
TGF	B
-	I
beta1	I
production	O
.	O

Thus	O
,	O
SAG	B
appears	O
to	O
control	O
cell	O
cycle	O
progression	O
in	O
yeast	O
by	O
promoting	O
ubiquitination	O
and	O
degradation	O
of	O
cell	O
cycle	O
regulatory	O
proteins	O
.	O

SETTING	O
:	O
University	O
of	O
Paris	O
VII	O
hospital	O
.	O
Patient	O
(	O
s	O
):	O
Nine	O
women	O
had	O
embolization	O
for	O
symptomatic	O
myoma	O
,	O
with	O
12	O
pregnancies	O
observed	O
.	O

The	O
Menopause	O
-	O
Rating	O
-	O
Scale	O
(	O
MRS	O
I	O
)	O
was	O
used	O
in	O
clinical	O
practice	O
since	O
1992	O
.	O

The	O
MRS	O
II	O
meets	O
a	O
high	O
methodological	O
standard	O
as	O
an	O
instrument	O
standardized	O
in	O
the	O
population	O
.	O

The	O
protein	O
encoded	O
by	O
the	O
fruA	B
transcript	I
is	O
well	O
conserved	O
with	O
the	O
D	O
.	O
melanogaster	O
type	O
A	O
protein	O
,	O
particularly	O
the	O
BTB	B
protein	I
-	I
protein	I
-	I
binding	I
domain	I
,	O
which	O
is	O
encoded	O
by	O
exons	O
I	O
and	O
II	O
and	O
is	O
100	O
%	O
conserved	O
.	O

The	O
presence	O
of	O
such	O
a	O
putative	O
RNA	B
-	I
binding	I
domain	I
suggests	O
a	O
mechanism	O
for	O
the	O
observed	O
autoregulation	O
of	O
bacteriophage	O
T4	B
DNA	I
polymerase	I
synthesis	O
by	O
binding	O
to	O
its	O
own	O
mRNA	O
.	O

Vascular	B
endothelial	I
growth	I
factor	I
(	O
VEGF	B
),	O
a	O
potent	O
agonist	O
secreted	O
by	O
virtually	O
all	O
cells	O
,	O
controls	O
migration	O
and	O
division	O
of	O
vascular	O
endothelial	O
cells	O
.	O

Phd	B
antibody	I
-	I
immunoreactive	I
peptides	I
are	O
seen	O
in	O
light	O
-	O
adapted	O
mouse	O
retinal	O
cytosolic	O
and	O
nuclear	O
extracts	O
.	O

In	O
situ	O
hybridization	O
with	O
the	O
antisense	O
RNA	O
probes	O
further	O
supported	O
the	O
expression	O
changes	O
of	O
these	O
six	O
clones	O
and	O
localized	O
the	O
changes	O
in	O
multiple	O
germ	O
cell	O
stages	O
as	O
well	O
as	O
other	O
cell	O
types	O
(	O
Sertoli	O
,	O
interstitial	O
and	O
peritubular	O
cells	O
).	O

Mutation	O
analysis	O
demonstrates	O
that	O
the	O
motif	O
TCCCCT	O
is	O
critical	O
for	O
PyRo1	B
interaction	O
.	O

G	O
.,	O
and	O
Hyde	O
,	O
C	O
.	O

AIMS	O
:	O
To	O
evaluate	O
the	O
role	O
of	O
environmental	O
intra	O
-	O
uterine	O
factors	O
in	O
determining	O
the	O
birthweights	O
of	O
twins	O
with	O
increased	O
susceptibility	O
to	O
diabetes	O
and	O
discordant	O
for	O
abnormal	O
responses	O
to	O
the	O
oral	O
glucose	O
tolerance	O
test	O
(	O
OGTT	O
)	O
and	O
verify	O
the	O
possible	O
association	O
of	O
within	O
-	O
pair	O
birthweight	O
differences	O
and	O
metabolic	O
abnormalities	O
in	O
adult	O
life	O
.	O

In	O
NASCIS	O
III	O
,	O
a	O
randomization	O
imbalance	O
occurred	O
that	O
allocated	O
a	O
disproportionate	O
number	O
of	O
patients	O
with	O
no	O
motor	O
deficit	O
(	O
and	O
therefore	O
no	O
chance	O
for	O
recovery	O
)	O
to	O
the	O
lower	O
dose	O
control	O
group	O
.	O

GAP	B
JUNCTIONS	O
IN	O
THE	O
BRAIN	O
:	O
PREFACE	O
.	O

We	O
have	O
isolated	O
and	O
functionally	O
characterized	O
the	O
mouse	B
gene	I
for	O
the	O
C2	B
subunit	I
of	O
the	O
20S	B
proteasome	I
.	O

Furthermore	O
,	O
as	O
in	O
the	O
human	B
gene	I
,	O
the	O
3	O
'	O
end	O
of	O
the	O
Cacna1f	B
gene	I
maps	O
within	O
5	O
kb	O
of	O
the	O
5	O
'	O
end	O
of	O
the	O
mouse	B
synaptophysin	I
gene	I
in	O
a	O
region	O
orthologous	O
to	O
Xp11	O
.	O
23	O
.	O

Next	O
,	O
we	O
show	O
that	O
two	O
EMS	O
-	O
induced	O
mutations	O
,	O
previously	O
shown	O
to	O
interact	O
genetically	O
with	O
zipper	O
(	O
Ebr	B
),	O
disrupt	O
the	O
RhoA	B
locus	I
.	O

The	O
science	O
of	O
tissue	O
engineering	O
.	O

However	O
,	O
little	O
was	O
understood	O
about	O
the	O
normal	O
function	O
of	O
CREB	B
-	I
2	I
in	O
mammalian	O
development	O
or	O
organ	O
physiology	O
.	O

Both	O
the	O
MVBF	O
and	O
the	O
maximum	O
EMG	O
activity	O
in	O
the	O
right	O
masseter	O
and	O
the	O
left	O
anterior	O
temporalis	O
muscles	O
were	O
significantly	O
decreased	O
during	O
muscle	O
pain	O
when	O
the	O
subjects	O
bit	O
on	O
the	O
painful	O
side	O
.	O

The	O
total	O
alkaloids	O
contained	O
in	O
the	O
peel	O
of	O
Atzimba	O
,	O
Lopez	O
,	O
Marciana	O
,	O
Montsama	O
,	O
Murca	O
,	O
and	O
Puebla	O
was	O
lower	O
than	O
the	O
limits	O
recommended	O
for	O
food	O
safety	O
.	O

The	O
detection	O
success	O
rate	O
was	O
determined	O
for	O
different	O
markers	O
using	O
this	O
MEK	B
.	O

Screening	O
,	O
counseling	O
,	O
and	O
treatment	O
for	O
alcohol	O
and	O
illicit	O
drug	O
use	O
should	O
be	O
essential	O
components	O
in	O
comprehensive	O
HBP	O
care	O
.	O

The	O
unfolded	O
protein	O
response	O
regulates	O
multiple	O
aspects	O
of	O
secretory	O
and	O
membrane	O
protein	O
biogenesis	O
and	O
endoplasmic	O
reticulum	O
quality	O
control	O
.	O

The	O
chromosomal	O
localization	O
on	O
distal	O
chromosome	O
7	O
places	O
it	O
in	O
a	O
cluster	O
of	O
imprinted	O
genes	O
,	O
flanked	O
by	O
the	O
previously	O
described	O
Tapa1	B
and	O
Kcnq1	B
genes	I
.	O

Biochemical	O
examinations	O
of	O
calcium	O
-	O
phosphorus	O
metabolism	O
included	O
ions	O
and	O
PTH	B
concentrations	O
in	O
blood	O
serum	O
,	O
and	O
the	O
activity	O
of	O
bone	O
isoenzyme	O
of	O
AP	B
.	O

From	O
transient	O
expression	O
studies	O
,	O
we	O
could	O
demonstrate	O
that	O
the	O
SH3	B
domain	I
of	O
PLC	B
-	I
gamma1	I
is	O
necessary	O
for	O
the	O
association	O
with	O
SOS1	B
in	O
vivo	O
.	O

A	O
2	O
kb	O
transcript	O
was	O
isolated	O
from	O
brain	O
that	O
encodes	O
a	O
approximately	O
57	O
kDa	O
protein	O
;	O
the	O
predicted	O
protein	O
contains	O
the	O
known	O
N	B
-	I
terminal	I
Ets	I
domain	I
of	O
PE1	B
and	O
a	O
novel	O
C	B
-	I
terminal	I
domain	I
with	O
signficant	O
homology	O
to	O
murine	B
ERF	I
.	O

Twenty	O
eligible	O
patients	O
with	O
cirrhosis	O
were	O
randomized	O
into	O
two	O
groups	O
:	O
10	O
patients	O
treated	O
with	O
6	O
million	O
units	O
of	O
natural	O
IFN	B
-	I
beta	I
twice	O
a	O
week	O
for	O
36	O
months	O
and	O
10	O
patients	O
without	O
IFN	B
therapy	O
.	O

Intravenous	O
versus	O
oral	O
administration	O
of	O
amitriptyline	O
in	O
patients	O
with	O
major	O
depression	O
.	O

While	O
interactions	O
of	O
WT	O
and	O
variant	O
TGF	B
-	I
alpha	I
with	O
the	O
ErbBs	B
all	O
result	O
in	O
ErbB2	B
activation	O
,	O
they	O
produce	O
different	O
biological	O
consequences	O
,	O
suggesting	O
that	O
the	O
various	O
TGF	B
-	I
alpha	I
precursors	I
differentially	O
modulate	O
ErbB	B
signaling	O
.	O

Whereas	O
MARTA1	B
is	O
clearly	O
detectable	O
in	O
crude	O
lysates	O
,	O
cytosolic	O
and	O
ribosomal	O
salt	O
-	O
wash	O
fractions	O
,	O
and	O
in	O
nuclear	O
extracts	O
,	O
MARTA2	B
is	O
preferentially	O
found	O
in	O
the	O
ribosomal	O
salt	O
-	O
wash	O
preparation	O
.	O

Five	O
of	O
the	O
PDP1	B
isoforms	I
differ	O
by	O
the	O
substitution	O
or	O
insertion	O
of	O
amino	O
acids	O
at	O
or	O
near	O
the	O
N	O
-	O
terminal	O
of	O
the	O
protein	O
.	O

We	O
recently	O
reported	O
the	O
molecular	O
cloning	O
of	O
a	O
PL	B
scramblase	I
of	O
human	O
(	O
HuPLSCR1	B
)	O
and	O
mouse	O
origin	O
,	O
respectively	O
.	O

Using	O
an	O
oligomer	O
duplex	O
5	O
'-	O
A	O
(	O
GGGTTA	O
)(	O
5	O
)-	O
3	O
'/	O
5	O
'-(	O
TAACCC	O
)(	O
5	O
)	O
T	O
-	O
3	O
'	O
as	O
a	O
template	O
-	O
primer	O
,	O
we	O
show	O
that	O
both	O
the	O
Klenow	B
fragment	I
of	O
Escherichia	B
coli	I
DNA	I
polymerase	I
I	I
and	O
HIV	B
reverse	I
transcriptase	I
could	O
expand	O
telomere	O
DNA	O
sequences	O
as	O
well	O
,	O
giving	O
products	O
greater	O
than	O
the	O
size	O
of	O
the	O
template	O
DNA	O
.	O

Despite	O
these	O
limitations	O
the	O
CHIME	O
monitor	O
provides	O
an	O
opportunity	O
to	O
record	O
physiological	O
data	O
previously	O
unavailable	O
in	O
the	O
home	O
.	O

CREST	O
syndrome	O
;	O
a	O
changing	O
clinical	O
significance	O

X	O
-	O
ray	O
crystallographic	O
data	O
show	O
that	O
the	O
PLZF	B
BTB	I
/	I
POZ	O
domain	O
forms	O
an	O
obligate	O
homodimer	O
via	O
an	O
extensive	O
interface	O
.	O

Mis3	B
is	O
needed	O
for	O
the	O
formation	O
of	O
18S	B
ribosome	I
RNA	I
,	O
and	O
may	O
hence	O
direct	O
the	O
level	O
of	O
proteins	O
required	O
for	O
the	O
coupling	O
.	O

CONCLUSION	O
:	O
Vitrectomy	O
for	O
vitreous	O
hemorrhage	O
in	O
Terson	O
syndrome	O
is	O
a	O
safe	O
and	O
effective	O
procedure	O
,	O
offering	O
a	O
rapid	O
and	O
prolonged	O
improvement	O
in	O
vision	O
.	O

To	O
facilitate	O
manipulation	O
of	O
large	O
genomic	O
sequences	O
,	O
we	O
developed	O
a	O
method	O
of	O
converting	O
Escherichia	O
coli	O
P1	O
artificial	O
chromosomes	O
(	O
PACs	O
)	O
into	O
yeast	O
artificial	O
chromosomes	O
(	O
YACs	O
).	O

A	O
2	O
.	O
3	O
-	O
kb	O
full	B
-	I
length	I
cDNA	I
clone	O
of	O
an	O
Atlantic	B
halibut	I
Mx	I
gene	I
was	O
isolated	O
from	O
a	O
liver	O
cDNA	O
library	O
.	O

The	O
reduced	O
efficiency	O
in	O
the	O
glycosylase	B
activity	O
is	O
also	O
reflected	O
in	O
a	O
reduced	O
ability	O
of	O
S120K	B
MutY	I
to	O
prevent	O
DNA	O
mutations	O
in	O
vivo	O
.	O

This	O
intracellular	O
signaling	O
,	O
known	O
as	O
the	O
unfolded	O
protein	O
response	O
(	O
UPR	O
),	O
is	O
mediated	O
by	O
the	O
cis	O
-	O
acting	O
ER	O
stress	O
response	O
element	O
(	O
ERSE	O
)	O
in	O
mammals	O
.	O

The	O
spacing	O
of	O
the	O
essential	O
N	O
-	O
terminal	O
domain	O
(	O
END	O
)	O
relative	O
to	O
the	O
HFD	B
can	O
be	O
changed	O
significantly	O
without	O
an	O
apparent	O
effect	O
on	O
Cse4p	B
function	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
the	O
level	O
of	O
oxidative	O
stress	O
in	O
healthy	O
controls	O
(	O
CTL	O
)	O
compared	O
with	O
CRF	O
and	O
HD	O
patients	O
before	O
(	O
pre	O
-	O
HD	O
)	O
and	O
after	O
(	O
post	O
-	O
HD	O
)	O
the	O
dialysis	O
session	O
,	O
carried	O
out	O
on	O
a	O
high	O
biocompatible	O
polyacrylonitrile	O
membrane	O
AN69	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
expression	O
of	O
Cktsf1b1	B
,	O
a	O
gene	O
associated	O
with	O
early	O
development	O
and	O
cell	O
transformation	O
,	O
is	O
sensitive	O
to	O
MKK	B
levels	O
and	O
may	O
be	O
regulated	O
via	O
multiple	O
transcription	O
factor	O
complexes	O
.	O

Because	O
GH	B
-	I
induced	O
Akt	B
activation	O
was	O
completely	O
inhibited	O
in	O
both	O
cells	O
by	O
the	O
same	O
concentration	O
of	O
LY294002	O
,	O
these	O
findings	O
indicate	O
that	O
the	O
wortmannin	O
sensitivity	O
of	O
both	O
the	O
IRS	B
-	I
1	I
-	I
independent	O
and	O
-	O
dependent	O
GH	B
-	I
induced	O
MAP	B
kinase	I
activation	O
may	O
reflect	O
the	O
activity	O
of	O
another	O
wortmannin	O
-	O
sensitive	O
target	O
(	O
s	O
)	O
in	O
addition	O
to	O
PI3K	B
in	O
mediation	O
of	O
GH	B
-	I
induced	O
MAP	B
kinase	I
activation	O
in	O
these	O
cells	O
.	O

Abrogation	O
of	O
p53	B
function	O
by	O
E6	B
resulted	O
in	O
an	O
increase	O
in	O
the	O
spontaneous	O
mutation	O
frequencies	O
at	O
the	O
heterozygous	O
thymidine	B
kinase	I
(	O
TK	B
)	I
locus	I
but	O
not	O
at	O
the	O
hemizygous	O
hypoxanthine	B
phosphoribosyl	I
transferase	I
(	O
HPRT	B
)	I
locus	I
.	O

RESULTS	O
:	O
No	O
significant	O
deformation	O
in	O
vertebral	O
artery	O
flow	O
was	O
noted	O
in	O
the	O
flexion	O
-	O
distraction	O
Stage	O
I	O
injuries	O
within	O
the	O
physiologic	O
range	O
of	O
cervical	O
flexion	O
.	O

The	O
human	O
cDNA	O
clone	O
NFBD1	O
(	O
previously	O
designated	O
KIAA0170	O
)	O
encodes	O
a	O
novel	O
protein	O
(	O
2089	O
amino	O
acids	O
in	O
length	O
;	O
calculated	O
molecular	O
mass	O
226	O
,	O
440	O
D	O
)	O
with	O
possible	O
BRCT	B
domains	I
at	O
its	O
carboxy	O
terminus	O
(	O
amino	O
acid	O
residues	O
1894	O
-	O
2089	O
).	O

RESULTS	O
:	O
Neither	O
basal	O
FSH	B
level	O
nor	O
stimulated	O
FSH	B
level	O
alone	O
were	O
statistically	O
significant	O
predictors	O
of	O
IVF	O
success	O
;	O
however	O
,	O
no	O
patient	O
with	O
a	O
day	O
3	O
FSH	B
level	O
>	O
11	O
.	O
1	O
mIU	O
/	O
ml	O
or	O
a	O
stimulated	O
day	O
10	O
FSH	B
level	O
>	O
13	O
.	O
5	O
mIU	O
/	O
ml	O
conceived	O
and	O
carried	O
a	O
pregnancy	O
.	O

Linking	O
continuous	O
community	O
-	O
based	O
morbidity	O
recording	O
of	O
influenza	B
-	I
like	I
illness	O
(	O
ILI	O
)	O
with	O
virological	O
sampling	O
has	O
consistently	O
proved	O
its	O
value	O
as	O
one	O
of	O
the	O
earliest	O
indicators	O
of	O
circulating	O
influenza	O
activity	O
.	O

Mucosal	O
application	O
of	O
NCX	O
-	O
4016	O
,	O
however	O
,	O
did	O
not	O
cause	O
PD	O
reduction	O
and	O
luminal	O
H	O
+	O
loss	O
,	O
but	O
produced	O
a	O
marked	O
hyperemia	O
,	O
resulting	O
in	O
no	O
damage	O
in	O
the	O
stomach	O
of	O
both	O
normal	O
and	O
STZ	O
-	O
diabetic	O
rats	O
.	O

No	O
specific	O
subgroup	O
of	O
clients	O
benefited	O
more	O
from	O
URD	O
,	O
although	O
a	O
prospective	O
study	O
employing	O
random	O
assignment	O
might	O
be	O
more	O
successful	O
in	O
identifying	O
such	O
a	O
group	O
.	O

In	O
the	O
lattice	O
,	O
23	O
%	O
of	O
the	O
sites	O
are	O
occupied	O
,	O
95	O
%	O
of	O
the	O
atoms	O
are	O
in	O
the	O
lowest	O
energy	O
magnetic	O
sublevel	O
,	O
and	O
37	O
%	O
are	O
in	O
the	O
lowest	O
3D	O
vibrational	O
state	O
.	O

The	O
Spo0F	B
residues	O
making	O
up	O
the	O
hydrophobic	O
patch	O
are	O
very	O
similar	O
in	O
all	O
response	O
regulators	O
suggesting	O
that	O
the	O
binding	O
is	O
initiated	O
through	O
the	O
same	O
residues	O
in	O
all	O
interacting	O
response	O
regulator	B
-	I
kinase	I
pairs	O
.	O

Quantitative	O
evaluation	O
of	O
magneto	O
-	O
optical	O
parameters	O
is	O
necessary	O
in	O
order	O
to	O
apply	O
scanning	O
near	O
-	O
field	O
optical	O
microscope	O
(	O
SNOM	O
)	O
technology	O
to	O
the	O
study	O
of	O
magnetism	O
on	O
the	O
mesoscopic	O
scale	O
.	O

The	O
variable	O
phenotype	O
of	O
the	O
allotetraploids	O
could	O
not	O
be	O
explained	O
by	O
cytological	O
abnormalities	O
.	O

Analysis	O
of	O
intron	O
/	O
exon	O
boundaries	O
of	O
the	O
genomic	O
BAC	O
clones	O
demonstrate	O
that	O
junctin	B
,	O
junctate	B
,	O
and	O
aspartyl	B
beta	I
-	I
hydroxylase	I
result	O
from	O
alternative	O
splicing	O
of	O
the	O
same	O
gene	O
.	O

It	O
is	O
now	O
estimated	O
that	O
inactivation	O
mutants	O
of	O
PTEN	B
exist	O
in	O
60	O
%	O
of	O
all	O
forms	O
of	O
solid	O
tumors	O
.	O

The	O
growth	B
factor	I
receptor	I
-	I
bound	I
protein	I
2	I
(	I
Grb2	I
)	I
adaptor	I
when	O
complexed	O
with	O
Sos	B
(	O
Son	B
of	I
sevenless	I
),	O
the	O
exchange	O
factor	O
of	O
Ras	B
,	O
conveys	O
the	O
signal	O
induced	O
by	O
tyrosine	B
kinase	I
-	I
activated	I
receptor	I
to	O
Ras	B
by	O
recruiting	O
Sos	B
to	O
the	O
membrane	O
,	O
allowing	O
activation	O
of	O
Ras	B
.	O

Perceptual	O
learning	O
for	O
a	O
pattern	O
discrimination	O
task	O
.	O

While	O
this	O
Saccharomyces	O
cerevisiae	O
SIN4	B
gene	I
product	I
is	O
a	O
component	O
of	O
a	O
mediator	O
complex	O
associated	O
with	O
RNA	B
polymerase	I
II	I
,	O
various	O
studies	O
suggest	O
the	O
involvement	O
of	O
Sin4	B
in	O
the	O
alteration	O
of	O
higher	O
-	O
order	O
chromatin	O
structure	O
.	O

The	O
use	O
of	O
the	O
PLCgamma	B
inhibitory	I
peptide	I
,	O
neomycin	O
and	O
the	O
calcium	O
chelator	O
BAPTA	O
-	O
AM	O
on	O
oocytes	O
expressing	O
FGFR1	B
or	O
the	O
stimulation	O
by	O
PDGF	B
-	I
BB	I
of	O
oocytes	O
expressing	O
PDGFR	B
-	O
FGFR1	B
mutated	O
on	O
the	O
PLCgamma	B
binding	I
site	I
,	O
prevented	O
GVBD	O
and	O
ERK2	B
phosphorylation	O
.	O

To	O
determine	O
whether	O
interaction	O
of	O
arsenite	O
with	O
the	O
hormone	O
-	O
binding	O
domain	O
results	O
in	O
receptor	O
activation	O
,	O
COS	O
-	O
1	O
cells	O
were	O
transiently	O
cotransfected	O
with	O
the	O
chimeric	B
receptors	I
GAL	I
-	I
ER	I
,	O
which	O
contains	O
the	O
hormone	O
-	O
binding	O
domain	O
of	O
ERalpha	B
and	O
the	O
DNA	B
-	I
binding	I
domain	I
of	O
the	O
transcription	O
factor	O
GAL4	B
,	O
and	O
a	O
GAL4	B
-	I
responsive	I
CAT	I
reporter	I
gene	I
.	O

We	O
could	O
demonstrate	O
the	O
involvement	O
of	O
cAMP	B
-	I
dependent	I
protein	I
kinase	I
(	O
PKA	B
)	O
in	O
the	O
phosphorylation	O
of	O
CDC25Mm	B
in	O
fibroblasts	O
overexpressing	O
this	O
RasGEF	B
as	O
well	O
as	O
in	O
mouse	O
brain	O
synaptosomal	O
membranes	O
.	O

The	O
cost	O
per	O
test	O
is	O
less	O
than	O
those	O
for	O
CC	O
,	O
kEIA	O
and	O
PACE2	O
.	O

Altogether	O
these	O
results	O
suggest	O
that	O
,	O
in	O
KG1a	O
cells	O
,	O
TNFalpha	B
can	O
stimulate	O
in	O
parallel	O
PC	B
-	I
PLC	I
and	O
PLD	O
,	O
whose	O
lipid	O
products	O
activate	O
in	O
turn	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	I
MAP	I
kinase	I
)	O
and	O
NF	B
-	I
kappaB	I
signalling	O
respectively	O
.	O

Concurrently	O
,	O
we	O
monitored	O
weather	O
conditions	O
and	O
used	O
time	O
-	O
activity	O
budget	O
data	O
of	O
free	O
-	O
living	O
birds	O
and	O
laboratory	O
data	O
on	O
resting	O
metabolic	O
rate	O
to	O
construct	O
time	O
-	O
activity	O
laboratory	O
(	O
TAL	O
)	O
estimates	O
of	O
daily	O
energy	O
expenditure	O
(	O
DEE	O
)	O
and	O
to	O
partition	O
the	O
verdins	O
'	O
energy	O
budget	O
into	O
thermoregulatory	O
,	O
activity	O
and	O
basal	O
components	O
.	O

When	O
cotransfected	O
in	O
fibroblasts	O
with	O
a	O
C	B
/	I
EBP	I
alpha	I
expression	O
vector	O
,	O
reporter	O
gene	O
expression	O
increased	O
3	O
-	O
fold	O
only	O
in	O
the	O
wild	B
-	I
type	I
constructs	I
.	O

In	O
transient	O
analysis	O
using	O
particle	O
bombardment	O
of	O
tobacco	O
leaf	O
sections	O
,	O
a	O
tetramer	O
of	O
the	O
distB	O
ABRE	O
(	O
abscisic	O
acid	O
-	O
responsive	O
element	O
)	O
mediated	O
transactivation	O
by	O
ABI3	B
and	O
ABI3	B
-	I
dependent	I
response	I
to	O
ABA	O
,	O
whereas	O
a	O
tetramer	O
of	O
the	O
composite	O
RY	O
/	O
G	O
complex	O
,	O
containing	O
RY	O
repeats	O
and	O
a	O
G	B
-	I
box	I
,	O
mediated	O
only	O
ABA	O
-	O
independent	O
transactivation	O
by	O
ABI3	B
.	O

The	O
LMW	B
FGF	I
-	I
2	I
up	O
-	O
regulated	O
the	O
PKC	B
epsilon	I
levels	O
by	O
1	O
.	O
6	O
-	O
fold	O
;	O
by	O
contrast	O
the	O
HMW	B
isoform	I
down	O
-	O
regulated	O
the	O
level	O
of	O
this	O
PKC	B
isotype	I
by	O
about	O
3	O
-	O
fold	O
and	O
increased	O
the	O
amount	O
of	O
PKC	B
delta	I
by	O
1	O
.	O
7	O
-	O
fold	O
.	O

Helicobacter	O
pylori	O
and	O
stomach	O
diseases	O
:	O
from	O
clinical	O
point	O
of	O
view	O

In	O
vitro	O
,	O
Arix	B
and	O
NBPhox	B
form	O
DNA	O
-	O
independent	O
multimers	O
and	O
exhibit	O
cooperative	O
binding	O
to	O
the	O
DB1	B
regulatory	I
element	I
,	O
which	O
contains	O
two	O
homeodomain	B
recognition	I
sites	I
.	O

We	O
conclude	O
from	O
this	O
study	O
that	O
Arix	B
and	O
NBPhox	B
exhibit	O
indistinguishable	O
and	O
independent	O
transcriptional	O
regulatory	O
properties	O
on	O
the	O
DBH	B
promoter	I
.	O

Catch	O
-	O
up	O
growth	O
and	O
craniofacial	O
dimensions	O
following	O
administration	O
of	O
the	O
antineoplastic	O
agent	O
vincristine	O
to	O
young	O
rats	O
.	O

CONCLUSIONS	O
:	O
LSCC	O
malformation	O
,	O
like	O
other	O
inner	O
ear	O
malformations	O
such	O
as	O
large	O
vestibular	O
aqueduct	O
and	O
X	O
-	O
linked	O
mixed	O
deafness	O
with	O
perilymph	O
gusher	O
,	O
can	O
be	O
associated	O
with	O
CHL	O
,	O
SNHL	O
,	O
or	O
normal	O
hearing	O
.	O

The	O
present	O
study	O
shows	O
that	O
phosphatidylinositol	B
3	I
-	I
kinase	I
-	I
dependent	O
p38	B
kinase	I
activation	O
regulates	O
Akt	B
phosphorylation	O
and	O
activity	O
in	O
human	O
neutrophils	O
.	O

Another	O
cis	O
-	O
acting	O
element	O
,	O
exonic	O
splicing	O
suppressor	O
1	O
(	O
ESS1	O
),	O
represses	O
use	O
of	O
the	O
nt	O
3225	O
3	O
'	O
splice	O
site	O
.	O

Fisher	O
'	O
s	O
exact	O
test	O
or	O
Pearson	O
'	O
s	O
chi2	O
test	O
were	O
used	O
for	O
statistical	O
analysis	O
.	O

These	O
results	O
provide	O
direct	O
evidence	O
for	O
differential	O
susceptibility	O
to	O
endonuclease	O
-	O
mediated	O
mRNA	O
decay	O
resulting	O
from	O
the	O
differential	O
affinity	O
of	O
a	O
RNA	B
-	I
binding	I
protein	I
for	O
cis	O
-	O
acting	O
stability	O
determinants	O
.	O

Expression	O
of	O
a	O
hybrid	O
protein	O
containing	O
the	O
cytoplasmic	O
C	O
-	O
terminal	O
half	O
of	O
UhpB	B
fused	O
to	O
glutathione	B
S	I
-	I
transferase	I
(	O
GST	B
)	O
also	O
interfered	O
with	O
Uhp	B
signaling	O
.	O

MED1	B
has	O
a	O
weak	O
glycosylase	B
activity	O
on	O
the	O
mutagenic	O
adduct	O
3	O
,	O
N	O
(	O
4	O
)-	O
ethenocytosine	O
,	O
a	O
metabolite	O
of	O
vinyl	O
chloride	O
and	O
ethyl	O
carbamate	O
.	O

Epidermal	B
growth	I
factor	I
receptor	I
transcriptionally	O
up	O
-	O
regulates	O
vascular	B
endothelial	I
growth	I
factor	I
expression	O
in	O
human	O
glioblastoma	O
cells	O
via	O
a	O
pathway	O
involving	O
phosphatidylinositol	B
3	I
'-	I
kinase	I
and	O
distinct	O
from	O
that	O
induced	O
by	O
hypoxia	O
.	O

Stress	B
-	I
activated	I
protein	I
kinase	I
1	I
(	O
SAPK1	B
),	O
also	O
called	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
(	O
JNK	B
),	O
becomes	O
activated	O
in	O
vivo	O
in	O
response	O
to	O
pro	O
-	O
inflammatory	O
cytokines	O
or	O
cellular	O
stresses	O
.	O

These	O
two	O
mAbs	O
used	O
the	O
same	O
V	O
(	O
H	O
)	O
and	O
J	O
(	O
H	B
)	I
gene	I
segments	O
,	O
but	O
different	O
D	O
,	O
Vkappa	O
,	O
and	O
Jkappa	B
genes	I
.	O

Abbreviations	O
:	O
CAS	O
,	O
CRK	B
-	I
associated	I
substrate	I
;	O
CH	B
,	O
calponin	B
-	I
homology	I
domain	I
;	O
CSK	B
,	I
C	I
-	I
terminal	I
SRC	I
kinase	I
;	O
E6	B
,	O
Papillomavirus	B
E6	I
protein	I
;	O
FAK	B
,	O
focal	B
adhesion	I
kinase	I
;	O
GIT	O
,	O
GRK	B
interacter	I
;	O
GPCR	B
,	O
heterotrimeric	B
-	I
G	I
-	I
protein	I
-	I
coupled	I
receptor	I
;	O
GRK	B
,	O
G	B
-	I
protein	I
-	I
coupled	I
-	I
receptor	I
kinase	I
;	O
MAPK	B
,	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	O
ERK	B
,	O
p38	B
,	O
JNK	B
);	O
PAK	B
,	O
p21	B
-	I
activated	I
kinase	I
;	O
PBS	O
,	O
paxillin	B
-	I
binding	I
subdomain	I
;	O
PIX	B
,	O
PAK	B
-	I
interacting	I
exchange	I
factor	I
;	O
PKL	B
,	O
paxillin	B
kinase	I
linker	I
;	O
POR1	B
,	O
partner	O
of	O
Rac	B
;	O
PS	O
,	O
phosphoserine	O
;	O
PT	O
,	O
phosphothreonine	O
;	O
PY	O
,	O
phosphotyrosine	O
;	O
RTK	B
,	I
growth	I
factor	I
receptor	I
tyrosine	I
kinase	I
;	O
SH	O
,	O
SRC	B
-	I
homology	I
domain	I
.	O

There	O
were	O
122	O
cases	O
of	O
tuberculosis	O
over	O
an	O
average	O
10	O
.	O
3	O
yr	O
of	O
follow	O
-	O
up	O
(	O
crude	O
annual	O
incidence	O
,	O
76	O
.	O
2	O
/	O
100	O
,	O
000	O
).	O

The	O
U17	B
/	O
U16	B
and	O
the	O
U16	B
+	I
gene	I
products	I
transactivated	O
the	O
HIV	B
LTR	I
.	O

Thus	O
,	O
blocks	O
in	O
the	O
RARalpha	B
-	I
specific	I
pathway	O
of	O
retinoid	B
-	I
induced	O
differentiation	O
may	O
be	O
bypassed	O
during	O
retinoid	O
induction	O
of	O
FR	B
-	I
beta	I
expression	O
.	O

To	O
test	O
whether	O
or	O
not	O
SOCS	B
-	I
3	I
also	O
binds	O
to	O
the	O
IGFIR	B
,	O
we	O
cloned	O
human	B
SOCS	I
-	I
3	I
by	O
reverse	B
transcription	I
-	I
polymerase	I
chain	I
reaction	O
from	O
human	B
skeletal	I
muscle	I
mRNA	I
.	O

A	O
protein	O
lacking	O
the	O
SH2	B
and	I
RING	I
finger	I
domains	I
has	O
no	O
activity	O
,	O
but	O
a	O
chimeric	O
protein	O
with	O
the	O
SH2	B
and	I
RING	I
finger	I
domains	I
of	O
SLI	B
-	I
1	I
replaced	O
by	O
the	O
equivalent	O
domains	O
of	O
c	B
-	I
Cbl	I
has	O
activity	O
.	O

Tightly	O
ordered	O
proteasomal	O
degradation	O
of	O
proteins	O
critical	O
for	O
cell	O
cycle	O
control	O
implies	O
a	O
role	O
of	O
the	O
proteasome	O
in	O
maintaining	O
cell	O
proliferation	O
and	O
cell	O
survival	O
.	O

The	O
Psc2	B
cDNA	I
contained	O
an	O
open	O
reading	O
frame	O
homologous	O
to	O
CP2	B
family	I
proteins	I
.	O

In	O
addition	O
,	O
npm3	B
,	O
which	O
is	O
usually	O
coactivated	O
with	O
fgf8	B
by	O
MMTV	O
insertion	O
,	O
was	O
not	O
up	O
-	O
regulated	O
by	O
androgens	O
in	O
SC	O
-	O
3	O
cells	O
.	O

Interestingly	O
,	O
this	O
mutant	O
cell	O
line	O
lacks	O
expression	O
of	O
the	O
IKK	B
regulatory	I
protein	I
,	O
IKKgamma	B
.	O

The	O
Tax	B
/	O
IKKgamma	B
interaction	O
serves	O
to	O
recruit	O
Tax	B
to	O
the	O
IKK	B
catalytic	I
subunits	I
,	O
IKKalpha	B
and	O
IKKbeta	B
,	O
and	O
this	O
recruitment	O
appears	O
to	O
be	O
an	O
essential	O
mechanism	O
by	O
which	O
Tax	B
stimulates	O
the	O
activity	O
of	O
IKK	B
.	O

Ten	O
males	O
performed	O
both	O
test	O
conditions	O
and	O
oxygen	O
uptake	O
VO2	O
,	O
heart	O
rate	O
,	O
minute	O
ventilation	O
VE	O
,	O
perceived	O
exertion	O
and	O
spinal	O
shrinkage	O
were	O
recorded	O
.	O

DNA	O
binding	O
and	O
glutathione	B
S	I
-	I
transferase	I
pull	O
-	O
down	O
assays	O
demonstrate	O
that	O
binding	O
requires	O
Elk	B
-	I
1	I
(	I
1	I
-	I
212	I
)	O
but	O
not	O
the	O
C	O
-	O
terminal	O
transactivation	O
domain	O
.	O

Transformation	O
of	O
the	O
sconC3	B
mutant	I
with	O
sconB	B
+	I
restores	O
the	O
wild	B
-	I
type	I
phenotype	O
.	O

Influence	O
of	O
oil	O
emulsions	O
and	O
diphenyl	O
on	O
post	O
-	O
harvest	O
physiconutritional	O
changes	O
in	O
Kagzi	O
limes	O
(	O
Citrus	O
aurantifolia	O
)	O
was	O
studied	O
.	O

The	O
non	O
-	O
homologous	O
sequences	O
in	O
the	O
5	O
'	O
untranslated	O
regions	O
might	O
be	O
acquired	O
at	O
or	O
after	O
transcription	O
during	O
retrotransposition	O
of	O
the	O
ATLN	O
elements	O
.	O

In	O
addition	O
,	O
our	O
results	O
show	O
that	O
ERKs	B
and	O
PI3Ks	B
can	O
synergise	O
to	O
convert	O
ectoderm	O
into	O
mesoderm	O
.	O

Based	O
on	O
16S	B
rRNA	I
gene	I
sequence	I
analysis	O
,	O
the	O
11	O
species	O
having	O
two	O
tuf	B
genes	I
all	O
have	O
a	O
common	O
ancestor	O
,	O
while	O
the	O
six	O
species	O
having	O
only	O
one	O
copy	O
diverged	O
from	O
the	O
enterococcal	O
lineage	O
before	O
that	O
common	O
ancestor	O
.	O

Subsequently	O
,	O
we	O
show	O
that	O
the	O
reexpression	O
of	O
the	O
r	B
-	I
PTPeta	I
gene	I
in	O
highly	O
malignant	O
rat	O
thyroid	O
cells	O
transformed	O
by	O
retroviruses	O
carrying	O
the	O
v	B
-	I
mos	I
and	O
v	B
-	I
ras	I
-	I
Ki	I
oncogenes	I
suppresses	O
their	O
malignant	O
phenotype	O
.	O

Induced	O
expression	O
of	O
Rnd3	B
is	O
associated	O
with	O
transformation	O
of	O
polarized	O
epithelial	O
cells	O
by	O
the	O
Raf	B
-	I
MEK	I
-	I
extracellular	I
signal	I
-	I
regulated	I
kinase	I
pathway	O
.	O

NH2	O
-	O
terminal	O
trimming	O
of	O
Xenopus	O
and	O
mammalian	B
FGF3s	I
may	O
therefore	O
be	O
a	O
prerequisite	O
of	O
optimal	O
biological	O
activity	O
.	O

Here	O
,	O
we	O
identified	O
three	O
cis	O
-	O
elements	O
required	O
for	O
replication	O
within	O
the	O
200	O
bp	O
promoter	O
,	O
using	O
autonomously	O
replicating	O
plasmids	O
carrying	O
various	O
mutations	O
and	O
deletions	O
.	O

The	O
Aie1	B
locus	I
was	O
mapped	O
to	O
mouse	O
chromosome	O
7A2	O
-	O
A3	O
by	O
fluorescent	O
in	O
situ	O
hybridization	O
.	O

Thyrotoxicosis	O
due	O
to	O
amiodarone	O
is	O
difficult	O
to	O
treat	O
and	O
is	O
further	O
complicated	O
by	O
the	O
pro	O
-	O
arrhythmic	O
potential	O
of	O
thyrotoxicosis	O
and	O
the	O
fading	O
antiarrhythmic	O
effect	O
after	O
amiodarone	O
withdrawal	O
.	O

Chaperones	O
/	O
HSPs	B
thus	O
play	O
important	O
roles	O
within	O
cell	O
cycle	O
processes	O
.	O

This	O
study	O
allows	O
us	O
to	O
draw	O
conclusions	O
about	O
the	O
identity	O
of	O
proteins	O
required	O
for	O
the	O
development	O
of	O
the	O
nervous	O
system	O
in	O
Drosophila	O
and	O
provides	O
an	O
example	O
of	O
a	O
molecular	O
approach	O
to	O
characterize	O
en	O
masse	O
transposon	O
-	O
tagged	O
mutations	O
identified	O
in	O
genetic	O
screens	O
.	O

Where	O
UMDNJ	O
is	O
headed	O
.	O

CONCLUSION	O
:	O
Our	O
results	O
suggest	O
that	O
AIF	O
peak	O
saturation	O
leads	O
to	O
a	O
significant	O
systematic	O
error	O
in	O
the	O
determination	O
of	O
CBV	O
and	O
CBF	O
values	O
and	O
has	O
necessarily	O
to	O
be	O
taken	O
into	O
account	O
for	O
dynamic	O
contrast	O
-	O
enhanced	O
MR	O
perfusion	O
studies	O
.	O

Toward	O
this	O
end	O
,	O
we	O
prepared	O
synthetic	O
proteins	O
with	O
either	O
the	O
catalytic	O
domain	O
of	O
FAP	B
-	I
1	I
(	I
C	I
-	I
terminal	I
399	I
amino	O
acids	O
)	O
or	O
its	O
inactive	O
form	O
(	O
Cys2408	O
-->	O
Ser	O
)	O
fused	O
to	O
glutathione	B
-	I
S	I
-	I
transferase	I
(	O
GST	B
).	O

Acoust	O
.	O

Young	O
fish	O
(	O
Oreochromis	O
mossambicus	O
)	O
were	O
exposed	O
to	O
microgravity	O
(	O
micro	O
g	O
)	O
for	O
9	O
to	O
10	O
days	O
during	O
space	O
missions	O
STS	O
-	O
55	O
and	O
STS	O
-	O
84	O
,	O
or	O
to	O
hypergravity	O
(	O
hg	O
)	O
for	O
9	O
days	O
.	O

Pretreatment	O
of	O
cells	O
with	O
the	O
mitogen	B
-	I
activated	I
protein	I
-	I
extracellular	I
signal	I
-	I
regulated	I
kinase	I
kinase	I
(	O
MEK	B
)	O
inhibitor	O
U0126	O
inhibited	O
S6K2	B
activation	O
to	O
a	O
greater	O
extent	O
than	O
S6K1	B
.	O

T	O
cells	O
express	O
two	O
isoforms	O
of	O
S6k1	B
:	O
a	O
70	O
kDa	O
cytoplasmic	B
kinase	I
and	O
an	O
85	O
kDa	O
isoform	O
that	O
has	O
a	O
classic	O
nuclear	O
localisation	O
.	O

These	O
results	O
also	O
suggest	O
the	O
involvement	O
of	O
additional	O
elements	O
in	O
the	O
UPR	O
.	O

Four	O
cases	O
of	O
synovial	O
chondromatosis	O
are	O
presented	O
.	O

These	O
cells	O
produced	O
P2Y	B
(	I
11	I
)	I
mRNA	I
during	O
culture	O
.	O

Among	O
eight	O
graminaceous	O
species	O
tested	O
,	O
Ids3	B
expression	O
was	O
observed	O
only	O
in	O
Fe	O
-	O
deficient	O
roots	O
of	O
H	O
.	O
vulgare	O
and	O
Secale	O
cereale	O
.	O
which	O
not	O
only	O
secrete	O
2	O
'-	O
deoxymugineic	O
acid	O
(	O
DMA	O
),	O
but	O
also	O
mugineic	O
acid	O
(	O
MA	O
)	O
and	O
3	O
-	O
epihydroxymugineic	O
acid	O
(	O
epiHMA	O
,	O
H	O
.	O
vulgare	O
),	O
and	O
3	O
-	O
hydroxymugineic	O
acid	O
(	O
HMA	O
,	O
S	O
.	O
cereale	O
).	O

In	O
contrast	O
,	O
high	O
COUP	B
-	I
TFI	I
expression	O
impeded	O
the	O
neuronal	O
differentiation	O
of	O
P19	O
cells	O
induced	O
with	O
RA	O
,	O
resulting	O
in	O
cell	O
cultures	O
lacking	O
neurons	O
.	O

Therefore	O
,	O
in	O
our	O
in	O
vitro	O
model	O
,	O
the	O
localization	O
of	O
the	O
mutation	O
in	O
the	O
K	B
-	I
ras	I
gene	I
predisposes	O
to	O
a	O
different	O
level	O
of	O
aggressiveness	O
in	O
the	O
transforming	O
phenotype	O
.	O

Tec	B
kinase	I
signaling	O
in	O
T	O
cells	O
is	O
regulated	O
by	O
phosphatidylinositol	B
3	I
-	I
kinase	I
and	O
the	O
Tec	B
pleckstrin	I
homology	I
domain	I
.	O

RESULTS	O
:	O
Prevalence	O
of	O
obesity	O
(	O
BMI	O
SDS	O
>	O
2	O
.	O
0	O
)	O
was	O
<	O
2	O
%	O
at	O
diagnosis	O
,	O
but	O
increased	O
to	O
16	O
%	O
at	O
3y	O
.	O

In	O
a	O
prospective	O
,	O
multicentre	O
trial	O
the	O
efficacy	O
of	O
an	O
Vitex	O
agnus	O
castus	O
L	O
extract	O
Ze	O
440	O
was	O
investigated	O
in	O
50	O
patients	O
with	O
pre	O
-	O
menstrual	O
syndrome	O
(	O
PMS	O
).	O

Depending	O
on	O
treatment	O
exposures	O
,	O
this	O
at	O
-	O
risk	O
population	O
may	O
experience	O
life	O
-	O
threatening	O
late	O
effects	O
,	O
such	O
as	O
cirrhosis	O
secondary	O
to	O
hepatitis	O
C	O
or	O
late	O
-	O
onset	O
anthracycline	O
-	O
induced	O
cardiomyopathy	O
,	O
or	O
life	O
-	O
changing	O
late	O
effects	O
,	O
such	O
as	O
cognitive	O
dysfunction	O
.	O

We	O
produced	O
transgenic	O
plants	O
expressing	O
the	O
antisense	O
Arabidopsis	O
HD	O
(	O
AtHD1	B
)	I
gene	I
.	O

We	O
used	O
the	O
Toshiba	O
IIDR	O
system	O
,	O
which	O
is	O
composed	O
of	O
an	O
X	O
-	O
ray	O
TV	O
system	O
and	O
a	O
digital	O
image	O
managing	O
circuit	O
.	O

[	O
18F	O
](+)-	O
4	O
-	O
fluorobenzyltrozamicol	O
(	O
FBT	O
),	O
which	O
selectively	O
binds	O
to	O
the	O
vesicular	O
acetylcholine	B
transporter	I
in	O
the	O
presynaptic	O
cholinergic	O
neuron	O
,	O
has	O
previously	O
been	O
shown	O
to	O
be	O
a	O
useful	O
ligand	O
for	O
the	O
study	O
of	O
cholinergic	O
terminal	O
density	O
in	O
the	O
basal	O
ganglia	O
with	O
PET	O
.	O

Promoter	O
analysis	O
demonstrated	O
that	O
the	O
sequence	O
identical	O
to	O
consensus	O
cAMP	B
-	I
responsive	I
element	I
(	O
CRE	O
)	O
located	O
at	O
-	O
481	O
of	O
the	O
SMemb	B
promoter	I
was	O
critical	O
for	O
Hex	B
responsiveness	O
.	O

We	O
compare	O
the	O
results	O
of	O
this	O
algorithm	O
with	O
the	O
results	O
obtained	O
with	O
two	O
other	O
algorithms	O
,	O
the	O
optimal	O
algorithm	O
for	O
monochannel	O
nonoverlapping	O
noise	O
and	O
the	O
optimal	O
algorithm	O
for	O
multichannel	O
additive	O
noise	O
,	O
and	O
we	O
show	O
that	O
in	O
both	O
cases	O
improvement	O
can	O
be	O
obtained	O
.	O

The	O
P69	O
cell	O
line	O
was	O
derived	O
by	O
immortalization	O
of	O
human	O
primary	O
prostate	O
epithelial	O
cells	O
with	O
simian	B
virus	I
-	I
40	I
T	I
antigen	I
and	O
is	O
rarely	O
tumorigenic	O
.	O

Because	O
the	O
high	B
-	I
density	I
lipoprotein	I
receptor	I
(	O
HDL	B
-	I
R	I
)	O
is	O
a	O
key	O
element	O
in	O
cholesterol	O
homeostasis	O
and	O
a	O
potential	O
therapeutic	O
target	O
for	O
hypercholesterolemic	O
drugs	O
,	O
an	O
understanding	O
of	O
HDL	B
-	I
R	I
regulation	O
is	O
essential	O
.	O

IFN	B
-	I
stimulated	I
gene	I
factor	I
-	I
3	I
and	O
STAT1	B
homodimers	I
formed	O
and	O
bound	O
an	O
IFN	B
-	I
stimulated	I
response	I
element	I
(	O
ISRE	B
)	I
and	I
gamma	I
-	I
activated	I
sequence	I
(	O
GAS	B
)	I
element	I
,	O
respectively	O
.	O

